,Sentence,ESG BERT Topic 1,ESG BERT Topic 2,ESG BERT Topic 3,Mapped Criteria Topic 1,Mapped Criteria Topic 2,Mapped Criteria Topic 3
Line 1,"FY 2021    Environmental, Social  and Governance Report Together We AdvanceAppendices  Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Table of contents 3 T o our stakeholders  ESG highlights  About this r eport  About BD  About our business   Stakeholder  engagement  ESG assessment  ESG str ategy  ESG go vernance  Alignment with  UN SDGs85  A wards and recognitions   Appendices 87 En vironmental, social and  governance (ESG) issues  UN Sust ainable Development  Goals (SDGs)  Dat a tables  GRI inde x  S ASB index  T CFD disclosures  P olicies, guidelines and  statements center  A cronyms and glossary75 Transparency 76 BD c ommitment and goals  ESG r eporting governance  C orporate governance  P articipation in the  policymaking process  Ent erprise risk management  Ethics and c ompliance  Ethics in sales and mark eting  Human rights  C ybersecurity program51 Health y workforce  and communities 52 BD c ommitment and goals Human c apital management  Human c apital development  Inclusion, div ersity  and equity  C ompensation, benefits and  well-being  Good J obs Strategy  Health and saf ety  Health y communities  A dvancing healthcare access  and equity  Antimicr obial resistance  (AMR) 43 R esponsible supply  chain 44 BD c ommitment and goals R esponsible sourcing  Global supply chain33 P roduct impact 34 BD c ommitment and goals BD Sust ainable Medical  Technology Institute  (BD SMTI)  Management of mat erials  of concern  Pr oduct takeback  Pr oduct safety  Labor atory animal welfare  Medic al affairs  Global clinic al affairs23 Climate change 24 BD c ommitment and goals  Climat e change  management   Energy  W ater management  W aste management  Air emissions  En vironmental data  governance and collection  En vironmental justice  En vironment, health and  safety management2021 ESG Report2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction While the pandemic challenged the way every business operates, at BD, it pushed  us to evolve to be more agile and efficient, using our scale and speed to create more innovative solutions faster than ever before.
","('Supply_Chain_Management', 0.36621567606925964)","('Physical_Impacts_Of_Climate_Change', 0.22008803486824036)","('Business_Model_Resilience', 0.11872199177742004)","('NON-ESG', 0.36621567606925964)","('NON-ESG', 0.22008803486824036)","('NON-ESG', 0.11872199177742004)"
Line 2,"FY 2021    Environmental, Social  and Governance Report Together We AdvanceAppendices  Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Table of contents 3 T o our stakeholders  ESG highlights  About this r eport  About BD  About our business   Stakeholder  engagement  ESG assessment  ESG str ategy  ESG go vernance  Alignment with  UN SDGs85  A wards and recognitions   Appendices 87 En vironmental, social and  governance (ESG) issues  UN Sust ainable Development  Goals (SDGs)  Dat a tables  GRI inde x  S ASB index  T CFD disclosures  P olicies, guidelines and  statements center  A cronyms and glossary75 Transparency 76 BD c ommitment and goals  ESG r eporting governance  C orporate governance  P articipation in the  policymaking process  Ent erprise risk management  Ethics and c ompliance  Ethics in sales and mark eting  Human rights  C ybersecurity program51 Health y workforce  and communities 52 BD c ommitment and goals Human c apital management  Human c apital development  Inclusion, div ersity  and equity  C ompensation, benefits and  well-being  Good J obs Strategy  Health and saf ety  Health y communities  A dvancing healthcare access  and equity  Antimicr obial resistance  (AMR) 43 R esponsible supply  chain 44 BD c ommitment and goals R esponsible sourcing  Global supply chain33 P roduct impact 34 BD c ommitment and goals BD Sust ainable Medical  Technology Institute  (BD SMTI)  Management of mat erials  of concern  Pr oduct takeback  Pr oduct safety  Labor atory animal welfare  Medic al affairs  Global clinic al affairs23 Climate change 24 BD c ommitment and goals  Climat e change  management   Energy  W ater management  W aste management  Air emissions  En vironmental data  governance and collection  En vironmental justice  En vironment, health and  safety management2021 ESG Report2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction While the pandemic challenged the way every business operates, at BD, it pushed  us to evolve to be more agile and efficient, using our scale and speed to create more innovative solutions faster than ever before.
","('Business_Ethics', 0.9714909791946411)","('Management_Of_Legal_And_Regulatory_Framework', 0.002387196524068713)","('Competitive_Behavior', 0.002349890535697341)","(['Business Ethics'], 0.9714909791946411)","('NON-ESG', 0.002387196524068713)","('NON-ESG', 0.002349890535697341)"
Line 3,"FY 2021    Environmental, Social  and Governance Report Together We AdvanceAppendices  Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Table of contents 3 T o our stakeholders  ESG highlights  About this r eport  About BD  About our business   Stakeholder  engagement  ESG assessment  ESG str ategy  ESG go vernance  Alignment with  UN SDGs85  A wards and recognitions   Appendices 87 En vironmental, social and  governance (ESG) issues  UN Sust ainable Development  Goals (SDGs)  Dat a tables  GRI inde x  S ASB index  T CFD disclosures  P olicies, guidelines and  statements center  A cronyms and glossary75 Transparency 76 BD c ommitment and goals  ESG r eporting governance  C orporate governance  P articipation in the  policymaking process  Ent erprise risk management  Ethics and c ompliance  Ethics in sales and mark eting  Human rights  C ybersecurity program51 Health y workforce  and communities 52 BD c ommitment and goals Human c apital management  Human c apital development  Inclusion, div ersity  and equity  C ompensation, benefits and  well-being  Good J obs Strategy  Health and saf ety  Health y communities  A dvancing healthcare access  and equity  Antimicr obial resistance  (AMR) 43 R esponsible supply  chain 44 BD c ommitment and goals R esponsible sourcing  Global supply chain33 P roduct impact 34 BD c ommitment and goals BD Sust ainable Medical  Technology Institute  (BD SMTI)  Management of mat erials  of concern  Pr oduct takeback  Pr oduct safety  Labor atory animal welfare  Medic al affairs  Global clinic al affairs23 Climate change 24 BD c ommitment and goals  Climat e change  management   Energy  W ater management  W aste management  Air emissions  En vironmental data  governance and collection  En vironmental justice  En vironment, health and  safety management2021 ESG Report2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction While the pandemic challenged the way every business operates, at BD, it pushed  us to evolve to be more agile and efficient, using our scale and speed to create more innovative solutions faster than ever before.
","('Supply_Chain_Management', 0.9450423717498779)","('Systemic_Risk_Management', 0.006223512347787619)","('Product_Design_And_Lifecycle_Management', 0.004532140213996172)","(['Supply Chain Management'], 0.9450423717498779)","('NON-ESG', 0.006223512347787619)","('NON-ESG', 0.004532140213996172)"
Line 4,"FY 2021    Environmental, Social  and Governance Report Together We AdvanceAppendices  Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Table of contents 3 T o our stakeholders  ESG highlights  About this r eport  About BD  About our business   Stakeholder  engagement  ESG assessment  ESG str ategy  ESG go vernance  Alignment with  UN SDGs85  A wards and recognitions   Appendices 87 En vironmental, social and  governance (ESG) issues  UN Sust ainable Development  Goals (SDGs)  Dat a tables  GRI inde x  S ASB index  T CFD disclosures  P olicies, guidelines and  statements center  A cronyms and glossary75 Transparency 76 BD c ommitment and goals  ESG r eporting governance  C orporate governance  P articipation in the  policymaking process  Ent erprise risk management  Ethics and c ompliance  Ethics in sales and mark eting  Human rights  C ybersecurity program51 Health y workforce  and communities 52 BD c ommitment and goals Human c apital management  Human c apital development  Inclusion, div ersity  and equity  C ompensation, benefits and  well-being  Good J obs Strategy  Health and saf ety  Health y communities  A dvancing healthcare access  and equity  Antimicr obial resistance  (AMR) 43 R esponsible supply  chain 44 BD c ommitment and goals R esponsible sourcing  Global supply chain33 P roduct impact 34 BD c ommitment and goals BD Sust ainable Medical  Technology Institute  (BD SMTI)  Management of mat erials  of concern  Pr oduct takeback  Pr oduct safety  Labor atory animal welfare  Medic al affairs  Global clinic al affairs23 Climate change 24 BD c ommitment and goals  Climat e change  management   Energy  W ater management  W aste management  Air emissions  En vironmental data  governance and collection  En vironmental justice  En vironment, health and  safety management2021 ESG Report2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction While the pandemic challenged the way every business operates, at BD, it pushed  us to evolve to be more agile and efficient, using our scale and speed to create more innovative solutions faster than ever before.
","('Air_Quality', 0.5809741616249084)","('Product_Quality_And_Safety', 0.09248737245798111)","('Employee_Health_And_Safety', 0.07365402579307556)","(['Operational Eco-Efficiency'], 0.5809741616249084)","('NON-ESG', 0.09248737245798111)","('NON-ESG', 0.07365402579307556)"
Line 5,"FY 2021    Environmental, Social  and Governance Report Together We AdvanceAppendices  Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Table of contents 3 T o our stakeholders  ESG highlights  About this r eport  About BD  About our business   Stakeholder  engagement  ESG assessment  ESG str ategy  ESG go vernance  Alignment with  UN SDGs85  A wards and recognitions   Appendices 87 En vironmental, social and  governance (ESG) issues  UN Sust ainable Development  Goals (SDGs)  Dat a tables  GRI inde x  S ASB index  T CFD disclosures  P olicies, guidelines and  statements center  A cronyms and glossary75 Transparency 76 BD c ommitment and goals  ESG r eporting governance  C orporate governance  P articipation in the  policymaking process  Ent erprise risk management  Ethics and c ompliance  Ethics in sales and mark eting  Human rights  C ybersecurity program51 Health y workforce  and communities 52 BD c ommitment and goals Human c apital management  Human c apital development  Inclusion, div ersity  and equity  C ompensation, benefits and  well-being  Good J obs Strategy  Health and saf ety  Health y communities  A dvancing healthcare access  and equity  Antimicr obial resistance  (AMR) 43 R esponsible supply  chain 44 BD c ommitment and goals R esponsible sourcing  Global supply chain33 P roduct impact 34 BD c ommitment and goals BD Sust ainable Medical  Technology Institute  (BD SMTI)  Management of mat erials  of concern  Pr oduct takeback  Pr oduct safety  Labor atory animal welfare  Medic al affairs  Global clinic al affairs23 Climate change 24 BD c ommitment and goals  Climat e change  management   Energy  W ater management  W aste management  Air emissions  En vironmental data  governance and collection  En vironmental justice  En vironment, health and  safety management2021 ESG Report2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction While the pandemic challenged the way every business operates, at BD, it pushed  us to evolve to be more agile and efficient, using our scale and speed to create more innovative solutions faster than ever before.
","('Business_Model_Resilience', 0.508194088935852)","('Product_Design_And_Lifecycle_Management', 0.11285145580768585)","('Systemic_Risk_Management', 0.07625552266836166)","(['Codes of Business Conduct'], 0.508194088935852)","('NON-ESG', 0.11285145580768585)","('NON-ESG', 0.07625552266836166)"
Line 6,"And now, we’re strengthening those muscles so we remain agile in the future and continue to deliver on our ambitious plans to accelerate the future of healthcare for decades to come.
","('Business_Model_Resilience', 0.4056605398654938)","('Access_And_Affordability', 0.09118224680423737)","('Systemic_Risk_Management', 0.07278172671794891)","('NON-ESG', 0.4056605398654938)","('NON-ESG', 0.09118224680423737)","('NON-ESG', 0.07278172671794891)"
Line 7,"As we look ahead, we’re using that same mindset as we take action to address the  most relevant environmental, social and governance (ESG) issues.
","('Human_Rights_And_Community_Relations', 0.7602099180221558)","('Business_Model_Resilience', 0.03821565955877304)","('Management_Of_Legal_And_Regulatory_Framework', 0.03771490231156349)","(['Community Relations'], 0.7602099180221558)","('NON-ESG', 0.03821565955877304)","('NON-ESG', 0.03771490231156349)"
Line 8,"We’ve made commitments that build on our Purpose of advancing the world of health TM and  focus on enhancing the stewardship of our company, planet, community and human health.
","('Human_Rights_And_Community_Relations', 0.8967228531837463)","('Access_And_Affordability', 0.018198346719145775)","('Ecological_Impacts', 0.012571518309414387)","(['Community Relations'], 0.8967228531837463)","('NON-ESG', 0.018198346719145775)","('NON-ESG', 0.012571518309414387)"
Line 9,"True to our culture, we’re delivering on these commitments today.
","('Human_Rights_And_Community_Relations', 0.48738527297973633)","('Business_Model_Resilience', 0.16826088726520538)","('Employee_Engagement_Inclusion_And_Diversity', 0.054875411093235016)","('NON-ESG', 0.48738527297973633)","('NON-ESG', 0.16826088726520538)","('NON-ESG', 0.054875411093235016)"
Line 10,"Together we advance We have strong momentum behind our BD 2025 strategy, which focuses on three pillars: GROW  through category innovations that improve customer outcomes  and reinvent the future of healthcare globally; SIMPLIFY the company and how we do business; and EMPOWER our people.
","('Business_Model_Resilience', 0.4736279249191284)","('Product_Design_And_Lifecycle_Management', 0.20627446472644806)","('Customer_Welfare', 0.056272365152835846)","('NON-ESG', 0.4736279249191284)","('NON-ESG', 0.20627446472644806)","('NON-ESG', 0.056272365152835846)"
Line 11,"Centered around our durable core and transformative solutions, our portfolio delivers reliable products and solutions that serve as the backbone of healthcare, and new innovations that are advancing three irreversible forces changing the future of healthcare: smart connected care, the shift to alternative care settings and improving chronic disease outcomes.
","('Product_Design_And_Lifecycle_Management', 0.7119209170341492)","('Customer_Welfare', 0.04679140821099281)","('Access_And_Affordability', 0.038605548441410065)","(['Product Stewardship'], 0.7119209170341492)","('NON-ESG', 0.04679140821099281)","('NON-ESG', 0.038605548441410065)"
Line 12,"Integral to our success is our deep commitment to improving individual and public  health at a global scale.
","('Access_And_Affordability', 0.4982103705406189)","('Employee_Health_And_Safety', 0.1430758237838745)","('Human_Rights_And_Community_Relations', 0.0752781480550766)","('NON-ESG', 0.4982103705406189)","('NON-ESG', 0.1430758237838745)","('NON-ESG', 0.0752781480550766)"
Line 13,"In early FY22, we launched our 2030+ ESG strategy, Together We Advance, which serves as a framework to address some of the most relevant ESG issues for our business and our stakeholders.
","('Business_Model_Resilience', 0.6821976900100708)","('Systemic_Risk_Management', 0.09518665075302124)","('Physical_Impacts_Of_Climate_Change', 0.03422059863805771)","(['Codes of Business Conduct'], 0.6821976900100708)","('NON-ESG', 0.09518665075302124)","('NON-ESG', 0.03422059863805771)"
Line 14,"To our stakeholders We’ve made commitments in five areas where we see the most opportunity to create meaningful change over the next decade: climate change, product impact, a responsible supply chain, a healthy workforce and community, and transparency.
","('Physical_Impacts_Of_Climate_Change', 0.7006665468215942)","('Supply_Chain_Management', 0.17178113758563995)","('Business_Model_Resilience', 0.0215840432792902)","(['Climate Change'], 0.7006665468215942)","('NON-ESG', 0.17178113758563995)","('NON-ESG', 0.0215840432792902)"
Line 15,"Our report details each area, our accomplishments and the steps we are taking on this journey.
","('Business_Model_Resilience', 0.23918652534484863)","('Human_Rights_And_Community_Relations', 0.23395654559135437)","('Employee_Engagement_Inclusion_And_Diversity', 0.07969281077384949)","('NON-ESG', 0.23918652534484863)","('NON-ESG', 0.23395654559135437)","('NON-ESG', 0.07969281077384949)"
Line 16,"Our performance Environment We recognize the impact of climate change on human health around the world, and as a healthcare company, we’re committed to reducing our own impact.
","('Physical_Impacts_Of_Climate_Change', 0.9468133449554443)","('Critical_Incident_Risk_Management', 0.006963728927075863)","('Business_Model_Resilience', 0.006673859432339668)","(['Climate Change'], 0.9468133449554443)","('NON-ESG', 0.006963728927075863)","('NON-ESG', 0.006673859432339668)"
Line 17,"As a result, we committed to the UN Race to Zero and the Science Based Targets initiative (SBTi) in September.
","('Management_Of_Legal_And_Regulatory_Framework', 0.20655204355716705)","('Human_Rights_And_Community_Relations', 0.15268775820732117)","('Competitive_Behavior', 0.1518143117427826)","('NON-ESG', 0.20655204355716705)","('NON-ESG', 0.15268775820732117)","('NON-ESG', 0.1518143117427826)"
Line 18,"We’ve made progress aligned with our established targets to reduce our Scope 1  and 2 greenhouse gas (GHG) emissions, and we continue to work on setting science-based targets for Scope 3.
","('GHG_Emissions', 0.9691433310508728)","('Ecological_Impacts', 0.004328710492700338)","('Management_Of_Legal_And_Regulatory_Framework', 0.0025818629655987024)","(['Climate Change'], 0.9691433310508728)","('NON-ESG', 0.004328710492700338)","('NON-ESG', 0.0025818629655987024)"
Line 19,"By minimizing energy demand, we’ve achieved a 14 percent reduction and continued to increase our investment in on-site renewable energy.
","('Energy_Management', 0.980540931224823)","('Management_Of_Legal_And_Regulatory_Framework', 0.0022996345069259405)","('Critical_Incident_Risk_Management', 0.001542302081361413)","(['Operational Eco-Efficiency'], 0.980540931224823)","('NON-ESG', 0.0022996345069259405)","('NON-ESG', 0.001542302081361413)"
Line 20,"Currently, 13 BD locations obtain 100 percent of their electric power from renewable sources.
","('Energy_Management', 0.9746906757354736)","('Management_Of_Legal_And_Regulatory_Framework', 0.002877058694139123)","('Water_And_Wastewater_Management', 0.002332002855837345)","(['Operational Eco-Efficiency'], 0.9746906757354736)","('NON-ESG', 0.002877058694139123)","('NON-ESG', 0.002332002855837345)"
Line 21,"Product impact Our newly formed BD Sustainable Medical Technology Institute will guide us in reducing the environmental impact of our portfolio, setting sustainable design standards for our products and identifying more sustainable sterilization technologies.
","('Product_Design_And_Lifecycle_Management', 0.9646531343460083)","('Product_Quality_And_Safety', 0.005336305126547813)","('Selling_Practices_And_Product_Labeling', 0.0024588133674114943)","(['Product Stewardship'], 0.9646531343460083)","('NON-ESG', 0.005336305126547813)","('NON-ESG', 0.0024588133674114943)"
Line 22,"We also established the BD Product Impact Council to support and track progress toward achieving our 2030+ product impact goals.Throughout our 125-year history as one of the largest global medical technology companies, we’ve used our capabilities, expertise  and scale to address critical healthcare needs for people around the world.
","('Product_Design_And_Lifecycle_Management', 0.9027528762817383)","('Customer_Welfare', 0.01762307435274124)","('Product_Quality_And_Safety', 0.015848761424422264)","(['Product Stewardship'], 0.9027528762817383)","('NON-ESG', 0.01762307435274124)","('NON-ESG', 0.015848761424422264)"
Line 23,"Time and time again, BD has stepped up to make a difference by innovating faster to deliver critical products and solutions that save lives.
","('Product_Design_And_Lifecycle_Management', 0.9422019720077515)","('Business_Model_Resilience', 0.0072638774290680885)","('Supply_Chain_Management', 0.006166121922433376)","(['Product Stewardship'], 0.9422019720077515)","('NON-ESG', 0.0072638774290680885)","('NON-ESG', 0.006166121922433376)"
Line 24,"We’ve done this to help patients no matter where they are in their healthcare journey—getting routine checks or battling chronic illness—and we’ve done this on a large, global scale to combat some of the world’s biggest health crises like polio, HIV and more recently COVID-19.
","('Employee_Health_And_Safety', 0.6211873292922974)","('Access_And_Affordability', 0.07911071926355362)","('Critical_Incident_Risk_Management', 0.078925721347332)","(['Operational Eco-Efficiency'], 0.6211873292922974)","('NON-ESG', 0.07911071926355362)","('NON-ESG', 0.078925721347332)"
Line 25,"Chairman,  CEO and PresidentTom Polen2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction Supplier diversity  While facing significant disruptions to global supply chains, our associates stayed  true to our ESG commitments by spending over $1.5 billion with 2,766 diverse-owned and small-business suppliers in the U.S. In FY21, we initiated a third-party desktop audit program to assess the ESG performance of our suppliers, completing 160 supplier audits, representing 15 percent of our overall spend.
","('Supply_Chain_Management', 0.9519052505493164)","('Labor_Practices', 0.004537183791399002)","('Systemic_Risk_Management', 0.004106655716896057)","(['Supply Chain Management'], 0.9519052505493164)","('NON-ESG', 0.004537183791399002)","('NON-ESG', 0.004106655716896057)"
Line 26,"Chairman,  CEO and PresidentTom Polen2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction Supplier diversity  While facing significant disruptions to global supply chains, our associates stayed  true to our ESG commitments by spending over $1.5 billion with 2,766 diverse-owned and small-business suppliers in the U.S. In FY21, we initiated a third-party desktop audit program to assess the ESG performance of our suppliers, completing 160 supplier audits, representing 15 percent of our overall spend.
","('Supply_Chain_Management', 0.94495689868927)","('Labor_Practices', 0.004903388675302267)","('Product_Design_And_Lifecycle_Management', 0.0043655876070261)","(['Supply Chain Management'], 0.94495689868927)","('NON-ESG', 0.004903388675302267)","('NON-ESG', 0.0043655876070261)"
Line 27,"Talent We must continue to attract, retain and develop the best talent, who are passionate about bringing our Purpose to life and helping us deliver on our commitments.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7950242757797241)","('Human_Rights_And_Community_Relations', 0.023442672565579414)","('Business_Ethics', 0.017371224239468575)","(['Human Capital Development'], 0.7950242757797241)","('NON-ESG', 0.023442672565579414)","('NON-ESG', 0.017371224239468575)"
Line 28,"BD is known for our inclusive culture, which is underscored by our commitment to well-being and to empowering our associates to unleash their fullest potential.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8417581915855408)","('Human_Rights_And_Community_Relations', 0.050393808633089066)","('Access_And_Affordability', 0.015232534147799015)","(['Human Capital Development'], 0.8417581915855408)","('NON-ESG', 0.050393808633089066)","('NON-ESG', 0.015232534147799015)"
Line 29,"Externally, we’re pleased to have been recognized in this area and named to Forbes’  Best Employers for Diversity, and America’s Best Large Employers List; Bloomberg’s Gender-Equality Index; The Human Rights Campaign Foundation’s Best Places to Work for LGBTQ+ Equality; the Corporate Equality Index; and the Disability Equality Index ® Best Places to Work for Disability Inclusion.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9632965326309204)","('Employee_Health_And_Safety', 0.006072173826396465)","('Human_Rights_And_Community_Relations', 0.003869788721203804)","(['Human Capital Development'], 0.9632965326309204)","('NON-ESG', 0.006072173826396465)","('NON-ESG', 0.003869788721203804)"
Line 30,"I am also proud to have signed  the Disability:IN CEO letter and joined a coalition of leaders seeking to raise awareness of the importance of disability inclusion and the benefits of an inclusive workforce where everyone is empowered.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9642304182052612)","('Employee_Health_And_Safety', 0.007327447645366192)","('Human_Rights_And_Community_Relations', 0.0023436015471816063)","(['Human Capital Development'], 0.9642304182052612)","('NON-ESG', 0.007327447645366192)","('NON-ESG', 0.0023436015471816063)"
Line 31,"Social investing We play an important role in expanding access to health by collaborating with partners around the world.
","('Access_And_Affordability', 0.886237621307373)","('Employee_Health_And_Safety', 0.015186026692390442)","('Human_Rights_And_Community_Relations', 0.014262163080275059)","(['Health Outcome Contribution'], 0.886237621307373)","('NON-ESG', 0.015186026692390442)","('NON-ESG', 0.014262163080275059)"
Line 32,"We have made $30 million in philanthropic investments in free and charitable clinics and community health centers in the U.S. since 2008.
","('Access_And_Affordability', 0.8327687382698059)","('Human_Rights_And_Community_Relations', 0.031628403812646866)","('Management_Of_Legal_And_Regulatory_Framework', 0.021424198523163795)","(['Health Outcome Contribution'], 0.8327687382698059)","('NON-ESG', 0.031628403812646866)","('NON-ESG', 0.021424198523163795)"
Line 33,"In India and Indonesia, we continued our partnership with the U.S. Agency for International Development (USAID) on Strengthening TB Resistance Testing and Diagnostic Systems (STRIDES).
","('Product_Quality_And_Safety', 0.14168114960193634)","('Employee_Health_And_Safety', 0.1402701735496521)","('Critical_Incident_Risk_Management', 0.1060660108923912)","('NON-ESG', 0.14168114960193634)","('NON-ESG', 0.1402701735496521)","('NON-ESG', 0.1060660108923912)"
Line 34,"This partnership works in close collaboration with the ministries of health to improve access to, and increase capacity for, liquid culture and drug-susceptibility testing in these regions.In the continued fight against COVID-19, BD and the BD Foundation have issued nearly $2.8 million in philanthropic grants and product donations to nonprofit partners that are working to protect the most vulnerable communities and individuals from the pandemic’s spread and negative impacts.
","('Access_And_Affordability', 0.46429577469825745)","('Human_Rights_And_Community_Relations', 0.1060226783156395)","('Critical_Incident_Risk_Management', 0.09078323096036911)","('NON-ESG', 0.46429577469825745)","('NON-ESG', 0.1060226783156395)","('NON-ESG', 0.09078323096036911)"
Line 35,"In addition, BD associates around the world have volunteered their time and capabilities to assist communities hard-hit by COVID-19.
","('Human_Rights_And_Community_Relations', 0.8256959319114685)","('Access_And_Affordability', 0.04281619191169739)","('Critical_Incident_Risk_Management', 0.020163871347904205)","(['Community Relations'], 0.8256959319114685)","('NON-ESG', 0.04281619191169739)","('NON-ESG', 0.020163871347904205)"
Line 36,"Committed to accountability Doing what is right is a core principle of our culture at BD, and we will continue to hold ourselves to the highest levels of transparency and governance as we continue on this journey.
","('Business_Ethics', 0.9651650786399841)","('Management_Of_Legal_And_Regulatory_Framework', 0.00486699678003788)","('Systemic_Risk_Management', 0.002894519129768014)","(['Business Ethics'], 0.9651650786399841)","('NON-ESG', 0.00486699678003788)","('NON-ESG', 0.002894519129768014)"
Line 37,"We’ll do this through regular reporting such as this ESG report, our Cybersecurity Annual Report and our Global Inclusion, Diversity and Equity Report, “Together We Advance ID&E.” Our transparency has garnered us external recognition from, among others, Newsweek’s America’s Most Trustworthy Companies and America’s Most Responsible Companies lists; the Drucker Institute’s Wall Street Journal Management Top 250 list, cited in the top 10 for our results in helping to achieve the United Nation’s Sustainable Development Goals; and JUST Capital’s America’s Most JUST Companies list.
","('Business_Ethics', 0.6557545065879822)","('Employee_Engagement_Inclusion_And_Diversity', 0.14016500115394592)","('Systemic_Risk_Management', 0.030982811003923416)","(['Business Ethics'], 0.6557545065879822)","('NON-ESG', 0.14016500115394592)","('NON-ESG', 0.030982811003923416)"
Line 38,"We’ll do this through regular reporting such as this ESG report, our Cybersecurity Annual Report and our Global Inclusion, Diversity and Equity Report, “Together We Advance ID&E.” Our transparency has garnered us external recognition from, among others, Newsweek’s America’s Most Trustworthy Companies and America’s Most Responsible Companies lists; the Drucker Institute’s Wall Street Journal Management Top 250 list, cited in the top 10 for our results in helping to achieve the United Nation’s Sustainable Development Goals; and JUST Capital’s America’s Most JUST Companies list.
","('Systemic_Risk_Management', 0.4621283710002899)","('Business_Model_Resilience', 0.30091938376426697)","('Competitive_Behavior', 0.0641273632645607)","('NON-ESG', 0.4621283710002899)","('NON-ESG', 0.30091938376426697)","('NON-ESG', 0.0641273632645607)"
Line 39,"While there is more work to be done, I’m very proud of our achievements and of  the more than 75,000 BD associates whose passion and dedication are helping us build a healthier, more resilient world for all.
","('Business_Model_Resilience', 0.824366569519043)","('Physical_Impacts_Of_Climate_Change', 0.02222338691353798)","('Human_Rights_And_Community_Relations', 0.0202040895819664)","(['Codes of Business Conduct'], 0.824366569519043)","('NON-ESG', 0.02222338691353798)","('NON-ESG', 0.0202040895819664)"
Line 40,"Thank you for your unwavering support of our vision.
","('Human_Rights_And_Community_Relations', 0.26250535249710083)","('Business_Model_Resilience', 0.10481896996498108)","('Management_Of_Legal_And_Regulatory_Framework', 0.07054256647825241)","('NON-ESG', 0.26250535249710083)","('NON-ESG', 0.10481896996498108)","('NON-ESG', 0.07054256647825241)"
Line 41,"Tom Polen Chairman, CEO and PresidentThe best way to help customers and patients is to truly  know them.
","('Access_And_Affordability', 0.2970060706138611)","('Employee_Engagement_Inclusion_And_Diversity', 0.09015382826328278)","('Customer_Welfare', 0.07368037104606628)","('NON-ESG', 0.2970060706138611)","('NON-ESG', 0.09015382826328278)","('NON-ESG', 0.07368037104606628)"
Line 42,"That means understanding our customers’ goals  and how we can help achieve them together.
","('Business_Model_Resilience', 0.5050479173660278)","('Product_Design_And_Lifecycle_Management', 0.07653374969959259)","('Human_Rights_And_Community_Relations', 0.06454266607761383)","(['Codes of Business Conduct'], 0.5050479173660278)","('NON-ESG', 0.07653374969959259)","('NON-ESG', 0.06454266607761383)"
Line 43,"Challenges  are opportunities  to grow and improve.
","('Business_Model_Resilience', 0.16666708886623383)","('Human_Rights_And_Community_Relations', 0.13649465143680573)","('Employee_Engagement_Inclusion_And_Diversity', 0.12131503969430923)","('NON-ESG', 0.16666708886623383)","('NON-ESG', 0.13649465143680573)","('NON-ESG', 0.12131503969430923)"
Line 44,"Strong teams,  inclusive collaboration and diversity of ideas   will be essential to successfully achieving our ESG goals.Keeping our goals simple  and aligned with stakeholder needs  and expectations will enable innovation and agility.Speaking up builds trust and leads to better outcomes faster,  for us and our stakeholders.2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction ClimateProduct   impactResponsible   supply   chainHealthy workforce   and communitiesTransparency   Joined R ace to Zero in  September   Implemented 142 efficiency   projects in FY 2021, expected  to generate $5.1 million in energy savings   In FY 2021, reduced energy  consumption by 14 percent, with 13 locations using 100 percent renewable electricity   R educed water consumption  by 23 percent   Diverted 79 per cent of  nonhazardous waste from landfill  Spent $1,399 million  on  R&D in FY   Announced cr eation of the  Scientific Advisory Board in FY 2021 and launched Sustainable Medical Technology Institute in FY   P rofiled in Science  magazine, demonstrating landmark advancement in flow Cytometry   Deplo yed BD Production  System (BDPS) at over 90 percent of manufacturing sites over 3 years, driving best-in-class operational excellence  In FY 2021, c ompleted 160  supplier audits, representing 15 percent of total spend   In FY 2021, spent $1 billion  with small-business suppliers, impacting 2,766 suppliers   Established Sc ope 3 baselines   for category 1, 4 and   In FY 2021, o ver 10,000  associates who interact with our supply chain completed Modern Slavery and Human Trafficking training  Achieved 95 per cent  improvement in responses to questions as compared to previous Voice of Associate survey   In FY 2021, c ompleted global  pay equity assessment, finding our U.S. female associates earn 99 cents for every $1 earned by male associates   In FY 2021, donat ed over  $24 million in cash and products   Invested $30 million  in free and  charitable clinics and community centers since 2008  Published first Inclusion, Diversity and Equity report and second Cybersecurity report   Scored 100 percent on the  2021 c orporate political  disclosure and accountability index, from the Center for Political Accountability   F irst medical technology  company authorized as a Common Vulnerability and Exposures (CVE ®) Authority by  the CVE Program   Named one of America’s  Most Responsible Companies and on the inaugural list of America’s Most Trusted Companies (Health Care and Life Sciences) by NewsweekESG highlightsAbout this report This report provides information about our global ESG strategy and programs.
","('Supply_Chain_Management', 0.828245997428894)","('Physical_Impacts_Of_Climate_Change', 0.07527469843626022)","('Business_Model_Resilience', 0.01551796868443489)","(['Supply Chain Management'], 0.828245997428894)","('NON-ESG', 0.07527469843626022)","('NON-ESG', 0.01551796868443489)"
Line 45,"Strong teams,  inclusive collaboration and diversity of ideas   will be essential to successfully achieving our ESG goals.Keeping our goals simple  and aligned with stakeholder needs  and expectations will enable innovation and agility.Speaking up builds trust and leads to better outcomes faster,  for us and our stakeholders.2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction ClimateProduct   impactResponsible   supply   chainHealthy workforce   and communitiesTransparency   Joined R ace to Zero in  September   Implemented 142 efficiency   projects in FY 2021, expected  to generate $5.1 million in energy savings   In FY 2021, reduced energy  consumption by 14 percent, with 13 locations using 100 percent renewable electricity   R educed water consumption  by 23 percent   Diverted 79 per cent of  nonhazardous waste from landfill  Spent $1,399 million  on  R&D in FY   Announced cr eation of the  Scientific Advisory Board in FY 2021 and launched Sustainable Medical Technology Institute in FY   P rofiled in Science  magazine, demonstrating landmark advancement in flow Cytometry   Deplo yed BD Production  System (BDPS) at over 90 percent of manufacturing sites over 3 years, driving best-in-class operational excellence  In FY 2021, c ompleted 160  supplier audits, representing 15 percent of total spend   In FY 2021, spent $1 billion  with small-business suppliers, impacting 2,766 suppliers   Established Sc ope 3 baselines   for category 1, 4 and   In FY 2021, o ver 10,000  associates who interact with our supply chain completed Modern Slavery and Human Trafficking training  Achieved 95 per cent  improvement in responses to questions as compared to previous Voice of Associate survey   In FY 2021, c ompleted global  pay equity assessment, finding our U.S. female associates earn 99 cents for every $1 earned by male associates   In FY 2021, donat ed over  $24 million in cash and products   Invested $30 million  in free and  charitable clinics and community centers since 2008  Published first Inclusion, Diversity and Equity report and second Cybersecurity report   Scored 100 percent on the  2021 c orporate political  disclosure and accountability index, from the Center for Political Accountability   F irst medical technology  company authorized as a Common Vulnerability and Exposures (CVE ®) Authority by  the CVE Program   Named one of America’s  Most Responsible Companies and on the inaugural list of America’s Most Trusted Companies (Health Care and Life Sciences) by NewsweekESG highlightsAbout this report This report provides information about our global ESG strategy and programs.
","('Energy_Management', 0.856115460395813)","('Waste_And_Hazardous_Materials_Management', 0.04495599865913391)","('Water_And_Wastewater_Management', 0.023310812190175056)","(['Operational Eco-Efficiency'], 0.856115460395813)","('NON-ESG', 0.04495599865913391)","('NON-ESG', 0.023310812190175056)"
Line 46,"Strong teams,  inclusive collaboration and diversity of ideas   will be essential to successfully achieving our ESG goals.Keeping our goals simple  and aligned with stakeholder needs  and expectations will enable innovation and agility.Speaking up builds trust and leads to better outcomes faster,  for us and our stakeholders.2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction ClimateProduct   impactResponsible   supply   chainHealthy workforce   and communitiesTransparency   Joined R ace to Zero in  September   Implemented 142 efficiency   projects in FY 2021, expected  to generate $5.1 million in energy savings   In FY 2021, reduced energy  consumption by 14 percent, with 13 locations using 100 percent renewable electricity   R educed water consumption  by 23 percent   Diverted 79 per cent of  nonhazardous waste from landfill  Spent $1,399 million  on  R&D in FY   Announced cr eation of the  Scientific Advisory Board in FY 2021 and launched Sustainable Medical Technology Institute in FY   P rofiled in Science  magazine, demonstrating landmark advancement in flow Cytometry   Deplo yed BD Production  System (BDPS) at over 90 percent of manufacturing sites over 3 years, driving best-in-class operational excellence  In FY 2021, c ompleted 160  supplier audits, representing 15 percent of total spend   In FY 2021, spent $1 billion  with small-business suppliers, impacting 2,766 suppliers   Established Sc ope 3 baselines   for category 1, 4 and   In FY 2021, o ver 10,000  associates who interact with our supply chain completed Modern Slavery and Human Trafficking training  Achieved 95 per cent  improvement in responses to questions as compared to previous Voice of Associate survey   In FY 2021, c ompleted global  pay equity assessment, finding our U.S. female associates earn 99 cents for every $1 earned by male associates   In FY 2021, donat ed over  $24 million in cash and products   Invested $30 million  in free and  charitable clinics and community centers since 2008  Published first Inclusion, Diversity and Equity report and second Cybersecurity report   Scored 100 percent on the  2021 c orporate political  disclosure and accountability index, from the Center for Political Accountability   F irst medical technology  company authorized as a Common Vulnerability and Exposures (CVE ®) Authority by  the CVE Program   Named one of America’s  Most Responsible Companies and on the inaugural list of America’s Most Trusted Companies (Health Care and Life Sciences) by NewsweekESG highlightsAbout this report This report provides information about our global ESG strategy and programs.
","('Supply_Chain_Management', 0.9388408660888672)","('Product_Design_And_Lifecycle_Management', 0.006464883219450712)","('Customer_Welfare', 0.004508696962147951)","(['Supply Chain Management'], 0.9388408660888672)","('NON-ESG', 0.006464883219450712)","('NON-ESG', 0.004508696962147951)"
Line 47,"Strong teams,  inclusive collaboration and diversity of ideas   will be essential to successfully achieving our ESG goals.Keeping our goals simple  and aligned with stakeholder needs  and expectations will enable innovation and agility.Speaking up builds trust and leads to better outcomes faster,  for us and our stakeholders.2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction ClimateProduct   impactResponsible   supply   chainHealthy workforce   and communitiesTransparency   Joined R ace to Zero in  September   Implemented 142 efficiency   projects in FY 2021, expected  to generate $5.1 million in energy savings   In FY 2021, reduced energy  consumption by 14 percent, with 13 locations using 100 percent renewable electricity   R educed water consumption  by 23 percent   Diverted 79 per cent of  nonhazardous waste from landfill  Spent $1,399 million  on  R&D in FY   Announced cr eation of the  Scientific Advisory Board in FY 2021 and launched Sustainable Medical Technology Institute in FY   P rofiled in Science  magazine, demonstrating landmark advancement in flow Cytometry   Deplo yed BD Production  System (BDPS) at over 90 percent of manufacturing sites over 3 years, driving best-in-class operational excellence  In FY 2021, c ompleted 160  supplier audits, representing 15 percent of total spend   In FY 2021, spent $1 billion  with small-business suppliers, impacting 2,766 suppliers   Established Sc ope 3 baselines   for category 1, 4 and   In FY 2021, o ver 10,000  associates who interact with our supply chain completed Modern Slavery and Human Trafficking training  Achieved 95 per cent  improvement in responses to questions as compared to previous Voice of Associate survey   In FY 2021, c ompleted global  pay equity assessment, finding our U.S. female associates earn 99 cents for every $1 earned by male associates   In FY 2021, donat ed over  $24 million in cash and products   Invested $30 million  in free and  charitable clinics and community centers since 2008  Published first Inclusion, Diversity and Equity report and second Cybersecurity report   Scored 100 percent on the  2021 c orporate political  disclosure and accountability index, from the Center for Political Accountability   F irst medical technology  company authorized as a Common Vulnerability and Exposures (CVE ®) Authority by  the CVE Program   Named one of America’s  Most Responsible Companies and on the inaugural list of America’s Most Trusted Companies (Health Care and Life Sciences) by NewsweekESG highlightsAbout this report This report provides information about our global ESG strategy and programs.
","('Supply_Chain_Management', 0.4198615252971649)","('Labor_Practices', 0.3204200863838196)","('Employee_Health_And_Safety', 0.046325307339429855)","('NON-ESG', 0.4198615252971649)","('NON-ESG', 0.3204200863838196)","('NON-ESG', 0.046325307339429855)"
Line 48,"Strong teams,  inclusive collaboration and diversity of ideas   will be essential to successfully achieving our ESG goals.Keeping our goals simple  and aligned with stakeholder needs  and expectations will enable innovation and agility.Speaking up builds trust and leads to better outcomes faster,  for us and our stakeholders.2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction ClimateProduct   impactResponsible   supply   chainHealthy workforce   and communitiesTransparency   Joined R ace to Zero in  September   Implemented 142 efficiency   projects in FY 2021, expected  to generate $5.1 million in energy savings   In FY 2021, reduced energy  consumption by 14 percent, with 13 locations using 100 percent renewable electricity   R educed water consumption  by 23 percent   Diverted 79 per cent of  nonhazardous waste from landfill  Spent $1,399 million  on  R&D in FY   Announced cr eation of the  Scientific Advisory Board in FY 2021 and launched Sustainable Medical Technology Institute in FY   P rofiled in Science  magazine, demonstrating landmark advancement in flow Cytometry   Deplo yed BD Production  System (BDPS) at over 90 percent of manufacturing sites over 3 years, driving best-in-class operational excellence  In FY 2021, c ompleted 160  supplier audits, representing 15 percent of total spend   In FY 2021, spent $1 billion  with small-business suppliers, impacting 2,766 suppliers   Established Sc ope 3 baselines   for category 1, 4 and   In FY 2021, o ver 10,000  associates who interact with our supply chain completed Modern Slavery and Human Trafficking training  Achieved 95 per cent  improvement in responses to questions as compared to previous Voice of Associate survey   In FY 2021, c ompleted global  pay equity assessment, finding our U.S. female associates earn 99 cents for every $1 earned by male associates   In FY 2021, donat ed over  $24 million in cash and products   Invested $30 million  in free and  charitable clinics and community centers since 2008  Published first Inclusion, Diversity and Equity report and second Cybersecurity report   Scored 100 percent on the  2021 c orporate political  disclosure and accountability index, from the Center for Political Accountability   F irst medical technology  company authorized as a Common Vulnerability and Exposures (CVE ®) Authority by  the CVE Program   Named one of America’s  Most Responsible Companies and on the inaugural list of America’s Most Trusted Companies (Health Care and Life Sciences) by NewsweekESG highlightsAbout this report This report provides information about our global ESG strategy and programs.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7630600333213806)","('Business_Ethics', 0.035441890358924866)","('Human_Rights_And_Community_Relations', 0.021564578637480736)","(['Human Capital Development'], 0.7630600333213806)","('NON-ESG', 0.035441890358924866)","('NON-ESG', 0.021564578637480736)"
Line 49,"Strong teams,  inclusive collaboration and diversity of ideas   will be essential to successfully achieving our ESG goals.Keeping our goals simple  and aligned with stakeholder needs  and expectations will enable innovation and agility.Speaking up builds trust and leads to better outcomes faster,  for us and our stakeholders.2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction ClimateProduct   impactResponsible   supply   chainHealthy workforce   and communitiesTransparency   Joined R ace to Zero in  September   Implemented 142 efficiency   projects in FY 2021, expected  to generate $5.1 million in energy savings   In FY 2021, reduced energy  consumption by 14 percent, with 13 locations using 100 percent renewable electricity   R educed water consumption  by 23 percent   Diverted 79 per cent of  nonhazardous waste from landfill  Spent $1,399 million  on  R&D in FY   Announced cr eation of the  Scientific Advisory Board in FY 2021 and launched Sustainable Medical Technology Institute in FY   P rofiled in Science  magazine, demonstrating landmark advancement in flow Cytometry   Deplo yed BD Production  System (BDPS) at over 90 percent of manufacturing sites over 3 years, driving best-in-class operational excellence  In FY 2021, c ompleted 160  supplier audits, representing 15 percent of total spend   In FY 2021, spent $1 billion  with small-business suppliers, impacting 2,766 suppliers   Established Sc ope 3 baselines   for category 1, 4 and   In FY 2021, o ver 10,000  associates who interact with our supply chain completed Modern Slavery and Human Trafficking training  Achieved 95 per cent  improvement in responses to questions as compared to previous Voice of Associate survey   In FY 2021, c ompleted global  pay equity assessment, finding our U.S. female associates earn 99 cents for every $1 earned by male associates   In FY 2021, donat ed over  $24 million in cash and products   Invested $30 million  in free and  charitable clinics and community centers since 2008  Published first Inclusion, Diversity and Equity report and second Cybersecurity report   Scored 100 percent on the  2021 c orporate political  disclosure and accountability index, from the Center for Political Accountability   F irst medical technology  company authorized as a Common Vulnerability and Exposures (CVE ®) Authority by  the CVE Program   Named one of America’s  Most Responsible Companies and on the inaugural list of America’s Most Trusted Companies (Health Care and Life Sciences) by NewsweekESG highlightsAbout this report This report provides information about our global ESG strategy and programs.
","('Business_Model_Resilience', 0.5153682231903076)","('Access_And_Affordability', 0.08317244797945023)","('Systemic_Risk_Management', 0.044514257460832596)","(['Codes of Business Conduct'], 0.5153682231903076)","('NON-ESG', 0.08317244797945023)","('NON-ESG', 0.044514257460832596)"
Line 50,"It is issued on an annual basis to  highlight our sustainability performance and progress.
","('Business_Model_Resilience', 0.3635382056236267)","('Physical_Impacts_Of_Climate_Change', 0.07409254461526871)","('Supply_Chain_Management', 0.06923424452543259)","('NON-ESG', 0.3635382056236267)","('NON-ESG', 0.07409254461526871)","('NON-ESG', 0.06923424452543259)"
Line 51,"Unless otherwise stated, this report is current through the first half of fiscal year 2022 (March 31, 2022); performance data regarding our 2030+ commitments and goals is provided through the end of fiscal year 2021 (October 1, 2020, to September 30, 2021); and all information is provided for Becton, Dickinson and Company (BD) and our subsidiaries.
","('Business_Model_Resilience', 0.290796160697937)","('Management_Of_Legal_And_Regulatory_Framework', 0.20661801099777222)","('Director_Removal', 0.059068020433187485)","('NON-ESG', 0.290796160697937)","('NON-ESG', 0.20661801099777222)","('NON-ESG', 0.059068020433187485)"
Line 52,"In May 2021, we announced our intention to spin off the  Diabetes Care business to create a new independent, publicly traded company called Embecta Corp (“embecta”).
","('Business_Model_Resilience', 0.21927449107170105)","('Systemic_Risk_Management', 0.1661112904548645)","('Competitive_Behavior', 0.12228211015462875)","('NON-ESG', 0.21927449107170105)","('NON-ESG', 0.1661112904548645)","('NON-ESG', 0.12228211015462875)"
Line 53,"The separation was completed on April 1, 2022.
","('Management_Of_Legal_And_Regulatory_Framework', 0.38768431544303894)","('GHG_Emissions', 0.07624203711748123)","('Business_Model_Resilience', 0.06081493943929672)","('NON-ESG', 0.38768431544303894)","('NON-ESG', 0.07624203711748123)","('NON-ESG', 0.06081493943929672)"
Line 54,"In fiscal year 2019, we began assessing our climate  management program in alignment with recommendations of the Task Force on Climate-related Financial Disclosures (TCFD ).
","('Physical_Impacts_Of_Climate_Change', 0.9205734729766846)","('GHG_Emissions', 0.016723936423659325)","('Business_Model_Resilience', 0.015598415397107601)","(['Climate Change'], 0.9205734729766846)","('NON-ESG', 0.016723936423659325)","('NON-ESG', 0.015598415397107601)"
Line 55,"The disclosures in this report follow the guidelines in the October 2021 report “Implementing the Recommendations of the Task Force on Climate-related Financial Disclosures.” TCFD disclosures can be found in the appendices.
","('Physical_Impacts_Of_Climate_Change', 0.8888639211654663)","('Business_Model_Resilience', 0.025114811956882477)","('GHG_Emissions', 0.018824409693479538)","(['Climate Change'], 0.8888639211654663)","('NON-ESG', 0.025114811956882477)","('NON-ESG', 0.018824409693479538)"
Line 56,"We will continue to use this framework to advance our initiatives and disclose information where relevant.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9076711535453796)","('Human_Rights_And_Community_Relations', 0.013973221182823181)","('Access_And_Affordability', 0.012223698198795319)","(['Corporate Governance'], 0.9076711535453796)","('NON-ESG', 0.013973221182823181)","('NON-ESG', 0.012223698198795319)"
Line 57,"This includes our long-standing public disclosure via the CDP .
","('Management_Of_Legal_And_Regulatory_Framework', 0.7542567253112793)","('Ecological_Impacts', 0.06131753697991371)","('GHG_Emissions', 0.04043487459421158)","(['Corporate Governance'], 0.7542567253112793)","('NON-ESG', 0.06131753697991371)","('NON-ESG', 0.04043487459421158)"
Line 58,"This report contains standard disclosures from the Global Reporting Initiative™ ( GRI) guidelines and the Value Reporting  Foundation’s Sustainability Accounting Standards Board (SASB ) Medical Equipment and Supplies Sustainability  Accounting Standard.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4335702061653137)","('Systemic_Risk_Management', 0.11911176890134811)","('Business_Model_Resilience', 0.09040560573339462)","('NON-ESG', 0.4335702061653137)","('NON-ESG', 0.11911176890134811)","('NON-ESG', 0.09040560573339462)"
Line 59,"A GRI index and a SASB index can be found in the appendices.Reporting and performance data includes information on our owned and operated facilities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.18249568343162537)","('Systemic_Risk_Management', 0.10242599993944168)","('Supply_Chain_Management', 0.07529591768980026)","('NON-ESG', 0.18249568343162537)","('NON-ESG', 0.10242599993944168)","('NON-ESG', 0.07529591768980026)"
Line 60,"We have processes in place to ensure that reporting on key sustainability performance indicators is as accurate and robust as possible, and we continually work to improve them.
","('Business_Model_Resilience', 0.25674042105674744)","('Systemic_Risk_Management', 0.17791107296943665)","('Management_Of_Legal_And_Regulatory_Framework', 0.11644133925437927)","('NON-ESG', 0.25674042105674744)","('NON-ESG', 0.17791107296943665)","('NON-ESG', 0.11644133925437927)"
Line 61,"Data in this report has not been externally assured.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3102823793888092)","('Customer_Privacy', 0.19210472702980042)","('Data_Security', 0.06999839097261429)","('NON-ESG', 0.3102823793888092)","('NON-ESG', 0.19210472702980042)","('NON-ESG', 0.06999839097261429)"
Line 62,"Various data tables can be found in the appendices.
","('Management_Of_Legal_And_Regulatory_Framework', 0.23835782706737518)","('Data_Security', 0.13238415122032166)","('Systemic_Risk_Management', 0.11238807439804077)","('NON-ESG', 0.23835782706737518)","('NON-ESG', 0.13238415122032166)","('NON-ESG', 0.11238807439804077)"
Line 63,"Commonly used acronyms, a glossary of terms and links to  BD documents can be found in the appendices.
","('Management_Of_Legal_And_Regulatory_Framework', 0.26560717821121216)","('Business_Ethics', 0.15610437095165253)","('Competitive_Behavior', 0.12075261026620865)","('NON-ESG', 0.26560717821121216)","('NON-ESG', 0.15610437095165253)","('NON-ESG', 0.12075261026620865)"
Line 64,"All monetary amounts are U.S. dollars unless otherwise  stated.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7762678265571594)","('Systemic_Risk_Management', 0.048584721982479095)","('Business_Ethics', 0.0169949010014534)","(['Corporate Governance'], 0.7762678265571594)","('NON-ESG', 0.048584721982479095)","('NON-ESG', 0.0169949010014534)"
Line 65,"We seek feedback from stakeholders each year, which informs  our selection of content for sustainability reporting.
","('Business_Model_Resilience', 0.23847784101963043)","('Management_Of_Legal_And_Regulatory_Framework', 0.135081946849823)","('Product_Design_And_Lifecycle_Management', 0.07911022007465363)","('NON-ESG', 0.23847784101963043)","('NON-ESG', 0.135081946849823)","('NON-ESG', 0.07911022007465363)"
Line 66,"For contact information, see the final page of this report.
","('Customer_Privacy', 0.6141272783279419)","('Business_Model_Resilience', 0.07191815972328186)","('Selling_Practices_And_Product_Labeling', 0.031185753643512726)","(['Privacy Protection'], 0.6141272783279419)","('NON-ESG', 0.07191815972328186)","('NON-ESG', 0.031185753643512726)"
Line 67,"Our previous sustainability report is available on our website.
","('Business_Model_Resilience', 0.16897065937519073)","('Supply_Chain_Management', 0.15555469691753387)","('Product_Design_And_Lifecycle_Management', 0.15208183228969574)","('NON-ESG', 0.16897065937519073)","('NON-ESG', 0.15555469691753387)","('NON-ESG', 0.15208183228969574)"
Line 68,"2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionAbout BD BD is one of the largest global medical technology  companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.
","('Supply_Chain_Management', 0.8999028205871582)","('Physical_Impacts_Of_Climate_Change', 0.026884261518716812)","('Systemic_Risk_Management', 0.009250293485820293)","(['Supply Chain Management'], 0.8999028205871582)","('NON-ESG', 0.026884261518716812)","('NON-ESG', 0.009250293485820293)"
Line 69,"The company develops innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers.
","('Access_And_Affordability', 0.3844295144081116)","('Customer_Welfare', 0.14814285933971405)","('Product_Design_And_Lifecycle_Management', 0.05317821353673935)","('NON-ESG', 0.3844295144081116)","('NON-ESG', 0.14814285933971405)","('NON-ESG', 0.05317821353673935)"
Line 70,"BD and its 75,000 employees have a passion and commitment to  help improve patient outcomes, improve the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics.
","('Employee_Health_And_Safety', 0.38767990469932556)","('Product_Quality_And_Safety', 0.22216485440731049)","('Customer_Welfare', 0.07961403578519821)","('NON-ESG', 0.38767990469932556)","('NON-ESG', 0.22216485440731049)","('NON-ESG', 0.07961403578519821)"
Line 71,"BD has a presence in virtually every country and partners with  organizations around the world to address some of the most challenging global health issues.
","('Employee_Health_And_Safety', 0.4369007647037506)","('Access_And_Affordability', 0.13454896211624146)","('Critical_Incident_Risk_Management', 0.07138382643461227)","('NON-ESG', 0.4369007647037506)","('NON-ESG', 0.13454896211624146)","('NON-ESG', 0.07138382643461227)"
Line 72,"BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare.
","('Employee_Health_And_Safety', 0.7963600158691406)","('Product_Quality_And_Safety', 0.09608656167984009)","('Access_And_Affordability', 0.020145438611507416)","(['Operational Eco-Efficiency'], 0.7963600158691406)","('NON-ESG', 0.09608656167984009)","('NON-ESG', 0.020145438611507416)"
Line 73,"For more information on BD, please visit bd.com.
","('Management_Of_Legal_And_Regulatory_Framework', 0.23154692351818085)","('Access_And_Affordability', 0.1600245237350464)","('Selling_Practices_And_Product_Labeling', 0.05396072939038277)","('NON-ESG', 0.23154692351818085)","('NON-ESG', 0.1600245237350464)","('NON-ESG', 0.05396072939038277)"
Line 74,"Our Purpose Our Purpose – advancing the world of health™ – is the  basis for all that we do.
","('Access_And_Affordability', 0.20420759916305542)","('Human_Rights_And_Community_Relations', 0.1540893316268921)","('Employee_Engagement_Inclusion_And_Diversity', 0.0983421802520752)","('NON-ESG', 0.20420759916305542)","('NON-ESG', 0.1540893316268921)","('NON-ESG', 0.0983421802520752)"
Line 75,"It motivates us and drives the decisions we make every day, because we know our work means something.By the numbers 45B+ devices made annually 190+ countries served 29,000+ active patents $1B+ annual R&D spending 75,000+ BD associates 50th consecutive year of   dividend increase Note: BD financial information is for  fiscal year 2021.
","('Systemic_Risk_Management', 0.3124004602432251)","('Business_Model_Resilience', 0.19024723768234253)","('Management_Of_Legal_And_Regulatory_Framework', 0.08795101940631866)","('NON-ESG', 0.3124004602432251)","('NON-ESG', 0.19024723768234253)","('NON-ESG', 0.08795101940631866)"
Line 76,"Market share information and rank based on internal estimates and publicly available information.The BD WAY The BD WAY embodies who we are, what we stand for and  why we exist.
","('Competitive_Behavior', 0.2980915904045105)","('Business_Model_Resilience', 0.24139633774757385)","('Systemic_Risk_Management', 0.1291550248861313)","('NON-ESG', 0.2980915904045105)","('NON-ESG', 0.24139633774757385)","('NON-ESG', 0.1291550248861313)"
Line 77,"It reflects the behaviors we’re all expected to demonstrate every day, no matter what we do.
","('Competitive_Behavior', 0.23942433297634125)","('Employee_Health_And_Safety', 0.10039252787828445)","('Labor_Practices', 0.08317051082849503)","('NON-ESG', 0.23942433297634125)","('NON-ESG', 0.10039252787828445)","('NON-ESG', 0.08317051082849503)"
Line 78,"Values Our standards of behavior • W e do what is right •  W e are all accountable •  W e thrive on innovation and demand quality •  W e learn and improve every day •  W e help each other be great Mindset The attitude we bring to our work • Speaking up builds tr ust and gets to better outcomes faster •  Inclusion and div ersity make us a stronger team •  K eeping it simple enables innovation and agility •  T he best way to help customers and patients is to truly  know them •  Challenges ar e opportunities to grow and improve Leadership commitments How we lead ourselves and our work • Be bold and str ategic •  R emove obstacles and empower others •  Deliv er results that matter •  Debat e and decide, then commit and go •  Hav e the courage to iterate, try new things and  embrace change 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionOur 2025 strategy We're focused on delivering durable growth and creating shareholder value, while making appropriate investments for the future.
","('Employee_Engagement_Inclusion_And_Diversity', 0.274125337600708)","('Business_Model_Resilience', 0.11976876854896545)","('Business_Ethics', 0.11133132874965668)","('NON-ESG', 0.274125337600708)","('NON-ESG', 0.11976876854896545)","('NON-ESG', 0.11133132874965668)"
Line 79,"Values Our standards of behavior • W e do what is right •  W e are all accountable •  W e thrive on innovation and demand quality •  W e learn and improve every day •  W e help each other be great Mindset The attitude we bring to our work • Speaking up builds tr ust and gets to better outcomes faster •  Inclusion and div ersity make us a stronger team •  K eeping it simple enables innovation and agility •  T he best way to help customers and patients is to truly  know them •  Challenges ar e opportunities to grow and improve Leadership commitments How we lead ourselves and our work • Be bold and str ategic •  R emove obstacles and empower others •  Deliv er results that matter •  Debat e and decide, then commit and go •  Hav e the courage to iterate, try new things and  embrace change 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionOur 2025 strategy We're focused on delivering durable growth and creating shareholder value, while making appropriate investments for the future.
","('Physical_Impacts_Of_Climate_Change', 0.4739338755607605)","('Supply_Chain_Management', 0.33015722036361694)","('Business_Model_Resilience', 0.0607953742146492)","('NON-ESG', 0.4739338755607605)","('NON-ESG', 0.33015722036361694)","('NON-ESG', 0.0607953742146492)"
Line 80,"Values Our standards of behavior • W e do what is right •  W e are all accountable •  W e thrive on innovation and demand quality •  W e learn and improve every day •  W e help each other be great Mindset The attitude we bring to our work • Speaking up builds tr ust and gets to better outcomes faster •  Inclusion and div ersity make us a stronger team •  K eeping it simple enables innovation and agility •  T he best way to help customers and patients is to truly  know them •  Challenges ar e opportunities to grow and improve Leadership commitments How we lead ourselves and our work • Be bold and str ategic •  R emove obstacles and empower others •  Deliv er results that matter •  Debat e and decide, then commit and go •  Hav e the courage to iterate, try new things and  embrace change 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionOur 2025 strategy We're focused on delivering durable growth and creating shareholder value, while making appropriate investments for the future.
","('Management_Of_Legal_And_Regulatory_Framework', 0.27337485551834106)","('Business_Model_Resilience', 0.23160859942436218)","('Systemic_Risk_Management', 0.09697023034095764)","('NON-ESG', 0.27337485551834106)","('NON-ESG', 0.23160859942436218)","('NON-ESG', 0.09697023034095764)"
Line 81,"BD 2025, our current phase of value creation, is anchored in three key pillars—Grow, Simplify and Empower.
","('Business_Model_Resilience', 0.8171148300170898)","('Systemic_Risk_Management', 0.02971963956952095)","('Supply_Chain_Management', 0.025046292692422867)","(['Codes of Business Conduct'], 0.8171148300170898)","('NON-ESG', 0.02971963956952095)","('NON-ESG', 0.025046292692422867)"
Line 82,"Read more at bd.com Key announcements • In April 2021, we announced the investment of $65 million to construct a  state - of-the-art facility in Tucson, Arizona, that will be a hub for the company's  supply chain, serving as a final-stage manufacturing and sterilization center.
","('Supply_Chain_Management', 0.8897994160652161)","('Product_Design_And_Lifecycle_Management', 0.014902430586516857)","('Waste_And_Hazardous_Materials_Management', 0.011392776854336262)","(['Supply Chain Management'], 0.8897994160652161)","('NON-ESG', 0.014902430586516857)","('NON-ESG', 0.011392776854336262)"
Line 83,"•  In  May 2021, we announced our intention to spin off the Diabetes Care  business, to create embecta.
","('Access_And_Affordability', 0.2587888240814209)","('Customer_Welfare', 0.18327036499977112)","('Product_Quality_And_Safety', 0.06929278373718262)","('NON-ESG', 0.2587888240814209)","('NON-ESG', 0.18327036499977112)","('NON-ESG', 0.06929278373718262)"
Line 84,"The spin-off was completed in April 2022, and  embecta is one of the largest pure-play diabetes management companies in the world.
","('Business_Model_Resilience', 0.49381691217422485)","('Systemic_Risk_Management', 0.25902146100997925)","('Supply_Chain_Management', 0.04212294518947601)","('NON-ESG', 0.49381691217422485)","('NON-ESG', 0.25902146100997925)","('NON-ESG', 0.04212294518947601)"
Line 85,"For more information, visit embecta.com.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5193272829055786)","('Systemic_Risk_Management', 0.07763296365737915)","('Business_Ethics', 0.057416267693042755)","(['Corporate Governance'], 0.5193272829055786)","('NON-ESG', 0.07763296365737915)","('NON-ESG', 0.057416267693042755)"
Line 86,"•  In  June 2021, we announced that we had become the first medical technology  company authorized as a Common Vulnerability and Exposures (CVE®)  Numbering Authority by the CVE Program, further demonstrating our leadership in healthcare cybersecurity.
","('Data_Security', 0.9419499635696411)","('Systemic_Risk_Management', 0.010508746840059757)","('Physical_Impacts_Of_Climate_Change', 0.005592990200966597)","(['Information Security/Cybersecurity & System Availability'], 0.9419499635696411)","('NON-ESG', 0.010508746840059757)","('NON-ESG', 0.005592990200966597)"
Line 87,"Read more about our cybersecurity program here.• In September 2021, we officially signed on to the Race to Zero via the  Science Based Targets initiative (SBTi) and in partnership with the Business Ambition for 1.5⁰C.
","('Data_Security', 0.7633404731750488)","('Systemic_Risk_Management', 0.07622439414262772)","('Business_Model_Resilience', 0.031051969155669212)","(['Information Security/Cybersecurity & System Availability'], 0.7633404731750488)","('NON-ESG', 0.07622439414262772)","('NON-ESG', 0.031051969155669212)"
Line 88,"This milestone was celebrated at Global Citizen LIVE.
","('Human_Rights_And_Community_Relations', 0.18231701850891113)","('Business_Model_Resilience', 0.143637016415596)","('Employee_Engagement_Inclusion_And_Diversity', 0.14096137881278992)","('NON-ESG', 0.18231701850891113)","('NON-ESG', 0.143637016415596)","('NON-ESG', 0.14096137881278992)"
Line 89,"•  In  November 2021, we broke ground on a €165 million ($200 million)  manufacturing facility in the city of Zaragoza, located in the Aragon region of Spain.
","('Product_Design_And_Lifecycle_Management', 0.6065464019775391)","('Supply_Chain_Management', 0.08460837602615356)","('Energy_Management', 0.056654054671525955)","(['Product Stewardship'], 0.6065464019775391)","('NON-ESG', 0.08460837602615356)","('NON-ESG', 0.056654054671525955)"
Line 90,"The facility, which is expected to be completed in 2023, will be a sustainable and fully automated facility incorporating the latest in intelligent and autonomous solutions.
","('Product_Design_And_Lifecycle_Management', 0.42530038952827454)","('Energy_Management', 0.16465029120445251)","('Data_Security', 0.052428800612688065)","('NON-ESG', 0.42530038952827454)","('NON-ESG', 0.16465029120445251)","('NON-ESG', 0.052428800612688065)"
Line 91,"The new site is part of the $1.2 billion, four - year  investment that was announced in late 2020 to expand and upgrade BD’s manufacturing capacity and technology for pre - fillable syringes and advanced  drug delivery systems as part of the company’s 2025 growth strategy.
","('Product_Design_And_Lifecycle_Management', 0.5028708577156067)","('Customer_Welfare', 0.16181346774101257)","('Energy_Management', 0.060580942779779434)","(['Product Stewardship'], 0.5028708577156067)","('NON-ESG', 0.16181346774101257)","('NON-ESG', 0.060580942779779434)"
Line 92,"Key awards • Named t o Newsweek‘s inaugural list of America’s Most Trusted Companies in the  Health Care and Life Sciences category •  BD R anked first in its industry in Forbes America’s Best Large Employers List •  Named one of  America’s Most Just Companies in the Annual JUST 100 Ranking •  Named one of  America’s Most Responsible Companies by Newsweek •  Named t o Forbes 2022 List of Best Employers for Diversity 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionAbout our business 54 % United States22 % Europe 7% China 18 % Rest of worldFY21 revenue by segment Values in this exhibit reflect rounded numbers in billions of dollars $20.Total BD revenueBD Medical Medication Delivery Systems Medication Management SolutionsDiabetes Care*Pharmaceutical Systems$9.$4.$2.4$1.2$1.BD Life Sciences Integrated Diagnostics Solutions Biosciences$6.$5.$1.BD Interventional Peripheral Intervention SurgeryUrology and Critical Care$4.$1.$1.3$1.*  On April 1, 2022, BD e xecuted the spin of its Diabetes Care business, which is now a  stand-alone and publicly traded company named Embecta Corp.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9510819911956787)","('Employee_Health_And_Safety', 0.0072096409276127815)","('Human_Rights_And_Community_Relations', 0.003764052875339985)","(['Human Capital Development'], 0.9510819911956787)","('NON-ESG', 0.0072096409276127815)","('NON-ESG', 0.003764052875339985)"
Line 93,"Key awards • Named t o Newsweek‘s inaugural list of America’s Most Trusted Companies in the  Health Care and Life Sciences category •  BD R anked first in its industry in Forbes America’s Best Large Employers List •  Named one of  America’s Most Just Companies in the Annual JUST 100 Ranking •  Named one of  America’s Most Responsible Companies by Newsweek •  Named t o Forbes 2022 List of Best Employers for Diversity 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionAbout our business 54 % United States22 % Europe 7% China 18 % Rest of worldFY21 revenue by segment Values in this exhibit reflect rounded numbers in billions of dollars $20.Total BD revenueBD Medical Medication Delivery Systems Medication Management SolutionsDiabetes Care*Pharmaceutical Systems$9.$4.$2.4$1.2$1.BD Life Sciences Integrated Diagnostics Solutions Biosciences$6.$5.$1.BD Interventional Peripheral Intervention SurgeryUrology and Critical Care$4.$1.$1.3$1.*  On April 1, 2022, BD e xecuted the spin of its Diabetes Care business, which is now a  stand-alone and publicly traded company named Embecta Corp.
","('Physical_Impacts_Of_Climate_Change', 0.8749150633811951)","('Business_Model_Resilience', 0.040140192955732346)","('Supply_Chain_Management', 0.015862636268138885)","(['Climate Change'], 0.8749150633811951)","('NON-ESG', 0.040140192955732346)","('NON-ESG', 0.015862636268138885)"
Line 94,"Key awards • Named t o Newsweek‘s inaugural list of America’s Most Trusted Companies in the  Health Care and Life Sciences category •  BD R anked first in its industry in Forbes America’s Best Large Employers List •  Named one of  America’s Most Just Companies in the Annual JUST 100 Ranking •  Named one of  America’s Most Responsible Companies by Newsweek •  Named t o Forbes 2022 List of Best Employers for Diversity 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionAbout our business 54 % United States22 % Europe 7% China 18 % Rest of worldFY21 revenue by segment Values in this exhibit reflect rounded numbers in billions of dollars $20.Total BD revenueBD Medical Medication Delivery Systems Medication Management SolutionsDiabetes Care*Pharmaceutical Systems$9.$4.$2.4$1.2$1.BD Life Sciences Integrated Diagnostics Solutions Biosciences$6.$5.$1.BD Interventional Peripheral Intervention SurgeryUrology and Critical Care$4.$1.$1.3$1.*  On April 1, 2022, BD e xecuted the spin of its Diabetes Care business, which is now a  stand-alone and publicly traded company named Embecta Corp.
","('Customer_Welfare', 0.19439196586608887)","('Systemic_Risk_Management', 0.15164676308631897)","('Competitive_Behavior', 0.13352233171463013)","('NON-ESG', 0.19439196586608887)","('NON-ESG', 0.15164676308631897)","('NON-ESG', 0.13352233171463013)"
Line 95,"(NASDAQ: EMBC).
","('Business_Model_Resilience', 0.25357183814048767)","('Systemic_Risk_Management', 0.21898683905601501)","('Competitive_Behavior', 0.10325553268194199)","('NON-ESG', 0.25357183814048767)","('NON-ESG', 0.21898683905601501)","('NON-ESG', 0.10325553268194199)"
Line 96,"FY21 revenue by region 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionBD Medical  The BD Medical segment produces a broad array of medical technologies and devices that improve healthcare delivery in a wide range of settings.
","('Supply_Chain_Management', 0.889675498008728)","('Product_Design_And_Lifecycle_Management', 0.022333532571792603)","('Physical_Impacts_Of_Climate_Change', 0.017413858324289322)","(['Supply Chain Management'], 0.889675498008728)","('NON-ESG', 0.022333532571792603)","('NON-ESG', 0.017413858324289322)"
Line 97,"The primary customers served by BD Medical are hospitals and clinics; physicians’ office practices; consumers and retail pharmacies; governmental and nonprofit public health agencies; pharmaceutical companies; and healthcare workers.
","('Customer_Welfare', 0.3299736976623535)","('Competitive_Behavior', 0.10741026699542999)","('Access_And_Affordability', 0.09278839081525803)","('NON-ESG', 0.3299736976623535)","('NON-ESG', 0.10741026699542999)","('NON-ESG', 0.09278839081525803)"
Line 98,"Key categories Leadership positionMedication   delivery   solutions• V ascular access devices •  V ascular care and maintenance •  Inf usion specialty disposables #Medication  management solutions• A cute infusion •  A cute dispensing •  Non-ac ute medication management #Pharmaceutical  systems• Pr efilled syringes •  Self-administ ered injection systems •  Saf ety and shielding solutions #1BD position based on management’s internal estimates.
","('Customer_Welfare', 0.48498326539993286)","('Product_Design_And_Lifecycle_Management', 0.08438083529472351)","('Access_And_Affordability', 0.054777830839157104)","('NON-ESG', 0.48498326539993286)","('NON-ESG', 0.08438083529472351)","('NON-ESG', 0.054777830839157104)"
Line 99,"Represents leadership position across majority of each business unit’s portfolio.
","('Director_Removal', 0.2910580635070801)","('Business_Model_Resilience', 0.23944231867790222)","('Employee_Engagement_Inclusion_And_Diversity', 0.12308889627456665)","('NON-ESG', 0.2910580635070801)","('NON-ESG', 0.23944231867790222)","('NON-ESG', 0.12308889627456665)"
Line 100,"2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionBD Life Sciences The BD Life Sciences segment provides products for the safe collection and transport of diagnostic specimens, and instruments and reagent systems to detect a broad  range of infectious diseases, healthcare-associated infections and cancers.
","('Product_Design_And_Lifecycle_Management', 0.32997244596481323)","('Supply_Chain_Management', 0.255814790725708)","('Product_Quality_And_Safety', 0.10163960605859756)","('NON-ESG', 0.32997244596481323)","('NON-ESG', 0.255814790725708)","('NON-ESG', 0.10163960605859756)"
Line 101,"In addition, BD Life Sciences produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes.
","('Customer_Welfare', 0.2280256152153015)","('Access_And_Affordability', 0.09060893952846527)","('Selling_Practices_And_Product_Labeling', 0.08283412456512451)","('NON-ESG', 0.2280256152153015)","('NON-ESG', 0.09060893952846527)","('NON-ESG', 0.08283412456512451)"
Line 102,"That information is used to aid the discovery and development of new drugs and vaccines, and to improve the diagnosis and management of diseases.
","('Selling_Practices_And_Product_Labeling', 0.3415220081806183)","('Product_Quality_And_Safety', 0.139747753739357)","('Customer_Welfare', 0.1252480149269104)","('NON-ESG', 0.3415220081806183)","('NON-ESG', 0.139747753739357)","('NON-ESG', 0.1252480149269104)"
Line 103,"The primary customers served by BD Life Sciences are hospitals, laboratories and clinics; blood banks; healthcare workers; public health agencies; physicians’ office practices; retail pharmacies; academic and government institutions; and pharmaceutical and biotechnology companies.
","('Access_And_Affordability', 0.31965288519859314)","('Customer_Welfare', 0.2078178972005844)","('Selling_Practices_And_Product_Labeling', 0.04242200404405594)","('NON-ESG', 0.31965288519859314)","('NON-ESG', 0.2078178972005844)","('NON-ESG', 0.04242200404405594)"
Line 104,"With the emergency use authorization approval of the BD Veritor TM At Home COVID-19 test, BD Life Sciences also serves patients directly.
","('Critical_Incident_Risk_Management', 0.968602180480957)","('Employee_Health_And_Safety', 0.0043966504745185375)","('Air_Quality', 0.0035042627714574337)","(['Risk & Crisis Management'], 0.968602180480957)","('NON-ESG', 0.0043966504745185375)","('NON-ESG', 0.0035042627714574337)"
Line 105,"Key categories Leadership positionBiosciences• R esearch Flow Cytometry •  Clinic al Flow Cytometry •  Single-c ell Multiomics Integrated  diagnostic solutions• Micr obiology •  Specimen Management •  Molec ular and Women’s Health Point of care• Pr ofessional POC Diagnostics•  A t-Home Diagnostics 2BD position based on management’s internal estimates.
","('Access_And_Affordability', 0.429151713848114)","('Employee_Health_And_Safety', 0.17803172767162323)","('Customer_Welfare', 0.06602023541927338)","('NON-ESG', 0.429151713848114)","('NON-ESG', 0.17803172767162323)","('NON-ESG', 0.06602023541927338)"
Line 106,"Includes COVID testing revenue.#1To p Flow Cytometry Single-cell Multiomics To p 2 #1To p Microbiology Specimen  ManagementMolecular To p Professional POC Diagnostics 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionBD Interventional The BD Interventional segment provides vascular, urology, oncology and surgical specialty products—with the exception of the V.
","('Supply_Chain_Management', 0.637904942035675)","('Product_Design_And_Lifecycle_Management', 0.09833871573209763)","('Physical_Impacts_Of_Climate_Change', 0.0881575345993042)","(['Supply Chain Management'], 0.637904942035675)","('NON-ESG', 0.09833871573209763)","('NON-ESG', 0.0881575345993042)"
Line 107,"Mueller™ surgical  and laparoscopic instrumentation products—that are intended to be used once and then discarded or are either temporarily or permanently implanted.
","('Product_Design_And_Lifecycle_Management', 0.528383195400238)","('Waste_And_Hazardous_Materials_Management', 0.05521664395928383)","('Customer_Welfare', 0.05085316672921181)","(['Product Stewardship'], 0.528383195400238)","('NON-ESG', 0.05521664395928383)","('NON-ESG', 0.05085316672921181)"
Line 108,"The primary customers served by BD Interventional are hospitals, individual healthcare professionals, extended care facilities, alternate site facilities and patients via our Homecare business.
","('Access_And_Affordability', 0.7971917986869812)","('Customer_Welfare', 0.025020195171236992)","('Critical_Incident_Risk_Management', 0.021894149482250214)","(['Health Outcome Contribution'], 0.7971917986869812)","('NON-ESG', 0.025020195171236992)","('NON-ESG', 0.021894149482250214)"
Line 109,"Key categories Leadership positionPeripheral  intervention• P eripheral Vascular Disease •  End-st age Kidney Disease •  Onc ology #Surgery• Hernia R epair & Reconstruction•  Inf ection Prevention •  Biosur gery #Urology &  critical care• A cute Urological Drainage •  Endour ology •  Homec are Urology •  T argeted Temperature Management#3BD position based on management’s internal estimates.
","('Employee_Health_And_Safety', 0.691949725151062)","('Access_And_Affordability', 0.041237328201532364)","('Employee_Engagement_Inclusion_And_Diversity', 0.038543153554201126)","(['Operational Eco-Efficiency'], 0.691949725151062)","('NON-ESG', 0.041237328201532364)","('NON-ESG', 0.038543153554201126)"
Line 110,"Represents leadership position across majority of each Business Unit’s portfolio.
","('Director_Removal', 0.2910580635070801)","('Business_Model_Resilience', 0.23944231867790222)","('Employee_Engagement_Inclusion_And_Diversity', 0.12308889627456665)","('NON-ESG', 0.2910580635070801)","('NON-ESG', 0.23944231867790222)","('NON-ESG', 0.12308889627456665)"
Line 111,"2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction>100 >25 >New product launches  expected by FY25New products with potential to generate $50m+ per year 4New products with potential to generate $30m – $50m per year 4Innovation at BD Research and development BD conducts its research and development (R&D) activities at its operating units and across global  enterprise centers of excellence located in the United States, India, China, Singapore and Ireland.
","('Supply_Chain_Management', 0.46817201375961304)","('Product_Design_And_Lifecycle_Management', 0.28702878952026367)","('Physical_Impacts_Of_Climate_Change', 0.05016078054904938)","('NON-ESG', 0.46817201375961304)","('NON-ESG', 0.28702878952026367)","('NON-ESG', 0.05016078054904938)"
Line 112,"2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction>100 >25 >New product launches  expected by FY25New products with potential to generate $50m+ per year 4New products with potential to generate $30m – $50m per year 4Innovation at BD Research and development BD conducts its research and development (R&D) activities at its operating units and across global  enterprise centers of excellence located in the United States, India, China, Singapore and Ireland.
","('Management_Of_Legal_And_Regulatory_Framework', 0.34064996242523193)","('Competitive_Behavior', 0.18015320599079132)","('Business_Model_Resilience', 0.047725725919008255)","('NON-ESG', 0.34064996242523193)","('NON-ESG', 0.18015320599079132)","('NON-ESG', 0.047725725919008255)"
Line 113,"The majority of BD’s R&D activities are conducted in North America.
","('Supply_Chain_Management', 0.26045241951942444)","('Business_Model_Resilience', 0.2533300220966339)","('Systemic_Risk_Management', 0.10044649243354797)","('NON-ESG', 0.26045241951942444)","('NON-ESG', 0.2533300220966339)","('NON-ESG', 0.10044649243354797)"
Line 114,"BD also collaborates with certain universities, medical centers and other entities on R&D programs and retains individual consultants and partners to support its efforts in specialized fields.
","('Access_And_Affordability', 0.3789554536342621)","('Employee_Engagement_Inclusion_And_Diversity', 0.08224660158157349)","('Management_Of_Legal_And_Regulatory_Framework', 0.07004082202911377)","('NON-ESG', 0.3789554536342621)","('NON-ESG', 0.08224660158157349)","('NON-ESG', 0.07004082202911377)"
Line 115,"Management highlights In April 2021, we announced the appointment of Elizabeth McCombs as executive vice president and  chief technology officer.
","('Business_Model_Resilience', 0.5490486025810242)","('Director_Removal', 0.09687209874391556)","('Product_Design_And_Lifecycle_Management', 0.05483866110444069)","(['Codes of Business Conduct'], 0.5490486025810242)","('NON-ESG', 0.09687209874391556)","('NON-ESG', 0.05483866110444069)"
Line 116,"She is responsible for driving the company’s category innovation strategy and leading all R&D activities, including executing the current innovation pipeline and developing the future product portfolio.
","('Product_Design_And_Lifecycle_Management', 0.9612016677856445)","('Product_Quality_And_Safety', 0.004631692543625832)","('Customer_Welfare', 0.0038683100137859583)","(['Product Stewardship'], 0.9612016677856445)","('NON-ESG', 0.004631692543625832)","('NON-ESG', 0.0038683100137859583)"
Line 117,"In April 2021, we also announced the creation of an external Scientific Advisory Board (SAB), which will  comprise key top medical opinion leaders, science and technology experts and experienced innovation leaders.
","('Management_Of_Legal_And_Regulatory_Framework', 0.47087860107421875)","('Ecological_Impacts', 0.058565665036439896)","('Director_Removal', 0.04749639332294464)","('NON-ESG', 0.47087860107421875)","('NON-ESG', 0.058565665036439896)","('NON-ESG', 0.04749639332294464)"
Line 118,"The SAB will review BD’s technology capabilities, innovation pipeline, tuck-in M&A (merger and acquisition) opportunities and early-stage investments.
","('Business_Model_Resilience', 0.6446918845176697)","('Product_Design_And_Lifecycle_Management', 0.09047489613294601)","('Supply_Chain_Management', 0.029224788770079613)","(['Codes of Business Conduct'], 0.6446918845176697)","('NON-ESG', 0.09047489613294601)","('NON-ESG', 0.029224788770079613)"
Line 119,"The SAB will also advise BD’s leadership on its growth prioritization as well as emerging trends in healthcare, science and technology, and the potential implications for BD.
","('Business_Model_Resilience', 0.635780930519104)","('Systemic_Risk_Management', 0.12808382511138916)","('Supply_Chain_Management', 0.03434285894036293)","(['Codes of Business Conduct'], 0.635780930519104)","('NON-ESG', 0.12808382511138916)","('NON-ESG', 0.03434285894036293)"
Line 120,"John DeFord, who retired as chief technology officer in May 2021, is the founding member and  co-chair of the SAB.
","('Director_Removal', 0.22535163164138794)","('Business_Model_Resilience', 0.20476680994033813)","('Systemic_Risk_Management', 0.08413268625736237)","('NON-ESG', 0.22535163164138794)","('NON-ESG', 0.20476680994033813)","('NON-ESG', 0.08413268625736237)"
Line 121,"The SAB is also co-chaired by BD’s senior vice president and chief scientific officer, Dr. Joseph M.
","('GHG_Emissions', 0.20074833929538727)","('Ecological_Impacts', 0.13238462805747986)","('Management_Of_Legal_And_Regulatory_Framework', 0.08165942877531052)","('NON-ESG', 0.20074833929538727)","('NON-ESG', 0.13238462805747986)","('NON-ESG', 0.08165942877531052)"
Line 122,"Smith,  who joined BD in November 2021.
","('Business_Model_Resilience', 0.2944639027118683)","('Systemic_Risk_Management', 0.12123128026723862)","('Director_Removal', 0.10319492965936661)","('NON-ESG', 0.2944639027118683)","('NON-ESG', 0.12123128026723862)","('NON-ESG', 0.10319492965936661)"
Line 123,"As chief scientific officer, Dr. Smith is primarily responsible for external innovation and BD’s technology roadmap to deliver transformative innovations.
","('Business_Model_Resilience', 0.4727421998977661)","('Product_Design_And_Lifecycle_Management', 0.14411911368370056)","('Supply_Chain_Management', 0.07750250399112701)","('NON-ESG', 0.4727421998977661)","('NON-ESG', 0.14411911368370056)","('NON-ESG', 0.07750250399112701)"
Line 124,"BD  announced the inaugural members of the SAB in May 2022.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5538883209228516)","('Director_Removal', 0.09530333429574966)","('Business_Model_Resilience', 0.029658343642950058)","(['Corporate Governance'], 0.5538883209228516)","('NON-ESG', 0.09530333429574966)","('NON-ESG', 0.029658343642950058)"
Line 125,"R&D initiativesIn December 2021, we announced  plans to invest €70 million over five years in BD’s Research Centre Ireland R&D Centre of Excellence in Limerick.
","('Business_Model_Resilience', 0.24000726640224457)","('Access_And_Affordability', 0.11020833253860474)","('Management_Of_Legal_And_Regulatory_Framework', 0.10191857814788818)","('NON-ESG', 0.24000726640224457)","('NON-ESG', 0.11020833253860474)","('NON-ESG', 0.10191857814788818)"
Line 126,"This investment will further  position the facility as a hub for the development of smart, secure and connected health and infection monitoring solutions in clinical and nonclinical settings.
","('Access_And_Affordability', 0.30676400661468506)","('Employee_Health_And_Safety', 0.22801782190799713)","('Product_Quality_And_Safety', 0.10132481902837753)","('NON-ESG', 0.30676400661468506)","('NON-ESG', 0.22801782190799713)","('NON-ESG', 0.10132481902837753)"
Line 127,"As a result, BD will add approximately 130 new, high-quality research and development positions in engineering and scientific disciplines such as software, electronics, hardware and immunology.
","('Access_And_Affordability', 0.2715752422809601)","('Ecological_Impacts', 0.1253683716058731)","('Management_Of_Legal_And_Regulatory_Framework', 0.06285933405160904)","('NON-ESG', 0.2715752422809601)","('NON-ESG', 0.1253683716058731)","('NON-ESG', 0.06285933405160904)"
Line 128,"The expansion of the facility will include a state-of-the-art laboratory, workspaces and technologies to support cutting-edge innovation.
","('Product_Design_And_Lifecycle_Management', 0.19530300796031952)","('Access_And_Affordability', 0.12307961285114288)","('Employee_Engagement_Inclusion_And_Diversity', 0.11613602936267853)","('NON-ESG', 0.19530300796031952)","('NON-ESG', 0.12307961285114288)","('NON-ESG', 0.11613602936267853)"
Line 129,"This project is supported by the Irish  Government through IDA Ireland.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9145577549934387)","('Human_Rights_And_Community_Relations', 0.01424364373087883)","('Access_And_Affordability', 0.007826115004718304)","(['Corporate Governance'], 0.9145577549934387)","('NON-ESG', 0.01424364373087883)","('NON-ESG', 0.007826115004718304)"
Line 130,"4Revenues are based on estimated fifth-year sales post launch, which may occur after FY25.
","('Business_Model_Resilience', 0.2136705368757248)","('Systemic_Risk_Management', 0.19860005378723145)","('Competitive_Behavior', 0.1526658833026886)","('NON-ESG', 0.2136705368757248)","('NON-ESG', 0.19860005378723145)","('NON-ESG', 0.1526658833026886)"
Line 131,"2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionCredit: Tobias Wuestefeld / illustratoren.de Product launches Our continued commitment to and significant investment in R&D have once again  enabled BD to launch new and innovative products and technologies.
","('Supply_Chain_Management', 0.7872100472450256)","('Product_Design_And_Lifecycle_Management', 0.05755883827805519)","('Physical_Impacts_Of_Climate_Change', 0.0432528480887413)","(['Supply Chain Management'], 0.7872100472450256)","('NON-ESG', 0.05755883827805519)","('NON-ESG', 0.0432528480887413)"
Line 132,"Here are some that launched in 2021.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2616420090198517)","('Business_Model_Resilience', 0.13288675248622894)","('Competitive_Behavior', 0.1024957224726677)","('NON-ESG', 0.2616420090198517)","('NON-ESG', 0.13288675248622894)","('NON-ESG', 0.1024957224726677)"
Line 133,"BD ® AbSeq Immune Discovery Panel: a tool that enables researchers to uncover up  to 30 immune markers in a single experiment, offering convenience, reliability and  flexibility as both a multiomics-enabled and cost-efficient tool to aid in immune research and discovery.
","('Customer_Welfare', 0.15020988881587982)","('Access_And_Affordability', 0.1288294494152069)","('Competitive_Behavior', 0.09436741471290588)","('NON-ESG', 0.15020988881587982)","('NON-ESG', 0.1288294494152069)","('NON-ESG', 0.09436741471290588)"
Line 134,"BD COR™ Molecular Diagnostic System: a new, fully automated, high-throughput  molecular diagnostic platform that uses robotics and sample management software algorithms to set a new standard in automation for infectious disease molecular testing in core and other centralized laboratories in the U.S. This system allows the BD Onclarity™ HPV Assay with extended genotyping for the BD COR™ System to be made available to the high-throughput labs that process the majority of cervical cancer screening specimens in the U.S.BD FACSymphony™ A1 Cell Analyzer: a new fluorescence-activated cell analyzer that offers advanced research capabilities in a compact design, and helps improve access to instrumentation for complex scientific research for laboratories of all sizes.
","('Access_And_Affordability', 0.24934636056423187)","('Customer_Welfare', 0.13099762797355652)","('Competitive_Behavior', 0.07111470401287079)","('NON-ESG', 0.24934636056423187)","('NON-ESG', 0.13099762797355652)","('NON-ESG', 0.07111470401287079)"
Line 135,"BD COR™ Molecular Diagnostic System: a new, fully automated, high-throughput  molecular diagnostic platform that uses robotics and sample management software algorithms to set a new standard in automation for infectious disease molecular testing in core and other centralized laboratories in the U.S. This system allows the BD Onclarity™ HPV Assay with extended genotyping for the BD COR™ System to be made available to the high-throughput labs that process the majority of cervical cancer screening specimens in the U.S.BD FACSymphony™ A1 Cell Analyzer: a new fluorescence-activated cell analyzer that offers advanced research capabilities in a compact design, and helps improve access to instrumentation for complex scientific research for laboratories of all sizes.
","('Energy_Management', 0.17475396394729614)","('GHG_Emissions', 0.15115906298160553)","('Access_And_Affordability', 0.11611520498991013)","('NON-ESG', 0.17475396394729614)","('NON-ESG', 0.15115906298160553)","('NON-ESG', 0.11611520498991013)"
Line 136,"BD Kiestra™ Lab Automation System: U.S. launch of Urine Culture Application for  use with the BD Kiestra™ lab automation, incubation and imaging system that can transform the way microbiology labs approach urine culture analysis.
","('Waste_And_Hazardous_Materials_Management', 0.3835735619068146)","('Water_And_Wastewater_Management', 0.12111014127731323)","('Customer_Welfare', 0.10292332619428635)","('NON-ESG', 0.3835735619068146)","('NON-ESG', 0.12111014127731323)","('NON-ESG', 0.10292332619428635)"
Line 137,"The application was designed using artificial intelligence.
","('Data_Security', 0.47985559701919556)","('Competitive_Behavior', 0.0731343924999237)","('Business_Model_Resilience', 0.051064055413007736)","('NON-ESG', 0.47985559701919556)","('NON-ESG', 0.0731343924999237)","('NON-ESG', 0.051064055413007736)"
Line 138,"BD Pristine™ Long-Term Hemodialysis Catheter: a differentiated product that  received 510(k) clearance in 2021, adding to the company’s diversified portfolio to support clinicians who care for end-stage kidney disease patients requiring hemodialysis.
","('Access_And_Affordability', 0.2911052405834198)","('Customer_Welfare', 0.16145944595336914)","('Employee_Engagement_Inclusion_And_Diversity', 0.07521113008260727)","('NON-ESG', 0.2911052405834198)","('NON-ESG', 0.16145944595336914)","('NON-ESG', 0.07521113008260727)"
Line 139,"BD Onclarity™ HPV Assay CE marked for Self-Collection: an industry-first product  that allows laboratories and facilities to process at-home, self-collected vaginal samples.
","('Customer_Welfare', 0.23689986765384674)","('Waste_And_Hazardous_Materials_Management', 0.10826173424720764)","('Selling_Practices_And_Product_Labeling', 0.10664684325456619)","('NON-ESG', 0.23689986765384674)","('NON-ESG', 0.10826173424720764)","('NON-ESG', 0.10664684325456619)"
Line 140,"BD Surgiphor™ Surgical Irrigation System: an industry-first, ready-to-use,  iodine-based surgical irrigation system that mechanically loosens and removes wound debris.
","('Water_And_Wastewater_Management', 0.4866151809692383)","('Waste_And_Hazardous_Materials_Management', 0.19044087827205658)","('Customer_Welfare', 0.04009775072336197)","('NON-ESG', 0.4866151809692383)","('NON-ESG', 0.19044087827205658)","('NON-ESG', 0.04009775072336197)"
Line 141,"New BD innovation in flow Cytometry BD was profiled in a cover story of the January issue of Science  magazine, demonstrating landmark advancement in flow Cytometry technology with potential to transform a wide range of disciplines, from immunology and genomics research to cell-based therapeutics.FY19 FY20 FYResearch and development expense (in millions) $1,062 $1,096 $1,% of revenues 6.1% 6.4% 6.6% 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionOur Durable Core—approximately $14 billion of our FY 2021  revenue—consists of our well-known products and solutions that form the backbone of healthcare around the world: blood collection tubes, ports and catheters; syringes; urinary catheters; acute care pumps and IV sets; hernia mesh; and blood culture testing.
","('Supply_Chain_Management', 0.8596330881118774)","('Product_Design_And_Lifecycle_Management', 0.047522109001874924)","('Customer_Welfare', 0.010541794821619987)","(['Supply Chain Management'], 0.8596330881118774)","('NON-ESG', 0.047522109001874924)","('NON-ESG', 0.010541794821619987)"
Line 142,"New BD innovation in flow Cytometry BD was profiled in a cover story of the January issue of Science  magazine, demonstrating landmark advancement in flow Cytometry technology with potential to transform a wide range of disciplines, from immunology and genomics research to cell-based therapeutics.FY19 FY20 FYResearch and development expense (in millions) $1,062 $1,096 $1,% of revenues 6.1% 6.4% 6.6% 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionOur Durable Core—approximately $14 billion of our FY 2021  revenue—consists of our well-known products and solutions that form the backbone of healthcare around the world: blood collection tubes, ports and catheters; syringes; urinary catheters; acute care pumps and IV sets; hernia mesh; and blood culture testing.
","('Physical_Impacts_Of_Climate_Change', 0.886287271976471)","('Critical_Incident_Risk_Management', 0.016981955617666245)","('Business_Model_Resilience', 0.014270996674895287)","(['Climate Change'], 0.886287271976471)","('NON-ESG', 0.016981955617666245)","('NON-ESG', 0.014270996674895287)"
Line 143,"The Durable Core touches 90 percent of people in the hospital with 45 billion medical devices each year.
","('Product_Design_And_Lifecycle_Management', 0.44914311170578003)","('Energy_Management', 0.14001166820526123)","('Access_And_Affordability', 0.09795556217432022)","('NON-ESG', 0.44914311170578003)","('NON-ESG', 0.14001166820526123)","('NON-ESG', 0.09795556217432022)"
Line 144,"The performance of our Durable Core fuels our investments  in Transformative Solutions, which constitute about $4 billion of our FY 2021 revenue.
","('Business_Model_Resilience', 0.5276274681091309)","('Product_Design_And_Lifecycle_Management', 0.1032005026936531)","('Systemic_Risk_Management', 0.06384816020727158)","(['Codes of Business Conduct'], 0.5276274681091309)","('NON-ESG', 0.1032005026936531)","('NON-ESG', 0.06384816020727158)"
Line 145,"These are advances in higher-growth spaces that are transforming the future of global healthcare and that we are targeting with our R&D and M&A investments.
","('Business_Model_Resilience', 0.505959153175354)","('Systemic_Risk_Management', 0.1373933106660843)","('Supply_Chain_Management', 0.046781621873378754)","(['Codes of Business Conduct'], 0.505959153175354)","('NON-ESG', 0.1373933106660843)","('NON-ESG', 0.046781621873378754)"
Line 146,"The future of healthcare is changing, and we see three  irreversible forces that are going to be shaping healthcare in new ways.
","('Business_Model_Resilience', 0.2594665288925171)","('Systemic_Risk_Management', 0.15526089072227478)","('Access_And_Affordability', 0.07728104293346405)","('NON-ESG', 0.2594665288925171)","('NON-ESG', 0.15526089072227478)","('NON-ESG', 0.07728104293346405)"
Line 147,"•  Smart c onnected care: Artificial Intelligence (AI),  informatics and robotics will transform healthcare processes,  tools and treatments.
","('Business_Model_Resilience', 0.1625591516494751)","('Data_Security', 0.15188157558441162)","('Competitive_Behavior', 0.08126981556415558)","('NON-ESG', 0.1625591516494751)","('NON-ESG', 0.15188157558441162)","('NON-ESG', 0.08126981556415558)"
Line 148,"•  A shift to ne w care settings: Care is moving increasingly  to surgery centers, ambulatory centers, retail clinics and the home, a trend accelerated during the COVID-19 pandemic.
","('Access_And_Affordability', 0.5256294012069702)","('Critical_Incident_Risk_Management', 0.0942135751247406)","('Employee_Health_And_Safety', 0.08749612420797348)","(['Health Outcome Contribution'], 0.5256294012069702)","('NON-ESG', 0.0942135751247406)","('NON-ESG', 0.08749612420797348)"
Line 149,"This is creating significant opportunities for us to reinvent solutions that will improve patient outcomes in these settings, while lowering costs.
","('Access_And_Affordability', 0.668240487575531)","('Customer_Welfare', 0.032704323530197144)","('Critical_Incident_Risk_Management', 0.02924424409866333)","(['Health Outcome Contribution'], 0.668240487575531)","('NON-ESG', 0.032704323530197144)","('NON-ESG', 0.02924424409866333)"
Line 150,"•  Chr onic disease outcomes: Improving outcomes in chronic  disease is a leading global health priority.
","('Employee_Health_And_Safety', 0.6753939986228943)","('Product_Quality_And_Safety', 0.04421594366431236)","('Access_And_Affordability', 0.03875786066055298)","(['Operational Eco-Efficiency'], 0.6753939986228943)","('NON-ESG', 0.04421594366431236)","('NON-ESG', 0.03875786066055298)"
Line 151,"Although it is traditionally addressed by the pharmaceutical industry with treatment through medication, BD has tackled infectious disease challenges and looks forward to stepping up in a meaningful way, using technology innovation to positively impact chronic disease treatment.Two axes of growth: durable core and transformative solutions Backbone of healthcare Reinventing the future of healthcare Smart connected care AI, informatics and robotics will transform healthcare processes, tools and treatments.New care settings Shift into new settings creates major opportunities to improve patient outcomes and costs.Chronic disease outcomes Medical technology will have a growing role in improving outcomes in chronic diseases.
","('Access_And_Affordability', 0.23044930398464203)","('Systemic_Risk_Management', 0.12626998126506805)","('Business_Model_Resilience', 0.11122608929872513)","('NON-ESG', 0.23044930398464203)","('NON-ESG', 0.12626998126506805)","('NON-ESG', 0.11122608929872513)"
Line 152,"Although it is traditionally addressed by the pharmaceutical industry with treatment through medication, BD has tackled infectious disease challenges and looks forward to stepping up in a meaningful way, using technology innovation to positively impact chronic disease treatment.Two axes of growth: durable core and transformative solutions Backbone of healthcare Reinventing the future of healthcare Smart connected care AI, informatics and robotics will transform healthcare processes, tools and treatments.New care settings Shift into new settings creates major opportunities to improve patient outcomes and costs.Chronic disease outcomes Medical technology will have a growing role in improving outcomes in chronic diseases.
","('Employee_Health_And_Safety', 0.60663241147995)","('Access_And_Affordability', 0.10072886198759079)","('Product_Quality_And_Safety', 0.04831891879439354)","(['Operational Eco-Efficiency'], 0.60663241147995)","('NON-ESG', 0.10072886198759079)","('NON-ESG', 0.04831891879439354)"
Line 153,"5FY21 revenue excluding $2.0 billion of COVID-only testing.
","('Competitive_Behavior', 0.30398210883140564)","('Management_Of_Legal_And_Regulatory_Framework', 0.2022498995065689)","('Systemic_Risk_Management', 0.08778887242078781)","('NON-ESG', 0.30398210883140564)","('NON-ESG', 0.2022498995065689)","('NON-ESG', 0.08778887242078781)"
Line 154,"Refer to the BD Q4 FY21 earnings presentation for a reconciliation back to GAAP revenue.~$14BDurable core ~$4BTransformative solutions 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionStakeholder engagement Due to our global reach and the nature of our work, we serve and rely on a wide range of stakeholders.
","('Supply_Chain_Management', 0.7058850526809692)","('Physical_Impacts_Of_Climate_Change', 0.16040146350860596)","('Business_Model_Resilience', 0.02602132223546505)","(['Supply Chain Management'], 0.7058850526809692)","('NON-ESG', 0.16040146350860596)","('NON-ESG', 0.02602132223546505)"
Line 155,"Engaging with them  through a variety of channels across many parts of our organization is critical to how we apply the principle of shared value and therefore is essential to our business success.
","('Business_Model_Resilience', 0.6574991345405579)","('Systemic_Risk_Management', 0.03872157260775566)","('Product_Design_And_Lifecycle_Management', 0.03806902840733528)","(['Codes of Business Conduct'], 0.6574991345405579)","('NON-ESG', 0.03872157260775566)","('NON-ESG', 0.03806902840733528)"
Line 156,"Often, we work collaboratively with stakeholders who share our objectives and, in the process, we gain a deep understanding of their work.
","('Human_Rights_And_Community_Relations', 0.7496626377105713)","('Business_Model_Resilience', 0.03586553782224655)","('Management_Of_Legal_And_Regulatory_Framework', 0.019896728917956352)","(['Community Relations'], 0.7496626377105713)","('NON-ESG', 0.03586553782224655)","('NON-ESG', 0.019896728917956352)"
Line 157,"We listen to our stakeholders’ views and suggestions, and use that feedback to improve our products, services and business practices.
","('Product_Design_And_Lifecycle_Management', 0.7161786556243896)","('Business_Model_Resilience', 0.10604595392942429)","('Supply_Chain_Management', 0.020336773246526718)","(['Product Stewardship'], 0.7161786556243896)","('NON-ESG', 0.10604595392942429)","('NON-ESG', 0.020336773246526718)"
Line 158,"Stakeholder group How we conduct meaningful engagementAdditional ways for stakeholders to engage with us  Customers To create a deep understanding of the healthcare  market and its customers, and to provide education and training to expand those markets, we strategically engage with our customers in all regions where we operate.
","('Business_Model_Resilience', 0.5096009373664856)","('Employee_Engagement_Inclusion_And_Diversity', 0.12105396389961243)","('Human_Rights_And_Community_Relations', 0.0669030174612999)","(['Codes of Business Conduct'], 0.5096009373664856)","('NON-ESG', 0.12105396389961243)","('NON-ESG', 0.0669030174612999)"
Line 159,"This allows us to develop and deploy products and solutions to meet customers’ needs, today and in the future.Engagement is carried out primarily through our Sales and Marketing teams, who are often located close to their customers.
","('Product_Design_And_Lifecycle_Management', 0.9554088115692139)","('Business_Model_Resilience', 0.005600143689662218)","('Customer_Welfare', 0.004676667973399162)","(['Product Stewardship'], 0.9554088115692139)","('NON-ESG', 0.005600143689662218)","('NON-ESG', 0.004676667973399162)"
Line 160,"This allows them to better understand the needs and culture of our customers and the patients they serve.
","('Product_Design_And_Lifecycle_Management', 0.16101054847240448)","('Customer_Welfare', 0.14690914750099182)","('Business_Model_Resilience', 0.12952440977096558)","('NON-ESG', 0.16101054847240448)","('NON-ESG', 0.14690914750099182)","('NON-ESG', 0.12952440977096558)"
Line 161,"Often, senior leaders and/or leaders from functions such as  Sustainability, Quality and Procurement will engage with strategic customers on specific topics.
","('Business_Model_Resilience', 0.5895825624465942)","('Product_Design_And_Lifecycle_Management', 0.06766296923160553)","('Director_Removal', 0.060451071709394455)","(['Codes of Business Conduct'], 0.5895825624465942)","('NON-ESG', 0.06766296923160553)","('NON-ESG', 0.060451071709394455)"
Line 162,"customer_support@bd.com1.844.8.BD.LIFE (+844.823.5433).Or local customer support Shareholders Our focus on shareholders is to communicate that the combination of our business and geographic diversity—our balanced capital allocation and our drive for efficiency—provides a long-term pathway toward sustainable profit growth that returns capital to shareholders.We engage with shareholders in a variety of forms, including annual shareholder meetings, quarterly calls, an annual shareholder outreach program, and other in-person meetings and investor events such as conferences.
","('Business_Model_Resilience', 0.36749377846717834)","('Employee_Engagement_Inclusion_And_Diversity', 0.1108439564704895)","('Customer_Privacy', 0.07975923269987106)","('NON-ESG', 0.36749377846717834)","('NON-ESG', 0.1108439564704895)","('NON-ESG', 0.07975923269987106)"
Line 163,"customer_support@bd.com1.844.8.BD.LIFE (+844.823.5433).Or local customer support Shareholders Our focus on shareholders is to communicate that the combination of our business and geographic diversity—our balanced capital allocation and our drive for efficiency—provides a long-term pathway toward sustainable profit growth that returns capital to shareholders.We engage with shareholders in a variety of forms, including annual shareholder meetings, quarterly calls, an annual shareholder outreach program, and other in-person meetings and investor events such as conferences.
","('Management_Of_Legal_And_Regulatory_Framework', 0.38714224100112915)","('Business_Model_Resilience', 0.0769352912902832)","('Director_Removal', 0.07435080409049988)","('NON-ESG', 0.38714224100112915)","('NON-ESG', 0.0769352912902832)","('NON-ESG', 0.07435080409049988)"
Line 164,"Engagement is often with more significant holders; however, we also engage with groups of smaller investors on specific topics.
","('Management_Of_Legal_And_Regulatory_Framework', 0.23768483102321625)","('Competitive_Behavior', 0.16062292456626892)","('Business_Model_Resilience', 0.14138849079608917)","('NON-ESG', 0.23768483102321625)","('NON-ESG', 0.16062292456626892)","('NON-ESG', 0.14138849079608917)"
Line 165,"investor.relations@bd.com+1-800-284-6845.
","('Business_Model_Resilience', 0.23079481720924377)","('Management_Of_Legal_And_Regulatory_Framework', 0.14759637415409088)","('Systemic_Risk_Management', 0.081440769135952)","('NON-ESG', 0.23079481720924377)","('NON-ESG', 0.14759637415409088)","('NON-ESG', 0.081440769135952)"
Line 166,"BD associates The attraction, development and retention of talent are critical to executing our strategy and fulfilling our Purpose.
","('Employee_Engagement_Inclusion_And_Diversity', 0.955944836139679)","('Employee_Health_And_Safety', 0.00469762459397316)","('Business_Model_Resilience', 0.0027010617777705193)","(['Human Capital Development'], 0.955944836139679)","('NON-ESG', 0.00469762459397316)","('NON-ESG', 0.0027010617777705193)"
Line 167,"We are committed to being an employer of choice by supporting associates’ well-being in all aspects of their personal and work lives.We engage and develop relationships with associates through a variety of mechanisms.
","('Human_Rights_And_Community_Relations', 0.3116590678691864)","('Employee_Health_And_Safety', 0.22727379202842712)","('Employee_Engagement_Inclusion_And_Diversity', 0.10930490493774414)","('NON-ESG', 0.3116590678691864)","('NON-ESG', 0.22727379202842712)","('NON-ESG', 0.10930490493774414)"
Line 168,"Our associate resource groups provide a forum for associates and their allies to drive change while fostering a deep sense of community within the company and surrounding communities we serve.
","('Human_Rights_And_Community_Relations', 0.9485909342765808)","('Employee_Engagement_Inclusion_And_Diversity', 0.005433498416095972)","('Access_And_Affordability', 0.004110441077500582)","(['Community Relations'], 0.9485909342765808)","('NON-ESG', 0.005433498416095972)","('NON-ESG', 0.004110441077500582)"
Line 169,"Where appropriate, engagement is carried out in the local language in order to address language barriers and create inclusion.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9432002305984497)","('Human_Rights_And_Community_Relations', 0.009170318953692913)","('Access_And_Affordability', 0.0060051241889595985)","(['Human Capital Development'], 0.9432002305984497)","('NON-ESG', 0.009170318953692913)","('NON-ESG', 0.0060051241889595985)"
Line 170,"Voice of Associate surveys, skip-level meetings and town halls are used to solicit associate feedback, and our mentoring and leadership development programs focus on building leadership capabilities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7707798480987549)","('Business_Model_Resilience', 0.03395508974790573)","('Director_Removal', 0.02648310549557209)","(['Human Capital Development'], 0.7707798480987549)","('NON-ESG', 0.03395508974790573)","('NON-ESG', 0.02648310549557209)"
Line 171,"Current associates can engage with BD via: •  Int ernal social media platforms •  Ethics Helpline, anon ymous  online reporting tool and email at  ethicsoffice@bd.com •  HR Helpline and the Emplo yee Relations  team •  Quart erly town halls Future associates can engage with us via: •  Our C areers website  •  Link edIn 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionStakeholder group How we conduct meaningful engagementAdditional ways for stakeholders to  engage with us  Business partners Our suppliers, distributors and other partners in the supply chain help us effectively serve our customers around the world.
","('Supply_Chain_Management', 0.49752748012542725)","('Physical_Impacts_Of_Climate_Change', 0.130972757935524)","('Business_Ethics', 0.0741611197590828)","('NON-ESG', 0.49752748012542725)","('NON-ESG', 0.130972757935524)","('NON-ESG', 0.0741611197590828)"
Line 172,"Current associates can engage with BD via: •  Int ernal social media platforms •  Ethics Helpline, anon ymous  online reporting tool and email at  ethicsoffice@bd.com •  HR Helpline and the Emplo yee Relations  team •  Quart erly town halls Future associates can engage with us via: •  Our C areers website  •  Link edIn 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionStakeholder group How we conduct meaningful engagementAdditional ways for stakeholders to  engage with us  Business partners Our suppliers, distributors and other partners in the supply chain help us effectively serve our customers around the world.
","('Supply_Chain_Management', 0.9360262155532837)","('Product_Design_And_Lifecycle_Management', 0.008187271654605865)","('Labor_Practices', 0.005791358184069395)","(['Supply Chain Management'], 0.9360262155532837)","('NON-ESG', 0.008187271654605865)","('NON-ESG', 0.005791358184069395)"
Line 173,"Our close engagement with these partners allows us to collaborate with them on critical initiatives, allowing us to build an agile and resilient supply chain.We engage our partners through a variety of strategic programs.
","('Supply_Chain_Management', 0.9348445534706116)","('Business_Model_Resilience', 0.010316834785044193)","('Product_Design_And_Lifecycle_Management', 0.005834690295159817)","(['Supply Chain Management'], 0.9348445534706116)","('NON-ESG', 0.010316834785044193)","('NON-ESG', 0.005834690295159817)"
Line 174,"Engagement is primarily carried out by supplier relationship owners, category managers and procurement managers within our procurement function, as well as the Global Supply Chain, Quality, R&D functions and the central Product Stewardship team.
","('Supply_Chain_Management', 0.9280202388763428)","('Product_Design_And_Lifecycle_Management', 0.015156906098127365)","('Labor_Practices', 0.0042410073801875114)","(['Supply Chain Management'], 0.9280202388763428)","('NON-ESG', 0.015156906098127365)","('NON-ESG', 0.0042410073801875114)"
Line 175,"• supplier_diversity@bd.com  • BDResponsibleSourcing@bd.com •  Ne w product ideas –  BDTechnologiesBusDev@bd.com   Community affairs and local operations engagementCOVID-19 and evolving needs to address pandemic preparedness have highlighted the critical role community engagement plays in ensuring continuity of operations and preventing supply chain disruptions.
","('Supply_Chain_Management', 0.9527531862258911)","('Product_Design_And_Lifecycle_Management', 0.003950418904423714)","('Labor_Practices', 0.003633638611063361)","(['Supply Chain Management'], 0.9527531862258911)","('NON-ESG', 0.003950418904423714)","('NON-ESG', 0.003633638611063361)"
Line 176,"The increasing importance of trade policy, cross - border collaboration and globalization  requires alignment and cooperation with local officials who affect the well-being of BD operations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8626498579978943)","('Competitive_Behavior', 0.022650104016065598)","('Human_Rights_And_Community_Relations', 0.018186518922448158)","(['Corporate Governance'], 0.8626498579978943)","('NON-ESG', 0.022650104016065598)","('NON-ESG', 0.018186518922448158)"
Line 177,"Facility leadership plays an important role in developing relationships with local stakeholders and government officials who can help BD achieve economic development, sustainability and customer engagement goals.Deploying proactive, strategic stakeholder engagement serves to strengthen relationships with community leaders in locales where we operate and to promote associate involvement and the pipeline of talent.
","('Human_Rights_And_Community_Relations', 0.9350398182868958)","('Employee_Engagement_Inclusion_And_Diversity', 0.007645952049642801)","('Access_And_Affordability', 0.005995850544422865)","(['Community Relations'], 0.9350398182868958)","('NON-ESG', 0.007645952049642801)","('NON-ESG', 0.005995850544422865)"
Line 178,"Strong local engagement also drives economic development, sustainability and supply chain resiliency goals.Stakeholder group How we conduct meaningful engagementAdditional ways for stakeholders to  engage with us  Governments, policymakers and  regulatory bodiesWe engage at the agency and legislative levels in many countries to enhance our understanding of governments’ priorities.
","('Supply_Chain_Management', 0.8725847005844116)","('Business_Model_Resilience', 0.03462132811546326)","('Product_Design_And_Lifecycle_Management', 0.015261296182870865)","(['Supply Chain Management'], 0.8725847005844116)","('NON-ESG', 0.03462132811546326)","('NON-ESG', 0.015261296182870865)"
Line 179,"Through these engagements, we seek ways to deploy our capabilities, products and solutions to help support and achieve national health objectives.
","('Product_Design_And_Lifecycle_Management', 0.9235842227935791)","('Product_Quality_And_Safety', 0.013960175216197968)","('Customer_Welfare', 0.010714846663177013)","(['Product Stewardship'], 0.9235842227935791)","('NON-ESG', 0.013960175216197968)","('NON-ESG', 0.010714846663177013)"
Line 180,"This includes participation in public-private partnerships and collaborative communities supporting product safety, cybersecurity and technical standard initiatives to support the advancement of innovation and how innovation is regulated to bring technologies to market faster while prioritizing product safety.We engage governments and policymakers in various ways, primarily through our Global Public Affairs team.
","('Product_Quality_And_Safety', 0.9194137454032898)","('Selling_Practices_And_Product_Labeling', 0.010124552063643932)","('Employee_Health_And_Safety', 0.00938236154615879)","(['Product Quality & Recall Management'], 0.9194137454032898)","('NON-ESG', 0.010124552063643932)","('NON-ESG', 0.00938236154615879)"
Line 181,"In addition, we engage on a variety of topics via trade associations and technical coalitions, where a partnership approach allows us to more effectively drive change.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7294437885284424)","('Competitive_Behavior', 0.07050777971744537)","('Human_Rights_And_Community_Relations', 0.029618218541145325)","(['Corporate Governance'], 0.7294437885284424)","('NON-ESG', 0.07050777971744537)","('NON-ESG', 0.029618218541145325)"
Line 182,"International agencies and nongovernmental organizations (NGOs)We engage with international organizations (e.g., World Health Organization), NGOs (e.g., the Global Fund) and the public sector (e.g., Institute for Safe Medication Practices) to understand unmet needs and priority challenges; to provide global humanitarian relief; to serve vulnerable populations; and to collaborate on health system strengthening initiatives in support of global public health.We engage with international organizations through direct partnership in delivery programs as well as by providing complementary support aligned with global public health initiatives.
","('Access_And_Affordability', 0.3682068884372711)","('Critical_Incident_Risk_Management', 0.2271430641412735)","('Human_Rights_And_Community_Relations', 0.2012866586446762)","('NON-ESG', 0.3682068884372711)","('NON-ESG', 0.2271430641412735)","('NON-ESG', 0.2012866586446762)"
Line 183,"International agencies and nongovernmental organizations (NGOs)We engage with international organizations (e.g., World Health Organization), NGOs (e.g., the Global Fund) and the public sector (e.g., Institute for Safe Medication Practices) to understand unmet needs and priority challenges; to provide global humanitarian relief; to serve vulnerable populations; and to collaborate on health system strengthening initiatives in support of global public health.We engage with international organizations through direct partnership in delivery programs as well as by providing complementary support aligned with global public health initiatives.
","('Access_And_Affordability', 0.7694590091705322)","('Human_Rights_And_Community_Relations', 0.04222149774432182)","('Management_Of_Legal_And_Regulatory_Framework', 0.03738941252231598)","(['Health Outcome Contribution'], 0.7694590091705322)","('NON-ESG', 0.04222149774432182)","('NON-ESG', 0.03738941252231598)"
Line 184,"We engage through participation in private sector constituencies, by responding to public requests for information, through publication of white papers, by witnessing the work of our humanitarian relief partners and policy briefs, and by investing BD’s resources and people in support of these programs.
","('Human_Rights_And_Community_Relations', 0.5689442753791809)","('Critical_Incident_Risk_Management', 0.11531383544206619)","('Access_And_Affordability', 0.08485526591539383)","(['Community Relations'], 0.5689442753791809)","('NON-ESG', 0.11531383544206619)","('NON-ESG', 0.08485526591539383)"
Line 185,"Stakeholders can also engage with us via these channels: • BD’s Ext ernal Funding Program,  FundingRequest@bd.com or visit  www.bd.com/en-us/about-bd/global- funding• Media C ontacts webpage •  Priv acy – privacy@bd.com• Facebook • Instagram • LinkedIn• Twitter • YouTube 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionESG assessment BD partnered with Business for Social Responsibility™ (BSR™)—a global nonprofit  organization of sustainable business experts that works with its global network of the world’s leading companies to help build a just and sustainable world—to carry out an assessment of ESG issues relevant to BD and important to our stakeholders.
","('Supply_Chain_Management', 0.4689316153526306)","('Physical_Impacts_Of_Climate_Change', 0.34811070561408997)","('Business_Model_Resilience', 0.04095249995589256)","('NON-ESG', 0.4689316153526306)","('NON-ESG', 0.34811070561408997)","('NON-ESG', 0.04095249995589256)"
Line 186,"Stakeholders can also engage with us via these channels: • BD’s Ext ernal Funding Program,  FundingRequest@bd.com or visit  www.bd.com/en-us/about-bd/global- funding• Media C ontacts webpage •  Priv acy – privacy@bd.com• Facebook • Instagram • LinkedIn• Twitter • YouTube 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change IntroductionESG assessment BD partnered with Business for Social Responsibility™ (BSR™)—a global nonprofit  organization of sustainable business experts that works with its global network of the world’s leading companies to help build a just and sustainable world—to carry out an assessment of ESG issues relevant to BD and important to our stakeholders.
","('Business_Model_Resilience', 0.6129058599472046)","('Human_Rights_And_Community_Relations', 0.0662727877497673)","('Systemic_Risk_Management', 0.06398507207632065)","(['Codes of Business Conduct'], 0.6129058599472046)","('NON-ESG', 0.0662727877497673)","('NON-ESG', 0.06398507207632065)"
Line 187,"This assessment was carried out in 2019.
","('Management_Of_Legal_And_Regulatory_Framework', 0.39376845955848694)","('GHG_Emissions', 0.14371539652347565)","('Ecological_Impacts', 0.12229938060045242)","('NON-ESG', 0.39376845955848694)","('NON-ESG', 0.14371539652347565)","('NON-ESG', 0.12229938060045242)"
Line 188,"A series of interviews were conducted across stakeholder groups, geographies and  job levels to identify and refine relevant ESG issues for the organization.
","('Human_Rights_And_Community_Relations', 0.5479850769042969)","('Business_Model_Resilience', 0.1127532422542572)","('Competitive_Behavior', 0.04296702891588211)","(['Community Relations'], 0.5479850769042969)","('NON-ESG', 0.1127532422542572)","('NON-ESG', 0.04296702891588211)"
Line 189,"A full list of our ESG issues and how we define them can be found in the appendices.
","('Systemic_Risk_Management', 0.24690519273281097)","('Management_Of_Legal_And_Regulatory_Framework', 0.1591532677412033)","('Business_Model_Resilience', 0.1502394676208496)","('NON-ESG', 0.24690519273281097)","('NON-ESG', 0.1591532677412033)","('NON-ESG', 0.1502394676208496)"
Line 190,"BSR™ conducted a workshop with associates to help us develop qualitative  scenarios to stress-test our assessment of ESG issues for plausible future developments.
","('Business_Model_Resilience', 0.507361650466919)","('Systemic_Risk_Management', 0.16405659914016724)","('Ecological_Impacts', 0.048024389892816544)","(['Codes of Business Conduct'], 0.507361650466919)","('NON-ESG', 0.16405659914016724)","('NON-ESG', 0.048024389892816544)"
Line 191,"This allowed us to determine which issues are likely to increase in importance, regardless of scenario, and which issues are highly dynamic—in other words, those issues that are more responsive to different scenarios—and therefore require close monitoring and a foresight-driven management approach.
","('Systemic_Risk_Management', 0.7538107633590698)","('Business_Model_Resilience', 0.06778303533792496)","('Physical_Impacts_Of_Climate_Change', 0.0484352670609951)","(['Risk & Crisis Management'], 0.7538107633590698)","('NON-ESG', 0.06778303533792496)","('NON-ESG', 0.0484352670609951)"
Line 192,"Further details on this approach can be found in the Scenario Analysis section.
","('Physical_Impacts_Of_Climate_Change', 0.24184206128120422)","('Business_Model_Resilience', 0.18343497812747955)","('GHG_Emissions', 0.1349552571773529)","('NON-ESG', 0.24184206128120422)","('NON-ESG', 0.18343497812747955)","('NON-ESG', 0.1349552571773529)"
Line 193,"The following graphic shows each of our ESG issues in relation to importance to  BD’s success and importance to stakeholders.
","('Human_Rights_And_Community_Relations', 0.3984110355377197)","('Business_Model_Resilience', 0.23925280570983887)","('Systemic_Risk_Management', 0.054419808089733124)","('NON-ESG', 0.3984110355377197)","('NON-ESG', 0.23925280570983887)","('NON-ESG', 0.054419808089733124)"
Line 194,"Also indicated are issues that were identified as highly dynamic and/or moved to the top-right quadrant (increased in importance) during our future scenario assessment.
","('Business_Model_Resilience', 0.3745061755180359)","('Physical_Impacts_Of_Climate_Change', 0.2929244041442871)","('Systemic_Risk_Management', 0.10202927142381668)","('NON-ESG', 0.3745061755180359)","('NON-ESG', 0.2929244041442871)","('NON-ESG', 0.10202927142381668)"
Line 195,"Details of how we manage our ESG issues can be found in the appendices.
","('Systemic_Risk_Management', 0.6411011219024658)","('Business_Model_Resilience', 0.09549547731876373)","('Supply_Chain_Management', 0.03149152547121048)","(['Risk & Crisis Management'], 0.6411011219024658)","('NON-ESG', 0.09549547731876373)","('NON-ESG', 0.03149152547121048)"
Line 196,"The inclusion of information in this report should not be construed as a  characterization regarding the materiality or financial impact of that information.
","('Management_Of_Legal_And_Regulatory_Framework', 0.45218491554260254)","('Business_Model_Resilience', 0.11643796414136887)","('Systemic_Risk_Management', 0.08968594670295715)","('NON-ESG', 0.45218491554260254)","('NON-ESG', 0.11643796414136887)","('NON-ESG', 0.08968594670295715)"
Line 197,"For additional information regarding BD, please see our current and periodic reports with the Securities and Exchange Commission, including our Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9315676093101501)","('Director_Removal', 0.008140225894749165)","('Business_Ethics', 0.007920200936496258)","(['Corporate Governance'], 0.9315676093101501)","('NON-ESG', 0.008140225894749165)","('NON-ESG', 0.007920200936496258)"
Line 198,"The ESG analysis and assessment is based on our understanding of current events at the time of the assessment and is subject to change, and we undertake no obligation to update or revise this assessment and analysis.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3590743839740753)","('Business_Model_Resilience', 0.18372972309589386)","('Ecological_Impacts', 0.07122395187616348)","('NON-ESG', 0.3590743839740753)","('NON-ESG', 0.18372972309589386)","('NON-ESG', 0.07122395187616348)"
Line 199,"We did not interview or account for every stakeholder who may have interests in these subjects.
","('Competitive_Behavior', 0.6127076745033264)","('Management_Of_Legal_And_Regulatory_Framework', 0.07316996157169342)","('Business_Model_Resilience', 0.060426317155361176)","(['Business Ethics'], 0.6127076745033264)","('NON-ESG', 0.07316996157169342)","('NON-ESG', 0.060426317155361176)"
Line 200,"Pricing Pressure Customer-Centric Care Affordability TransparencyHealthcare Market  Transformation  Human RightsAvailabilityProduct Quality and Safety Cybersecurity Accessibility Intellectual Property Rights and Product IntegritySupply Chain Continuity  and SustainabilityProduct Impacts on Human Health and the Environment Social ImpactRegulatory ComplianceAdvancing Medical Analytics and Automation Water Energy and Emissions  from our OperationsInclusion, Diversity and TalentImportance to Stakeholders Importance to Business SuccessMoved to the top right quadrantHighly Dynamic Issue (moved in 3 or more scenarios)Global SystemicHealth Challenges Collaborationand Partnerships Ethical Business Practices Health Literacy and Adherence Employee and Worker Health  and Safety 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction2021 ESG Report Climate change Product impact Responsible supply chain Healthy workforce and communities Transparency Appendices Introduction ESG strategy BD created our new ESG strategy—Together We Advance—to serve as a four-pillar framework through which we address the most relevant ESG issues for our business and stakeholders.
","('Business_Ethics', 0.557265043258667)","('Product_Quality_And_Safety', 0.13090157508850098)","('Competitive_Behavior', 0.0664021223783493)","(['Business Ethics'], 0.557265043258667)","('NON-ESG', 0.13090157508850098)","('NON-ESG', 0.0664021223783493)"
Line 201,"Pricing Pressure Customer-Centric Care Affordability TransparencyHealthcare Market  Transformation  Human RightsAvailabilityProduct Quality and Safety Cybersecurity Accessibility Intellectual Property Rights and Product IntegritySupply Chain Continuity  and SustainabilityProduct Impacts on Human Health and the Environment Social ImpactRegulatory ComplianceAdvancing Medical Analytics and Automation Water Energy and Emissions  from our OperationsInclusion, Diversity and TalentImportance to Stakeholders Importance to Business SuccessMoved to the top right quadrantHighly Dynamic Issue (moved in 3 or more scenarios)Global SystemicHealth Challenges Collaborationand Partnerships Ethical Business Practices Health Literacy and Adherence Employee and Worker Health  and Safety 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction2021 ESG Report Climate change Product impact Responsible supply chain Healthy workforce and communities Transparency Appendices Introduction ESG strategy BD created our new ESG strategy—Together We Advance—to serve as a four-pillar framework through which we address the most relevant ESG issues for our business and stakeholders.
","('Supply_Chain_Management', 0.7903389930725098)","('Systemic_Risk_Management', 0.04516499117016792)","('Physical_Impacts_Of_Climate_Change', 0.038451991975307465)","(['Supply Chain Management'], 0.7903389930725098)","('NON-ESG', 0.04516499117016792)","('NON-ESG', 0.038451991975307465)"
Line 202,"Pricing Pressure Customer-Centric Care Affordability TransparencyHealthcare Market  Transformation  Human RightsAvailabilityProduct Quality and Safety Cybersecurity Accessibility Intellectual Property Rights and Product IntegritySupply Chain Continuity  and SustainabilityProduct Impacts on Human Health and the Environment Social ImpactRegulatory ComplianceAdvancing Medical Analytics and Automation Water Energy and Emissions  from our OperationsInclusion, Diversity and TalentImportance to Stakeholders Importance to Business SuccessMoved to the top right quadrantHighly Dynamic Issue (moved in 3 or more scenarios)Global SystemicHealth Challenges Collaborationand Partnerships Ethical Business Practices Health Literacy and Adherence Employee and Worker Health  and Safety 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction2021 ESG Report Climate change Product impact Responsible supply chain Healthy workforce and communities Transparency Appendices Introduction ESG strategy BD created our new ESG strategy—Together We Advance—to serve as a four-pillar framework through which we address the most relevant ESG issues for our business and stakeholders.
","('Business_Model_Resilience', 0.6780492067337036)","('Systemic_Risk_Management', 0.10121607035398483)","('Human_Rights_And_Community_Relations', 0.025868205353617668)","(['Codes of Business Conduct'], 0.6780492067337036)","('NON-ESG', 0.10121607035398483)","('NON-ESG', 0.025868205353617668)"
Line 203,"Using this  strategy and the issues raised through our ESG assessment, we’ve made commitments in five specific areas where we see the most opportunity for BD to create meaningful, measurable change over the next decade.
","('Business_Model_Resilience', 0.47120362520217896)","('Systemic_Risk_Management', 0.10245306044816971)","('Human_Rights_And_Community_Relations', 0.07898491621017456)","('NON-ESG', 0.47120362520217896)","('NON-ESG', 0.10245306044816971)","('NON-ESG', 0.07898491621017456)"
Line 204,"Together We Advance BD developed a new ESG strategy that directly supports our core Purpose—advancing the world of health™ – and embraces the connections and interdependence between our four pillars of Company Health, Planet Health, Community Health and Human  Health.
","('Human_Rights_And_Community_Relations', 0.6611905097961426)","('Employee_Health_And_Safety', 0.13930454850196838)","('Access_And_Affordability', 0.04764023423194885)","(['Community Relations'], 0.6611905097961426)","('NON-ESG', 0.13930454850196838)","('NON-ESG', 0.04764023423194885)"
Line 205,"When we successfully address the health of one area, we often solve for challenges in another, ultimately driving positive collective outcomes across all four pillars.2021 ESG Report Climate change Product impact Responsible supply chain Healthy workforce and communities Transparency Appendices Introduction Healthy  workforce   and   communities2030+   commitments  Responsible supply chainProduct  impactClimate  changeUnder our Together We Advance strategy, we’ve made ESG commitments and set goals in specific areas where we see the most opportunity for BD to create meaningful, measurable change over the next decade and beyond.
","('Supply_Chain_Management', 0.8130588531494141)","('Physical_Impacts_Of_Climate_Change', 0.08672734349966049)","('Business_Model_Resilience', 0.016178876161575317)","(['Supply Chain Management'], 0.8130588531494141)","('NON-ESG', 0.08672734349966049)","('NON-ESG', 0.016178876161575317)"
Line 206,"When we successfully address the health of one area, we often solve for challenges in another, ultimately driving positive collective outcomes across all four pillars.2021 ESG Report Climate change Product impact Responsible supply chain Healthy workforce and communities Transparency Appendices Introduction Healthy  workforce   and   communities2030+   commitments  Responsible supply chainProduct  impactClimate  changeUnder our Together We Advance strategy, we’ve made ESG commitments and set goals in specific areas where we see the most opportunity for BD to create meaningful, measurable change over the next decade and beyond.
","('Business_Model_Resilience', 0.3297294080257416)","('Human_Rights_And_Community_Relations', 0.1748596429824829)","('Management_Of_Legal_And_Regulatory_Framework', 0.06239014118909836)","('NON-ESG', 0.3297294080257416)","('NON-ESG', 0.1748596429824829)","('NON-ESG', 0.06239014118909836)"
Line 207,"These areas are Climate Change, Product Impact, Responsible Supply Chain, Healthy Workforce and Communities, and Transparency, all of which have the potential to create lasting impact on our company, our planet, our communities and human health.
","('Physical_Impacts_Of_Climate_Change', 0.4941142797470093)","('Supply_Chain_Management', 0.35156553983688354)","('Business_Model_Resilience', 0.022693749517202377)","('NON-ESG', 0.4941142797470093)","('NON-ESG', 0.35156553983688354)","('NON-ESG', 0.022693749517202377)"
Line 208,"To achieve these commitments, we established goals for 2030 and beyond that we will use to track and measure our progress in  meeting our commitments and to better align with the UN Sustainable Development Goals (SDGs).
","('Human_Rights_And_Community_Relations', 0.6098253726959229)","('Business_Model_Resilience', 0.09456827491521835)","('Ecological_Impacts', 0.048332735896110535)","(['Community Relations'], 0.6098253726959229)","('NON-ESG', 0.09456827491521835)","('NON-ESG', 0.048332735896110535)"
Line 209,"These five impact areas allow us to simultaneously care for the long-standing ESG issues that we have managed and will continue to  manage every day, while prioritizing specific areas where we are well-positioned to drive significant change in our industry, business and society into the future.
","('Business_Model_Resilience', 0.6534299850463867)","('Systemic_Risk_Management', 0.06532279402017593)","('Human_Rights_And_Community_Relations', 0.05425730720162392)","(['Codes of Business Conduct'], 0.6534299850463867)","('NON-ESG', 0.06532279402017593)","('NON-ESG', 0.05425730720162392)"
Line 210,"These five areas connect across—and advance—the four pillars of our ESG strategy.
","('Business_Model_Resilience', 0.618507981300354)","('Systemic_Risk_Management', 0.1936449557542801)","('Ecological_Impacts', 0.019018029794096947)","(['Codes of Business Conduct'], 0.618507981300354)","('NON-ESG', 0.1936449557542801)","('NON-ESG', 0.019018029794096947)"
Line 211,"Further details on each of these commitment areas can be found in the relevant sections of this report.
","('Human_Rights_And_Community_Relations', 0.4690043330192566)","('Management_Of_Legal_And_Regulatory_Framework', 0.2260221391916275)","('Business_Model_Resilience', 0.04566412791609764)","('NON-ESG', 0.4690043330192566)","('NON-ESG', 0.2260221391916275)","('NON-ESG', 0.04566412791609764)"
Line 212,"Transparency Minimize our  contribution to global emissions and utilize our capabilities to address unmet health needs for climate-vulnerable populationsReduce the environmental impact of our portfolio and address the sustainability needs of our customersMaintain a healthy and thriving workforce that cultivates our culture of inclusion, safety and well-being and contributes to community healthCreate a supply chain adaptable to disruption and able to contribute to strong environmental and social performanceInvite trust across stakeholder groups through transparent performance reporting on ESG issues relevant to our business2021 ESG Report Climate change Product impact Responsible supply chain Healthy workforce and communities Transparency Appendices Introduction ESG governance To provide good governance, we’ve established Board- to management-level oversight of ESG  topics.
","('Supply_Chain_Management', 0.8180439472198486)","('Employee_Health_And_Safety', 0.026609603315591812)","('Human_Rights_And_Community_Relations', 0.022427788004279137)","(['Supply Chain Management'], 0.8180439472198486)","('NON-ESG', 0.026609603315591812)","('NON-ESG', 0.022427788004279137)"
Line 213,"Transparency Minimize our  contribution to global emissions and utilize our capabilities to address unmet health needs for climate-vulnerable populationsReduce the environmental impact of our portfolio and address the sustainability needs of our customersMaintain a healthy and thriving workforce that cultivates our culture of inclusion, safety and well-being and contributes to community healthCreate a supply chain adaptable to disruption and able to contribute to strong environmental and social performanceInvite trust across stakeholder groups through transparent performance reporting on ESG issues relevant to our business2021 ESG Report Climate change Product impact Responsible supply chain Healthy workforce and communities Transparency Appendices Introduction ESG governance To provide good governance, we’ve established Board- to management-level oversight of ESG  topics.
","('Physical_Impacts_Of_Climate_Change', 0.5448712706565857)","('Systemic_Risk_Management', 0.11462819576263428)","('Supply_Chain_Management', 0.0915972962975502)","(['Climate Change'], 0.5448712706565857)","('NON-ESG', 0.11462819576263428)","('NON-ESG', 0.0915972962975502)"
Line 214,"We recognize the importance of having an enterprisewide approach to work toward our ambitious ESG goals.
","('Business_Model_Resilience', 0.7432142496109009)","('Systemic_Risk_Management', 0.04396875575184822)","('Human_Rights_And_Community_Relations', 0.026928532868623734)","(['Codes of Business Conduct'], 0.7432142496109009)","('NON-ESG', 0.04396875575184822)","('NON-ESG', 0.026928532868623734)"
Line 215,"The table below lays out the Board’s and Committee’s oversight of BD’s 2030+ commitments and goals (indicated by bold italics) and other important ESG matters.
","('Business_Model_Resilience', 0.3699415624141693)","('Management_Of_Legal_And_Regulatory_Framework', 0.13995425403118134)","('Director_Removal', 0.0833163633942604)","('NON-ESG', 0.3699415624141693)","('NON-ESG', 0.13995425403118134)","('NON-ESG', 0.0833163633942604)"
Line 216,"At the Board level, the Corporate Governance and Nominating Committee has oversight responsibility for the processes, policies  and practices related to ESG matters.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7719587087631226)","('Director_Removal', 0.04424867779016495)","('Human_Rights_And_Community_Relations', 0.02633865363895893)","(['Corporate Governance'], 0.7719587087631226)","('NON-ESG', 0.04424867779016495)","('NON-ESG', 0.02633865363895893)"
Line 217,"The oversight of our 2030+ commitments and goals and other important ESG matters is allocated among the Board and its four Committees—the Corporate Governance and Nominating Committee, the Compensation and Human Capital Committee, the Audit Committee, and the Quality and Regulatory Committee.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7417906522750854)","('Business_Ethics', 0.051305707544088364)","('Director_Removal', 0.04647147282958031)","(['Corporate Governance'], 0.7417906522750854)","('NON-ESG', 0.051305707544088364)","('NON-ESG', 0.04647147282958031)"
Line 218,"The full Board also receives regular reports on topics concerning Climate Change and Healthy Workforce and Communities, among others.
","('Physical_Impacts_Of_Climate_Change', 0.9480668306350708)","('Business_Model_Resilience', 0.00782030913978815)","('GHG_Emissions', 0.004826943855732679)","(['Climate Change'], 0.9480668306350708)","('NON-ESG', 0.00782030913978815)","('NON-ESG', 0.004826943855732679)"
Line 219,"In 2021, the Board conducted a deep dive on Inclusion, Diversity and Equity (ID&E) and plans to conduct such reviews annually.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9719551801681519)","('Human_Rights_And_Community_Relations', 0.0024779443629086018)","('Employee_Health_And_Safety', 0.002004532376304269)","(['Human Capital Development'], 0.9719551801681519)","('NON-ESG', 0.0024779443629086018)","('NON-ESG', 0.002004532376304269)"
Line 220,"At the management level, we have established an Enterprise Risk and ESG Committee (ERC) that provides oversight of our  Enterprise Risk Management program, our 2030+ commitments and goals, and other ESG priority matters.
","('Systemic_Risk_Management', 0.49697041511535645)","('Business_Model_Resilience', 0.32612544298171997)","('Physical_Impacts_Of_Climate_Change', 0.02082579769194126)","('NON-ESG', 0.49697041511535645)","('NON-ESG', 0.32612544298171997)","('NON-ESG', 0.02082579769194126)"
Line 221,"The ERC consists of a cross-functional group of management and works with various internal operating committees that are executing BD’s ESG strategy, to monitor and ensure accountability for progress on the 2030+ commitments and goals.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2643435299396515)","('Business_Model_Resilience', 0.23844455182552338)","('Human_Rights_And_Community_Relations', 0.1299932599067688)","('NON-ESG', 0.2643435299396515)","('NON-ESG', 0.23844455182552338)","('NON-ESG', 0.1299932599067688)"
Line 222,"The ERC aims to create an enterprisewide culture that promotes open discussion regarding risk and opportunities and integrates effective risk management into our goals and objectives.
","('Systemic_Risk_Management', 0.8824695348739624)","('Business_Model_Resilience', 0.026260022073984146)","('Business_Ethics', 0.022044796496629715)","(['Risk & Crisis Management'], 0.8824695348739624)","('NON-ESG', 0.026260022073984146)","('NON-ESG', 0.022044796496629715)"
Line 223,"The ERC is also responsible for reporting to the Board and its Committees and overseeing external and internal reporting on ESG matters.
","('Management_Of_Legal_And_Regulatory_Framework', 0.690782904624939)","('Director_Removal', 0.11739137768745422)","('Business_Ethics', 0.020627688616514206)","(['Corporate Governance'], 0.690782904624939)","('NON-ESG', 0.11739137768745422)","('NON-ESG', 0.020627688616514206)"
Line 224,"At the corporate level, BD has an Environment, Health and Safety (EHS), Sustainability and Product Stewardship team, led  by the vice president, sustainability and environment, health and safety (VP S&EHS); the VP S&EHS reports to the company’s executive vice president, integrated supply chain (EVP ISC).
","('Product_Quality_And_Safety', 0.4525417983531952)","('Product_Design_And_Lifecycle_Management', 0.3414779305458069)","('Employee_Health_And_Safety', 0.031677890568971634)","('NON-ESG', 0.4525417983531952)","('NON-ESG', 0.3414779305458069)","('NON-ESG', 0.031677890568971634)"
Line 225,"Reporting to the VP S&EHS are the following individuals with responsibility for sustainability activities 6: •  Dir ector, sustainability.
","('Business_Model_Resilience', 0.17043238878250122)","('Management_Of_Legal_And_Regulatory_Framework', 0.15343745052814484)","('Human_Rights_And_Community_Relations', 0.0868011862039566)","('NON-ESG', 0.17043238878250122)","('NON-ESG', 0.15343745052814484)","('NON-ESG', 0.0868011862039566)"
Line 226,"In addition to stakeholder engagement and development of our ESG strategy, this individual is  responsible for the development of management programs for certain environmental and social issues, such as human rights, water stewardship and climate change.
","('Human_Rights_And_Community_Relations', 0.8285014629364014)","('Physical_Impacts_Of_Climate_Change', 0.03212098777294159)","('Business_Model_Resilience', 0.022471921518445015)","(['Community Relations'], 0.8285014629364014)","('NON-ESG', 0.03212098777294159)","('NON-ESG', 0.022471921518445015)"
Line 227,"•  Senior dir ector, sustainability.
","('Business_Model_Resilience', 0.22865723073482513)","('Product_Design_And_Lifecycle_Management', 0.19704940915107727)","('Supply_Chain_Management', 0.10445235669612885)","('NON-ESG', 0.22865723073482513)","('NON-ESG', 0.19704940915107727)","('NON-ESG', 0.10445235669612885)"
Line 228,"This individual is responsible for the development of and supports achievement of  environmental targets and reductions in Scope 1 and 2 GHG emissions within our operations.
","('GHG_Emissions', 0.9688230752944946)","('Ecological_Impacts', 0.0034359043929725885)","('Management_Of_Legal_And_Regulatory_Framework', 0.0031293798238039017)","(['Climate Change'], 0.9688230752944946)","('NON-ESG', 0.0034359043929725885)","('NON-ESG', 0.0031293798238039017)"
Line 229,"This individual leads the Sustainable Operations Council.Board’s Role of Oversight of ESG Corporate Governance   and Nominating   CommitteeCompensation and  Human Capital  CommitteeAudit   CommitteeQuality and   Regulatory   CommitteeFull   Board •  ESG Goals and Sust ainability R eview •  Climate Change •  P roduct Impact •  T ransparency •  Boar d Compensation •  Lobb ying/Political  Contributions •  Social In vesting •  Health y  Workforce and Communities •  Inclusion,  Div ersity &  Equity (ID&E) •  Human C apital •  Ex ecutive  Compensation•  R esponsible  Supply Chain •  C ybersecurity  and Privacy •  Business Ethics and C ompliance•  Pr oduct  Quality and Safety•  Climate Change •  Health y Workforce  and Communities •  ID&E •  Human C apital •  Pr oduct Quality and  Safety •  C ybersecurity and  Privacy •  Boar d Compensation •  Ex ecutive  Compensation BD Enterprise Risk and ESG Committee BD Operating Committees 6Associates with responsibility for management of specific ESG issues are noted where relevant in this report.2021 ESG Report Climate change Product impact Responsible supply chain Healthy workforce and communities Transparency Appendices Introduction The global effort to achieve the bold targets set out by the UN Sustainable Development Goals (UN SDGs) will require a high level of  engagement from the business sector, working in collaboration with governments, international agencies, NGOs and civil society.
","('Physical_Impacts_Of_Climate_Change', 0.4784363806247711)","('Business_Model_Resilience', 0.11978588998317719)","('Human_Rights_And_Community_Relations', 0.09764163941144943)","('NON-ESG', 0.4784363806247711)","('NON-ESG', 0.11978588998317719)","('NON-ESG', 0.09764163941144943)"
Line 230,"This individual leads the Sustainable Operations Council.Board’s Role of Oversight of ESG Corporate Governance   and Nominating   CommitteeCompensation and  Human Capital  CommitteeAudit   CommitteeQuality and   Regulatory   CommitteeFull   Board •  ESG Goals and Sust ainability R eview •  Climate Change •  P roduct Impact •  T ransparency •  Boar d Compensation •  Lobb ying/Political  Contributions •  Social In vesting •  Health y  Workforce and Communities •  Inclusion,  Div ersity &  Equity (ID&E) •  Human C apital •  Ex ecutive  Compensation•  R esponsible  Supply Chain •  C ybersecurity  and Privacy •  Business Ethics and C ompliance•  Pr oduct  Quality and Safety•  Climate Change •  Health y Workforce  and Communities •  ID&E •  Human C apital •  Pr oduct Quality and  Safety •  C ybersecurity and  Privacy •  Boar d Compensation •  Ex ecutive  Compensation BD Enterprise Risk and ESG Committee BD Operating Committees 6Associates with responsibility for management of specific ESG issues are noted where relevant in this report.2021 ESG Report Climate change Product impact Responsible supply chain Healthy workforce and communities Transparency Appendices Introduction The global effort to achieve the bold targets set out by the UN Sustainable Development Goals (UN SDGs) will require a high level of  engagement from the business sector, working in collaboration with governments, international agencies, NGOs and civil society.
","('Business_Ethics', 0.3380820155143738)","('Systemic_Risk_Management', 0.2400483340024948)","('Supply_Chain_Management', 0.10036694258451462)","('NON-ESG', 0.3380820155143738)","('NON-ESG', 0.2400483340024948)","('NON-ESG', 0.10036694258451462)"
Line 231,"This individual leads the Sustainable Operations Council.Board’s Role of Oversight of ESG Corporate Governance   and Nominating   CommitteeCompensation and  Human Capital  CommitteeAudit   CommitteeQuality and   Regulatory   CommitteeFull   Board •  ESG Goals and Sust ainability R eview •  Climate Change •  P roduct Impact •  T ransparency •  Boar d Compensation •  Lobb ying/Political  Contributions •  Social In vesting •  Health y  Workforce and Communities •  Inclusion,  Div ersity &  Equity (ID&E) •  Human C apital •  Ex ecutive  Compensation•  R esponsible  Supply Chain •  C ybersecurity  and Privacy •  Business Ethics and C ompliance•  Pr oduct  Quality and Safety•  Climate Change •  Health y Workforce  and Communities •  ID&E •  Human C apital •  Pr oduct Quality and  Safety •  C ybersecurity and  Privacy •  Boar d Compensation •  Ex ecutive  Compensation BD Enterprise Risk and ESG Committee BD Operating Committees 6Associates with responsibility for management of specific ESG issues are noted where relevant in this report.2021 ESG Report Climate change Product impact Responsible supply chain Healthy workforce and communities Transparency Appendices Introduction The global effort to achieve the bold targets set out by the UN Sustainable Development Goals (UN SDGs) will require a high level of  engagement from the business sector, working in collaboration with governments, international agencies, NGOs and civil society.
","('Physical_Impacts_Of_Climate_Change', 0.4502488076686859)","('Supply_Chain_Management', 0.4021757245063782)","('Business_Model_Resilience', 0.020404106006026268)","('NON-ESG', 0.4502488076686859)","('NON-ESG', 0.4021757245063782)","('NON-ESG', 0.020404106006026268)"
Line 232,"There is incentive for business to engage in these activities, as noted in the January 2017 report “Better Business, Better World”, 7 which estimated  that achievement of the SDGs could open up $12 trillion in market opportunities8 by 2030.
","('Systemic_Risk_Management', 0.3028654456138611)","('Business_Model_Resilience', 0.2851758599281311)","('Competitive_Behavior', 0.1528249830007553)","('NON-ESG', 0.3028654456138611)","('NON-ESG', 0.2851758599281311)","('NON-ESG', 0.1528249830007553)"
Line 233,"In addition to evaluating the UN SDGs as  part of our ESG assessment, we have also carried out an assessment of the type of impact BD has on the UN SDG targets, the location of impacts within our value chain and our degree of control.
","('Business_Model_Resilience', 0.6050258874893188)","('Systemic_Risk_Management', 0.1439991444349289)","('Supply_Chain_Management', 0.03489994257688522)","(['Codes of Business Conduct'], 0.6050258874893188)","('NON-ESG', 0.1439991444349289)","('NON-ESG', 0.03489994257688522)"
Line 234,"The UN SDGs provide a framework for BD to understand its material issues within a greater sustainability context and with reference to  broader sustainable development conditions and goals.
","('Business_Model_Resilience', 0.31838640570640564)","('Human_Rights_And_Community_Relations', 0.1356484740972519)","('Management_Of_Legal_And_Regulatory_Framework', 0.0921175628900528)","('NON-ESG', 0.31838640570640564)","('NON-ESG', 0.1356484740972519)","('NON-ESG', 0.0921175628900528)"
Line 235,"As a healthcare company, BD aligns most prominently with SDG 3: Ensure healthy lives and promote well-being for all at all ages.
","('Access_And_Affordability', 0.5615054368972778)","('Employee_Health_And_Safety', 0.15504322946071625)","('Human_Rights_And_Community_Relations', 0.042706213891506195)","(['Health Outcome Contribution'], 0.5615054368972778)","('NON-ESG', 0.15504322946071625)","('NON-ESG', 0.042706213891506195)"
Line 236,"BD has many activities to support SDG 3 targets, including: •  t echnologies integral to the diagnosis and management of infectious diseases; •  long-st anding work to protect the safety of health workers through products and partnerships; •  business units f ocused on addressing noncommunicable diseases, including cervical cancer •  partner ships to strengthen the capacity of health systems in developing economies.
","('Employee_Health_And_Safety', 0.9716155529022217)","('Product_Quality_And_Safety', 0.004939498845487833)","('Product_Design_And_Lifecycle_Management', 0.002756548812612891)","(['Operational Eco-Efficiency'], 0.9716155529022217)","('NON-ESG', 0.004939498845487833)","('NON-ESG', 0.002756548812612891)"
Line 237,"BD has tackled infectious disease challenges and looks forward to stepping up in a meaningful way, to positively impact chronic disease  treatment using technology innovation.
","('Access_And_Affordability', 0.20607416331768036)","('Employee_Health_And_Safety', 0.11668182164430618)","('Business_Model_Resilience', 0.08302251994609833)","('NON-ESG', 0.20607416331768036)","('NON-ESG', 0.11668182164430618)","('NON-ESG', 0.08302251994609833)"
Line 238,"While BD’s activities are clearly centered on SDG 3, our 2030+ commitments and goals reflect the interdependencies that exist among the  SDGs, and are also well-aligned with SDG 5 (gender equality), SDG 8 (decent work and economic growth) and SDG 9 (industry, innovation and infrastructure).
","('Employee_Engagement_Inclusion_And_Diversity', 0.47646740078926086)","('Human_Rights_And_Community_Relations', 0.22361429035663605)","('Labor_Practices', 0.09866894781589508)","('NON-ESG', 0.47646740078926086)","('NON-ESG', 0.22361429035663605)","('NON-ESG', 0.09866894781589508)"
Line 239,"Furthermore, our environmental goals support multiple UN SDGs and are inherently tied back to healthy lives and well-being for all.
","('Human_Rights_And_Community_Relations', 0.42532774806022644)","('Access_And_Affordability', 0.29665398597717285)","('Employee_Health_And_Safety', 0.04836326837539673)","('NON-ESG', 0.42532774806022644)","('NON-ESG', 0.29665398597717285)","('NON-ESG', 0.04836326837539673)"
Line 240,"An overview of how we support achievement of each UN SDG can be found in the appendices.In 2021, BD was named to The Wall Street Journal Management Top 250 list, as ranked by The Drucker Institute, recognizing the best- managed companies.
","('Systemic_Risk_Management', 0.5718377232551575)","('Business_Model_Resilience', 0.19112196564674377)","('Supply_Chain_Management', 0.04607723280787468)","(['Risk & Crisis Management'], 0.5718377232551575)","('NON-ESG', 0.19112196564674377)","('NON-ESG', 0.04607723280787468)"
Line 241,"We also ranked in the top 10 for a new metric weighing measurable results and tangible practices that are most aligned with the UN SDGs.Alignment with UN SDGs 7Business & Sustainable Development Commission, “Better Business, Better World”(January 2017).
","('Management_Of_Legal_And_Regulatory_Framework', 0.34135639667510986)","('Business_Model_Resilience', 0.1874779611825943)","('Human_Rights_And_Community_Relations', 0.08936385810375214)","('NON-ESG', 0.34135639667510986)","('NON-ESG', 0.1874779611825943)","('NON-ESG', 0.08936385810375214)"
Line 242,"8These achievements were calculated across four systems: (1) food and agriculture; (2) cities; (3) energy and materials; and (4) health and well-being.2021 ESG Report Introduction Climate change Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change2021 ESG Report Introduction Climate change Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact 2030 goals: 1 2 3 We will commit to setting science-based emissions reduction targets  across all scopes, in line with 1.5°C emissions scenarios and the criteria and recommendations of the Science Based Targets initiative.
","('Supply_Chain_Management', 0.7536713480949402)","('Physical_Impacts_Of_Climate_Change', 0.05604742467403412)","('Product_Design_And_Lifecycle_Management', 0.051650963723659515)","(['Supply Chain Management'], 0.7536713480949402)","('NON-ESG', 0.05604742467403412)","('NON-ESG', 0.051650963723659515)"
Line 243,"8These achievements were calculated across four systems: (1) food and agriculture; (2) cities; (3) energy and materials; and (4) health and well-being.2021 ESG Report Introduction Climate change Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change2021 ESG Report Introduction Climate change Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact 2030 goals: 1 2 3 We will commit to setting science-based emissions reduction targets  across all scopes, in line with 1.5°C emissions scenarios and the criteria and recommendations of the Science Based Targets initiative.
","('GHG_Emissions', 0.8445033431053162)","('Air_Quality', 0.05764460191130638)","('Energy_Management', 0.021622397005558014)","(['Climate Change'], 0.8445033431053162)","('NON-ESG', 0.05764460191130638)","('NON-ESG', 0.021622397005558014)"
Line 244,"Reduce Scope 1 and 2 emissions by 46% by 2030 (from 2019 baseline, absolute).
","('GHG_Emissions', 0.8763149380683899)","('Air_Quality', 0.04124142602086067)","('Energy_Management', 0.01568942703306675)","(['Climate Change'], 0.8763149380683899)","('NON-ESG', 0.04124142602086067)","('NON-ESG', 0.01568942703306675)"
Line 245,"Be carbon-neutral across direct operations by 2040.Scope 3 emissions targets for material Scope 3 categories expected to be set  within 2 years.We will advocate for net-zero emissions.We will achieve additional environmental efficiency targets in our direct operations.We will use our capabilities to contribute to solutions that address unmet climate-related health needs.
","('GHG_Emissions', 0.45320847630500793)","('Air_Quality', 0.18964795768260956)","('Energy_Management', 0.17542769014835358)","('NON-ESG', 0.45320847630500793)","('NON-ESG', 0.18964795768260956)","('NON-ESG', 0.17542769014835358)"
Line 246,"Our commitment:  Minimize our contribution to global emissions and utilize our capabilities to address unmet health needs for climate-vulnerable populations Metrics and targets2030+ impact area: climate change BD commitment and goals 9 Market-based approach quantifies Scope 2 GHG emissions based on GHG emissions emitted by the generators from which the reporter  contractually purchases electricity bundled with contractual instruments, or by instruments on their own (e.g., utility-specific emission factors, renewable energy certificates).
","('GHG_Emissions', 0.9629798531532288)","('Air_Quality', 0.007230518385767937)","('Physical_Impacts_Of_Climate_Change', 0.004443379584699869)","(['Climate Change'], 0.9629798531532288)","('NON-ESG', 0.007230518385767937)","('NON-ESG', 0.004443379584699869)"
Line 247,"Our commitment:  Minimize our contribution to global emissions and utilize our capabilities to address unmet health needs for climate-vulnerable populations Metrics and targets2030+ impact area: climate change BD commitment and goals 9 Market-based approach quantifies Scope 2 GHG emissions based on GHG emissions emitted by the generators from which the reporter  contractually purchases electricity bundled with contractual instruments, or by instruments on their own (e.g., utility-specific emission factors, renewable energy certificates).
","('Energy_Management', 0.5697215795516968)","('Management_Of_Legal_And_Regulatory_Framework', 0.30640071630477905)","('GHG_Emissions', 0.015956969931721687)","(['Operational Eco-Efficiency'], 0.5697215795516968)","('NON-ESG', 0.30640071630477905)","('NON-ESG', 0.015956969931721687)"
Line 248,"Climate change management Details of how we manage governance, strategy, and risks and opportunities can be found in the TCFD section of the appendices.
","('Physical_Impacts_Of_Climate_Change', 0.9476351141929626)","('Business_Model_Resilience', 0.012748947367072105)","('Systemic_Risk_Management', 0.005014748778194189)","(['Climate Change'], 0.9476351141929626)","('NON-ESG', 0.012748947367072105)","('NON-ESG', 0.005014748778194189)"
Line 249,"2030+ goals: Reduce Scope 1 and 2 by 46% by 2030   (from 2019 baseline, absolute) Be carbon-neutral across direct operations by 2040Scope 3 emissions targets for material   Scope 3 categories to be set within 2 yearsCurrent status: Decreased by 7%—(market-based9, excluding unbundled REC purchase in FY 2019),  increased by 23%—(market-based, including unbundled REC purchase in FY 2019).
","('GHG_Emissions', 0.48961809277534485)","('Energy_Management', 0.2100304663181305)","('Management_Of_Legal_And_Regulatory_Framework', 0.06305099278688431)","('NON-ESG', 0.48961809277534485)","('NON-ESG', 0.2100304663181305)","('NON-ESG', 0.06305099278688431)"
Line 250,"Baselines established for category 1, 4 and 9.
","('Ecological_Impacts', 0.1792786568403244)","('Management_Of_Legal_And_Regulatory_Framework', 0.15891890227794647)","('Competitive_Behavior', 0.1520664542913437)","('NON-ESG', 0.1792786568403244)","('NON-ESG', 0.15891890227794647)","('NON-ESG', 0.1520664542913437)"
Line 251,"Project initiated to calculate baseline for  category 11 and 12.2021 ESG Report Introduction Climate change Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact At the end of 2020, we announced our first set of targets in the climate change impact area.
","('Physical_Impacts_Of_Climate_Change', 0.885162889957428)","('Supply_Chain_Management', 0.033241141587495804)","('Business_Model_Resilience', 0.016374759376049042)","(['Climate Change'], 0.885162889957428)","('NON-ESG', 0.033241141587495804)","('NON-ESG', 0.016374759376049042)"
Line 252,"Reaching these targets would reduce  our contribution to global greenhouse gas emissions from direct operations.
","('GHG_Emissions', 0.9681648015975952)","('Air_Quality', 0.004211967810988426)","('Ecological_Impacts', 0.00327753066085279)","(['Climate Change'], 0.9681648015975952)","('NON-ESG', 0.004211967810988426)","('NON-ESG', 0.00327753066085279)"
Line 253,"Our reduction target is science-based, aligned with the 1.5°C global emissions reduction pathway.
","('GHG_Emissions', 0.851161777973175)","('Air_Quality', 0.036848582327365875)","('Energy_Management', 0.027168653905391693)","(['Climate Change'], 0.851161777973175)","('NON-ESG', 0.036848582327365875)","('NON-ESG', 0.027168653905391693)"
Line 254,"In September 2021, we strengthened our commitment to reducing emissions by joining the UN Race to Zero, via the Business  Ambition for 1.5°C and Science Based Targets initiative (SBTi).
","('GHG_Emissions', 0.758383572101593)","('Air_Quality', 0.11795113980770111)","('Energy_Management', 0.03588901087641716)","(['Climate Change'], 0.758383572101593)","('NON-ESG', 0.11795113980770111)","('NON-ESG', 0.03588901087641716)"
Line 255,"Throughout FY 2021 and 2022, we are partnering with the company ERM—the largest global pure-play sustainability consultancy— to establish baseline emissions for our significant sources of Scope 3 emissions: category 1, purchased goods and services; category 4 and 9, upstream and downstream transportation and distribution; and category 11 and 12, emissions from the use of and end-of-life disposal of our products.
","('Product_Design_And_Lifecycle_Management', 0.9457315802574158)","('Energy_Management', 0.010083180852234364)","('Product_Quality_And_Safety', 0.004980525933206081)","(['Product Stewardship'], 0.9457315802574158)","('NON-ESG', 0.010083180852234364)","('NON-ESG', 0.004980525933206081)"
Line 256,"We expect to have our science-based reduction targets verified by SBTi and published no later than end of FY 2023.Additional metrics used to assess climate-related risks include the following 2030+ goals: Transition risks Reduce energy consumption by 25% by 2030 (from 2019 baseline, normalized to cost of products sold [COPS]) Physical risks –  operationsReduce water consumption by 40% by 2030 (from 2019 baseline, normalized to COPS) Physical risks –upstreamESG desktop audits for strategic, preferred and critical suppliers completed by 2023; 90% of total spend reflected in completed supplier ESG desktop audits by 2025.
","('Energy_Management', 0.696397066116333)","('Physical_Impacts_Of_Climate_Change', 0.09042330086231232)","('Supply_Chain_Management', 0.02833404392004013)","(['Operational Eco-Efficiency'], 0.696397066116333)","('NON-ESG', 0.09042330086231232)","('NON-ESG', 0.02833404392004013)"
Line 257,"We expect to have our science-based reduction targets verified by SBTi and published no later than end of FY 2023.Additional metrics used to assess climate-related risks include the following 2030+ goals: Transition risks Reduce energy consumption by 25% by 2030 (from 2019 baseline, normalized to cost of products sold [COPS]) Physical risks –  operationsReduce water consumption by 40% by 2030 (from 2019 baseline, normalized to COPS) Physical risks –upstreamESG desktop audits for strategic, preferred and critical suppliers completed by 2023; 90% of total spend reflected in completed supplier ESG desktop audits by 2025.
","('Supply_Chain_Management', 0.9414991736412048)","('Labor_Practices', 0.004519619978964329)","('GHG_Emissions', 0.004512251354753971)","(['Supply Chain Management'], 0.9414991736412048)","('NON-ESG', 0.004519619978964329)","('NON-ESG', 0.004512251354753971)"
Line 258,"As we establish science-based targets for our significant sources of Scope 3 emissions, we expect that further metrics will be identified and assessed for suitability to measure climate-related risk and opportunity.
","('Physical_Impacts_Of_Climate_Change', 0.7577943801879883)","('GHG_Emissions', 0.12307976186275482)","('Business_Model_Resilience', 0.023051273077726364)","(['Climate Change'], 0.7577943801879883)","('NON-ESG', 0.12307976186275482)","('NON-ESG', 0.023051273077726364)"
Line 259,"Scope 1, 2 and 3 emissions data (including calculation methodology where relevant) can be found in the data tables within the  appendices.
","('GHG_Emissions', 0.5026531219482422)","('Air_Quality', 0.33967483043670654)","('Energy_Management', 0.036789268255233765)","(['Climate Change'], 0.5026531219482422)","('NON-ESG', 0.33967483043670654)","('NON-ESG', 0.036789268255233765)"
Line 260,"We also disclose emissions annually via the CDP .2021 ESG Report Introduction Climate change Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Energy Current status: Reduced by 14%2030+ goal: Reduce energy consumption by 25% by 2030 (from 2019 baseline,  normalized to COPS) In FY 2021, 14 locations10 obtained 100 percent of their electric power from renewable sources.
","('Physical_Impacts_Of_Climate_Change', 0.5070251822471619)","('Energy_Management', 0.20824694633483887)","('GHG_Emissions', 0.07989480346441269)","(['Climate Change'], 0.5070251822471619)","('NON-ESG', 0.20824694633483887)","('NON-ESG', 0.07989480346441269)"
Line 261,"Our reliance on unbundled renewable energy credits has decreased, with a focused shift to on-site solar, usage of renewable energy sources and equipment efficiency upgrades.
","('Energy_Management', 0.9796159267425537)","('Management_Of_Legal_And_Regulatory_Framework', 0.003116802778095007)","('Product_Design_And_Lifecycle_Management', 0.0016832484398037195)","(['Operational Eco-Efficiency'], 0.9796159267425537)","('NON-ESG', 0.003116802778095007)","('NON-ESG', 0.0016832484398037195)"
Line 262,"Energy consumption data (including renewables usage) can be found in the data tables within the appendices.
","('Energy_Management', 0.9782383441925049)","('Air_Quality', 0.0019384160405024886)","('Water_And_Wastewater_Management', 0.0019059327896684408)","(['Operational Eco-Efficiency'], 0.9782383441925049)","('NON-ESG', 0.0019384160405024886)","('NON-ESG', 0.0019059327896684408)"
Line 263,"Further information regarding investments and projects initiated to reduce our energy consumption can be found in the TCFD  section of the appendices.
","('Energy_Management', 0.9805434346199036)","('Management_Of_Legal_And_Regulatory_Framework', 0.0021979976445436478)","('Air_Quality', 0.001820421894080937)","(['Operational Eco-Efficiency'], 0.9805434346199036)","('NON-ESG', 0.0021979976445436478)","('NON-ESG', 0.001820421894080937)"
Line 264,"EPA Green Power Partnership As an EPA Green Power Partner since 2008, we report our use of renewable energy in the U.S. on an annual basis.
","('Energy_Management', 0.950253427028656)","('Management_Of_Legal_And_Regulatory_Framework', 0.01666506566107273)","('GHG_Emissions', 0.004201686475425959)","(['Operational Eco-Efficiency'], 0.950253427028656)","('NON-ESG', 0.01666506566107273)","('NON-ESG', 0.004201686475425959)"
Line 265,"Details of the Green Power Partnership and our current ranking can be found at epa.gov/greenpower.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5674513578414917)","('Human_Rights_And_Community_Relations', 0.06581546366214752)","('Ecological_Impacts', 0.06001117452979088)","(['Corporate Governance'], 0.5674513578414917)","('NON-ESG', 0.06581546366214752)","('NON-ESG', 0.06001117452979088)"
Line 266,"10This includes one site which is now part of embecta.2021 ESG Report Introduction Climate change Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Water management Current status: Reduced by 23%2030+ goal: Reduce water consumption by 40% by 2030 (from 2019 baseline,  normalized to COPS) Operational improvements such as implementing water conservation and water reduction projects resulted in a decrease of water consumption for FY 2021.
","('Water_And_Wastewater_Management', 0.9753559231758118)","('Energy_Management', 0.0027512814849615097)","('GHG_Emissions', 0.0024824924767017365)","(['Operational Eco-Efficiency'], 0.9753559231758118)","('NON-ESG', 0.0027512814849615097)","('NON-ESG', 0.0024824924767017365)"
Line 267,"Several manufacturing sites implemented such techniques as rainwater harvesting and greywater re-use.
","('Water_And_Wastewater_Management', 0.929542601108551)","('Ecological_Impacts', 0.024686088785529137)","('GHG_Emissions', 0.010406789369881153)","(['Operational Eco-Efficiency'], 0.929542601108551)","('NON-ESG', 0.024686088785529137)","('NON-ESG', 0.010406789369881153)"
Line 268,"We continue to actively encourage and provide awareness of current and future  water reduction projects as part of our regional Sustainability Operations calls.
","('Water_And_Wastewater_Management', 0.9696469902992249)","('GHG_Emissions', 0.004152556415647268)","('Energy_Management', 0.0036928458139300346)","(['Operational Eco-Efficiency'], 0.9696469902992249)","('NON-ESG', 0.004152556415647268)","('NON-ESG', 0.0036928458139300346)"
Line 269,"Sites have the opportunity to highlight improvements, discuss challenges and solve problems.
","('Systemic_Risk_Management', 0.2338886708021164)","('Human_Rights_And_Community_Relations', 0.11187872290611267)","('Business_Model_Resilience', 0.09391020983457565)","('NON-ESG', 0.2338886708021164)","('NON-ESG', 0.11187872290611267)","('NON-ESG', 0.09391020983457565)"
Line 270,"Water consumption data (including wastewater discharges) can be found in the  data tables within the appendices.
","('Water_And_Wastewater_Management', 0.9738953709602356)","('Energy_Management', 0.0033150447998195887)","('Waste_And_Hazardous_Materials_Management', 0.0023592126090079546)","(['Operational Eco-Efficiency'], 0.9738953709602356)","('NON-ESG', 0.0033150447998195887)","('NON-ESG', 0.0023592126090079546)"
Line 271,"Further information regarding investments and projects initiated to reduce our  water consumption can be found in the TCFD section of the appendices.
","('Water_And_Wastewater_Management', 0.9620780944824219)","('Energy_Management', 0.008951130323112011)","('GHG_Emissions', 0.004612648859620094)","(['Operational Eco-Efficiency'], 0.9620780944824219)","('NON-ESG', 0.008951130323112011)","('NON-ESG', 0.004612648859620094)"
Line 272,"Water is vital for sustaining healthy lives and the planet.
","('Water_And_Wastewater_Management', 0.9628744125366211)","('Ecological_Impacts', 0.006009943783283234)","('GHG_Emissions', 0.00374795263633132)","(['Operational Eco-Efficiency'], 0.9628744125366211)","('NON-ESG', 0.006009943783283234)","('NON-ESG', 0.00374795263633132)"
Line 273,"Having access to a clean  and sufficient supply of water is critical for our operations and the communities where we live, work and do business.
","('Water_And_Wastewater_Management', 0.9673252701759338)","('GHG_Emissions', 0.0034101223573088646)","('Energy_Management', 0.0029597340617328882)","(['Operational Eco-Efficiency'], 0.9673252701759338)","('NON-ESG', 0.0034101223573088646)","('NON-ESG', 0.0029597340617328882)"
Line 274,"Water quality and quantity are fundamental to ensure that the highest healthcare product safety standards are met.
","('Product_Quality_And_Safety', 0.9245134592056274)","('Employee_Health_And_Safety', 0.008995569311082363)","('Product_Design_And_Lifecycle_Management', 0.0067804958671331406)","(['Product Quality & Recall Management'], 0.9245134592056274)","('NON-ESG', 0.008995569311082363)","('NON-ESG', 0.0067804958671331406)"
Line 275,"Water conservation is important to our operational strategy, especially for products that contain purified water.
","('Water_And_Wastewater_Management', 0.9634430408477783)","('Ecological_Impacts', 0.006546477787196636)","('GHG_Emissions', 0.003480372717604041)","(['Operational Eco-Efficiency'], 0.9634430408477783)","('NON-ESG', 0.006546477787196636)","('NON-ESG', 0.003480372717604041)"
Line 276,"Freshwater is used in manufacturing, sanitation, sterilization, processing and cooling for our direct operations.
","('Water_And_Wastewater_Management', 0.9741137623786926)","('Waste_And_Hazardous_Materials_Management', 0.0028081159107387066)","('GHG_Emissions', 0.0026786276139318943)","(['Operational Eco-Efficiency'], 0.9741137623786926)","('NON-ESG', 0.0028081159107387066)","('NON-ESG', 0.0026786276139318943)"
Line 277,"Indirect water is used in the manufacturing and/or processing of many raw materials used in our products, such as resins, steel, packaging and electrical components.
","('Product_Design_And_Lifecycle_Management', 0.5936320424079895)","('Water_And_Wastewater_Management', 0.12649187445640564)","('Waste_And_Hazardous_Materials_Management', 0.080732062458992)","(['Product Stewardship'], 0.5936320424079895)","('NON-ESG', 0.12649187445640564)","('NON-ESG', 0.080732062458992)"
Line 278,"Recycled/brackish water is used in ancillary operations, such as cooling towers,  because it does not meet quality standards for most other uses.
","('Water_And_Wastewater_Management', 0.9697186946868896)","('GHG_Emissions', 0.0036687864921987057)","('Ecological_Impacts', 0.0029839470516890287)","(['Operational Eco-Efficiency'], 0.9697186946868896)","('NON-ESG', 0.0036687864921987057)","('NON-ESG', 0.0029839470516890287)"
Line 279,"Operating in accordance with local regulations, approximately 90 percent of water  used at our facilities comes from, and is discharged to, third-party sources (such as local municipal water sources).
","('Water_And_Wastewater_Management', 0.9749634265899658)","('Waste_And_Hazardous_Materials_Management', 0.002304011955857277)","('GHG_Emissions', 0.0021752994507551193)","(['Operational Eco-Efficiency'], 0.9749634265899658)","('NON-ESG', 0.002304011955857277)","('NON-ESG', 0.0021752994507551193)"
Line 280,"We collect water-related data for total withdrawals from our sites worldwide through an online system.
","('Water_And_Wastewater_Management', 0.9720472097396851)","('Energy_Management', 0.0035640045534819365)","('GHG_Emissions', 0.0026514914352446795)","(['Operational Eco-Efficiency'], 0.9720472097396851)","('NON-ESG', 0.0035640045534819365)","('NON-ESG', 0.0026514914352446795)"
Line 281,"This data is monitored and reviewed on an ongoing basis.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3019430339336395)","('Access_And_Affordability', 0.09513375163078308)","('Customer_Privacy', 0.07279512286186218)","('NON-ESG', 0.3019430339336395)","('NON-ESG', 0.09513375163078308)","('NON-ESG', 0.07279512286186218)"
Line 282,"We are committed to responsible and sustainable use of water and strive to  include water sustainability considerations in business decisions.
","('Water_And_Wastewater_Management', 0.975741982460022)","('GHG_Emissions', 0.0027963353786617517)","('Energy_Management', 0.0022402866743505)","(['Operational Eco-Efficiency'], 0.975741982460022)","('NON-ESG', 0.0027963353786617517)","('NON-ESG', 0.0022402866743505)"
Line 283,"We seek to achieve efficient use of water resources at our operational locations by investing in and using new technologies when feasible and implementing water conservation and water management practices.
","('Water_And_Wastewater_Management', 0.9756465554237366)","('Ecological_Impacts', 0.002946726977825165)","('GHG_Emissions', 0.00241179415024817)","(['Operational Eco-Efficiency'], 0.9756465554237366)","('NON-ESG', 0.002946726977825165)","('NON-ESG', 0.00241179415024817)"
Line 284,"The central S&EHS team, led by our VP S&EHS, has direct responsibility for our  water management strategy.
","('Water_And_Wastewater_Management', 0.9721017479896545)","('GHG_Emissions', 0.003618016606196761)","('Energy_Management', 0.002791727427393198)","(['Operational Eco-Efficiency'], 0.9721017479896545)","('NON-ESG', 0.003618016606196761)","('NON-ESG', 0.002791727427393198)"
Line 285,"The central S&EHS team provides guidance and tools, develops standards and  supports development of water-related projects.
","('Water_And_Wastewater_Management', 0.9659113883972168)","('GHG_Emissions', 0.003756595076993108)","('Air_Quality', 0.0031978581100702286)","(['Operational Eco-Efficiency'], 0.9659113883972168)","('NON-ESG', 0.003756595076993108)","('NON-ESG', 0.0031978581100702286)"
Line 286,"Our 2030+ commitments established corporate-level water reduction targets.
","('Water_And_Wastewater_Management', 0.9724695682525635)","('GHG_Emissions', 0.003870445303618908)","('Energy_Management', 0.0026978824753314257)","(['Operational Eco-Efficiency'], 0.9724695682525635)","('NON-ESG', 0.003870445303618908)","('NON-ESG', 0.0026978824753314257)"
Line 287,"The central S&EHS team has established site roadmaps and site-level targets.
","('Management_Of_Legal_And_Regulatory_Framework', 0.24852080643177032)","('Systemic_Risk_Management', 0.14465081691741943)","('Business_Model_Resilience', 0.098140187561512)","('NON-ESG', 0.24852080643177032)","('NON-ESG', 0.14465081691741943)","('NON-ESG', 0.098140187561512)"
Line 288,"These are tracked and monitored throughout the fiscal year.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7579526901245117)","('Director_Removal', 0.025491515174508095)","('Systemic_Risk_Management', 0.025441568344831467)","(['Corporate Governance'], 0.7579526901245117)","('NON-ESG', 0.025491515174508095)","('NON-ESG', 0.025441568344831467)"
Line 289,"Updates are provided to integrated supply chain leadership at least quarterly and BD executive leadership semiannually.
","('Supply_Chain_Management', 0.944361686706543)","('Business_Model_Resilience', 0.005732545163482428)","('Systemic_Risk_Management', 0.0048681763000786304)","(['Supply Chain Management'], 0.944361686706543)","('NON-ESG', 0.005732545163482428)","('NON-ESG', 0.0048681763000786304)"
Line 290,"Water risk is considered part of business continuity planning.
","('Water_And_Wastewater_Management', 0.9747023582458496)","('Waste_And_Hazardous_Materials_Management', 0.0021319270599633455)","('GHG_Emissions', 0.0019225974101573229)","(['Operational Eco-Efficiency'], 0.9747023582458496)","('NON-ESG', 0.0021319270599633455)","('NON-ESG', 0.0019225974101573229)"
Line 291,"Water-related risks  within operations are identified, assessed and addressed by the central S&EHS team.
","('Water_And_Wastewater_Management', 0.9707818031311035)","('GHG_Emissions', 0.0029586241580545902)","('Energy_Management', 0.002635067328810692)","(['Operational Eco-Efficiency'], 0.9707818031311035)","('NON-ESG', 0.0029586241580545902)","('NON-ESG', 0.002635067328810692)"
Line 292,"We use established water risk tools to evaluate the basin risk and operational risk at the corporate level as a screening tool.
","('Water_And_Wastewater_Management', 0.9716898202896118)","('Waste_And_Hazardous_Materials_Management', 0.0028422728646546602)","('GHG_Emissions', 0.0028184629045426846)","(['Operational Eco-Efficiency'], 0.9716898202896118)","('NON-ESG', 0.0028422728646546602)","('NON-ESG', 0.0028184629045426846)"
Line 293,"The results are provided to the Sustainability Operations Council, which also sets the strategy for prioritizing projects or providing insights for how to improve overall water management programs.
","('Water_And_Wastewater_Management', 0.9640970230102539)","('Ecological_Impacts', 0.007555803749710321)","('GHG_Emissions', 0.003989621996879578)","(['Operational Eco-Efficiency'], 0.9640970230102539)","('NON-ESG', 0.007555803749710321)","('NON-ESG', 0.003989621996879578)"
Line 294,"Mitigation activities are implemented as part of business continuity planning.
","('Business_Model_Resilience', 0.3759608864784241)","('Physical_Impacts_Of_Climate_Change', 0.13500870764255524)","('Ecological_Impacts', 0.07714201509952545)","('NON-ESG', 0.3759608864784241)","('NON-ESG', 0.13500870764255524)","('NON-ESG', 0.07714201509952545)"
Line 295,"Efficiency audits are conducted at the site level to identify opportunities for  reduction of water usage and consumption.
","('Water_And_Wastewater_Management', 0.9654006958007812)","('Energy_Management', 0.008730988949537277)","('GHG_Emissions', 0.0033031783532351255)","(['Operational Eco-Efficiency'], 0.9654006958007812)","('NON-ESG', 0.008730988949537277)","('NON-ESG', 0.0033031783532351255)"
Line 296,"These local site efficiency audits also include energy, waste and emissions to provide prioritization for conservation projects.
","('Energy_Management', 0.9705069661140442)","('Air_Quality', 0.004276196472346783)","('Management_Of_Legal_And_Regulatory_Framework', 0.0030679316259920597)","(['Operational Eco-Efficiency'], 0.9705069661140442)","('NON-ESG', 0.004276196472346783)","('NON-ESG', 0.0030679316259920597)"
Line 297,"These are projects that may reduce energy consumption along with having an impact on water reduction associated with it.
","('Energy_Management', 0.9536048173904419)","('Water_And_Wastewater_Management', 0.014451311901211739)","('GHG_Emissions', 0.0033658421598374844)","(['Operational Eco-Efficiency'], 0.9536048173904419)","('NON-ESG', 0.014451311901211739)","('NON-ESG', 0.0033658421598374844)"
Line 298,"Water-related issues (such as resilience to water scarcity and internal water  efficiencies) are a part of our long-term business objectives.
","('Water_And_Wastewater_Management', 0.9747332334518433)","('Energy_Management', 0.0022742783185094595)","('Ecological_Impacts', 0.002232741331681609)","(['Operational Eco-Efficiency'], 0.9747332334518433)","('NON-ESG', 0.0022742783185094595)","('NON-ESG', 0.002232741331681609)"
Line 299,"We see opportunities to continue to improve operational efficiencies.
","('Energy_Management', 0.305921345949173)","('Business_Model_Resilience', 0.12885873019695282)","('Supply_Chain_Management', 0.11278699338436127)","('NON-ESG', 0.305921345949173)","('NON-ESG', 0.12885873019695282)","('NON-ESG', 0.11278699338436127)"
Line 300,"Further information about our water management strategy and programs can be  found in our responses to the CDP (formerly the Carbon Disclosure Project).
","('Water_And_Wastewater_Management', 0.9721633791923523)","('Ecological_Impacts', 0.003179759718477726)","('GHG_Emissions', 0.0026488006114959717)","(['Operational Eco-Efficiency'], 0.9721633791923523)","('NON-ESG', 0.003179759718477726)","('NON-ESG', 0.0026488006114959717)"
Line 301,"We recognize that water scarcity and water quality issues are impediments to our  Purpose of advancing the world of health™, because clean water plays a critical role in human health.
","('Water_And_Wastewater_Management', 0.9771767258644104)","('GHG_Emissions', 0.002089478075504303)","('Ecological_Impacts', 0.0019360511796548963)","(['Operational Eco-Efficiency'], 0.9771767258644104)","('NON-ESG', 0.002089478075504303)","('NON-ESG', 0.0019360511796548963)"
Line 302,"Over the past four years, BD has worked with our NGO partner Planet Water to bring clean drinking water and hygiene education to people around the world.
","('Water_And_Wastewater_Management', 0.972582221031189)","('Energy_Management', 0.0034264272544533014)","('Waste_And_Hazardous_Materials_Management', 0.0021040504798293114)","(['Operational Eco-Efficiency'], 0.972582221031189)","('NON-ESG', 0.0034264272544533014)","('NON-ESG', 0.0021040504798293114)"
Line 303,"You can read more about our efforts on the BD Blog.
","('Access_And_Affordability', 0.39666152000427246)","('Management_Of_Legal_And_Regulatory_Framework', 0.05749136582016945)","('Product_Quality_And_Safety', 0.05379325523972511)","('NON-ESG', 0.39666152000427246)","('NON-ESG', 0.05749136582016945)","('NON-ESG', 0.05379325523972511)"
Line 304,"Access to water,  sanitation and hygiene is a human right.
","('Water_And_Wastewater_Management', 0.9113300442695618)","('Critical_Incident_Risk_Management', 0.008192678913474083)","('Air_Quality', 0.0063413651660084724)","(['Operational Eco-Efficiency'], 0.9113300442695618)","('NON-ESG', 0.008192678913474083)","('NON-ESG', 0.0063413651660084724)"
Line 305,"2021 ESG Report Introduction Climate change Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact 2030+ goals: Current status: Reduce nonhazardous waste by 50% by  2030 (from 2019 baseline, normalized to COPS)Reduced by 16% Increase landfill diversion to 90% by 2030 (from 2019 baseline, absolute)Diversion rate of 79% Increase recycling to 80% by 2030 (from 2019 baseline, absolute)Recycling rate of 63% Reduce hazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS)Reduced by 6%Waste management Effective waste prevention and management practices are critical for protecting human health and the environment.
","('Waste_And_Hazardous_Materials_Management', 0.9739927649497986)","('Product_Design_And_Lifecycle_Management', 0.0035119373351335526)","('Water_And_Wastewater_Management', 0.0022193819750100374)","(['Operational Eco-Efficiency'], 0.9739927649497986)","('NON-ESG', 0.0035119373351335526)","('NON-ESG', 0.0022193819750100374)"
Line 306,"2021 ESG Report Introduction Climate change Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact 2030+ goals: Current status: Reduce nonhazardous waste by 50% by  2030 (from 2019 baseline, normalized to COPS)Reduced by 16% Increase landfill diversion to 90% by 2030 (from 2019 baseline, absolute)Diversion rate of 79% Increase recycling to 80% by 2030 (from 2019 baseline, absolute)Recycling rate of 63% Reduce hazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS)Reduced by 6%Waste management Effective waste prevention and management practices are critical for protecting human health and the environment.
","('Waste_And_Hazardous_Materials_Management', 0.9840449094772339)","('Data_Security', 0.0012047654017806053)","('Water_And_Wastewater_Management', 0.0011093898210674524)","(['Operational Eco-Efficiency'], 0.9840449094772339)","('NON-ESG', 0.0012047654017806053)","('NON-ESG', 0.0011093898210674524)"
Line 307,"BD acknowledges the importance of responsible end-disposal management for the various types of waste generated from our operations.
","('Waste_And_Hazardous_Materials_Management', 0.9840096235275269)","('Water_And_Wastewater_Management', 0.0014873816398903728)","('Data_Security', 0.0011319596087560058)","(['Operational Eco-Efficiency'], 0.9840096235275269)","('NON-ESG', 0.0014873816398903728)","('NON-ESG', 0.0011319596087560058)"
Line 308,"Recognizing the current and future potential consequences associated with waste disposal is necessary to safeguard our company, communities and planet.
","('Waste_And_Hazardous_Materials_Management', 0.9845031499862671)","('Water_And_Wastewater_Management', 0.001337523339316249)","('Data_Security', 0.0010752715170383453)","(['Operational Eco-Efficiency'], 0.9845031499862671)","('NON-ESG', 0.001337523339316249)","('NON-ESG', 0.0010752715170383453)"
Line 309,"We are committed to reducing nonhazardous and hazardous waste generation.
","('Waste_And_Hazardous_Materials_Management', 0.984320878982544)","('Data_Security', 0.0011642910540103912)","('Water_And_Wastewater_Management', 0.001155173173174262)","(['Operational Eco-Efficiency'], 0.984320878982544)","('NON-ESG', 0.0011642910540103912)","('NON-ESG', 0.001155173173174262)"
Line 310,"We are examining ways to move beyond the traditional hierarchy of waste management by focusing on opportunities to prevent waste from occurring and proactively planning how to extend the life of materials that would otherwise become waste.
","('Waste_And_Hazardous_Materials_Management', 0.9846742153167725)","('Data_Security', 0.0011014242190867662)","('Water_And_Wastewater_Management', 0.0010516500333324075)","(['Operational Eco-Efficiency'], 0.9846742153167725)","('NON-ESG', 0.0011014242190867662)","('NON-ESG', 0.0010516500333324075)"
Line 311,"Through management of change processes, our manufacturing locations are  required to review and assess what waste would be generated by process changes and design transfers.
","('Waste_And_Hazardous_Materials_Management', 0.9840717911720276)","('Water_And_Wastewater_Management', 0.0017226490890607238)","('Air_Quality', 0.0012368394527584314)","(['Operational Eco-Efficiency'], 0.9840717911720276)","('NON-ESG', 0.0017226490890607238)","('NON-ESG', 0.0012368394527584314)"
Line 312,"Cross-functional teams will also evaluate source reduction and waste minimization opportunities and will partner with our waste disposal vendors to evaluate areas for waste reduction, reuse, redesign and recycling.
","('Waste_And_Hazardous_Materials_Management', 0.9789538979530334)","('Product_Design_And_Lifecycle_Management', 0.0020459459628909826)","('Water_And_Wastewater_Management', 0.001765772351063788)","(['Operational Eco-Efficiency'], 0.9789538979530334)","('NON-ESG', 0.0020459459628909826)","('NON-ESG', 0.001765772351063788)"
Line 313,"Data associated with the generation of waste is reported by each of our locations via  an online system, and this data is reviewed and monitored on an ongoing basis.
","('Waste_And_Hazardous_Materials_Management', 0.9820340871810913)","('Water_And_Wastewater_Management', 0.0022592071909457445)","('Air_Quality', 0.0015292938333004713)","(['Operational Eco-Efficiency'], 0.9820340871810913)","('NON-ESG', 0.0022592071909457445)","('NON-ESG', 0.0015292938333004713)"
Line 314,"This enables us to assess the type and amount of material that is being generated and to identify opportunities for improvement that can occur at a local or regional level.
","('Product_Design_And_Lifecycle_Management', 0.5572674870491028)","('Supply_Chain_Management', 0.09727948904037476)","('Waste_And_Hazardous_Materials_Management', 0.06872658431529999)","(['Product Stewardship'], 0.5572674870491028)","('NON-ESG', 0.09727948904037476)","('NON-ESG', 0.06872658431529999)"
Line 315,"Risks associated with the transportation, storage and disposal of waste are  identified, managed and mitigated through a series of mechanisms, such as internal governance protocols, end-disposal selection approval processes, vendor management and end-disposal site audits.
","('Waste_And_Hazardous_Materials_Management', 0.9827757477760315)","('Water_And_Wastewater_Management', 0.002000345615670085)","('Product_Design_And_Lifecycle_Management', 0.0011115780798718333)","(['Operational Eco-Efficiency'], 0.9827757477760315)","('NON-ESG', 0.002000345615670085)","('NON-ESG', 0.0011115780798718333)"
Line 316,"Waste performance As we continue to assess and implement waste reduction projects, our efforts have resulted in a decrease in total nonhazardous waste generated in FY 2021.
","('Waste_And_Hazardous_Materials_Management', 0.9847344160079956)","('Data_Security', 0.0011770473793148994)","('Air_Quality', 0.001129455165937543)","(['Operational Eco-Efficiency'], 0.9847344160079956)","('NON-ESG', 0.0011770473793148994)","('NON-ESG', 0.001129455165937543)"
Line 317,"Facility projects implemented have included reviewing the alternatives to single-use products such as lab coats, installing upgraded technology such as combined hand-washers and -dryers to reduce paper disposal and the reuse of material-handling trays.
","('Product_Design_And_Lifecycle_Management', 0.8876019716262817)","('Waste_And_Hazardous_Materials_Management', 0.037452735006809235)","('Product_Quality_And_Safety', 0.009953306056559086)","(['Product Stewardship'], 0.8876019716262817)","('NON-ESG', 0.037452735006809235)","('NON-ESG', 0.009953306056559086)"
Line 318,"As our practices have become more efficient, less waste requires disposal via  incineration and landfilling.
","('Waste_And_Hazardous_Materials_Management', 0.9825693368911743)","('Water_And_Wastewater_Management', 0.0018842960707843304)","('Air_Quality', 0.0013431230327114463)","(['Operational Eco-Efficiency'], 0.9825693368911743)","('NON-ESG', 0.0018842960707843304)","('NON-ESG', 0.0013431230327114463)"
Line 319,"The volume of hazardous waste generated decreased in FY 2021 due to a reduction in the number of “clean out” events (for example, lean manufacturing and kaizen events where unnecessary material is removed from our facilities).
","('Waste_And_Hazardous_Materials_Management', 0.9846621751785278)","('Employee_Health_And_Safety', 0.00109379761852324)","('Water_And_Wastewater_Management', 0.0010826600482687354)","(['Operational Eco-Efficiency'], 0.9846621751785278)","('NON-ESG', 0.00109379761852324)","('NON-ESG', 0.0010826600482687354)"
Line 320,"Regulated waste generation also decreased as a result of greater understanding of the precautions that were required to protect our associates from COVID-19.
","('Waste_And_Hazardous_Materials_Management', 0.9832741618156433)","('Water_And_Wastewater_Management', 0.0018969858065247536)","('Air_Quality', 0.0014272804837673903)","(['Operational Eco-Efficiency'], 0.9832741618156433)","('NON-ESG', 0.0018969858065247536)","('NON-ESG', 0.0014272804837673903)"
Line 321,"Waste data and information on how we define categories of waste can be found  within the appendices.
","('Waste_And_Hazardous_Materials_Management', 0.9844398498535156)","('Air_Quality', 0.0013001156039536)","('Water_And_Wastewater_Management', 0.0012380704283714294)","(['Operational Eco-Efficiency'], 0.9844398498535156)","('NON-ESG', 0.0013001156039536)","('NON-ESG', 0.0012380704283714294)"
Line 322,"2021 ESG Report Introduction Climate change Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Air emissions Air emissions data can be found in the data tables within the appendices.
","('Air_Quality', 0.9772142171859741)","('Physical_Impacts_Of_Climate_Change', 0.002344685373827815)","('GHG_Emissions', 0.0021155152935534716)","(['Operational Eco-Efficiency'], 0.9772142171859741)","('NON-ESG', 0.002344685373827815)","('NON-ESG', 0.0021155152935534716)"
Line 323,"2030+ goals: Reduce volatile organic compounds  (VOCs) and hazardous air pollutants (HAPs) by 30% by 2030 (from 2019 baseline, normalized to COPS)Reduce ozone-depleting substances (ODS) by 50% by 2030 (from 2019 baseline, normalized to COPS)Eliminate use of R22 by 2030 (absolute) Current status: Reduced by 32% We saw a reduction of around 100  metric tonnes in VOC emissions, due to the installation of additional abatement equipment following a transfer of product lines between two of our manufacturing locations.Reduced by 87% As part of ongoing programs, we achieved  further reductions in ODS emissions at our BD Medical manufacturing facilities.
","('Air_Quality', 0.26902031898498535)","('Energy_Management', 0.22389937937259674)","('Product_Design_And_Lifecycle_Management', 0.13009794056415558)","('NON-ESG', 0.26902031898498535)","('NON-ESG', 0.22389937937259674)","('NON-ESG', 0.13009794056415558)"
Line 324,"2030+ goals: Reduce volatile organic compounds  (VOCs) and hazardous air pollutants (HAPs) by 30% by 2030 (from 2019 baseline, normalized to COPS)Reduce ozone-depleting substances (ODS) by 50% by 2030 (from 2019 baseline, normalized to COPS)Eliminate use of R22 by 2030 (absolute) Current status: Reduced by 32% We saw a reduction of around 100  metric tonnes in VOC emissions, due to the installation of additional abatement equipment following a transfer of product lines between two of our manufacturing locations.Reduced by 87% As part of ongoing programs, we achieved  further reductions in ODS emissions at our BD Medical manufacturing facilities.
","('Air_Quality', 0.6159961223602295)","('GHG_Emissions', 0.20939937233924866)","('Energy_Management', 0.0662812665104866)","(['Operational Eco-Efficiency'], 0.6159961223602295)","('NON-ESG', 0.20939937233924866)","('NON-ESG', 0.0662812665104866)"
Line 325,"A large proportion of the reduction was  made in FY 2019 and FY 2020 through elimination projects at one of our manufacturing facilities.
","('Product_Design_And_Lifecycle_Management', 0.5062902569770813)","('Energy_Management', 0.11905042827129364)","('Supply_Chain_Management', 0.10949910432100296)","(['Product Stewardship'], 0.5062902569770813)","('NON-ESG', 0.11905042827129364)","('NON-ESG', 0.10949910432100296)"
Line 326,"Two additional manufacturing facilities accounted for a significant proportion of the reduction in FY 2021.R22 refrigerant (also known as R22 freon and HCFC-22 freon) is a chemical used in both air conditioners and heat pumps.
","('Air_Quality', 0.6453129053115845)","('Energy_Management', 0.22590751945972443)","('Product_Design_And_Lifecycle_Management', 0.013037213124334812)","(['Operational Eco-Efficiency'], 0.6453129053115845)","('NON-ESG', 0.22590751945972443)","('NON-ESG', 0.013037213124334812)"
Line 327,"It has a harmful impact on the ozone layer when released into the air and therefore has been banned from manufacture or import in many jurisdictions where BD operates.
","('Air_Quality', 0.39457282423973083)","('Waste_And_Hazardous_Materials_Management', 0.14311449229717255)","('GHG_Emissions', 0.13256698846817017)","('NON-ESG', 0.39457282423973083)","('NON-ESG', 0.14311449229717255)","('NON-ESG', 0.13256698846817017)"
Line 328,"Through FY 2021 and FY 2022, we are carrying out an  audit of all our locations worldwide in order to capture the number and type of R22 units in use.
","('Product_Design_And_Lifecycle_Management', 0.2158738672733307)","('Product_Quality_And_Safety', 0.11288630962371826)","('Supply_Chain_Management', 0.09775509685277939)","('NON-ESG', 0.2158738672733307)","('NON-ESG', 0.11288630962371826)","('NON-ESG', 0.09775509685277939)"
Line 329,"For sites with multiple R22 units, we are working with external partners to conduct these studies.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3313017189502716)","('GHG_Emissions', 0.13267722725868225)","('Access_And_Affordability', 0.11491214483976364)","('NON-ESG', 0.3313017189502716)","('NON-ESG', 0.13267722725868225)","('NON-ESG', 0.11491214483976364)"
Line 330,"Using our Replace with a Purpose approach, site-level  plans will be developed that focus on compliance, reliability, redundancy and long-term capacity while optimizing efficiency.
","('Energy_Management', 0.3004385232925415)","('Management_Of_Legal_And_Regulatory_Framework', 0.19682839512825012)","('Business_Model_Resilience', 0.1409616470336914)","('NON-ESG', 0.3004385232925415)","('NON-ESG', 0.19682839512825012)","('NON-ESG', 0.1409616470336914)"
Line 331,"By avoiding like-for-like replacements, our Replace with a Purpose approach will ensure that the long-term needs of our sites are met.2021 ESG Report Introduction Climate change Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Our Human Rights  Policy states that we are “committed to operating in a way that respects all human rights of associates and the communities in which we operate our business.”Environmental data governance and collection Scope 1 and 2 environmental data from all locations globally is collected via a  third-party data collection and analysis platform.
","('Human_Rights_And_Community_Relations', 0.41744285821914673)","('Physical_Impacts_Of_Climate_Change', 0.3046742081642151)","('Supply_Chain_Management', 0.09761501103639603)","('NON-ESG', 0.41744285821914673)","('NON-ESG', 0.3046742081642151)","('NON-ESG', 0.09761501103639603)"
Line 332,"By avoiding like-for-like replacements, our Replace with a Purpose approach will ensure that the long-term needs of our sites are met.2021 ESG Report Introduction Climate change Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Our Human Rights  Policy states that we are “committed to operating in a way that respects all human rights of associates and the communities in which we operate our business.”Environmental data governance and collection Scope 1 and 2 environmental data from all locations globally is collected via a  third-party data collection and analysis platform.
","('Customer_Privacy', 0.4673978388309479)","('Data_Security', 0.10599596798419952)","('Supply_Chain_Management', 0.03415035083889961)","('NON-ESG', 0.4673978388309479)","('NON-ESG', 0.10599596798419952)","('NON-ESG', 0.03415035083889961)"
Line 333,"Our environmental inventory management plan (IMP) documents key governance and measurement processes for energy, greenhouse gas emissions, water and waste.
","('GHG_Emissions', 0.9626806974411011)","('Ecological_Impacts', 0.0058202785439789295)","('Air_Quality', 0.0037965618539601564)","(['Climate Change'], 0.9626806974411011)","('NON-ESG', 0.0058202785439789295)","('NON-ESG', 0.0037965618539601564)"
Line 334,"It also defines roles, responsibilities and processes, including triggers for recalculation and restatement (for example, merger, acquisition or divestiture that results in a significant structural change to the data).
","('Business_Model_Resilience', 0.5702217221260071)","('Systemic_Risk_Management', 0.15108732879161835)","('Director_Removal', 0.04642556980252266)","(['Codes of Business Conduct'], 0.5702217221260071)","('NON-ESG', 0.15108732879161835)","('NON-ESG', 0.04642556980252266)"
Line 335,"The IMP seeks to provide confidence of information to support decision-making, and consistent and transparent reporting.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4091888964176178)","('Business_Ethics', 0.3881649374961853)","('Customer_Privacy', 0.03097662329673767)","('NON-ESG', 0.4091888964176178)","('NON-ESG', 0.3881649374961853)","('NON-ESG', 0.03097662329673767)"
Line 336,"An operational control approach is used for the purpose of setting inventory  boundaries.
","('Supply_Chain_Management', 0.13731332123279572)","('Waste_And_Hazardous_Materials_Management', 0.10155033320188522)","('Systemic_Risk_Management', 0.10133209079504013)","('NON-ESG', 0.13731332123279572)","('NON-ESG', 0.10155033320188522)","('NON-ESG', 0.10133209079504013)"
Line 337,"These boundaries include facilities where BD has at least a controlling interest from an operational perspective or, at most, facilities owned entirely by BD.
","('Competitive_Behavior', 0.22729220986366272)","('Systemic_Risk_Management', 0.14959068596363068)","('Management_Of_Legal_And_Regulatory_Framework', 0.12334547936916351)","('NON-ESG', 0.22729220986366272)","('NON-ESG', 0.14959068596363068)","('NON-ESG', 0.12334547936916351)"
Line 338,"In cases where BD has operational control but does not wholly own facilities, these facilities will be included in the inventory.
","('Supply_Chain_Management', 0.2831267714500427)","('Systemic_Risk_Management', 0.12730607390403748)","('Business_Model_Resilience', 0.08491376042366028)","('NON-ESG', 0.2831267714500427)","('NON-ESG', 0.12730607390403748)","('NON-ESG', 0.08491376042366028)"
Line 339,"This approach is consistent with the World Resources Institute (WRI)/World Business Council for Sustainable Development (WBCSD) Greenhouse Gas Protocol (GHGP) and general sustainability reporting protocols and guidance.
","('GHG_Emissions', 0.968683123588562)","('Ecological_Impacts', 0.004342265892773867)","('Water_And_Wastewater_Management', 0.0029399695340543985)","(['Climate Change'], 0.968683123588562)","('NON-ESG', 0.004342265892773867)","('NON-ESG', 0.0029399695340543985)"
Line 340,"Facilities within BD's boundaries include main offices, manufacturing facilities,  R&D facilities, laboratories and distribution centers (DCs).
","('Supply_Chain_Management', 0.28662464022636414)","('Customer_Welfare', 0.19377501308918)","('Employee_Engagement_Inclusion_And_Diversity', 0.04659036919474602)","('NON-ESG', 0.28662464022636414)","('NON-ESG', 0.19377501308918)","('NON-ESG', 0.04659036919474602)"
Line 341,"A screening approach is applied every year to determine sites that should be excluded from the operational boundary based on an established material threshold.
","('Business_Model_Resilience', 0.26838448643684387)","('Ecological_Impacts', 0.20940811932086945)","('Management_Of_Legal_And_Regulatory_Framework', 0.06526533514261246)","('NON-ESG', 0.26838448643684387)","('NON-ESG', 0.20940811932086945)","('NON-ESG', 0.06526533514261246)"
Line 342,"The threshold values are updated every three to four years, or when significant acquisitions happen.
","('Systemic_Risk_Management', 0.36419934034347534)","('Management_Of_Legal_And_Regulatory_Framework', 0.20965750515460968)","('Competitive_Behavior', 0.13218791782855988)","('NON-ESG', 0.36419934034347534)","('NON-ESG', 0.20965750515460968)","('NON-ESG', 0.13218791782855988)"
Line 343,"Improvements in our operational practices and improved visibility to  environmental performance metrics have encouraged emissions reduction and facilitated identifying water and waste reduction opportunities.
","('Water_And_Wastewater_Management', 0.8439649343490601)","('GHG_Emissions', 0.03923983499407768)","('Energy_Management', 0.022731216624379158)","(['Operational Eco-Efficiency'], 0.8439649343490601)","('NON-ESG', 0.03923983499407768)","('NON-ESG', 0.022731216624379158)"
Line 344,"Sites report on data completion and provide operational insight to our regional Sustainability Operations team throughout the year.
","('Business_Model_Resilience', 0.6872584223747253)","('Systemic_Risk_Management', 0.05083758383989334)","('Supply_Chain_Management', 0.0367850735783577)","(['Codes of Business Conduct'], 0.6872584223747253)","('NON-ESG', 0.05083758383989334)","('NON-ESG', 0.0367850735783577)"
Line 345,"Updates are provided frequently to our Sustainability Operations Council, and of  the integrated supply chain leadership at least quarterly.
","('Supply_Chain_Management', 0.9462552666664124)","('Product_Design_And_Lifecycle_Management', 0.0063634649850428104)","('Physical_Impacts_Of_Climate_Change', 0.0038047118578106165)","(['Supply Chain Management'], 0.9462552666664124)","('NON-ESG', 0.0063634649850428104)","('NON-ESG', 0.0038047118578106165)"
Line 346,"At the company level, progress on overall sustainability performance is reviewed with the ERC.Environmental justice The goal of environmental justice is to address the inequitable exposure of poor and marginalized communities to harm to their health and environment.
","('Human_Rights_And_Community_Relations', 0.9356386661529541)","('Access_And_Affordability', 0.014990132302045822)","('Labor_Practices', 0.006317560561001301)","(['Community Relations'], 0.9356386661529541)","('NON-ESG', 0.014990132302045822)","('NON-ESG', 0.006317560561001301)"
Line 347,"The pattern of inequitable exposure to environmental harms—especially in communities of color in the U.S.—has been documented in multiple studies.
","('Human_Rights_And_Community_Relations', 0.3159201145172119)","('Employee_Health_And_Safety', 0.21366053819656372)","('Access_And_Affordability', 0.1855497658252716)","('NON-ESG', 0.3159201145172119)","('NON-ESG', 0.21366053819656372)","('NON-ESG', 0.1855497658252716)"
Line 348,"Exposure to these harms has led to higher rates of chronic health problems, disease and mortality among poor and marginalized communities.
","('Employee_Health_And_Safety', 0.40292611718177795)","('Access_And_Affordability', 0.23791541159152985)","('Human_Rights_And_Community_Relations', 0.18916626274585724)","('NON-ESG', 0.40292611718177795)","('NON-ESG', 0.23791541159152985)","('NON-ESG', 0.18916626274585724)"
Line 349,"Efforts are continuing globally to implement policies and legislation to ensure  the fair treatment and meaningful involvement of all people with respect to the development, implementation and enforcement of environmental laws, regulations and policies.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9563901424407959)","('Human_Rights_And_Community_Relations', 0.005462815053761005)","('Ecological_Impacts', 0.00417356938123703)","(['Corporate Governance'], 0.9563901424407959)","('NON-ESG', 0.005462815053761005)","('NON-ESG', 0.00417356938123703)"
Line 350,"An example includes the 2020 Environmental Justice Law in BD’s home state of New Jersey, U.S., which requires the evaluation of the environmental and public health impacts of certain facilities on overburdened communities when reviewing certain permit applications.
","('Ecological_Impacts', 0.4941753149032593)","('Human_Rights_And_Community_Relations', 0.12601163983345032)","('GHG_Emissions', 0.058930668979883194)","('NON-ESG', 0.4941753149032593)","('NON-ESG', 0.12601163983345032)","('NON-ESG', 0.058930668979883194)"
Line 351,"We have established environmental and health & safety management systems at  our facilities globally that help identify, manage and mitigate environmental and safety risks, as part of our continuous improvement efforts.
","('Employee_Health_And_Safety', 0.9666231274604797)","('Critical_Incident_Risk_Management', 0.005944118835031986)","('Product_Quality_And_Safety', 0.004463394172489643)","(['Operational Eco-Efficiency'], 0.9666231274604797)","('NON-ESG', 0.005944118835031986)","('NON-ESG', 0.004463394172489643)"
Line 352,"Oversight of identified environmental justice issues would be carried out via our  established ESG governance structures.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8835871815681458)","('Business_Ethics', 0.025462893769145012)","('Human_Rights_And_Community_Relations', 0.019320955500006676)","(['Corporate Governance'], 0.8835871815681458)","('NON-ESG', 0.025462893769145012)","('NON-ESG', 0.019320955500006676)"
Line 353,"We are in the process of carrying out an initial screening of our U.S. operations  using publicly available tools to determine if they are located in impacted communities.
","('Human_Rights_And_Community_Relations', 0.4876290261745453)","('Critical_Incident_Risk_Management', 0.09410345554351807)","('Access_And_Affordability', 0.08433452248573303)","('NON-ESG', 0.4876290261745453)","('NON-ESG', 0.09410345554351807)","('NON-ESG', 0.08433452248573303)"
Line 354,"The results of this screening will be used to determine next steps.2021 ESG Report Introduction Climate change Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Environment, health and  safety management We set expectations for environmental, health and safety (EHS) management via  three key documents:    Purpose  At BD, we consistently strive to provide superior products and services in pursuit of our purpose of advancing the  world of health ™.
","('Product_Design_And_Lifecycle_Management', 0.7069277167320251)","('Product_Quality_And_Safety', 0.18647778034210205)","('Selling_Practices_And_Product_Labeling', 0.01301350723952055)","(['Product Stewardship'], 0.7069277167320251)","('NON-ESG', 0.18647778034210205)","('NON-ESG', 0.01301350723952055)"
Line 355,"In the process of doing so, we promote environmentally sound and sustainable practices and  protect the health, safety and well-being of our associates, our customers and partners, and the communities in  which we live and w ork.
","('Employee_Health_And_Safety', 0.9189165234565735)","('Product_Design_And_Lifecycle_Management', 0.012545105069875717)","('Product_Quality_And_Safety', 0.011674831621348858)","(['Operational Eco-Efficiency'], 0.9189165234565735)","('NON-ESG', 0.012545105069875717)","('NON-ESG', 0.011674831621348858)"
Line 356,"Scope  This policy applies to all BD associates, visitors and c ontractor s and to all owned or leased BD facilities , worldwide.
","('Management_Of_Legal_And_Regulatory_Framework', 0.27919667959213257)","('Supply_Chain_Management', 0.10043127089738846)","('Competitive_Behavior', 0.05427808314561844)","('NON-ESG', 0.27919667959213257)","('NON-ESG', 0.10043127089738846)","('NON-ESG', 0.05427808314561844)"
Line 357,"As a global company, we recognize the positive impac t we can have on communit ies ac ross our supply chain.
","('Supply_Chain_Management', 0.9515436291694641)","('Labor_Practices', 0.004102305043488741)","('Physical_Impacts_Of_Climate_Change', 0.003498457372188568)","(['Supply Chain Management'], 0.9515436291694641)","('NON-ESG', 0.004102305043488741)","('NON-ESG', 0.003498457372188568)"
Line 358,"To that  extent, we also expect our partners to have simila r Environm ent H ealth and Safety programs/policies in pl ace,  detailed in our Expectations for Suppliers document.
","('Product_Quality_And_Safety', 0.9051177501678467)","('Employee_Health_And_Safety', 0.016926294192671776)","('Selling_Practices_And_Product_Labeling', 0.008578775450587273)","(['Product Quality & Recall Management'], 0.9051177501678467)","('NON-ESG', 0.016926294192671776)","('NON-ESG', 0.008578775450587273)"
Line 359," Policy  Fundamental to this Policy is c omplianc e with all applicable laws and regulations, a commitment to continuous  improvement, and alignment w ith our  BD Code o f Conduct,  which applies to al l associates.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9719884991645813)","('Energy_Management', 0.002327150432392955)","('Director_Removal', 0.0020026538986712694)","(['Corporate Governance'], 0.9719884991645813)","('NON-ESG', 0.002327150432392955)","('NON-ESG', 0.0020026538986712694)"
Line 360,"Global Environment, Health and  Safety Policy   Effective:  April  2021   DocuSign Envelope ID: 5181EA3A-2029-4AF3-A5B4-C6651613F18A Our EHS Policy BD Expectations for Suppliers  April Our Expectations for Suppliers The BD Code of ConductBringing our values to life Revised and reinstated January 25, Our Code of ConductEHS governance At the corporate level, BD has an EHS team led by the VP S&EHS; the VP S&EHS reports to the company’s EVP ISC.
","('Product_Quality_And_Safety', 0.5494274497032166)","('Employee_Health_And_Safety', 0.2453000545501709)","('Supply_Chain_Management', 0.029938943684101105)","(['Product Quality & Recall Management'], 0.5494274497032166)","('NON-ESG', 0.2453000545501709)","('NON-ESG', 0.029938943684101105)"
Line 361,"Reporting to the VP S&EHS is the senior director, EHS governance and compliance.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7544856071472168)","('Business_Ethics', 0.042455583810806274)","('Systemic_Risk_Management', 0.037907447665929794)","(['Corporate Governance'], 0.7544856071472168)","('NON-ESG', 0.042455583810806274)","('NON-ESG', 0.037907447665929794)"
Line 362,"This individual is responsible for governance and compliance activities, including our company’s internal EHS audit program, remediation, due diligence, mergers and acquisitions, EHS standards and training programs.
","('Business_Ethics', 0.5147907137870789)","('Management_Of_Legal_And_Regulatory_Framework', 0.36484482884407043)","('Product_Quality_And_Safety', 0.016402099281549454)","(['Business Ethics'], 0.5147907137870789)","('NON-ESG', 0.36484482884407043)","('NON-ESG', 0.016402099281549454)"
Line 363,"In addition, this person communicates EHS matters that are relevant to stakeholders throughout the organization and oversees the Global EHS Advisory Council.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9208803176879883)","('Director_Removal', 0.008631623350083828)","('Human_Rights_And_Community_Relations', 0.007734249345958233)","(['Corporate Governance'], 0.9208803176879883)","('NON-ESG', 0.008631623350083828)","('NON-ESG', 0.007734249345958233)"
Line 364,"In FY 2021, we continued to solidify and streamline our standards and practices across 90+ facilities with a focus on sites gained through recent acquisitions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5129795074462891)","('Product_Quality_And_Safety', 0.1358673870563507)","('Business_Ethics', 0.112714022397995)","(['Corporate Governance'], 0.5129795074462891)","('NON-ESG', 0.1358673870563507)","('NON-ESG', 0.112714022397995)"
Line 365,"The Global EHS Advisory Council, with representation from all BD businesses, provides a unified direction in establishing global objectives and strong collaboration efforts across the organization to streamline processes and work as one team.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6318088173866272)","('Human_Rights_And_Community_Relations', 0.06478282064199448)","('Director_Removal', 0.052435193210840225)","(['Corporate Governance'], 0.6318088173866272)","('NON-ESG', 0.06478282064199448)","('NON-ESG', 0.052435193210840225)"
Line 366,"EHS management systems To foster continuous improvement of environmental performance at a facility level, BD is implementing ISO 14001-certified environmental management systems EMS at our manufacturing sites around the world.
","('Product_Design_And_Lifecycle_Management', 0.6392771601676941)","('Energy_Management', 0.06909271329641342)","('Supply_Chain_Management', 0.03480798751115799)","(['Product Stewardship'], 0.6392771601676941)","('NON-ESG', 0.06909271329641342)","('NON-ESG', 0.03480798751115799)"
Line 367,"Currently, 45 BD sites have ISO 14001-certified EMS.
","('Product_Quality_And_Safety', 0.32555219531059265)","('Product_Design_And_Lifecycle_Management', 0.2559562027454376)","('Management_Of_Legal_And_Regulatory_Framework', 0.04711173102259636)","('NON-ESG', 0.32555219531059265)","('NON-ESG', 0.2559562027454376)","('NON-ESG', 0.04711173102259636)"
Line 368,"Most of these sites are manufacturing locations, but HQ offices and some sales offices in Europe are also certified.
","('Business_Model_Resilience', 0.23605772852897644)","('Product_Design_And_Lifecycle_Management', 0.1746889054775238)","('Customer_Welfare', 0.13058042526245117)","('NON-ESG', 0.23605772852897644)","('NON-ESG', 0.1746889054775238)","('NON-ESG', 0.13058042526245117)"
Line 369,"In total, about 32 percent of BD manufacturing sites are certified to the ISO-14001 EMS standard.
","('Product_Quality_And_Safety', 0.36485207080841064)","('Product_Design_And_Lifecycle_Management', 0.3061150014400482)","('Management_Of_Legal_And_Regulatory_Framework', 0.03398589417338371)","('NON-ESG', 0.36485207080841064)","('NON-ESG', 0.3061150014400482)","('NON-ESG', 0.03398589417338371)"
Line 370,"In 2022, two additional manufacturing sites, in Puerto Rico and Nebraska, U.S., are in the process of obtaining their certifications.
","('Product_Quality_And_Safety', 0.4787028729915619)","('Product_Design_And_Lifecycle_Management', 0.20695634186267853)","('Competitive_Behavior', 0.04290833696722984)","('NON-ESG', 0.4787028729915619)","('NON-ESG', 0.20695634186267853)","('NON-ESG', 0.04290833696722984)"
Line 371,"Around two-thirds of these certified locations are part of a group certificate,  where we have established standardized procedures and methods for program implementation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.48568496108055115)","('Product_Quality_And_Safety', 0.14489391446113586)","('Human_Rights_And_Community_Relations', 0.0647311881184578)","('NON-ESG', 0.48568496108055115)","('NON-ESG', 0.14489391446113586)","('NON-ESG', 0.0647311881184578)"
Line 372,"This standardized approach allows sites to work together in a collaborative way with extensive sharing and interaction to enhance program effectiveness.
","('Access_And_Affordability', 0.39337578415870667)","('Management_Of_Legal_And_Regulatory_Framework', 0.22261810302734375)","('Human_Rights_And_Community_Relations', 0.10423155128955841)","('NON-ESG', 0.39337578415870667)","('NON-ESG', 0.22261810302734375)","('NON-ESG', 0.10423155128955841)"
Line 373,"For example, all corrective actions are logged and shared with all sites in the respective group certificates to facilitate learning from each other’s experience and to take proactive actions to prevent similar issues from happening at other sites.
","('Business_Ethics', 0.34746798872947693)","('Management_Of_Legal_And_Regulatory_Framework', 0.19254662096500397)","('Human_Rights_And_Community_Relations', 0.07299992442131042)","('NON-ESG', 0.34746798872947693)","('NON-ESG', 0.19254662096500397)","('NON-ESG', 0.07299992442131042)"
Line 374,"Furthermore, every EMS-certified site sets environmental improvement objectives on an annual basis, and they are reviewed for progress quarterly.
","('Product_Design_And_Lifecycle_Management', 0.18994133174419403)","('Ecological_Impacts', 0.15621402859687805)","('Human_Rights_And_Community_Relations', 0.10267801582813263)","('NON-ESG', 0.18994133174419403)","('NON-ESG', 0.15621402859687805)","('NON-ESG', 0.10267801582813263)"
Line 375,"Our plan is to continue ISO 14001 certification of remaining BD manufacturing plants over the coming years.The ISO 50001 energy management standard provides a framework of requirements to measure and use data for better understanding of energy use, set objectives for energy use reduction and continually improve energy management.
","('Energy_Management', 0.9800992608070374)","('Product_Design_And_Lifecycle_Management', 0.0018182112835347652)","('Critical_Incident_Risk_Management', 0.0017476214561611414)","(['Operational Eco-Efficiency'], 0.9800992608070374)","('NON-ESG', 0.0018182112835347652)","('NON-ESG', 0.0017476214561611414)"
Line 376,"Many BD facilities have a strong focus on energy management and reduction and are pursuing many aspects of a responsible energy management program.
","('Energy_Management', 0.9798905849456787)","('Air_Quality', 0.002157552633434534)","('Critical_Incident_Risk_Management', 0.001936158281750977)","(['Operational Eco-Efficiency'], 0.9798905849456787)","('NON-ESG', 0.002157552633434534)","('NON-ESG', 0.001936158281750977)"
Line 377,"We currently have two facilities, in Spain and Hungary, that have implemented energy management systems that are certified to ISO 50001.
","('Energy_Management', 0.9566616415977478)","('Product_Design_And_Lifecycle_Management', 0.007402780000120401)","('Management_Of_Legal_And_Regulatory_Framework', 0.00321566523052752)","(['Operational Eco-Efficiency'], 0.9566616415977478)","('NON-ESG', 0.007402780000120401)","('NON-ESG', 0.00321566523052752)"
Line 378,"All BD manufacturing locations maintain a strong focus on occupational health  and safety (OHS) management for injury reduction and prevention.
","('Employee_Health_And_Safety', 0.9849066138267517)","('Employee_Engagement_Inclusion_And_Diversity', 0.0017395114991813898)","('Critical_Incident_Risk_Management', 0.0012561355251818895)","(['Operational Eco-Efficiency'], 0.9849066138267517)","('NON-ESG', 0.0017395114991813898)","('NON-ESG', 0.0012561355251818895)"
Line 379,"Significant OHS risks associated with our activities are identified and reviewed for elimination and/ or control to minimize their potential effects on our employees.
","('Systemic_Risk_Management', 0.6387709379196167)","('Employee_Health_And_Safety', 0.10514277964830399)","('Supply_Chain_Management', 0.06784985214471817)","(['Risk & Crisis Management'], 0.6387709379196167)","('NON-ESG', 0.10514277964830399)","('NON-ESG', 0.06784985214471817)"
Line 380,"Two BD sites, in Spain and China, are certified to the OHSAS-18001 occupational health and safety management standard.
","('Employee_Health_And_Safety', 0.9821280241012573)","('Employee_Engagement_Inclusion_And_Diversity', 0.0021111085079610348)","('Product_Quality_And_Safety', 0.0014139034319669008)","(['Operational Eco-Efficiency'], 0.9821280241012573)","('NON-ESG', 0.0021111085079610348)","('NON-ESG', 0.0014139034319669008)"
Line 381,"The OHSAS-18001 standard is currently being replaced by ISO-45001, and both of our sites have converted to this new standard.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4121558964252472)","('Product_Quality_And_Safety', 0.21958893537521362)","('Product_Design_And_Lifecycle_Management', 0.030301347374916077)","('NON-ESG', 0.4121558964252472)","('NON-ESG', 0.21958893537521362)","('NON-ESG', 0.030301347374916077)"
Line 382,"Although our other sites are currently not certified to a third-party OHS management standard, their on-site OHS programs follow many of the elements included in the OHSAS-18001/ISO-45001 standards.
","('Product_Quality_And_Safety', 0.47631320357322693)","('Management_Of_Legal_And_Regulatory_Framework', 0.21683061122894287)","('Product_Design_And_Lifecycle_Management', 0.03790438175201416)","('NON-ESG', 0.47631320357322693)","('NON-ESG', 0.21683061122894287)","('NON-ESG', 0.03790438175201416)"
Line 383,"For additional details on work carried out in FY 2021 related to associate health and  safety, please see the Healthy workforce and communities section of this report.
","('Employee_Health_And_Safety', 0.9834014177322388)","('Critical_Incident_Risk_Management', 0.0021420728880912066)","('Employee_Engagement_Inclusion_And_Diversity', 0.0016533416928723454)","(['Operational Eco-Efficiency'], 0.9834014177322388)","('NON-ESG', 0.0021420728880912066)","('NON-ESG', 0.0016533416928723454)"
Line 384,"2021 ESG Report Introduction Climate change Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Training The central EHS team provides new-hire orientation that is customized to roles and  responsibilities.
","('Supply_Chain_Management', 0.6804831027984619)","('Physical_Impacts_Of_Climate_Change', 0.18020856380462646)","('Business_Model_Resilience', 0.02096681110560894)","(['Supply Chain Management'], 0.6804831027984619)","('NON-ESG', 0.18020856380462646)","('NON-ESG', 0.02096681110560894)"
Line 385,"It encompasses a comprehensive EHS curriculum that is delivered to business leaders, EHS professionals, and other applicable roles.
","('Employee_Engagement_Inclusion_And_Diversity', 0.41197124123573303)","('Access_And_Affordability', 0.1703779399394989)","('Business_Model_Resilience', 0.0450444370508194)","('NON-ESG', 0.41197124123573303)","('NON-ESG', 0.1703779399394989)","('NON-ESG', 0.0450444370508194)"
Line 386,"This orientation includes training on all applicable EHS management information system platforms that allow us to track progress against performance measures.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4641743004322052)","('Systemic_Risk_Management', 0.11358841508626938)","('Business_Model_Resilience', 0.06756830215454102)","('NON-ESG', 0.4641743004322052)","('NON-ESG', 0.11358841508626938)","('NON-ESG', 0.06756830215454102)"
Line 387,"In addition, the central EHS team conducts a training needs assessment that is  based on current incident trends, audit results and regulatory requirements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9708686470985413)","('Business_Ethics', 0.0023131854832172394)","('Director_Removal', 0.0021927845664322376)","(['Corporate Governance'], 0.9708686470985413)","('NON-ESG', 0.0023131854832172394)","('NON-ESG', 0.0021927845664322376)"
Line 388,"A BD EHS training matrix defines training assignments based on the roles and priorities identified, and training is assigned accordingly.
","('Employee_Engagement_Inclusion_And_Diversity', 0.24710649251937866)","('Access_And_Affordability', 0.18398045003414154)","('Employee_Health_And_Safety', 0.17915086448192596)","('NON-ESG', 0.24710649251937866)","('NON-ESG', 0.18398045003414154)","('NON-ESG', 0.17915086448192596)"
Line 389,"EHS Corporate Standards contain requirements on training frequency and  curriculum.
","('Product_Quality_And_Safety', 0.2598646283149719)","('Management_Of_Legal_And_Regulatory_Framework', 0.17295894026756287)","('Access_And_Affordability', 0.13583604991436005)","('NON-ESG', 0.2598646283149719)","('NON-ESG', 0.17295894026756287)","('NON-ESG', 0.13583604991436005)"
Line 390,"Training completion is evaluated as part of the corporate audit program.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3629082143306732)","('Business_Ethics', 0.23011420667171478)","('Product_Quality_And_Safety', 0.0907716453075409)","('NON-ESG', 0.3629082143306732)","('NON-ESG', 0.23011420667171478)","('NON-ESG', 0.0907716453075409)"
Line 391,"Upon deployment of new or revised corporate EHS standards, training is an integral part of the process for adherence.
","('Management_Of_Legal_And_Regulatory_Framework', 0.41610002517700195)","('Product_Quality_And_Safety', 0.30220088362693787)","('Business_Ethics', 0.04245058819651604)","('NON-ESG', 0.41610002517700195)","('NON-ESG', 0.30220088362693787)","('NON-ESG', 0.04245058819651604)"
Line 392,"The central EHS team deployed People Leaders training in FY 2021 to enhance leadership knowledge, reinforce roles and responsibilities, and drive engagement through all levels of the organization.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6501058340072632)","('Human_Rights_And_Community_Relations', 0.10583867132663727)","('Business_Model_Resilience', 0.03226716071367264)","(['Human Capital Development'], 0.6501058340072632)","('NON-ESG', 0.10583867132663727)","('NON-ESG', 0.03226716071367264)"
Line 393,"The central EHS team uses a variety of training mediums, including classroom training,  webinars and on-demand compliance training via our company’s online training system.
","('Access_And_Affordability', 0.22171613574028015)","('Product_Quality_And_Safety', 0.16210316121578217)","('Management_Of_Legal_And_Regulatory_Framework', 0.12484242022037506)","('NON-ESG', 0.22171613574028015)","('NON-ESG', 0.16210316121578217)","('NON-ESG', 0.12484242022037506)"
Line 394,"Individual sites are responsible for identifying site-specific EHS training needs and implementing training programs on a variety of EHS topics, taking into consideration the risks that are present and any local regulatory requirements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9619016647338867)","('Product_Quality_And_Safety', 0.004087002016603947)","('Access_And_Affordability', 0.002848547650501132)","(['Corporate Governance'], 0.9619016647338867)","('NON-ESG', 0.004087002016603947)","('NON-ESG', 0.002848547650501132)"
Line 395,"In FY 2021 a Learning and Development leader joined the central EHS team.
","('Access_And_Affordability', 0.44972696900367737)","('Employee_Engagement_Inclusion_And_Diversity', 0.1457127183675766)","('Human_Rights_And_Community_Relations', 0.04498859867453575)","('NON-ESG', 0.44972696900367737)","('NON-ESG', 0.1457127183675766)","('NON-ESG', 0.04498859867453575)"
Line 396,"This  investment strengthens the central team’s capabilities and processes for delivering training and development across BD.
","('Access_And_Affordability', 0.2625430226325989)","('Employee_Engagement_Inclusion_And_Diversity', 0.12055791169404984)","('Human_Rights_And_Community_Relations', 0.09488885849714279)","('NON-ESG', 0.2625430226325989)","('NON-ESG', 0.12055791169404984)","('NON-ESG', 0.09488885849714279)"
Line 397,"EHS training is also provided at a site level, with subjects and frequency determined  by job role and local requirements, in addition to requirements set by Corporate EHS Standards.EHS management information systems In FY 2021, we implemented a new EHS management-of-information system across the company.
","('Management_Of_Legal_And_Regulatory_Framework', 0.25345703959465027)","('Product_Quality_And_Safety', 0.16367299854755402)","('Data_Security', 0.11231601983308792)","('NON-ESG', 0.25345703959465027)","('NON-ESG', 0.16367299854755402)","('NON-ESG', 0.11231601983308792)"
Line 398,"This eliminated multiple instances of the legacy platform, allowing us to establish uniform and efficient processes and reduce cost.
","('Competitive_Behavior', 0.18986177444458008)","('Management_Of_Legal_And_Regulatory_Framework', 0.18740753829479218)","('Systemic_Risk_Management', 0.16880951821804047)","('NON-ESG', 0.18986177444458008)","('NON-ESG', 0.18740753829479218)","('NON-ESG', 0.16880951821804047)"
Line 399,"The platform was implemented over two phases and allows us to track these items at a site level: •  EHS incident management •  EHS audits •  Risk assessments •  C ompliance tracking •  W aste management •  En vironmental aspects & impacts •  P ermits •  Inspections EHS sub ject-matter experts from across BD were brought together to configure the  new system to meet BD's requirements.
","('Business_Ethics', 0.35262200236320496)","('Systemic_Risk_Management', 0.15707333385944366)","('Management_Of_Legal_And_Regulatory_Framework', 0.1358921229839325)","('NON-ESG', 0.35262200236320496)","('NON-ESG', 0.15707333385944366)","('NON-ESG', 0.1358921229839325)"
Line 400,"All users received training on how to use  the platform, and guidance tools are available within it.
","('Access_And_Affordability', 0.1339978575706482)","('Product_Quality_And_Safety', 0.12766402959823608)","('Management_Of_Legal_And_Regulatory_Framework', 0.12084858864545822)","('NON-ESG', 0.1339978575706482)","('NON-ESG', 0.12766402959823608)","('NON-ESG', 0.12084858864545822)"
Line 401,"In addition, we use a platform provided by a third party to manage Safety Data  Sheets (SDSs) within our operations.
","('Product_Quality_And_Safety', 0.5899108648300171)","('Employee_Health_And_Safety', 0.2628610134124756)","('Customer_Privacy', 0.011763837188482285)","(['Product Quality & Recall Management'], 0.5899108648300171)","('NON-ESG', 0.2628610134124756)","('NON-ESG', 0.011763837188482285)"
Line 402,"Internal audits We have a global EHS audit program covering all BD manufacturing, R&D, distribution center and major office locations.
","('Business_Ethics', 0.6431288123130798)","('Management_Of_Legal_And_Regulatory_Framework', 0.12900087237358093)","('Systemic_Risk_Management', 0.08810291439294815)","(['Business Ethics'], 0.6431288123130798)","('NON-ESG', 0.12900087237358093)","('NON-ESG', 0.08810291439294815)"
Line 403,"Audits are typically carried out by a third party and a representative from the central EHS team who leads and monitors audit performance and outcomes.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4271365702152252)","('Business_Ethics', 0.2871420681476593)","('Systemic_Risk_Management', 0.09374937415122986)","('NON-ESG', 0.4271365702152252)","('NON-ESG', 0.2871420681476593)","('NON-ESG', 0.09374937415122986)"
Line 404,"In FY 2020, the BD EHS team implemented a new risk-based audit model that evaluates facilities on three main components: inherent risk, changes and performance.
","('Systemic_Risk_Management', 0.9221692085266113)","('Business_Ethics', 0.018731018528342247)","('Business_Model_Resilience', 0.008232359774410725)","(['Risk & Crisis Management'], 0.9221692085266113)","('NON-ESG', 0.018731018528342247)","('NON-ESG', 0.008232359774410725)"
Line 405,"The inherent-risk factors include the type and size of the facility and take into consideration any high-hazard processes 11.
","('Critical_Incident_Risk_Management', 0.2503795623779297)","('Employee_Health_And_Safety', 0.1438600867986679)","('Systemic_Risk_Management', 0.1207590252161026)","('NON-ESG', 0.2503795623779297)","('NON-ESG', 0.1438600867986679)","('NON-ESG', 0.1207590252161026)"
Line 406,"The change factors include new regulations, new processes and changes to site management or EHS personnel.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9509217143058777)","('Director_Removal', 0.0065898890607059)","('Physical_Impacts_Of_Climate_Change', 0.004174905829131603)","(['Corporate Governance'], 0.9509217143058777)","('NON-ESG', 0.0065898890607059)","('NON-ESG', 0.004174905829131603)"
Line 407,"Performance factors include the site’s performance in EHS over the past 12 months, including the outcome of any inspections by relevant authorities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.36457744240760803)","('Business_Ethics', 0.18973666429519653)","('Product_Quality_And_Safety', 0.11290094256401062)","('NON-ESG', 0.36457744240760803)","('NON-ESG', 0.18973666429519653)","('NON-ESG', 0.11290094256401062)"
Line 408,"This enabled a more deliberate focus for the selection of sites to be audited during the year.
","('Management_Of_Legal_And_Regulatory_Framework', 0.34535861015319824)","('Competitive_Behavior', 0.15928977727890015)","('Systemic_Risk_Management', 0.14435216784477234)","('NON-ESG', 0.34535861015319824)","('NON-ESG', 0.15928977727890015)","('NON-ESG', 0.14435216784477234)"
Line 409,"Audits are typically three full days and consist of an opening meeting, a site tour,  document examination and finally, a closing meeting.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5607002973556519)","('Director_Removal', 0.10106993466615677)","('Business_Ethics', 0.08151517808437347)","(['Corporate Governance'], 0.5607002973556519)","('NON-ESG', 0.10106993466615677)","('NON-ESG', 0.08151517808437347)"
Line 410,"Findings are included in the audit tool, and the site is responsible for ensuring that all actions are closed out.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7881590723991394)","('Business_Ethics', 0.09459304809570312)","('Systemic_Risk_Management', 0.023058492690324783)","(['Corporate Governance'], 0.7881590723991394)","('NON-ESG', 0.09459304809570312)","('NON-ESG', 0.023058492690324783)"
Line 411,"Four different levels of findings are potentially recorded: repeat findings where an issue was raised previously in an audit and deemed to be open again; high-level findings where there is a serious potential environmental or health-and-safety impact; medium-level findings in which there is a systemic issue; and low-level findings in which the issue is administrative or an isolated one-off.
","('Systemic_Risk_Management', 0.8384239077568054)","('Business_Ethics', 0.032577384263277054)","('Product_Quality_And_Safety', 0.014388294890522957)","(['Risk & Crisis Management'], 0.8384239077568054)","('NON-ESG', 0.032577384263277054)","('NON-ESG', 0.014388294890522957)"
Line 412,"Executive summaries from each audit are provided to site management,  operational leaders, EHS business team leaders, VP S&EHS, EVP ISC and the CEO.
","('Director_Removal', 0.31579723954200745)","('Business_Model_Resilience', 0.2640373110771179)","('Employee_Engagement_Inclusion_And_Diversity', 0.0883098915219307)","('NON-ESG', 0.31579723954200745)","('NON-ESG', 0.2640373110771179)","('NON-ESG', 0.0883098915219307)"
Line 413,"All corrective actions are tracked to closure with follow-up audits carried out approximately six and 12 months later to verify completion.
","('Management_Of_Legal_And_Regulatory_Framework', 0.48861587047576904)","('Business_Ethics', 0.2712259888648987)","('Systemic_Risk_Management', 0.05028678849339485)","('NON-ESG', 0.48861587047576904)","('NON-ESG', 0.2712259888648987)","('NON-ESG', 0.05028678849339485)"
Line 414,"Once findings are verified and closed, the site will be issued a closure confirmation  from the central EHS team to document that the findings are effectively closed out.
","('Water_And_Wastewater_Management', 0.11644410341978073)","('Management_Of_Legal_And_Regulatory_Framework', 0.09719855338335037)","('Ecological_Impacts', 0.09149612486362457)","('NON-ESG', 0.11644410341978073)","('NON-ESG', 0.09719855338335037)","('NON-ESG', 0.09149612486362457)"
Line 415,"In FY 2022, all findings that remain open after the follow-up audit are tracked on a monthly basis and are communicated to top management and the CEO.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6258465647697449)","('Business_Ethics', 0.14858579635620117)","('Systemic_Risk_Management', 0.06500766426324844)","(['Corporate Governance'], 0.6258465647697449)","('NON-ESG', 0.14858579635620117)","('NON-ESG', 0.06500766426324844)"
Line 416,"As a result of the ongoing pandemic, in FY 2022, the audit team launched a hybrid  approach to auditing at several high-hazard facilities.
","('Systemic_Risk_Management', 0.4055899381637573)","('Physical_Impacts_Of_Climate_Change', 0.2668198049068451)","('Air_Quality', 0.05750076472759247)","('NON-ESG', 0.4055899381637573)","('NON-ESG', 0.2668198049068451)","('NON-ESG', 0.05750076472759247)"
Line 417,"These sites must submit relevant documentation for review in advance of an in-person audit later in the year.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8463473916053772)","('Business_Ethics', 0.04458962380886078)","('Director_Removal', 0.013989964500069618)","(['Corporate Governance'], 0.8463473916053772)","('NON-ESG', 0.04458962380886078)","('NON-ESG', 0.013989964500069618)"
Line 418,"This allows us to begin auditing sites despite travel restrictions.
","('Customer_Privacy', 0.2769871652126312)","('Labor_Practices', 0.11972770094871521)","('Director_Removal', 0.07387624680995941)","('NON-ESG', 0.2769871652126312)","('NON-ESG', 0.11972770094871521)","('NON-ESG', 0.07387624680995941)"
Line 419,"With a shift to virtual audits and a transformation of methodologies to address  this new platform, we were able to continue to audit facilities to provide an effective level of governance oversight and address new challenges during these unprecedented times.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6085262298583984)","('Business_Ethics', 0.20101259648799896)","('Systemic_Risk_Management', 0.061690494418144226)","(['Corporate Governance'], 0.6085262298583984)","('NON-ESG', 0.20101259648799896)","('NON-ESG', 0.061690494418144226)"
Line 420,"Additionally, the updated closure and extension process provides visibility to leadership and helps all sites document the complete closure of outstanding findings.
","('Systemic_Risk_Management', 0.19566777348518372)","('Critical_Incident_Risk_Management', 0.08107563853263855)","('Business_Model_Resilience', 0.06907350569963455)","('NON-ESG', 0.19566777348518372)","('NON-ESG', 0.08107563853263855)","('NON-ESG', 0.06907350569963455)"
Line 421,"11 BD has defined high-hazard processes as those that meet the definition per local regulations of high hazard, or those that exceed 50 percent of the threshold quantity value in a process per OSHA 1910.119, Process Safety Management.
","('Employee_Health_And_Safety', 0.6953438520431519)","('Product_Quality_And_Safety', 0.06546257436275482)","('Critical_Incident_Risk_Management', 0.05888787657022476)","(['Operational Eco-Efficiency'], 0.6953438520431519)","('NON-ESG', 0.06546257436275482)","('NON-ESG', 0.05888787657022476)"
Line 422,"Other processes including large boilers, autoclaves, radiation hazards, toxic chemicals, etc.,  are also defined as high-hazard.2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Climate change Introduction Product impact Product impact2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Climate change Introduction Product impact BD Sustainable Medical Technology Institute (BD SMTI) In FY 2022, BD announced the formation of the BD SMTI, which will develop and support programs to achieve our 2030+  Product Impact goals.
","('Supply_Chain_Management', 0.5404252409934998)","('Product_Design_And_Lifecycle_Management', 0.11670808494091034)","('Physical_Impacts_Of_Climate_Change', 0.11058638989925385)","(['Supply Chain Management'], 0.5404252409934998)","('NON-ESG', 0.11670808494091034)","('NON-ESG', 0.11058638989925385)"
Line 423,"Other processes including large boilers, autoclaves, radiation hazards, toxic chemicals, etc.,  are also defined as high-hazard.2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Climate change Introduction Product impact Product impact2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Climate change Introduction Product impact BD Sustainable Medical Technology Institute (BD SMTI) In FY 2022, BD announced the formation of the BD SMTI, which will develop and support programs to achieve our 2030+  Product Impact goals.
","('Product_Design_And_Lifecycle_Management', 0.9360448122024536)","('Product_Quality_And_Safety', 0.010457721538841724)","('Customer_Welfare', 0.009753125719726086)","(['Product Stewardship'], 0.9360448122024536)","('NON-ESG', 0.010457721538841724)","('NON-ESG', 0.009753125719726086)"
Line 424,"Focused on sustainability, the institute will help guide the environmental impact reduction of our portfolio and address the  sustainability needs of our customers.
","('Product_Design_And_Lifecycle_Management', 0.8453041315078735)","('Business_Model_Resilience', 0.026487799361348152)","('Supply_Chain_Management', 0.022102762013673782)","(['Product Stewardship'], 0.8453041315078735)","('NON-ESG', 0.026487799361348152)","('NON-ESG', 0.022102762013673782)"
Line 425,"It will be composed of members from the R&D and ISC functions of BD, both centrally and within our business units.
","('Director_Removal', 0.4282184839248657)","('Management_Of_Legal_And_Regulatory_Framework', 0.13096213340759277)","('Business_Model_Resilience', 0.08494437485933304)","('NON-ESG', 0.4282184839248657)","('NON-ESG', 0.13096213340759277)","('NON-ESG', 0.08494437485933304)"
Line 426,"By focusing on three key areas—addressing Materials of Concern (MOC), new and more sustainable sterilization technologies,  and sustainable product design—BD SMTI and its community of practitioners will support efforts to reduce the carbon footprint and environmental impact of our products.
","('Product_Design_And_Lifecycle_Management', 0.966921865940094)","('Product_Quality_And_Safety', 0.004287093877792358)","('Energy_Management', 0.002578455489128828)","(['Product Stewardship'], 0.966921865940094)","('NON-ESG', 0.004287093877792358)","('NON-ESG', 0.002578455489128828)"
Line 427,"BD SMTI is led by the director of sustainability research and development, a new role that was established in early FY 2022.
","('Business_Model_Resilience', 0.20824483036994934)","('Management_Of_Legal_And_Regulatory_Framework', 0.16777190566062927)","('Access_And_Affordability', 0.06527721136808395)","('NON-ESG', 0.20824483036994934)","('NON-ESG', 0.16777190566062927)","('NON-ESG', 0.06527721136808395)"
Line 428,"This individual reports to the senior vice president, enterprise R&D, with dotted-line reporting to the VP S&EHS.
","('Business_Model_Resilience', 0.3633694052696228)","('Director_Removal', 0.15442945063114166)","('Systemic_Risk_Management', 0.06560568511486053)","('NON-ESG', 0.3633694052696228)","('NON-ESG', 0.15442945063114166)","('NON-ESG', 0.06560568511486053)"
Line 429,"Throughout FY 2022, our central R&D team will be working with the company ERM and our business teams to calculate the  greenhouse gas emissions that are generated during the use and end-of-life disposal of our products.
","('GHG_Emissions', 0.8912385106086731)","('Product_Design_And_Lifecycle_Management', 0.013616812415421009)","('Energy_Management', 0.013226179406046867)","(['Climate Change'], 0.8912385106086731)","('NON-ESG', 0.013616812415421009)","('NON-ESG', 0.013226179406046867)"
Line 430,"The results will be used to set science-based targets, in line with our commitment to the UN Race to Zero.
","('Management_Of_Legal_And_Regulatory_Framework', 0.38512420654296875)","('Human_Rights_And_Community_Relations', 0.15139174461364746)","('Competitive_Behavior', 0.12422915548086166)","('NON-ESG', 0.38512420654296875)","('NON-ESG', 0.15139174461364746)","('NON-ESG', 0.12422915548086166)"
Line 431,"Strategic partnerships Building on our continued engagement with the Healthcare Plastics Recycling Council (HPRC) in both the United States and the European Union, and the Sustainable Healthcare Coalition (SHC) in Europe, we will develop strategic partnerships to help achieve our commitment to reducing the environmental impact of our products.2030+ impact area: product impact BD commitment and goals 2030+ goals: Our commitment: Reduce the environmental impact of our portfolio and address the sustainability needs of our customers.1  We will address plastic and packaging material consumption in our product portfolio through considerations in product design, including: •  chemic al elimination/replacement; •  mat erial reduction; •  saf e product reuse models;•  closed-loop r ecovery; and/or •  open-loop r ecovery.2  We will apply minimum environmental and human health criteria (based on customer  EPP standards) to new products and product changes to ensure meaningful and sustainable product improvements across the life cycle.
","('Product_Design_And_Lifecycle_Management', 0.962786078453064)","('Product_Quality_And_Safety', 0.006694570183753967)","('Selling_Practices_And_Product_Labeling', 0.0032637559343129396)","(['Product Stewardship'], 0.962786078453064)","('NON-ESG', 0.006694570183753967)","('NON-ESG', 0.0032637559343129396)"
Line 432,"Strategic partnerships Building on our continued engagement with the Healthcare Plastics Recycling Council (HPRC) in both the United States and the European Union, and the Sustainable Healthcare Coalition (SHC) in Europe, we will develop strategic partnerships to help achieve our commitment to reducing the environmental impact of our products.2030+ impact area: product impact BD commitment and goals 2030+ goals: Our commitment: Reduce the environmental impact of our portfolio and address the sustainability needs of our customers.1  We will address plastic and packaging material consumption in our product portfolio through considerations in product design, including: •  chemic al elimination/replacement; •  mat erial reduction; •  saf e product reuse models;•  closed-loop r ecovery; and/or •  open-loop r ecovery.2  We will apply minimum environmental and human health criteria (based on customer  EPP standards) to new products and product changes to ensure meaningful and sustainable product improvements across the life cycle.
","('Product_Design_And_Lifecycle_Management', 0.9595777988433838)","('Product_Quality_And_Safety', 0.006833734922111034)","('Selling_Practices_And_Product_Labeling', 0.004289860371500254)","(['Product Stewardship'], 0.9595777988433838)","('NON-ESG', 0.006833734922111034)","('NON-ESG', 0.004289860371500254)"
Line 433,"Strategic partnerships Building on our continued engagement with the Healthcare Plastics Recycling Council (HPRC) in both the United States and the European Union, and the Sustainable Healthcare Coalition (SHC) in Europe, we will develop strategic partnerships to help achieve our commitment to reducing the environmental impact of our products.2030+ impact area: product impact BD commitment and goals 2030+ goals: Our commitment: Reduce the environmental impact of our portfolio and address the sustainability needs of our customers.1  We will address plastic and packaging material consumption in our product portfolio through considerations in product design, including: •  chemic al elimination/replacement; •  mat erial reduction; •  saf e product reuse models;•  closed-loop r ecovery; and/or •  open-loop r ecovery.2  We will apply minimum environmental and human health criteria (based on customer  EPP standards) to new products and product changes to ensure meaningful and sustainable product improvements across the life cycle.
","('Ecological_Impacts', 0.3112858533859253)","('Supply_Chain_Management', 0.12314922362565994)","('GHG_Emissions', 0.056276749819517136)","('NON-ESG', 0.3112858533859253)","('NON-ESG', 0.12314922362565994)","('NON-ESG', 0.056276749819517136)"
Line 434,"•  Publish BD minimum en vironmental standards for products by end of FY 2022.
","('Product_Quality_And_Safety', 0.672555685043335)","('Product_Design_And_Lifecycle_Management', 0.14403069019317627)","('Management_Of_Legal_And_Regulatory_Framework', 0.025109851732850075)","(['Product Quality & Recall Management'], 0.672555685043335)","('NON-ESG', 0.14403069019317627)","('NON-ESG', 0.025109851732850075)"
Line 435,"•  E stablish medium- and long-term targets for products to meet minimum  environmental standards within 6 months of publication of the standard.3  We will work to address the impact of  plastics through existing and new strategic partnerships that work across the value chain2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Climate change Introduction Product impact Management of materials  of concern Our materials of concern list guides the way we address the reduction of MOCs across our portfolio.
","('Product_Design_And_Lifecycle_Management', 0.6515443921089172)","('Product_Quality_And_Safety', 0.1400223821401596)","('Supply_Chain_Management', 0.07363433390855789)","(['Product Stewardship'], 0.6515443921089172)","('NON-ESG', 0.1400223821401596)","('NON-ESG', 0.07363433390855789)"
Line 436,"•  E stablish medium- and long-term targets for products to meet minimum  environmental standards within 6 months of publication of the standard.3  We will work to address the impact of  plastics through existing and new strategic partnerships that work across the value chain2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Climate change Introduction Product impact Management of materials  of concern Our materials of concern list guides the way we address the reduction of MOCs across our portfolio.
","('GHG_Emissions', 0.32302501797676086)","('Energy_Management', 0.22238899767398834)","('Air_Quality', 0.05199362710118294)","('NON-ESG', 0.32302501797676086)","('NON-ESG', 0.22238899767398834)","('NON-ESG', 0.05199362710118294)"
Line 437,"The list contains both regulated and nonregulated substances that we consider to be of concern and is updated twice a year.
","('Selling_Practices_And_Product_Labeling', 0.28835368156433105)","('Product_Quality_And_Safety', 0.13652881979942322)","('Customer_Welfare', 0.10858749598264694)","('NON-ESG', 0.28835368156433105)","('NON-ESG', 0.13652881979942322)","('NON-ESG', 0.10858749598264694)"
Line 438,"BD considers the potential impact of the materials we use in our products and packaging,  and reviews customer preferences related to materials of concern in finished goods.
","('Product_Design_And_Lifecycle_Management', 0.9459449648857117)","('Selling_Practices_And_Product_Labeling', 0.012111824005842209)","('Product_Quality_And_Safety', 0.0043990882113575935)","(['Product Stewardship'], 0.9459449648857117)","('NON-ESG', 0.012111824005842209)","('NON-ESG', 0.0043990882113575935)"
Line 439,"In order to monitor the changing landscape around materials of concern among customers, regulatory bodies and advocacy groups, BD established a Chemical Review Board in 2013.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9319642186164856)","('Ecological_Impacts', 0.008546693250536919)","('Access_And_Affordability', 0.006546792108565569)","(['Corporate Governance'], 0.9319642186164856)","('NON-ESG', 0.008546693250536919)","('NON-ESG', 0.006546792108565569)"
Line 440,"This internal board, led by our director of product stewardship compliance, includes representation from R&D for each of our business units and functional expertise from toxicology.
","('Product_Quality_And_Safety', 0.5885935425758362)","('Product_Design_And_Lifecycle_Management', 0.18052688241004944)","('Customer_Welfare', 0.03963116183876991)","(['Product Quality & Recall Management'], 0.5885935425758362)","('NON-ESG', 0.18052688241004944)","('NON-ESG', 0.03963116183876991)"
Line 441,"This group is equipped to evaluate the feasibility of alternative materials, provide guidance to R&D within the company, and leverage material expertise across the organization to accelerate our work to reduce MOCs from the portfolio.At the corporate level, BD has a central Product Stewardship team, led by the director of product stewardship compliance.
","('Product_Design_And_Lifecycle_Management', 0.9227486252784729)","('Product_Quality_And_Safety', 0.018755894154310226)","('Selling_Practices_And_Product_Labeling', 0.009609067812561989)","(['Product Stewardship'], 0.9227486252784729)","('NON-ESG', 0.018755894154310226)","('NON-ESG', 0.009609067812561989)"
Line 442,"This central team reports to the VP S&EHS.
","('Management_Of_Legal_And_Regulatory_Framework', 0.529032289981842)","('Systemic_Risk_Management', 0.07669676095247269)","('Director_Removal', 0.05069015175104141)","(['Corporate Governance'], 0.529032289981842)","('NON-ESG', 0.07669676095247269)","('NON-ESG', 0.05069015175104141)"
Line 443,"The central Product Stewardship team is in place to monitor changing global environmental  regulations affecting our product portfolio, including materials of concern, and to provide governance over compliance activities carried out by our business units.
","('Product_Design_And_Lifecycle_Management', 0.8144577145576477)","('Product_Quality_And_Safety', 0.07154426723718643)","('Selling_Practices_And_Product_Labeling', 0.028448818251490593)","(['Product Stewardship'], 0.8144577145576477)","('NON-ESG', 0.07154426723718643)","('NON-ESG', 0.028448818251490593)"
Line 444,"The Product Stewardship team also administers our system of collecting information from suppliers through a dedicated team of supply-base compliance associates.
","('Supply_Chain_Management', 0.7454635500907898)","('Product_Design_And_Lifecycle_Management', 0.09400977939367294)","('Selling_Practices_And_Product_Labeling', 0.024602197110652924)","(['Supply Chain Management'], 0.7454635500907898)","('NON-ESG', 0.09400977939367294)","('NON-ESG', 0.024602197110652924)"
Line 445,"The team also maintains our MOC list and the central database used to manage chemical information.
","('Waste_And_Hazardous_Materials_Management', 0.32465657591819763)","('Selling_Practices_And_Product_Labeling', 0.16171367466449738)","('Customer_Welfare', 0.06226865202188492)","('NON-ESG', 0.32465657591819763)","('NON-ESG', 0.16171367466449738)","('NON-ESG', 0.06226865202188492)"
Line 446,"The Product Stewardship team, and in turn our central S&EHS team, is accountable for the  company’s overall system of chemicals management.
","('Product_Design_And_Lifecycle_Management', 0.8932349681854248)","('Product_Quality_And_Safety', 0.021573880687355995)","('Selling_Practices_And_Product_Labeling', 0.015860358253121376)","(['Product Stewardship'], 0.8932349681854248)","('NON-ESG', 0.021573880687355995)","('NON-ESG', 0.015860358253121376)"
Line 447,"They are responsible for governance over compliance with environmental regulations of products, such as REACH and RoHS.
","('Product_Design_And_Lifecycle_Management', 0.6059033274650574)","('Product_Quality_And_Safety', 0.17259150743484497)","('Management_Of_Legal_And_Regulatory_Framework', 0.05633307248353958)","(['Product Stewardship'], 0.6059033274650574)","('NON-ESG', 0.17259150743484497)","('NON-ESG', 0.05633307248353958)"
Line 448,"Our MOC list and additional materials for suppliers are available on our website.
","('Supply_Chain_Management', 0.8217253088951111)","('Waste_And_Hazardous_Materials_Management', 0.03405725955963135)","('Product_Design_And_Lifecycle_Management', 0.020756011828780174)","(['Supply Chain Management'], 0.8217253088951111)","('NON-ESG', 0.03405725955963135)","('NON-ESG', 0.020756011828780174)"
Line 449,"Product takeback Where required by law, we participate in compliance schemes to ensure the responsible  collection, management and disposal (including recycling) of packaging, batteries, and electrical and electronic waste.
","('Waste_And_Hazardous_Materials_Management', 0.9558488726615906)","('Product_Design_And_Lifecycle_Management', 0.011795488186180592)","('Selling_Practices_And_Product_Labeling', 0.0029364500660449266)","(['Operational Eco-Efficiency'], 0.9558488726615906)","('NON-ESG', 0.011795488186180592)","('NON-ESG', 0.0029364500660449266)"
Line 450,"BD actively engages in dialogue with our customers and advocacy groups to discuss the use of safer chemicals for consideration in our work to reduce priority MOCs. This engagement includes our continued response to the Chemical Footprint Project (CFP).
","('Product_Quality_And_Safety', 0.3005750775337219)","('Product_Design_And_Lifecycle_Management', 0.2113618105649948)","('Selling_Practices_And_Product_Labeling', 0.1331116408109665)","('NON-ESG', 0.3005750775337219)","('NON-ESG', 0.2113618105649948)","('NON-ESG', 0.1331116408109665)"
Line 451,"The mission of the CFP is to transform global chemical use by measuring and disclosing data on business progress toward safer chemicals.
","('Product_Quality_And_Safety', 0.2752515971660614)","('Selling_Practices_And_Product_Labeling', 0.22116927802562714)","('Customer_Welfare', 0.14063753187656403)","('NON-ESG', 0.2752515971660614)","('NON-ESG', 0.22116927802562714)","('NON-ESG', 0.14063753187656403)"
Line 452,"It provides a tool for benchmarking companies as they select safer alternatives and reduce their use of chemicals of high concern.
","('Product_Quality_And_Safety', 0.2760327160358429)","('Customer_Welfare', 0.19458262622356415)","('Product_Design_And_Lifecycle_Management', 0.1930207759141922)","('NON-ESG', 0.2760327160358429)","('NON-ESG', 0.19458262622356415)","('NON-ESG', 0.1930207759141922)"
Line 453,"As in previous years, we have chosen to make our response public and, as such, have been recognized as a CFP 2020 Disclosure Leader.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7334301471710205)","('Business_Model_Resilience', 0.04051230102777481)","('Systemic_Risk_Management', 0.033930640667676926)","(['Corporate Governance'], 0.7334301471710205)","('NON-ESG', 0.04051230102777481)","('NON-ESG', 0.033930640667676926)"
Line 454,"We continue to manage the end-of-life disposal of products from the BD Pyxis™ Portfolio at our San Diego, California, facility by recovering materials and components for refurbishment or recycling.
","('Product_Design_And_Lifecycle_Management', 0.9633480906486511)","('Product_Quality_And_Safety', 0.003182640066370368)","('Waste_And_Hazardous_Materials_Management', 0.002849164418876171)","(['Product Stewardship'], 0.9633480906486511)","('NON-ESG', 0.003182640066370368)","('NON-ESG', 0.002849164418876171)"
Line 455,"In FY 2021, 20,771 units were processed  through our facility, representing 1,855 metric tonnes of materials that were either refurbished, reused or recycled.
","('Product_Design_And_Lifecycle_Management', 0.6057066321372986)","('Energy_Management', 0.13652582466602325)","('Waste_And_Hazardous_Materials_Management', 0.07706969976425171)","(['Product Stewardship'], 0.6057066321372986)","('NON-ESG', 0.13652582466602325)","('NON-ESG', 0.07706969976425171)"
Line 456,"No materials were disposed of via landfill.2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Climate change Introduction Product impact Product safety Product safety means patient and customer safety.
","('Product_Quality_And_Safety', 0.8908867835998535)","('Product_Design_And_Lifecycle_Management', 0.027700893580913544)","('Selling_Practices_And_Product_Labeling', 0.014139572158455849)","(['Product Quality & Recall Management'], 0.8908867835998535)","('NON-ESG', 0.027700893580913544)","('NON-ESG', 0.014139572158455849)"
Line 457,"We create value for our patients and  customers through the predictable delivery of high-quality, safe and effective products and services.
","('Product_Design_And_Lifecycle_Management', 0.7636434435844421)","('Product_Quality_And_Safety', 0.06696446239948273)","('Customer_Welfare', 0.0427403524518013)","(['Product Stewardship'], 0.7636434435844421)","('NON-ESG', 0.06696446239948273)","('NON-ESG', 0.0427403524518013)"
Line 458,"We develop innovative solutions that advance the world of health and do so with compliance to global regulatory laws, worker safety and product performance.
","('Product_Quality_And_Safety', 0.8580175638198853)","('Employee_Health_And_Safety', 0.04525654762983322)","('Product_Design_And_Lifecycle_Management', 0.02057958021759987)","(['Product Quality & Recall Management'], 0.8580175638198853)","('NON-ESG', 0.04525654762983322)","('NON-ESG', 0.02057958021759987)"
Line 459,"Safety, quality and service are at the heart of how we design, manufacture and deliver products.Inspire quality Quality is the foundation of customer and patient trust; it is embedded in THE BD WAY values: “We thrive on innovation and demand quality.” We are on a multiyear journey to simplify the delivery of high-quality products and services to  our customers and patients in a way that values compliance, helps reduce enterprise risk and makes it easier to do business with us.
","('Product_Design_And_Lifecycle_Management', 0.789435863494873)","('Product_Quality_And_Safety', 0.1151064932346344)","('Customer_Welfare', 0.011717539280653)","(['Product Stewardship'], 0.789435863494873)","('NON-ESG', 0.1151064932346344)","('NON-ESG', 0.011717539280653)"
Line 460,"OUR QUALITY POLICY “We will consistently provide superior  products and services in pursuit of our Purpose of advancing the world of health™.
","('Product_Design_And_Lifecycle_Management', 0.9284849166870117)","('Product_Quality_And_Safety', 0.016714878380298615)","('Customer_Welfare', 0.01090184599161148)","(['Product Stewardship'], 0.9284849166870117)","('NON-ESG', 0.016714878380298615)","('NON-ESG', 0.01090184599161148)"
Line 461,"This will be achieved through customer-focused continuous improvement and maintaining an effective quality system which complies with regulatory requirements.” Tom Polen Chairman, CEO and President David Shan EVP and Chief Quality Officer GPOL-001 ENG  OUR ROLE Provide products and services that are safe, reliable and eﬀective EVOLVING 21,120+ quality management systems (QMS) MORE training and education when needed OUR ASSOCIATES GET OUR ASSOCIATES INSPIRE conﬁdence in BDJoin our quality journey       Working together to deliver our best BD 2025Quality is thefoundation of patientand customer trust.
","('Product_Design_And_Lifecycle_Management', 0.38601431250572205)","('Product_Quality_And_Safety', 0.37707948684692383)","('Supply_Chain_Management', 0.02486899495124817)","('NON-ESG', 0.38601431250572205)","('NON-ESG', 0.37707948684692383)","('NON-ESG', 0.02486899495124817)"
Line 462,"This will be achieved through customer-focused continuous improvement and maintaining an effective quality system which complies with regulatory requirements.” Tom Polen Chairman, CEO and President David Shan EVP and Chief Quality Officer GPOL-001 ENG  OUR ROLE Provide products and services that are safe, reliable and eﬀective EVOLVING 21,120+ quality management systems (QMS) MORE training and education when needed OUR ASSOCIATES GET OUR ASSOCIATES INSPIRE conﬁdence in BDJoin our quality journey       Working together to deliver our best BD 2025Quality is thefoundation of patientand customer trust.
","('Business_Ethics', 0.3632622957229614)","('Systemic_Risk_Management', 0.1328045278787613)","('Competitive_Behavior', 0.11113247275352478)","('NON-ESG', 0.3632622957229614)","('NON-ESG', 0.1328045278787613)","('NON-ESG', 0.11113247275352478)"
Line 463,"TODAY’S COMPLEXITIES global regulatory requirements policies andprocedures MORE time to do their best work LESS opportunity for errors and riskDECREASE SIMPLIFY ENSURE complianceOUR GOAL risk processesPut patient LIVE SPEAK UP and listen inOUR ASSOCIATES ARE EMPOWERED TO: SAFETY FIRST THE BD WAYGROW  MEET INVEST more in innovationWE WILL customer trust  and quality global regulatory requirements Together, we’ll deliver SAFE, RELIABLE AND EFFECTIVEproducts and servicesBut we’ve grown,and healthcareis changing.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9141406416893005)","('Business_Ethics', 0.03144126385450363)","('Product_Quality_And_Safety', 0.006830005906522274)","(['Corporate Governance'], 0.9141406416893005)","('NON-ESG', 0.03144126385450363)","('NON-ESG', 0.006830005906522274)"
Line 464,"TODAY’S COMPLEXITIES global regulatory requirements policies andprocedures MORE time to do their best work LESS opportunity for errors and riskDECREASE SIMPLIFY ENSURE complianceOUR GOAL risk processesPut patient LIVE SPEAK UP and listen inOUR ASSOCIATES ARE EMPOWERED TO: SAFETY FIRST THE BD WAYGROW  MEET INVEST more in innovationWE WILL customer trust  and quality global regulatory requirements Together, we’ll deliver SAFE, RELIABLE AND EFFECTIVEproducts and servicesBut we’ve grown,and healthcareis changing.
","('Competitive_Behavior', 0.09812983870506287)","('Access_And_Affordability', 0.08103787153959274)","('Energy_Management', 0.08059953898191452)","('NON-ESG', 0.09812983870506287)","('NON-ESG', 0.08103787153959274)","('NON-ESG', 0.08059953898191452)"
Line 465,"So, we’ve createda plan calledInspire Quality.
","('Systemic_Risk_Management', 0.19793666899204254)","('Competitive_Behavior', 0.1957087367773056)","('Management_Of_Legal_And_Regulatory_Framework', 0.09251946955919266)","('NON-ESG', 0.19793666899204254)","('NON-ESG', 0.1957087367773056)","('NON-ESG', 0.09251946955919266)"
Line 466,"Everyone hasa role to play.Together, we’ll berecognized asbest-in-class inhealthcare quality.2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Climate change Introduction Product impact Inspiring quality culture While the QMS redesign is critical to simplifying and enhancing quality at BD,  equally key to our transformation success is the culture of quality itself for all of our 75,000+ associates.
","('Product_Design_And_Lifecycle_Management', 0.7714133262634277)","('Supply_Chain_Management', 0.10171656310558319)","('Product_Quality_And_Safety', 0.019842101261019707)","(['Product Stewardship'], 0.7714133262634277)","('NON-ESG', 0.10171656310558319)","('NON-ESG', 0.019842101261019707)"
Line 467,"In 2021, we undertook our first culture-of-quality audit through a benchmarking exercise with Gartner—an organization that delivers actionable, objective insight to executives and their teams—to better understand our culture-of-quality baseline and how our associates engage in quality-producing behaviors.
","('Business_Ethics', 0.22507864236831665)","('Systemic_Risk_Management', 0.2140415757894516)","('Business_Model_Resilience', 0.09064950048923492)","('NON-ESG', 0.22507864236831665)","('NON-ESG', 0.2140415757894516)","('NON-ESG', 0.09064950048923492)"
Line 468,"We were pleased with our associates’ engagement—as 72 percent participated  in the survey—as well as with our placement within the 80th percentile in terms of performance against similarly benchmarked companies.
","('Competitive_Behavior', 0.253242552280426)","('Business_Model_Resilience', 0.2339104413986206)","('Systemic_Risk_Management', 0.1535223424434662)","('NON-ESG', 0.253242552280426)","('NON-ESG', 0.2339104413986206)","('NON-ESG', 0.1535223424434662)"
Line 469,"These results reflect our associates’ deep, caring commitment to quality, personal accountability and comfort in speaking up when there are issues.
","('Human_Rights_And_Community_Relations', 0.7642794251441956)","('Employee_Health_And_Safety', 0.03183220699429512)","('Access_And_Affordability', 0.0223788321018219)","(['Community Relations'], 0.7642794251441956)","('NON-ESG', 0.03183220699429512)","('NON-ESG', 0.0223788321018219)"
Line 470,"We will continue to use these insights to drive targeted action planning at the local-site, business and regional level.
","('Human_Rights_And_Community_Relations', 0.27193716168403625)","('Management_Of_Legal_And_Regulatory_Framework', 0.25474119186401367)","('Business_Model_Resilience', 0.11709875613451004)","('NON-ESG', 0.27193716168403625)","('NON-ESG', 0.25474119186401367)","('NON-ESG', 0.11709875613451004)"
Line 471,"Suzhou II, China – 2021 H.P .
","('Management_Of_Legal_And_Regulatory_Framework', 0.15844716131687164)","('Business_Model_Resilience', 0.1132296770811081)","('GHG_Emissions', 0.1042296439409256)","('NON-ESG', 0.15844716131687164)","('NON-ESG', 0.1132296770811081)","('NON-ESG', 0.1042296439409256)"
Line 472,"Becton Gold Award Winners Across BD, we continue to engage our associates through the education, training and celebration of a culture of quality.
","('Access_And_Affordability', 0.44209474325180054)","('Employee_Engagement_Inclusion_And_Diversity', 0.12571100890636444)","('Product_Quality_And_Safety', 0.07348133623600006)","('NON-ESG', 0.44209474325180054)","('NON-ESG', 0.12571100890636444)","('NON-ESG', 0.07348133623600006)"
Line 473,"In November, BD celebrated World Quality Day with a Global Inspire Quality Week that included an 18-Day Quality Culture Commitment Challenge, engaging and education activities, panel forum discussions and customer-centric videos specific to the role quality plays in our COVID-19 pandemic support efforts.Prevention Consistency Courage Accountability Patient focusPrevention Consistency Courage Accountability Patient focus Every BD associate and team is responsible for meeting customers’ expectations.Promoting a blame- free environment encourages everyone to speak up and listen in.Less variability and  enhanced simplicity means fewer mistakes and better service of patients’ needs.Develop a learning  organization that proactively innovates to avoid issues.
","('Access_And_Affordability', 0.18378888070583344)","('Product_Quality_And_Safety', 0.14648258686065674)","('Business_Ethics', 0.1340314894914627)","('NON-ESG', 0.18378888070583344)","('NON-ESG', 0.14648258686065674)","('NON-ESG', 0.1340314894914627)"
Line 474,"In November, BD celebrated World Quality Day with a Global Inspire Quality Week that included an 18-Day Quality Culture Commitment Challenge, engaging and education activities, panel forum discussions and customer-centric videos specific to the role quality plays in our COVID-19 pandemic support efforts.Prevention Consistency Courage Accountability Patient focusPrevention Consistency Courage Accountability Patient focus Every BD associate and team is responsible for meeting customers’ expectations.Promoting a blame- free environment encourages everyone to speak up and listen in.Less variability and  enhanced simplicity means fewer mistakes and better service of patients’ needs.Develop a learning  organization that proactively innovates to avoid issues.
","('Human_Rights_And_Community_Relations', 0.2267419844865799)","('Access_And_Affordability', 0.15647676587104797)","('Business_Ethics', 0.15559063851833344)","('NON-ESG', 0.2267419844865799)","('NON-ESG', 0.15647676587104797)","('NON-ESG', 0.15559063851833344)"
Line 475,"Grow Simplify EmpowerPatients and healthcare providers come ﬁrst; there is a patient at the beginningand end of everything we do.Our Quality Management System journey We are delivering meaningful enhancements to our quality  management system (QMS) and renewing our commitment to a culture of quality across the organization.
","('Product_Quality_And_Safety', 0.19502641260623932)","('Employee_Engagement_Inclusion_And_Diversity', 0.09513367712497711)","('Business_Ethics', 0.09085134416818619)","('NON-ESG', 0.19502641260623932)","('NON-ESG', 0.09513367712497711)","('NON-ESG', 0.09085134416818619)"
Line 476,"By doing so, we will bring to life our harmonization, simplification and compliance goals consistently for all businesses and regions in BD and engage our associates on our journey toward best-in-class quality.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7403104305267334)","('Business_Ethics', 0.04935656860470772)","('Systemic_Risk_Management', 0.029996229335665703)","(['Corporate Governance'], 0.7403104305267334)","('NON-ESG', 0.04935656860470772)","('NON-ESG', 0.029996229335665703)"
Line 477,"Our QMS simplification is intended to ensure that each site  maintains certifications throughout the harmonization process and enables other BD sites to move toward certification status.
","('Product_Quality_And_Safety', 0.361669659614563)","('Management_Of_Legal_And_Regulatory_Framework', 0.19219551980495453)","('Business_Ethics', 0.08664773404598236)","('NON-ESG', 0.361669659614563)","('NON-ESG', 0.19219551980495453)","('NON-ESG', 0.08664773404598236)"
Line 478,"ISO13485 117  sites ISO9001 24 sites ISO17025 5 sites Ninety-six percent of manufacturing sites and 93 percent of  design centers have a certified QMS.2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Climate change Introduction Product impact Inspiring quality embedded in our governance To provide continued quality pversight and governance for key quality, regulatory and medical matters, in FY21 we maintained  our cross-functional governance mechanisms.
","('Supply_Chain_Management', 0.5360935926437378)","('Physical_Impacts_Of_Climate_Change', 0.23217712342739105)","('Systemic_Risk_Management', 0.049776289612054825)","(['Supply Chain Management'], 0.5360935926437378)","('NON-ESG', 0.23217712342739105)","('NON-ESG', 0.049776289612054825)"
Line 479,"This enhanced system has empowered our leaders across functions (including regulatory affairs, medical affairs, integrated supply chain, and R&D) with management responsibility for quality matters to be more proactive, transparent and engaged in the process.
","('Supply_Chain_Management', 0.6744604706764221)","('Management_Of_Legal_And_Regulatory_Framework', 0.1230725571513176)","('Physical_Impacts_Of_Climate_Change', 0.02040201611816883)","(['Supply Chain Management'], 0.6744604706764221)","('NON-ESG', 0.1230725571513176)","('NON-ESG', 0.02040201611816883)"
Line 480,"We continue to leverage data-driven insights to address potential quality deviations sooner and with greater accuracy, and to align on joint goals and initiatives.
","('Data_Security', 0.30431562662124634)","('Customer_Privacy', 0.10226473957300186)","('Systemic_Risk_Management', 0.08051265776157379)","('NON-ESG', 0.30431562662124634)","('NON-ESG', 0.10226473957300186)","('NON-ESG', 0.08051265776157379)"
Line 481,"The Quality and Regulatory Committee provides oversight of matters relating to regulatory compliance and the quality and safety of BD’s products and services.
","('Product_Quality_And_Safety', 0.8985274434089661)","('Product_Design_And_Lifecycle_Management', 0.02098163776099682)","('Selling_Practices_And_Product_Labeling', 0.01191528607159853)","(['Product Quality & Recall Management'], 0.8985274434089661)","('NON-ESG', 0.02098163776099682)","('NON-ESG', 0.01191528607159853)"
Line 482,"Additionally, the Board receives periodic updates on product quality and patient safety risks.
","('Product_Quality_And_Safety', 0.9190936088562012)","('Product_Design_And_Lifecycle_Management', 0.013636134564876556)","('Selling_Practices_And_Product_Labeling', 0.007738975342363119)","(['Product Quality & Recall Management'], 0.9190936088562012)","('NON-ESG', 0.013636134564876556)","('NON-ESG', 0.007738975342363119)"
Line 483,"BD’s management, through its Inspire Quality program, has established tiered governance forums for improved oversight of key  quality, regulatory affairs and medical matters.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9625834822654724)","('Business_Ethics', 0.005812688264995813)","('Director_Removal', 0.0030683560762554407)","(['Corporate Governance'], 0.9625834822654724)","('NON-ESG', 0.005812688264995813)","('NON-ESG', 0.0030683560762554407)"
Line 484,"Core governance of key quality, regulatory and medical matters Steering/Oversight Senior Leade rship Review Forums Steering Committees Inspi re Quality StatusCQRB & eCQRB – Corporate Quality and Regulatory Board (Monthly)Other Exec.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8931129574775696)","('Business_Ethics', 0.0347285121679306)","('Competitive_Behavior', 0.008993317373096943)","(['Corporate Governance'], 0.8931129574775696)","('NON-ESG', 0.0347285121679306)","('NON-ESG', 0.008993317373096943)"
Line 485,"Forums (Operating Committee and  Executive Leadership team) Inspire quality leadership team Review overall program design and process.
","('Director_Removal', 0.2549717426300049)","('Employee_Engagement_Inclusion_And_Diversity', 0.1678081452846527)","('Business_Model_Resilience', 0.11994539201259613)","('NON-ESG', 0.2549717426300049)","('NON-ESG', 0.1678081452846527)","('NON-ESG', 0.11994539201259613)"
Line 486,"Align and decide next steps  across augmented tracks in detail, supported by PMOReviews and provides input on product-related quality and regulatory compliance issues, insights & trends Quality, Regulatory and Medical Aﬀairs ForumCustomer Experience Council Quality, Manufacturing & Supply Chain Forum Focused on Functional ExcellenceFocused on Customer Excellence Specimen Management Steering Committee Oversight of WL commitments and related actionsInfusion Steering Committees Oversight of quality improvement  plan & regulatory submission programFocused on  Operational ExcellenceMedical Aﬀairs Safety Council Focused on Patient Safety and Medical Safety trendsInspiring quality by design Part of THE BD WAY is driving product quality through innovation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3068028688430786)","('Product_Quality_And_Safety', 0.3065587878227234)","('Business_Ethics', 0.05717845261096954)","('NON-ESG', 0.3068028688430786)","('NON-ESG', 0.3065587878227234)","('NON-ESG', 0.05717845261096954)"
Line 487,"Align and decide next steps  across augmented tracks in detail, supported by PMOReviews and provides input on product-related quality and regulatory compliance issues, insights & trends Quality, Regulatory and Medical Aﬀairs ForumCustomer Experience Council Quality, Manufacturing & Supply Chain Forum Focused on Functional ExcellenceFocused on Customer Excellence Specimen Management Steering Committee Oversight of WL commitments and related actionsInfusion Steering Committees Oversight of quality improvement  plan & regulatory submission programFocused on  Operational ExcellenceMedical Aﬀairs Safety Council Focused on Patient Safety and Medical Safety trendsInspiring quality by design Part of THE BD WAY is driving product quality through innovation.
","('Product_Quality_And_Safety', 0.8949645161628723)","('Employee_Health_And_Safety', 0.02067600190639496)","('Product_Design_And_Lifecycle_Management', 0.017921673133969307)","(['Product Quality & Recall Management'], 0.8949645161628723)","('NON-ESG', 0.02067600190639496)","('NON-ESG', 0.017921673133969307)"
Line 488,"At every step of the BD product development process, we innovate the design and drive risk reduction.
","('Product_Design_And_Lifecycle_Management', 0.960252583026886)","('Product_Quality_And_Safety', 0.006428299006074667)","('Customer_Welfare', 0.0036339862272143364)","(['Product Stewardship'], 0.960252583026886)","('NON-ESG', 0.006428299006074667)","('NON-ESG', 0.0036339862272143364)"
Line 489,"BD accomplishes this through interweaving the risk management process with product development.
","('Product_Design_And_Lifecycle_Management', 0.9510141611099243)","('Customer_Welfare', 0.005956537555903196)","('Product_Quality_And_Safety', 0.005620869807898998)","(['Product Stewardship'], 0.9510141611099243)","('NON-ESG', 0.005956537555903196)","('NON-ESG', 0.005620869807898998)"
Line 490,"Post-market surveillance Product development Produc�on controls                   RISK  MANAGEMENT  LIFECYCLE    Design inputs Design veriﬁca�onrisk evalua�onOverall residual Risk controlDesign outputsDesign reviewDesign planningRisk analysisRisk  planningProduc�on and post-produc�on reviewRisk managementDesign change2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Climate change Introduction Product impact Inspiring quality in manufacturing Like many companies around the world, BD is experiencing unprecedented supply  chain challenges resulting in limited availability of, and access to, raw materials, as well as shipping and transportation delays, labor shortages and back-order situations.
","('Supply_Chain_Management', 0.5786210894584656)","('Physical_Impacts_Of_Climate_Change', 0.1257620006799698)","('Business_Model_Resilience', 0.08627940714359283)","(['Supply Chain Management'], 0.5786210894584656)","('NON-ESG', 0.1257620006799698)","('NON-ESG', 0.08627940714359283)"
Line 491,"Post-market surveillance Product development Produc�on controls                   RISK  MANAGEMENT  LIFECYCLE    Design inputs Design veriﬁca�onrisk evalua�onOverall residual Risk controlDesign outputsDesign reviewDesign planningRisk analysisRisk  planningProduc�on and post-produc�on reviewRisk managementDesign change2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Climate change Introduction Product impact Inspiring quality in manufacturing Like many companies around the world, BD is experiencing unprecedented supply  chain challenges resulting in limited availability of, and access to, raw materials, as well as shipping and transportation delays, labor shortages and back-order situations.
","('Supply_Chain_Management', 0.9261976480484009)","('Labor_Practices', 0.011741488240659237)","('Employee_Health_And_Safety', 0.006681793835014105)","(['Supply Chain Management'], 0.9261976480484009)","('NON-ESG', 0.011741488240659237)","('NON-ESG', 0.006681793835014105)"
Line 492,"These impacts are felt across almost every industry and in our everyday lives.
","('Systemic_Risk_Management', 0.24012325704097748)","('Supply_Chain_Management', 0.23710602521896362)","('Physical_Impacts_Of_Climate_Change', 0.11851998418569565)","('NON-ESG', 0.24012325704097748)","('NON-ESG', 0.23710602521896362)","('NON-ESG', 0.11851998418569565)"
Line 493,"We are working diligently to mitigate the challenges, both at BD and across our supplier base, while continuing to invest in innovations and technologies to address demand surge and market dynamics.
","('Supply_Chain_Management', 0.9507421255111694)","('Product_Design_And_Lifecycle_Management', 0.004217407666146755)","('Labor_Practices', 0.00405594427138567)","(['Supply Chain Management'], 0.9507421255111694)","('NON-ESG', 0.004217407666146755)","('NON-ESG', 0.00405594427138567)"
Line 494,"We remain committed to delivering the highest level of quality, transparency and continuity as we work in close partnership with our customers, suppliers, transportation providers and government stakeholders to minimize the impact of the supply chain crisis, so healthcare providers can continue to deliver uninterrupted patient care.
","('Supply_Chain_Management', 0.9445843696594238)","('Labor_Practices', 0.004889333620667458)","('Product_Design_And_Lifecycle_Management', 0.004285546950995922)","(['Supply Chain Management'], 0.9445843696594238)","('NON-ESG', 0.004889333620667458)","('NON-ESG', 0.004285546950995922)"
Line 495,"Our approach to risk management includes the constant monitoring of the  quality of our products using quality tools, statistical trends, quality-control data and automated high-speed inspections and manufacturing execution system (MES) data monitoring.
","('Product_Quality_And_Safety', 0.43586286902427673)","('Product_Design_And_Lifecycle_Management', 0.39428287744522095)","('Supply_Chain_Management', 0.021011464297771454)","('NON-ESG', 0.43586286902427673)","('NON-ESG', 0.39428287744522095)","('NON-ESG', 0.021011464297771454)"
Line 496,"These data points are integrated into our single, unified operating system, the BDPS, as a framework for high-quality operational excellence.
","('Data_Security', 0.5546233057975769)","('Customer_Privacy', 0.08985252678394318)","('Systemic_Risk_Management', 0.07553321868181229)","(['Information Security/Cybersecurity & System Availability'], 0.5546233057975769)","('NON-ESG', 0.08985252678394318)","('NON-ESG', 0.07553321868181229)"
Line 497,"The use of this system is taught through our global LEAN Academy with over 90 percent of our worldwide manufacturing sites actively using this approach.
","('Product_Design_And_Lifecycle_Management', 0.29617708921432495)","('Customer_Welfare', 0.11062974482774734)","('Energy_Management', 0.10569975525140762)","('NON-ESG', 0.29617708921432495)","('NON-ESG', 0.11062974482774734)","('NON-ESG', 0.10569975525140762)"
Line 498,"At BD, we believe quality is everyone’s responsibility.
","('Human_Rights_And_Community_Relations', 0.2919197380542755)","('Employee_Engagement_Inclusion_And_Diversity', 0.19109901785850525)","('Employee_Health_And_Safety', 0.09378576278686523)","('NON-ESG', 0.2919197380542755)","('NON-ESG', 0.19109901785850525)","('NON-ESG', 0.09378576278686523)"
Line 499,"Our 40,000+ manufacturing  associates are committed to a culture of quality that empowers each associate to be accountable to stop production if they see any problem with a product.
","('Product_Design_And_Lifecycle_Management', 0.9267773032188416)","('Product_Quality_And_Safety', 0.01805884949862957)","('Customer_Welfare', 0.006773121189326048)","(['Product Stewardship'], 0.9267773032188416)","('NON-ESG', 0.01805884949862957)","('NON-ESG', 0.006773121189326048)"
Line 500,"We are proud of our global supply chain associates for their continued commitment to quality customer and patient care, which has helped us to ensure business continuity and a high level of quality care throughout the global COVID-19 pandemic.
","('Supply_Chain_Management', 0.6867635250091553)","('Product_Design_And_Lifecycle_Management', 0.07130549848079681)","('Energy_Management', 0.03981410339474678)","(['Supply Chain Management'], 0.6867635250091553)","('NON-ESG', 0.07130549848079681)","('NON-ESG', 0.03981410339474678)"
Line 501,"Inspiring quality through our suppliers A strong supplier quality program is key to ensuring that BD products meet the highest standards of quality.
","('Product_Design_And_Lifecycle_Management', 0.7516316771507263)","('Product_Quality_And_Safety', 0.07618100196123123)","('Supply_Chain_Management', 0.05763624608516693)","(['Product Stewardship'], 0.7516316771507263)","('NON-ESG', 0.07618100196123123)","('NON-ESG', 0.05763624608516693)"
Line 502,"The Quality team partners with the Procurement team so that systems and controls are in place to select, qualify and monitor suppliers.
","('Supply_Chain_Management', 0.9180166125297546)","('Product_Design_And_Lifecycle_Management', 0.013260581530630589)","('Business_Model_Resilience', 0.0058628772385418415)","(['Supply Chain Management'], 0.9180166125297546)","('NON-ESG', 0.013260581530630589)","('NON-ESG', 0.0058628772385418415)"
Line 503,"Key aspects of the program include qualification of suppliers based on risk, auditing and monitoring of supplier performance, and managing supplier changes.In 2021, BD focused on developing harmonized global processes for managing supplier quality to improve efficiency.
","('Supply_Chain_Management', 0.9438550472259521)","('Labor_Practices', 0.006642983760684729)","('Product_Design_And_Lifecycle_Management', 0.0049370466731488705)","(['Supply Chain Management'], 0.9438550472259521)","('NON-ESG', 0.006642983760684729)","('NON-ESG', 0.0049370466731488705)"
Line 504,"The new harmonized global processes will be launched in 2022.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8144359588623047)","('Competitive_Behavior', 0.02520289085805416)","('Human_Rights_And_Community_Relations', 0.023083707317709923)","(['Corporate Governance'], 0.8144359588623047)","('NON-ESG', 0.02520289085805416)","('NON-ESG', 0.023083707317709923)"
Line 505,"BD also released version 2.0 of the Supplier Change Request Portal, which enables suppliers to directly communicate potential changes to BD and receive responses from BD.
","('Supply_Chain_Management', 0.9397686719894409)","('Labor_Practices', 0.007200595457106829)","('Systemic_Risk_Management', 0.004850358702242374)","(['Supply Chain Management'], 0.9397686719894409)","('NON-ESG', 0.007200595457106829)","('NON-ESG', 0.004850358702242374)"
Line 506,"Key updates were made based on user feedback to improve the overall experience of the Supplier Change Request Portal.
","('Supply_Chain_Management', 0.9337291717529297)","('Physical_Impacts_Of_Climate_Change', 0.005481235217303038)","('Business_Model_Resilience', 0.00522607984021306)","(['Supply Chain Management'], 0.9337291717529297)","('NON-ESG', 0.005481235217303038)","('NON-ESG', 0.00522607984021306)"
Line 507,"Inspiring quality through performance  monitoring One of our core values is “we do what is right.” When an issue has been identified,  initiating a field action, such as recalling a product from the marketplace, we do what is right for our patients and end users.
","('Product_Design_And_Lifecycle_Management', 0.8513201475143433)","('Product_Quality_And_Safety', 0.03701276332139969)","('Selling_Practices_And_Product_Labeling', 0.02851100265979767)","(['Product Stewardship'], 0.8513201475143433)","('NON-ESG', 0.03701276332139969)","('NON-ESG', 0.02851100265979767)"
Line 508,"In FY 2021, we launched a new digital communication pathway in North America designed to streamline and simplify the way we inform our customers of product field actions with greater transparency, real-time updates and a simple, intuitive user interface.
","('Product_Design_And_Lifecycle_Management', 0.8021385073661804)","('Business_Model_Resilience', 0.030223162844777107)","('Product_Quality_And_Safety', 0.01974533498287201)","(['Product Stewardship'], 0.8021385073661804)","('NON-ESG', 0.030223162844777107)","('NON-ESG', 0.01974533498287201)"
Line 509,"Post-market surveillance data is key to delivering patient safety and is a valuable  data point in our product development life cycle which incorporates quality performance inputs into any future product development or enhancement activities.
","('Product_Quality_And_Safety', 0.6981000304222107)","('Product_Design_And_Lifecycle_Management', 0.13324476778507233)","('Selling_Practices_And_Product_Labeling', 0.04159347712993622)","(['Product Quality & Recall Management'], 0.6981000304222107)","('NON-ESG', 0.13324476778507233)","('NON-ESG', 0.04159347712993622)"
Line 510,"Key Quality Indicators FY19 FY20 FYNumber of FDA Class I recalls 4 10* Number of FDA Class II recalls 33 25 Number of FDA Class III recalls 7 11 Products listed in FDA MedWatch Safety AlertsSee FDA’s MedWatch: The FDA Safety  Information and Adverse Event Reporting  Program Number of serious injuries and deaths related to BD productsSee FDA’s About Manufacturer and User  Facility Device Experience (MAUDE) Number of FDA warning letters received0 0 Number of FDA warning letters resolved1 0 *Increase in FDA Class I recalls in FY 2020 (7 of 10) related to BD Alaris™ System.BD production system The size and complexity of our manufacturing and supply chain network call for a consistent approach by every associate to identify and eliminate waste in every part of our operation and supply chain activities.
","('Product_Quality_And_Safety', 0.8748427033424377)","('Employee_Health_And_Safety', 0.022105589509010315)","('Selling_Practices_And_Product_Labeling', 0.01542520709335804)","(['Product Quality & Recall Management'], 0.8748427033424377)","('NON-ESG', 0.022105589509010315)","('NON-ESG', 0.01542520709335804)"
Line 511,"Key Quality Indicators FY19 FY20 FYNumber of FDA Class I recalls 4 10* Number of FDA Class II recalls 33 25 Number of FDA Class III recalls 7 11 Products listed in FDA MedWatch Safety AlertsSee FDA’s MedWatch: The FDA Safety  Information and Adverse Event Reporting  Program Number of serious injuries and deaths related to BD productsSee FDA’s About Manufacturer and User  Facility Device Experience (MAUDE) Number of FDA warning letters received0 0 Number of FDA warning letters resolved1 0 *Increase in FDA Class I recalls in FY 2020 (7 of 10) related to BD Alaris™ System.BD production system The size and complexity of our manufacturing and supply chain network call for a consistent approach by every associate to identify and eliminate waste in every part of our operation and supply chain activities.
","('Supply_Chain_Management', 0.8058644533157349)","('Waste_And_Hazardous_Materials_Management', 0.08186431974172592)","('Product_Design_And_Lifecycle_Management', 0.012816856615245342)","(['Supply Chain Management'], 0.8058644533157349)","('NON-ESG', 0.08186431974172592)","('NON-ESG', 0.012816856615245342)"
Line 512,"The BD Production System (BDPS) is the application of LEAN principles, practices, tools and techniques designed to optimize quality, delivery and cost while improving safety.
","('Employee_Health_And_Safety', 0.7128629684448242)","('Product_Quality_And_Safety', 0.16329869627952576)","('Product_Design_And_Lifecycle_Management', 0.028512125834822655)","(['Operational Eco-Efficiency'], 0.7128629684448242)","('NON-ESG', 0.16329869627952576)","('NON-ESG', 0.028512125834822655)"
Line 513,"It is a systematic approach to eliminating the sources of loss from entire value streams to close the gap between actual performance and the requirements of customers and shareholders.
","('Systemic_Risk_Management', 0.5782198309898376)","('Competitive_Behavior', 0.18833963572978973)","('Business_Model_Resilience', 0.06479218602180481)","(['Risk & Crisis Management'], 0.5782198309898376)","('NON-ESG', 0.18833963572978973)","('NON-ESG', 0.06479218602180481)"
Line 514,"The BDPS provides performance visibility, control,  management practices and mechanisms that are designed to drive culture change and greater effectiveness across the entire organization, increasing customer value.
","('Business_Model_Resilience', 0.625517725944519)","('Systemic_Risk_Management', 0.10746932774782181)","('Employee_Engagement_Inclusion_And_Diversity', 0.034649066627025604)","(['Codes of Business Conduct'], 0.625517725944519)","('NON-ESG', 0.10746932774782181)","('NON-ESG', 0.034649066627025604)"
Line 515,"The deployment of the BDPS in FY21 extended to more than 50 manufacturing sites actively involved in the implementation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3846034109592438)","('GHG_Emissions', 0.0723564401268959)","('Product_Quality_And_Safety', 0.05642718821763992)","('NON-ESG', 0.3846034109592438)","('NON-ESG', 0.0723564401268959)","('NON-ESG', 0.05642718821763992)"
Line 516,"The expansion of BDPS principles also continued in FY21 with initial deployment outside of manufacturing to the rest of the integrated supply chain to drive a consistent end-to-end approach.2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Climate change Introduction Product impact Inspiring quality compliance BD continues to drive increased transparency in quality & regulatory compliance  across the organization.
","('Supply_Chain_Management', 0.7379550337791443)","('Systemic_Risk_Management', 0.05251757800579071)","('Physical_Impacts_Of_Climate_Change', 0.042629171162843704)","(['Supply Chain Management'], 0.7379550337791443)","('NON-ESG', 0.05251757800579071)","('NON-ESG', 0.042629171162843704)"
Line 517,"By evaluating external regulatory trends, BD has been able to provide insights and to work to establish best practices for regulatory compliance, while enabling BD businesses to proactively identify potential improvement opportunities.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9618335366249084)","('Business_Ethics', 0.006471062544733286)","('Competitive_Behavior', 0.0028154742904007435)","(['Corporate Governance'], 0.9618335366249084)","('NON-ESG', 0.006471062544733286)","('NON-ESG', 0.0028154742904007435)"
Line 518,"For example, as we continue the QMS redesign, the Quality & Regulatory Compliance team collaborates with the cross-functional teams to incorporate these insights into the development of the newly harmonized processes and procedures.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9424777626991272)","('Business_Ethics', 0.012535642832517624)","('Product_Quality_And_Safety', 0.0048913476057350636)","(['Corporate Governance'], 0.9424777626991272)","('NON-ESG', 0.012535642832517624)","('NON-ESG', 0.0048913476057350636)"
Line 519,"The Quality Audit Network (QAN), a consortium of quality auditors across BD,  is leveraged to identify and drive the resolution of potential compliance gaps.
","('Business_Ethics', 0.6104441285133362)","('Management_Of_Legal_And_Regulatory_Framework', 0.15134111046791077)","('Systemic_Risk_Management', 0.059123460203409195)","(['Business Ethics'], 0.6104441285133362)","('NON-ESG', 0.15134111046791077)","('NON-ESG', 0.059123460203409195)"
Line 520,"In FY 2021, there was also a focused effort to enhance auditor competency by improving training and establishing uniform auditor qualifications.
","('Management_Of_Legal_And_Regulatory_Framework', 0.302792489528656)","('Business_Ethics', 0.28609421849250793)","('Product_Quality_And_Safety', 0.10434398055076599)","('NON-ESG', 0.302792489528656)","('NON-ESG', 0.28609421849250793)","('NON-ESG', 0.10434398055076599)"
Line 521,"This has helped BD to drive consistency in audits and compliance assessments across the BD businesses and regions.
","('Business_Ethics', 0.48923259973526)","('Management_Of_Legal_And_Regulatory_Framework', 0.3905998468399048)","('Product_Quality_And_Safety', 0.013874529860913754)","('NON-ESG', 0.48923259973526)","('NON-ESG', 0.3905998468399048)","('NON-ESG', 0.013874529860913754)"
Line 522,"Additionally, BD has participated in the FDA Remote Regulatory Assessment  (RRA) program, a voluntary program for medical device manufacturers.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8490234613418579)","('Competitive_Behavior', 0.025909895077347755)","('Product_Quality_And_Safety', 0.02044610306620598)","(['Corporate Governance'], 0.8490234613418579)","('NON-ESG', 0.025909895077347755)","('NON-ESG', 0.02044610306620598)"
Line 523,"Through this participation, the compliance at three BD facilities was assessed by an FDA investigator.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9181771874427795)","('Business_Ethics', 0.01744529791176319)","('Product_Quality_And_Safety', 0.009054498746991158)","(['Corporate Governance'], 0.9181771874427795)","('NON-ESG', 0.01744529791176319)","('NON-ESG', 0.009054498746991158)"
Line 524,"Participation in this program not only provides a review of the site’s regulatory compliance posture, but also strengthens BD’s rapport with the FDA.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9509578943252563)","('Competitive_Behavior', 0.005896823480725288)","('Business_Ethics', 0.005471831187605858)","(['Corporate Governance'], 0.9509578943252563)","('NON-ESG', 0.005896823480725288)","('NON-ESG', 0.005471831187605858)"
Line 525,"FY19 FY20 FYNumber of inspections by worldwide regulatory agencies 34 41 Percentage with zero observations 59% 81% 69% Number of FDA inspections 15 6 Percentage with zero observations 73% 50% 50% Number of corporate audits 35 47 Inspiring quality with  registration excellence Global health authorities are modernizing and evolving their standards of care to  keep pace with the challenges of managing public health.
","('Business_Ethics', 0.4037229120731354)","('Management_Of_Legal_And_Regulatory_Framework', 0.3584386110305786)","('Product_Quality_And_Safety', 0.061351701617240906)","('NON-ESG', 0.4037229120731354)","('NON-ESG', 0.3584386110305786)","('NON-ESG', 0.061351701617240906)"
Line 526,"Regulations, standards and policies must also change to meet these standards.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9225342869758606)","('Product_Quality_And_Safety', 0.013238607905805111)","('Director_Removal', 0.007013492751866579)","(['Corporate Governance'], 0.9225342869758606)","('NON-ESG', 0.013238607905805111)","('NON-ESG', 0.007013492751866579)"
Line 527,"As these transformations occur at a significantly increasing rate, the Regulatory Affairs team has become more agile and efficient in identifying, advocating for and assessing these changes to ensure we have registrations that comply with current health authority expectations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9707208871841431)","('Director_Removal', 0.0024753909092396498)","('Energy_Management', 0.0019155156332999468)","(['Corporate Governance'], 0.9707208871841431)","('NON-ESG', 0.0024753909092396498)","('NON-ESG', 0.0019155156332999468)"
Line 528,"BD Regulatory Affairs has centralized regulatory intelligence monitoring and linked  this activity to BD’s global standards process to ensure a structured approach to conducting risk assessments, identifying gaps, remediating and ultimately updating our regulatory filings as needed.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9539414048194885)","('Business_Ethics', 0.008054574020206928)","('Systemic_Risk_Management', 0.004159392789006233)","(['Corporate Governance'], 0.9539414048194885)","('NON-ESG', 0.008054574020206928)","('NON-ESG', 0.004159392789006233)"
Line 529,"In 2021, 44 draft regulations and 125 new and revised regulations were monitored for impact to BD products.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6700664758682251)","('Product_Design_And_Lifecycle_Management', 0.09075529873371124)","('Product_Quality_And_Safety', 0.078953817486763)","(['Corporate Governance'], 0.6700664758682251)","('NON-ESG', 0.09075529873371124)","('NON-ESG', 0.078953817486763)"
Line 530,"At BD, we are also empowering cross-functional teams within each business  unit and region to drive accountability for incorporating new requirements from standards and regulations into our new-product development process as well as legacy products, re-baselining historical regulatory submissions for products that have evolved over time, and enabling future innovation by refreshing product data on file with regulatory authorities.
","('Product_Quality_And_Safety', 0.3709064722061157)","('Management_Of_Legal_And_Regulatory_Framework', 0.19823436439037323)","('Product_Design_And_Lifecycle_Management', 0.1923135370016098)","('NON-ESG', 0.3709064722061157)","('NON-ESG', 0.19823436439037323)","('NON-ESG', 0.1923135370016098)"
Line 531,"In addition to working on significant initiatives like compliance with new EU medical device and in vitro diagnostic medical device regulations (MDRs and IVDRs), we are also focusing on countries that have seen significant changes to their product regulatory framework.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9308221936225891)","('Product_Quality_And_Safety', 0.012490963563323021)","('Competitive_Behavior', 0.008822795003652573)","(['Corporate Governance'], 0.9308221936225891)","('NON-ESG', 0.012490963563323021)","('NON-ESG', 0.008822795003652573)"
Line 532,"To that end, the BD Regulatory Affairs team and partnering functions—R&D,  Manufacturing, Quality, Cybersecurity, Sterilization, EHS, Medical Affairs, Clinical Development, Marketing, and Compliance—work together to ensure that our product registrations are compliant with global laws, regulations, standards and policies.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4351920485496521)","('Product_Quality_And_Safety', 0.27134305238723755)","('Business_Ethics', 0.07664581388235092)","('NON-ESG', 0.4351920485496521)","('NON-ESG', 0.27134305238723755)","('NON-ESG', 0.07664581388235092)"
Line 533,"We are also digitizing and connecting registration-related processes and content management to enable efficient global registrations that are compliant and will positively impact public health.Inspiring quality in industry We are committed to enabling healthcare providers deliver the best possible patient care.
","('Access_And_Affordability', 0.38705217838287354)","('Management_Of_Legal_And_Regulatory_Framework', 0.21712128818035126)","('Product_Quality_And_Safety', 0.05279231816530228)","('NON-ESG', 0.38705217838287354)","('NON-ESG', 0.21712128818035126)","('NON-ESG', 0.05279231816530228)"
Line 534,"Through our memberships in organizations and trade associations such as AdvaMed, the Medical Device Innovation Consortium (MDIC) and the Association  for the Advancement of Medical Instrumentation (AAMI), BD works to drive quality and shape the external environment through industrywide standards and initiatives consistent with our Purpose of advancing the world of health™.
","('Product_Quality_And_Safety', 0.3105495274066925)","('Management_Of_Legal_And_Regulatory_Framework', 0.1720338761806488)","('Business_Ethics', 0.1269909292459488)","('NON-ESG', 0.3105495274066925)","('NON-ESG', 0.1720338761806488)","('NON-ESG', 0.1269909292459488)"
Line 535,"Enforcement action While we have implemented, and continue to improve upon, programs and management systems addressing product quality and safety, we are, on occasion, subject to enforcement action.
","('Product_Quality_And_Safety', 0.9228728413581848)","('Product_Design_And_Lifecycle_Management', 0.01012294553220272)","('Selling_Practices_And_Product_Labeling', 0.00816271360963583)","(['Product Quality & Recall Management'], 0.9228728413581848)","('NON-ESG', 0.01012294553220272)","('NON-ESG', 0.00816271360963583)"
Line 536,"For a description of certain enforcement matters, see our Form 10-Q for the quarterly period ended March 31, 2021, and our subsequent SEC filings.2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Climate change Introduction Product impact Laboratory animal welfare BD is committed to animal welfare across the BD Research Animal Program.
","('Supply_Chain_Management', 0.44832369685173035)","('Selling_Practices_And_Product_Labeling', 0.05627238377928734)","('Access_And_Affordability', 0.055188264697790146)","('NON-ESG', 0.44832369685173035)","('NON-ESG', 0.05627238377928734)","('NON-ESG', 0.055188264697790146)"
Line 537,"We  follow federal animal welfare regulations and laws that are designed to ensure the responsible use of research animals for patient safety.
","('Product_Quality_And_Safety', 0.5973901152610779)","('Selling_Practices_And_Product_Labeling', 0.06544388085603714)","('Customer_Welfare', 0.04510386288166046)","(['Product Quality & Recall Management'], 0.5973901152610779)","('NON-ESG', 0.06544388085603714)","('NON-ESG', 0.04510386288166046)"
Line 538,"Our corporate policy is available on bd.com and applies to all BD associates whose responsibilities involve the handling, care and/or use of animals.
","('Ecological_Impacts', 0.3740865886211395)","('Employee_Health_And_Safety', 0.1702292263507843)","('Access_And_Affordability', 0.07298445701599121)","('NON-ESG', 0.3740865886211395)","('NON-ESG', 0.1702292263507843)","('NON-ESG', 0.07298445701599121)"
Line 539,"It includes responsibility and oversight, as well as provisions for the handling, care and use of animals.
","('Ecological_Impacts', 0.33340585231781006)","('Employee_Health_And_Safety', 0.13194189965724945)","('Access_And_Affordability', 0.07656889408826828)","('NON-ESG', 0.33340585231781006)","('NON-ESG', 0.13194189965724945)","('NON-ESG', 0.07656889408826828)"
Line 540,"Our mission is to provide for the well-being of all research animals that are  purpose-bred to support important medical device development and testing that helps both human and veterinary patients.
","('Access_And_Affordability', 0.1734580248594284)","('Ecological_Impacts', 0.15384632349014282)","('Customer_Welfare', 0.0977235957980156)","('NON-ESG', 0.1734580248594284)","('NON-ESG', 0.15384632349014282)","('NON-ESG', 0.0977235957980156)"
Line 541,"The BD Research Animal Program undergoes voluntary accreditation by the  Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International every three years.
","('Product_Quality_And_Safety', 0.2137964516878128)","('Access_And_Affordability', 0.18225745856761932)","('Management_Of_Legal_And_Regulatory_Framework', 0.10201092809438705)","('NON-ESG', 0.2137964516878128)","('NON-ESG', 0.18225745856761932)","('NON-ESG', 0.10201092809438705)"
Line 542,"The program has been accredited since 1975 and includes site visits by credentialed veterinarians and animal care professionals to ensure we are following the Guide for the Care and Use of Laboratory Animals 8th edition.
","('Ecological_Impacts', 0.40425413846969604)","('Access_And_Affordability', 0.08138691633939743)","('Selling_Practices_And_Product_Labeling', 0.06271109730005264)","('NON-ESG', 0.40425413846969604)","('NON-ESG', 0.08138691633939743)","('NON-ESG', 0.06271109730005264)"
Line 543,"This includes a Program of Veterinary Care, Institutional Animal Care and Use Committee (IACUC), a Program of Occupational Health and a gold-standard animal facility that promotes animal health and welfare with environments that promote natural behavior.
","('Ecological_Impacts', 0.3371521830558777)","('Employee_Health_And_Safety', 0.3056652247905731)","('Waste_And_Hazardous_Materials_Management', 0.06013078987598419)","('NON-ESG', 0.3371521830558777)","('NON-ESG', 0.3056652247905731)","('NON-ESG', 0.06013078987598419)"
Line 544,"BD is highly committed to providing research animals with care.
","('Access_And_Affordability', 0.38215431571006775)","('Ecological_Impacts', 0.15033213794231415)","('Employee_Health_And_Safety', 0.1486397087574005)","('NON-ESG', 0.38215431571006775)","('NON-ESG', 0.15033213794231415)","('NON-ESG', 0.1486397087574005)"
Line 545,"Good animal welfare leads to good scientific data in support of product safety.
","('Product_Quality_And_Safety', 0.8765769004821777)","('Selling_Practices_And_Product_Labeling', 0.029086874797940254)","('Customer_Welfare', 0.01196600403636694)","(['Product Quality & Recall Management'], 0.8765769004821777)","('NON-ESG', 0.029086874797940254)","('NON-ESG', 0.01196600403636694)"
Line 546,"BDs institutional official and attending veterinarian provides oversight to a corporate  committee known as the Animal Welfare and Oversight Policy committee.
","('Management_Of_Legal_And_Regulatory_Framework', 0.39565351605415344)","('Ecological_Impacts', 0.26678115129470825)","('Access_And_Affordability', 0.04362575337290764)","('NON-ESG', 0.39565351605415344)","('NON-ESG', 0.26678115129470825)","('NON-ESG', 0.04362575337290764)"
Line 547,"This dedicated committee of professionals working with animals across BD routinely meets to share best practices and discuss animal regulation updates and application of the 4Rs: replacement, refinement, reduction and retirement.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9599305987358093)","('Ecological_Impacts', 0.0048266868107020855)","('GHG_Emissions', 0.004499335773289204)","(['Corporate Governance'], 0.9599305987358093)","('NON-ESG', 0.0048266868107020855)","('NON-ESG', 0.004499335773289204)"
Line 548,"BD supports replacement by using in vitro testing when possible; refinement by following veterinary gold-standard practice across all animal studies; reduction of animal numbers by reviewing the extensive literature of previous studies; and an active retirement program that provides adoption opportunities to BD research animal heroes.
","('Access_And_Affordability', 0.18079489469528198)","('GHG_Emissions', 0.15519936382770538)","('Customer_Welfare', 0.11947392672300339)","('NON-ESG', 0.18079489469528198)","('NON-ESG', 0.15519936382770538)","('NON-ESG', 0.11947392672300339)"
Line 549,"BD is a member of the National Association of Biomedical Research and the  European Animal Research Association, both of whom help educate the public about the importance of laboratory animal research and support advancements and best practices in laboratory animal medicine.
","('GHG_Emissions', 0.18929900228977203)","('Ecological_Impacts', 0.1397804170846939)","('Customer_Welfare', 0.09043924510478973)","('NON-ESG', 0.18929900228977203)","('NON-ESG', 0.1397804170846939)","('NON-ESG', 0.09043924510478973)"
Line 550,"The BD Research Animal Program veterinarians conduct animal welfare audits  across all animal vendors to establish that they provide the same level of care as the BD standards.
","('Business_Ethics', 0.16385293006896973)","('Product_Quality_And_Safety', 0.16142520308494568)","('Management_Of_Legal_And_Regulatory_Framework', 0.15635183453559875)","('NON-ESG', 0.16385293006896973)","('NON-ESG', 0.16142520308494568)","('NON-ESG', 0.15635183453559875)"
Line 551,"The audits are combined with our Quality Assurance program.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4001132845878601)","('Business_Ethics', 0.36797890067100525)","('Product_Quality_And_Safety', 0.056187309324741364)","('NON-ESG', 0.4001132845878601)","('NON-ESG', 0.36797890067100525)","('NON-ESG', 0.056187309324741364)"
Line 552,"We require that all third parties who carry out animal testing on our behalf are covered by our Expectations for Suppliers (EFS) and our company policy.
","('Selling_Practices_And_Product_Labeling', 0.19219349324703217)","('Product_Quality_And_Safety', 0.10019444674253464)","('Management_Of_Legal_And_Regulatory_Framework', 0.09757037460803986)","('NON-ESG', 0.19219349324703217)","('NON-ESG', 0.10019444674253464)","('NON-ESG', 0.09757037460803986)"
Line 553,"AAALAC-accredited third parties are preferred as they ensure the same level of commitment to the animal regulations and gold standards.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9427957534790039)","('Product_Quality_And_Safety', 0.007749421987682581)","('Business_Ethics', 0.007487064227461815)","(['Corporate Governance'], 0.9427957534790039)","('NON-ESG', 0.007749421987682581)","('NON-ESG', 0.007487064227461815)"
Line 554,"BD will continue to host a BRAD (Biomedical Research Awareness Day) event each  year as part of an international effort to celebrate the contributions of research animals in biomedical research.
","('Access_And_Affordability', 0.3584975004196167)","('Management_Of_Legal_And_Regulatory_Framework', 0.12159574776887894)","('Ecological_Impacts', 0.09292149543762207)","('NON-ESG', 0.3584975004196167)","('NON-ESG', 0.12159574776887894)","('NON-ESG', 0.09292149543762207)"
Line 555,"This effort helps to further educate the BD community on the significant, lifesaving medical contributions research animals have made to improve both human and veterinary medicine.
","('Access_And_Affordability', 0.37308943271636963)","('Customer_Welfare', 0.08054254949092865)","('Ecological_Impacts', 0.07580666244029999)","('NON-ESG', 0.37308943271636963)","('NON-ESG', 0.08054254949092865)","('NON-ESG', 0.07580666244029999)"
Line 556,"BD is committed to ensuring  that our medical devices are safe for veterinary, as well as human, patient use.
","('Product_Design_And_Lifecycle_Management', 0.365756630897522)","('Product_Quality_And_Safety', 0.13270032405853271)","('Selling_Practices_And_Product_Labeling', 0.08219100534915924)","('NON-ESG', 0.365756630897522)","('NON-ESG', 0.13270032405853271)","('NON-ESG', 0.08219100534915924)"
Line 557,"Medical Affairs Medical Affairs is a human health-focused organization serving as the bridge between  the clinical practice of medicine and BD.
","('Access_And_Affordability', 0.3843766450881958)","('Employee_Engagement_Inclusion_And_Diversity', 0.07173159718513489)","('Management_Of_Legal_And_Regulatory_Framework', 0.062426745891571045)","('NON-ESG', 0.3843766450881958)","('NON-ESG', 0.07173159718513489)","('NON-ESG', 0.062426745891571045)"
Line 558,"The organization consists of a team of experts with hands-on clinical experience across a range of medical areas and specialties.
","('Employee_Engagement_Inclusion_And_Diversity', 0.25400906801223755)","('Access_And_Affordability', 0.12953431904315948)","('Customer_Welfare', 0.07847429066896439)","('NON-ESG', 0.25400906801223755)","('NON-ESG', 0.12953431904315948)","('NON-ESG', 0.07847429066896439)"
Line 559,"This clinical expertise is leveraged to understand and evaluate how our products work in the clinical settings where they are used.
","('Product_Design_And_Lifecycle_Management', 0.5166814923286438)","('Customer_Welfare', 0.2022753357887268)","('Product_Quality_And_Safety', 0.05277974531054497)","(['Product Stewardship'], 0.5166814923286438)","('NON-ESG', 0.2022753357887268)","('NON-ESG', 0.05277974531054497)"
Line 560,"This includes understanding unmet medical needs, translating these insights into innovation, and determining the need for evidence that defines the clinical value of our products.
","('Product_Design_And_Lifecycle_Management', 0.7808603644371033)","('Customer_Welfare', 0.07262637466192245)","('Selling_Practices_And_Product_Labeling', 0.028176434338092804)","(['Product Stewardship'], 0.7808603644371033)","('NON-ESG', 0.07262637466192245)","('NON-ESG', 0.028176434338092804)"
Line 561,"It also includes communicating the evidence that defines our products through conversations, publications and presentations.
","('Product_Design_And_Lifecycle_Management', 0.8334107398986816)","('Product_Quality_And_Safety', 0.045339182019233704)","('Selling_Practices_And_Product_Labeling', 0.037090811878442764)","(['Product Stewardship'], 0.8334107398986816)","('NON-ESG', 0.045339182019233704)","('NON-ESG', 0.037090811878442764)"
Line 562,"Being the only organization at BD that consists of clinicians with a clinical remit, the Medical Affairs organization is also responsible for oversight of the safety of human subjects when conducting research and evaluating product issues that may threaten the health and well-being of those who use our products.
","('Product_Quality_And_Safety', 0.699222207069397)","('Selling_Practices_And_Product_Labeling', 0.09251811355352402)","('Product_Design_And_Lifecycle_Management', 0.07368296384811401)","(['Product Quality & Recall Management'], 0.699222207069397)","('NON-ESG', 0.09251811355352402)","('NON-ESG', 0.07368296384811401)"
Line 563,"As part of the BD Inspire Quality initiative, Global Medical Safety and Governance  is involved in restructuring how Medical Affairs will support quality—specifically, product risk management file review and approvals across BD.
","('Product_Quality_And_Safety', 0.9162784218788147)","('Employee_Health_And_Safety', 0.011572129093110561)","('Product_Design_And_Lifecycle_Management', 0.008888881653547287)","(['Product Quality & Recall Management'], 0.9162784218788147)","('NON-ESG', 0.011572129093110561)","('NON-ESG', 0.008888881653547287)"
Line 564,"This is fundamental to consistent product benefit–risk assessments throughout the BD portfolio of products.
","('Product_Design_And_Lifecycle_Management', 0.9525107741355896)","('Product_Quality_And_Safety', 0.006592521443963051)","('Customer_Welfare', 0.005613541230559349)","(['Product Stewardship'], 0.9525107741355896)","('NON-ESG', 0.006592521443963051)","('NON-ESG', 0.005613541230559349)"
Line 565,"Global Medical Safety and Governance has been directly involved and has served as the Medical Affairs representative for several of the BD Inspire Quality initiative efforts, which are redefining the BD quality process.
","('Product_Quality_And_Safety', 0.5836050510406494)","('Employee_Health_And_Safety', 0.27031078934669495)","('Access_And_Affordability', 0.01486433856189251)","(['Product Quality & Recall Management'], 0.5836050510406494)","('NON-ESG', 0.27031078934669495)","('NON-ESG', 0.01486433856189251)"
Line 566,"The Global Medical Safety and Governance (GMS&G) organization is a dedicated  and specialized independent medical safety organization that maintains a constant and proactive monitoring process that encourages a consistent and efficient means for product safety as well as Quality, Regulatory, and Ethics & Compliance alignment.
","('Product_Quality_And_Safety', 0.8897873163223267)","('Employee_Health_And_Safety', 0.02337702363729477)","('Business_Ethics', 0.010050857439637184)","(['Product Quality & Recall Management'], 0.8897873163223267)","('NON-ESG', 0.02337702363729477)","('NON-ESG', 0.010050857439637184)"
Line 567,"It is also intended to provide a neutral and independent assessment and  objective means for escalation, independent of the BD business unit.2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Climate change Introduction Product impact Medical Safety Officers in the Global Medical Safety and Governance Organization  are in place to work closely with Medical Safety Specialists (MSS) in each Medical Affairs business team and with each Medical Affairs regional team.
","('Product_Quality_And_Safety', 0.7965620756149292)","('Employee_Health_And_Safety', 0.07690972834825516)","('Business_Ethics', 0.01018417626619339)","(['Product Quality & Recall Management'], 0.7965620756149292)","('NON-ESG', 0.07690972834825516)","('NON-ESG', 0.01018417626619339)"
Line 568,"It is also intended to provide a neutral and independent assessment and  objective means for escalation, independent of the BD business unit.2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Climate change Introduction Product impact Medical Safety Officers in the Global Medical Safety and Governance Organization  are in place to work closely with Medical Safety Specialists (MSS) in each Medical Affairs business team and with each Medical Affairs regional team.
","('Access_And_Affordability', 0.12105616182088852)","('Employee_Engagement_Inclusion_And_Diversity', 0.11835682392120361)","('Labor_Practices', 0.06736583262681961)","('NON-ESG', 0.12105616182088852)","('NON-ESG', 0.11835682392120361)","('NON-ESG', 0.06736583262681961)"
Line 569,"This process provides an independent but shared accountability model for medical safety.
","('Product_Quality_And_Safety', 0.43990734219551086)","('Employee_Health_And_Safety', 0.3685910701751709)","('Access_And_Affordability', 0.02814708650112152)","('NON-ESG', 0.43990734219551086)","('NON-ESG', 0.3685910701751709)","('NON-ESG', 0.02814708650112152)"
Line 570,"The Medical Affairs Safety Council (MASC) was established in FY 2020 as a forum  that could be used for specific issues that would benefit from an independent medical review.
","('Product_Quality_And_Safety', 0.8823107481002808)","('Employee_Health_And_Safety', 0.017138810828328133)","('Access_And_Affordability', 0.008671757765114307)","(['Product Quality & Recall Management'], 0.8823107481002808)","('NON-ESG', 0.017138810828328133)","('NON-ESG', 0.008671757765114307)"
Line 571,"The MASC is led by the VP of Global Medical Safety and Governance (GMS&G) and includes the EVP and chief medical officer along with the VP of Medical Affairs from each business unit.
","('Product_Quality_And_Safety', 0.6576037406921387)","('Employee_Health_And_Safety', 0.14870843291282654)","('Competitive_Behavior', 0.014350597746670246)","(['Product Quality & Recall Management'], 0.6576037406921387)","('NON-ESG', 0.14870843291282654)","('NON-ESG', 0.014350597746670246)"
Line 572,"The MASC provides a mechanism for regular as well as ad hoc independent  medical and/or product safety reviews or escalations related to Business Unit or Regional Medical Affairs organizations.
","('Product_Quality_And_Safety', 0.9187804460525513)","('Selling_Practices_And_Product_Labeling', 0.010940561071038246)","('Employee_Health_And_Safety', 0.007274346891790628)","(['Product Quality & Recall Management'], 0.9187804460525513)","('NON-ESG', 0.010940561071038246)","('NON-ESG', 0.007274346891790628)"
Line 573,"Global clinical affairs Clinical studies are carried out by a central function within Medical Affairs, serving all BD businesses and regions.
","('Access_And_Affordability', 0.24229545891284943)","('Customer_Welfare', 0.09961983561515808)","('Management_Of_Legal_And_Regulatory_Framework', 0.06619057059288025)","('NON-ESG', 0.24229545891284943)","('NON-ESG', 0.09961983561515808)","('NON-ESG', 0.06619057059288025)"
Line 574,"The vice president of global clinical affairs (VP GCA) reports directly to the company’s executive vice president and chief medical officer and has overall responsibility for clinical studies.
","('Access_And_Affordability', 0.13961903750896454)","('Customer_Welfare', 0.11106258630752563)","('GHG_Emissions', 0.09912807494401932)","('NON-ESG', 0.13961903750896454)","('NON-ESG', 0.11106258630752563)","('NON-ESG', 0.09912807494401932)"
Line 575,"The VP GCA is responsible for ensuring that clinical studies are carried out in an  ethical manner and in adherence to good clinical practice (GCP).
","('Access_And_Affordability', 0.35910937190055847)","('Management_Of_Legal_And_Regulatory_Framework', 0.12315619736909866)","('Product_Quality_And_Safety', 0.07545515149831772)","('NON-ESG', 0.35910937190055847)","('NON-ESG', 0.12315619736909866)","('NON-ESG', 0.07545515149831772)"
Line 576,"In addition, an independent Ethics Committee/Institutional Review Board (EC/IRB) reviews all studies and has the authority to approve, modify or stop a study at any time.
","('Management_Of_Legal_And_Regulatory_Framework', 0.606292188167572)","('Business_Ethics', 0.12691518664360046)","('Director_Removal', 0.11215362697839737)","(['Corporate Governance'], 0.606292188167572)","('NON-ESG', 0.12691518664360046)","('NON-ESG', 0.11215362697839737)"
Line 577,"Prior to the start of each study, a risk assessment is carried out by the GCA  study team and representatives from the Medical Affairs Quality team.
","('Systemic_Risk_Management', 0.2881939709186554)","('Physical_Impacts_Of_Climate_Change', 0.15626412630081177)","('Supply_Chain_Management', 0.06382068246603012)","('NON-ESG', 0.2881939709186554)","('NON-ESG', 0.15626412630081177)","('NON-ESG', 0.06382068246603012)"
Line 578,"The risk assessment is shared with the EC/IRB and any oversight bodies, such as a clinical event committee, and regulatory agencies where applicable.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9535143375396729)","('GHG_Emissions', 0.004535167943686247)","('Access_And_Affordability', 0.004123485181480646)","(['Corporate Governance'], 0.9535143375396729)","('NON-ESG', 0.004535167943686247)","('NON-ESG', 0.004123485181480646)"
Line 579,"Identified risks are assessed during the study on an ongoing basis, by examination of adverse events or other factors.
","('Systemic_Risk_Management', 0.4980434775352478)","('Physical_Impacts_Of_Climate_Change', 0.09873974323272705)","('Critical_Incident_Risk_Management', 0.07008189707994461)","('NON-ESG', 0.4980434775352478)","('NON-ESG', 0.09873974323272705)","('NON-ESG', 0.07008189707994461)"
Line 580,"Free and informed consent is obtained from all study participants prior to the  start of each study.
","('Access_And_Affordability', 0.20588360726833344)","('Management_Of_Legal_And_Regulatory_Framework', 0.11823385953903198)","('Human_Rights_And_Community_Relations', 0.1150745078921318)","('NON-ESG', 0.20588360726833344)","('NON-ESG', 0.11823385953903198)","('NON-ESG', 0.1150745078921318)"
Line 581,"Consent is obtained by the principal investigator of the study site and designees, as per site procedures.
","('Ecological_Impacts', 0.777236819267273)","('GHG_Emissions', 0.036962684243917465)","('Human_Rights_And_Community_Relations', 0.02814875729382038)","(['Natural Capital'], 0.777236819267273)","('NON-ESG', 0.036962684243917465)","('NON-ESG', 0.02814875729382038)"
Line 582,"The names and contact information of the study site’s principal investigator and the EC/IRB are provided to each study participant in written form, usually by listing this information in the subject’s informed consent.
","('Customer_Privacy', 0.9175620079040527)","('Selling_Practices_And_Product_Labeling', 0.011025374755263329)","('Data_Security', 0.007401207461953163)","(['Privacy Protection'], 0.9175620079040527)","('NON-ESG', 0.011025374755263329)","('NON-ESG', 0.007401207461953163)"
Line 583,"Participants are encouraged to reach out to either of these contacts if they have questions or concerns about the study.
","('Management_Of_Legal_And_Regulatory_Framework', 0.25281229615211487)","('Human_Rights_And_Community_Relations', 0.13261935114860535)","('Access_And_Affordability', 0.12894362211227417)","('NON-ESG', 0.25281229615211487)","('NON-ESG', 0.13261935114860535)","('NON-ESG', 0.12894362211227417)"
Line 584,"Extensive training in BD policies related to human subject research and in GCA’s  formal Quality System, consisting of standard operating procedures (SOPs) and work instructions, is required of all BD associates who engage in clinical study activities.
","('Access_And_Affordability', 0.2657115161418915)","('Management_Of_Legal_And_Regulatory_Framework', 0.2613561451435089)","('Product_Quality_And_Safety', 0.10917911678552628)","('NON-ESG', 0.2657115161418915)","('NON-ESG', 0.2613561451435089)","('NON-ESG', 0.10917911678552628)"
Line 585,"This training occurs through course and procedure review via the BD online training system, as well as through direct education during study team meetings.
","('Access_And_Affordability', 0.3614700734615326)","('Employee_Engagement_Inclusion_And_Diversity', 0.13376566767692566)","('Management_Of_Legal_And_Regulatory_Framework', 0.08544255793094635)","('NON-ESG', 0.3614700734615326)","('NON-ESG', 0.13376566767692566)","('NON-ESG', 0.08544255793094635)"
Line 586,"BD clinical studies are conducted in various regions by ethical and competent  clinical research teams.
","('Access_And_Affordability', 0.41943269968032837)","('Management_Of_Legal_And_Regulatory_Framework', 0.08511564135551453)","('Product_Quality_And_Safety', 0.0498712956905365)","('NON-ESG', 0.41943269968032837)","('NON-ESG', 0.08511564135551453)","('NON-ESG', 0.0498712956905365)"
Line 587,"The Medical Affairs and GCA teams have decision-making responsibilities in this area.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8164166212081909)","('Human_Rights_And_Community_Relations', 0.02011551707983017)","('Director_Removal', 0.016611358150839806)","(['Corporate Governance'], 0.8164166212081909)","('NON-ESG', 0.02011551707983017)","('NON-ESG', 0.016611358150839806)"
Line 588,"However, the locations of the teams may vary from where products are ultimately marketed.
","('Product_Design_And_Lifecycle_Management', 0.7188996076583862)","('Customer_Welfare', 0.07563461363315582)","('Selling_Practices_And_Product_Labeling', 0.07052463293075562)","(['Product Stewardship'], 0.7188996076583862)","('NON-ESG', 0.07563461363315582)","('NON-ESG', 0.07052463293075562)"
Line 589,"In accordance with the GCA’s SOPs, a formal monitoring plan is written for each  study.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8125981688499451)","('GHG_Emissions', 0.03112132102251053)","('Human_Rights_And_Community_Relations', 0.029556969180703163)","(['Corporate Governance'], 0.8125981688499451)","('NON-ESG', 0.03112132102251053)","('NON-ESG', 0.029556969180703163)"
Line 590,"This plan defines the method and timing by which BD associates maintain oversight of each study site.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5926295518875122)","('Director_Removal', 0.069309763610363)","('Competitive_Behavior', 0.04401079937815666)","(['Corporate Governance'], 0.5926295518875122)","('NON-ESG', 0.069309763610363)","('NON-ESG', 0.04401079937815666)"
Line 591,"Clinical study monitoring may occur through frequent communications via phone and email, and multiple visits to the site.
","('Access_And_Affordability', 0.18530987203121185)","('Customer_Privacy', 0.15655972063541412)","('Selling_Practices_And_Product_Labeling', 0.10068053007125854)","('NON-ESG', 0.18530987203121185)","('NON-ESG', 0.15655972063541412)","('NON-ESG', 0.10068053007125854)"
Line 592,"The site and its principal investigator are qualified for participation by GCA procedures.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5324853658676147)","('GHG_Emissions', 0.11023527383804321)","('Human_Rights_And_Community_Relations', 0.057501040399074554)","(['Corporate Governance'], 0.5324853658676147)","('NON-ESG', 0.11023527383804321)","('NON-ESG', 0.057501040399074554)"
Line 593,"Compliance to the study protocol and GCP , especially when related to safety issues, is reviewed regularly through the medical record and study database for each site participant.
","('Product_Quality_And_Safety', 0.8539366126060486)","('Employee_Health_And_Safety', 0.053892724215984344)","('Product_Design_And_Lifecycle_Management', 0.008070118725299835)","(['Product Quality & Recall Management'], 0.8539366126060486)","('NON-ESG', 0.053892724215984344)","('NON-ESG', 0.008070118725299835)"
Line 594,"In addition, external audits are conducted using selected high-risk studies by BD  auditors external to the GCA team.
","('Systemic_Risk_Management', 0.3138114809989929)","('Business_Ethics', 0.31065842509269714)","('Management_Of_Legal_And_Regulatory_Framework', 0.1897232085466385)","('NON-ESG', 0.3138114809989929)","('NON-ESG', 0.31065842509269714)","('NON-ESG', 0.1897232085466385)"
Line 595,"All studies are registered in public databases (such as clinicaltrials.gov) as required  by U.S. federal law.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5131669640541077)","('Access_And_Affordability', 0.10674094408750534)","('Competitive_Behavior', 0.03321654722094536)","(['Corporate Governance'], 0.5131669640541077)","('NON-ESG', 0.10674094408750534)","('NON-ESG', 0.03321654722094536)"
Line 596,"This includes information about the study protocol, clinical study sites and, eventually, adverse events and other study results.
","('Product_Quality_And_Safety', 0.1896316260099411)","('Employee_Health_And_Safety', 0.12528303265571594)","('Selling_Practices_And_Product_Labeling', 0.09442560374736786)","('NON-ESG', 0.1896316260099411)","('NON-ESG', 0.12528303265571594)","('NON-ESG', 0.09442560374736786)"
Line 597,"Reporting on significant problems discovered during monitoring, deviations to the protocol and necessary corrective actions are reported to the responsible EC/IRB and, when required, to the regulatory agency with jurisdiction (e.g., FDA).
","('Management_Of_Legal_And_Regulatory_Framework', 0.9148165583610535)","('Business_Ethics', 0.01267974078655243)","('Product_Quality_And_Safety', 0.010089811868965626)","(['Corporate Governance'], 0.9148165583610535)","('NON-ESG', 0.01267974078655243)","('NON-ESG', 0.010089811868965626)"
Line 598,"We are committed to seeking the publication of the results of our completed  applicable clinical trials on any marketed product in peer-reviewed scientific literature, regardless of the trial’s outcome.
","('Competitive_Behavior', 0.37529242038726807)","('Customer_Welfare', 0.10437536239624023)","('Selling_Practices_And_Product_Labeling', 0.10055620223283768)","('NON-ESG', 0.37529242038726807)","('NON-ESG', 0.10437536239624023)","('NON-ESG', 0.10055620223283768)"
Line 599,"We will provide the final statistical reports of protocol-derived outcomes to external authors.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8054511547088623)","('Competitive_Behavior', 0.030130047351121902)","('Access_And_Affordability', 0.02128426544368267)","(['Corporate Governance'], 0.8054511547088623)","('NON-ESG', 0.030130047351121902)","('NON-ESG', 0.02128426544368267)"
Line 600,"As a study sponsor, BD does not approve or veto such publications.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9321974515914917)","('Competitive_Behavior', 0.007620024494826794)","('Director_Removal', 0.006375193130224943)","(['Corporate Governance'], 0.9321974515914917)","('NON-ESG', 0.007620024494826794)","('NON-ESG', 0.006375193130224943)"
Line 601,"View our clinical trial publication policy .In 2021 and early 2022, we announced the  publication of a number of clinical trials, including: A first-of-its-kind, randomized clinical trial published in  The Lancet Infectious Diseases that outlines potential new standard-setting best practices for peripheral IV catheters.
","('Competitive_Behavior', 0.2674196660518646)","('Access_And_Affordability', 0.11119894683361053)","('Management_Of_Legal_And_Regulatory_Framework', 0.08021663129329681)","('NON-ESG', 0.2674196660518646)","('NON-ESG', 0.11119894683361053)","('NON-ESG', 0.08021663129329681)"
Line 602,"(February 2) The first-ever peer-reviewed study evaluating the  outcomes using midline catheters for blood collection published in the Journal of the Association for Vascular Access.
","('Access_And_Affordability', 0.2043411284685135)","('Water_And_Wastewater_Management', 0.11395570635795593)","('Employee_Health_And_Safety', 0.08671735972166061)","('NON-ESG', 0.2043411284685135)","('NON-ESG', 0.11395570635795593)","('NON-ESG', 0.08671735972166061)"
Line 603,"The study evaluated the BD PowerGlide Pro™ Midline Catheter and showed that this option may reduce the need for direct venipuncture in patients who have midline catheters.
","('Access_And_Affordability', 0.518291711807251)","('Employee_Health_And_Safety', 0.07064694166183472)","('Critical_Incident_Risk_Management', 0.038653139024972916)","(['Health Outcome Contribution'], 0.518291711807251)","('NON-ESG', 0.07064694166183472)","('NON-ESG', 0.038653139024972916)"
Line 604,"Fewer needlesticks can reduce complications and lead to greater patient safety and satisfaction.
","('Product_Quality_And_Safety', 0.5592729449272156)","('Employee_Health_And_Safety', 0.233194962143898)","('Business_Ethics', 0.028981871902942657)","(['Product Quality & Recall Management'], 0.5592729449272156)","('NON-ESG', 0.233194962143898)","('NON-ESG', 0.028981871902942657)"
Line 605,"Publication of the clinical trial results in Clinical and  Translation Science for the BD Libertas™ Wearable Injector.
","('Product_Design_And_Lifecycle_Management', 0.20088601112365723)","('Customer_Welfare', 0.1304597556591034)","('Energy_Management', 0.12985193729400635)","('NON-ESG', 0.20088601112365723)","('NON-ESG', 0.1304597556591034)","('NON-ESG', 0.12985193729400635)"
Line 606,"The BD Libertas™ Subcutaneous Ready-to-use Injector is designed for drugs that have higher viscosities, such as biologics, and is currently in final phases of development.
","('Customer_Welfare', 0.4350440800189972)","('Product_Design_And_Lifecycle_Management', 0.13236230611801147)","('Energy_Management', 0.10274266451597214)","('NON-ESG', 0.4350440800189972)","('NON-ESG', 0.13236230611801147)","('NON-ESG', 0.10274266451597214)"
Line 607,"A peer-reviewed study published in the journal  of Obstetrics & Gynecology showed molecular diagnostics could improve the accuracy of vaginitis diagnosis and lead to more appropriate and timely treatment decisions.
","('Employee_Health_And_Safety', 0.6314705610275269)","('Employee_Engagement_Inclusion_And_Diversity', 0.06598734855651855)","('Access_And_Affordability', 0.06330864131450653)","(['Operational Eco-Efficiency'], 0.6314705610275269)","('NON-ESG', 0.06598734855651855)","('NON-ESG', 0.06330864131450653)"
Line 608,"Using real-world data, the study demonstrated the effectiveness of vaginal panels performed on the BD MAX™ Molecular Diagnostic System as compared to clinicians’ assessments.2021 ESG Report Appendices Transparency Healthy workforce and communities Product impact Climate change Introduction Responsible supply chain Responsible  supply chain2021 ESG Report Appendices Transparency Healthy workforce and communities Product impact Climate change Introduction Responsible supply chain Responsible sourcing Our 2030+ commitments and goals recognize that a significant way BD can reduce  our impact is through what materials and goods we buy and how we buy them.
","('Supply_Chain_Management', 0.6606629490852356)","('Product_Design_And_Lifecycle_Management', 0.17802177369594574)","('Product_Quality_And_Safety', 0.022569764405488968)","(['Supply Chain Management'], 0.6606629490852356)","('NON-ESG', 0.17802177369594574)","('NON-ESG', 0.022569764405488968)"
Line 609,"Using real-world data, the study demonstrated the effectiveness of vaginal panels performed on the BD MAX™ Molecular Diagnostic System as compared to clinicians’ assessments.2021 ESG Report Appendices Transparency Healthy workforce and communities Product impact Climate change Introduction Responsible supply chain Responsible  supply chain2021 ESG Report Appendices Transparency Healthy workforce and communities Product impact Climate change Introduction Responsible supply chain Responsible sourcing Our 2030+ commitments and goals recognize that a significant way BD can reduce  our impact is through what materials and goods we buy and how we buy them.
","('Product_Design_And_Lifecycle_Management', 0.9304736256599426)","('Supply_Chain_Management', 0.014328709803521633)","('Energy_Management', 0.006974097341299057)","(['Product Stewardship'], 0.9304736256599426)","('NON-ESG', 0.014328709803521633)","('NON-ESG', 0.006974097341299057)"
Line 610,"Our Responsible Sourcing program was established to work collaboratively across the company to seek out opportunities to engage with our suppliers and improve our environmental, social and governance impacts.
","('Supply_Chain_Management', 0.909751832485199)","('Product_Design_And_Lifecycle_Management', 0.017871905118227005)","('Business_Model_Resilience', 0.007769465912133455)","(['Supply Chain Management'], 0.909751832485199)","('NON-ESG', 0.017871905118227005)","('NON-ESG', 0.007769465912133455)"
Line 611,"In doing so, we will avoid risk and address key compliance requirements as well as establishing shared value and having positive impact on the places and people where and with whom we do business.
","('Management_Of_Legal_And_Regulatory_Framework', 0.21608352661132812)","('Systemic_Risk_Management', 0.1481160670518875)","('Human_Rights_And_Community_Relations', 0.13427941501140594)","('NON-ESG', 0.21608352661132812)","('NON-ESG', 0.1481160670518875)","('NON-ESG', 0.13427941501140594)"
Line 612,"Our Responsible Sourcing Program incorporates six key focus areas of work—human  rights due diligence within our supply chain; Category 1 Emissions; Sustainable Products and Services; Transparency; Supplier Diversity; and Supply Base Resiliency.
","('Supply_Chain_Management', 0.8964191675186157)","('Product_Design_And_Lifecycle_Management', 0.03828321397304535)","('Business_Model_Resilience', 0.008780761621892452)","(['Supply Chain Management'], 0.8964191675186157)","('NON-ESG', 0.03828321397304535)","('NON-ESG', 0.008780761621892452)"
Line 613,"These focus areas address global challenges that impact our suppliers, associates and customers, as well as the communities in which we live and work.
","('Supply_Chain_Management', 0.9111632704734802)","('Product_Design_And_Lifecycle_Management', 0.012985486537218094)","('Human_Rights_And_Community_Relations', 0.006704687140882015)","(['Supply Chain Management'], 0.9111632704734802)","('NON-ESG', 0.012985486537218094)","('NON-ESG', 0.006704687140882015)"
Line 614,"Program governance Responsible sourcing operating committee BD’s Responsible Sourcing Operating Committee was established to guide and facilitate our ESG efforts within procurement.
","('Supply_Chain_Management', 0.2019227147102356)","('Competitive_Behavior', 0.186902716755867)","('Systemic_Risk_Management', 0.17627038061618805)","('NON-ESG', 0.2019227147102356)","('NON-ESG', 0.186902716755867)","('NON-ESG', 0.17627038061618805)"
Line 615,"A key part of this work is human rights due diligence in our supply chain.
","('Supply_Chain_Management', 0.6500082612037659)","('Human_Rights_And_Community_Relations', 0.1597932130098343)","('Labor_Practices', 0.03362300992012024)","(['Supply Chain Management'], 0.6500082612037659)","('NON-ESG', 0.1597932130098343)","('NON-ESG', 0.03362300992012024)"
Line 616,"This committee reviews all suppliers that score below our acceptable threshold in our assessments and, in collaboration with appropriate associates outside the committee, determines next steps for mitigating the risk.
","('Supply_Chain_Management', 0.9385849833488464)","('Systemic_Risk_Management', 0.008402382954955101)","('Physical_Impacts_Of_Climate_Change', 0.004229646176099777)","(['Supply Chain Management'], 0.9385849833488464)","('NON-ESG', 0.008402382954955101)","('NON-ESG', 0.004229646176099777)"
Line 617,"The Committee also oversees our overall human rights due diligence in the supply chain process and relevant policies and is asked to review special issues as they arise.
","('Supply_Chain_Management', 0.9127209186553955)","('Human_Rights_And_Community_Relations', 0.010912598110735416)","('Labor_Practices', 0.007534034550189972)","(['Supply Chain Management'], 0.9127209186553955)","('NON-ESG', 0.010912598110735416)","('NON-ESG', 0.007534034550189972)"
Line 618,"Standing Committee members are subject matter experts from across the company.
","('Management_Of_Legal_And_Regulatory_Framework', 0.696267306804657)","('Director_Removal', 0.1058633103966713)","('Business_Ethics', 0.021164877340197563)","(['Corporate Governance'], 0.696267306804657)","('NON-ESG', 0.1058633103966713)","('NON-ESG', 0.021164877340197563)"
Line 619,"In addition to human rights due diligence in the supply chain, the Committee is also involved in environmental issues as they relate to responsible sourcing (emissions, sustainable products and services, etc.).2030+ impact area: responsible supply chain BD commitment and goals Our commitment: 2030+ goals: Create a supply chain adaptable to  disruption and able to contribute to strong environmental and social performance.1 2 3 We will strengthen engagement with supply chain partners on their labor and environmental practices and performance by completing ESG desktop audits for strategic, preferred and critical suppliers by 2023.We will partner with strategic/preferred/critical suppliers to evaluate risk in Tier 2 by 2030.We will seek to have 90% of total spend reflected in completed supplier ESG desktop audits by 2025.We will incorporate climate risk into supply chain and network architecture strategies.
","('Supply_Chain_Management', 0.9318376183509827)","('Product_Design_And_Lifecycle_Management', 0.015191975049674511)","('Labor_Practices', 0.004326843656599522)","(['Supply Chain Management'], 0.9318376183509827)","('NON-ESG', 0.015191975049674511)","('NON-ESG', 0.004326843656599522)"
Line 620,"In addition to human rights due diligence in the supply chain, the Committee is also involved in environmental issues as they relate to responsible sourcing (emissions, sustainable products and services, etc.).2030+ impact area: responsible supply chain BD commitment and goals Our commitment: 2030+ goals: Create a supply chain adaptable to  disruption and able to contribute to strong environmental and social performance.1 2 3 We will strengthen engagement with supply chain partners on their labor and environmental practices and performance by completing ESG desktop audits for strategic, preferred and critical suppliers by 2023.We will partner with strategic/preferred/critical suppliers to evaluate risk in Tier 2 by 2030.We will seek to have 90% of total spend reflected in completed supplier ESG desktop audits by 2025.We will incorporate climate risk into supply chain and network architecture strategies.
","('Supply_Chain_Management', 0.9548046588897705)","('Physical_Impacts_Of_Climate_Change', 0.00409357575699687)","('Systemic_Risk_Management', 0.0034339185804128647)","(['Supply Chain Management'], 0.9548046588897705)","('NON-ESG', 0.00409357575699687)","('NON-ESG', 0.0034339185804128647)"
Line 621,"2021 ESG Report Appendices Transparency Healthy workforce and communities Product impact Climate change Introduction Responsible supply chain Human rights  due diligence Investigating/ mitigating/remediating  the human rights  practices of our suppliersScope 3 greenhouse  gas emissions Understanding and  reducing greenhouse gas  emissions from the  products/services we buySustainable products  and services Reducing the environmental  impact of our products  and services Transparency Sharing our eﬀorts  externally and  collaborating to establish  stronger relationships Responsible Sourcing ProgramSupply base  resiliency Understanding and  mitigating risk across our  supply baseSupplier  diversity Creating a positive  community impact and a  diversiﬁed supply base  We look to our suppliers to match our efforts in addressing these global challenges, as outlined in our  Expectations for Suppliers document.
","('Product_Design_And_Lifecycle_Management', 0.5072833299636841)","('Supply_Chain_Management', 0.1366899311542511)","('GHG_Emissions', 0.0780785009264946)","(['Product Stewardship'], 0.5072833299636841)","('NON-ESG', 0.1366899311542511)","('NON-ESG', 0.0780785009264946)"
Line 622,"2021 ESG Report Appendices Transparency Healthy workforce and communities Product impact Climate change Introduction Responsible supply chain Human rights  due diligence Investigating/ mitigating/remediating  the human rights  practices of our suppliersScope 3 greenhouse  gas emissions Understanding and  reducing greenhouse gas  emissions from the  products/services we buySustainable products  and services Reducing the environmental  impact of our products  and services Transparency Sharing our eﬀorts  externally and  collaborating to establish  stronger relationships Responsible Sourcing ProgramSupply base  resiliency Understanding and  mitigating risk across our  supply baseSupplier  diversity Creating a positive  community impact and a  diversiﬁed supply base  We look to our suppliers to match our efforts in addressing these global challenges, as outlined in our  Expectations for Suppliers document.
","('Supply_Chain_Management', 0.9461035132408142)","('Product_Design_And_Lifecycle_Management', 0.007206638343632221)","('Business_Model_Resilience', 0.00681928638368845)","(['Supply Chain Management'], 0.9461035132408142)","('NON-ESG', 0.007206638343632221)","('NON-ESG', 0.00681928638368845)"
Line 623,"This document has guided our suppliers since it was published in 2012 and is a fundamental part of our relationship with our suppliers around the world.
","('Supply_Chain_Management', 0.911739706993103)","('Product_Design_And_Lifecycle_Management', 0.01774159073829651)","('GHG_Emissions', 0.005256086587905884)","(['Supply Chain Management'], 0.911739706993103)","('NON-ESG', 0.01774159073829651)","('NON-ESG', 0.005256086587905884)"
Line 624,"BD expects all our suppliers to fully comply with these standards and, if requested, be able to demonstrate their compliance.
","('Product_Quality_And_Safety', 0.3108264207839966)","('Management_Of_Legal_And_Regulatory_Framework', 0.18764424324035645)","('Business_Ethics', 0.16290022432804108)","('NON-ESG', 0.3108264207839966)","('NON-ESG', 0.18764424324035645)","('NON-ESG', 0.16290022432804108)"
Line 625,"We also expect them to have similar requirements and standards for their own suppliers.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4163513481616974)","('Product_Quality_And_Safety', 0.18607354164123535)","('Labor_Practices', 0.0804058089852333)","('NON-ESG', 0.4163513481616974)","('NON-ESG', 0.18607354164123535)","('NON-ESG', 0.0804058089852333)"
Line 626,"BD Expectations for Suppliers  April 2021 ESG Report Appendices Transparency Healthy workforce and communities Product impact Climate change Introduction Responsible supply chain Human rights due diligence in our supply chain Our Expectations for Suppliers (Expectations) is the foundation on which we have built our human rights program within Responsible Sourcing.
","('Supply_Chain_Management', 0.9408370852470398)","('Physical_Impacts_Of_Climate_Change', 0.0058841523714363575)","('Labor_Practices', 0.0051161544397473335)","(['Supply Chain Management'], 0.9408370852470398)","('NON-ESG', 0.0058841523714363575)","('NON-ESG', 0.0051161544397473335)"
Line 627,"BD actively  assesses supplier compliance with these Expectations as part of our wider process for human rights due diligence in the supply chain.
","('Supply_Chain_Management', 0.9316643476486206)","('Labor_Practices', 0.010878099128603935)","('Human_Rights_And_Community_Relations', 0.004906427580863237)","(['Supply Chain Management'], 0.9316643476486206)","('NON-ESG', 0.010878099128603935)","('NON-ESG', 0.004906427580863237)"
Line 628,"BD’s human rights due diligence in the supply chain efforts are made up of three key work components—Prioritize, Assess and Mitigate.Human rights due diligence in the supply chain –  key accomplishments Across all of our programs that address human rights and modern slavery, we assess  management effectiveness through periodic program reviews and have started to implement key performance indicators (KPIs) to track progress against our 2030+ goals for responsible supply chain.
","('Supply_Chain_Management', 0.8018108606338501)","('Human_Rights_And_Community_Relations', 0.05593396723270416)","('Labor_Practices', 0.024256594479084015)","(['Supply Chain Management'], 0.8018108606338501)","('NON-ESG', 0.05593396723270416)","('NON-ESG', 0.024256594479084015)"
Line 629,"As of the end of FY 2021, we completed 160 supplier audits; these represent 15 percent of our  total spend, having completed a supplier scorecard.
","('Supply_Chain_Management', 0.9365108013153076)","('Labor_Practices', 0.006989025045186281)","('Product_Design_And_Lifecycle_Management', 0.006027502473443747)","(['Supply Chain Management'], 0.9365108013153076)","('NON-ESG', 0.006989025045186281)","('NON-ESG', 0.006027502473443747)"
Line 630,"Of those 160 audits, one high-risk supplier was identified; BD took action to engage with the supplier to better understand the risk and assign corrective actions.
","('Supply_Chain_Management', 0.9404271245002747)","('Systemic_Risk_Management', 0.0069802976213395596)","('Labor_Practices', 0.006052205804735422)","(['Supply Chain Management'], 0.9404271245002747)","('NON-ESG', 0.0069802976213395596)","('NON-ESG', 0.006052205804735422)"
Line 631,"In the following months the supplier was reassessed and improved its score.
","('Supply_Chain_Management', 0.896662175655365)","('Systemic_Risk_Management', 0.014440862461924553)","('Business_Model_Resilience', 0.012713438831269741)","(['Supply Chain Management'], 0.896662175655365)","('NON-ESG', 0.014440862461924553)","('NON-ESG', 0.012713438831269741)"
Line 632,"The Responsible Sourcing Operating Committee closely monitored this progress and will continue to evaluate this supplier to ensure ongoing compliance with our Expectations.
","('Supply_Chain_Management', 0.949736475944519)","('Labor_Practices', 0.004113419912755489)","('Water_And_Wastewater_Management', 0.003401032881811261)","(['Supply Chain Management'], 0.949736475944519)","('NON-ESG', 0.004113419912755489)","('NON-ESG', 0.003401032881811261)"
Line 633,"BD recognizes that establishing our Expectations and building due diligence programs for our  supply chain is an important step.
","('Supply_Chain_Management', 0.9517333507537842)","('Labor_Practices', 0.003636762034147978)","('Physical_Impacts_Of_Climate_Change', 0.0036198245361447334)","(['Supply Chain Management'], 0.9517333507537842)","('NON-ESG', 0.003636762034147978)","('NON-ESG', 0.0036198245361447334)"
Line 634,"We understand that we must also establish training and feedback sessions to continuously improve practice.
","('Access_And_Affordability', 0.20398502051830292)","('Management_Of_Legal_And_Regulatory_Framework', 0.1560261845588684)","('Business_Ethics', 0.10012740641832352)","('NON-ESG', 0.20398502051830292)","('NON-ESG', 0.1560261845588684)","('NON-ESG', 0.10012740641832352)"
Line 635,"To enable this, we have established both internal training and supplier training.
","('Supply_Chain_Management', 0.7815865278244019)","('Labor_Practices', 0.034550949931144714)","('Employee_Health_And_Safety', 0.023935619741678238)","(['Supply Chain Management'], 0.7815865278244019)","('NON-ESG', 0.034550949931144714)","('NON-ESG', 0.023935619741678238)"
Line 636,"Internally, BD has rolled out our annual Modern Slavery and Human Trafficking training to  teach our associates who may interact with a supplier how to identify potential indicators of human rights abuses; we also inform our associates how to report known or suspected abuses.
","('Human_Rights_And_Community_Relations', 0.4188768267631531)","('Business_Ethics', 0.3129323124885559)","('Labor_Practices', 0.05395844578742981)","('NON-ESG', 0.4188768267631531)","('NON-ESG', 0.3129323124885559)","('NON-ESG', 0.05395844578742981)"
Line 637,"In FY 2021, nearly 10,000 associates completed this course.
","('Employee_Engagement_Inclusion_And_Diversity', 0.22279949486255646)","('Management_Of_Legal_And_Regulatory_Framework', 0.16378535330295563)","('Access_And_Affordability', 0.10375183820724487)","('NON-ESG', 0.22279949486255646)","('NON-ESG', 0.16378535330295563)","('NON-ESG', 0.10375183820724487)"
Line 638,"BD has also worked to ensure that auditors from across the company who might visit a supplier manufacturing site (for instance, quality auditors) are equipped to report any information that might have relevance to negative human rights practices.
","('Supply_Chain_Management', 0.350445955991745)","('Human_Rights_And_Community_Relations', 0.3249087333679199)","('Labor_Practices', 0.08798877894878387)","('NON-ESG', 0.350445955991745)","('NON-ESG', 0.3249087333679199)","('NON-ESG', 0.08798877894878387)"
Line 639,"BD also seeks opportunities to train and engage with our suppliers on human rights.
","('Human_Rights_And_Community_Relations', 0.9445866942405701)","('Labor_Practices', 0.006398878991603851)","('Access_And_Affordability', 0.005486303474754095)","(['Community Relations'], 0.9445866942405701)","('NON-ESG', 0.006398878991603851)","('NON-ESG', 0.005486303474754095)"
Line 640,"We have  integrated a training for new suppliers around our Expectations document as part of the supplier on-boarding process.
","('Supply_Chain_Management', 0.944743812084198)","('Labor_Practices', 0.00614760909229517)","('Product_Design_And_Lifecycle_Management', 0.004700463265180588)","(['Supply Chain Management'], 0.944743812084198)","('NON-ESG', 0.00614760909229517)","('NON-ESG', 0.004700463265180588)"
Line 641,"In April 2022, we hosted training based on our Expectations document for suppliers worldwide—part of our ongoing efforts to continue to emphasize these expectations with our suppliers.
","('Supply_Chain_Management', 0.9161214232444763)","('Labor_Practices', 0.009535429999232292)","('Product_Design_And_Lifecycle_Management', 0.006890957709401846)","(['Supply Chain Management'], 0.9161214232444763)","('NON-ESG', 0.009535429999232292)","('NON-ESG', 0.006890957709401846)"
Line 642,"To learn more about our human rights due diligence in the supply chain progress, we encourage you to read our Modern Slavery compliance statements at bd.comIn FY21 we completed 160  supplier audits,   representing 15% of our total spend.
","('Supply_Chain_Management', 0.9209451079368591)","('Labor_Practices', 0.011309424415230751)","('Systemic_Risk_Management', 0.005994535982608795)","(['Supply Chain Management'], 0.9209451079368591)","('NON-ESG', 0.011309424415230751)","('NON-ESG', 0.005994535982608795)"
Line 643,"PrioritizeWithin our supply chain (where our highest risk of modern slavery and human trafficking exists), suppliers are evaluated internally, in a process outlined by our Supply Base Resiliency Program, and by a third-party tool to understand human rights risk, which includes risk factors identified in the International Labor Organization (ILO)’s “Declaration on Fundamental Principles and Rights ” at work,  such as child labor, forced labor and other workers’ rights.
","('Labor_Practices', 0.9353815317153931)","('Supply_Chain_Management', 0.016746021807193756)","('Human_Rights_And_Community_Relations', 0.006499140523374081)","(['Labor Practice Indicators'], 0.9353815317153931)","('NON-ESG', 0.016746021807193756)","('NON-ESG', 0.006499140523374081)"
Line 644,"BD recognizes that our highest-risk suppliers are likely to be found in countries and industries cited for having the highest prevalence of modern slavery, human trafficking and other human rights violations.
","('Human_Rights_And_Community_Relations', 0.4334440231323242)","('Employee_Health_And_Safety', 0.20977310836315155)","('Business_Ethics', 0.08221416175365448)","('NON-ESG', 0.4334440231323242)","('NON-ESG', 0.20977310836315155)","('NON-ESG', 0.08221416175365448)"
Line 645,"The results of this risk evaluation will help determine which suppliers are prioritized for further assessment.
","('Supply_Chain_Management', 0.9339159727096558)","('Systemic_Risk_Management', 0.007483314722776413)","('Physical_Impacts_Of_Climate_Change', 0.006218498572707176)","(['Supply Chain Management'], 0.9339159727096558)","('NON-ESG', 0.007483314722776413)","('NON-ESG', 0.006218498572707176)"
Line 646,"AssessBD deploys desktop audits administered by a third party to assess performance against ESG topics, including labor and human rights.
","('Human_Rights_And_Community_Relations', 0.8787848949432373)","('Labor_Practices', 0.04909094423055649)","('Access_And_Affordability', 0.008970442228019238)","(['Community Relations'], 0.8787848949432373)","('NON-ESG', 0.04909094423055649)","('NON-ESG', 0.008970442228019238)"
Line 647,"This third-party expert reviews supplier responses and documentation to ensure a non-biased evaluation.
","('Supply_Chain_Management', 0.9254558086395264)","('Labor_Practices', 0.012010852806270123)","('Waste_And_Hazardous_Materials_Management', 0.0049549308605492115)","(['Supply Chain Management'], 0.9254558086395264)","('NON-ESG', 0.012010852806270123)","('NON-ESG', 0.0049549308605492115)"
Line 648,"MitigateIf a supplier receives an unacceptable score on their desktop audit, BD will evaluate results through our Responsible Sourcing Operating Committee to determine the best path for further engagement; this may include the assignment and review of corrective actions, in-person human rights-focused audits and/or remediation as necessary.2021 ESG Report Appendices Transparency Healthy workforce and communities Product impact Climate change Introduction Responsible supply chain Emissions – Scope 3 category 1  (purchased goods and services) BD recognizes that the single greatest contributor to our overall emissions is the Scope 3 category of purchased goods and services (Category 1).
","('Supply_Chain_Management', 0.9417252540588379)","('Physical_Impacts_Of_Climate_Change', 0.007931013591587543)","('Systemic_Risk_Management', 0.005681829992681742)","(['Supply Chain Management'], 0.9417252540588379)","('NON-ESG', 0.007931013591587543)","('NON-ESG', 0.005681829992681742)"
Line 649,"MitigateIf a supplier receives an unacceptable score on their desktop audit, BD will evaluate results through our Responsible Sourcing Operating Committee to determine the best path for further engagement; this may include the assignment and review of corrective actions, in-person human rights-focused audits and/or remediation as necessary.2021 ESG Report Appendices Transparency Healthy workforce and communities Product impact Climate change Introduction Responsible supply chain Emissions – Scope 3 category 1  (purchased goods and services) BD recognizes that the single greatest contributor to our overall emissions is the Scope 3 category of purchased goods and services (Category 1).
","('Product_Design_And_Lifecycle_Management', 0.8614798188209534)","('Energy_Management', 0.04360282048583031)","('Supply_Chain_Management', 0.01649308204650879)","(['Product Stewardship'], 0.8614798188209534)","('NON-ESG', 0.04360282048583031)","('NON-ESG', 0.01649308204650879)"
Line 650,"12 In 2021, we  began work to establish a baseline for these emissions.
","('GHG_Emissions', 0.8205920457839966)","('Air_Quality', 0.09361457824707031)","('Management_Of_Legal_And_Regulatory_Framework', 0.016130970790982246)","(['Climate Change'], 0.8205920457839966)","('NON-ESG', 0.09361457824707031)","('NON-ESG', 0.016130970790982246)"
Line 651,"This work was performed by the company ERM, which completed a baseline using the composite method.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2800297737121582)","('Competitive_Behavior', 0.12019334733486176)","('Systemic_Risk_Management', 0.07815807312726974)","('NON-ESG', 0.2800297737121582)","('NON-ESG', 0.12019334733486176)","('NON-ESG', 0.07815807312726974)"
Line 652,"For further information about the methodology used, please refer to the Scope 3 data table.
","('Management_Of_Legal_And_Regulatory_Framework', 0.28916850686073303)","('Access_And_Affordability', 0.10170005261898041)","('GHG_Emissions', 0.06296006590127945)","('NON-ESG', 0.28916850686073303)","('NON-ESG', 0.10170005261898041)","('NON-ESG', 0.06296006590127945)"
Line 653,"We have calculated our baseline to be 3,007,771 metric tonnes of CO 2e.
","('GHG_Emissions', 0.5476685762405396)","('Energy_Management', 0.11330989003181458)","('Management_Of_Legal_And_Regulatory_Framework', 0.0772957056760788)","(['Climate Change'], 0.5476685762405396)","('NON-ESG', 0.11330989003181458)","('NON-ESG', 0.0772957056760788)"
Line 654,"We are working to establish a science-based target for this category as part of our commitment to the UN Race to Zero.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9176338911056519)","('Competitive_Behavior', 0.01041287463158369)","('Human_Rights_And_Community_Relations', 0.008228857070207596)","(['Human Capital Development'], 0.9176338911056519)","('NON-ESG', 0.01041287463158369)","('NON-ESG', 0.008228857070207596)"
Line 655,"We anticipate that this goal will be confirmed and verified in 2023 alongside our other Scope 3 category goals.Sustainable products and services BD’s efforts to introduce more sustainable solutions across our products and  services stretch to include our relationship with our suppliers and the things we purchase.
","('Product_Design_And_Lifecycle_Management', 0.9683657884597778)","('Product_Quality_And_Safety', 0.003746152389794588)","('Selling_Practices_And_Product_Labeling', 0.002589816926047206)","(['Product Stewardship'], 0.9683657884597778)","('NON-ESG', 0.003746152389794588)","('NON-ESG', 0.002589816926047206)"
Line 656,"We work collaboratively with our suppliers to identify solutions to help them to reduce emissions or introduce innovative, sustainability-focused solutions to the purchases we make.
","('Supply_Chain_Management', 0.5132138729095459)","('GHG_Emissions', 0.1779794991016388)","('Energy_Management', 0.05612630397081375)","(['Supply Chain Management'], 0.5132138729095459)","('NON-ESG', 0.1779794991016388)","('NON-ESG', 0.05612630397081375)"
Line 657,"We have equipped our Procurement team with the tools to help them to understand how their choices impact emissions—both Category 1 emissions and those across the company.
","('GHG_Emissions', 0.5964377522468567)","('Air_Quality', 0.271153062582016)","('Energy_Management', 0.02660534903407097)","(['Climate Change'], 0.5964377522468567)","('NON-ESG', 0.271153062582016)","('NON-ESG', 0.02660534903407097)"
Line 658,"Furthermore, our procurement associates actively seek to implement strategies  that drive sustainability—both in the impact of our purchased goods and services and in other categories.
","('Product_Design_And_Lifecycle_Management', 0.9524001479148865)","('Energy_Management', 0.005116843152791262)","('Supply_Chain_Management', 0.0049094040878117085)","(['Product Stewardship'], 0.9524001479148865)","('NON-ESG', 0.005116843152791262)","('NON-ESG', 0.0049094040878117085)"
Line 659,"For instance, we work toward driving greener fleet usage, which impacts what we buy and also the emissions from those vehicles.
","('Air_Quality', 0.5370085835456848)","('Energy_Management', 0.2239709049463272)","('GHG_Emissions', 0.09796611219644547)","(['Operational Eco-Efficiency'], 0.5370085835456848)","('NON-ESG', 0.2239709049463272)","('NON-ESG', 0.09796611219644547)"
Line 660,"Not only do we seek to buy more sustainable materials, we are strategic about where we buy when possible, focusing on best-country sourcing.
","('Product_Design_And_Lifecycle_Management', 0.8569276332855225)","('Supply_Chain_Management', 0.044632308185100555)","('Energy_Management', 0.01671661250293255)","(['Product Stewardship'], 0.8569276332855225)","('NON-ESG', 0.044632308185100555)","('NON-ESG', 0.01671661250293255)"
Line 661,"Strategy to reduce emissions As we work to establish a long-term science-based goal with interim targets, we can also work in parallel to achieve reductions.
","('GHG_Emissions', 0.8014639616012573)","('Air_Quality', 0.07759697735309601)","('Energy_Management', 0.03531843051314354)","(['Climate Change'], 0.8014639616012573)","('NON-ESG', 0.07759697735309601)","('NON-ESG', 0.03531843051314354)"
Line 662,"To do so, we  have built a strategy that includes internal and external engagement and collaboration.
","('Human_Rights_And_Community_Relations', 0.23973223567008972)","('Business_Model_Resilience', 0.1863795965909958)","('Management_Of_Legal_And_Regulatory_Framework', 0.0969056487083435)","('NON-ESG', 0.23973223567008972)","('NON-ESG', 0.1863795965909958)","('NON-ESG', 0.0969056487083435)"
Line 663,"Internally, we are developing a number of tools for BD associates to better engage with, quantify and understand the carbon impact of their  projects.
","('GHG_Emissions', 0.46783608198165894)","('Physical_Impacts_Of_Climate_Change', 0.15972329676151276)","('Ecological_Impacts', 0.0532250814139843)","('NON-ESG', 0.46783608198165894)","('NON-ESG', 0.15972329676151276)","('NON-ESG', 0.0532250814139843)"
Line 664,"This is paired with an ongoing effort to educate associates about emissions and the impact of the purchasing decisions they make; it is not just what we buy that impacts our emissions, but also how  we buy it.
","('Air_Quality', 0.5851579308509827)","('GHG_Emissions', 0.17982909083366394)","('Energy_Management', 0.11355613172054291)","(['Operational Eco-Efficiency'], 0.5851579308509827)","('NON-ESG', 0.17982909083366394)","('NON-ESG', 0.11355613172054291)"
Line 665,"Externally, we are mapping our suppliers to understand their efforts to reduce their own emissions and collect their emissions data.
","('GHG_Emissions', 0.6208332180976868)","('Air_Quality', 0.2335817813873291)","('Energy_Management', 0.03095126338303089)","(['Climate Change'], 0.6208332180976868)","('NON-ESG', 0.2335817813873291)","('NON-ESG', 0.03095126338303089)"
Line 666,"Those suppliers that demonstrate leading practices will be leveraged to identify potential projects that we can work on collaboratively to further reduce emissions.
","('GHG_Emissions', 0.3886141777038574)","('Supply_Chain_Management', 0.28145065903663635)","('Energy_Management', 0.08187337964773178)","('NON-ESG', 0.3886141777038574)","('NON-ESG', 0.28145065903663635)","('NON-ESG', 0.08187337964773178)"
Line 667,"Suppliers that have not yet measured baselines or set reduction goals will be offered assistance in trainings and mentorships with the aim of moving them toward setting their own science-based targets.
","('Supply_Chain_Management', 0.6157782673835754)","('GHG_Emissions', 0.10894972831010818)","('Selling_Practices_And_Product_Labeling', 0.02714119479060173)","(['Supply Chain Management'], 0.6157782673835754)","('NON-ESG', 0.10894972831010818)","('NON-ESG', 0.02714119479060173)"
Line 668,"12As defined by the Greenhouse Gas Protocol.Transparency BD recognizes that much of our work across our supply chain is supported by the work our peers are doing.
","('Supply_Chain_Management', 0.4192011058330536)","('GHG_Emissions', 0.38291916251182556)","('Physical_Impacts_Of_Climate_Change', 0.02273714169859886)","('NON-ESG', 0.4192011058330536)","('NON-ESG', 0.38291916251182556)","('NON-ESG', 0.02273714169859886)"
Line 669,"For that reason, we have joined the Pharmaceutical Supply Chain Initiative, in addition to maintaining membership in working groups and peer collaboratives.
","('Supply_Chain_Management', 0.9495168328285217)","('Physical_Impacts_Of_Climate_Change', 0.00417643366381526)","('Labor_Practices', 0.0035262529272586107)","(['Supply Chain Management'], 0.9495168328285217)","('NON-ESG', 0.00417643366381526)","('NON-ESG', 0.0035262529272586107)"
Line 670,"We believe that external collaboration on the key issues addressed by our Responsible Sourcing team can magnify our impact.
","('Supply_Chain_Management', 0.5260123610496521)","('Product_Design_And_Lifecycle_Management', 0.2462507039308548)","('Business_Model_Resilience', 0.06314188987016678)","(['Supply Chain Management'], 0.5260123610496521)","('NON-ESG', 0.2462507039308548)","('NON-ESG', 0.06314188987016678)"
Line 671,"Outside of this, BD is separately engaging in peer and supplier conversations to share goals and tools and collaborate on reductions.
","('Supply_Chain_Management', 0.939635694026947)","('Labor_Practices', 0.005703699309378862)","('GHG_Emissions', 0.004530678503215313)","(['Supply Chain Management'], 0.939635694026947)","('NON-ESG', 0.005703699309378862)","('NON-ESG', 0.004530678503215313)"
Line 672,"We actively seek out opportunities to learn from best-in-class programs—both within our industry and in the wider business world.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2980625629425049)","('Access_And_Affordability', 0.21620060503482819)","('Business_Model_Resilience', 0.055864643305540085)","('NON-ESG', 0.2980625629425049)","('NON-ESG', 0.21620060503482819)","('NON-ESG', 0.055864643305540085)"
Line 673,"We are also partnering closely with our strategic customers to provide visibility and transparency in our supplier resiliency and responsible sourcing efforts.2021 ESG Report Appendices Transparency Healthy workforce and communities Product impact Climate change Introduction Responsible supply chain reported that many of these roles were filled by women, persons aged  50+ and African Americans.
","('Supply_Chain_Management', 0.8941749334335327)","('Physical_Impacts_Of_Climate_Change', 0.018381262198090553)","('Business_Model_Resilience', 0.01643078587949276)","(['Supply Chain Management'], 0.8941749334335327)","('NON-ESG', 0.018381262198090553)","('NON-ESG', 0.01643078587949276)"
Line 674,"These supported roles added wages, taxes and subsequent spend all totaling $951M in economic impact.
","('Labor_Practices', 0.9311316609382629)","('Management_Of_Legal_And_Regulatory_Framework', 0.021088173612952232)","('Director_Removal', 0.0044967192225158215)","(['Labor Practice Indicators'], 0.9311316609382629)","('NON-ESG', 0.021088173612952232)","('NON-ESG', 0.0044967192225158215)"
Line 675,"As we move forward, continued insight into our year-over-year economic  impact will help us shape how we interact with our communities in the future.
","('Human_Rights_And_Community_Relations', 0.7344778776168823)","('Business_Model_Resilience', 0.08101170510053635)","('Access_And_Affordability', 0.023058004677295685)","(['Community Relations'], 0.7344778776168823)","('NON-ESG', 0.08101170510053635)","('NON-ESG', 0.023058004677295685)"
Line 676,"The long-term goals of the Economic Impact project will allow us to demonstrate further ways in which our efforts translate into advocacy for diverse communities.
","('Human_Rights_And_Community_Relations', 0.4102286398410797)","('Employee_Engagement_Inclusion_And_Diversity', 0.3602311909198761)","('Access_And_Affordability', 0.08050458133220673)","('NON-ESG', 0.4102286398410797)","('NON-ESG', 0.3602311909198761)","('NON-ESG', 0.08050458133220673)"
Line 677,"Our impact campaign will measure various ways in which the  BD Supplier Diversity program positively affects both upstream and downstream stakeholders.
","('Supply_Chain_Management', 0.9185394048690796)","('Labor_Practices', 0.012646893039345741)","('Employee_Engagement_Inclusion_And_Diversity', 0.006263362243771553)","(['Supply Chain Management'], 0.9185394048690796)","('NON-ESG', 0.012646893039345741)","('NON-ESG', 0.006263362243771553)"
Line 678,"Effects include: •  Impact on c ommunity – increasing economic and societal inclusion; •  Impact of BD’s influenc e on suppliers to focus on economic and  societal inclusion; •  Impact of our c ustomers’ efforts to grow their own supplier diversity  programs; •  Impact on BD’s br and as a responsible corporation, raising our  visibility and establishing BD as best-practice leader.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9671559929847717)","('Human_Rights_And_Community_Relations', 0.0026919390074908733)","('Employee_Health_And_Safety', 0.00267303385771811)","(['Human Capital Development'], 0.9671559929847717)","('NON-ESG', 0.0026919390074908733)","('NON-ESG', 0.00267303385771811)"
Line 679,"We understand that improving our world starts with improving the world  for others; our work is centered on doing just that.
","('Human_Rights_And_Community_Relations', 0.5001448392868042)","('Business_Model_Resilience', 0.09016090631484985)","('Access_And_Affordability', 0.04956212639808655)","(['Community Relations'], 0.5001448392868042)","('NON-ESG', 0.09016090631484985)","('NON-ESG', 0.04956212639808655)"
Line 680,"16%151%Year-over-year Diversity  Spend Achievements14%59% 8%21% –39% –7%69% Percentage of change Percentage of eligible spend–50%0%50%100%150%200% FY21 FY20* FY19* FY18 FY17 FY16 FY15 FY14 FY130%5%10%15%20%25%30%OUR 2021 SUPPLIER DIVERSITY ,   EQUITY AND INCLUSION IMPACT within U.S. & Puerto Rico $565M spent with woman-, minority-,  veteran-, LGBT- and Disability-owned business suppliers17% spent with woman-, minority-, veteran-, LGBT- and disability owned business suppliers $1B spent with small-business suppliers31% spent with small-business suppliers 2,small and diverse-owned suppliers were partnered with * Fluctuations in div erse spend were observed in FY 2018 through FY 2020.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9734223484992981)","('Employee_Health_And_Safety', 0.002639054087921977)","('Human_Rights_And_Community_Relations', 0.0017471250612288713)","(['Human Capital Development'], 0.9734223484992981)","('NON-ESG', 0.002639054087921977)","('NON-ESG', 0.0017471250612288713)"
Line 681,"16%151%Year-over-year Diversity  Spend Achievements14%59% 8%21% –39% –7%69% Percentage of change Percentage of eligible spend–50%0%50%100%150%200% FY21 FY20* FY19* FY18 FY17 FY16 FY15 FY14 FY130%5%10%15%20%25%30%OUR 2021 SUPPLIER DIVERSITY ,   EQUITY AND INCLUSION IMPACT within U.S. & Puerto Rico $565M spent with woman-, minority-,  veteran-, LGBT- and Disability-owned business suppliers17% spent with woman-, minority-, veteran-, LGBT- and disability owned business suppliers $1B spent with small-business suppliers31% spent with small-business suppliers 2,small and diverse-owned suppliers were partnered with * Fluctuations in div erse spend were observed in FY 2018 through FY 2020.
","('Supply_Chain_Management', 0.9338124394416809)","('Labor_Practices', 0.006043975707143545)","('Water_And_Wastewater_Management', 0.005656047724187374)","(['Supply Chain Management'], 0.9338124394416809)","('NON-ESG', 0.006043975707143545)","('NON-ESG', 0.005656047724187374)"
Line 682,"This is due to   (1) the implementation and normalization of a new classification validation system;  (2) the integration of a supplier survey into our registration process for new suppliers; and (3) finalizing the merger of legacy BARD supplier and spend data into our existing systems.Supplier diversity Supplier diversity encompasses more than simply tracking spending or  “doing the right thing.” It supports our business values and objectives.
","('Supply_Chain_Management', 0.9120320081710815)","('Labor_Practices', 0.01317847054451704)","('Employee_Health_And_Safety', 0.005772352684289217)","(['Supply Chain Management'], 0.9120320081710815)","('NON-ESG', 0.01317847054451704)","('NON-ESG', 0.005772352684289217)"
Line 683,"Being committed to supplier diversity entails developing and implementing strategies that align our supply base with the diverse customers, communities and patients we serve, as well as the diverse markets we seek.
","('Supply_Chain_Management', 0.803168535232544)","('Employee_Engagement_Inclusion_And_Diversity', 0.0394139289855957)","('Labor_Practices', 0.027790425345301628)","(['Supply Chain Management'], 0.803168535232544)","('NON-ESG', 0.0394139289855957)","('NON-ESG', 0.027790425345301628)"
Line 684,"Having a successful Supplier Diversity program supports sustainable procurement efforts and is integral to how we support the economic empowerment of underutilized and underserved communities.
","('Access_And_Affordability', 0.9343199133872986)","('Product_Quality_And_Safety', 0.0068088374100625515)","('Human_Rights_And_Community_Relations', 0.005909432657063007)","(['Health Outcome Contribution'], 0.9343199133872986)","('NON-ESG', 0.0068088374100625515)","('NON-ESG', 0.005909432657063007)"
Line 685,"Further details on our Supplier Diversity program can be found on our website.Working through the challenges brought about by the COVID-19 pandemic  during the 2019 and 2020 fiscal years, we have maintained our investment in the importance of a diverse supply base.
","('Supply_Chain_Management', 0.9470201730728149)","('Labor_Practices', 0.006041820161044598)","('Product_Design_And_Lifecycle_Management', 0.004084881395101547)","(['Supply Chain Management'], 0.9470201730728149)","('NON-ESG', 0.006041820161044598)","('NON-ESG', 0.004084881395101547)"
Line 686,"We introduced the BD Diverse Supplier Inclusion Portal to assist in more accurately capturing, tracking and reporting our impact with small and diverse-owned business suppliers, both Tier 1 and Tier 2 suppliers.
","('Supply_Chain_Management', 0.9224947094917297)","('Labor_Practices', 0.00828048586845398)","('Product_Design_And_Lifecycle_Management', 0.007556841243058443)","(['Supply Chain Management'], 0.9224947094917297)","('NON-ESG', 0.00828048586845398)","('NON-ESG', 0.007556841243058443)"
Line 687,"Concurrently with our portal introduction, we extended our concerted  effort to offer the best net payment terms to small-business suppliers, both diverse- and nondiverse-owned.
","('Supply_Chain_Management', 0.747992217540741)","('Competitive_Behavior', 0.028442030772566795)","('Systemic_Risk_Management', 0.02515891194343567)","(['Supply Chain Management'], 0.747992217540741)","('NON-ESG', 0.028442030772566795)","('NON-ESG', 0.02515891194343567)"
Line 688,"Both efforts have increased accuracy in the identification of our small and diverse-owned suppliers, resulting in a more accurate picture of our diverse supply base and accomplishments, as well as our remaining opportunities.
","('Supply_Chain_Management', 0.9388648271560669)","('Product_Design_And_Lifecycle_Management', 0.005856896750628948)","('Labor_Practices', 0.005102457944303751)","(['Supply Chain Management'], 0.9388648271560669)","('NON-ESG', 0.005856896750628948)","('NON-ESG', 0.005102457944303751)"
Line 689,"Economic impact BD understands the importance of quantifying the economic impact that  our work has across the communities we serve.
","('Human_Rights_And_Community_Relations', 0.8507770299911499)","('Access_And_Affordability', 0.032284755259752274)","('Business_Model_Resilience', 0.015183462761342525)","(['Community Relations'], 0.8507770299911499)","('NON-ESG', 0.032284755259752274)","('NON-ESG', 0.015183462761342525)"
Line 690,"We’re proud to report that in FY 2020, we spent $502M with 1,660 small and diverse-owned suppliers, thereby supporting the maintenance of 1,702 jobs and the hiring of 280 additional persons.
","('Labor_Practices', 0.4667627513408661)","('Employee_Engagement_Inclusion_And_Diversity', 0.23542365431785583)","('Supply_Chain_Management', 0.063958078622818)","('NON-ESG', 0.4667627513408661)","('NON-ESG', 0.23542365431785583)","('NON-ESG', 0.063958078622818)"
Line 691,"While the intersectionality of these hires varied, it was In FY 2021, our Supplier Diversity  program spent $565M with diverse-owned business suppliers and $1B with small-business suppliers, impacting 2,766 suppliers in total.
","('Supply_Chain_Management', 0.904541552066803)","('Labor_Practices', 0.018125420436263084)","('Employee_Health_And_Safety', 0.007399523630738258)","(['Supply Chain Management'], 0.904541552066803)","('NON-ESG', 0.018125420436263084)","('NON-ESG', 0.007399523630738258)"
Line 692,"This reflects an average 33% increase in supplier diversity spend from FY 2020, across all categories of diverse-owned businesses and small business suppliers.2021 ESG Report Appendices Transparency Healthy workforce and communities Product impact Climate change Introduction Responsible supply chain Supplier resiliency program Supplier risk management is a strategic focus area for BD, where our Global  Procurement teams strive to deliver a competitive advantage.
","('Supply_Chain_Management', 0.9488442540168762)","('Physical_Impacts_Of_Climate_Change', 0.0050343237817287445)","('Business_Model_Resilience', 0.004647530149668455)","(['Supply Chain Management'], 0.9488442540168762)","('NON-ESG', 0.0050343237817287445)","('NON-ESG', 0.004647530149668455)"
Line 693,"The program has a top down directive from our CEO, Tom Polen.
","('Systemic_Risk_Management', 0.21061186492443085)","('Director_Removal', 0.18542931973934174)","('Business_Ethics', 0.1473461538553238)","('NON-ESG', 0.21061186492443085)","('NON-ESG', 0.18542931973934174)","('NON-ESG', 0.1473461538553238)"
Line 694,"It is centrally located and resourced in BD’s Global Procurement Center of Excellence, and has resources available to assist with processes, technologies and risk mitigation solutions to help deliver an agile and resilient supply chain.
","('Supply_Chain_Management', 0.9399511218070984)","('Product_Design_And_Lifecycle_Management', 0.007963734678924084)","('Business_Model_Resilience', 0.007183853071182966)","(['Supply Chain Management'], 0.9399511218070984)","('NON-ESG', 0.007963734678924084)","('NON-ESG', 0.007183853071182966)"
Line 695,"BD has developed a robust assessment process to identify both our “critical  to healthcare” and “critical to business” products.
","('Product_Design_And_Lifecycle_Management', 0.943266749382019)","('Supply_Chain_Management', 0.008513260632753372)","('Product_Quality_And_Safety', 0.006860543042421341)","(['Product Stewardship'], 0.943266749382019)","('NON-ESG', 0.008513260632753372)","('NON-ESG', 0.006860543042421341)"
Line 696,"This segmentation has enabled us to prioritize risk management best practices for not only our strategic products, but also those critical to the healthcare market.
","('Business_Model_Resilience', 0.7629155516624451)","('Systemic_Risk_Management', 0.09967144578695297)","('Supply_Chain_Management', 0.027785813435912132)","(['Codes of Business Conduct'], 0.7629155516624451)","('NON-ESG', 0.09967144578695297)","('NON-ESG', 0.027785813435912132)"
Line 697,"BD has implemented a risk management model that continues to evolve with emergent risks, while applying a consistent and robust framework across all our business units to assess, identify, prioritize, mitigate and monitor top risks.
","('Systemic_Risk_Management', 0.9400637149810791)","('Business_Model_Resilience', 0.012806829996407032)","('Physical_Impacts_Of_Climate_Change', 0.008549041114747524)","(['Risk & Crisis Management'], 0.9400637149810791)","('NON-ESG', 0.012806829996407032)","('NON-ESG', 0.008549041114747524)"
Line 698,"The program takes a quantifiable approach to assessing multiple risk factors, including direct supplier-driven risks such as operational and financial risk, as well as indirect or market-driven risks such as natural disaster and geopolitical risks.
","('Supply_Chain_Management', 0.6929782629013062)","('Systemic_Risk_Management', 0.201044499874115)","('Physical_Impacts_Of_Climate_Change', 0.02370063215494156)","(['Supply Chain Management'], 0.6929782629013062)","('NON-ESG', 0.201044499874115)","('NON-ESG', 0.02370063215494156)"
Line 699,"With over 40 discrete supplier criteria measured, sustainability and human  rights factors have a significant weighting in the BD supplier risk model.
","('Supply_Chain_Management', 0.9372206926345825)","('Labor_Practices', 0.006974197458475828)","('Product_Design_And_Lifecycle_Management', 0.005753587000072002)","(['Supply Chain Management'], 0.9372206926345825)","('NON-ESG', 0.006974197458475828)","('NON-ESG', 0.005753587000072002)"
Line 700,"The supplier assessment results in these areas directly affect the resourcing decisions for supplier engagements in risk mitigation efforts, and the results are ultimately fed back into the procurement selection approval criteria and decision-making.
","('Supply_Chain_Management', 0.9347494840621948)","('Product_Design_And_Lifecycle_Management', 0.01136000081896782)","('Business_Model_Resilience', 0.00802772305905819)","(['Supply Chain Management'], 0.9347494840621948)","('NON-ESG', 0.01136000081896782)","('NON-ESG', 0.00802772305905819)"
Line 701,"Significant investment in procurement processes and playbooks has been made in these areas, and BD continually partners with our suppliers to ensure they are also making the required investments and efforts in managing their risk and prioritizing sustainability and human rights.Prioritize Assess Due Diligence Mitigate &  Monitor LIKELIHOOD OF RISK Tiered approach by  criticality 14 Risk Domains IMPACT Business Continuity Financial: GP Impact Reputation14 RISK DOMAINSCRITICAL TO HEALTHCARE Location•  Geopolitic al •  Natur al Disaster Performance•  Quality •  Deliv ery •  C apacityFinancial•  Pric e Volatility •  % of Supplier R evenue •  F inancial HealthInformation Security•   C ybersecurity Sustainability•  Mat erial  Compliance •  En vironment •  Human RightsOper ational •  Obsolesc ence •  Single/Sole Sour ce Risk Mitigation Plans in collaboration with Businesses Risk-adjusted Category  Strategies Incident ManagementProduct Criticality Business CriticalityPhase Phase 2Phase 2Phase 1Phase 2Phase 2Phase 1Phase Phase 1Critical to healthcare  and critical to business products are those that are deemed to be significant to the delivery of care and to the strength of our businesses.
","('Supply_Chain_Management', 0.9363491535186768)","('Systemic_Risk_Management', 0.010764882899820805)","('Physical_Impacts_Of_Climate_Change', 0.005948216654360294)","(['Supply Chain Management'], 0.9363491535186768)","('NON-ESG', 0.010764882899820805)","('NON-ESG', 0.005948216654360294)"
Line 702,"Significant investment in procurement processes and playbooks has been made in these areas, and BD continually partners with our suppliers to ensure they are also making the required investments and efforts in managing their risk and prioritizing sustainability and human rights.Prioritize Assess Due Diligence Mitigate &  Monitor LIKELIHOOD OF RISK Tiered approach by  criticality 14 Risk Domains IMPACT Business Continuity Financial: GP Impact Reputation14 RISK DOMAINSCRITICAL TO HEALTHCARE Location•  Geopolitic al •  Natur al Disaster Performance•  Quality •  Deliv ery •  C apacityFinancial•  Pric e Volatility •  % of Supplier R evenue •  F inancial HealthInformation Security•   C ybersecurity Sustainability•  Mat erial  Compliance •  En vironment •  Human RightsOper ational •  Obsolesc ence •  Single/Sole Sour ce Risk Mitigation Plans in collaboration with Businesses Risk-adjusted Category  Strategies Incident ManagementProduct Criticality Business CriticalityPhase Phase 2Phase 2Phase 1Phase 2Phase 2Phase 1Phase Phase 1Critical to healthcare  and critical to business products are those that are deemed to be significant to the delivery of care and to the strength of our businesses.
","('Systemic_Risk_Management', 0.5119556784629822)","('Supply_Chain_Management', 0.3029555082321167)","('Business_Model_Resilience', 0.0509093813598156)","(['Risk & Crisis Management'], 0.5119556784629822)","('NON-ESG', 0.3029555082321167)","('NON-ESG', 0.0509093813598156)"
Line 703,"Significant investment in procurement processes and playbooks has been made in these areas, and BD continually partners with our suppliers to ensure they are also making the required investments and efforts in managing their risk and prioritizing sustainability and human rights.Prioritize Assess Due Diligence Mitigate &  Monitor LIKELIHOOD OF RISK Tiered approach by  criticality 14 Risk Domains IMPACT Business Continuity Financial: GP Impact Reputation14 RISK DOMAINSCRITICAL TO HEALTHCARE Location•  Geopolitic al •  Natur al Disaster Performance•  Quality •  Deliv ery •  C apacityFinancial•  Pric e Volatility •  % of Supplier R evenue •  F inancial HealthInformation Security•   C ybersecurity Sustainability•  Mat erial  Compliance •  En vironment •  Human RightsOper ational •  Obsolesc ence •  Single/Sole Sour ce Risk Mitigation Plans in collaboration with Businesses Risk-adjusted Category  Strategies Incident ManagementProduct Criticality Business CriticalityPhase Phase 2Phase 2Phase 1Phase 2Phase 2Phase 1Phase Phase 1Critical to healthcare  and critical to business products are those that are deemed to be significant to the delivery of care and to the strength of our businesses.
","('Product_Design_And_Lifecycle_Management', 0.9422451853752136)","('Customer_Welfare', 0.008715743198990822)","('Product_Quality_And_Safety', 0.006773075088858604)","(['Product Stewardship'], 0.9422451853752136)","('NON-ESG', 0.008715743198990822)","('NON-ESG', 0.006773075088858604)"
Line 704,"With the exponential growth in supply chain constraints and disruptions, BD  continues to invest in and build leading-edge capabilities to include the leveraging of artificial intelligence and advanced analytics services that are capable of identifying and monitoring our sub-tier supply chain network, and those supply chain distribution lanes.
","('Supply_Chain_Management', 0.9520153403282166)","('Systemic_Risk_Management', 0.004288839176297188)","('Labor_Practices', 0.004094863310456276)","(['Supply Chain Management'], 0.9520153403282166)","('NON-ESG', 0.004288839176297188)","('NON-ESG', 0.004094863310456276)"
Line 705,"As data and real-world events have consistently demonstrated across numerous companies and industries of all sizes, the source of the vast majority of supply chain impacts occurs upstream from direct suppliers.
","('Supply_Chain_Management', 0.9448949098587036)","('Labor_Practices', 0.005767219699919224)","('Physical_Impacts_Of_Climate_Change', 0.004292443860322237)","(['Supply Chain Management'], 0.9448949098587036)","('NON-ESG', 0.005767219699919224)","('NON-ESG', 0.004292443860322237)"
Line 706,"By having advanced knowledge of, and visibility into, BD’s sub-supply base, we help BD supply chain teams’ ability to see further, react sooner and plan better.
","('Supply_Chain_Management', 0.9466320276260376)","('Waste_And_Hazardous_Materials_Management', 0.004467365797609091)","('Labor_Practices', 0.0037103197537362576)","(['Supply Chain Management'], 0.9466320276260376)","('NON-ESG', 0.004467365797609091)","('NON-ESG', 0.0037103197537362576)"
Line 707,"Looking forward, BD’s investment in advanced supply chain lane mapping will  support the supplier distribution and logistics capabilities, not just the supply parts availability, to be agile and resilient.
","('Supply_Chain_Management', 0.9503975510597229)","('Business_Model_Resilience', 0.0052387770265340805)","('Physical_Impacts_Of_Climate_Change', 0.004695798736065626)","(['Supply Chain Management'], 0.9503975510597229)","('NON-ESG', 0.0052387770265340805)","('NON-ESG', 0.004695798736065626)"
Line 708,"While implementation of these newer technologies is recent, BD has already leveraged these capabilities in multiple sustainability and human rights assessments and engagement efforts, at both the supplier and sub-supply tiers.2021 ESG Report Appendices Transparency Healthy workforce and communities Product impact Climate change Introduction Responsible supply chain Global supply chain BD’s products are marketed and distributed in the United States and  internationally through independent distribution channels, and directly to hospitals and other healthcare institutions by BD and independent sales representatives.
","('Supply_Chain_Management', 0.9372417330741882)","('Product_Design_And_Lifecycle_Management', 0.009767460636794567)","('Physical_Impacts_Of_Climate_Change', 0.005575690884143114)","(['Supply Chain Management'], 0.9372417330741882)","('NON-ESG', 0.009767460636794567)","('NON-ESG', 0.005575690884143114)"
Line 709,"While implementation of these newer technologies is recent, BD has already leveraged these capabilities in multiple sustainability and human rights assessments and engagement efforts, at both the supplier and sub-supply tiers.2021 ESG Report Appendices Transparency Healthy workforce and communities Product impact Climate change Introduction Responsible supply chain Global supply chain BD’s products are marketed and distributed in the United States and  internationally through independent distribution channels, and directly to hospitals and other healthcare institutions by BD and independent sales representatives.
","('Competitive_Behavior', 0.23116512596607208)","('Customer_Welfare', 0.18222106993198395)","('Systemic_Risk_Management', 0.08075292408466339)","('NON-ESG', 0.23116512596607208)","('NON-ESG', 0.18222106993198395)","('NON-ESG', 0.08075292408466339)"
Line 710,"BD uses acute care, non-acute care, laboratory and drug wholesale distributors to broadly support our overall disposable product demand from our end-user customers in the United States.
","('Product_Design_And_Lifecycle_Management', 0.8830917477607727)","('Customer_Welfare', 0.03285425528883934)","('Selling_Practices_And_Product_Labeling', 0.011749312281608582)","(['Product Stewardship'], 0.8830917477607727)","('NON-ESG', 0.03285425528883934)","('NON-ESG', 0.011749312281608582)"
Line 711,"In international markets, products are distributed either directly or through distributors, with the practice varying by country.
","('Product_Design_And_Lifecycle_Management', 0.8556424975395203)","('Selling_Practices_And_Product_Labeling', 0.05028529092669487)","('Customer_Welfare', 0.019335288554430008)","(['Product Stewardship'], 0.8556424975395203)","('NON-ESG', 0.05028529092669487)","('NON-ESG', 0.019335288554430008)"
Line 712,"In order to service our customers, optimize logistics, lower facility costs and reduce  finished goods inventory levels, we operate consolidated distribution facilities around the world.
","('Product_Design_And_Lifecycle_Management', 0.675628662109375)","('Supply_Chain_Management', 0.11537855863571167)","('Energy_Management', 0.051405780017375946)","(['Product Stewardship'], 0.675628662109375)","('NON-ESG', 0.11537855863571167)","('NON-ESG', 0.051405780017375946)"
Line 713,"Emissions – Scope 3, category 4   (upstream transportation and distribution) As our products are distributed using a variety of modalities around the world,  transportation and distribution represent a significant source of emissions.
","('Energy_Management', 0.41354459524154663)","('Product_Design_And_Lifecycle_Management', 0.15907561779022217)","('GHG_Emissions', 0.1557520478963852)","('NON-ESG', 0.41354459524154663)","('NON-ESG', 0.15907561779022217)","('NON-ESG', 0.1557520478963852)"
Line 714,"In FY 2021, we worked with the company ERM to align our greenhouse gas (GHG)  accounting practices for transportation activities with those of the Global Logistics Emissions Council (GLEC) Framework.
","('GHG_Emissions', 0.9702771902084351)","('Ecological_Impacts', 0.0040497323498129845)","('Air_Quality', 0.0027383090928196907)","(['Climate Change'], 0.9702771902084351)","('NON-ESG', 0.0040497323498129845)","('NON-ESG', 0.0027383090928196907)"
Line 715,"Specifically, GLEC Framework default emission-intensity factors in gram carbon  dioxide equivalent (gCO 2e) per tonne-kilometer (t-km) (g CO2e/t-km) were utilized  to estimate emissions from air, rail, road and sea transportation activities of finished products to the customer.
","('Air_Quality', 0.844714343547821)","('GHG_Emissions', 0.08422628790140152)","('Energy_Management', 0.012652475386857986)","(['Operational Eco-Efficiency'], 0.844714343547821)","('NON-ESG', 0.08422628790140152)","('NON-ESG', 0.012652475386857986)"
Line 716,"These transportation activities are estimated to have resulted in 317,124 tonnes CO 2e of emissions.BD assumes that it is responsible for the payment of these outbound transportation activities and, as such, the emissions are categorized as Scope 3, category 4.
","('GHG_Emissions', 0.8833497166633606)","('Air_Quality', 0.052303992211818695)","('Management_Of_Legal_And_Regulatory_Framework', 0.009364931844174862)","(['Climate Change'], 0.8833497166633606)","('NON-ESG', 0.052303992211818695)","('NON-ESG', 0.009364931844174862)"
Line 717,"This data, while estimated, will be used to set science-based targets, as part of our  commitment to the UN Race to Zero.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3897148668766022)","('Human_Rights_And_Community_Relations', 0.2522359788417816)","('Access_And_Affordability', 0.04505135491490364)","('NON-ESG', 0.3897148668766022)","('NON-ESG', 0.2522359788417816)","('NON-ESG', 0.04505135491490364)"
Line 718,"In FY 2021, we saw an increase in movement of goods by air.
","('Air_Quality', 0.9343810677528381)","('Energy_Management', 0.011607745662331581)","('Critical_Incident_Risk_Management', 0.005152212921530008)","(['Operational Eco-Efficiency'], 0.9343810677528381)","('NON-ESG', 0.011607745662331581)","('NON-ESG', 0.005152212921530008)"
Line 719,"This was driven by  shipment of products used for COVID-19 testing and by capacity challenges in the global supply chain.
","('Product_Design_And_Lifecycle_Management', 0.49501311779022217)","('Supply_Chain_Management', 0.34776413440704346)","('Energy_Management', 0.016471700742840767)","('NON-ESG', 0.49501311779022217)","('NON-ESG', 0.34776413440704346)","('NON-ESG', 0.016471700742840767)"
Line 720,"Ahead of setting science-based targets, we have begun to explore and implement improvement plans, focusing on optimizing transportation modes and routes; increasing cube utilization; and partnering with our carriers to identify opportunities.
","('Energy_Management', 0.3327488601207733)","('Business_Model_Resilience', 0.12198696285486221)","('Air_Quality', 0.052745409309864044)","('NON-ESG', 0.3327488601207733)","('NON-ESG', 0.12198696285486221)","('NON-ESG', 0.052745409309864044)"
Line 721,"For example, many of our transportation partners have been switching to more fuel-efficient vessels and trucks, and we are watching with interest the testing of sustainable aircraft fuels by airlines.
","('Energy_Management', 0.9719436764717102)","('Air_Quality', 0.003558760043233633)","('Product_Design_And_Lifecycle_Management', 0.002593484940007329)","(['Operational Eco-Efficiency'], 0.9719436764717102)","('NON-ESG', 0.003558760043233633)","('NON-ESG', 0.002593484940007329)"
Line 722,"SmartWay: BD has been a U.S. EPA Transport SmartWay® partner since  2010.
","('Business_Model_Resilience', 0.2262461632490158)","('Product_Design_And_Lifecycle_Management', 0.0884149968624115)","('Energy_Management', 0.07489749789237976)","('NON-ESG', 0.2262461632490158)","('NON-ESG', 0.0884149968624115)","('NON-ESG', 0.07489749789237976)"
Line 723,"The SmartWay transport partnership provides a framework to assess energy-efficiency and environmental impact of transportation in supply chains.
","('Energy_Management', 0.45315903425216675)","('Supply_Chain_Management', 0.37843775749206543)","('Product_Design_And_Lifecycle_Management', 0.03553302213549614)","('NON-ESG', 0.45315903425216675)","('NON-ESG', 0.37843775749206543)","('NON-ESG', 0.03553302213549614)"
Line 724,"2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Healthy   workforce and communities2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Human capital management At BD, our associates are guided by our Purpose—advancing the world of health™ — and by THE BD WAY, a set of values that embodies our culture and values.
","('Supply_Chain_Management', 0.7661992907524109)","('Physical_Impacts_Of_Climate_Change', 0.06876932084560394)","('Systemic_Risk_Management', 0.030544588342308998)","(['Supply Chain Management'], 0.7661992907524109)","('NON-ESG', 0.06876932084560394)","('NON-ESG', 0.030544588342308998)"
Line 725,"Each  empowers our associates to contribute individuality, unique ideas and experiences to fuel innovation and better patient outcomes.
","('Access_And_Affordability', 0.3854546844959259)","('Human_Rights_And_Community_Relations', 0.12404751777648926)","('Employee_Engagement_Inclusion_And_Diversity', 0.11297807842493057)","('NON-ESG', 0.3854546844959259)","('NON-ESG', 0.12404751777648926)","('NON-ESG', 0.11297807842493057)"
Line 726,"As of September 30, 2021, BD comprised approximately 75,13 associates  located in over 62 countries.
","('Management_Of_Legal_And_Regulatory_Framework', 0.267448365688324)","('Systemic_Risk_Management', 0.12415442615747452)","('Business_Ethics', 0.06726458668708801)","('NON-ESG', 0.267448365688324)","('NON-ESG', 0.12415442615747452)","('NON-ESG', 0.06726458668708801)"
Line 727,"Attracting, developing and retaining talented people  in technical, marketing, sales, research and other positions is crucial to executing our strategy and to our ability to compete effectively in a highly competitive medical technology industry.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5199148058891296)","('Business_Model_Resilience', 0.11661604046821594)","('Competitive_Behavior', 0.09580814093351364)","(['Human Capital Development'], 0.5199148058891296)","('NON-ESG', 0.11661604046821594)","('NON-ESG', 0.09580814093351364)"
Line 728,"Our ability to recruit and retain such talent depends on several factors, including compensation and benefits, talent development and career opportunities, and our unique culture.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9625016450881958)","('Employee_Health_And_Safety', 0.004465731792151928)","('Human_Rights_And_Community_Relations', 0.0021631710696965456)","(['Human Capital Development'], 0.9625016450881958)","('NON-ESG', 0.004465731792151928)","('NON-ESG', 0.0021631710696965456)"
Line 729,"To that end, we continually invest in our associates in order to be an employer of choice.
","('Competitive_Behavior', 0.23562121391296387)","('Customer_Welfare', 0.08767016977071762)","('Employee_Engagement_Inclusion_And_Diversity', 0.06671910732984543)","('NON-ESG', 0.23562121391296387)","('NON-ESG', 0.08767016977071762)","('NON-ESG', 0.06671910732984543)"
Line 730,"13Just prior to the spin of embecta, we had over 77,000 associates.
","('Systemic_Risk_Management', 0.5364483594894409)","('Business_Model_Resilience', 0.09397957473993301)","('Director_Removal', 0.0573754720389843)","(['Risk & Crisis Management'], 0.5364483594894409)","('NON-ESG', 0.09397957473993301)","('NON-ESG', 0.0573754720389843)"
Line 731,"35% North America28% Latin America 22% EMEA15% Greater Asia2030+ impact area: healthy workforce and communities Our associates, by regionBD commitment and goals  Our commitment: Maintain a healthy and thriving workforce that cultivates our culture of inclusion, safety and well-being and contributes to community health.2030 goals: 1  We will provide tools and resources to empower our workforce in managing their physical, mental and financial health.2  We will proactively manage the needs of our future workforce through training, development and reskilling strategies.3  We will foster our culture of inclusion, safety and well-being, and contribute to the global communities  in which we operate and serve, by: •  Impr oving ethnic and gender diversity by 1% year over year at the management and executive levels; •  De veloping servant leaders and exemplifying THE BD WAY; •  Ensuring equal pay (b y gender) worldwide; and •  P aying competitive market rates and utilizing living-wage assessments in key regions or countries to inform  wage strategies.2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Human capital development At BD, we are focused on creating an environment where associates feel supported in their performance, growth and development in all stages of their careers.
","('Employee_Health_And_Safety', 0.9411123991012573)","('Employee_Engagement_Inclusion_And_Diversity', 0.013312350027263165)","('Access_And_Affordability', 0.00673585943877697)","(['Operational Eco-Efficiency'], 0.9411123991012573)","('NON-ESG', 0.013312350027263165)","('NON-ESG', 0.00673585943877697)"
Line 732,"35% North America28% Latin America 22% EMEA15% Greater Asia2030+ impact area: healthy workforce and communities Our associates, by regionBD commitment and goals  Our commitment: Maintain a healthy and thriving workforce that cultivates our culture of inclusion, safety and well-being and contributes to community health.2030 goals: 1  We will provide tools and resources to empower our workforce in managing their physical, mental and financial health.2  We will proactively manage the needs of our future workforce through training, development and reskilling strategies.3  We will foster our culture of inclusion, safety and well-being, and contribute to the global communities  in which we operate and serve, by: •  Impr oving ethnic and gender diversity by 1% year over year at the management and executive levels; •  De veloping servant leaders and exemplifying THE BD WAY; •  Ensuring equal pay (b y gender) worldwide; and •  P aying competitive market rates and utilizing living-wage assessments in key regions or countries to inform  wage strategies.2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Human capital development At BD, we are focused on creating an environment where associates feel supported in their performance, growth and development in all stages of their careers.
","('Employee_Engagement_Inclusion_And_Diversity', 0.975207507610321)","('Human_Rights_And_Community_Relations', 0.0021430260967463255)","('Employee_Health_And_Safety', 0.0018833798822015524)","(['Human Capital Development'], 0.975207507610321)","('NON-ESG', 0.0021430260967463255)","('NON-ESG', 0.0018833798822015524)"
Line 733,"35% North America28% Latin America 22% EMEA15% Greater Asia2030+ impact area: healthy workforce and communities Our associates, by regionBD commitment and goals  Our commitment: Maintain a healthy and thriving workforce that cultivates our culture of inclusion, safety and well-being and contributes to community health.2030 goals: 1  We will provide tools and resources to empower our workforce in managing their physical, mental and financial health.2  We will proactively manage the needs of our future workforce through training, development and reskilling strategies.3  We will foster our culture of inclusion, safety and well-being, and contribute to the global communities  in which we operate and serve, by: •  Impr oving ethnic and gender diversity by 1% year over year at the management and executive levels; •  De veloping servant leaders and exemplifying THE BD WAY; •  Ensuring equal pay (b y gender) worldwide; and •  P aying competitive market rates and utilizing living-wage assessments in key regions or countries to inform  wage strategies.2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Human capital development At BD, we are focused on creating an environment where associates feel supported in their performance, growth and development in all stages of their careers.
","('Supply_Chain_Management', 0.5665357708930969)","('Physical_Impacts_Of_Climate_Change', 0.26588642597198486)","('Business_Model_Resilience', 0.03343058377504349)","(['Supply Chain Management'], 0.5665357708930969)","('NON-ESG', 0.26588642597198486)","('NON-ESG', 0.03343058377504349)"
Line 734,"Our Talent@BD Center of Excellence is focused on growing and enabling talent through career  development initiatives, mentoring, targeted leadership development and learning programs for all associates via our BD University.
","('Employee_Engagement_Inclusion_And_Diversity', 0.934808611869812)","('Employee_Health_And_Safety', 0.006644303910434246)","('Access_And_Affordability', 0.006373080890625715)","(['Human Capital Development'], 0.934808611869812)","('NON-ESG', 0.006644303910434246)","('NON-ESG', 0.006373080890625715)"
Line 735,"We have developed a career growth cycle centered around our Purpose—advancing the world of health™—that outlines critical moments in an associate’s career and is designed to empower continuous growth: INSPIRE AND HIRE  (Talent Acquisition) Align to our Purpose and share  stories about your work to  attract and motivate internal  and external talent; hire fairly  based on capability, need  and aspirationsWELCOME AND ENABLE  (Onboarding) Celebrate differences; consciously  include new team members;  participate in onboarding experiences  that enable team integration and  support effectivenessCAREER PLANNING  (Career Blueprint) Create a Career Blueprint utilizing  manager/associate conversations  that identify building blocks to  achieve both career aspirations  and business goalsPERFORM  (Performance @ BD) Connect for growth: set impactful  goals, collaborate with team members  and drive yourself and the business  forward by delivering on objectives  rooted in strategy and cultureBUILD CAPABILITIES  (BD University + Functional Training) Continuously grow through varied  on-the-job projects, support networks  and learning curriculum—guided by  performance feedback and the Career  Blueprint action planSMOOTH TRANSITION  (Succession Planning) Continue to move into new roles,  experiences and life stages to  broaden perspective, uncover  diversity of thought and broaden  associates network Career growth cycle2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities In addition to the career growth cycle, each of BD’s business, regional and central  teams refreshes its Strategic Organizational Plan (SOP) annually.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9315422773361206)","('Business_Model_Resilience', 0.006896687671542168)","('Employee_Health_And_Safety', 0.005798121448606253)","(['Human Capital Development'], 0.9315422773361206)","('NON-ESG', 0.006896687671542168)","('NON-ESG', 0.005798121448606253)"
Line 736,"We have developed a career growth cycle centered around our Purpose—advancing the world of health™—that outlines critical moments in an associate’s career and is designed to empower continuous growth: INSPIRE AND HIRE  (Talent Acquisition) Align to our Purpose and share  stories about your work to  attract and motivate internal  and external talent; hire fairly  based on capability, need  and aspirationsWELCOME AND ENABLE  (Onboarding) Celebrate differences; consciously  include new team members;  participate in onboarding experiences  that enable team integration and  support effectivenessCAREER PLANNING  (Career Blueprint) Create a Career Blueprint utilizing  manager/associate conversations  that identify building blocks to  achieve both career aspirations  and business goalsPERFORM  (Performance @ BD) Connect for growth: set impactful  goals, collaborate with team members  and drive yourself and the business  forward by delivering on objectives  rooted in strategy and cultureBUILD CAPABILITIES  (BD University + Functional Training) Continuously grow through varied  on-the-job projects, support networks  and learning curriculum—guided by  performance feedback and the Career  Blueprint action planSMOOTH TRANSITION  (Succession Planning) Continue to move into new roles,  experiences and life stages to  broaden perspective, uncover  diversity of thought and broaden  associates network Career growth cycle2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities In addition to the career growth cycle, each of BD’s business, regional and central  teams refreshes its Strategic Organizational Plan (SOP) annually.
","('Employee_Engagement_Inclusion_And_Diversity', 0.783650815486908)","('Business_Model_Resilience', 0.0385034903883934)","('Product_Design_And_Lifecycle_Management', 0.02233581244945526)","(['Human Capital Development'], 0.783650815486908)","('NON-ESG', 0.0385034903883934)","('NON-ESG', 0.02233581244945526)"
Line 737,"We have developed a career growth cycle centered around our Purpose—advancing the world of health™—that outlines critical moments in an associate’s career and is designed to empower continuous growth: INSPIRE AND HIRE  (Talent Acquisition) Align to our Purpose and share  stories about your work to  attract and motivate internal  and external talent; hire fairly  based on capability, need  and aspirationsWELCOME AND ENABLE  (Onboarding) Celebrate differences; consciously  include new team members;  participate in onboarding experiences  that enable team integration and  support effectivenessCAREER PLANNING  (Career Blueprint) Create a Career Blueprint utilizing  manager/associate conversations  that identify building blocks to  achieve both career aspirations  and business goalsPERFORM  (Performance @ BD) Connect for growth: set impactful  goals, collaborate with team members  and drive yourself and the business  forward by delivering on objectives  rooted in strategy and cultureBUILD CAPABILITIES  (BD University + Functional Training) Continuously grow through varied  on-the-job projects, support networks  and learning curriculum—guided by  performance feedback and the Career  Blueprint action planSMOOTH TRANSITION  (Succession Planning) Continue to move into new roles,  experiences and life stages to  broaden perspective, uncover  diversity of thought and broaden  associates network Career growth cycle2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities In addition to the career growth cycle, each of BD’s business, regional and central  teams refreshes its Strategic Organizational Plan (SOP) annually.
","('Physical_Impacts_Of_Climate_Change', 0.5167731046676636)","('Supply_Chain_Management', 0.31121760606765747)","('Business_Model_Resilience', 0.03412957862019539)","(['Climate Change'], 0.5167731046676636)","('NON-ESG', 0.31121760606765747)","('NON-ESG', 0.03412957862019539)"
Line 738,"We have developed a career growth cycle centered around our Purpose—advancing the world of health™—that outlines critical moments in an associate’s career and is designed to empower continuous growth: INSPIRE AND HIRE  (Talent Acquisition) Align to our Purpose and share  stories about your work to  attract and motivate internal  and external talent; hire fairly  based on capability, need  and aspirationsWELCOME AND ENABLE  (Onboarding) Celebrate differences; consciously  include new team members;  participate in onboarding experiences  that enable team integration and  support effectivenessCAREER PLANNING  (Career Blueprint) Create a Career Blueprint utilizing  manager/associate conversations  that identify building blocks to  achieve both career aspirations  and business goalsPERFORM  (Performance @ BD) Connect for growth: set impactful  goals, collaborate with team members  and drive yourself and the business  forward by delivering on objectives  rooted in strategy and cultureBUILD CAPABILITIES  (BD University + Functional Training) Continuously grow through varied  on-the-job projects, support networks  and learning curriculum—guided by  performance feedback and the Career  Blueprint action planSMOOTH TRANSITION  (Succession Planning) Continue to move into new roles,  experiences and life stages to  broaden perspective, uncover  diversity of thought and broaden  associates network Career growth cycle2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities In addition to the career growth cycle, each of BD’s business, regional and central  teams refreshes its Strategic Organizational Plan (SOP) annually.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7969213128089905)","('Human_Rights_And_Community_Relations', 0.04720252752304077)","('Business_Model_Resilience', 0.030147859826683998)","(['Human Capital Development'], 0.7969213128089905)","('NON-ESG', 0.04720252752304077)","('NON-ESG', 0.030147859826683998)"
Line 739,"At BD, the SOP is a tool used for a critical, forward-looking process to evaluate BD’s workforce and organization of today against the talent and capability needs of tomorrow, in line with our strategic objectives.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9285538196563721)","('Business_Model_Resilience', 0.00914410687983036)","('Employee_Health_And_Safety', 0.00709580909460783)","(['Human Capital Development'], 0.9285538196563721)","('NON-ESG', 0.00914410687983036)","('NON-ESG', 0.00709580909460783)"
Line 740,"The SOP helps to create a talent strategy that builds and develops our associates’ capabilities now to enable us to deliver in the future.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7289832830429077)","('Business_Model_Resilience', 0.08240441977977753)","('Systemic_Risk_Management', 0.01911511830985546)","(['Human Capital Development'], 0.7289832830429077)","('NON-ESG', 0.08240441977977753)","('NON-ESG', 0.01911511830985546)"
Line 741,"This process is designed to allow BD to capture and proactively address potential areas of human capital risk and/or retention needs, and to provide long-term career paths for our associates.
","('Business_Model_Resilience', 0.604649007320404)","('Systemic_Risk_Management', 0.10786977410316467)","('Employee_Engagement_Inclusion_And_Diversity', 0.10481345653533936)","(['Codes of Business Conduct'], 0.604649007320404)","('NON-ESG', 0.10786977410316467)","('NON-ESG', 0.10481345653533936)"
Line 742,"This work culminates in annual CEO Organization Review discussions, where  business leaders and senior HR business partners discuss and refine these plans and key associate development action items directly with the CEO, chief people officer and talent management leadership.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8527363538742065)","('Business_Model_Resilience', 0.02865130454301834)","('Human_Rights_And_Community_Relations', 0.01103808544576168)","(['Human Capital Development'], 0.8527363538742065)","('NON-ESG', 0.02865130454301834)","('NON-ESG', 0.01103808544576168)"
Line 743,"Enterprise themes from these plans and discussions are aggregated and shared with our Executive Leadership team and Board of Directors so that we are having the appropriate conversations on talent and, as leaders, are helping to mitigate any obstacles to achieving desired outcomes for our associates and the customers and patients we serve.
","('Director_Removal', 0.2608441114425659)","('Employee_Engagement_Inclusion_And_Diversity', 0.18238070607185364)","('Business_Model_Resilience', 0.13504095375537872)","('NON-ESG', 0.2608441114425659)","('NON-ESG', 0.18238070607185364)","('NON-ESG', 0.13504095375537872)"
Line 744,"In preparation for the SOP , BD also conducts regular talent reviews.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8067423701286316)","('Product_Quality_And_Safety', 0.01491408422589302)","('Business_Ethics', 0.014709281735122204)","(['Human Capital Development'], 0.8067423701286316)","('NON-ESG', 0.01491408422589302)","('NON-ESG', 0.014709281735122204)"
Line 745,"These are  focused sessions designed to review, discuss and commit to development, capability and succession planning for the talent needed to deliver on current and future business objectives.
","('Business_Model_Resilience', 0.28712189197540283)","('Employee_Engagement_Inclusion_And_Diversity', 0.11081553995609283)","('Management_Of_Legal_And_Regulatory_Framework', 0.09358572959899902)","('NON-ESG', 0.28712189197540283)","('NON-ESG', 0.11081553995609283)","('NON-ESG', 0.09358572959899902)"
Line 746,"During these sessions, we evaluate our succession pipeline health, and our ongoing commitment to diverse representation across positions and succession slates, and seek specific opportunities and plans to drive the movement, development and growth of our associates.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8080282211303711)","('Competitive_Behavior', 0.03350197896361351)","('Business_Model_Resilience', 0.028308523818850517)","(['Human Capital Development'], 0.8080282211303711)","('NON-ESG', 0.03350197896361351)","('NON-ESG', 0.028308523818850517)"
Line 747,"We also identify individuals with differentiated potential and connect them with additional learning experiences called career accelerator programs to further support their growth and the achievement of their career aspirations.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8495449423789978)","('Access_And_Affordability', 0.020116014406085014)","('Business_Model_Resilience', 0.01190673466771841)","(['Human Capital Development'], 0.8495449423789978)","('NON-ESG', 0.020116014406085014)","('NON-ESG', 0.01190673466771841)"
Line 748,"We encourage and train our people leaders on having ongoing discussions with their associates where rich development plans can be built and advanced, with the support of near-term feedback and coaching.
","('Employee_Engagement_Inclusion_And_Diversity', 0.32168349623680115)","('Human_Rights_And_Community_Relations', 0.1323399692773819)","('Business_Model_Resilience', 0.12962433695793152)","('NON-ESG', 0.32168349623680115)","('NON-ESG', 0.1323399692773819)","('NON-ESG', 0.12962433695793152)"
Line 749,"We have a deeply rooted practice of investing in our next generation of leaders  and offer a number of leadership development programs.
","('Employee_Engagement_Inclusion_And_Diversity', 0.611424446105957)","('Business_Model_Resilience', 0.09476519376039505)","('Director_Removal', 0.04255199059844017)","(['Human Capital Development'], 0.611424446105957)","('NON-ESG', 0.09476519376039505)","('NON-ESG', 0.04255199059844017)"
Line 750,"The early career programs are dedicated to specific areas, such as finance and technology, and they serve to introduce new talent into BD, while other programs focus on building specific leadership skills to promote a healthy succession pipeline at the director and above levels.
","('Employee_Engagement_Inclusion_And_Diversity', 0.933733344078064)","('Business_Model_Resilience', 0.006672753486782312)","('Employee_Health_And_Safety', 0.005344677250832319)","(['Human Capital Development'], 0.933733344078064)","('NON-ESG', 0.006672753486782312)","('NON-ESG', 0.005344677250832319)"
Line 751,"We offer associates and their managers several tools to help in their personal and professional development, including career development plans, mentoring programs and in-house learning opportunities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.842835545539856)","('Access_And_Affordability', 0.03126034140586853)","('Human_Rights_And_Community_Relations', 0.014195065014064312)","(['Human Capital Development'], 0.842835545539856)","('NON-ESG', 0.03126034140586853)","('NON-ESG', 0.014195065014064312)"
Line 752,"This includes BD University (BDU), our in-house continuing education program, which follows a ""leaders-as-teachers"" approach.
","('Access_And_Affordability', 0.4540136158466339)","('Employee_Engagement_Inclusion_And_Diversity', 0.23499752581119537)","('Ecological_Impacts', 0.028568707406520844)","('NON-ESG', 0.4540136158466339)","('NON-ESG', 0.23499752581119537)","('NON-ESG', 0.028568707406520844)"
Line 753,"For 20 years, BDU has helped shape a culture of continuous learning aligned with company strategic goals.
","('Business_Model_Resilience', 0.6654927730560303)","('Product_Design_And_Lifecycle_Management', 0.06174006685614586)","('Employee_Engagement_Inclusion_And_Diversity', 0.04126530513167381)","(['Codes of Business Conduct'], 0.6654927730560303)","('NON-ESG', 0.06174006685614586)","('NON-ESG', 0.04126530513167381)"
Line 754,"Our learning philosophy follows a 60-20-20 rule: 60%  of learning on the job20%  through coaching and mentoring20%  coming from formal training BD University has implemented several new approaches and programs designed to meet the new and emerging needs of our associates, managers and leaders.
","('Employee_Engagement_Inclusion_And_Diversity', 0.4357946515083313)","('Access_And_Affordability', 0.22428619861602783)","('Human_Rights_And_Community_Relations', 0.04116375744342804)","('NON-ESG', 0.4357946515083313)","('NON-ESG', 0.22428619861602783)","('NON-ESG', 0.04116375744342804)"
Line 755,"We launched a robust digital and virtual learning curriculum for our associates, who are now working in a hybrid environment.
","('Access_And_Affordability', 0.5551694631576538)","('Employee_Engagement_Inclusion_And_Diversity', 0.13165010511875153)","('Ecological_Impacts', 0.03181957080960274)","(['Health Outcome Contribution'], 0.5551694631576538)","('NON-ESG', 0.13165010511875153)","('NON-ESG', 0.03181957080960274)"
Line 756,"We began an organization-wide rollout of growth-mindset training to foster the belief that qualities and talents can be developed through dedication and hard work.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6084077954292297)","('Human_Rights_And_Community_Relations', 0.0630565881729126)","('Employee_Health_And_Safety', 0.056827835738658905)","(['Human Capital Development'], 0.6084077954292297)","('NON-ESG', 0.0630565881729126)","('NON-ESG', 0.056827835738658905)"
Line 757,"This year, we launched new flagship programs to help our more than 8,000 people managers become more effective, and create work environments that facilitate growth and success.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6603663563728333)","('Business_Model_Resilience', 0.05830061063170433)","('Employee_Health_And_Safety', 0.033303599804639816)","(['Human Capital Development'], 0.6603663563728333)","('NON-ESG', 0.05830061063170433)","('NON-ESG', 0.033303599804639816)"
Line 758,"We have, in addition, conducted several virtual programs for our executive leaders to support them in their roles as company leaders who are responsible for navigating the new leadership challenges presented by the pandemic.
","('Business_Model_Resilience', 0.4614049196243286)","('Systemic_Risk_Management', 0.16946561634540558)","('Employee_Engagement_Inclusion_And_Diversity', 0.10014715045690536)","('NON-ESG', 0.4614049196243286)","('NON-ESG', 0.16946561634540558)","('NON-ESG', 0.10014715045690536)"
Line 759,"In particular, our emphasis has been on servant leadership, a philosophy that we believe will enable leaders to unleash the potential of the organization by focusing on the growth and well-being of our associates so that they will be empowered to develop, perform and thrive while meeting business objectives.
","('Business_Model_Resilience', 0.3308502435684204)","('Human_Rights_And_Community_Relations', 0.17557193338871002)","('Employee_Engagement_Inclusion_And_Diversity', 0.15871764719486237)","('NON-ESG', 0.3308502435684204)","('NON-ESG', 0.17557193338871002)","('NON-ESG', 0.15871764719486237)"
Line 760,"BD is committed to creating an inclusive environment, and promoting a culture of  ongoing feedback, continuous performance conversations and forward-focused development discussions aligned with our cultural principles.
","('Human_Rights_And_Community_Relations', 0.614456832408905)","('Employee_Engagement_Inclusion_And_Diversity', 0.1708485186100006)","('Access_And_Affordability', 0.04918334260582924)","(['Community Relations'], 0.614456832408905)","('NON-ESG', 0.1708485186100006)","('NON-ESG', 0.04918334260582924)"
Line 761,"Our journey of impact and growth begins with setting clear objectives aligned to the BD 2025 strategy and rooted in our cultural foundation.
","('Business_Model_Resilience', 0.5619142651557922)","('Human_Rights_And_Community_Relations', 0.07334709912538528)","('Employee_Engagement_Inclusion_And_Diversity', 0.06200877204537392)","(['Codes of Business Conduct'], 0.5619142651557922)","('NON-ESG', 0.07334709912538528)","('NON-ESG', 0.06200877204537392)"
Line 762,"It continues with promoting regular conversations throughout the year to help our associates grow and maximize their impact.
","('Business_Model_Resilience', 0.48043757677078247)","('Employee_Engagement_Inclusion_And_Diversity', 0.08383424580097198)","('Systemic_Risk_Management', 0.05118996277451515)","('NON-ESG', 0.48043757677078247)","('NON-ESG', 0.08383424580097198)","('NON-ESG', 0.05118996277451515)"
Line 763,"The end of the year is our opportunity to reflect upon impact and development during the year and focus on future growth and opportunity.2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Inclusion, diversity and equity We strive to make inclusion, diversity and equity (ID&E) a prominent and lived  piece of our culture.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9665288329124451)","('Human_Rights_And_Community_Relations', 0.0031406558118760586)","('Employee_Health_And_Safety', 0.0031154928728938103)","(['Human Capital Development'], 0.9665288329124451)","('NON-ESG', 0.0031406558118760586)","('NON-ESG', 0.0031154928728938103)"
Line 764,"We believe that when our associates are holistically healthy and feel included, they believe in their self-worth and feel a sense of belonging—they feel connected to people and the community.
","('Human_Rights_And_Community_Relations', 0.6461995840072632)","('Employee_Engagement_Inclusion_And_Diversity', 0.08498261868953705)","('Customer_Privacy', 0.03737923130393028)","(['Community Relations'], 0.6461995840072632)","('NON-ESG', 0.08498261868953705)","('NON-ESG', 0.03737923130393028)"
Line 765,"Supporting our associates in aspects of their personal and work lives enables them to thrive and realize their full potential.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3981661796569824)","('Human_Rights_And_Community_Relations', 0.11339236050844193)","('Business_Model_Resilience', 0.08216454833745956)","('NON-ESG', 0.3981661796569824)","('NON-ESG', 0.11339236050844193)","('NON-ESG', 0.08216454833745956)"
Line 766,"We are committed to working toward making all of our associates feel valued and find a welcoming and inviting place for their ideas—a place where they can be their authentic selves.
","('Employee_Engagement_Inclusion_And_Diversity', 0.2673225700855255)","('Employee_Health_And_Safety', 0.1246589869260788)","('Product_Design_And_Lifecycle_Management', 0.09343896806240082)","('NON-ESG', 0.2673225700855255)","('NON-ESG', 0.1246589869260788)","('NON-ESG', 0.09343896806240082)"
Line 767,"Our progress  Our ID&E foundation is built on systems, processes and tools that we use to drive action and accountability and to measure our progress toward achieving our goals.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3987002670764923)","('Human_Rights_And_Community_Relations', 0.24810762703418732)","('Business_Ethics', 0.08519401401281357)","('NON-ESG', 0.3987002670764923)","('NON-ESG', 0.24810762703418732)","('NON-ESG', 0.08519401401281357)"
Line 768,"Engagement – voice of the associate  surveys Surveying how our associates feel about working at BD is one of our best ways to  measure our success.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5708097219467163)","('Business_Model_Resilience', 0.08086554706096649)","('Human_Rights_And_Community_Relations', 0.06978798657655716)","(['Human Capital Development'], 0.5708097219467163)","('NON-ESG', 0.08086554706096649)","('NON-ESG', 0.06978798657655716)"
Line 769,"Over the last three years, we’ve been on a cultural journey to remove barriers and unleash our associates’ full potential.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7664961218833923)","('Human_Rights_And_Community_Relations', 0.08927957713603973)","('Business_Model_Resilience', 0.01458582654595375)","(['Human Capital Development'], 0.7664961218833923)","('NON-ESG', 0.08927957713603973)","('NON-ESG', 0.01458582654595375)"
Line 770,"Our voice of the associate (VoA) survey in FY 2021 showed a 95 percent improvement in responses to comparable questions from our previous engagement survey in FY 2018.
","('Management_Of_Legal_And_Regulatory_Framework', 0.1573231816291809)","('Business_Model_Resilience', 0.1386021077632904)","('Employee_Engagement_Inclusion_And_Diversity', 0.1366838812828064)","('NON-ESG', 0.1573231816291809)","('NON-ESG', 0.1386021077632904)","('NON-ESG', 0.1366838812828064)"
Line 771,"While associates have told us that culture is one of the best aspects of working at BD, our survey results clarify an overarching theme: we must empower our teams through belonging and agile decision making.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3397110104560852)","('Business_Model_Resilience', 0.13087113201618195)","('Human_Rights_And_Community_Relations', 0.11686107516288757)","('NON-ESG', 0.3397110104560852)","('NON-ESG', 0.13087113201618195)","('NON-ESG', 0.11686107516288757)"
Line 772,"Our results validate the direction we set with our strategy and show a highly committed and engaged workforce, but we still have work to do.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8498404026031494)","('Labor_Practices', 0.02618424780666828)","('Employee_Health_And_Safety', 0.020838482305407524)","(['Human Capital Development'], 0.8498404026031494)","('NON-ESG', 0.02618424780666828)","('NON-ESG', 0.020838482305407524)"
Line 773,"We will continue to use interim pulse surveys to measure our progress in executing our action plans.
","('Management_Of_Legal_And_Regulatory_Framework', 0.638619065284729)","('Human_Rights_And_Community_Relations', 0.09534342586994171)","('Physical_Impacts_Of_Climate_Change', 0.042536452412605286)","(['Corporate Governance'], 0.638619065284729)","('NON-ESG', 0.09534342586994171)","('NON-ESG', 0.042536452412605286)"
Line 774,"Equal pay and gender pay parity  We are committed to compensating our associates fairly and equitably.
","('Labor_Practices', 0.975757896900177)","('Employee_Engagement_Inclusion_And_Diversity', 0.0026433912571519613)","('Director_Removal', 0.0023105815052986145)","(['Labor Practice Indicators'], 0.975757896900177)","('NON-ESG', 0.0026433912571519613)","('NON-ESG', 0.0023105815052986145)"
Line 775,"We take  a pr oactive approach to gender and ethnic pay equity and continually monitor  our compensation programs.
","('Employee_Engagement_Inclusion_And_Diversity', 0.857087254524231)","('Labor_Practices', 0.0792936384677887)","('Human_Rights_And_Community_Relations', 0.005827595014125109)","(['Human Capital Development'], 0.857087254524231)","('NON-ESG', 0.0792936384677887)","('NON-ESG', 0.005827595014125109)"
Line 776,"Annually, we work with an independent third party to conduct a comprehensive pay equity review based on gender and ethnicity in the U.S. Our review assesses pay on a statistical basis and considers several factors that are relevant and known to impact compensation, including but not limited to tenure, role, career level and geographic differentials.
","('Labor_Practices', 0.5824788212776184)","('Employee_Engagement_Inclusion_And_Diversity', 0.3159622848033905)","('Employee_Health_And_Safety', 0.009395863860845566)","(['Labor Practice Indicators'], 0.5824788212776184)","('NON-ESG', 0.3159622848033905)","('NON-ESG', 0.009395863860845566)"
Line 777,"Where necessary and appropriate, we take action and make pay adjustments to address any inconsistencies.
","('Systemic_Risk_Management', 0.41087302565574646)","('Management_Of_Legal_And_Regulatory_Framework', 0.20996244251728058)","('Business_Ethics', 0.11616349220275879)","('NON-ESG', 0.41087302565574646)","('NON-ESG', 0.20996244251728058)","('NON-ESG', 0.11616349220275879)"
Line 778,"We believe that pay equity is critical to our success in supporting a global,  diverse and inclusive workforce.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9638330340385437)","('Labor_Practices', 0.006306011695414782)","('Employee_Health_And_Safety', 0.0029293952975422144)","(['Human Capital Development'], 0.9638330340385437)","('NON-ESG', 0.006306011695414782)","('NON-ESG', 0.0029293952975422144)"
Line 779,"We have a history of conducting targeted annual pay assessments and have committed to expanding our assessment to BD associates globally on a biennial basis.
","('Labor_Practices', 0.7755058407783508)","('Management_Of_Legal_And_Regulatory_Framework', 0.08785956352949142)","('Business_Ethics', 0.029205843806266785)","(['Labor Practice Indicators'], 0.7755058407783508)","('NON-ESG', 0.08785956352949142)","('NON-ESG', 0.029205843806266785)"
Line 780,"In 2021, we conducted a global pay equity assessment for associates in 57 countries, representing approximately 70 percent of BD’s global salaried associate population.
","('Labor_Practices', 0.718587338924408)","('Competitive_Behavior', 0.023718323558568954)","('Systemic_Risk_Management', 0.021538065746426582)","(['Labor Practice Indicators'], 0.718587338924408)","('NON-ESG', 0.023718323558568954)","('NON-ESG', 0.021538065746426582)"
Line 781,"The results showed that BD associates are paid fairly and equitably, and that, on average, both women and men are paid within a range that would be expected after controlling for legitimate differentiating factors.
","('Labor_Practices', 0.9033954739570618)","('Business_Ethics', 0.019710956141352654)","('Management_Of_Legal_And_Regulatory_Framework', 0.010167988017201424)","(['Labor Practice Indicators'], 0.9033954739570618)","('NON-ESG', 0.019710956141352654)","('NON-ESG', 0.010167988017201424)"
Line 782,"Our female associates in 2021 earned an average of 99 cents for every $1 earned by male associates in the U.S., and 98 cents globally.
","('Labor_Practices', 0.6016625761985779)","('Management_Of_Legal_And_Regulatory_Framework', 0.07837126404047012)","('Competitive_Behavior', 0.06303144991397858)","(['Labor Practice Indicators'], 0.6016625761985779)","('NON-ESG', 0.07837126404047012)","('NON-ESG', 0.06303144991397858)"
Line 783,"We consider these results as a baseline for our commitment to achieving 100 percent pay equity and remain focused on managing our compensation processes with the goal of identifying and remedying any practices that may contribute to pay gaps now or over time.
","('Labor_Practices', 0.9539068341255188)","('Employee_Engagement_Inclusion_And_Diversity', 0.004867794457823038)","('Business_Ethics', 0.00420275516808033)","(['Labor Practice Indicators'], 0.9539068341255188)","('NON-ESG', 0.004867794457823038)","('NON-ESG', 0.00420275516808033)"
Line 784,"Training We value diversity of thought in solving challenges and driving innovation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9426059722900391)","('Business_Model_Resilience', 0.005490542389452457)","('Human_Rights_And_Community_Relations', 0.0045872638002038)","(['Human Capital Development'], 0.9426059722900391)","('NON-ESG', 0.005490542389452457)","('NON-ESG', 0.0045872638002038)"
Line 785,"Learning is how we transform ourselves and the organization, by connecting to our culture and building strategic capabilities.
","('Business_Model_Resilience', 0.3826170265674591)","('Employee_Engagement_Inclusion_And_Diversity', 0.2391975075006485)","('Product_Design_And_Lifecycle_Management', 0.06130383536219597)","('NON-ESG', 0.3826170265674591)","('NON-ESG', 0.2391975075006485)","('NON-ESG', 0.06130383536219597)"
Line 786,"At BD, we believe everyone is a leader, and our culture of learning encourages and empowers all associates to reach their full potential.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6529654860496521)","('Human_Rights_And_Community_Relations', 0.07405608892440796)","('Access_And_Affordability', 0.02792070247232914)","(['Human Capital Development'], 0.6529654860496521)","('NON-ESG', 0.07405608892440796)","('NON-ESG', 0.02792070247232914)"
Line 787,"This year, in addition to our conscious-inclusion training, we also provided  supplemental micro-learnings that continue to upskill our associates on topics such as active listening, being color brave instead of color blind, inclusion through storytelling and working together when you have differences.2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Key driver goals Having representation of different dimensions of diversity globally is important to BD.
","('Human_Rights_And_Community_Relations', 0.26750943064689636)","('Supply_Chain_Management', 0.21618978679180145)","('Physical_Impacts_Of_Climate_Change', 0.17412471771240234)","('NON-ESG', 0.26750943064689636)","('NON-ESG', 0.21618978679180145)","('NON-ESG', 0.17412471771240234)"
Line 788,"This year, in addition to our conscious-inclusion training, we also provided  supplemental micro-learnings that continue to upskill our associates on topics such as active listening, being color brave instead of color blind, inclusion through storytelling and working together when you have differences.2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Key driver goals Having representation of different dimensions of diversity globally is important to BD.
","('Management_Of_Legal_And_Regulatory_Framework', 0.317760705947876)","('Systemic_Risk_Management', 0.2017131745815277)","('Access_And_Affordability', 0.0832652673125267)","('NON-ESG', 0.317760705947876)","('NON-ESG', 0.2017131745815277)","('NON-ESG', 0.0832652673125267)"
Line 789,"We value our associates  having diverse perspectives; it is what fuels the innovation needed to solve complex healthcare challenges.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9001553654670715)","('Business_Model_Resilience', 0.015111354179680347)","('Human_Rights_And_Community_Relations', 0.009990743361413479)","(['Human Capital Development'], 0.9001553654670715)","('NON-ESG', 0.015111354179680347)","('NON-ESG', 0.009990743361413479)"
Line 790,"We use key driver goals to measure the progression of key talent metrics tied to dimensions of diversity and representation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.975522518157959)","('Employee_Health_And_Safety', 0.0018186831148341298)","('Competitive_Behavior', 0.001489178161136806)","(['Human Capital Development'], 0.975522518157959)","('NON-ESG', 0.0018186831148341298)","('NON-ESG', 0.001489178161136806)"
Line 791,"Our goal is to increase diverse representation at each level 14 of our company by 1 percent each  for gender and ethnicity, year over year, by 2030.
","('Employee_Engagement_Inclusion_And_Diversity', 0.973527729511261)","('Customer_Privacy', 0.0019280803389847279)","('Human_Rights_And_Community_Relations', 0.00175953540019691)","(['Human Capital Development'], 0.973527729511261)","('NON-ESG', 0.0019280803389847279)","('NON-ESG', 0.00175953540019691)"
Line 792,"Data for FY 2021 is provided below.
","('Physical_Impacts_Of_Climate_Change', 0.18755117058753967)","('Systemic_Risk_Management', 0.14472626149654388)","('Business_Model_Resilience', 0.1080276146531105)","('NON-ESG', 0.18755117058753967)","('NON-ESG', 0.14472626149654388)","('NON-ESG', 0.1080276146531105)"
Line 793,"Historical data can be found here.Our most recent consolidated EEO-1 report 15 is available on bd.com.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5787335634231567)","('Human_Rights_And_Community_Relations', 0.06845559179782867)","('GHG_Emissions', 0.032610904425382614)","(['Corporate Governance'], 0.5787335634231567)","('NON-ESG', 0.06845559179782867)","('NON-ESG', 0.032610904425382614)"
Line 794,"BD is committed to integrating and systematically embedding equity considerations into the design, delivery  and monitoring of our talent initiatives and programs to enable equal access and opportunity for everyone.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9619301557540894)","('Access_And_Affordability', 0.004224739503115416)","('Human_Rights_And_Community_Relations', 0.004199592862278223)","(['Human Capital Development'], 0.9619301557540894)","('NON-ESG', 0.004224739503115416)","('NON-ESG', 0.004199592862278223)"
Line 795,"We will continue to take meaningful action to improve our diversity measures over time.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9719100594520569)","('Human_Rights_And_Community_Relations', 0.0020106087904423475)","('Employee_Health_And_Safety', 0.0017551154596731067)","(['Human Capital Development'], 0.9719100594520569)","('NON-ESG', 0.0020106087904423475)","('NON-ESG', 0.0017551154596731067)"
Line 796,"For more information on BD’s commitment to advancing ID&E by building an empowered and inclusive  workforce, please review our 2021 Inclusion, Diversity & Equity report.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9758453965187073)","('Employee_Health_And_Safety', 0.002059139544144273)","('Human_Rights_And_Community_Relations', 0.0016289545455947518)","(['Human Capital Development'], 0.9758453965187073)","('NON-ESG', 0.002059139544144273)","('NON-ESG', 0.0016289545455947518)"
Line 797,"ETHNICITY*** GENDER*** Female Male AGE 0-34 35-54 55+ 9 White 1 Hispanic, Latino or Spanish Origin1 Black or African American Board of Directors 75.2% White 10.9% Asian5.0% Hispanic or Latino 4.6% Unknown3.6% Black or African American 0.7% OtherExecutives* Total – 38266% White 14.4% Asian8.6% Hispanic or Latino 5.4% Unknown3.8% Black or African American 1.8% OtherManagement** Total – 6,52.0% White 11.1% Asian16.0% Hispanic or Latino 9.6% Unknown9.3% Black or African American 2.0% OtherAll Associates Total – 25,645  New hi re rate**** Turnover rate**** Executive Officers***Board of Directors*** Officers*** All Associates: Total of 75,402   Management**: Total of 11,443    Executives*: Total of 3813 1 5 30% 70% 40% 29% 25%25% 21%60% 49% 51%Executives*: Total of 0.3% 11% 12% 14% 6%13% 13%New hire rate**** Turnover rate**** Management**: Total of 11,All Associates: Total of 75,40269% 31% 71% 18% 38% 50% 52% 40% 14These levels are as follows: (i) “executives” are associates in positions of vice president and above; (ii) “management” positions are defined as those in manager, director or equivalent roles; and (iii) “individual contributors” are defined as exempt associates that are not in executive or management positions.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9639824628829956)","('Customer_Privacy', 0.002216178458184004)","('Business_Model_Resilience', 0.0021855621598660946)","(['Human Capital Development'], 0.9639824628829956)","('NON-ESG', 0.002216178458184004)","('NON-ESG', 0.0021855621598660946)"
Line 798,"ETHNICITY*** GENDER*** Female Male AGE 0-34 35-54 55+ 9 White 1 Hispanic, Latino or Spanish Origin1 Black or African American Board of Directors 75.2% White 10.9% Asian5.0% Hispanic or Latino 4.6% Unknown3.6% Black or African American 0.7% OtherExecutives* Total – 38266% White 14.4% Asian8.6% Hispanic or Latino 5.4% Unknown3.8% Black or African American 1.8% OtherManagement** Total – 6,52.0% White 11.1% Asian16.0% Hispanic or Latino 9.6% Unknown9.3% Black or African American 2.0% OtherAll Associates Total – 25,645  New hi re rate**** Turnover rate**** Executive Officers***Board of Directors*** Officers*** All Associates: Total of 75,402   Management**: Total of 11,443    Executives*: Total of 3813 1 5 30% 70% 40% 29% 25%25% 21%60% 49% 51%Executives*: Total of 0.3% 11% 12% 14% 6%13% 13%New hire rate**** Turnover rate**** Management**: Total of 11,All Associates: Total of 75,40269% 31% 71% 18% 38% 50% 52% 40% 14These levels are as follows: (i) “executives” are associates in positions of vice president and above; (ii) “management” positions are defined as those in manager, director or equivalent roles; and (iii) “individual contributors” are defined as exempt associates that are not in executive or management positions.
","('Director_Removal', 0.4877331256866455)","('Employee_Engagement_Inclusion_And_Diversity', 0.20208173990249634)","('Business_Model_Resilience', 0.034264445304870605)","('NON-ESG', 0.4877331256866455)","('NON-ESG', 0.20208173990249634)","('NON-ESG', 0.034264445304870605)"
Line 799,"ETHNICITY*** GENDER*** Female Male AGE 0-34 35-54 55+ 9 White 1 Hispanic, Latino or Spanish Origin1 Black or African American Board of Directors 75.2% White 10.9% Asian5.0% Hispanic or Latino 4.6% Unknown3.6% Black or African American 0.7% OtherExecutives* Total – 38266% White 14.4% Asian8.6% Hispanic or Latino 5.4% Unknown3.8% Black or African American 1.8% OtherManagement** Total – 6,52.0% White 11.1% Asian16.0% Hispanic or Latino 9.6% Unknown9.3% Black or African American 2.0% OtherAll Associates Total – 25,645  New hi re rate**** Turnover rate**** Executive Officers***Board of Directors*** Officers*** All Associates: Total of 75,402   Management**: Total of 11,443    Executives*: Total of 3813 1 5 30% 70% 40% 29% 25%25% 21%60% 49% 51%Executives*: Total of 0.3% 11% 12% 14% 6%13% 13%New hire rate**** Turnover rate**** Management**: Total of 11,All Associates: Total of 75,40269% 31% 71% 18% 38% 50% 52% 40% 14These levels are as follows: (i) “executives” are associates in positions of vice president and above; (ii) “management” positions are defined as those in manager, director or equivalent roles; and (iii) “individual contributors” are defined as exempt associates that are not in executive or management positions.
","('Director_Removal', 0.6893301010131836)","('Employee_Engagement_Inclusion_And_Diversity', 0.05166139081120491)","('Labor_Practices', 0.03524116426706314)","(['Anti-Crime Policy & Measures'], 0.6893301010131836)","('NON-ESG', 0.05166139081120491)","('NON-ESG', 0.03524116426706314)"
Line 800,"15 The data in the consolidated EEO-1 report is based on BD’s population in the U.S. in December  2020 and reflects BD’s U.S. workforce as of that time.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8406956195831299)","('Labor_Practices', 0.021168742328882217)","('Customer_Welfare', 0.01499414537101984)","(['Human Capital Development'], 0.8406956195831299)","('NON-ESG', 0.021168742328882217)","('NON-ESG', 0.01499414537101984)"
Line 801,"The EEO-1 report requires that we categorize employees into 10 broad EEO-1 Component 1 Data Collection Job Categories.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9102016687393188)","('Labor_Practices', 0.019395872950553894)","('Employee_Health_And_Safety', 0.008351507596671581)","(['Human Capital Development'], 0.9102016687393188)","('NON-ESG', 0.019395872950553894)","('NON-ESG', 0.008351507596671581)"
Line 802,"These categories do not necessarily match the job  levels in which BD organizes its workforce and evaluates its diversity and inclusion data.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9751262068748474)","('Employee_Health_And_Safety', 0.001714975223876536)","('Labor_Practices', 0.001710074837319553)","(['Human Capital Development'], 0.9751262068748474)","('NON-ESG', 0.001714975223876536)","('NON-ESG', 0.001710074837319553)"
Line 803,"Thus, meaningful comparisons between EEO-1 report data and other descriptions of BD’s diversity statistics and disclosures may not be possible.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9553213715553284)","('Competitive_Behavior', 0.0036195386201143265)","('Business_Model_Resilience', 0.003228898858651519)","(['Human Capital Development'], 0.9553213715553284)","('NON-ESG', 0.0036195386201143265)","('NON-ESG', 0.003228898858651519)"
Line 804,"*We define “executives” as associates in positions of vice president and above.**We define “management” as associates in positions of manager, director or equivalent roles.***  Inf ormation regarding race and gender is based on information provided by associates.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9626637101173401)","('Labor_Practices', 0.0031322785653173923)","('Director_Removal', 0.00282685412093997)","(['Human Capital Development'], 0.9626637101173401)","('NON-ESG', 0.0031322785653173923)","('NON-ESG', 0.00282685412093997)"
Line 805,"Ethnicity data for executives, management and associates reflects that of the U.S. workforce including Alaska and Hawaii, and Puerto Rico but excluding any other U.S. territories.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9631787538528442)","('Customer_Privacy', 0.003815361065790057)","('Competitive_Behavior', 0.0025720451958477497)","(['Human Capital Development'], 0.9631787538528442)","('NON-ESG', 0.003815361065790057)","('NON-ESG', 0.0025720451958477497)"
Line 806,"Information regarding Board of Directors, Executive  Officers and Officers is current as of April 26, 2022.
","('Director_Removal', 0.7760350704193115)","('Management_Of_Legal_And_Regulatory_Framework', 0.02468852698802948)","('Business_Ethics', 0.018620790913701057)","(['Anti-Crime Policy & Measures'], 0.7760350704193115)","('NON-ESG', 0.02468852698802948)","('NON-ESG', 0.018620790913701057)"
Line 807,"Total number of Officers includes Executive Officers.
","('Director_Removal', 0.730169951915741)","('Employee_Engagement_Inclusion_And_Diversity', 0.03213374316692352)","('Business_Model_Resilience', 0.019389839842915535)","(['Anti-Crime Policy & Measures'], 0.730169951915741)","('NON-ESG', 0.03213374316692352)","('NON-ESG', 0.019389839842915535)"
Line 808,"****How we calculate new hire rate and turnover rate can be found in the data tables.2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Compensation, benefits and  well-being We are committed to rewarding, supporting and developing the associates who  make it possible to deliver on our strategy.
","('Supply_Chain_Management', 0.9220352172851562)","('Physical_Impacts_Of_Climate_Change', 0.0165422260761261)","('Systemic_Risk_Management', 0.007162487134337425)","(['Supply Chain Management'], 0.9220352172851562)","('NON-ESG', 0.0165422260761261)","('NON-ESG', 0.007162487134337425)"
Line 809,"To that end, we offer a comprehensive Total Rewards program aimed at supporting the varying needs of our diverse and global associates.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8705523610115051)","('Access_And_Affordability', 0.019840972498059273)","('Customer_Welfare', 0.013002166524529457)","(['Human Capital Development'], 0.8705523610115051)","('NON-ESG', 0.019840972498059273)","('NON-ESG', 0.013002166524529457)"
Line 810,"The components of our Total Rewards program are designed to work together to provide competitive compensation grounded in pay for performance, protecting overall associate well-being and helping BD to attract and retain high-quality talent.
","('Competitive_Behavior', 0.31470000743865967)","('Employee_Engagement_Inclusion_And_Diversity', 0.2853647768497467)","('Business_Ethics', 0.08026500046253204)","('NON-ESG', 0.31470000743865967)","('NON-ESG', 0.2853647768497467)","('NON-ESG', 0.08026500046253204)"
Line 811,"Our Total Rewards (which varies by country) can include market-competitive  pay, broad-based stock grants and bonuses, healthcare benefits, pension and retirement savings plans, paid time off and family leave, employee assistance programs, flexible work schedules, and well-being education and resources focused on physical, emotional, financial and social well-being.
","('Labor_Practices', 0.34808599948883057)","('Access_And_Affordability', 0.16816078126430511)","('Employee_Health_And_Safety', 0.16409659385681152)","('NON-ESG', 0.34808599948883057)","('NON-ESG', 0.16816078126430511)","('NON-ESG', 0.16409659385681152)"
Line 812,"Each year, we review and implement program enhancements and investments that  are intended to ensure that our benefits are inclusive and representative of the needs of BD associates and their families.
","('Access_And_Affordability', 0.6854801774024963)","('Human_Rights_And_Community_Relations', 0.04325638711452484)","('Management_Of_Legal_And_Regulatory_Framework', 0.033409010618925095)","(['Health Outcome Contribution'], 0.6854801774024963)","('NON-ESG', 0.04325638711452484)","('NON-ESG', 0.033409010618925095)"
Line 813,"Additionally, over the last few years, in the U.S., we have increased efforts to mitigate the impact of rising healthcare costs and to offer more affordable benefit options, with a specific focus on affordability for BD associates earning $50,000 per year or less.
","('Access_And_Affordability', 0.8096049427986145)","('Energy_Management', 0.033214349299669266)","('Product_Quality_And_Safety', 0.017707262188196182)","(['Health Outcome Contribution'], 0.8096049427986145)","('NON-ESG', 0.033214349299669266)","('NON-ESG', 0.017707262188196182)"
Line 814,"The post-pandemic world demands a new approach to how and where we work.
","('Physical_Impacts_Of_Climate_Change', 0.5139042139053345)","('Systemic_Risk_Management', 0.09576554596424103)","('Air_Quality', 0.07232122123241425)","(['Climate Change'], 0.5139042139053345)","('NON-ESG', 0.09576554596424103)","('NON-ESG', 0.07232122123241425)"
Line 815,"There is a demand for greater flexibility and a need to reimagine the purpose of the office—from being the location of the workplace to serving a purpose of collaboration, connection with team members, mentorship and enabling associates to solve complex problems together.
","('Employee_Health_And_Safety', 0.26244670152664185)","('Human_Rights_And_Community_Relations', 0.16019247472286224)","('Access_And_Affordability', 0.13482634723186493)","('NON-ESG', 0.26244670152664185)","('NON-ESG', 0.16019247472286224)","('NON-ESG', 0.13482634723186493)"
Line 816,"How we work is an important enabler of our culture, and it is a competitive  advantage that allows us to attract and retain the best talent while also driving company performance.
","('Competitive_Behavior', 0.5401594042778015)","('Employee_Engagement_Inclusion_And_Diversity', 0.24102072417736053)","('Business_Model_Resilience', 0.02988719381392002)","(['Business Ethics'], 0.5401594042778015)","('NON-ESG', 0.24102072417736053)","('NON-ESG', 0.02988719381392002)"
Line 817,"Our multiyear strategy and ambition is to have a highly collaborative, engaged workforce whose culture is defined by empowerment, trust and flexibility, and where rewards are based on outcomes and value, not on proximity or location.
","('Employee_Engagement_Inclusion_And_Diversity', 0.822734534740448)","('Human_Rights_And_Community_Relations', 0.04791638255119324)","('Employee_Health_And_Safety', 0.017466701567173004)","(['Human Capital Development'], 0.822734534740448)","('NON-ESG', 0.04791638255119324)","('NON-ESG', 0.017466701567173004)"
Line 818,"Good Jobs Strategy Our Good Jobs Strategy provides a framework that puts our manufacturing associates at the center of BD’s culture to drive performance and deliver on our Purpose of advancing the world of health ™.
","('Employee_Health_And_Safety', 0.3931581974029541)","('Access_And_Affordability', 0.1702728569507599)","('Employee_Engagement_Inclusion_And_Diversity', 0.07463723421096802)","('NON-ESG', 0.3931581974029541)","('NON-ESG', 0.1702728569507599)","('NON-ESG', 0.07463723421096802)"
Line 819,"We are committed to offering attractive  careers by:  •  Cr eating a safe work environment that provides high job attractiveness and a  strong culture aligned to THE BD WAY; •  Ensuring associat es experience job satisfaction and a sense of belonging; and •  Pr oviding competitive healthcare and compensation, as well as training and  development opportunities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9025154709815979)","('Employee_Health_And_Safety', 0.02751772478222847)","('Labor_Practices', 0.009071392938494682)","(['Human Capital Development'], 0.9025154709815979)","('NON-ESG', 0.02751772478222847)","('NON-ESG', 0.009071392938494682)"
Line 820,"Our journey started in 2019 with the launch of a Good Jobs Strategy assessment  tool.
","('Business_Model_Resilience', 0.25828468799591064)","('Management_Of_Legal_And_Regulatory_Framework', 0.11686518788337708)","('Product_Design_And_Lifecycle_Management', 0.10656847804784775)","('NON-ESG', 0.25828468799591064)","('NON-ESG', 0.11686518788337708)","('NON-ESG', 0.10656847804784775)"
Line 821,"On an annual basis, each site conducts an assessment that evaluates effectiveness in five key areas: workplace safety and harassment free environment; fair wages and benefits; working conditions; managerial effectiveness; and associate engagement and career progression.
","('Labor_Practices', 0.6462236642837524)","('Employee_Health_And_Safety', 0.25736528635025024)","('Employee_Engagement_Inclusion_And_Diversity', 0.015499674715101719)","(['Labor Practice Indicators'], 0.6462236642837524)","('NON-ESG', 0.25736528635025024)","('NON-ESG', 0.015499674715101719)"
Line 822,"As a result of the annual assessment, site action plans are put into place to continue to make progress on our Good Jobs Strategy.
","('Ecological_Impacts', 0.25283223390579224)","('Business_Model_Resilience', 0.18893255293369293)","('Management_Of_Legal_And_Regulatory_Framework', 0.08659040182828903)","('NON-ESG', 0.25283223390579224)","('NON-ESG', 0.18893255293369293)","('NON-ESG', 0.08659040182828903)"
Line 823,"Since beginning the journey, we have improved working conditions by investing in  facility upgrades globally, by improving work patterns, such as reducing mandatory overtime in the U.S.; and by investing in manager-effectiveness training.
","('Labor_Practices', 0.8192781805992126)","('Employee_Health_And_Safety', 0.10786724835634232)","('Employee_Engagement_Inclusion_And_Diversity', 0.0068794903345406055)","(['Labor Practice Indicators'], 0.8192781805992126)","('NON-ESG', 0.10786724835634232)","('NON-ESG', 0.0068794903345406055)"
Line 824,"In addition, we have made significant investments in wage increases globally and introduced a no-cost and low-cost benefit plan for U.S. associates earning less than $50,000.
","('Labor_Practices', 0.9300057291984558)","('Energy_Management', 0.009006722830235958)","('Competitive_Behavior', 0.006412619259208441)","(['Labor Practice Indicators'], 0.9300057291984558)","('NON-ESG', 0.009006722830235958)","('NON-ESG', 0.006412619259208441)"
Line 825,"Finally, we have added focus to our talent acquisition process through enhancing the candidate’s experience during the hiring process and changing our talent-acquisition partner in the U.S. These are just a few examples of the progress we have made since we launched the Good Jobs Strategy.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9533056020736694)","('Employee_Health_And_Safety', 0.005295510869473219)","('Business_Model_Resilience', 0.00459170201793313)","(['Human Capital Development'], 0.9533056020736694)","('NON-ESG', 0.005295510869473219)","('NON-ESG', 0.00459170201793313)"
Line 826,"Over the coming years, we will continue to advance the foundational pillars to drive  associate satisfaction and attract talent in an evolving talent market.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9349796772003174)","('Business_Model_Resilience', 0.005857208278030157)","('Competitive_Behavior', 0.005077852867543697)","(['Human Capital Development'], 0.9349796772003174)","('NON-ESG', 0.005857208278030157)","('NON-ESG', 0.005077852867543697)"
Line 827,"To facilitate sustainability and ongoing sustainability, we have integrated our Good Jobs Strategy assessment tool into the BD Production System.2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities OUR SAFETY POLICY “We are committed to driving a  culture in which the health, safety and well-being of our associates, visitors and contractors is an integral part of every decision we make.
","('Employee_Health_And_Safety', 0.5172714591026306)","('Product_Quality_And_Safety', 0.2629435062408447)","('Product_Design_And_Lifecycle_Management', 0.08944603055715561)","(['Operational Eco-Efficiency'], 0.5172714591026306)","('NON-ESG', 0.2629435062408447)","('NON-ESG', 0.08944603055715561)"
Line 828,"Each of us must take personal responsibility for the safety and care of each other to ensure that we all remain safe at work each and every day.” Tom Polen  Chairman, CEO and PresidentHealth and safety A copy of our environment, health and safety (EHS) policy is available on bd.com.
","('Employee_Health_And_Safety', 0.9567052721977234)","('Product_Quality_And_Safety', 0.010846992023289204)","('Product_Design_And_Lifecycle_Management', 0.004268426913768053)","(['Operational Eco-Efficiency'], 0.9567052721977234)","('NON-ESG', 0.010846992023289204)","('NON-ESG', 0.004268426913768053)"
Line 829,"FY 2021 performance 0.17 Lost-time injury frequency rate Occupational illness frequency rate 0.33 Injury and illness rate Fatalities Please refer to the data tables for previous years’ data.
","('Employee_Health_And_Safety', 0.984653651714325)","('Employee_Engagement_Inclusion_And_Diversity', 0.0015271628508344293)","('Critical_Incident_Risk_Management', 0.0014857846545055509)","(['Operational Eco-Efficiency'], 0.984653651714325)","('NON-ESG', 0.0015271628508344293)","('NON-ESG', 0.0014857846545055509)"
Line 830,"COVID-19 pandemic During the COVID-19 pandemic, we redoubled our efforts to ensure the safety of our associates, and our business  continuity.
","('Employee_Health_And_Safety', 0.4014092981815338)","('Critical_Incident_Risk_Management', 0.3568839728832245)","('Air_Quality', 0.07041729986667633)","('NON-ESG', 0.4014092981815338)","('NON-ESG', 0.3568839728832245)","('NON-ESG', 0.07041729986667633)"
Line 831,"This work meant undertaking major new initiatives, such as: •  Institutionalizing the use of additional lay ers of personal protective equipment (PPE) while simultaneously  ensuring that we have access to a continuous supply of PPE; •  R edesigning our facilities and process flows to minimize transmission of the virus; •  C onducting effective contact tracing and investigations through systematic methodologies; •  R olling out educational campaigns to modify behavior inside and outside facilities to reduce transmission; and •  C onducting COVID-19 testing in locations where community spikes have impacted our facilities.
","('Employee_Health_And_Safety', 0.6248448491096497)","('Critical_Incident_Risk_Management', 0.06118420138955116)","('Product_Quality_And_Safety', 0.04982578754425049)","(['Operational Eco-Efficiency'], 0.6248448491096497)","('NON-ESG', 0.06118420138955116)","('NON-ESG', 0.04982578754425049)"
Line 832,"This work meant undertaking major new initiatives, such as: •  Institutionalizing the use of additional lay ers of personal protective equipment (PPE) while simultaneously  ensuring that we have access to a continuous supply of PPE; •  R edesigning our facilities and process flows to minimize transmission of the virus; •  C onducting effective contact tracing and investigations through systematic methodologies; •  R olling out educational campaigns to modify behavior inside and outside facilities to reduce transmission; and •  C onducting COVID-19 testing in locations where community spikes have impacted our facilities.
","('Human_Rights_And_Community_Relations', 0.6692807078361511)","('Critical_Incident_Risk_Management', 0.04958373308181763)","('Access_And_Affordability', 0.03791090473532677)","(['Community Relations'], 0.6692807078361511)","('NON-ESG', 0.04958373308181763)","('NON-ESG', 0.03791090473532677)"
Line 833,"Our response to COVID-For details on our response to COVID-19, including testing and vaccine preparedness and tools and  trainings, please visit our website and newsroom.2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Hazard and risk assessment Sites are required to establish an inventory of all equipment/processes and conduct risk assessments on a predetermined frequency based on risk rating.
","('Physical_Impacts_Of_Climate_Change', 0.44608065485954285)","('Supply_Chain_Management', 0.38948583602905273)","('Business_Model_Resilience', 0.03291607275605202)","('NON-ESG', 0.44608065485954285)","('NON-ESG', 0.38948583602905273)","('NON-ESG', 0.03291607275605202)"
Line 834,"This requirement is  under the umbrella of our leading indicator metric, the EHS Index, and is formalized under our Metrics and Reporting Escalation standard.
","('Management_Of_Legal_And_Regulatory_Framework', 0.35818952322006226)","('Systemic_Risk_Management', 0.34165868163108826)","('Competitive_Behavior', 0.057249557226896286)","('NON-ESG', 0.35818952322006226)","('NON-ESG', 0.34165868163108826)","('NON-ESG', 0.057249557226896286)"
Line 835,"The improvement is tracked in our EHS MIS platform and performance is reviewed on a monthly basis.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4738023579120636)","('Systemic_Risk_Management', 0.11085715144872665)","('Business_Ethics', 0.07684452831745148)","('NON-ESG', 0.4738023579120636)","('NON-ESG', 0.11085715144872665)","('NON-ESG', 0.07684452831745148)"
Line 836,"Subsequently, this standard is audited by the central EHS Audit team to monitor compliance.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6625373363494873)","('Business_Ethics', 0.1091335341334343)","('Product_Quality_And_Safety', 0.06336002051830292)","(['Corporate Governance'], 0.6625373363494873)","('NON-ESG', 0.1091335341334343)","('NON-ESG', 0.06336002051830292)"
Line 837,"BD has established and implemented the EHS Golden Rules, a consistent set of essential workplace EHS rules for all associates.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9170616865158081)","('Business_Ethics', 0.020318686962127686)","('Product_Quality_And_Safety', 0.00782664492726326)","(['Corporate Governance'], 0.9170616865158081)","('NON-ESG', 0.020318686962127686)","('NON-ESG', 0.00782664492726326)"
Line 838,"These are rules that, if violated, have the  potential to cause a serious injury or significant environmental impact.
","('Employee_Health_And_Safety', 0.969131350517273)","('Critical_Incident_Risk_Management', 0.007287954445928335)","('Access_And_Affordability', 0.001900909119285643)","(['Operational Eco-Efficiency'], 0.969131350517273)","('NON-ESG', 0.007287954445928335)","('NON-ESG', 0.001900909119285643)"
Line 839,"As such, violations of golden rules are investigated and appropriate disciplinary actions are taken to promote the safety of all associates.
","('Employee_Health_And_Safety', 0.47231733798980713)","('Business_Ethics', 0.19402113556861877)","('Product_Quality_And_Safety', 0.08958318084478378)","('NON-ESG', 0.47231733798980713)","('NON-ESG', 0.19402113556861877)","('NON-ESG', 0.08958318084478378)"
Line 840,"EHS Golden Rules Environmental  stewardshipFall protectionMobile equipmentMachine guarding Lockout/ tagoutChemical safety BD associates shall follow all  environmental protection procedures established by the site.
","('Ecological_Impacts', 0.38101691007614136)","('Employee_Health_And_Safety', 0.15457619726657867)","('Air_Quality', 0.06179455667734146)","('NON-ESG', 0.38101691007614136)","('NON-ESG', 0.15457619726657867)","('NON-ESG', 0.06179455667734146)"
Line 841,"•  R eport spills.
","('Critical_Incident_Risk_Management', 0.7954676151275635)","('Air_Quality', 0.040165014564991)","('Waste_And_Hazardous_Materials_Management', 0.0379047654569149)","(['Risk & Crisis Management'], 0.7954676151275635)","('NON-ESG', 0.040165014564991)","('NON-ESG', 0.0379047654569149)"
Line 842,"Clean up spills  following site protocols.
","('Critical_Incident_Risk_Management', 0.7621159553527832)","('Waste_And_Hazardous_Materials_Management', 0.046694833785295486)","('Air_Quality', 0.043782103806734085)","(['Risk & Crisis Management'], 0.7621159553527832)","('NON-ESG', 0.046694833785295486)","('NON-ESG', 0.043782103806734085)"
Line 843,"•  Plac e waste in proper containers.
","('Waste_And_Hazardous_Materials_Management', 0.9834330081939697)","('Water_And_Wastewater_Management', 0.0014493425842374563)","('Data_Security', 0.0013471554266288877)","(['Operational Eco-Efficiency'], 0.9834330081939697)","('NON-ESG', 0.0014493425842374563)","('NON-ESG', 0.0013471554266288877)"
Line 844,"•  F ollow site recycling rules.
","('Waste_And_Hazardous_Materials_Management', 0.4394400715827942)","('Product_Design_And_Lifecycle_Management', 0.09607815742492676)","('Water_And_Wastewater_Management', 0.0716908797621727)","('NON-ESG', 0.4394400715827942)","('NON-ESG', 0.09607815742492676)","('NON-ESG', 0.0716908797621727)"
Line 845,"•  Do not pour chemic als down the  drain or place in the trash.BD associates shall use fall prevention  devices when working from heights.
","('Waste_And_Hazardous_Materials_Management', 0.9756696820259094)","('Water_And_Wastewater_Management', 0.002494093496352434)","('Air_Quality', 0.0019292859360575676)","(['Operational Eco-Efficiency'], 0.9756696820259094)","('NON-ESG', 0.002494093496352434)","('NON-ESG', 0.0019292859360575676)"
Line 846,"•  W ear fall protection when working  on elevated surfaces without  barriers.
","('Employee_Health_And_Safety', 0.404430627822876)","('Critical_Incident_Risk_Management', 0.11895211786031723)","('Ecological_Impacts', 0.05889591947197914)","('NON-ESG', 0.404430627822876)","('NON-ESG', 0.11895211786031723)","('NON-ESG', 0.05889591947197914)"
Line 847,"•  Inspect port able ladders before  climbing and maintain three points of contact.
","('Employee_Health_And_Safety', 0.48322057723999023)","('Critical_Incident_Risk_Management', 0.2031237632036209)","('Water_And_Wastewater_Management', 0.041393641382455826)","('NON-ESG', 0.48322057723999023)","('NON-ESG', 0.2031237632036209)","('NON-ESG', 0.041393641382455826)"
Line 848,"•  Use f all protection when accessing  fixed ladders, where provided •  Do not climb o ver guardrails and  fall-prevention barriers.BD associates shall be trained and certified to operate powered industrial equipment and shall abide by site traffic rules.
","('Data_Security', 0.1904781609773636)","('Employee_Health_And_Safety', 0.1464472860097885)","('Water_And_Wastewater_Management', 0.10750512033700943)","('NON-ESG', 0.1904781609773636)","('NON-ESG', 0.1464472860097885)","('NON-ESG', 0.10750512033700943)"
Line 849,"•  Inspect mobile equipment bef ore  use.
","('Management_Of_Legal_And_Regulatory_Framework', 0.19384461641311646)","('Critical_Incident_Risk_Management', 0.1391235589981079)","('Air_Quality', 0.10163754969835281)","('NON-ESG', 0.19384461641311646)","('NON-ESG', 0.1391235589981079)","('NON-ESG', 0.10163754969835281)"
Line 850,"•  Slo w down near pedestrians and  make eye or verbal contact.
","('Employee_Health_And_Safety', 0.31468385457992554)","('Business_Ethics', 0.23259766399860382)","('Customer_Privacy', 0.07417717576026917)","('NON-ESG', 0.31468385457992554)","('NON-ESG', 0.23259766399860382)","('NON-ESG', 0.07417717576026917)"
Line 851,"•  F ollow speed limits and stop signs.
","('Labor_Practices', 0.12992963194847107)","('Customer_Privacy', 0.11012227088212967)","('Competitive_Behavior', 0.09222816675901413)","('NON-ESG', 0.12992963194847107)","('NON-ESG', 0.11012227088212967)","('NON-ESG', 0.09222816675901413)"
Line 852,"•  Maint ain line of sight at all times  when driving.
","('Employee_Health_And_Safety', 0.1742687076330185)","('Customer_Privacy', 0.12657997012138367)","('Critical_Incident_Risk_Management', 0.1096118688583374)","('NON-ESG', 0.1742687076330185)","('NON-ESG', 0.12657997012138367)","('NON-ESG', 0.1096118688583374)"
Line 853,"•  W ear your seat belt and keep your  body inside the vehicle.BD associates shall not tamper with or  disable machine/equipment guarding while operating under normal conditions.
","('Business_Ethics', 0.6801828742027283)","('Employee_Health_And_Safety', 0.05390170216560364)","('Customer_Privacy', 0.04525171220302582)","(['Business Ethics'], 0.6801828742027283)","('NON-ESG', 0.05390170216560364)","('NON-ESG', 0.04525171220302582)"
Line 854,"•  Ne ver reach inside moving  equipment.
","('Energy_Management', 0.3708602488040924)","('Product_Design_And_Lifecycle_Management', 0.08889728784561157)","('Supply_Chain_Management', 0.07055359333753586)","('NON-ESG', 0.3708602488040924)","('NON-ESG', 0.08889728784561157)","('NON-ESG', 0.07055359333753586)"
Line 855,"•  Do not b ypass guards for the sake  of production or for any reason.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3389914929866791)","('Product_Design_And_Lifecycle_Management', 0.1333589404821396)","('Energy_Management', 0.12040470540523529)","('NON-ESG', 0.3389914929866791)","('NON-ESG', 0.1333589404821396)","('NON-ESG', 0.12040470540523529)"
Line 856,"•  R einstall guards using all bolts.
","('Energy_Management', 0.23928271234035492)","('Employee_Health_And_Safety', 0.11328636854887009)","('Supply_Chain_Management', 0.09154006838798523)","('NON-ESG', 0.23928271234035492)","('NON-ESG', 0.11328636854887009)","('NON-ESG', 0.09154006838798523)"
Line 857,"•  Use t ools and PPE when clearing  jams.BD associates shall not work on  equipment that is not locked out as per energy control procedures.
","('Critical_Incident_Risk_Management', 0.6156228184700012)","('Air_Quality', 0.12367180734872818)","('Data_Security', 0.04650748521089554)","(['Risk & Crisis Management'], 0.6156228184700012)","('NON-ESG', 0.12367180734872818)","('NON-ESG', 0.04650748521089554)"
Line 858,"•  Lock out all f orms of energy before  working on equipment.
","('Energy_Management', 0.9586181640625)","('Air_Quality', 0.005639917217195034)","('Critical_Incident_Risk_Management', 0.00416178023442626)","(['Operational Eco-Efficiency'], 0.9586181640625)","('NON-ESG', 0.005639917217195034)","('NON-ESG', 0.00416178023442626)"
Line 859,"•  V erify zero energy state.
","('Energy_Management', 0.6746603846549988)","('Competitive_Behavior', 0.057820625603199005)","('GHG_Emissions', 0.05759652331471443)","(['Operational Eco-Efficiency'], 0.6746603846549988)","('NON-ESG', 0.057820625603199005)","('NON-ESG', 0.05759652331471443)"
Line 860,"•  Do not w ork on or touch live  electrical equipment unless  authorized.
","('Energy_Management', 0.7722330093383789)","('Critical_Incident_Risk_Management', 0.024622319266200066)","('Air_Quality', 0.02353629283607006)","(['Operational Eco-Efficiency'], 0.7722330093383789)","('NON-ESG', 0.024622319266200066)","('NON-ESG', 0.02353629283607006)"
Line 861,"•  Use one lock per per son.
","('Energy_Management', 0.18598788976669312)","('Water_And_Wastewater_Management', 0.12139055877923965)","('Waste_And_Hazardous_Materials_Management', 0.11319269984960556)","('NON-ESG', 0.18598788976669312)","('NON-ESG', 0.12139055877923965)","('NON-ESG', 0.11319269984960556)"
Line 862,"•  U tilize procedure for authorized  nonroutine machine interventions.BD associates shall handle and store chemicals safely, in alignment with safety and data sheets.
","('Product_Quality_And_Safety', 0.7602659463882446)","('Waste_And_Hazardous_Materials_Management', 0.06098885461688042)","('Employee_Health_And_Safety', 0.0269747506827116)","(['Product Quality & Recall Management'], 0.7602659463882446)","('NON-ESG', 0.06098885461688042)","('NON-ESG', 0.0269747506827116)"
Line 863,"•  Use pr oper PPE at all times when  handling chemicals.
","('Waste_And_Hazardous_Materials_Management', 0.5340549945831299)","('Product_Design_And_Lifecycle_Management', 0.10916256904602051)","('Water_And_Wastewater_Management', 0.05623900145292282)","(['Operational Eco-Efficiency'], 0.5340549945831299)","('NON-ESG', 0.10916256904602051)","('NON-ESG', 0.05623900145292282)"
Line 864,"•  Use  exhaust systems, when provided.
","('Air_Quality', 0.7565045356750488)","('Energy_Management', 0.04302235692739487)","('Critical_Incident_Risk_Management', 0.02863808535039425)","(['Operational Eco-Efficiency'], 0.7565045356750488)","('NON-ESG', 0.04302235692739487)","('NON-ESG', 0.02863808535039425)"
Line 865,"•  Ensur e that chemicals are properly  labeled and stored.
","('Waste_And_Hazardous_Materials_Management', 0.49657800793647766)","('Selling_Practices_And_Product_Labeling', 0.12486632913351059)","('Customer_Welfare', 0.07616079598665237)","('NON-ESG', 0.49657800793647766)","('NON-ESG', 0.12486632913351059)","('NON-ESG', 0.07616079598665237)"
Line 866,"•  Do not bring ne w chemicals on site  without EHS approval.2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Globally, all sites are required to implement the leading indicator EHS Index.
","('Supply_Chain_Management', 0.722283661365509)","('Physical_Impacts_Of_Climate_Change', 0.15136733651161194)","('Systemic_Risk_Management', 0.020308425650000572)","(['Supply Chain Management'], 0.722283661365509)","('NON-ESG', 0.15136733651161194)","('NON-ESG', 0.020308425650000572)"
Line 867,"The  intent of the EHS Index is to focus on prevention rather than reaction by: •  Pr omoting disciplined EHS behavior; •  Pr oviding a continuous improvement model; •  F ostering a preventative EHS culture;  •  Pr omoting best practice sharing among our locations; and •  Enabling tr ending and focus on areas for improvement and opportunity.
","('Access_And_Affordability', 0.44551247358322144)","('Employee_Health_And_Safety', 0.08630597591400146)","('Critical_Incident_Risk_Management', 0.06064695864915848)","('NON-ESG', 0.44551247358322144)","('NON-ESG', 0.08630597591400146)","('NON-ESG', 0.06064695864915848)"
Line 868,"The Index comprises the following elements:Risk assessments: Sites are required to conduct task-based risk assessments on  processes and equipment.
","('Systemic_Risk_Management', 0.9145793914794922)","('Physical_Impacts_Of_Climate_Change', 0.014113563112914562)","('Business_Model_Resilience', 0.009308633394539356)","(['Risk & Crisis Management'], 0.9145793914794922)","('NON-ESG', 0.014113563112914562)","('NON-ESG', 0.009308633394539356)"
Line 869,"These assessments are prioritized based on the hazards associated with the process or equipment.
","('Employee_Health_And_Safety', 0.5217474102973938)","('Waste_And_Hazardous_Materials_Management', 0.2526340186595917)","('Water_And_Wastewater_Management', 0.03387896344065666)","(['Operational Eco-Efficiency'], 0.5217474102973938)","('NON-ESG', 0.2526340186595917)","('NON-ESG', 0.03387896344065666)"
Line 870,"These hazards are evaluated on a routine basis based on risk level.
","('Employee_Health_And_Safety', 0.33666303753852844)","('Critical_Incident_Risk_Management', 0.2012902945280075)","('Water_And_Wastewater_Management', 0.09937188029289246)","('NON-ESG', 0.33666303753852844)","('NON-ESG', 0.2012902945280075)","('NON-ESG', 0.09937188029289246)"
Line 871,"Environmental, Health and Safety Opportunities (ESOs): Sites are required  to implement a mechanism to report ESOs (unsafe conditions, unsafe behaviors or near misses).
","('Employee_Health_And_Safety', 0.9733420014381409)","('Product_Quality_And_Safety', 0.0031595854088664055)","('Critical_Incident_Risk_Management', 0.0030441093258559704)","(['Operational Eco-Efficiency'], 0.9733420014381409)","('NON-ESG', 0.0031595854088664055)","('NON-ESG', 0.0030441093258559704)"
Line 872,"This gives associates the opportunity to identify issues to be corrected in a timely manner.
","('Critical_Incident_Risk_Management', 0.24532762169837952)","('Systemic_Risk_Management', 0.14303436875343323)","('Business_Ethics', 0.13104325532913208)","('NON-ESG', 0.24532762169837952)","('NON-ESG', 0.14303436875343323)","('NON-ESG', 0.13104325532913208)"
Line 873,"Injury reduction: Associates are trained to report all incidents to leadership  and EHS.
","('Employee_Health_And_Safety', 0.9786521792411804)","('Critical_Incident_Risk_Management', 0.005747918039560318)","('Employee_Engagement_Inclusion_And_Diversity', 0.0015698653878644109)","(['Operational Eco-Efficiency'], 0.9786521792411804)","('NON-ESG', 0.005747918039560318)","('NON-ESG', 0.0015698653878644109)"
Line 874,"An investigation, reporting and root-cause analysis are required for all incidents.
","('Critical_Incident_Risk_Management', 0.6730961203575134)","('Business_Ethics', 0.0894550159573555)","('Systemic_Risk_Management', 0.0403456911444664)","(['Risk & Crisis Management'], 0.6730961203575134)","('NON-ESG', 0.0894550159573555)","('NON-ESG', 0.0403456911444664)"
Line 875,"Action items are tracked to closure.
","('Waste_And_Hazardous_Materials_Management', 0.1769101470708847)","('Ecological_Impacts', 0.09939399361610413)","('Management_Of_Legal_And_Regulatory_Framework', 0.0850456953048706)","('NON-ESG', 0.1769101470708847)","('NON-ESG', 0.09939399361610413)","('NON-ESG', 0.0850456953048706)"
Line 876,"Engagement: Leadership is required to hold 1:1 meetings monthly with operators  about safety and environmental conditions and concerns.
","('Employee_Health_And_Safety', 0.9513190984725952)","('Critical_Incident_Risk_Management', 0.018986277282238007)","('Air_Quality', 0.0031405251938849688)","(['Operational Eco-Efficiency'], 0.9513190984725952)","('NON-ESG', 0.018986277282238007)","('NON-ESG', 0.0031405251938849688)"
Line 877,"For sites that are considered high hazard based on our High Hazard Operations/ Process Safety Management standard, operations are required to conduct a process hazard analysis to ensure that adequate engineering controls are in place to minimize any potential hazard from that process or equipment.
","('Employee_Health_And_Safety', 0.9342857599258423)","('Critical_Incident_Risk_Management', 0.013553453609347343)","('Product_Quality_And_Safety', 0.008628937415778637)","(['Operational Eco-Efficiency'], 0.9342857599258423)","('NON-ESG', 0.013553453609347343)","('NON-ESG', 0.008628937415778637)"
Line 878,"The BD Code of Conduct requires all associates to follow health and safety policies  and procedures and to report any unhealthy or unsafe work conditions.
","('Employee_Health_And_Safety', 0.9742041826248169)","('Product_Quality_And_Safety', 0.0026332286652177572)","('Employee_Engagement_Inclusion_And_Diversity', 0.0025038225576281548)","(['Operational Eco-Efficiency'], 0.9742041826248169)","('NON-ESG', 0.0026332286652177572)","('NON-ESG', 0.0025038225576281548)"
Line 879,"This also includes not taking unnecessary risks in the workplace or telling anyone  else to do so, and not taking shortcuts or bypassing health and safety policies and procedures.
","('Employee_Health_And_Safety', 0.9754894971847534)","('Product_Quality_And_Safety', 0.003658950561657548)","('Critical_Incident_Risk_Management', 0.0023986478336155415)","(['Operational Eco-Efficiency'], 0.9754894971847534)","('NON-ESG', 0.003658950561657548)","('NON-ESG', 0.0023986478336155415)"
Line 880,"If an associate feels pressured to cut corners, they should report it.
","('Business_Ethics', 0.283540815114975)","('Systemic_Risk_Management', 0.27924445271492004)","('Competitive_Behavior', 0.14242905378341675)","('NON-ESG', 0.283540815114975)","('NON-ESG', 0.27924445271492004)","('NON-ESG', 0.14242905378341675)"
Line 881,"Associates can report health and safety issues to their manager, Human Resources,  the central EHS team and/or the BD Ethics office.BD takes all reports of violations of laws, BD policies and ethical standards seriously and will promptly, fairly and thoroughly investigate all such reports.
","('Business_Ethics', 0.8101222515106201)","('Employee_Health_And_Safety', 0.044819943606853485)","('Product_Quality_And_Safety', 0.03887637332081795)","(['Business Ethics'], 0.8101222515106201)","('NON-ESG', 0.044819943606853485)","('NON-ESG', 0.03887637332081795)"
Line 882,"BD does not tolerate any form of retaliation against any person who in good faith reports an actual or suspected violation or cooperates in BD investigations.
","('Business_Ethics', 0.9374580383300781)","('Management_Of_Legal_And_Regulatory_Framework', 0.016435202211141586)","('Product_Quality_And_Safety', 0.005089264363050461)","(['Business Ethics'], 0.9374580383300781)","('NON-ESG', 0.016435202211141586)","('NON-ESG', 0.005089264363050461)"
Line 883,"Tools are provided to the sites to conduct investigations utilizing root-cause  analysis techniques that focus on systemic failure.
","('Systemic_Risk_Management', 0.946023166179657)","('Business_Model_Resilience', 0.009302484802901745)","('Supply_Chain_Management', 0.005594809073954821)","(['Risk & Crisis Management'], 0.946023166179657)","('NON-ESG', 0.009302484802901745)","('NON-ESG', 0.005594809073954821)"
Line 884,"The EHS MIS platform supports the investigation process and tracks action-item closure to ensure accountability.
","('Business_Ethics', 0.4706099331378937)","('Management_Of_Legal_And_Regulatory_Framework', 0.4124942421913147)","('Access_And_Affordability', 0.010281774215400219)","('NON-ESG', 0.4706099331378937)","('NON-ESG', 0.4124942421913147)","('NON-ESG', 0.010281774215400219)"
Line 885,"Every site follows the same root-cause guidelines, enabling the corporation to trend and continuously improve injury reduction or environmental incidents.
","('Employee_Health_And_Safety', 0.9805018305778503)","('Critical_Incident_Risk_Management', 0.0037726799491792917)","('Employee_Engagement_Inclusion_And_Diversity', 0.001434630947187543)","(['Operational Eco-Efficiency'], 0.9805018305778503)","('NON-ESG', 0.0037726799491792917)","('NON-ESG', 0.001434630947187543)"
Line 886,"Occupational health Larger facilities have trained and certified occupational health professionals on site.
","('Employee_Health_And_Safety', 0.9826232194900513)","('Employee_Engagement_Inclusion_And_Diversity', 0.0019349652575328946)","('Critical_Incident_Risk_Management', 0.0015853304648771882)","(['Operational Eco-Efficiency'], 0.9826232194900513)","('NON-ESG', 0.0019349652575328946)","('NON-ESG', 0.0015853304648771882)"
Line 887,"Any associate’s health-related information is required to be treated as confidential and maintained in accordance with HIPAA or equivalent local legislations to protect associate confidentiality.
","('Customer_Privacy', 0.844436764717102)","('Data_Security', 0.04278670623898506)","('Business_Ethics', 0.02828988991677761)","(['Privacy Protection'], 0.844436764717102)","('NON-ESG', 0.04278670623898506)","('NON-ESG', 0.02828988991677761)"
Line 888,"Smaller facilities have first aid response teams and, if required, injured associates  are sent to a local occupational health clinic for treatment.
","('Employee_Health_And_Safety', 0.9663290977478027)","('Critical_Incident_Risk_Management', 0.013494771905243397)","('Employee_Engagement_Inclusion_And_Diversity', 0.0015287045389413834)","(['Operational Eco-Efficiency'], 0.9663290977478027)","('NON-ESG', 0.013494771905243397)","('NON-ESG', 0.0015287045389413834)"
Line 889,"Site leadership and EHS teams partners will provide accommodations for  associates with occupational health restrictions.
","('Employee_Health_And_Safety', 0.9828070402145386)","('Employee_Engagement_Inclusion_And_Diversity', 0.0019387862412258983)","('Critical_Incident_Risk_Management', 0.0016849134117364883)","(['Operational Eco-Efficiency'], 0.9828070402145386)","('NON-ESG', 0.0019387862412258983)","('NON-ESG', 0.0016849134117364883)"
Line 890,"Worker participation Corporate standards are available and were created in collaboration with site leaders and relevant safety committees.
","('Employee_Health_And_Safety', 0.9502407908439636)","('Product_Quality_And_Safety', 0.00921377819031477)","('Employee_Engagement_Inclusion_And_Diversity', 0.005881535820662975)","(['Operational Eco-Efficiency'], 0.9502407908439636)","('NON-ESG', 0.00921377819031477)","('NON-ESG', 0.005881535820662975)"
Line 891,"ISO-certified sites collaborate on regional platforms to share learnings and foster compliance with management systems.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5434162616729736)","('Product_Quality_And_Safety', 0.1633264273405075)","('Business_Ethics', 0.03877507150173187)","(['Corporate Governance'], 0.5434162616729736)","('NON-ESG', 0.1633264273405075)","('NON-ESG', 0.03877507150173187)"
Line 892,"All sites have a tiered management system to communicate EHS performance at the line, site and management level to allow for relevant occupational health and safety information to be regularly communicated.
","('Employee_Health_And_Safety', 0.9843387603759766)","('Critical_Incident_Risk_Management', 0.0016629616729915142)","('Employee_Engagement_Inclusion_And_Diversity', 0.001530925976112485)","(['Operational Eco-Efficiency'], 0.9843387603759766)","('NON-ESG', 0.0016629616729915142)","('NON-ESG', 0.001530925976112485)"
Line 893,"At a site level, safety committees exist and all areas of site operations are  represented.
","('Employee_Health_And_Safety', 0.5381892323493958)","('Product_Quality_And_Safety', 0.2086898237466812)","('Critical_Incident_Risk_Management', 0.04590533673763275)","(['Operational Eco-Efficiency'], 0.5381892323493958)","('NON-ESG', 0.2086898237466812)","('NON-ESG', 0.04590533673763275)"
Line 894,"Their meeting frequency varies, but at a minimum they meet quarterly.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2632705271244049)","('Director_Removal', 0.09484130144119263)","('Competitive_Behavior', 0.08791885524988174)","('NON-ESG', 0.2632705271244049)","('NON-ESG', 0.09484130144119263)","('NON-ESG', 0.08791885524988174)"
Line 895,"Responsibilities include evaluating challenges and assisting EHS teams in implementing environmental and safety intervention programs.BD continues to reinforce systems that strengthen our goal to drive a culture in which the health and well-being of our associates, visitors and contractors are an integral part of every decision we make.
","('Employee_Health_And_Safety', 0.9728886485099792)","('Critical_Incident_Risk_Management', 0.005668726284056902)","('Access_And_Affordability', 0.002291887765750289)","(['Operational Eco-Efficiency'], 0.9728886485099792)","('NON-ESG', 0.005668726284056902)","('NON-ESG', 0.002291887765750289)"
Line 896,"Instrumental in this vision is the continuation of programs that drive management and leadership engagement, peer-to-peer coaching, and education and training.
","('Employee_Engagement_Inclusion_And_Diversity', 0.565101683139801)","('Access_And_Affordability', 0.1505568027496338)","('Human_Rights_And_Community_Relations', 0.06894807517528534)","(['Human Capital Development'], 0.565101683139801)","('NON-ESG', 0.1505568027496338)","('NON-ESG', 0.06894807517528534)"
Line 897,"For further details about our EHS management programs, please see EHS  management in the climate change section of this report.
","('Physical_Impacts_Of_Climate_Change', 0.9449833631515503)","('Business_Model_Resilience', 0.011008061468601227)","('GHG_Emissions', 0.008118042722344398)","(['Climate Change'], 0.9449833631515503)","('NON-ESG', 0.011008061468601227)","('NON-ESG', 0.008118042722344398)"
Line 898,"2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Our contribution to healthy communities Charitable giving summary,   by the numbers: Total cash donations $11.1  million   for BD  $2.1 million   for BD  Foundation Total product donations $11.1  million Total contributions  $22.2 million for BD + $2.1 million for BD Foundation BD Foundation Expanding Healthcare Access: $900,Advancing Human Potential: $813,Supporting Resilient Communities: $410,Expanding Healthcare Access Health and human services: $5,255,Advancing Human Potential Education: $2,136,Other: $1,263,311  (Volunteerism and ID&E) Arts and culture: $473,Civic and social welfare: $1,516,740Disaster relief: $432,Environment: $55,570Supporting Resilient Communities Value of company match to associate  donations $1.9 million No. of grants issued, worldwide 381 for BD + 18 from BD Foundation No. of nonprofit beneficiaries 274 from BD + 13 from BD Foundation No. of matching gifts distributed  28,Volunteering (skills based) 4,000 hours valued at $550,000 for virtual Volunteer Service Trips Volunteering ~$120,value of pro bono hours donated We work to advance healthcare access  and equity in communities worldwide We rely on meaningful, long-term and strategic partnerships and programs to help ensure that we are advancing the health of our communities and our people by enabling a healthy workforce.
","('Supply_Chain_Management', 0.3963967263698578)","('Physical_Impacts_Of_Climate_Change', 0.2915830910205841)","('Business_Model_Resilience', 0.06944737583398819)","('NON-ESG', 0.3963967263698578)","('NON-ESG', 0.2915830910205841)","('NON-ESG', 0.06944737583398819)"
Line 899,"2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Our contribution to healthy communities Charitable giving summary,   by the numbers: Total cash donations $11.1  million   for BD  $2.1 million   for BD  Foundation Total product donations $11.1  million Total contributions  $22.2 million for BD + $2.1 million for BD Foundation BD Foundation Expanding Healthcare Access: $900,Advancing Human Potential: $813,Supporting Resilient Communities: $410,Expanding Healthcare Access Health and human services: $5,255,Advancing Human Potential Education: $2,136,Other: $1,263,311  (Volunteerism and ID&E) Arts and culture: $473,Civic and social welfare: $1,516,740Disaster relief: $432,Environment: $55,570Supporting Resilient Communities Value of company match to associate  donations $1.9 million No. of grants issued, worldwide 381 for BD + 18 from BD Foundation No. of nonprofit beneficiaries 274 from BD + 13 from BD Foundation No. of matching gifts distributed  28,Volunteering (skills based) 4,000 hours valued at $550,000 for virtual Volunteer Service Trips Volunteering ~$120,value of pro bono hours donated We work to advance healthcare access  and equity in communities worldwide We rely on meaningful, long-term and strategic partnerships and programs to help ensure that we are advancing the health of our communities and our people by enabling a healthy workforce.
","('Business_Model_Resilience', 0.3800688087940216)","('Human_Rights_And_Community_Relations', 0.20835921168327332)","('Employee_Engagement_Inclusion_And_Diversity', 0.09675054997205734)","('NON-ESG', 0.3800688087940216)","('NON-ESG', 0.20835921168327332)","('NON-ESG', 0.09675054997205734)"
Line 900,"2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Our contribution to healthy communities Charitable giving summary,   by the numbers: Total cash donations $11.1  million   for BD  $2.1 million   for BD  Foundation Total product donations $11.1  million Total contributions  $22.2 million for BD + $2.1 million for BD Foundation BD Foundation Expanding Healthcare Access: $900,Advancing Human Potential: $813,Supporting Resilient Communities: $410,Expanding Healthcare Access Health and human services: $5,255,Advancing Human Potential Education: $2,136,Other: $1,263,311  (Volunteerism and ID&E) Arts and culture: $473,Civic and social welfare: $1,516,740Disaster relief: $432,Environment: $55,570Supporting Resilient Communities Value of company match to associate  donations $1.9 million No. of grants issued, worldwide 381 for BD + 18 from BD Foundation No. of nonprofit beneficiaries 274 from BD + 13 from BD Foundation No. of matching gifts distributed  28,Volunteering (skills based) 4,000 hours valued at $550,000 for virtual Volunteer Service Trips Volunteering ~$120,value of pro bono hours donated We work to advance healthcare access  and equity in communities worldwide We rely on meaningful, long-term and strategic partnerships and programs to help ensure that we are advancing the health of our communities and our people by enabling a healthy workforce.
","('Access_And_Affordability', 0.5154550671577454)","('Human_Rights_And_Community_Relations', 0.18558186292648315)","('Employee_Health_And_Safety', 0.08978839963674545)","(['Health Outcome Contribution'], 0.5154550671577454)","('NON-ESG', 0.18558186292648315)","('NON-ESG', 0.08978839963674545)"
Line 901,"We do this in three ways:  We advance human potential by empowering BD employees to make a meaningful difference in the communities and for the causes they care about We help build resilient communities through strategic product donations and by supporting recovery efforts following disasters, pandemics and conflict2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities We are advancing  human potential Connecting with our communities: virtual volunteering For nearly 20 years, through the BD Volunteer Service Trip (VST) program, BD has sent teams of volunteers to low-resource communities to help strengthen local health systems through training, education, laboratory services and construction projects.
","('Supply_Chain_Management', 0.35055869817733765)","('Physical_Impacts_Of_Climate_Change', 0.22068150341510773)","('Business_Model_Resilience', 0.16297705471515656)","('NON-ESG', 0.35055869817733765)","('NON-ESG', 0.22068150341510773)","('NON-ESG', 0.16297705471515656)"
Line 902,"We do this in three ways:  We advance human potential by empowering BD employees to make a meaningful difference in the communities and for the causes they care about We help build resilient communities through strategic product donations and by supporting recovery efforts following disasters, pandemics and conflict2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities We are advancing  human potential Connecting with our communities: virtual volunteering For nearly 20 years, through the BD Volunteer Service Trip (VST) program, BD has sent teams of volunteers to low-resource communities to help strengthen local health systems through training, education, laboratory services and construction projects.
","('Employee_Health_And_Safety', 0.31166982650756836)","('Access_And_Affordability', 0.249271422624588)","('Human_Rights_And_Community_Relations', 0.197800874710083)","('NON-ESG', 0.31166982650756836)","('NON-ESG', 0.249271422624588)","('NON-ESG', 0.197800874710083)"
Line 903,"Although COVID-19 made in-person, inter-country volunteerism a challenge, our volunteers didn’t let that stop them.
","('Human_Rights_And_Community_Relations', 0.27404916286468506)","('Employee_Health_And_Safety', 0.2666078209877014)","('Critical_Incident_Risk_Management', 0.08897019177675247)","('NON-ESG', 0.27404916286468506)","('NON-ESG', 0.2666078209877014)","('NON-ESG', 0.08897019177675247)"
Line 904,"We created an innovative alternative: virtual service opportunities that kept BD volunteers connected with communities around the world and to our culture of service.
","('Human_Rights_And_Community_Relations', 0.27692076563835144)","('Employee_Health_And_Safety', 0.20647424459457397)","('Access_And_Affordability', 0.1329323649406433)","('NON-ESG', 0.27692076563835144)","('NON-ESG', 0.20647424459457397)","('NON-ESG', 0.1329323649406433)"
Line 905,"In 2021 and early 2022, BD volunteers from 14 countries  participated in company-sponsored, virtual volunteer service projects, each of which sought to expand healthcare access among vulnerable populations.
","('Access_And_Affordability', 0.8263096809387207)","('Human_Rights_And_Community_Relations', 0.0376708060503006)","('Employee_Health_And_Safety', 0.025108499452471733)","(['Health Outcome Contribution'], 0.8263096809387207)","('NON-ESG', 0.0376708060503006)","('NON-ESG', 0.025108499452471733)"
Line 906,"Celebrating service: BD Volunteers of the Year The Henry P .
","('Employee_Engagement_Inclusion_And_Diversity', 0.23985469341278076)","('Employee_Health_And_Safety', 0.18661607801914215)","('Human_Rights_And_Community_Relations', 0.07171490043401718)","('NON-ESG', 0.23985469341278076)","('NON-ESG', 0.18661607801914215)","('NON-ESG', 0.07171490043401718)"
Line 907,"Becton Volunteer Impact Awards celebrate the achievements of our BD “Volunteers of the Year” by issuing philanthropic grants to the nonprofit organizations they serve.
","('Employee_Health_And_Safety', 0.22999659180641174)","('Human_Rights_And_Community_Relations', 0.2141021192073822)","('Access_And_Affordability', 0.1482771933078766)","('NON-ESG', 0.22999659180641174)","('NON-ESG', 0.2141021192073822)","('NON-ESG', 0.1482771933078766)"
Line 908,"In 2021, BD awarded grants totaling $80,000 to 20 nonprofit organizations around the world, recognizing the community service of 20 BD volunteers from 10 countries.
","('Human_Rights_And_Community_Relations', 0.3634118437767029)","('Access_And_Affordability', 0.2714633345603943)","('Employee_Health_And_Safety', 0.07838745415210724)","('NON-ESG', 0.3634118437767029)","('NON-ESG', 0.2714633345603943)","('NON-ESG', 0.07838745415210724)"
Line 909,"California,  Iowa, Maryland, Massachusetts, New Jersey,  Rhode Island Brazil SpainItaly Singapore Ireland, UKCanada Mexico India 28,donations to eligible 501(c)(3) organizations matched by BD$1.9M  total investmentup to $5,per U.S. associate, per year,  matched by BDAmplifying the impact of employees’ charitable donations2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Creating a sense of belonging through team-based acts of service In just about every country in the world, BD associates find creative ways to join together to give back to the communities where they live and work.
","('Physical_Impacts_Of_Climate_Change', 0.7667644023895264)","('Supply_Chain_Management', 0.10976120829582214)","('Business_Model_Resilience', 0.023067384958267212)","(['Climate Change'], 0.7667644023895264)","('NON-ESG', 0.10976120829582214)","('NON-ESG', 0.023067384958267212)"
Line 910,"California,  Iowa, Maryland, Massachusetts, New Jersey,  Rhode Island Brazil SpainItaly Singapore Ireland, UKCanada Mexico India 28,donations to eligible 501(c)(3) organizations matched by BD$1.9M  total investmentup to $5,per U.S. associate, per year,  matched by BDAmplifying the impact of employees’ charitable donations2021 ESG Report Appendices Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Creating a sense of belonging through team-based acts of service In just about every country in the world, BD associates find creative ways to join together to give back to the communities where they live and work.
","('Human_Rights_And_Community_Relations', 0.9048454761505127)","('Access_And_Affordability', 0.02650376781821251)","('Ecological_Impacts', 0.006919747218489647)","(['Community Relations'], 0.9048454761505127)","('NON-ESG', 0.02650376781821251)","('NON-ESG', 0.006919747218489647)"
Line 911,"Since 2013, in recognition of the Dr. Martin Luther King, Jr. Day of Service, BD  associates from more than a dozen locations across the United States have joined together to pack shelf-stable meals for Rise Against Hunger , to be delivered to  hungry and food-insecure people around the world.
","('Access_And_Affordability', 0.2671920359134674)","('Customer_Welfare', 0.21088066697120667)","('Selling_Practices_And_Product_Labeling', 0.08372607082128525)","('NON-ESG', 0.2671920359134674)","('NON-ESG', 0.21088066697120667)","('NON-ESG', 0.08372607082128525)"
Line 912,"In 2022, BD volunteers at 14 U.S. locations reached the collective goal packing over 1 million meals.
","('Access_And_Affordability', 0.4061877429485321)","('Employee_Health_And_Safety', 0.0883563682436943)","('Labor_Practices', 0.07867681980133057)","('NON-ESG', 0.4061877429485321)","('NON-ESG', 0.0883563682436943)","('NON-ESG', 0.07867681980133057)"
Line 913,"The BD WIN + STEM associate resource group at our Franklin Lakes, New Jersey, U.S., campus demonstrated its commitment to encouraging girls and women to pursue careers in STEM by teaching local Girl Scouts about STEM career options, like coding and computer science, and by sharing tips to help participants stay safe online.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8438181281089783)","('Access_And_Affordability', 0.025118285790085793)","('Employee_Health_And_Safety', 0.012608611024916172)","(['Human Capital Development'], 0.8438181281089783)","('NON-ESG', 0.025118285790085793)","('NON-ESG', 0.012608611024916172)"
Line 914,"A team of BD volunteers who work at the Latin America Shared Service Center (LASCC) in Santiago, Chile, partnered with Cultiva to do their part to improve planet health by planting a hillside forest together.
","('Ecological_Impacts', 0.31075382232666016)","('Access_And_Affordability', 0.24213674664497375)","('Employee_Health_And_Safety', 0.09259580075740814)","('NON-ESG', 0.31075382232666016)","('NON-ESG', 0.24213674664497375)","('NON-ESG', 0.09259580075740814)"
Line 915,"BD volunteers in the Czech Republic collectively ran, walked and cycled more than 1,000 km (660.5 miles) to raise funds for abandoned and neglected children who are served by the Tereza Maxova Foundation.
","('Access_And_Affordability', 0.846950888633728)","('Employee_Health_And_Safety', 0.031021500006318092)","('Human_Rights_And_Community_Relations', 0.01594303362071514)","(['Health Outcome Contribution'], 0.846950888633728)","('NON-ESG', 0.031021500006318092)","('NON-ESG', 0.01594303362071514)"
Line 916,"“This service experience was an amazing opportunity to be part of an international team, and to connect with different cultures and different ways of working.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8039803504943848)","('Human_Rights_And_Community_Relations', 0.05070054158568382)","('Employee_Health_And_Safety', 0.0236516073346138)","(['Human Capital Development'], 0.8039803504943848)","('NON-ESG', 0.05070054158568382)","('NON-ESG', 0.0236516073346138)"
Line 917,"Our team of BD volunteers collaborated from different time zones, and we each brought a unique cultural perspective—proving that our diversity can improve results when we work with empathy.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9708572030067444)","('Employee_Health_And_Safety', 0.0023280801251530647)","('Human_Rights_And_Community_Relations', 0.0021896949037909508)","(['Human Capital Development'], 0.9708572030067444)","('NON-ESG', 0.0023280801251530647)","('NON-ESG', 0.0021896949037909508)"
Line 918,"This experience gave me the chance to live our Purpose of advancing the world of health TM, by helping a health clinic and its  patients, who are located far away from my home,” said Diogo Carvalho, communication and change management, manager for Latin America, and who is based in São Paulo, Brazil, who volunteered to help U.S. free and charitable clinics raise awareness of services, secure funding and recruit, onboard and train community health workers.
","('Access_And_Affordability', 0.6767157912254333)","('Employee_Health_And_Safety', 0.08914685249328613)","('Human_Rights_And_Community_Relations', 0.03937530145049095)","(['Health Outcome Contribution'], 0.6767157912254333)","('NON-ESG', 0.08914685249328613)","('NON-ESG', 0.03937530145049095)"
Line 919,"2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices $125K  Flood recovery in the Gulf Coast and the  East Coast of the United States$50K  Relief for veterans in the United States and refugees from Afghanistan$240K  Flood recovery in Germany, Belgium and the Netherlands $50K  Earthquake recovery in Haiti$600K  Humanitarian relief in Ukraine $300K  COVID-19 relief in IndiaHow we support resilient communities For more than a decade, BD has partnered with international relief agencies including the American Red Cross, Direct Relief, AmeriCares, MAP International, CMMB and  Heart to Heart International to deploy product donations and cash support quickly and efficiently to build the resiliency of communities worldwide as they work to recover from disasters, pandemics and conflict.
","('Physical_Impacts_Of_Climate_Change', 0.7890962362289429)","('Supply_Chain_Management', 0.06212674081325531)","('Critical_Incident_Risk_Management', 0.04109781235456467)","(['Climate Change'], 0.7890962362289429)","('NON-ESG', 0.06212674081325531)","('NON-ESG', 0.04109781235456467)"
Line 920,"2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices $125K  Flood recovery in the Gulf Coast and the  East Coast of the United States$50K  Relief for veterans in the United States and refugees from Afghanistan$240K  Flood recovery in Germany, Belgium and the Netherlands $50K  Earthquake recovery in Haiti$600K  Humanitarian relief in Ukraine $300K  COVID-19 relief in IndiaHow we support resilient communities For more than a decade, BD has partnered with international relief agencies including the American Red Cross, Direct Relief, AmeriCares, MAP International, CMMB and  Heart to Heart International to deploy product donations and cash support quickly and efficiently to build the resiliency of communities worldwide as they work to recover from disasters, pandemics and conflict.
","('Critical_Incident_Risk_Management', 0.8080220818519592)","('Physical_Impacts_Of_Climate_Change', 0.056767720729112625)","('Human_Rights_And_Community_Relations', 0.029007140547037125)","(['Risk & Crisis Management'], 0.8080220818519592)","('NON-ESG', 0.056767720729112625)","('NON-ESG', 0.029007140547037125)"
Line 921,"In 2021 and the early part of 2022, philanthropic cash and product donations from the BD Foundation were deployed to regions around the world.Responding to the conflict in Ukraine:BD and the BD Foundation committed $600,000 in cash to  support our trusted international relief partners—Americares, International Medical Corps and Project HOPE—in their response to the humanitarian crisis caused by the conflict in Ukraine.
","('Critical_Incident_Risk_Management', 0.8736732602119446)","('Physical_Impacts_Of_Climate_Change', 0.02256486378610134)","('Human_Rights_And_Community_Relations', 0.019080793485045433)","(['Risk & Crisis Management'], 0.8736732602119446)","('NON-ESG', 0.02256486378610134)","('NON-ESG', 0.019080793485045433)"
Line 922,"This cash support helped expand access to emergency healthcare services, mobile medical units, essential medicines and medical supplies.
","('Critical_Incident_Risk_Management', 0.9660059213638306)","('Access_And_Affordability', 0.004424249287694693)","('Employee_Health_And_Safety', 0.003248977940529585)","(['Risk & Crisis Management'], 0.9660059213638306)","('NON-ESG', 0.004424249287694693)","('NON-ESG', 0.003248977940529585)"
Line 923,"BD employees also contributed more than $90,000 to the BD Associate Relief Fund, which provided a total of 90 grants to BD colleagues who were impacted by the 2022 conflict in Ukraine.
","('Human_Rights_And_Community_Relations', 0.33516162633895874)","('Employee_Health_And_Safety', 0.18868157267570496)","('Access_And_Affordability', 0.1415555626153946)","('NON-ESG', 0.33516162633895874)","('NON-ESG', 0.18868157267570496)","('NON-ESG', 0.1415555626153946)"
Line 924,"Responding to flooding in Germany, Belgium and  the Netherlands:  In July 2021, heavy rains caused devastating flooding in regions of  Germany, Belgium and the Netherlands, causing tragic loss of life and widespread destruction of property and infrastructure.
","('Critical_Incident_Risk_Management', 0.637265682220459)","('Physical_Impacts_Of_Climate_Change', 0.2093524932861328)","('Water_And_Wastewater_Management', 0.019005389884114265)","(['Risk & Crisis Management'], 0.637265682220459)","('NON-ESG', 0.2093524932861328)","('NON-ESG', 0.019005389884114265)"
Line 925,"BD and the BD Foundation together donated $240,000 to the disaster response effort in the region, and more than a dozen BD associates served as volunteer firefighters who worked tirelessly to save and serve families whose lives or homes were endangered by the flooding.
","('Critical_Incident_Risk_Management', 0.9702050089836121)","('Employee_Health_And_Safety', 0.003951201681047678)","('Physical_Impacts_Of_Climate_Change', 0.0036284159868955612)","(['Risk & Crisis Management'], 0.9702050089836121)","('NON-ESG', 0.003951201681047678)","('NON-ESG', 0.0036284159868955612)"
Line 926,"“It is really hard to put into words the impact the floods had on our community…the floods stopped at nothing.
","('Physical_Impacts_Of_Climate_Change', 0.49292057752609253)","('Critical_Incident_Risk_Management', 0.3294370770454407)","('Water_And_Wastewater_Management', 0.020738346502184868)","('NON-ESG', 0.49292057752609253)","('NON-ESG', 0.3294370770454407)","('NON-ESG', 0.020738346502184868)"
Line 927,"Whole houses were washed away,” said Hermann Sicken, BD Environment, Health and Safety Specialist who serves as chief fire officer in a volunteer firefighter brigade that responded to extensive flooding in Kelberg, Germany.
","('Critical_Incident_Risk_Management', 0.8648086190223694)","('Water_And_Wastewater_Management', 0.024637002497911453)","('Physical_Impacts_Of_Climate_Change', 0.020380774512887)","(['Risk & Crisis Management'], 0.8648086190223694)","('NON-ESG', 0.024637002497911453)","('NON-ESG', 0.020380774512887)"
Line 928,"“I see firefighting as a passion and a certain duty to help other people.
","('Critical_Incident_Risk_Management', 0.9414752125740051)","('Employee_Health_And_Safety', 0.01923532783985138)","('Air_Quality', 0.005114220082759857)","(['Risk & Crisis Management'], 0.9414752125740051)","('NON-ESG', 0.01923532783985138)","('NON-ESG', 0.005114220082759857)"
Line 929,"It is an indescribable feeling when you are able to save someone.”2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices “We are so grateful for the opportunity to offer point-of-care lab  testing to our patients,” said Sharon Kallam, RN MSN, Director of Quality Assurance and Risk Management at Grace Clinic of Yadkin Valley, North Carolina, one of the dozens of U.S. free clinics that has received lab funding and volunteer support from BD.
","('Supply_Chain_Management', 0.9090431332588196)","('Physical_Impacts_Of_Climate_Change', 0.017542695626616478)","('Product_Design_And_Lifecycle_Management', 0.012107456102967262)","(['Supply Chain Management'], 0.9090431332588196)","('NON-ESG', 0.017542695626616478)","('NON-ESG', 0.012107456102967262)"
Line 930,"It is an indescribable feeling when you are able to save someone.”2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices “We are so grateful for the opportunity to offer point-of-care lab  testing to our patients,” said Sharon Kallam, RN MSN, Director of Quality Assurance and Risk Management at Grace Clinic of Yadkin Valley, North Carolina, one of the dozens of U.S. free clinics that has received lab funding and volunteer support from BD.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2727401852607727)","('Access_And_Affordability', 0.2671383023262024)","('Energy_Management', 0.054023727774620056)","('NON-ESG', 0.2727401852607727)","('NON-ESG', 0.2671383023262024)","('NON-ESG', 0.054023727774620056)"
Line 931,"“During the first month we were able to offer on-site diagnostic testing, we identified nine positive Hep C patients, four of which were unaware of their status and were referred to a center for treatment.”“By supporting this important, first-of-its-kind initiative, we’re helping to empower U.S. free and charitable clinics to measure and track the degree to which their healthcare services are effectively addressing inequities, so we can determine where additional support is needed to ensure more equitable healthcare quality and access for all.”  — T om Polen  BD Chairman, CEO and PresidentAdvancing healthcare access  and equity At BD, we are working to advance equity and access to healthcare around the  world.
","('Access_And_Affordability', 0.48489776253700256)","('Customer_Welfare', 0.07449072599411011)","('Product_Quality_And_Safety', 0.05990016832947731)","('NON-ESG', 0.48489776253700256)","('NON-ESG', 0.07449072599411011)","('NON-ESG', 0.05990016832947731)"
Line 932,"“During the first month we were able to offer on-site diagnostic testing, we identified nine positive Hep C patients, four of which were unaware of their status and were referred to a center for treatment.”“By supporting this important, first-of-its-kind initiative, we’re helping to empower U.S. free and charitable clinics to measure and track the degree to which their healthcare services are effectively addressing inequities, so we can determine where additional support is needed to ensure more equitable healthcare quality and access for all.”  — T om Polen  BD Chairman, CEO and PresidentAdvancing healthcare access  and equity At BD, we are working to advance equity and access to healthcare around the  world.
","('Access_And_Affordability', 0.8666868209838867)","('Product_Quality_And_Safety', 0.01472901739180088)","('Employee_Engagement_Inclusion_And_Diversity', 0.009993810206651688)","(['Health Outcome Contribution'], 0.8666868209838867)","('NON-ESG', 0.01472901739180088)","('NON-ESG', 0.009993810206651688)"
Line 933,"This effort is driven by (1) BD’s Social Investing team, which works with philanthropic and nongovernmental organizations (NGOs) to provide strategic support, investment and product donation; and (2) the BD Global Public Health team, which collaborates with governments and leading global NGOs to strengthen health and laboratory systems in low- and middle-income countries (LMICs) around the world.
","('Access_And_Affordability', 0.6062517762184143)","('Human_Rights_And_Community_Relations', 0.13812297582626343)","('Management_Of_Legal_And_Regulatory_Framework', 0.04217727482318878)","(['Health Outcome Contribution'], 0.6062517762184143)","('NON-ESG', 0.13812297582626343)","('NON-ESG', 0.04217727482318878)"
Line 934,"How we expand healthcare access and equity…in the United States Since 2009, we have invested more than $34.5 million in helping community-based family doctors provide quality care to traditionally underserved groups, because without them, more than 32 million uninsured and underinsured patients would go without healthcare.
","('Access_And_Affordability', 0.9441800117492676)","('Critical_Incident_Risk_Management', 0.00562130706384778)","('Product_Quality_And_Safety', 0.005043650045990944)","(['Health Outcome Contribution'], 0.9441800117492676)","('NON-ESG', 0.00562130706384778)","('NON-ESG', 0.005043650045990944)"
Line 935,"These investments expand access to quality patient care, particularly among  patients experiencing diabetes, hypertension, depression and difficulty with medication compliance.Peer-reviewed data demonstrates that our approach is working.
","('Access_And_Affordability', 0.7786166071891785)","('Employee_Health_And_Safety', 0.039435505867004395)","('Product_Quality_And_Safety', 0.03152141720056534)","(['Health Outcome Contribution'], 0.7786166071891785)","('NON-ESG', 0.039435505867004395)","('NON-ESG', 0.03152141720056534)"
Line 936,"Patients enrolled in a comprehensive medication management program at federally qualified health centers that received philanthropic funding from BD saw their hemoglobin A1C scores decrease by 1.2 percent in just six months—equating to a 20 percent lower risk of death.
","('Employee_Health_And_Safety', 0.43238985538482666)","('Access_And_Affordability', 0.19819806516170502)","('Product_Quality_And_Safety', 0.06034741550683975)","('NON-ESG', 0.43238985538482666)","('NON-ESG', 0.19819806516170502)","('NON-ESG', 0.06034741550683975)"
Line 937,"Our social investments in free and charitable clinics and community health centers  in action include: •  Shar e Our Selves in Costa Mesa, California: More than 68 percent of patients  served by Share Our Selves community health center identify as Latinx, and  many are homeless.
","('Access_And_Affordability', 0.8439955711364746)","('Human_Rights_And_Community_Relations', 0.02246042527258396)","('Employee_Health_And_Safety', 0.01851625367999077)","(['Health Outcome Contribution'], 0.8439955711364746)","('NON-ESG', 0.02246042527258396)","('NON-ESG', 0.01851625367999077)"
Line 938,"BD funding enables patients living in shelters—particularly those who face multiple chronic conditions and take multiple, complex medications—to receive individualized pharmacist counseling, in their native language, via telehealth technology.
","('Access_And_Affordability', 0.4949076175689697)","('Customer_Welfare', 0.10373644530773163)","('Product_Quality_And_Safety', 0.06617788225412369)","('NON-ESG', 0.4949076175689697)","('NON-ESG', 0.10373644530773163)","('NON-ESG', 0.06617788225412369)"
Line 939,"•  B VMI Healthcare Center in Bergen County, New Jersey: Located in  the same county where BD’s global headquarters is located, a team of more than 75 volunteer healthcare professionals provide quality care to a diverse population of more than 1,200 patients—most of whom may not otherwise have healthcare access.
","('Access_And_Affordability', 0.7212216854095459)","('Employee_Health_And_Safety', 0.035505738109350204)","('Customer_Welfare', 0.032244861125946045)","(['Health Outcome Contribution'], 0.7212216854095459)","('NON-ESG', 0.035505738109350204)","('NON-ESG', 0.032244861125946045)"
Line 940,"In 2021, BD sponsored the launch of their BVMI Women’s Health Initiative, which provides specialized, high-quality, compassionate healthcare services for nearly 800 women.
","('Access_And_Affordability', 0.6110444068908691)","('Employee_Engagement_Inclusion_And_Diversity', 0.09268207103013992)","('Employee_Health_And_Safety', 0.053299468010663986)","(['Health Outcome Contribution'], 0.6110444068908691)","('NON-ESG', 0.09268207103013992)","('NON-ESG', 0.053299468010663986)"
Line 941,"•  Helping f ree clinics provide better diagnostic care to underserved patients:   From FY 2017 to FY 2021, BD has invested more than $1.3 million in helping free and charitable clinics in the United States to streamline the treatment they deliver to patients by providing essential diagnostic point of care (POC) testing equipment, supplies and quality controls to administer and share the results of diagnostic tests during a single medical visit.
","('Access_And_Affordability', 0.9125989675521851)","('Product_Quality_And_Safety', 0.010983830317854881)","('Critical_Incident_Risk_Management', 0.007819470018148422)","(['Health Outcome Contribution'], 0.9125989675521851)","('NON-ESG', 0.010983830317854881)","('NON-ESG', 0.007819470018148422)"
Line 942,"BD volunteers with laboratory expertise have been deployed to 21 free clinics, providing hands-on training and support to clinic staff.
","('Access_And_Affordability', 0.7318189144134521)","('Employee_Engagement_Inclusion_And_Diversity', 0.04530172795057297)","('Ecological_Impacts', 0.02124932035803795)","(['Health Outcome Contribution'], 0.7318189144134521)","('NON-ESG', 0.04530172795057297)","('NON-ESG', 0.02124932035803795)"
Line 943,"In 2021, BD also provided participating clinics with SARS-COV-2 testing using the BD Veritor™ system.Investing in a more equitable healthcare future for all At BD, we know that racial, societal and economic  factors have a direct impact on people’s health and their ability to access needed healthcare and other resources.
","('Access_And_Affordability', 0.7384086847305298)","('Human_Rights_And_Community_Relations', 0.049600183963775635)","('Employee_Health_And_Safety', 0.04135620966553688)","(['Health Outcome Contribution'], 0.7384086847305298)","('NON-ESG', 0.049600183963775635)","('NON-ESG', 0.04135620966553688)"
Line 944,"We also know that a multifaceted approach is required to deliver care that does not vary in quality because of someone’s race, gender expression, sexual preference, income, abilities or location.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9722338914871216)","('Customer_Privacy', 0.00220888270996511)","('Employee_Health_And_Safety', 0.0021519979927688837)","(['Human Capital Development'], 0.9722338914871216)","('NON-ESG', 0.00220888270996511)","('NON-ESG', 0.0021519979927688837)"
Line 945,"That’s why in 2021, BD invested $500,000 in the Roadmap to Health Equity Initiative, spearheaded by Americares.
","('Access_And_Affordability', 0.5735169649124146)","('Systemic_Risk_Management', 0.07166675478219986)","('Management_Of_Legal_And_Regulatory_Framework', 0.03341662883758545)","(['Health Outcome Contribution'], 0.5735169649124146)","('NON-ESG', 0.07166675478219986)","('NON-ESG', 0.03341662883758545)"
Line 946,"$34.5 million:  our philanthropic investments in free and  charitable clinics and community health centers, since 2009.
","('Access_And_Affordability', 0.8091912269592285)","('Management_Of_Legal_And_Regulatory_Framework', 0.03592509403824806)","('Human_Rights_And_Community_Relations', 0.02660478465259075)","(['Health Outcome Contribution'], 0.8091912269592285)","('NON-ESG', 0.03592509403824806)","('NON-ESG', 0.02660478465259075)"
Line 947,"In the U.S., 32 million  patients receive care through free and charitable  clinics and community health centers 63% of community health center patients are members  of a racial/ethnic minority, even though racial/ethnic minorities comprise just 40% of the general U.S. population2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices Photo: Kenya, September 2020Statistics courtesy of UNICEF USAHow we expand healthcare access and  equity…globally Each year, 18.6 million people die due to lack of access to surgical care, 93 percent of whom are in Africa.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7752873301506042)","('Human_Rights_And_Community_Relations', 0.06161041557788849)","('Access_And_Affordability', 0.03263697028160095)","(['Human Capital Development'], 0.7752873301506042)","('NON-ESG', 0.06161041557788849)","('NON-ESG', 0.03263697028160095)"
Line 948,"In the U.S., 32 million  patients receive care through free and charitable  clinics and community health centers 63% of community health center patients are members  of a racial/ethnic minority, even though racial/ethnic minorities comprise just 40% of the general U.S. population2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices Photo: Kenya, September 2020Statistics courtesy of UNICEF USAHow we expand healthcare access and  equity…globally Each year, 18.6 million people die due to lack of access to surgical care, 93 percent of whom are in Africa.
","('Access_And_Affordability', 0.6420570015907288)","('Employee_Health_And_Safety', 0.13801339268684387)","('Critical_Incident_Risk_Management', 0.03712679073214531)","(['Health Outcome Contribution'], 0.6420570015907288)","('NON-ESG', 0.13801339268684387)","('NON-ESG', 0.03712679073214531)"
Line 949,"As the fragile healthcare systems in African nations continue to recover from the impacts of the COVID-19 pandemic, the need to provide basic life-saving surgical care is greater than ever.
","('Critical_Incident_Risk_Management', 0.33201974630355835)","('Access_And_Affordability', 0.31770452857017517)","('Employee_Health_And_Safety', 0.11645623296499252)","('NON-ESG', 0.33201974630355835)","('NON-ESG', 0.31770452857017517)","('NON-ESG', 0.11645623296499252)"
Line 950,"Over the past 28 years, BD has donated more than $2.5 million in cash and  product to Mercy Ships to support its mission of bringing free, safe surgical care to Africans in need, aboard its unique “floating hospital” ships.
","('Access_And_Affordability', 0.6257763504981995)","('Employee_Health_And_Safety', 0.11560670286417007)","('Critical_Incident_Risk_Management', 0.06989727914333344)","(['Health Outcome Contribution'], 0.6257763504981995)","('NON-ESG', 0.11560670286417007)","('NON-ESG', 0.06989727914333344)"
Line 951,"BD also provides philanthropic support to the Royal College of Surgeons (RCSI), Ireland, to help it expand surgical access to 8 million children in Malawi, and to help Operation Smile deliver cleft palate surgeries, globally.
","('Access_And_Affordability', 0.6578516364097595)","('Employee_Engagement_Inclusion_And_Diversity', 0.0851043164730072)","('Employee_Health_And_Safety', 0.0654699057340622)","(['Health Outcome Contribution'], 0.6578516364097595)","('NON-ESG', 0.0851043164730072)","('NON-ESG', 0.0654699057340622)"
Line 952,"Advancing maternal health and reducing avoidable newborn deaths, globally 80% 161Mof countries identiﬁed as “high risk” in 1999 have achieved elimination of the diseaseNeonatal tetanus kills 1 newborn every 21 minutes —but it is highly preventable women have been immunized against tetanus since 1999Tetanus toxoid vaccineconfers immunity for the ﬁrstmonth of life to a child born to an immunized woman Although maternal and neonatal tetanus (MNT) has been all but eliminated  in most economically advanced countries, it still kills one newborn every 21 minutes, or approximately 68 newborns every day.
","('Employee_Health_And_Safety', 0.6106318831443787)","('Access_And_Affordability', 0.14681757986545563)","('Critical_Incident_Risk_Management', 0.03809589147567749)","(['Operational Eco-Efficiency'], 0.6106318831443787)","('NON-ESG', 0.14681757986545563)","('NON-ESG', 0.03809589147567749)"
Line 953,"Advancing maternal health and reducing avoidable newborn deaths, globally 80% 161Mof countries identiﬁed as “high risk” in 1999 have achieved elimination of the diseaseNeonatal tetanus kills 1 newborn every 21 minutes —but it is highly preventable women have been immunized against tetanus since 1999Tetanus toxoid vaccineconfers immunity for the ﬁrstmonth of life to a child born to an immunized woman Although maternal and neonatal tetanus (MNT) has been all but eliminated  in most economically advanced countries, it still kills one newborn every 21 minutes, or approximately 68 newborns every day.
","('Employee_Health_And_Safety', 0.2517215609550476)","('Access_And_Affordability', 0.15145546197891235)","('Employee_Engagement_Inclusion_And_Diversity', 0.06044190004467964)","('NON-ESG', 0.2517215609550476)","('NON-ESG', 0.15145546197891235)","('NON-ESG', 0.06044190004467964)"
Line 954,"Knowing that MNT is entirely preventable with immunizations and consistent health services for mothers, BD began supporting UNICEF’s neonatal tetanus immunization program in 1997.
","('Access_And_Affordability', 0.7565904259681702)","('Employee_Health_And_Safety', 0.06553336977958679)","('Product_Quality_And_Safety', 0.03458516299724579)","(['Health Outcome Contribution'], 0.7565904259681702)","('NON-ESG', 0.06553336977958679)","('NON-ESG', 0.03458516299724579)"
Line 955,"The program ensures that mothers in remote geographic regions that experience high rates of MNT have access to life-saving immunizations and gynecological care.
","('Access_And_Affordability', 0.8556784987449646)","('Employee_Health_And_Safety', 0.02227887324988842)","('Critical_Incident_Risk_Management', 0.015758907422423363)","(['Health Outcome Contribution'], 0.8556784987449646)","('NON-ESG', 0.02227887324988842)","('NON-ESG', 0.015758907422423363)"
Line 956,"Since the inception of the program in 1997, with the help of $10.8 million in funding from BD, newborn deaths from MNT have declined by 88 percent.
","('Employee_Health_And_Safety', 0.39628303050994873)","('Access_And_Affordability', 0.21805386245250702)","('Critical_Incident_Risk_Management', 0.07650143653154373)","('NON-ESG', 0.39628303050994873)","('NON-ESG', 0.21805386245250702)","('NON-ESG', 0.07650143653154373)"
Line 957,"Collaborating with governments, leading  agencies and NGOs to strengthen health systems BD, PEPFAR and CDC public-private partnerships BD has established a series of partnerships with the U.S. President’s Emergency Plan for  AIDS Relief (PEPFAR) and the U.S. Center for Disease Control (CDC) and ministries of health.
","('Critical_Incident_Risk_Management', 0.9676152467727661)","('Physical_Impacts_Of_Climate_Change', 0.00411912752315402)","('Air_Quality', 0.0033383581321686506)","(['Risk & Crisis Management'], 0.9676152467727661)","('NON-ESG', 0.00411912752315402)","('NON-ESG', 0.0033383581321686506)"
Line 958,"These partnerships help us strengthen laboratory systems and upgrade clinical practices in blood culture specimen collection, phlebotomy, infusion and injection.
","('Customer_Welfare', 0.1841641664505005)","('Employee_Health_And_Safety', 0.12203104794025421)","('Access_And_Affordability', 0.12030366063117981)","('NON-ESG', 0.1841641664505005)","('NON-ESG', 0.12203104794025421)","('NON-ESG', 0.12030366063117981)"
Line 959,"Enhancing healthcare workers’ and patients’ safety in Kenya  in partnership with PEPFAR, CDC Kenya and Kenya’s ministry of health In September 2021, as part of BD’s long-standing partnership with PEPFAR, CDC  Kenya and the Kenya ministry of health (MOH), the first ever blood culture specimen management training for healthcare workers was conducted to enhance their safety and patients’ safety.
","('Employee_Health_And_Safety', 0.9790679216384888)","('Employee_Engagement_Inclusion_And_Diversity', 0.002162799471989274)","('Product_Quality_And_Safety', 0.0020707405637949705)","(['Operational Eco-Efficiency'], 0.9790679216384888)","('NON-ESG', 0.002162799471989274)","('NON-ESG', 0.0020707405637949705)"
Line 960,"The training curriculum—which was prepared by BD and reviewed and adopted by CDC and MOH—included topics such as introduction to antimicrobial resistance (AMR) and sepsis, safe blood culture collection and preparation of blood cultures, the blood culture sample pathway and diagnosis of catheter-related blood stream infection (CRBSI).
","('Employee_Health_And_Safety', 0.40241459012031555)","('Product_Quality_And_Safety', 0.08824861794710159)","('Selling_Practices_And_Product_Labeling', 0.056488074362277985)","('NON-ESG', 0.40241459012031555)","('NON-ESG', 0.08824861794710159)","('NON-ESG', 0.056488074362277985)"
Line 961,"Due to the COVID-19 pandemic travel restrictions, the training used a mixed methodology of virtual and in-person training.
","('Employee_Health_And_Safety', 0.7147007584571838)","('Labor_Practices', 0.03620896115899086)","('Critical_Incident_Risk_Management', 0.031326085329055786)","(['Operational Eco-Efficiency'], 0.7147007584571838)","('NON-ESG', 0.03620896115899086)","('NON-ESG', 0.031326085329055786)"
Line 962,"Over 40 participants from 12 facilities across Kenya were trained in two separate two-day training sessions.“ Antimicrobial resistance has become a global  challenge and Kenya is not spared.
","('Access_And_Affordability', 0.1554974913597107)","('Customer_Welfare', 0.14210329949855804)","('Selling_Practices_And_Product_Labeling', 0.12490863353013992)","('NON-ESG', 0.1554974913597107)","('NON-ESG', 0.14210329949855804)","('NON-ESG', 0.12490863353013992)"
Line 963,"Antimicrobial  stewardship programs are being scaled up in Kenya and they recommend the use of blood culture for diagnosis.
","('Water_And_Wastewater_Management', 0.32012614607810974)","('Ecological_Impacts', 0.11957570165395737)","('Customer_Welfare', 0.09311249852180481)","('NON-ESG', 0.32012614607810974)","('NON-ESG', 0.11957570165395737)","('NON-ESG', 0.09311249852180481)"
Line 964,"Proper collection and management of the blood culture specimen is critical for correct diagnosis.
","('Employee_Health_And_Safety', 0.2008361518383026)","('Water_And_Wastewater_Management', 0.19089947640895844)","('Waste_And_Hazardous_Materials_Management', 0.17188714444637299)","('NON-ESG', 0.2008361518383026)","('NON-ESG', 0.19089947640895844)","('NON-ESG', 0.17188714444637299)"
Line 965,"This training, therefore, came at the right point in time and was really appreciated.
","('Access_And_Affordability', 0.24528612196445465)","('Employee_Engagement_Inclusion_And_Diversity', 0.13675978779792786)","('Employee_Health_And_Safety', 0.1256098449230194)","('NON-ESG', 0.24528612196445465)","('NON-ESG', 0.13675978779792786)","('NON-ESG', 0.1256098449230194)"
Line 966,"The MOH hopes to scale this up in future.” Dr Daniel Kimani   Technical Advisor, Laboratory, Health Systems and Infection  Control.
","('Employee_Health_And_Safety', 0.8116489052772522)","('Critical_Incident_Risk_Management', 0.023205939680337906)","('Product_Quality_And_Safety', 0.022866500541567802)","(['Operational Eco-Efficiency'], 0.8116489052772522)","('NON-ESG', 0.023205939680337906)","('NON-ESG', 0.022866500541567802)"
Line 967,"CDC, Nairobi, Kenya “Currently, there are no guidelines for Kenyan  hospitals on how to identify and collect blood specimens from suspected sepsis patients.
","('Employee_Health_And_Safety', 0.593777060508728)","('Water_And_Wastewater_Management', 0.06495913118124008)","('Waste_And_Hazardous_Materials_Management', 0.05497470125555992)","(['Operational Eco-Efficiency'], 0.593777060508728)","('NON-ESG', 0.06495913118124008)","('NON-ESG', 0.05497470125555992)"
Line 968,"This was a tremendous opportunity to capacity build the clinicians, nurses and laboratory personnel who are responsible for implementing best practices in their respective hospitals across the selected counties in Kenya.” Timons Sigo  BD Senior Clinical Resource Consultant, Nairobi, Kenya 2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices Photo: Lindsey Mathison, Rwanda, Labs for Life For over 14 years, BD collaborated with PEPFAR, CDC and ministries of health in a  public-private partnership called “Labs for Life,” which focused on strengthening laboratory systems in various countries across Africa and Asia.
","('Supply_Chain_Management', 0.7022956013679504)","('Physical_Impacts_Of_Climate_Change', 0.1704762876033783)","('Business_Model_Resilience', 0.01769513264298439)","(['Supply Chain Management'], 0.7022956013679504)","('NON-ESG', 0.1704762876033783)","('NON-ESG', 0.01769513264298439)"
Line 969,"This was a tremendous opportunity to capacity build the clinicians, nurses and laboratory personnel who are responsible for implementing best practices in their respective hospitals across the selected counties in Kenya.” Timons Sigo  BD Senior Clinical Resource Consultant, Nairobi, Kenya 2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices Photo: Lindsey Mathison, Rwanda, Labs for Life For over 14 years, BD collaborated with PEPFAR, CDC and ministries of health in a  public-private partnership called “Labs for Life,” which focused on strengthening laboratory systems in various countries across Africa and Asia.
","('Access_And_Affordability', 0.5621682405471802)","('Customer_Welfare', 0.04953574389219284)","('Product_Quality_And_Safety', 0.04860054701566696)","(['Health Outcome Contribution'], 0.5621682405471802)","('NON-ESG', 0.04953574389219284)","('NON-ESG', 0.04860054701566696)"
Line 970,"Launched in 2007, Labs for Life provided frontline training for laboratory  staff in countries heavily burdened with HIV.
","('Access_And_Affordability', 0.7249137759208679)","('Product_Quality_And_Safety', 0.036858931183815)","('Employee_Engagement_Inclusion_And_Diversity', 0.029449239373207092)","(['Health Outcome Contribution'], 0.7249137759208679)","('NON-ESG', 0.036858931183815)","('NON-ESG', 0.029449239373207092)"
Line 971,"As part of this partnership, the U.S. Department of State brought strategic guidance, HIV/AIDS technical expertise and in-kind resources.
","('Access_And_Affordability', 0.4740169048309326)","('Product_Quality_And_Safety', 0.08760534971952438)","('Employee_Health_And_Safety', 0.0735156461596489)","('NON-ESG', 0.4740169048309326)","('NON-ESG', 0.08760534971952438)","('NON-ESG', 0.0735156461596489)"
Line 972,"The CDC provided oversight and technical guidance and served as the implementing agency through CDC country offices and local partners.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8861393332481384)","('Access_And_Affordability', 0.012759936973452568)","('Human_Rights_And_Community_Relations', 0.012268584221601486)","(['Corporate Governance'], 0.8861393332481384)","('NON-ESG', 0.012759936973452568)","('NON-ESG', 0.012268584221601486)"
Line 973,"BD contributed personnel time through trainers, mentors and subject matter experts, and deployed more than 300 BD Global Health Fellows to short-term, in-country assignments.
","('Access_And_Affordability', 0.5283265709877014)","('Employee_Engagement_Inclusion_And_Diversity', 0.10122659802436829)","('Management_Of_Legal_And_Regulatory_Framework', 0.038403332233428955)","(['Health Outcome Contribution'], 0.5283265709877014)","('NON-ESG', 0.10122659802436829)","('NON-ESG', 0.038403332233428955)"
Line 974,"The positive outcomes led to the renewal of the partnership twice, in 2012 and 2018, before the conclusion of project activities in 2021.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5826265215873718)","('Human_Rights_And_Community_Relations', 0.11145659536123276)","('Access_And_Affordability', 0.05431929603219032)","(['Corporate Governance'], 0.5826265215873718)","('NON-ESG', 0.11145659536123276)","('NON-ESG', 0.05431929603219032)"
Line 975,"BD partnered with the William Davidson Institute of the University of Michigan to carry out monitoring and evaluation of the program.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6317651271820068)","('Access_And_Affordability', 0.10905397683382034)","('GHG_Emissions', 0.038311153650283813)","(['Corporate Governance'], 0.6317651271820068)","('NON-ESG', 0.10905397683382034)","('NON-ESG', 0.038311153650283813)"
Line 976,"Key outcomes from Phase 3 (2018 – 2021) Labs for Life: Africa Labs for Life Africa Phase III supported 14 laboratories across Kenya, Uganda, Rwanda and Ethiopia.
","('Access_And_Affordability', 0.24698635935783386)","('GHG_Emissions', 0.12043612450361252)","('Customer_Welfare', 0.11382722109556198)","('NON-ESG', 0.24698635935783386)","('NON-ESG', 0.12043612450361252)","('NON-ESG', 0.11382722109556198)"
Line 977,"From June 2018 to January 2020, 55 BD Fellows were deployed across 28 mentorship rounds.
","('Employee_Engagement_Inclusion_And_Diversity', 0.40674063563346863)","('Access_And_Affordability', 0.1549452543258667)","('Management_Of_Legal_And_Regulatory_Framework', 0.06532629579305649)","('NON-ESG', 0.40674063563346863)","('NON-ESG', 0.1549452543258667)","('NON-ESG', 0.06532629579305649)"
Line 978,"When the COVID-19 pandemic halted travel in March 2020, Labs for Life began offering virtual learning opportunities for laboratory staff.
","('Access_And_Affordability', 0.21549682319164276)","('Systemic_Risk_Management', 0.10534580051898956)","('Physical_Impacts_Of_Climate_Change', 0.08904962241649628)","('NON-ESG', 0.21549682319164276)","('NON-ESG', 0.10534580051898956)","('NON-ESG', 0.08904962241649628)"
Line 979,"This included five webinars led by BD Kenya staff with 115 participants and the Laboratory Leadership & Management Essentials (LLME) course with 20 participants.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5426820516586304)","('Access_And_Affordability', 0.061242420226335526)","('Business_Model_Resilience', 0.05112503096461296)","(['Human Capital Development'], 0.5426820516586304)","('NON-ESG', 0.061242420226335526)","('NON-ESG', 0.05112503096461296)"
Line 980,"Nine laboratories in Kenya, Uganda and Rwanda were monitored for partnership  impact during Phase III.
","('Management_Of_Legal_And_Regulatory_Framework', 0.19609948992729187)","('Human_Rights_And_Community_Relations', 0.1640830636024475)","('Access_And_Affordability', 0.15851867198944092)","('NON-ESG', 0.19609948992729187)","('NON-ESG', 0.1640830636024475)","('NON-ESG', 0.15851867198944092)"
Line 981,"Five of the nine laboratories reached a 4-out-of-5-star rating using the WHO’s Stepwise Laboratory Improvement Process Towards Accreditation (SLIPTA) in the African Region.
","('Management_Of_Legal_And_Regulatory_Framework', 0.23800629377365112)","('Access_And_Affordability', 0.22518478333950043)","('Product_Quality_And_Safety', 0.13188204169273376)","('NON-ESG', 0.23800629377365112)","('NON-ESG', 0.22518478333950043)","('NON-ESG', 0.13188204169273376)"
Line 982,"Additionally, two of the five monitored laboratories in Kenya received an accreditation recommendation after initially starting Phase III with a 0-star SLIPTA rating in June 2018.
","('Management_Of_Legal_And_Regulatory_Framework', 0.29461684823036194)","('Access_And_Affordability', 0.268832802772522)","('Product_Quality_And_Safety', 0.10316026210784912)","('NON-ESG', 0.29461684823036194)","('NON-ESG', 0.268832802772522)","('NON-ESG', 0.10316026210784912)"
Line 983,"Fifty-seven percent of monitored tests in enrolled laboratories saw decreased or stable turnaround times from baseline to endline.
","('Systemic_Risk_Management', 0.24986805021762848)","('Competitive_Behavior', 0.18070296943187714)","('Management_Of_Legal_And_Regulatory_Framework', 0.07888521254062653)","('NON-ESG', 0.24986805021762848)","('NON-ESG', 0.18070296943187714)","('NON-ESG', 0.07888521254062653)"
Line 984,"During Phase III, laboratories secured critical resources such as staff vaccinations, computers and increased staffing.“[T]he first week we met with the Quality Officer, she said she didn’t know what she should be doing and what being a quality officer meant.
","('Product_Quality_And_Safety', 0.16521362960338593)","('Access_And_Affordability', 0.1487632691860199)","('Employee_Health_And_Safety', 0.087782122194767)","('NON-ESG', 0.16521362960338593)","('NON-ESG', 0.1487632691860199)","('NON-ESG', 0.087782122194767)"
Line 985,"We did a significant amount of individual mentorship with the Quality Officer.
","('Employee_Engagement_Inclusion_And_Diversity', 0.38239797949790955)","('Access_And_Affordability', 0.26646697521209717)","('Human_Rights_And_Community_Relations', 0.05645459145307541)","('NON-ESG', 0.38239797949790955)","('NON-ESG', 0.26646697521209717)","('NON-ESG', 0.05645459145307541)"
Line 986,"By the time we left, this person understood her role.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3876480162143707)","('Director_Removal', 0.1428002417087555)","('Business_Model_Resilience', 0.059204790741205215)","('NON-ESG', 0.3876480162143707)","('NON-ESG', 0.1428002417087555)","('NON-ESG', 0.059204790741205215)"
Line 987,"Before, it was a formality and just a title without a job description or clearly defined responsibilities.
","('Director_Removal', 0.3402007222175598)","('Labor_Practices', 0.153488427400589)","('Employee_Engagement_Inclusion_And_Diversity', 0.12881611287593842)","('NON-ESG', 0.3402007222175598)","('NON-ESG', 0.153488427400589)","('NON-ESG', 0.12881611287593842)"
Line 988,"Now, she embraces her role as Quality Officer and is accountable.” Lindsey Mathison  BD Global Public Health Fellow, Rwanda, February 2020“The mentors helped us on how to make reports  that we can take to the hospital and the county’s administration.
","('Access_And_Affordability', 0.44003111124038696)","('Management_Of_Legal_And_Regulatory_Framework', 0.1045738011598587)","('Human_Rights_And_Community_Relations', 0.06867159903049469)","('NON-ESG', 0.44003111124038696)","('NON-ESG', 0.1045738011598587)","('NON-ESG', 0.06867159903049469)"
Line 989,"And with that data, especially with the revenue side, which the county concentrates on, we are able to show the total number of tests done within the set turn around time and total revenue collected for the year 2019.” Lab manager2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices Phlebotomy hands-on training at GMC Aurangabad in IndiaLLME virtual course In partnership with the Association of Public Health Laboratories and the  William Davidson Institute of the University of Michigan, twenty managers and managers-in-training from Uganda, Rwanda and Kenya enrolled in the LLME virtual course in April 2021, with 16 participants completing all course requirements.
","('Supply_Chain_Management', 0.900619626045227)","('Physical_Impacts_Of_Climate_Change', 0.029453612864017487)","('Business_Model_Resilience', 0.00937971007078886)","(['Supply Chain Management'], 0.900619626045227)","('NON-ESG', 0.029453612864017487)","('NON-ESG', 0.00937971007078886)"
Line 990,"And with that data, especially with the revenue side, which the county concentrates on, we are able to show the total number of tests done within the set turn around time and total revenue collected for the year 2019.” Lab manager2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices Phlebotomy hands-on training at GMC Aurangabad in IndiaLLME virtual course In partnership with the Association of Public Health Laboratories and the  William Davidson Institute of the University of Michigan, twenty managers and managers-in-training from Uganda, Rwanda and Kenya enrolled in the LLME virtual course in April 2021, with 16 participants completing all course requirements.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5720813870429993)","('Management_Of_Legal_And_Regulatory_Framework', 0.056694626808166504)","('Access_And_Affordability', 0.04319671541452408)","(['Human Capital Development'], 0.5720813870429993)","('NON-ESG', 0.056694626808166504)","('NON-ESG', 0.04319671541452408)"
Line 991,"The course was based on the curriculum developed by the APHL and was modified for virtual learning using the ExtendEd on-line training platform developed by the WDI.
","('Access_And_Affordability', 0.4692976772785187)","('Employee_Engagement_Inclusion_And_Diversity', 0.11330436170101166)","('Product_Quality_And_Safety', 0.07526581734418869)","('NON-ESG', 0.4692976772785187)","('NON-ESG', 0.11330436170101166)","('NON-ESG', 0.07526581734418869)"
Line 992,"The results showed that knowledge scores increased by an average of 20 percent  following course completion.
","('Employee_Engagement_Inclusion_And_Diversity', 0.39496174454689026)","('Access_And_Affordability', 0.19400326907634735)","('Product_Quality_And_Safety', 0.04529703035950661)","('NON-ESG', 0.39496174454689026)","('NON-ESG', 0.19400326907634735)","('NON-ESG', 0.04529703035950661)"
Line 993,"Self-reports also noted improvements in the frequency of performance of managerial tasks such as reviewing lab budgets, holding management meetings and analyzing quality indicators.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2471647411584854)","('Labor_Practices', 0.2206888049840927)","('Business_Ethics', 0.12085814774036407)","('NON-ESG', 0.2471647411584854)","('NON-ESG', 0.2206888049840927)","('NON-ESG', 0.12085814774036407)"
Line 994,"Notably, at baseline, 46 percent of participants reported analyzing quality indicators every month, increasing to 75 percent at endline.
","('Systemic_Risk_Management', 0.20052334666252136)","('Management_Of_Legal_And_Regulatory_Framework', 0.12668205797672272)","('Product_Quality_And_Safety', 0.11813578754663467)","('NON-ESG', 0.20052334666252136)","('NON-ESG', 0.12668205797672272)","('NON-ESG', 0.11813578754663467)"
Line 995,"This pilot proved that hybrid virtual trainings (including synchronous and  asynchronous components) are an impactful and sustainable method for providing equitable access to knowledge—even beyond pandemic scenarios.
","('Access_And_Affordability', 0.44207289814949036)","('Employee_Engagement_Inclusion_And_Diversity', 0.10725538432598114)","('Management_Of_Legal_And_Regulatory_Framework', 0.056051407009363174)","('NON-ESG', 0.44207289814949036)","('NON-ESG', 0.10725538432598114)","('NON-ESG', 0.056051407009363174)"
Line 996,"The outcomes of this Laboratory Leadership training were presented at the Africa  Society for Laboratory Medicine (ASLM) Annual Conference in December 2021.
","('Access_And_Affordability', 0.2127215713262558)","('Employee_Engagement_Inclusion_And_Diversity', 0.19889599084854126)","('Product_Quality_And_Safety', 0.08020731061697006)","('NON-ESG', 0.2127215713262558)","('NON-ESG', 0.19889599084854126)","('NON-ESG', 0.08020731061697006)"
Line 997,"Labs for Life: India In India, the Labs for Life partnership established a Center of Excellence (COE) in phlebotomy and equipment management (EM) at the Government Medical College Aurangabad, Maharashtra.
","('Access_And_Affordability', 0.5318889021873474)","('Customer_Welfare', 0.06340326368808746)","('Employee_Health_And_Safety', 0.0448654480278492)","(['Health Outcome Contribution'], 0.5318889021873474)","('NON-ESG', 0.06340326368808746)","('NON-ESG', 0.0448654480278492)"
Line 998,"By the end of 2021, over 300 lab personnel and medical officers were trained on best practices in phlebotomy and EM, which increased the knowledge score from 48 percent to 76 percent.
","('Employee_Health_And_Safety', 0.3784395456314087)","('Access_And_Affordability', 0.2033708244562149)","('Employee_Engagement_Inclusion_And_Diversity', 0.07807493209838867)","('NON-ESG', 0.3784395456314087)","('NON-ESG', 0.2033708244562149)","('NON-ESG', 0.07807493209838867)"
Line 999,"Additionally, educational content on laboratory quality was developed under the partnership and is hosted at www.labsforlife.in (a ministry of health website) and on a YouTube channel called “LabsforLifeProject.” The YouTube channel has 150+ videos on lab strengthening and has garnered 55,000 subscribers with 4.8 million views from 20+ countries so far.“[In my lab], I was requested to teach our workshop staff how to design work plans.
","('Access_And_Affordability', 0.3631603419780731)","('Employee_Engagement_Inclusion_And_Diversity', 0.10874056816101074)","('Customer_Welfare', 0.06777225434780121)","('NON-ESG', 0.3631603419780731)","('NON-ESG', 0.10874056816101074)","('NON-ESG', 0.06777225434780121)"
Line 1000,"This I executed rightly and confidently using knowledge learned from this very training.” – LLME participant “I learned how to appropriately communicate with and motivate  staff.
","('Employee_Engagement_Inclusion_And_Diversity', 0.25529372692108154)","('Access_And_Affordability', 0.09484034031629562)","('Business_Model_Resilience', 0.08263833820819855)","('NON-ESG', 0.25529372692108154)","('NON-ESG', 0.09484034031629562)","('NON-ESG', 0.08263833820819855)"
Line 1001,"[Because] a manager achieves their goals through people, it is important that they remain motivated to accomplish their tasks, and that all communication is efficient and effective.” – LLME participant “The Labs for Life partnership in India has been successful in strengthening the laboratory systems for comprehensive management of people living with HIV/TB.
","('Access_And_Affordability', 0.5104653835296631)","('Employee_Health_And_Safety', 0.16976207494735718)","('Human_Rights_And_Community_Relations', 0.047823645174503326)","(['Health Outcome Contribution'], 0.5104653835296631)","('NON-ESG', 0.16976207494735718)","('NON-ESG', 0.047823645174503326)"
Line 1002,"Through collaborative efforts, we developed and implemented a strategic framework for continuous laboratory quality improvement towards certification/accreditation that was adopted by the MOH for scale up.
","('Product_Quality_And_Safety', 0.3085685968399048)","('Management_Of_Legal_And_Regulatory_Framework', 0.20639856159687042)","('Access_And_Affordability', 0.09245552867650986)","('NON-ESG', 0.3085685968399048)","('NON-ESG', 0.20639856159687042)","('NON-ESG', 0.09245552867650986)"
Line 1003,"Technical assistance and resources were provided for establishing a center of Excellence for capacity building of healthcare providers on best practices in phlebotomy and laboratory equipment management.
","('Access_And_Affordability', 0.771533191204071)","('Employee_Health_And_Safety', 0.02937445417046547)","('Customer_Welfare', 0.026257948949933052)","(['Health Outcome Contribution'], 0.771533191204071)","('NON-ESG', 0.02937445417046547)","('NON-ESG', 0.026257948949933052)"
Line 1004,"A knowledge repository with open access that systematically captured information on lab quality was hosted on the home page of the MOH website.
","('Management_Of_Legal_And_Regulatory_Framework', 0.27629566192626953)","('Access_And_Affordability', 0.10897447913885117)","('Data_Security', 0.09667836874723434)","('NON-ESG', 0.27629566192626953)","('NON-ESG', 0.10897447913885117)","('NON-ESG', 0.09667836874723434)"
Line 1005,"Currently, the work with the ministry of health is in progress for strengthening the specimen referral network for TB diagnosis in HIV patients through digital health innovations for early detection and treatment initiation.” Dr. Sunita Upadhyaya  Centers for Disease Control (CDC), India2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices Assessment of liquid culture and drug susceptibility testing labs Given the COVID-19 pandemic that disrupted normal work, life and travel in  India and around the globe, BD experts conducted in-depth hybrid—virtual and on-site—assessments of 10 LC-DST labs in the country in FY 2021.
","('Supply_Chain_Management', 0.6840236186981201)","('Physical_Impacts_Of_Climate_Change', 0.06740353256464005)","('Product_Design_And_Lifecycle_Management', 0.061785776168107986)","(['Supply Chain Management'], 0.6840236186981201)","('NON-ESG', 0.06740353256464005)","('NON-ESG', 0.061785776168107986)"
Line 1006,"Currently, the work with the ministry of health is in progress for strengthening the specimen referral network for TB diagnosis in HIV patients through digital health innovations for early detection and treatment initiation.” Dr. Sunita Upadhyaya  Centers for Disease Control (CDC), India2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices Assessment of liquid culture and drug susceptibility testing labs Given the COVID-19 pandemic that disrupted normal work, life and travel in  India and around the globe, BD experts conducted in-depth hybrid—virtual and on-site—assessments of 10 LC-DST labs in the country in FY 2021.
","('Critical_Incident_Risk_Management', 0.44993120431900024)","('Physical_Impacts_Of_Climate_Change', 0.17603561282157898)","('Air_Quality', 0.09171100705862045)","('NON-ESG', 0.44993120431900024)","('NON-ESG', 0.17603561282157898)","('NON-ESG', 0.09171100705862045)"
Line 1007,"This increased to 20 the total number of public sector labs assessed from the start of partnership.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5812345147132874)","('Access_And_Affordability', 0.11649257689714432)","('Energy_Management', 0.0496431328356266)","(['Corporate Governance'], 0.5812345147132874)","('NON-ESG', 0.11649257689714432)","('NON-ESG', 0.0496431328356266)"
Line 1008,"Lab assessment glimpses The assessments identified gaps in various aspects of lab biosafety and quality management, including processes followed—such as testing and sample management—documentation practices and the availability of adequate infrastructure.
","('Product_Quality_And_Safety', 0.39757731556892395)","('Supply_Chain_Management', 0.07000679522752762)","('Business_Ethics', 0.06568866223096848)","('NON-ESG', 0.39757731556892395)","('NON-ESG', 0.07000679522752762)","('NON-ESG', 0.06568866223096848)"
Line 1009,"Training and capacity building BD has trained microbiologists from 31 public sector labs on best practices in LC/DST , which led to a 25 percent to 40 percent increase in knowledge and skill levels.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7562029361724854)","('Access_And_Affordability', 0.06370636820793152)","('Employee_Health_And_Safety', 0.02832510694861412)","(['Human Capital Development'], 0.7562029361724854)","('NON-ESG', 0.06370636820793152)","('NON-ESG', 0.02832510694861412)"
Line 1010,"A follow-up skill assessment was conducted at a subset of 10 labs wherein 94 laboratory personnel were interviewed.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7981363534927368)","('Labor_Practices', 0.0495142936706543)","('Employee_Health_And_Safety', 0.02218739688396454)","(['Human Capital Development'], 0.7981363534927368)","('NON-ESG', 0.0495142936706543)","('NON-ESG', 0.02218739688396454)"
Line 1011,"During this assessment, it was found that overall knowledge scores from the original training were retained, highlighting the effectiveness of the training.
","('Access_And_Affordability', 0.2166454941034317)","('Product_Quality_And_Safety', 0.15311235189437866)","('Employee_Engagement_Inclusion_And_Diversity', 0.10499269515275955)","('NON-ESG', 0.2166454941034317)","('NON-ESG', 0.15311235189437866)","('NON-ESG', 0.10499269515275955)"
Line 1012,"Based on the findings from the skill assessment, targeted classroom and hands-on training was organized at the 10 labs to train 63 lab personnel on gaps observed.Making STRIDES against drug-resistant  tuberculosis in high-burden countries Drug-resistant tuberculosis (TB) is a major public health threat.
","('Access_And_Affordability', 0.20282705128192902)","('Employee_Health_And_Safety', 0.1902499943971634)","('Product_Quality_And_Safety', 0.10051073133945465)","('NON-ESG', 0.20282705128192902)","('NON-ESG', 0.1902499943971634)","('NON-ESG', 0.10051073133945465)"
Line 1013,"About a quarter  of world’s population is infected with tuberculosis bacteria (M.
","('Water_And_Wastewater_Management', 0.12268635630607605)","('Systemic_Risk_Management', 0.10591240227222443)","('Waste_And_Hazardous_Materials_Management', 0.07415954023599625)","('NON-ESG', 0.12268635630607605)","('NON-ESG', 0.10591240227222443)","('NON-ESG', 0.07415954023599625)"
Line 1014,"tuberculosis), and 5–10 percent of this cohort is expected to develop TB in their lifetime.
","('Employee_Health_And_Safety', 0.20856498181819916)","('Access_And_Affordability', 0.0829831138253212)","('Air_Quality', 0.06616851687431335)","('NON-ESG', 0.20856498181819916)","('NON-ESG', 0.0829831138253212)","('NON-ESG', 0.06616851687431335)"
Line 1015,"16 Without  treatment, the mortality rate for TB can be as high as 70 percent.In 2020, an estimated 9.9 million people fell ill with TB but only 5.8 million were identified.
","('Employee_Health_And_Safety', 0.6909595727920532)","('Critical_Incident_Risk_Management', 0.0599648617208004)","('Access_And_Affordability', 0.04779117554426193)","(['Operational Eco-Efficiency'], 0.6909595727920532)","('NON-ESG', 0.0599648617208004)","('NON-ESG', 0.04779117554426193)"
Line 1016,"17 Due to the COVID-19 pandemic, there was an 18 percent drop  in people diagnosed with TB (compared to 7.1 million in 2019).
","('Access_And_Affordability', 0.26013121008872986)","('Employee_Health_And_Safety', 0.19790159165859222)","('Critical_Incident_Risk_Management', 0.09609119594097137)","('NON-ESG', 0.26013121008872986)","('NON-ESG', 0.19790159165859222)","('NON-ESG', 0.09609119594097137)"
Line 1017,"In addition, enrollments for people with multidrug-resistant/rifampicin-resistant TB fell by 15 percent in 2020.
","('Product_Quality_And_Safety', 0.22149962186813354)","('Selling_Practices_And_Product_Labeling', 0.11338972300291061)","('Access_And_Affordability', 0.09475730359554291)","('NON-ESG', 0.22149962186813354)","('NON-ESG', 0.11338972300291061)","('NON-ESG', 0.09475730359554291)"
Line 1018,"For the first time since 2005, global TB deaths increased in 2020.
","('Employee_Health_And_Safety', 0.5779896974563599)","('Critical_Incident_Risk_Management', 0.1294981837272644)","('Air_Quality', 0.05514264106750488)","(['Operational Eco-Efficiency'], 0.5779896974563599)","('NON-ESG', 0.1294981837272644)","('NON-ESG', 0.05514264106750488)"
Line 1019,"Two high-TB-burden countries—India and Indonesia—accounted for 55 percent of the global drop in TB notifications due to COVID-19.
","('Systemic_Risk_Management', 0.19070255756378174)","('Air_Quality', 0.15062810480594635)","('Physical_Impacts_Of_Climate_Change', 0.07993340492248535)","('NON-ESG', 0.19070255756378174)","('NON-ESG', 0.15062810480594635)","('NON-ESG', 0.07993340492248535)"
Line 1020,"Lack of access to reliable drug-susceptibility testing (DST) is one of the key gaps in the fight against drug-resistant TB.
","('Product_Quality_And_Safety', 0.18381822109222412)","('Customer_Welfare', 0.12776221334934235)","('Access_And_Affordability', 0.12158729135990143)","('NON-ESG', 0.18381822109222412)","('NON-ESG', 0.12776221334934235)","('NON-ESG', 0.12158729135990143)"
Line 1021,"To better understand the barriers that stand in the way of patient access to this life- saving test, BD and the U.S. Agency for International Development (USAID) formed a partnership in 2017 called Strengthening TB Resistance Testing and Diagnostic Systems (STRIDES).
","('Access_And_Affordability', 0.7261683344841003)","('Product_Quality_And_Safety', 0.05106411501765251)","('Employee_Health_And_Safety', 0.03418460488319397)","(['Health Outcome Contribution'], 0.7261683344841003)","('NON-ESG', 0.05106411501765251)","('NON-ESG', 0.03418460488319397)"
Line 1022,"As part of this partnership, BD and USAID are working in India and Indonesia to improve access to, and increase capacity for, liquid culture (LC) and drug-susceptibility testing in close collaboration with MOHs.  India Under the overall leadership of the India Central TB Division (CTD), BD and USAID has continued to support strengthening the lab network for the diagnosis of drug-resistant TB.
","('Product_Quality_And_Safety', 0.22335633635520935)","('Access_And_Affordability', 0.14884890615940094)","('Systemic_Risk_Management', 0.07325711846351624)","('NON-ESG', 0.22335633635520935)","('NON-ESG', 0.14884890615940094)","('NON-ESG', 0.07325711846351624)"
Line 1023,"Key activities undertaken include: 16https://cdn.who.int/media/docs/default-source/hq-tuberculosis/tb-report-2021/2021-tb-reports-key-messages.pdf?sfvrsn=7951fb2d_5.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7517179250717163)","('Systemic_Risk_Management', 0.04541071876883507)","('Access_And_Affordability', 0.0317055769264698)","(['Corporate Governance'], 0.7517179250717163)","('NON-ESG', 0.04541071876883507)","('NON-ESG', 0.0317055769264698)"
Line 1024,"17Global tuberculosis Report, 2021.2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices As part of the CTP , BD has undertaken a TB Free Workplace campaign  across Indian office locations and sensitized about 50 percent of BD’s Indian associates on the importance of early and appropriate diagnosis of TB.
","('Supply_Chain_Management', 0.4091625213623047)","('Physical_Impacts_Of_Climate_Change', 0.4058074951171875)","('Systemic_Risk_Management', 0.026402970775961876)","('NON-ESG', 0.4091625213623047)","('NON-ESG', 0.4058074951171875)","('NON-ESG', 0.026402970775961876)"
Line 1025,"The sensitization sessions included talks by the CTD and USAID officials for BD associates, a video screening and a general awareness quiz.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3666636049747467)","('Access_And_Affordability', 0.30338054895401)","('Human_Rights_And_Community_Relations', 0.08251217752695084)","('NON-ESG', 0.3666636049747467)","('NON-ESG', 0.30338054895401)","('NON-ESG', 0.08251217752695084)"
Line 1026,"The campaign was highlighted in a Best Practices Compendium developed by the International Union Against Tuberculosis and Lung Disease (The Union) and released by the Honorable Minister of Health & Family Welfare Dr. Harsh Vardhan in August 2020.
","('Employee_Health_And_Safety', 0.7512128949165344)","('Access_And_Affordability', 0.06393260508775711)","('Product_Quality_And_Safety', 0.024674581363797188)","(['Operational Eco-Efficiency'], 0.7512128949165344)","('NON-ESG', 0.06393260508775711)","('NON-ESG', 0.024674581363797188)"
Line 1027,"Corporate social responsibility Initiative: Project sankalp—a  pledge to fight TB together BD in India has responded to a call by USAID and the MOH urging  corporations to support the MOH to achieve the goal of TB elimination by 2025.
","('Human_Rights_And_Community_Relations', 0.40521690249443054)","('Access_And_Affordability', 0.21042929589748383)","('Critical_Incident_Risk_Management', 0.05094033479690552)","('NON-ESG', 0.40521690249443054)","('NON-ESG', 0.21042929589748383)","('NON-ESG', 0.05094033479690552)"
Line 1028,"A district named Rewari, about 70 kilometers from India’s national capital New Delhi, where BD India’s manufacturing plant is located, has been adopted by BD to support the local MOH as it strengthens its systems to achieve TB-free status by 2025.
","('Management_Of_Legal_And_Regulatory_Framework', 0.27787476778030396)","('Product_Design_And_Lifecycle_Management', 0.10535143315792084)","('Energy_Management', 0.09880496561527252)","('NON-ESG', 0.27787476778030396)","('NON-ESG', 0.10535143315792084)","('NON-ESG', 0.09880496561527252)"
Line 1029,"BD has rolled out an ambitious field project that holistically addresses provider and community engagement aspects in collaboration with The Union.
","('Human_Rights_And_Community_Relations', 0.9489328265190125)","('Access_And_Affordability', 0.00555202504619956)","('Critical_Incident_Risk_Management', 0.0037936302833259106)","(['Community Relations'], 0.9489328265190125)","('NON-ESG', 0.00555202504619956)","('NON-ESG', 0.0037936302833259106)"
Line 1030,"Through active case-finding and a dedicated, fully equipped diagnostic  van, presumptive TB cases will be identified, and diagnostics will be brought closer to the patients to prevent dropouts and ensure that patients adhere to the entire care pathway to successfully complete treatment and achieve a cure, as per the National TB Elimination Program’s (NTEP’s) diagnostic and treatment algorithms.
","('Access_And_Affordability', 0.34725257754325867)","('Employee_Health_And_Safety', 0.1432209312915802)","('Critical_Incident_Risk_Management', 0.07688837498426437)","('NON-ESG', 0.34725257754325867)","('NON-ESG', 0.1432209312915802)","('NON-ESG', 0.07688837498426437)"
Line 1031,"Field activities are expected to start by Q3 FY 2022 for up to a three-to-five-year period.Strengthening specimen referral system for TB testing With the goal of bolstering the digital health ecosystem and enabling end-to-end specimen tracking, BD has been supporting CTD in the development of an online module within the national TB patient management application called Nikshay.
","('Product_Quality_And_Safety', 0.14943327009677887)","('Customer_Welfare', 0.11755620688199997)","('Access_And_Affordability', 0.10622883588075638)","('NON-ESG', 0.14943327009677887)","('NON-ESG', 0.11755620688199997)","('NON-ESG', 0.10622883588075638)"
Line 1032,"Increased visibility in the specimen movement can support improvement in the turnaround time to delivery of results and completion of diagnostic workup.
","('Product_Design_And_Lifecycle_Management', 0.1556452214717865)","('Customer_Welfare', 0.113283671438694)","('Supply_Chain_Management', 0.10905446857213974)","('NON-ESG', 0.1556452214717865)","('NON-ESG', 0.113283671438694)","('NON-ESG', 0.10905446857213974)"
Line 1033,"The initial phase of the application (both web and mobile) has been released across 25,000+ centers and downloaded 100,000+ times on the Google Play store.
","('Product_Design_And_Lifecycle_Management', 0.1317778378725052)","('Customer_Welfare', 0.12480667233467102)","('Data_Security', 0.10624556988477707)","('NON-ESG', 0.1317778378725052)","('NON-ESG', 0.12480667233467102)","('NON-ESG', 0.10624556988477707)"
Line 1034,"BD has also launched a usability assessment at 30 sites across five states and is gathering monthly feedback to understand the user experience and improve adoption.
","('Product_Design_And_Lifecycle_Management', 0.36856406927108765)","('Customer_Welfare', 0.07365281134843826)","('Business_Model_Resilience', 0.0692717581987381)","('NON-ESG', 0.36856406927108765)","('NON-ESG', 0.07365281134843826)","('NON-ESG', 0.0692717581987381)"
Line 1035,"TB Talk Unmasked campaign BD and USAID have partnered with an award-winning documentary filmmaker in India to launch TB Talk Unmasked, a platform through which policymakers, TB survivors and treating physicians can share their unique stories and perspectives.
","('Employee_Health_And_Safety', 0.25460243225097656)","('Systemic_Risk_Management', 0.09274332225322723)","('Business_Ethics', 0.08833649754524231)","('NON-ESG', 0.25460243225097656)","('NON-ESG', 0.09274332225322723)","('NON-ESG', 0.08833649754524231)"
Line 1036,"At the 50th Union World Conference on Lung Health in Hyderabad, USAID honored BD for its commitment to strengthening the national TB program in India.
","('Employee_Health_And_Safety', 0.5705129504203796)","('Access_And_Affordability', 0.15552161633968353)","('Product_Quality_And_Safety', 0.029755525290966034)","(['Operational Eco-Efficiency'], 0.5705129504203796)","('NON-ESG', 0.15552161633968353)","('NON-ESG', 0.029755525290966034)"
Line 1037,"Corporate TB Pledge In April 2019, U.S. Ambassador to India Kenneth I.
","('Management_Of_Legal_And_Regulatory_Framework', 0.39173540472984314)","('Business_Model_Resilience', 0.12179118394851685)","('Human_Rights_And_Community_Relations', 0.07540719211101532)","('NON-ESG', 0.39173540472984314)","('NON-ESG', 0.12179118394851685)","('NON-ESG', 0.07540719211101532)"
Line 1038,"Juster launched a new initiative, the Corporate TB Pledge (CTP), designed to help India’s corporate sector in the fight against TB.
","('Systemic_Risk_Management', 0.19198958575725555)","('Air_Quality', 0.14540594816207886)","('Business_Ethics', 0.09923649579286575)","('NON-ESG', 0.19198958575725555)","('NON-ESG', 0.14540594816207886)","('NON-ESG', 0.09923649579286575)"
Line 1039,"The initiative has supported the Indian government’s ambitious goal of eliminating TB by 2025, which would be five years ahead of the UN Sustainable Development Goal.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3538460433483124)","('Human_Rights_And_Community_Relations', 0.22875848412513733)","('Ecological_Impacts', 0.08434619009494781)","('NON-ESG', 0.3538460433483124)","('NON-ESG', 0.22875848412513733)","('NON-ESG', 0.08434619009494781)"
Line 1040,"It has created a shared platform for corporations committed to ending TB in India.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5966386198997498)","('Human_Rights_And_Community_Relations', 0.07393017411231995)","('Access_And_Affordability', 0.07107917219400406)","(['Corporate Governance'], 0.5966386198997498)","('NON-ESG', 0.07393017411231995)","('NON-ESG', 0.07107917219400406)"
Line 1041,"BD was recognized as a platinum partner on this prestigious platform as a result of BD’s unwavering commitment and support to strengthen TB lab systems and capacity building initiatives in India.
","('Human_Rights_And_Community_Relations', 0.24179710447788239)","('Access_And_Affordability', 0.22050753235816956)","('Business_Model_Resilience', 0.10545069724321365)","('NON-ESG', 0.24179710447788239)","('NON-ESG', 0.22050753235816956)","('NON-ESG', 0.10545069724321365)"
Line 1042,"More details on the CTP can be accessed here.“The BD-USAID partnership STRIDES has marched on with an additional 10 lab assessments at our public-sector liquid culture and drug susceptibility testing laboratories, despite COVID disruptions, by following innovative approaches.
","('Competitive_Behavior', 0.22525139153003693)","('Product_Quality_And_Safety', 0.11855445802211761)","('Customer_Welfare', 0.10288507491350174)","('NON-ESG', 0.22525139153003693)","('NON-ESG', 0.11855445802211761)","('NON-ESG', 0.10288507491350174)"
Line 1043,"We are always eager to understand their perspective in strengthening our lab systems.
","('Business_Model_Resilience', 0.20566298067569733)","('Access_And_Affordability', 0.13712210953235626)","('Human_Rights_And_Community_Relations', 0.11169431358575821)","('NON-ESG', 0.20566298067569733)","('NON-ESG', 0.13712210953235626)","('NON-ESG', 0.11169431358575821)"
Line 1044,"We look forward to continuing the collaboration with the STRIDES team to achieve the goal of eliminating TB from India by 2025.” Dr. Nishant  Central TB Division (CTD), Ministry of Health, India “The United States Agency for International  Development (USAID) has supported the National TB Elimination Program (NTEP) of India to transform and strengthen its laboratories and diagnostic networks for the past 10 years.
","('Employee_Health_And_Safety', 0.2276163548231125)","('Critical_Incident_Risk_Management', 0.0984831303358078)","('Systemic_Risk_Management', 0.09555478394031525)","('NON-ESG', 0.2276163548231125)","('NON-ESG', 0.0984831303358078)","('NON-ESG', 0.09555478394031525)"
Line 1045,"The collaboration with BD under STRIDES has demonstrated the important role the private sector, through its resources and expertise, can play in supporting NTEP .
","('Management_Of_Legal_And_Regulatory_Framework', 0.6276783347129822)","('Access_And_Affordability', 0.06656649708747864)","('Human_Rights_And_Community_Relations', 0.061717964708805084)","(['Corporate Governance'], 0.6276783347129822)","('NON-ESG', 0.06656649708747864)","('NON-ESG', 0.061717964708805084)"
Line 1046,"We acknowledge the efforts of BD and the leadership of the Central TB Division in their engagement and support for STRIDES.” Dr. Umesh Alavadi  Health Office, USAID India2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices “We are pleased to partner with BD to provide  valuable training for technicians at   liquid  culture drug susceptibility test TB laboratories in Indonesia.
","('Supply_Chain_Management', 0.8128936290740967)","('Physical_Impacts_Of_Climate_Change', 0.05623322352766991)","('Product_Design_And_Lifecycle_Management', 0.02081659436225891)","(['Supply Chain Management'], 0.8128936290740967)","('NON-ESG', 0.05623322352766991)","('NON-ESG', 0.02081659436225891)"
Line 1047,"We   are confident that as a result  of our partnership,   these laboratories will  be   better   able to adjust their testing and help roll  out   a   new patient-friendly oral treatment that will  benefit   tens of   thousands of people across the  country in the years to come.” USAID “The training material fits the purpose and needs  as it has been discussed extensively to align with Substansi TB (NTP-MOH)   and   BBLK Surabaya (CDST  NRL TB).” NTP of the MOH of IndonesiaIndonesia In FY 2019, BD signed a memorandum of understanding with USAID to  expand the STRIDES program to support the National TB Program (NTP) of the MOH of Indonesia, a country that has the second highest global TB burden after India and where one of the goals is building capacity for drug-resistant TB testing in the country.
","('Access_And_Affordability', 0.2820861041545868)","('Customer_Welfare', 0.17701756954193115)","('Product_Quality_And_Safety', 0.1278621107339859)","('NON-ESG', 0.2820861041545868)","('NON-ESG', 0.17701756954193115)","('NON-ESG', 0.1278621107339859)"
Line 1048,"We   are confident that as a result  of our partnership,   these laboratories will  be   better   able to adjust their testing and help roll  out   a   new patient-friendly oral treatment that will  benefit   tens of   thousands of people across the  country in the years to come.” USAID “The training material fits the purpose and needs  as it has been discussed extensively to align with Substansi TB (NTP-MOH)   and   BBLK Surabaya (CDST  NRL TB).” NTP of the MOH of IndonesiaIndonesia In FY 2019, BD signed a memorandum of understanding with USAID to  expand the STRIDES program to support the National TB Program (NTP) of the MOH of Indonesia, a country that has the second highest global TB burden after India and where one of the goals is building capacity for drug-resistant TB testing in the country.
","('Systemic_Risk_Management', 0.17238985002040863)","('Access_And_Affordability', 0.12290219962596893)","('Critical_Incident_Risk_Management', 0.09631725400686264)","('NON-ESG', 0.17238985002040863)","('NON-ESG', 0.12290219962596893)","('NON-ESG', 0.09631725400686264)"
Line 1049,"In June 2021, BD partnered with Project HOPE to conduct a four-day online  training session for 69 lab personnel across 21 public sector laboratories on LC and DST .
","('Access_And_Affordability', 0.4055178463459015)","('Employee_Engagement_Inclusion_And_Diversity', 0.18798354268074036)","('Labor_Practices', 0.05824334919452667)","('NON-ESG', 0.4055178463459015)","('NON-ESG', 0.18798354268074036)","('NON-ESG', 0.05824334919452667)"
Line 1050,"To understand the impact of the online training, in December 2021, an independent assessment was conducted among participants and showed significant knowledge retention with an average correct response rate of 87 percent.
","('Employee_Engagement_Inclusion_And_Diversity', 0.38987717032432556)","('Access_And_Affordability', 0.08673164248466492)","('Customer_Welfare', 0.06701648235321045)","('NON-ESG', 0.38987717032432556)","('NON-ESG', 0.08673164248466492)","('NON-ESG', 0.06701648235321045)"
Line 1051,"In addition, 88 percent of the respondents agreed that the training content met their expectations, with 98 percent mentioning that the training benefited them in their day-to-day operations at the lab.
","('Employee_Engagement_Inclusion_And_Diversity', 0.35775336623191833)","('Employee_Health_And_Safety', 0.10912284255027771)","('Access_And_Affordability', 0.09023025631904602)","('NON-ESG', 0.35775336623191833)","('NON-ESG', 0.10912284255027771)","('NON-ESG', 0.09023025631904602)"
Line 1052,"The STRIDES partnership has showcased BD’s commitment to be a solution  provider, and to support high-burden countries—India and Indonesia—in achieving their national targets to eliminate TB.
","('Systemic_Risk_Management', 0.25525549054145813)","('Access_And_Affordability', 0.17159821093082428)","('Business_Ethics', 0.06959696859121323)","('NON-ESG', 0.25525549054145813)","('NON-ESG', 0.17159821093082428)","('NON-ESG', 0.06959696859121323)"
Line 1053,"Evaluation of laboratory and e-learning at the BLK in Semarang, Indonesia, with Dr. Retno (MOH), and the National Reference Laboratory (NRL).
","('Ecological_Impacts', 0.16464854776859283)","('Access_And_Affordability', 0.16083578765392303)","('Employee_Engagement_Inclusion_And_Diversity', 0.09978282451629639)","('NON-ESG', 0.16464854776859283)","('NON-ESG', 0.16083578765392303)","('NON-ESG', 0.09978282451629639)"
Line 1054,"STRIDES monitoring and evaluation e-learning report to the MOH and online discussion with the TB Lab Network Workshop on lab strengthening capacity with NTP and the TB Lab Network2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices Antimicrobial resistance Since the introduction of penicillin in 1942, antimicrobials have transformed the  treatment of infections and have saved millions of lives.
","('Supply_Chain_Management', 0.3499104678630829)","('Physical_Impacts_Of_Climate_Change', 0.14897894859313965)","('Product_Design_And_Lifecycle_Management', 0.1342841386795044)","('NON-ESG', 0.3499104678630829)","('NON-ESG', 0.14897894859313965)","('NON-ESG', 0.1342841386795044)"
Line 1055,"But decades of misuse and outdated guidelines have driven a rise in the organisms that are resistant to these lifesaving drugs.
","('Management_Of_Legal_And_Regulatory_Framework', 0.27136221528053284)","('Product_Quality_And_Safety', 0.17097307741641998)","('Business_Ethics', 0.10954299569129944)","('NON-ESG', 0.27136221528053284)","('NON-ESG', 0.17097307741641998)","('NON-ESG', 0.10954299569129944)"
Line 1056,"Antimicrobial resistance (AMR)—bacteria’s ability to overcome the effects of  the drugs designed to kill or disarm them—is one of the world’s greatest public health threats.
","('Systemic_Risk_Management', 0.11456122249364853)","('Customer_Welfare', 0.11108707636594772)","('Product_Quality_And_Safety', 0.1107107400894165)","('NON-ESG', 0.11456122249364853)","('NON-ESG', 0.11108707636594772)","('NON-ESG', 0.1107107400894165)"
Line 1057,"Today, at least 1.27 million deaths worldwide are attributed to resistant bacterial  infections per year, and this number is growing.
","('Employee_Health_And_Safety', 0.43753284215927124)","('Product_Quality_And_Safety', 0.09646128118038177)","('Data_Security', 0.04825859144330025)","('NON-ESG', 0.43753284215927124)","('NON-ESG', 0.09646128118038177)","('NON-ESG', 0.04825859144330025)"
Line 1058,"18 According to the CDC, in the  United States alone, more than 2.8 million antibiotic-resistant infections occur each year; in fact, someone dies every 15 minutes from drug-resistant infection.
","('Employee_Health_And_Safety', 0.23585835099220276)","('Product_Quality_And_Safety', 0.08253396302461624)","('Systemic_Risk_Management', 0.07155440747737885)","('NON-ESG', 0.23585835099220276)","('NON-ESG', 0.08253396302461624)","('NON-ESG', 0.07155440747737885)"
Line 1059,"19  AMR is considered a “silent pandemic” that threatens modern medicine.
","('Physical_Impacts_Of_Climate_Change', 0.24252718687057495)","('Critical_Incident_Risk_Management', 0.23784326016902924)","('Air_Quality', 0.20244863629341125)","('NON-ESG', 0.24252718687057495)","('NON-ESG', 0.23784326016902924)","('NON-ESG', 0.20244863629341125)"
Line 1060,"As the pathogens that cause infections become increasingly drug-resistant, common medical procedures—including surgery, childbirth and chemotherapy—will become increasingly life-threatening.
","('Data_Security', 0.14614637196063995)","('Employee_Health_And_Safety', 0.10773222148418427)","('Systemic_Risk_Management', 0.08736360818147659)","('NON-ESG', 0.14614637196063995)","('NON-ESG', 0.10773222148418427)","('NON-ESG', 0.08736360818147659)"
Line 1061,"Put into perspective, if left unabated, the effects of AMR could be worse than COVID-19.
","('Systemic_Risk_Management', 0.25124555826187134)","('Competitive_Behavior', 0.12792734801769257)","('GHG_Emissions', 0.09529706090688705)","('NON-ESG', 0.25124555826187134)","('NON-ESG', 0.12792734801769257)","('NON-ESG', 0.09529706090688705)"
Line 1062,"20 Future projections suggest AMR  could result in millions of deaths and trillions of dollars in lost global production.21  These projections are daunting and show that AMR is a severe problem, right here, right now, and threatens every person on Earth.
","('Employee_Health_And_Safety', 0.16759388148784637)","('Systemic_Risk_Management', 0.12807992100715637)","('Business_Ethics', 0.10859968513250351)","('NON-ESG', 0.16759388148784637)","('NON-ESG', 0.12807992100715637)","('NON-ESG', 0.10859968513250351)"
Line 1063,"But together, we can make an impact, now, today.Our role in combating AMR BD is leveraging its extensive global capabilities to meaningfully engage around  five key strategies to reduce the burden of drug-resistant infections.
","('Systemic_Risk_Management', 0.13832689821720123)","('Access_And_Affordability', 0.109188012778759)","('Data_Security', 0.08721232414245605)","('NON-ESG', 0.13832689821720123)","('NON-ESG', 0.109188012778759)","('NON-ESG', 0.08721232414245605)"
Line 1064,"Our global public health efforts seek to expand access and drive capacity-building through partnerships with leading organizations and governments.
","('Access_And_Affordability', 0.8781777024269104)","('Human_Rights_And_Community_Relations', 0.016703132539987564)","('Critical_Incident_Risk_Management', 0.013039720244705677)","(['Health Outcome Contribution'], 0.8781777024269104)","('NON-ESG', 0.016703132539987564)","('NON-ESG', 0.013039720244705677)"
Line 1065,"We engage in advocacy with governments, funders and health agencies to advance innovations to address the world’s leading public health needs, including drug-resistant infections.
","('Access_And_Affordability', 0.3239046335220337)","('Critical_Incident_Risk_Management', 0.09750895947217941)","('Employee_Health_And_Safety', 0.08990161865949631)","('NON-ESG', 0.3239046335220337)","('NON-ESG', 0.09750895947217941)","('NON-ESG', 0.08990161865949631)"
Line 1066,"We possess important capabilities that are instrumental in the fight against AMR.
","('Human_Rights_And_Community_Relations', 0.26914945244789124)","('Critical_Incident_Risk_Management', 0.10607263445854187)","('Access_And_Affordability', 0.09954971075057983)","('NON-ESG', 0.26914945244789124)","('NON-ESG', 0.10607263445854187)","('NON-ESG', 0.09954971075057983)"
Line 1067,"We provide a wide range of medical products, platforms and offerings, such as diagnostic systems to screen, test and diagnose infection, including drug-resistant strains, as well as state-of-the-art surveillance and reporting capabilities to monitor, track and predict AMR outbreaks, that can be used to control the spread of infection in healthcare facilities.
","('Employee_Health_And_Safety', 0.6131916642189026)","('Critical_Incident_Risk_Management', 0.08338520675897598)","('Product_Quality_And_Safety', 0.03294534236192703)","(['Operational Eco-Efficiency'], 0.6131916642189026)","('NON-ESG', 0.08338520675897598)","('NON-ESG', 0.03294534236192703)"
Line 1068,"Enabled by our innovative programs and technologies, BD’s country teams across  the globe are directly engaging with AMR leaders in government, academia and professional societies to strengthen AMR awareness, health systems capacities, and infection prevention and diagnostic practices.
","('Employee_Health_And_Safety', 0.7439703941345215)","('Product_Quality_And_Safety', 0.04355787858366966)","('Access_And_Affordability', 0.032715797424316406)","(['Operational Eco-Efficiency'], 0.7439703941345215)","('NON-ESG', 0.04355787858366966)","('NON-ESG', 0.032715797424316406)"
Line 1069,"18 Antimicrobial Resistance Collaborators.
","('Customer_Welfare', 0.1406010240316391)","('Selling_Practices_And_Product_Labeling', 0.12914636731147766)","('GHG_Emissions', 0.11387123167514801)","('NON-ESG', 0.1406010240316391)","('NON-ESG', 0.12914636731147766)","('NON-ESG', 0.11387123167514801)"
Line 1070,"“Global burden of bacterial antimicrobial resistance in 2019: a  systematic analysis.” The Lancet.
","('Selling_Practices_And_Product_Labeling', 0.14746277034282684)","('Customer_Welfare', 0.13257469236850739)","('Systemic_Risk_Management', 0.08176491409540176)","('NON-ESG', 0.14746277034282684)","('NON-ESG', 0.13257469236850739)","('NON-ESG', 0.08176491409540176)"
Line 1071,"Published January 19, 2022.
","('Management_Of_Legal_And_Regulatory_Framework', 0.16896416246891022)","('Business_Model_Resilience', 0.09483109414577484)","('Product_Design_And_Lifecycle_Management', 0.07552716135978699)","('NON-ESG', 0.16896416246891022)","('NON-ESG', 0.09483109414577484)","('NON-ESG', 0.07552716135978699)"
Line 1072,"Accessed February 8, 2022.
","('Management_Of_Legal_And_Regulatory_Framework', 0.1697564423084259)","('Director_Removal', 0.08419947326183319)","('GHG_Emissions', 0.07444371283054352)","('NON-ESG', 0.1697564423084259)","('NON-ESG', 0.08419947326183319)","('NON-ESG', 0.07444371283054352)"
Line 1073,"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02724-0/fulltext 19 Centers for Disease Control and Prevention.
","('Access_And_Affordability', 0.21244248747825623)","('Systemic_Risk_Management', 0.0956391766667366)","('Product_Quality_And_Safety', 0.06969796121120453)","('NON-ESG', 0.21244248747825623)","('NON-ESG', 0.0956391766667366)","('NON-ESG', 0.06969796121120453)"
Line 1074,"“2019 AR Threats Report.” Accessed February 8, 2022.
","('Data_Security', 0.5785108208656311)","('Physical_Impacts_Of_Climate_Change', 0.10540618002414703)","('Systemic_Risk_Management', 0.061556730419397354)","(['Information Security/Cybersecurity & System Availability'], 0.5785108208656311)","('NON-ESG', 0.10540618002414703)","('NON-ESG', 0.061556730419397354)"
Line 1075,"https://www.cdc.gov/drugresistance/biggest-threats.html 20 Ukuhor H.
","('Data_Security', 0.4170657992362976)","('Systemic_Risk_Management', 0.25263288617134094)","('Business_Ethics', 0.052551958709955215)","('NON-ESG', 0.4170657992362976)","('NON-ESG', 0.25263288617134094)","('NON-ESG', 0.052551958709955215)"
Line 1076,"“The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics.” J Infect Public Health.
","('Systemic_Risk_Management', 0.15670788288116455)","('Customer_Welfare', 0.10258632898330688)","('Air_Quality', 0.0896373838186264)","('NON-ESG', 0.15670788288116455)","('NON-ESG', 0.10258632898330688)","('NON-ESG', 0.0896373838186264)"
Line 1077,"2021;14(1):53-60.
","('Management_Of_Legal_And_Regulatory_Framework', 0.34452852606773376)","('Competitive_Behavior', 0.07676322758197784)","('Business_Model_Resilience', 0.07246838510036469)","('NON-ESG', 0.34452852606773376)","('NON-ESG', 0.07676322758197784)","('NON-ESG', 0.07246838510036469)"
Line 1078,"21 O’Neill J (chair).
","('Management_Of_Legal_And_Regulatory_Framework', 0.6066166758537292)","('Business_Ethics', 0.06095894053578377)","('Director_Removal', 0.05586778745055199)","(['Corporate Governance'], 0.6066166758537292)","('NON-ESG', 0.06095894053578377)","('NON-ESG', 0.05586778745055199)"
Line 1079,"“ Antimicrobial resistance: tackling a crisis for the health and wealth of nations.” Accessed February 8, 2022.
","('Customer_Welfare', 0.21266235411167145)","('Selling_Practices_And_Product_Labeling', 0.10186321288347244)","('Product_Quality_And_Safety', 0.07088477164506912)","('NON-ESG', 0.21266235411167145)","('NON-ESG', 0.10186321288347244)","('NON-ESG', 0.07088477164506912)"
Line 1080,"https://amr-review.org/ sites/default/files/AMR%20Review%2-Paper%20-20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf Globally, at least 1,270,deaths per year are directly  attributable to AMR18New evidence shows that AMR is a leading cause of death globally, higher than HIV/AIDS and Malaria 1810 million deaths and more than $1 trillion per year by 2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices AMR is preventable: the role of  infection prevention  By partnering in prevention training and supporting infection control guidelines,  BD is leveraging its expertise in diagnostics, vascular access, surgical preparation and critical care to support hospitals’ infection prevention and control programs.
","('Physical_Impacts_Of_Climate_Change', 0.37195366621017456)","('Supply_Chain_Management', 0.16876275837421417)","('Employee_Health_And_Safety', 0.08197123557329178)","('NON-ESG', 0.37195366621017456)","('NON-ESG', 0.16876275837421417)","('NON-ESG', 0.08197123557329178)"
Line 1081,"https://amr-review.org/ sites/default/files/AMR%20Review%2-Paper%20-20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf Globally, at least 1,270,deaths per year are directly  attributable to AMR18New evidence shows that AMR is a leading cause of death globally, higher than HIV/AIDS and Malaria 1810 million deaths and more than $1 trillion per year by 2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices AMR is preventable: the role of  infection prevention  By partnering in prevention training and supporting infection control guidelines,  BD is leveraging its expertise in diagnostics, vascular access, surgical preparation and critical care to support hospitals’ infection prevention and control programs.
","('Employee_Health_And_Safety', 0.894770085811615)","('Critical_Incident_Risk_Management', 0.012200292199850082)","('Product_Quality_And_Safety', 0.008942965418100357)","(['Operational Eco-Efficiency'], 0.894770085811615)","('NON-ESG', 0.012200292199850082)","('NON-ESG', 0.008942965418100357)"
Line 1082,"BD is committed to helping clinicians improve patient outcomes through the standardization of care and adherence to best practices.
","('Access_And_Affordability', 0.8017040491104126)","('Human_Rights_And_Community_Relations', 0.02341741882264614)","('Employee_Health_And_Safety', 0.022331630811095238)","(['Health Outcome Contribution'], 0.8017040491104126)","('NON-ESG', 0.02341741882264614)","('NON-ESG', 0.022331630811095238)"
Line 1083,"•  In support of the inf ection prevention efforts of the Society for Healthcare  Epidemiology of America (SHEA), BD has provided an educational grant for  the “Prevention Course in HAI Knowledge and Control”—a free educational resource that provides critical information and skills to keep frontline providers, their families and patients safe.
","('Access_And_Affordability', 0.6215348839759827)","('Employee_Health_And_Safety', 0.08618619292974472)","('Critical_Incident_Risk_Management', 0.06922386586666107)","(['Health Outcome Contribution'], 0.6215348839759827)","('NON-ESG', 0.08618619292974472)","('NON-ESG', 0.06922386586666107)"
Line 1084,"As of December 2021, there have been 1,600 enrollments in the course.
","('Employee_Engagement_Inclusion_And_Diversity', 0.48434239625930786)","('Access_And_Affordability', 0.12589195370674133)","('Customer_Welfare', 0.04674834758043289)","('NON-ESG', 0.48434239625930786)","('NON-ESG', 0.12589195370674133)","('NON-ESG', 0.04674834758043289)"
Line 1085,"•  BD has partner ed with clinicians in addressing vascular access related  complications by identifying gaps in their current vascular access process.
","('Access_And_Affordability', 0.7712581157684326)","('Employee_Health_And_Safety', 0.05097461864352226)","('Critical_Incident_Risk_Management', 0.025530587881803513)","(['Health Outcome Contribution'], 0.7712581157684326)","('NON-ESG', 0.05097461864352226)","('NON-ESG', 0.025530587881803513)"
Line 1086,"Globally, in 2021, we completed over 200 assessments.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3158012628555298)","('Access_And_Affordability', 0.1445179432630539)","('GHG_Emissions', 0.08784882724285126)","('NON-ESG', 0.3158012628555298)","('NON-ESG', 0.1445179432630539)","('NON-ESG', 0.08784882724285126)"
Line 1087,"•  BD has w orked in collaboration with national governments in multiple countries,  including the United States, China, Kenya, Cambodia and India, via public-private partnerships, to improve hospitals’ capabilities with infection prevention and control.
","('Employee_Health_And_Safety', 0.5509145855903625)","('Access_And_Affordability', 0.08980762213468552)","('Product_Quality_And_Safety', 0.06190232187509537)","(['Operational Eco-Efficiency'], 0.5509145855903625)","('NON-ESG', 0.08980762213468552)","('NON-ESG', 0.06190232187509537)"
Line 1088,"AMR is real: the role of surveillance As we’ve seen with the COVID-19 pandemic, comprehensive surveillance is critical in identifying and responding to emerging threats to public health around the world.
","('Critical_Incident_Risk_Management', 0.48730602860450745)","('Physical_Impacts_Of_Climate_Change', 0.15868546068668365)","('Air_Quality', 0.044845473021268845)","('NON-ESG', 0.48730602860450745)","('NON-ESG', 0.15868546068668365)","('NON-ESG', 0.044845473021268845)"
Line 1089,"Surveillance is needed to understand the scope and risk of drug-resistant infections and to catch emerging threats when and where they arise—and develop an appropriate and effective response.
","('Systemic_Risk_Management', 0.12052367627620697)","('Critical_Incident_Risk_Management', 0.0941321849822998)","('Physical_Impacts_Of_Climate_Change', 0.09412351995706558)","('NON-ESG', 0.12052367627620697)","('NON-ESG', 0.0941321849822998)","('NON-ESG', 0.09412351995706558)"
Line 1090,"•  T he BD HealthSight™ platform leverages data to produce meaningful analytics  and insights for clients, BD’s business units and the scientific community/ industry.
","('Systemic_Risk_Management', 0.1983577311038971)","('Business_Model_Resilience', 0.1272244155406952)","('Competitive_Behavior', 0.108434297144413)","('NON-ESG', 0.1983577311038971)","('NON-ESG', 0.1272244155406952)","('NON-ESG', 0.108434297144413)"
Line 1091,"With over 2.3 billion patient messages per year, we transform these data points into client analytic reports, poster presentations and peer-reviewed publications.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3172224760055542)","('Access_And_Affordability', 0.1262519806623459)","('Customer_Privacy', 0.07678832858800888)","('NON-ESG', 0.3172224760055542)","('NON-ESG', 0.1262519806623459)","('NON-ESG', 0.07678832858800888)"
Line 1092,"We collaborate with other life science companies to publish these critical data sets.
","('Supply_Chain_Management', 0.1959860771894455)","('Data_Security', 0.1785261183977127)","('Customer_Privacy', 0.0918968915939331)","('NON-ESG', 0.1959860771894455)","('NON-ESG', 0.1785261183977127)","('NON-ESG', 0.0918968915939331)"
Line 1093,"•  T his data was integrated into the CDC’s “ Antibiotic Resistance Threats Report,”  highlighting the prevalence and impact of antibiotic-resistant bacteria and fungi on patients in the United States, and the Lancet’s report, “Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.” AMR is urgent: the role of diagnostic and  antibiotic stewardship Antimicrobial stewardship programs in healthcare settings are designed to optimize  antibiotic therapies, with the intention of slowing the emergence of drug resistance.
","('Customer_Welfare', 0.22083324193954468)","('Selling_Practices_And_Product_Labeling', 0.18782123923301697)","('Systemic_Risk_Management', 0.0676879957318306)","('NON-ESG', 0.22083324193954468)","('NON-ESG', 0.18782123923301697)","('NON-ESG', 0.0676879957318306)"
Line 1094,"•  T his data was integrated into the CDC’s “ Antibiotic Resistance Threats Report,”  highlighting the prevalence and impact of antibiotic-resistant bacteria and fungi on patients in the United States, and the Lancet’s report, “Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.” AMR is urgent: the role of diagnostic and  antibiotic stewardship Antimicrobial stewardship programs in healthcare settings are designed to optimize  antibiotic therapies, with the intention of slowing the emergence of drug resistance.
","('Systemic_Risk_Management', 0.14354202151298523)","('Competitive_Behavior', 0.10198183357715607)","('Customer_Welfare', 0.0764913558959961)","('NON-ESG', 0.14354202151298523)","('NON-ESG', 0.10198183357715607)","('NON-ESG', 0.0764913558959961)"
Line 1095,"Accurate and rapid diagnostic testing is a crucial element of stewardship.
","('Product_Quality_And_Safety', 0.20024046301841736)","('Access_And_Affordability', 0.10367987304925919)","('Management_Of_Legal_And_Regulatory_Framework', 0.0867471918463707)","('NON-ESG', 0.20024046301841736)","('NON-ESG', 0.10367987304925919)","('NON-ESG', 0.0867471918463707)"
Line 1096,"Diagnostic testing can identify the infection-causing organism, determine whether it is resistant and guide the appropriate therapeutic choice.
","('Product_Quality_And_Safety', 0.19128923118114471)","('Selling_Practices_And_Product_Labeling', 0.16679756343364716)","('Employee_Health_And_Safety', 0.09115024656057358)","('NON-ESG', 0.19128923118114471)","('NON-ESG', 0.16679756343364716)","('NON-ESG', 0.09115024656057358)"
Line 1097,"•  As part of the V alue-DX consortium, we have partnered on projects to assess the  impact of point-of-care diagnostic testing in reducing the overuse of antibiotics.
","('Customer_Welfare', 0.4135783612728119)","('Selling_Practices_And_Product_Labeling', 0.19963181018829346)","('Product_Quality_And_Safety', 0.05185723304748535)","('NON-ESG', 0.4135783612728119)","('NON-ESG', 0.19963181018829346)","('NON-ESG', 0.05185723304748535)"
Line 1098,"•  A c ollaboration with Pfizer Inc.
","('Competitive_Behavior', 0.2145693004131317)","('Customer_Welfare', 0.2065088450908661)","('Supply_Chain_Management', 0.08195508271455765)","('NON-ESG', 0.2145693004131317)","('NON-ESG', 0.2065088450908661)","('NON-ESG', 0.08195508271455765)"
Line 1099,"and global charitable foundation Wellcome  was started in 2021 to better understand the role of diagnostics in advancing  antimicrobial stewardship practices around the world.
","('Access_And_Affordability', 0.17383280396461487)","('Customer_Welfare', 0.13941584527492523)","('GHG_Emissions', 0.10760591924190521)","('NON-ESG', 0.17383280396461487)","('NON-ESG', 0.13941584527492523)","('NON-ESG', 0.10760591924190521)"
Line 1100,"Building on ongoing efforts to advance the role of diagnostics in tackling the challenge of AMR, this collaboration will survey existing diagnostic practices to highlight both benefits of and gaps in diagnostic testing in AMR stewardship to improve and further advocate for patient care, clinical practice and health care economics.
","('Access_And_Affordability', 0.45560863614082336)","('Customer_Welfare', 0.13532306253910065)","('Product_Quality_And_Safety', 0.04825529456138611)","('NON-ESG', 0.45560863614082336)","('NON-ESG', 0.13532306253910065)","('NON-ESG', 0.04825529456138611)"
Line 1101,"•  In 2019, BD w as awarded grants from The Fleming Fund, a United Kingdom aid  program designed to expand capacity for AMR diagnostics in 24 countries in sub-Saharan Africa and Asia, improving the surveillance of AMR and generating relevant data that is shared nationally and globally.
","('Access_And_Affordability', 0.28733330965042114)","('Critical_Incident_Risk_Management', 0.08287527412176132)","('Product_Quality_And_Safety', 0.07596676051616669)","('NON-ESG', 0.28733330965042114)","('NON-ESG', 0.08287527412176132)","('NON-ESG', 0.07596676051616669)"
Line 1102,"Since the award, BD has helped to expand automated blood culture and identification, and antimicrobial susceptibility testing (ID/AST) technologies, to help strengthen laboratory systems for combating AMR.
","('Customer_Welfare', 0.1717454493045807)","('Selling_Practices_And_Product_Labeling', 0.168825164437294)","('Product_Quality_And_Safety', 0.12006935477256775)","('NON-ESG', 0.1717454493045807)","('NON-ESG', 0.168825164437294)","('NON-ESG', 0.12006935477256775)"
Line 1103,"Our AMR solutions continue to be placed in countries with limited or no prior experience of using diagnostics to address AMR.
","('Access_And_Affordability', 0.31247004866600037)","('Product_Quality_And_Safety', 0.10364419966936111)","('Customer_Welfare', 0.08350712805986404)","('NON-ESG', 0.31247004866600037)","('NON-ESG', 0.10364419966936111)","('NON-ESG', 0.08350712805986404)"
Line 1104,"In 2021, we began rolling out instruments to BD-awarded countries, a process that will be completed in 2022.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8718915581703186)","('Competitive_Behavior', 0.02958502806723118)","('GHG_Emissions', 0.012287002056837082)","(['Corporate Governance'], 0.8718915581703186)","('NON-ESG', 0.02958502806723118)","('NON-ESG', 0.012287002056837082)"
Line 1105,"22Antimicrobial Resistance Collaborators.
","('Competitive_Behavior', 0.4079422652721405)","('Human_Rights_And_Community_Relations', 0.06206095218658447)","('Business_Ethics', 0.0582086555659771)","('NON-ESG', 0.4079422652721405)","('NON-ESG', 0.06206095218658447)","('NON-ESG', 0.0582086555659771)"
Line 1106,"“Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.” The Lancet.
","('Selling_Practices_And_Product_Labeling', 0.14746277034282684)","('Customer_Welfare', 0.13257469236850739)","('Systemic_Risk_Management', 0.08176491409540176)","('NON-ESG', 0.14746277034282684)","('NON-ESG', 0.13257469236850739)","('NON-ESG', 0.08176491409540176)"
Line 1107,"Published January 19, 2022.
","('Management_Of_Legal_And_Regulatory_Framework', 0.16896416246891022)","('Business_Model_Resilience', 0.09483109414577484)","('Product_Design_And_Lifecycle_Management', 0.07552716135978699)","('NON-ESG', 0.16896416246891022)","('NON-ESG', 0.09483109414577484)","('NON-ESG', 0.07552716135978699)"
Line 1108,"Accessed February 8, 2022.
","('Management_Of_Legal_And_Regulatory_Framework', 0.1697564423084259)","('Director_Removal', 0.08419947326183319)","('GHG_Emissions', 0.07444371283054352)","('NON-ESG', 0.1697564423084259)","('NON-ESG', 0.08419947326183319)","('NON-ESG', 0.07444371283054352)"
Line 1109,"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02724-0/fulltext2021 ESG Report Transparency Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices AMR is relevant: the role of awareness  and education Global experts have identified several challenges that low- and middle-income countries  face when addressing AMR.
","('Supply_Chain_Management', 0.47960537672042847)","('Physical_Impacts_Of_Climate_Change', 0.3381893038749695)","('Systemic_Risk_Management', 0.04048905521631241)","('NON-ESG', 0.47960537672042847)","('NON-ESG', 0.3381893038749695)","('NON-ESG', 0.04048905521631241)"
Line 1110,"Global Health Policy Leaders Activation Kit Patients & Patient Advocacy Groups Activation Kit Healthcare and Policy Organizations  Activation Kit There are too few trained microbiologists, few health facilities that routinely undertake bacterial culture and still fewer facilities that meet the requirements for accreditation.
","('Access_And_Affordability', 0.2996814548969269)","('Product_Quality_And_Safety', 0.14442428946495056)","('Customer_Welfare', 0.07300214469432831)","('NON-ESG', 0.2996814548969269)","('NON-ESG', 0.14442428946495056)","('NON-ESG', 0.07300214469432831)"
Line 1111,"To respond to these challenges, BD and The London School of Hygiene & Tropical Medicine (LSHTM), together with a global advisory group of experts, have partnered to create two online courses.
","('Access_And_Affordability', 0.28408822417259216)","('Product_Quality_And_Safety', 0.09942298382520676)","('Customer_Welfare', 0.07700160145759583)","('NON-ESG', 0.28408822417259216)","('NON-ESG', 0.09942298382520676)","('NON-ESG', 0.07700160145759583)"
Line 1112,"The first was launched in 2019 to educate participants about how diagnostics can be leveraged to reduce the inappropriate use of antibiotics, screen patients with resistant bacteria in healthcare settings and monitor AMR trends and the effectiveness of antibiotic stewardship strategies.
","('Customer_Welfare', 0.3196866810321808)","('Selling_Practices_And_Product_Labeling', 0.21896377205848694)","('Access_And_Affordability', 0.06897646188735962)","('NON-ESG', 0.3196866810321808)","('NON-ESG', 0.21896377205848694)","('NON-ESG', 0.06897646188735962)"
Line 1113,"This course, available in six languages, has since reached 13,000 participants in over 100 countries and continues to be available for users to access on the Futurelearn website.
","('Access_And_Affordability', 0.35579007863998413)","('Management_Of_Legal_And_Regulatory_Framework', 0.12756313383579254)","('Employee_Engagement_Inclusion_And_Diversity', 0.12041996419429779)","('NON-ESG', 0.35579007863998413)","('NON-ESG', 0.12756313383579254)","('NON-ESG', 0.12041996419429779)"
Line 1114,"In January 2022, in response to the COVID-19 pandemic, BD again collaborated with  LSHTM and launched a new online course focused on learnings from the COVID-19 response and the impact on global AMR programs, including the expanded adoption of diagnostic technologies during this time.
","('Critical_Incident_Risk_Management', 0.3090430796146393)","('Access_And_Affordability', 0.11281183362007141)","('Physical_Impacts_Of_Climate_Change', 0.10335949808359146)","('NON-ESG', 0.3090430796146393)","('NON-ESG', 0.11281183362007141)","('NON-ESG', 0.10335949808359146)"
Line 1115,"The course, entitled “Diagnostics for AMR: Building Back Better from the COVID-19 Pandemic,” continues to be available on the platform.
","('Critical_Incident_Risk_Management', 0.1834845095872879)","('Physical_Impacts_Of_Climate_Change', 0.17833784222602844)","('Systemic_Risk_Management', 0.07719412446022034)","('NON-ESG', 0.1834845095872879)","('NON-ESG', 0.17833784222602844)","('NON-ESG', 0.07719412446022034)"
Line 1116,"The launch of this course coincided with the Study UK campaign, the British Council and the GREAT Britain campaign that allows for free digital upgrades for learners who live in countries that are eligible for Official Development Assistance (ODA).
","('Management_Of_Legal_And_Regulatory_Framework', 0.363567978143692)","('Access_And_Affordability', 0.15835081040859222)","('Human_Rights_And_Community_Relations', 0.09617975354194641)","('NON-ESG', 0.363567978143692)","('NON-ESG', 0.15835081040859222)","('NON-ESG', 0.09617975354194641)"
Line 1117,"Since its launch, more than 1,000 users have accessed the course.Raising awareness is crucial because   AMR threatens everyone As the founding sponsor of the Antimicrobial Resistance Fighters Coalition (ARFC), BD  supports education, training and partnerships across the globe to raise awareness of AMR and to change behaviors to help maintain the effectiveness of antibiotics for our future generations.
","('Access_And_Affordability', 0.25648584961891174)","('Customer_Welfare', 0.1832420974969864)","('Selling_Practices_And_Product_Labeling', 0.10008018463850021)","('NON-ESG', 0.25648584961891174)","('NON-ESG', 0.1832420974969864)","('NON-ESG', 0.10008018463850021)"
Line 1118,"The Superbugs and You podcast series, co-produced with Center for Infectious Disease  Research & Policy (CIDRAP), has over 8,000 downloads.
","('Access_And_Affordability', 0.2094009965658188)","('Management_Of_Legal_And_Regulatory_Framework', 0.13720616698265076)","('Ecological_Impacts', 0.08123272657394409)","('NON-ESG', 0.2094009965658188)","('NON-ESG', 0.13720616698265076)","('NON-ESG', 0.08123272657394409)"
Line 1119,"The Superbugs and You podcasts feature stories from advocates, physicians, artists, researchers, pharmacists and educators working across the U.S. South Africa, Russia, Germany, Australia, the U.K. and India.
","('Access_And_Affordability', 0.1963299959897995)","('Management_Of_Legal_And_Regulatory_Framework', 0.10034976154565811)","('Competitive_Behavior', 0.09356973320245743)","('NON-ESG', 0.1963299959897995)","('NON-ESG', 0.10034976154565811)","('NON-ESG', 0.09356973320245743)"
Line 1120,"In planning the podcast series, the development team expected to hear stories of frightening illness and clinical frustration.
","('Employee_Health_And_Safety', 0.9115262031555176)","('Access_And_Affordability', 0.011494848877191544)","('Product_Quality_And_Safety', 0.00969692412763834)","(['Operational Eco-Efficiency'], 0.9115262031555176)","('NON-ESG', 0.011494848877191544)","('NON-ESG', 0.00969692412763834)"
Line 1121,"What was unexpected were the ways in which these stories of fear morphed into tales of resilience, a better understanding of the suffering of others, the drive to fight stigma and a new outlook on life as fighting AMR and creating systems of empowerment became a vocation.
","('Business_Model_Resilience', 0.48070406913757324)","('Human_Rights_And_Community_Relations', 0.19922059774398804)","('Employee_Engagement_Inclusion_And_Diversity', 0.056210558861494064)","('NON-ESG', 0.48070406913757324)","('NON-ESG', 0.19922059774398804)","('NON-ESG', 0.056210558861494064)"
Line 1122,"With over 80,000 page views in 2021, the ARFC website has successfully engaged key  stakeholders from around the world.
","('Management_Of_Legal_And_Regulatory_Framework', 0.32318398356437683)","('Data_Security', 0.06704510748386383)","('Business_Model_Resilience', 0.06598152965307236)","('NON-ESG', 0.32318398356437683)","('NON-ESG', 0.06704510748386383)","('NON-ESG', 0.06598152965307236)"
Line 1123,"It has provided facts about AMR and actions that we can take today to make change.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6693751811981201)","('Human_Rights_And_Community_Relations', 0.04773133248090744)","('Business_Model_Resilience', 0.034642308950424194)","(['Corporate Governance'], 0.6693751811981201)","('NON-ESG', 0.04773133248090744)","('NON-ESG', 0.034642308950424194)"
Line 1124,"The site was updated last year with Japanese translations to broaden impact.
","('Management_Of_Legal_And_Regulatory_Framework', 0.20618483424186707)","('Access_And_Affordability', 0.10497572273015976)","('Employee_Engagement_Inclusion_And_Diversity', 0.07159525156021118)","('NON-ESG', 0.20618483424186707)","('NON-ESG', 0.10497572273015976)","('NON-ESG', 0.07159525156021118)"
Line 1125,"With over 7,000 followers on our organic social media channels and over 28 million impressions via paid social engagements, we have successfully engaged a global audience from 167 countries on the topic of drug-resistant infections.
","('Access_And_Affordability', 0.13298477232456207)","('Product_Quality_And_Safety', 0.10963853448629379)","('Selling_Practices_And_Product_Labeling', 0.10791440308094025)","('NON-ESG', 0.13298477232456207)","('NON-ESG', 0.10963853448629379)","('NON-ESG', 0.10791440308094025)"
Line 1126,"The newly launched ARFC Activation Kits contain communication tools for patient advocacy, healthcare and policy organizations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.599804699420929)","('Human_Rights_And_Community_Relations', 0.14602583646774292)","('Access_And_Affordability', 0.047994811087846756)","(['Corporate Governance'], 0.599804699420929)","('NON-ESG', 0.14602583646774292)","('NON-ESG', 0.047994811087846756)"
Line 1127,"With over 5,000 downloads, the kits have reached a global audience ready to engage and make an impact against drug-resistant infections.
","('Access_And_Affordability', 0.17057308554649353)","('Data_Security', 0.12075060606002808)","('Selling_Practices_And_Product_Labeling', 0.1154312789440155)","('NON-ESG', 0.17057308554649353)","('NON-ESG', 0.12075060606002808)","('NON-ESG', 0.1154312789440155)"
Line 1128,"BD remains committed to investing in innovations to combat AMR through the  development of new diagnostics, devices and information systems that can help in clinical decision-making and reduce risks by: •  Supporting inf ection control guidelines; •  Expanding diagnostics t esting; and •  A dvancing medication management.
","('Systemic_Risk_Management', 0.36186012625694275)","('Customer_Welfare', 0.07014495879411697)","('Supply_Chain_Management', 0.0698699802160263)","('NON-ESG', 0.36186012625694275)","('NON-ESG', 0.07014495879411697)","('NON-ESG', 0.0698699802160263)"
Line 1129,"Halting and reversing this massive challenge will require the combined resources and efforts  of both public and private sectors.
","('Management_Of_Legal_And_Regulatory_Framework', 0.752787709236145)","('Systemic_Risk_Management', 0.041342560201883316)","('Access_And_Affordability', 0.026626965031027794)","(['Corporate Governance'], 0.752787709236145)","('NON-ESG', 0.041342560201883316)","('NON-ESG', 0.026626965031027794)"
Line 1130,"AMR has no single solution, and the challenges cannot be solved without multiple players working collectively on a common AMR agenda.
","('Systemic_Risk_Management', 0.27287599444389343)","('Competitive_Behavior', 0.11591798812150955)","('Management_Of_Legal_And_Regulatory_Framework', 0.0647820308804512)","('NON-ESG', 0.27287599444389343)","('NON-ESG', 0.11591798812150955)","('NON-ESG', 0.0647820308804512)"
Line 1131,"BD will continue to collaborate with global leaders around the world to address this urgent global health concern.2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Transparency2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Our commitment: Invite trust across  stakeholder groups through transparent performance reporting on ESG issues relevant to our business2030+ goals: 1  We will provide our stakeholders regularly with clear information about our ESG performance and programs, aligned with relevant and recognized external ESG reporting frameworks, via: •  Our annual Sust ainability Report •  Issue-specific disclosur es  – Climat e Change (aligned with TCFD)  – ID&E ( U.S. Federal Employment Information Report [EEO-1]) ESG reporting governance The ERC oversees external and internal reporting on ESG matters, which includes  this report and any other issue-specific disclosures and reports (including ID&E and cybersecurity).
","('Supply_Chain_Management', 0.5210501551628113)","('Physical_Impacts_Of_Climate_Change', 0.15215729176998138)","('Systemic_Risk_Management', 0.06209978461265564)","(['Supply Chain Management'], 0.5210501551628113)","('NON-ESG', 0.15215729176998138)","('NON-ESG', 0.06209978461265564)"
Line 1132,"BD will continue to collaborate with global leaders around the world to address this urgent global health concern.2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Transparency2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Our commitment: Invite trust across  stakeholder groups through transparent performance reporting on ESG issues relevant to our business2030+ goals: 1  We will provide our stakeholders regularly with clear information about our ESG performance and programs, aligned with relevant and recognized external ESG reporting frameworks, via: •  Our annual Sust ainability Report •  Issue-specific disclosur es  – Climat e Change (aligned with TCFD)  – ID&E ( U.S. Federal Employment Information Report [EEO-1]) ESG reporting governance The ERC oversees external and internal reporting on ESG matters, which includes  this report and any other issue-specific disclosures and reports (including ID&E and cybersecurity).
","('Business_Model_Resilience', 0.4043244421482086)","('Systemic_Risk_Management', 0.14511097967624664)","('Management_Of_Legal_And_Regulatory_Framework', 0.08676939457654953)","('NON-ESG', 0.4043244421482086)","('NON-ESG', 0.14511097967624664)","('NON-ESG', 0.08676939457654953)"
Line 1133,"BD will continue to collaborate with global leaders around the world to address this urgent global health concern.2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Transparency2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Our commitment: Invite trust across  stakeholder groups through transparent performance reporting on ESG issues relevant to our business2030+ goals: 1  We will provide our stakeholders regularly with clear information about our ESG performance and programs, aligned with relevant and recognized external ESG reporting frameworks, via: •  Our annual Sust ainability Report •  Issue-specific disclosur es  – Climat e Change (aligned with TCFD)  – ID&E ( U.S. Federal Employment Information Report [EEO-1]) ESG reporting governance The ERC oversees external and internal reporting on ESG matters, which includes  this report and any other issue-specific disclosures and reports (including ID&E and cybersecurity).
","('Data_Security', 0.5539031624794006)","('Systemic_Risk_Management', 0.2375037968158722)","('Business_Model_Resilience', 0.0482725128531456)","(['Information Security/Cybersecurity & System Availability'], 0.5539031624794006)","('NON-ESG', 0.2375037968158722)","('NON-ESG', 0.0482725128531456)"
Line 1134,"The Corporate Governance and Nominating Committee of the Board has oversight  of external reporting of ESG matters.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6750425696372986)","('Director_Removal', 0.07523695379495621)","('Business_Model_Resilience', 0.04040505364537239)","(['Corporate Governance'], 0.6750425696372986)","('NON-ESG', 0.07523695379495621)","('NON-ESG', 0.04040505364537239)"
Line 1135,"Corporate governance Our Corporate Governance Principles outline the BD Board’s views and practices regarding a number of governance topics, including the operation of our Board and its committees; strategic and succession planning; director qualifications and diversity; director independence, compensation and equity ownership; and the ability of shareholders and others to communicate directly with Board members.Further details can be found on the Corporate Governance website.
","('Director_Removal', 0.44526684284210205)","('Employee_Engagement_Inclusion_And_Diversity', 0.23188483715057373)","('Business_Model_Resilience', 0.03768176585435867)","('NON-ESG', 0.44526684284210205)","('NON-ESG', 0.23188483715057373)","('NON-ESG', 0.03768176585435867)"
Line 1136,"Information about members of our Board of Directors, including committee  composition and our Executive Leadership team, are available on our website.
","('Director_Removal', 0.7090436816215515)","('Employee_Engagement_Inclusion_And_Diversity', 0.03777091205120087)","('Business_Model_Resilience', 0.02777143567800522)","(['Anti-Crime Policy & Measures'], 0.7090436816215515)","('NON-ESG', 0.03777091205120087)","('NON-ESG', 0.02777143567800522)"
Line 1137,"Executive compensation Our goal is to provide an executive compensation program that best serves the long-term interests of our shareholders.
","('Labor_Practices', 0.4037654399871826)","('Director_Removal', 0.1401439905166626)","('Employee_Engagement_Inclusion_And_Diversity', 0.11436054855585098)","('NON-ESG', 0.4037654399871826)","('NON-ESG', 0.1401439905166626)","('NON-ESG', 0.11436054855585098)"
Line 1138,"We believe that attracting and retaining superior talent and rewarding performance are key to delivering long-term shareholder returns, and that a competitive compensation program is critical to that end.
","('Competitive_Behavior', 0.8919240236282349)","('Business_Model_Resilience', 0.017900198698043823)","('Employee_Engagement_Inclusion_And_Diversity', 0.014175157062709332)","(['Business Ethics'], 0.8919240236282349)","('NON-ESG', 0.017900198698043823)","('NON-ESG', 0.014175157062709332)"
Line 1139,"For further details of executive compensation, see our proxy statements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.24523159861564636)","('Labor_Practices', 0.21089239418506622)","('Business_Ethics', 0.1298593282699585)","('NON-ESG', 0.24523159861564636)","('NON-ESG', 0.21089239418506622)","('NON-ESG', 0.1298593282699585)"
Line 1140,"2030+ impact area: transparency  BD commitment and goals2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Oversight, accountability  and transparency The Corporate Governance and Nominating committee has oversight of BD’s  engagement in the political process.
","('Business_Ethics', 0.9213727712631226)","('Management_Of_Legal_And_Regulatory_Framework', 0.012686461210250854)","('Systemic_Risk_Management', 0.012082340195775032)","(['Business Ethics'], 0.9213727712631226)","('NON-ESG', 0.012686461210250854)","('NON-ESG', 0.012082340195775032)"
Line 1141,"The Committee maintains responsibility for ensuring that all BD political activities promote ethical and transparent engagement, advance the company’s Purpose and comply with applicable laws and reporting requirements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9307880401611328)","('Business_Ethics', 0.024933170527219772)","('Director_Removal', 0.005073448643088341)","(['Corporate Governance'], 0.9307880401611328)","('NON-ESG', 0.024933170527219772)","('NON-ESG', 0.005073448643088341)"
Line 1142,"Engaging with governments in  a transparent manner The Center for Political Accountability (CPA) recognized BD with a rating of  100 percent on their 2021 corporate political disclosure and accountability index.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5797560811042786)","('Business_Ethics', 0.31773465871810913)","('Director_Removal', 0.011093124747276306)","(['Corporate Governance'], 0.5797560811042786)","('NON-ESG', 0.31773465871810913)","('NON-ESG', 0.011093124747276306)"
Line 1143,"This is the fifth year in a row that the company has received a perfect score for the transparency with which we conduct our political engagement.
","('Business_Ethics', 0.9575785994529724)","('Systemic_Risk_Management', 0.00615666201338172)","('Management_Of_Legal_And_Regulatory_Framework', 0.004996209405362606)","(['Business Ethics'], 0.9575785994529724)","('NON-ESG', 0.00615666201338172)","('NON-ESG', 0.004996209405362606)"
Line 1144,"The ranking benchmarks Fortune 500 companies and is produced by the CPA in conjunction with the Zicklin Center for Business Ethics Research at the Wharton School at the University of Pennsylvania.
","('Business_Ethics', 0.8581365346908569)","('Systemic_Risk_Management', 0.040290042757987976)","('Competitive_Behavior', 0.030336417257785797)","(['Business Ethics'], 0.8581365346908569)","('NON-ESG', 0.040290042757987976)","('NON-ESG', 0.030336417257785797)"
Line 1145,"Public policy advocacy In areas where BD has deep experience, the company develops public policy positions that guide our advocacy efforts worldwide.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7951379418373108)","('Human_Rights_And_Community_Relations', 0.0772571936249733)","('Access_And_Affordability', 0.01093570701777935)","(['Corporate Governance'], 0.7951379418373108)","('NON-ESG', 0.0772571936249733)","('NON-ESG', 0.01093570701777935)"
Line 1146,"We currently have a range of global public policy positions available online.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8934966921806335)","('Human_Rights_And_Community_Relations', 0.013917071744799614)","('Competitive_Behavior', 0.009334568865597248)","(['Corporate Governance'], 0.8934966921806335)","('NON-ESG', 0.013917071744799614)","('NON-ESG', 0.009334568865597248)"
Line 1147,"We also engage in policy dialogue to advance regulatory and reimbursement frameworks that focus on the safety and efficacy of medical technologies and timely patient access to them.
","('Product_Quality_And_Safety', 0.8281728029251099)","('Selling_Practices_And_Product_Labeling', 0.019695986062288284)","('Access_And_Affordability', 0.01813264936208725)","(['Product Quality & Recall Management'], 0.8281728029251099)","('NON-ESG', 0.019695986062288284)","('NON-ESG', 0.01813264936208725)"
Line 1148,"We promote tax policies that we believe enhance competitiveness and innovation, support policies and programs that advance biomedical research and seek to expand access to care for all people.Political action committee: BD PAC As permitted under U.S. law, the company operates a political action committee (PAC).
","('Management_Of_Legal_And_Regulatory_Framework', 0.37935635447502136)","('Access_And_Affordability', 0.17426468431949615)","('Competitive_Behavior', 0.14138692617416382)","('NON-ESG', 0.37935635447502136)","('NON-ESG', 0.17426468431949615)","('NON-ESG', 0.14138692617416382)"
Line 1149,"The BD PAC is a mechanism to enable eligible U.S. associates to voluntarily support candidates for elected office who share our perspectives and approaches to public policy issues.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8155152201652527)","('Competitive_Behavior', 0.025213731452822685)","('Human_Rights_And_Community_Relations', 0.024875199422240257)","(['Corporate Governance'], 0.8155152201652527)","('NON-ESG', 0.025213731452822685)","('NON-ESG', 0.024875199422240257)"
Line 1150,"BD has not authorized the establishment of any PACs operating on the state or local level.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9352332949638367)","('Human_Rights_And_Community_Relations', 0.0078052617609500885)","('Director_Removal', 0.005823524668812752)","(['Corporate Governance'], 0.9352332949638367)","('NON-ESG', 0.0078052617609500885)","('NON-ESG', 0.005823524668812752)"
Line 1151,"Contributions to the BD PAC are entirely voluntary and are governed by the BD PAC Bylaws.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9040431976318359)","('Business_Ethics', 0.01332793664187193)","('Director_Removal', 0.012550760991871357)","(['Corporate Governance'], 0.9040431976318359)","('NON-ESG', 0.01332793664187193)","('NON-ESG', 0.012550760991871357)"
Line 1152,"BD provides administrative support to the PAC, as permitted under federal law.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9277307391166687)","('Business_Ethics', 0.02050384320318699)","('Competitive_Behavior', 0.007028114981949329)","(['Corporate Governance'], 0.9277307391166687)","('NON-ESG', 0.02050384320318699)","('NON-ESG', 0.007028114981949329)"
Line 1153,"The BD PAC is audited by an independent auditor every two years for compliance with policy and legal requirements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9582880139350891)","('Business_Ethics', 0.008461072109639645)","('Director_Removal', 0.003989351447671652)","(['Corporate Governance'], 0.9582880139350891)","('NON-ESG', 0.008461072109639645)","('NON-ESG', 0.003989351447671652)"
Line 1154,"The BD PAC contributed a total of $105,500 to candidates in 2021.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6092607975006104)","('Competitive_Behavior', 0.07986494153738022)","('Business_Ethics', 0.04171600192785263)","(['Corporate Governance'], 0.6092607975006104)","('NON-ESG', 0.07986494153738022)","('NON-ESG', 0.04171600192785263)"
Line 1155,"All  contributions made by the BD PAC are also publicly reported on government agency websites, including the Federal Election Commission’s website (www.fec.gov ).
","('Management_Of_Legal_And_Regulatory_Framework', 0.9147940278053284)","('Director_Removal', 0.007979891262948513)","('Ecological_Impacts', 0.007010691799223423)","(['Corporate Governance'], 0.9147940278053284)","('NON-ESG', 0.007979891262948513)","('NON-ESG', 0.007010691799223423)"
Line 1156,"For annual reporting of itemized PAC contributions and any other corporate contributions, visit our website.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7433722615242004)","('Labor_Practices', 0.03332948684692383)","('Director_Removal', 0.025860557332634926)","(['Corporate Governance'], 0.7433722615242004)","('NON-ESG', 0.03332948684692383)","('NON-ESG', 0.025860557332634926)"
Line 1157,"Process for corporate financial  contributions The company prohibits the use of corporate funds and assets to support  U.S. federal or state candidates, political parties, ballot measures or referendum campaigns.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9357286691665649)","('Business_Ethics', 0.010126201435923576)","('Director_Removal', 0.006052117329090834)","(['Corporate Governance'], 0.9357286691665649)","('NON-ESG', 0.010126201435923576)","('NON-ESG', 0.006052117329090834)"
Line 1158,"Exceptions to this policy require approval by the CEO, the general counsel and a designated member of the Corporate Governance and Nominating Committee.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7975687980651855)","('Director_Removal', 0.08929874747991562)","('Business_Ethics', 0.013056782074272633)","(['Corporate Governance'], 0.7975687980651855)","('NON-ESG', 0.08929874747991562)","('NON-ESG', 0.013056782074272633)"
Line 1159,"To date, no exceptions have been sought or approved.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7158582806587219)","('Competitive_Behavior', 0.07855161279439926)","('GHG_Emissions', 0.020365891978144646)","(['Corporate Governance'], 0.7158582806587219)","('NON-ESG', 0.07855161279439926)","('NON-ESG', 0.020365891978144646)"
Line 1160,"Certain conditions must also be met for any political contributions outside of the United States.Participation in the  policymaking process Strong, long-term relationships with policymakers help us better understand unmet  public health needs around the world.
","('Access_And_Affordability', 0.5220812559127808)","('Critical_Incident_Risk_Management', 0.0733635202050209)","('Employee_Health_And_Safety', 0.049598850309848785)","(['Health Outcome Contribution'], 0.5220812559127808)","('NON-ESG', 0.0733635202050209)","('NON-ESG', 0.049598850309848785)"
Line 1161,"BD engages in public policy advocacy through ongoing, constructive and transparent interactions with government officials and stakeholder groups.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9026817679405212)","('Human_Rights_And_Community_Relations', 0.029153093695640564)","('Access_And_Affordability', 0.008710997179150581)","(['Corporate Governance'], 0.9026817679405212)","('NON-ESG', 0.029153093695640564)","('NON-ESG', 0.008710997179150581)"
Line 1162,"All advocacy activities are directed toward furthering the company’s Purpose of advancing the world of health™, without regard to the personal political affiliations or views of any individual BD associates at any level across the organization.
","('Employee_Engagement_Inclusion_And_Diversity', 0.1937193125486374)","('Management_Of_Legal_And_Regulatory_Framework', 0.13797175884246826)","('Competitive_Behavior', 0.1373661309480667)","('NON-ESG', 0.1937193125486374)","('NON-ESG', 0.13797175884246826)","('NON-ESG', 0.1373661309480667)"
Line 1163,"We employ public affairs professionals who work closely with our country and business leaders to make constructive contributions to policy discussions relevant to the company and to the communities in which we operate.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7466320395469666)","('Human_Rights_And_Community_Relations', 0.12143442034721375)","('Physical_Impacts_Of_Climate_Change', 0.01288974191993475)","(['Corporate Governance'], 0.7466320395469666)","('NON-ESG', 0.12143442034721375)","('NON-ESG', 0.01288974191993475)"
Line 1164,"We leverage our diverse expertise, global reach and collaborations with healthcare professionals, patients and others to advance sound public policy.2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency U.S. lobbying expenditures $89,$135,$991,516$636,$131,$287,$1,279,300$701, BD associat es   Public polic y consultants   T rade associations   Issue-based c oalitions Data represents calendar years Trade associations: AdvaMed, Healthcare Institute of New Jersey, California Life Sciences Association,  North Carolina Biosciences Organization, Bio Nebraska Issue-based Coalitions: Diagnostic Test Working Group, Medical Device Competitiveness Coalition,  Physicians Fee Schedule Pathology Payment Coalition, United for Medical Research, Corporate Friends of CDC, Inc.
","('Supply_Chain_Management', 0.4060945510864258)","('Physical_Impacts_Of_Climate_Change', 0.38936707377433777)","('Systemic_Risk_Management', 0.049636758863925934)","('NON-ESG', 0.4060945510864258)","('NON-ESG', 0.38936707377433777)","('NON-ESG', 0.049636758863925934)"
Line 1165,"We leverage our diverse expertise, global reach and collaborations with healthcare professionals, patients and others to advance sound public policy.2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency U.S. lobbying expenditures $89,$135,$991,516$636,$131,$287,$1,279,300$701, BD associat es   Public polic y consultants   T rade associations   Issue-based c oalitions Data represents calendar years Trade associations: AdvaMed, Healthcare Institute of New Jersey, California Life Sciences Association,  North Carolina Biosciences Organization, Bio Nebraska Issue-based Coalitions: Diagnostic Test Working Group, Medical Device Competitiveness Coalition,  Physicians Fee Schedule Pathology Payment Coalition, United for Medical Research, Corporate Friends of CDC, Inc.
","('Competitive_Behavior', 0.9313056468963623)","('Management_Of_Legal_And_Regulatory_Framework', 0.010901998728513718)","('Customer_Welfare', 0.006663682870566845)","(['Business Ethics'], 0.9313056468963623)","('NON-ESG', 0.010901998728513718)","('NON-ESG', 0.006663682870566845)"
Line 1166,"In addition to the work of our Public Affairs team, BD is able to expand our reach  by leveraging state and federal public policy consultants, collaboratively engaging on issues that impact our industry through trade associations and advancing policy proposals focused on key priorities through advocacy coalitions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9295645356178284)","('Human_Rights_And_Community_Relations', 0.012233002111315727)","('Physical_Impacts_Of_Climate_Change', 0.005528391804546118)","(['Corporate Governance'], 0.9295645356178284)","('NON-ESG', 0.012233002111315727)","('NON-ESG', 0.005528391804546118)"
Line 1167,"For calendar year 2021, the company spent approximately $2.4 million on salaries and expenses associated with lobbying in the United States.
","('Management_Of_Legal_And_Regulatory_Framework', 0.44824376702308655)","('Labor_Practices', 0.2869175672531128)","('Director_Removal', 0.07723605632781982)","('NON-ESG', 0.44824376702308655)","('NON-ESG', 0.2869175672531128)","('NON-ESG', 0.07723605632781982)"
Line 1168,"We file quarterly reports regarding our federal lobbying activities with the Office  of the Clerk of the House of Representatives and the Secretary of the Senate.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7678780555725098)","('Competitive_Behavior', 0.04298340529203415)","('Director_Removal', 0.020363427698612213)","(['Corporate Governance'], 0.7678780555725098)","('NON-ESG', 0.04298340529203415)","('NON-ESG', 0.020363427698612213)"
Line 1169,"These reports are available by searching for “Becton Dickinson” as a “Registrant” on the U.S. Senate’s website, http://www.senate.gov/legislative/Public_Disclosure/LDA_reports.htmViolations and compliance BD maintains robust processes for reporting violations of, and validating compliance with, law and company policy.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8318483829498291)","('Business_Ethics', 0.09289109706878662)","('Product_Quality_And_Safety', 0.007376869674772024)","(['Corporate Governance'], 0.8318483829498291)","('NON-ESG', 0.09289109706878662)","('NON-ESG', 0.007376869674772024)"
Line 1170,"Company personnel who believe they have witnessed illegal or unethical behavior relating to the company’s political activities are encouraged to discuss the matter with their manager, senior managers, Human Resources representatives, the Legal department or the Ethics and Compliance department.
","('Business_Ethics', 0.9705461263656616)","('Product_Quality_And_Safety', 0.002668749773874879)","('Management_Of_Legal_And_Regulatory_Framework', 0.0024841430131345987)","(['Business Ethics'], 0.9705461263656616)","('NON-ESG', 0.002668749773874879)","('NON-ESG', 0.0024841430131345987)"
Line 1171,"Actual or potential violations may be reported without risk of retaliation by using the confidential Ethics Helpline.
","('Business_Ethics', 0.9711728096008301)","('Management_Of_Legal_And_Regulatory_Framework', 0.0030168474186211824)","('Customer_Privacy', 0.00229683518409729)","(['Business Ethics'], 0.9711728096008301)","('NON-ESG', 0.0030168474186211824)","('NON-ESG', 0.00229683518409729)"
Line 1172,"Company policies and bylaws governing BD’s political activities may be subject  to periodic compliance validation and/or internal audit review to determine the effectiveness of implementation and ongoing compliance with policy.
","('Management_Of_Legal_And_Regulatory_Framework', 0.952267050743103)","('Business_Ethics', 0.009942135773599148)","('Director_Removal', 0.0047426363453269005)","(['Corporate Governance'], 0.952267050743103)","('NON-ESG', 0.009942135773599148)","('NON-ESG', 0.0047426363453269005)"
Line 1173,"Findings and mitigation strategies may be reviewed with appropriate stakeholders.
","('Ecological_Impacts', 0.21761630475521088)","('Human_Rights_And_Community_Relations', 0.14560934901237488)","('Management_Of_Legal_And_Regulatory_Framework', 0.12937705218791962)","('NON-ESG', 0.21761630475521088)","('NON-ESG', 0.14560934901237488)","('NON-ESG', 0.12937705218791962)"
Line 1174,"Significant exceptions may be reported to the Corporate Governance and Nominating Committee.
","('Management_Of_Legal_And_Regulatory_Framework', 0.867219865322113)","('Director_Removal', 0.03172451630234718)","('Business_Ethics', 0.022627802565693855)","(['Corporate Governance'], 0.867219865322113)","('NON-ESG', 0.03172451630234718)","('NON-ESG', 0.022627802565693855)"
Line 1175,"Enterprise risk management Our Enterprise Risk Management program is overseen by the SVP Chief Risk Officer.
","('Systemic_Risk_Management', 0.8554282188415527)","('Business_Model_Resilience', 0.05798928439617157)","('Physical_Impacts_Of_Climate_Change', 0.010949584655463696)","(['Risk & Crisis Management'], 0.8554282188415527)","('NON-ESG', 0.05798928439617157)","('NON-ESG', 0.010949584655463696)"
Line 1176,"Operationally he reports to the Audit Committee of the Board, and administratively to the chief financial officer.
","('Director_Removal', 0.3453218340873718)","('Management_Of_Legal_And_Regulatory_Framework', 0.3318673372268677)","('Systemic_Risk_Management', 0.044092778116464615)","('NON-ESG', 0.3453218340873718)","('NON-ESG', 0.3318673372268677)","('NON-ESG', 0.044092778116464615)"
Line 1177,"The Audit Committee of the Board has responsibility to review BD’s guidelines and  policies relating to enterprise risk assessment and management, including financial risk, and cybersecurity and data privacy risk exposures.
","('Data_Security', 0.9251364469528198)","('Systemic_Risk_Management', 0.015125080943107605)","('Business_Ethics', 0.009028407745063305)","(['Information Security/Cybersecurity & System Availability'], 0.9251364469528198)","('NON-ESG', 0.015125080943107605)","('NON-ESG', 0.009028407745063305)"
Line 1178,"In addition, the Corporate Governance and Nominating Committee oversees BD’s  processes and practices relating to the management and oversight of various ESG matters.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7617365717887878)","('Business_Ethics', 0.04674987867474556)","('Systemic_Risk_Management', 0.03354308381676674)","(['Corporate Governance'], 0.7617365717887878)","('NON-ESG', 0.04674987867474556)","('NON-ESG', 0.03354308381676674)"
Line 1179,"Further details about how the Board oversees risk can be found in our  Proxy Statement.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3723042607307434)","('Director_Removal', 0.2639385461807251)","('Systemic_Risk_Management', 0.03952481970191002)","('NON-ESG', 0.3723042607307434)","('NON-ESG', 0.2639385461807251)","('NON-ESG', 0.03952481970191002)"
Line 1180,"Details of risk factors relevant to our business can be found in our annual report (10-K) and quarterly filings (10-Q).
","('Systemic_Risk_Management', 0.9292058944702148)","('Business_Model_Resilience', 0.01574372500181198)","('Physical_Impacts_Of_Climate_Change', 0.009836047887802124)","(['Risk & Crisis Management'], 0.9292058944702148)","('NON-ESG', 0.01574372500181198)","('NON-ESG', 0.009836047887802124)"
Line 1181,"Details of how risks related to specific ESG issues are identified, assessed and  managed, and how they integrate into the organization’s overall risk management program, can be found in the relevant sections of this report.2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Ethics and compliance We are committed to a strong ethics and compliance culture.
","('Business_Ethics', 0.9265336990356445)","('Systemic_Risk_Management', 0.015343111008405685)","('Data_Security', 0.007923327386379242)","(['Business Ethics'], 0.9265336990356445)","('NON-ESG', 0.015343111008405685)","('NON-ESG', 0.007923327386379242)"
Line 1182,"We do not tolerate  actions or behaviors that violate the BD Code of Conduct or applicable laws and regulations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9274856448173523)","('Business_Ethics', 0.023232942447066307)","('Product_Quality_And_Safety', 0.004499794915318489)","(['Corporate Governance'], 0.9274856448173523)","('NON-ESG', 0.023232942447066307)","('NON-ESG', 0.004499794915318489)"
Line 1183,"All BD associates are responsible for reinforcing our ethics and compliance culture and sustaining our reputation as a company dedicated to quality and integrity.
","('Business_Ethics', 0.9678337574005127)","('Product_Quality_And_Safety', 0.0024933088570833206)","('Customer_Privacy', 0.0024566466454416513)","(['Business Ethics'], 0.9678337574005127)","('NON-ESG', 0.0024933088570833206)","('NON-ESG', 0.0024566466454416513)"
Line 1184,"We encourage and expect everyone at BD to speak up by asking questions, raising concerns, seeking guidance and reporting actual or suspected violations of laws, our Code of Conduct, our policies or our high ethical standards.
","('Business_Ethics', 0.9603245854377747)","('Management_Of_Legal_And_Regulatory_Framework', 0.006024516653269529)","('Product_Quality_And_Safety', 0.005023536738008261)","(['Business Ethics'], 0.9603245854377747)","('NON-ESG', 0.006024516653269529)","('NON-ESG', 0.005023536738008261)"
Line 1185,"This requirement extends to all associates, vendors and other third parties working on our behalf.
","('Competitive_Behavior', 0.1719009131193161)","('Business_Ethics', 0.10579784214496613)","('Labor_Practices', 0.09563694894313812)","('NON-ESG', 0.1719009131193161)","('NON-ESG', 0.10579784214496613)","('NON-ESG', 0.09563694894313812)"
Line 1186,"Our BD Values further strengthen our culture of ethics and compliance and guide  how we hold ourselves accountable to our shareholders and stakeholders.
","('Business_Ethics', 0.9687708616256714)","('Management_Of_Legal_And_Regulatory_Framework', 0.003117439802736044)","('Competitive_Behavior', 0.002674081362783909)","(['Business Ethics'], 0.9687708616256714)","('NON-ESG', 0.003117439802736044)","('NON-ESG', 0.002674081362783909)"
Line 1187,"These values are cascaded through all levels of the organization.
","('Business_Model_Resilience', 0.18405240774154663)","('Business_Ethics', 0.14286383986473083)","('Competitive_Behavior', 0.10703873634338379)","('NON-ESG', 0.18405240774154663)","('NON-ESG', 0.14286383986473083)","('NON-ESG', 0.10703873634338379)"
Line 1188,"Read more about our commitment to ethics and compliance on our website.
","('Business_Ethics', 0.9631218314170837)","('Management_Of_Legal_And_Regulatory_Framework', 0.00419103167951107)","('Competitive_Behavior', 0.0033199368044734)","(['Business Ethics'], 0.9631218314170837)","('NON-ESG', 0.00419103167951107)","('NON-ESG', 0.0033199368044734)"
Line 1189,"Code of Conduct The BD Code of Conduct sets the foundation for how we behave at BD.
","('Business_Ethics', 0.8845474123954773)","('Management_Of_Legal_And_Regulatory_Framework', 0.0525125116109848)","('Product_Quality_And_Safety', 0.007877322845160961)","(['Business Ethics'], 0.8845474123954773)","('NON-ESG', 0.0525125116109848)","('NON-ESG', 0.007877322845160961)"
Line 1190,"Our value “We do what is right” is the cornerstone of our Code.
","('Business_Ethics', 0.15285582840442657)","('Management_Of_Legal_And_Regulatory_Framework', 0.1441710889339447)","('Human_Rights_And_Community_Relations', 0.12683813273906708)","('NON-ESG', 0.15285582840442657)","('NON-ESG', 0.1441710889339447)","('NON-ESG', 0.12683813273906708)"
Line 1191,"To do what is right, we follow the laws, rules and company policies that apply to us.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9474550485610962)","('Business_Ethics', 0.007067467551678419)","('Human_Rights_And_Community_Relations', 0.006100552622228861)","(['Corporate Governance'], 0.9474550485610962)","('NON-ESG', 0.007067467551678419)","('NON-ESG', 0.006100552622228861)"
Line 1192,"We also follow the highest ethical standards, even when there’s no specific law or policy.
","('Business_Ethics', 0.9082727432250977)","('Competitive_Behavior', 0.015695063397288322)","('Management_Of_Legal_And_Regulatory_Framework', 0.013574366457760334)","(['Business Ethics'], 0.9082727432250977)","('NON-ESG', 0.015695063397288322)","('NON-ESG', 0.013574366457760334)"
Line 1193,"Our Code provides guidance and resources to help us follow through on these ethical standards and protect our reputation.
","('Business_Ethics', 0.9424352645874023)","('Management_Of_Legal_And_Regulatory_Framework', 0.00997082144021988)","('Product_Quality_And_Safety', 0.009649873711168766)","(['Business Ethics'], 0.9424352645874023)","('NON-ESG', 0.00997082144021988)","('NON-ESG', 0.009649873711168766)"
Line 1194,"Everyone at BD—from directors to officers and associates—must follow our Code.
","('Director_Removal', 0.7517663836479187)","('Business_Ethics', 0.030847076326608658)","('Management_Of_Legal_And_Regulatory_Framework', 0.025606073439121246)","(['Anti-Crime Policy & Measures'], 0.7517663836479187)","('NON-ESG', 0.030847076326608658)","('NON-ESG', 0.025606073439121246)"
Line 1195,"It applies equally to everyone, no matter their position or level.
","('Director_Removal', 0.17216430604457855)","('Employee_Engagement_Inclusion_And_Diversity', 0.16385036706924438)","('Labor_Practices', 0.14055508375167847)","('NON-ESG', 0.17216430604457855)","('NON-ESG', 0.16385036706924438)","('NON-ESG', 0.14055508375167847)"
Line 1196,"BD associates receive information and training about the Code and other policies in several ways, including periodic communications and annual trainings.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9208908081054688)","('Business_Ethics', 0.009006373584270477)","('Human_Rights_And_Community_Relations', 0.008464885875582695)","(['Corporate Governance'], 0.9208908081054688)","('NON-ESG', 0.009006373584270477)","('NON-ESG', 0.008464885875582695)"
Line 1197,"Associates can access detailed information on our expectations through our intranet and on our ethics and compliance mobile app.
","('Business_Ethics', 0.9545803666114807)","('Management_Of_Legal_And_Regulatory_Framework', 0.009524942375719547)","('Product_Quality_And_Safety', 0.004379520192742348)","(['Business Ethics'], 0.9545803666114807)","('NON-ESG', 0.009524942375719547)","('NON-ESG', 0.004379520192742348)"
Line 1198,"Our Code of Conduct is also available on our website.Under the oversight of the Audit Committee of the Board, BD’s global ethics and  compliance function seeks to ensure that BD has a comprehensive compliance program that is designed to prevent and detect wrongdoing and continuously encourages lawful and ethical conduct.
","('Business_Ethics', 0.9738100171089172)","('Management_Of_Legal_And_Regulatory_Framework', 0.003126448020339012)","('Product_Quality_And_Safety', 0.0019535203464329243)","(['Business Ethics'], 0.9738100171089172)","('NON-ESG', 0.003126448020339012)","('NON-ESG', 0.0019535203464329243)"
Line 1199,"BD’s Senior Vice President, Deputy General Counsel and Chief Ethics & Compliance Officer leads the global ethics and compliance function and along with the BD Ethics and Compliance Committee, which comprises of members of BD’s Executive Leadership team, oversee these activities to ensure effective operation and enforcement of BD’s global ethics and compliance program.
","('Business_Ethics', 0.9639475345611572)","('Management_Of_Legal_And_Regulatory_Framework', 0.004389703739434481)","('Product_Quality_And_Safety', 0.0034709274768829346)","(['Business Ethics'], 0.9639475345611572)","('NON-ESG', 0.004389703739434481)","('NON-ESG', 0.0034709274768829346)"
Line 1200,"The program is integrated into our global business operations.
","('Business_Model_Resilience', 0.6777629852294922)","('Product_Design_And_Lifecycle_Management', 0.04839743301272392)","('Supply_Chain_Management', 0.032884180545806885)","(['Codes of Business Conduct'], 0.6777629852294922)","('NON-ESG', 0.04839743301272392)","('NON-ESG', 0.032884180545806885)"
Line 1201,"We evaluate the effectiveness of our program and adapt it periodically to ensure that it is appropriately tailored to address the risks inherent in our global business.
","('Systemic_Risk_Management', 0.8841337561607361)","('Physical_Impacts_Of_Climate_Change', 0.022817149758338928)","('Business_Model_Resilience', 0.018549922853708267)","(['Risk & Crisis Management'], 0.8841337561607361)","('NON-ESG', 0.022817149758338928)","('NON-ESG', 0.018549922853708267)"
Line 1202,"Reporting ethics concerns Except as prohibited by applicable law, BD associates are obligated to report any suspected violations of laws, industry codes, the BD Code of Conduct or BD policies in accordance with the BD Global Speaking Up Policy.
","('Business_Ethics', 0.9657633900642395)","('Management_Of_Legal_And_Regulatory_Framework', 0.005636052694171667)","('Product_Quality_And_Safety', 0.003113068640232086)","(['Business Ethics'], 0.9657633900642395)","('NON-ESG', 0.005636052694171667)","('NON-ESG', 0.003113068640232086)"
Line 1203,"BD takes all reports of violations of laws, BD policies and ethical standards seriously and will promptly, fairly and thoroughly investigate all such reports.
","('Business_Ethics', 0.9556397795677185)","('Management_Of_Legal_And_Regulatory_Framework', 0.007539680227637291)","('Product_Quality_And_Safety', 0.005550045985728502)","(['Business Ethics'], 0.9556397795677185)","('NON-ESG', 0.007539680227637291)","('NON-ESG', 0.005550045985728502)"
Line 1204,"BD does not tolerate any form of retaliation against any person who in good faith reports an actual or suspected violation.
","('Business_Ethics', 0.9268416166305542)","('Management_Of_Legal_And_Regulatory_Framework', 0.01765640266239643)","('Competitive_Behavior', 0.006226028315722942)","(['Business Ethics'], 0.9268416166305542)","('NON-ESG', 0.01765640266239643)","('NON-ESG', 0.006226028315722942)"
Line 1205,"BD is committed to creating an environment in which all associates feel comfortable raising concerns, seeking guidance or asking questions without fear of retaliation or discipline.Anyone can seek guidance or report ethics concerns in a number of ways, including the BD Ethics Helpline or via email.
","('Business_Ethics', 0.9675832390785217)","('Management_Of_Legal_And_Regulatory_Framework', 0.003843415528535843)","('Product_Quality_And_Safety', 0.003085397882387042)","(['Business Ethics'], 0.9675832390785217)","('NON-ESG', 0.003843415528535843)","('NON-ESG', 0.003085397882387042)"
Line 1206,"The Helpline is independently operated and available anywhere in the world 24 hours a day, 7 days a week.
","('Access_And_Affordability', 0.8262051343917847)","('Critical_Incident_Risk_Management', 0.03420998156070709)","('Employee_Health_And_Safety', 0.021611277014017105)","(['Health Outcome Contribution'], 0.8262051343917847)","('NON-ESG', 0.03420998156070709)","('NON-ESG', 0.021611277014017105)"
Line 1207,"The Helpline can be reached by telephone or online.
","('Access_And_Affordability', 0.5638403296470642)","('Critical_Incident_Risk_Management', 0.09685013443231583)","('Employee_Health_And_Safety', 0.03139632195234299)","(['Health Outcome Contribution'], 0.5638403296470642)","('NON-ESG', 0.09685013443231583)","('NON-ESG', 0.03139632195234299)"
Line 1208,"The Helpline provides translation services as needed, and reports can be made anonymously where permitted by law.
","('Management_Of_Legal_And_Regulatory_Framework', 0.21026960015296936)","('Access_And_Affordability', 0.18510259687900543)","('Customer_Privacy', 0.16180634498596191)","('NON-ESG', 0.21026960015296936)","('NON-ESG', 0.18510259687900543)","('NON-ESG', 0.16180634498596191)"
Line 1209,"BD associates can also report violations to their supervisor, management, Human Resources or the Law Group, or directly to Ethics & Compliance.
","('Business_Ethics', 0.9619969725608826)","('Management_Of_Legal_And_Regulatory_Framework', 0.004965593572705984)","('Product_Quality_And_Safety', 0.003552319947630167)","(['Business Ethics'], 0.9619969725608826)","('NON-ESG', 0.004965593572705984)","('NON-ESG', 0.003552319947630167)"
Line 1210,"In FY 2021, BD’s Ethics Office received more than 850 contacts from associates  worldwide seeking guidance or reporting concerns.
","('Business_Ethics', 0.9548618197441101)","('Management_Of_Legal_And_Regulatory_Framework', 0.0079316645860672)","('Product_Quality_And_Safety', 0.004914466291666031)","(['Business Ethics'], 0.9548618197441101)","('NON-ESG', 0.0079316645860672)","('NON-ESG', 0.004914466291666031)"
Line 1211,"When an investigation has a finding, we may take corrective action, such as discipline up to and including termination of employment or providing nondisciplinary-based training and process improvements in areas where a gap has been identified.
","('Labor_Practices', 0.4234903156757355)","('Employee_Engagement_Inclusion_And_Diversity', 0.19946986436843872)","('Employee_Health_And_Safety', 0.0923428013920784)","('NON-ESG', 0.4234903156757355)","('NON-ESG', 0.19946986436843872)","('NON-ESG', 0.0923428013920784)"
Line 1212,"Antibribery and anticorruption BD does not engage a third-party intermediary to do anything BD or its associates are prohibited from doing.
","('Business_Ethics', 0.5015722513198853)","('Competitive_Behavior', 0.18743029236793518)","('Management_Of_Legal_And_Regulatory_Framework', 0.166965514421463)","(['Business Ethics'], 0.5015722513198853)","('NON-ESG', 0.18743029236793518)","('NON-ESG', 0.166965514421463)"
Line 1213,"The central Ethics and Compliance team provides resources to regional and local country management to enhance their anticorruption and compliance business practices.
","('Business_Ethics', 0.9638778567314148)","('Management_Of_Legal_And_Regulatory_Framework', 0.007595869712531567)","('Product_Quality_And_Safety', 0.0030742273665964603)","(['Business Ethics'], 0.9638778567314148)","('NON-ESG', 0.007595869712531567)","('NON-ESG', 0.0030742273665964603)"
Line 1214,"This includes incorporating compliance requirements into existing business practices and advising local management on anticorruption compliance-related issues.
","('Management_Of_Legal_And_Regulatory_Framework', 0.44042232632637024)","('Business_Ethics', 0.4353184401988983)","('Product_Quality_And_Safety', 0.014342552050948143)","('NON-ESG', 0.44042232632637024)","('NON-ESG', 0.4353184401988983)","('NON-ESG', 0.014342552050948143)"
Line 1215,"A key focus for BD is driving compliance in our third-party intermediary networks  across the globe, resulting in stronger business relationships while upholding our reputation.
","('Business_Ethics', 0.5220900177955627)","('Management_Of_Legal_And_Regulatory_Framework', 0.22911138832569122)","('Systemic_Risk_Management', 0.039238881319761276)","(['Business Ethics'], 0.5220900177955627)","('NON-ESG', 0.22911138832569122)","('NON-ESG', 0.039238881319761276)"
Line 1216,"These efforts are advanced by fostering collaboration with business leaders to  deliver consistent and clear policies and approval processes—along with enhanced third-party life-cycle management procedures—to help provide assurance that BD is “doing business the right way.” BD is committed to training all associates via both in-person, scenario-based sessions and learning management system courses that leverage policy materials, such as the Global Antibribery & Anticorruption Policy and the Global Standards for Interactions with Healthcare Professionals, Healthcare Organizations and Government Officials.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8936740159988403)","('Business_Ethics', 0.024936746805906296)","('Human_Rights_And_Community_Relations', 0.012948061339557171)","(['Corporate Governance'], 0.8936740159988403)","('NON-ESG', 0.024936746805906296)","('NON-ESG', 0.012948061339557171)"
Line 1217,"These efforts are advanced by fostering collaboration with business leaders to  deliver consistent and clear policies and approval processes—along with enhanced third-party life-cycle management procedures—to help provide assurance that BD is “doing business the right way.” BD is committed to training all associates via both in-person, scenario-based sessions and learning management system courses that leverage policy materials, such as the Global Antibribery & Anticorruption Policy and the Global Standards for Interactions with Healthcare Professionals, Healthcare Organizations and Government Officials.
","('Access_And_Affordability', 0.4982786178588867)","('Human_Rights_And_Community_Relations', 0.07645231485366821)","('Employee_Health_And_Safety', 0.05255062133073807)","('NON-ESG', 0.4982786178588867)","('NON-ESG', 0.07645231485366821)","('NON-ESG', 0.05255062133073807)"
Line 1218,"Risk-based training with third-party intermediaries is a core component of the  Antibribery and Anticorruption program.
","('Systemic_Risk_Management', 0.7315704226493835)","('Business_Ethics', 0.06763068586587906)","('Management_Of_Legal_And_Regulatory_Framework', 0.035325635224580765)","(['Risk & Crisis Management'], 0.7315704226493835)","('NON-ESG', 0.06763068586587906)","('NON-ESG', 0.035325635224580765)"
Line 1219,"These sessions are focused on applicable antibribery and anticorruption laws, including the Foreign Corrupt Practices Act and relevant BD policies.
","('Business_Ethics', 0.9548892974853516)","('Management_Of_Legal_And_Regulatory_Framework', 0.015272167511284351)","('Competitive_Behavior', 0.004319531377404928)","(['Business Ethics'], 0.9548892974853516)","('NON-ESG', 0.015272167511284351)","('NON-ESG', 0.004319531377404928)"
Line 1220,"Associates are required to complete this training once every 18 months.2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Ethics in sales and marketing Interactions with  healthcare professionals In addition to our Code of Conduct, BD has a set of global policies and standards,  including our Global Standards for Interactions with Healthcare Professionals, Healthcare Organizations and Government Officials, that are designed to ensure that associates have clear guidance on how to do what is right in the context of their work for BD.
","('Business_Ethics', 0.6327297687530518)","('Supply_Chain_Management', 0.07724518328905106)","('Systemic_Risk_Management', 0.05288409814238548)","(['Business Ethics'], 0.6327297687530518)","('NON-ESG', 0.07724518328905106)","('NON-ESG', 0.05288409814238548)"
Line 1221,"Associates are required to complete this training once every 18 months.2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Ethics in sales and marketing Interactions with  healthcare professionals In addition to our Code of Conduct, BD has a set of global policies and standards,  including our Global Standards for Interactions with Healthcare Professionals, Healthcare Organizations and Government Officials, that are designed to ensure that associates have clear guidance on how to do what is right in the context of their work for BD.
","('Management_Of_Legal_And_Regulatory_Framework', 0.33985158801078796)","('Human_Rights_And_Community_Relations', 0.23859535157680511)","('Access_And_Affordability', 0.07998501509428024)","('NON-ESG', 0.33985158801078796)","('NON-ESG', 0.23859535157680511)","('NON-ESG', 0.07998501509428024)"
Line 1222,"We comply with all applicable laws and regulations that govern the interactions  between medical technology companies and healthcare professionals, healthcare organizations and government officials in the many countries in which we do business.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9626083374023438)","('Business_Ethics', 0.00390754546970129)","('Product_Quality_And_Safety', 0.002710682572796941)","(['Corporate Governance'], 0.9626083374023438)","('NON-ESG', 0.00390754546970129)","('NON-ESG', 0.002710682572796941)"
Line 1223,"To help support compliance, BD has adopted various industry codes, including the Advanced Medical Technology Association (AdvaMed) Code of Ethics in the United States, MedTech Europe, APACMed, Mecomed and Abimed.
","('Business_Ethics', 0.9498863816261292)","('Management_Of_Legal_And_Regulatory_Framework', 0.011462220922112465)","('Product_Quality_And_Safety', 0.003963901195675135)","(['Business Ethics'], 0.9498863816261292)","('NON-ESG', 0.011462220922112465)","('NON-ESG', 0.003963901195675135)"
Line 1224,"Key provisions of applicable industry codes are also incorporated into various global policies, including the Global Standards for Interactions with Healthcare Professionals, Healthcare Organizations and Government Officials.
","('Management_Of_Legal_And_Regulatory_Framework', 0.751238226890564)","('Business_Ethics', 0.09127715975046158)","('Product_Quality_And_Safety', 0.040503520518541336)","(['Corporate Governance'], 0.751238226890564)","('NON-ESG', 0.09127715975046158)","('NON-ESG', 0.040503520518541336)"
Line 1225,"BD associates receive information and training about these codes in a few ways,  including periodic communications and online and in-person trainings.
","('Product_Quality_And_Safety', 0.25053587555885315)","('Management_Of_Legal_And_Regulatory_Framework', 0.15614822506904602)","('Business_Ethics', 0.15426528453826904)","('NON-ESG', 0.25053587555885315)","('NON-ESG', 0.15614822506904602)","('NON-ESG', 0.15426528453826904)"
Line 1226,"Associates can access detailed information on our expectations through our intranet and our ethics and compliance mobile app.
","('Business_Ethics', 0.9568812847137451)","('Management_Of_Legal_And_Regulatory_Framework', 0.009285627864301205)","('Product_Quality_And_Safety', 0.0038337919395416975)","(['Business Ethics'], 0.9568812847137451)","('NON-ESG', 0.009285627864301205)","('NON-ESG', 0.0038337919395416975)"
Line 1227,"Product marketing BD has policies and procedures governing the advertising and promotion of our products, solutions and services in order to comply with applicable laws and regulations.
","('Selling_Practices_And_Product_Labeling', 0.8397628664970398)","('Product_Design_And_Lifecycle_Management', 0.03059508465230465)","('Customer_Welfare', 0.02424292266368866)","(['Marketing Practices'], 0.8397628664970398)","('NON-ESG', 0.03059508465230465)","('NON-ESG', 0.02424292266368866)"
Line 1228,"Expectations around the promotion of our products are laid out in our Code of Conduct.
","('Product_Design_And_Lifecycle_Management', 0.7937966585159302)","('Selling_Practices_And_Product_Labeling', 0.07689695805311203)","('Product_Quality_And_Safety', 0.038256317377090454)","(['Product Stewardship'], 0.7937966585159302)","('NON-ESG', 0.07689695805311203)","('NON-ESG', 0.038256317377090454)"
Line 1229,"Our advertising and promotions programs serve to create a globally harmonized  process for generating, reviewing and approving advertising and promotional communications.
","('Selling_Practices_And_Product_Labeling', 0.3600136935710907)","('Competitive_Behavior', 0.17224431037902832)","('Customer_Welfare', 0.1028480976819992)","('NON-ESG', 0.3600136935710907)","('NON-ESG', 0.17224431037902832)","('NON-ESG', 0.1028480976819992)"
Line 1230,"This program promotes consistency in definitions, rules, principles, governance and approval criteria to enable compliance across BD.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9448317289352417)","('Business_Ethics', 0.017202282324433327)","('Director_Removal', 0.005011270288378)","(['Corporate Governance'], 0.9448317289352417)","('NON-ESG', 0.017202282324433327)","('NON-ESG', 0.005011270288378)"
Line 1231,"Our advertising and promotion review and approval processes are overseen by a steering committee consisting of cross-functional representatives from each business unit, including marketing, medical affairs, regulatory affairs and legal.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9540547132492065)","('Competitive_Behavior', 0.006163462530821562)","('Business_Ethics', 0.003899693489074707)","(['Corporate Governance'], 0.9540547132492065)","('NON-ESG', 0.006163462530821562)","('NON-ESG', 0.003899693489074707)"
Line 1232,"Our global policy on advertising and promotion prohibits the development and distribution of advertising and promotional materials that have not been approved under the structure set out in the policy.
","('Selling_Practices_And_Product_Labeling', 0.5756727457046509)","('Management_Of_Legal_And_Regulatory_Framework', 0.0985841453075409)","('Customer_Privacy', 0.056842006742954254)","(['Marketing Practices'], 0.5756727457046509)","('NON-ESG', 0.0985841453075409)","('NON-ESG', 0.056842006742954254)"
Line 1233,"All policies outline the obligation to report noncompliance, how to report it—including via the BD Ethics Helpline—and potential disciplinary action that could be taken for noncompliance.
","('Business_Ethics', 0.9454758763313293)","('Management_Of_Legal_And_Regulatory_Framework', 0.015228292904794216)","('Product_Quality_And_Safety', 0.005369745194911957)","(['Business Ethics'], 0.9454758763313293)","('NON-ESG', 0.015228292904794216)","('NON-ESG', 0.005369745194911957)"
Line 1234,"All associates who are involved in the creation, review, approval and distribution of  advertising and promotional materials are required to complete annual training via the BD online training system.
","('Selling_Practices_And_Product_Labeling', 0.2540743350982666)","('Management_Of_Legal_And_Regulatory_Framework', 0.21499907970428467)","('Product_Quality_And_Safety', 0.06830454617738724)","('NON-ESG', 0.2540743350982666)","('NON-ESG', 0.21499907970428467)","('NON-ESG', 0.06830454617738724)"
Line 1235,"Training covers BD policies and procedures, as well as our systems used to manage and track approvals.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9334090948104858)","('Director_Removal', 0.008225950412452221)","('Business_Ethics', 0.0073850881308317184)","(['Corporate Governance'], 0.9334090948104858)","('NON-ESG', 0.008225950412452221)","('NON-ESG', 0.0073850881308317184)"
Line 1236,"In addition, topic-specific training is provided throughout the year.
","('Product_Quality_And_Safety', 0.14856146275997162)","('Employee_Engagement_Inclusion_And_Diversity', 0.13906888663768768)","('Access_And_Affordability', 0.136680468916893)","('NON-ESG', 0.14856146275997162)","('NON-ESG', 0.13906888663768768)","('NON-ESG', 0.136680468916893)"
Line 1237,"2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Human rights At BD, we integrate human rights principles into our business processes and practices.
","('Physical_Impacts_Of_Climate_Change', 0.36859458684921265)","('Supply_Chain_Management', 0.2262280136346817)","('Human_Rights_And_Community_Relations', 0.17307981848716736)","('NON-ESG', 0.36859458684921265)","('NON-ESG', 0.2262280136346817)","('NON-ESG', 0.17307981848716736)"
Line 1238,"We  believe that all people should be treated with dignity and respect, and we are committed to conducting our business in a manner consistent with this principle.
","('Human_Rights_And_Community_Relations', 0.7882683873176575)","('Business_Ethics', 0.036270562559366226)","('Employee_Health_And_Safety', 0.023271098732948303)","(['Community Relations'], 0.7882683873176575)","('NON-ESG', 0.036270562559366226)","('NON-ESG', 0.023271098732948303)"
Line 1239,"This includes respecting the human rights of all associates, as well as the people in our supply chains, the communities in which we operate and those who are impacted by our products.
","('Human_Rights_And_Community_Relations', 0.4903927147388458)","('Supply_Chain_Management', 0.24631336331367493)","('Employee_Health_And_Safety', 0.031995803117752075)","('NON-ESG', 0.4903927147388458)","('NON-ESG', 0.24631336331367493)","('NON-ESG', 0.031995803117752075)"
Line 1240,"Our commitment—detailed in our Global Human Rights Policy—is guided by the principles  outlined in the UN Declaration of Human Rights and the International Labor Organization’s Declaration on Fundamental Principles and Rights at Work.
","('Human_Rights_And_Community_Relations', 0.9084387421607971)","('Labor_Practices', 0.035193752497434616)","('Access_And_Affordability', 0.006036862265318632)","(['Community Relations'], 0.9084387421607971)","('NON-ESG', 0.035193752497434616)","('NON-ESG', 0.006036862265318632)"
Line 1241,"Our commitment extends beyond BD processes and practices to those in our supply chains.
","('Supply_Chain_Management', 0.9454719424247742)","('Labor_Practices', 0.005438288673758507)","('Product_Design_And_Lifecycle_Management', 0.004402798600494862)","(['Supply Chain Management'], 0.9454719424247742)","('NON-ESG', 0.005438288673758507)","('NON-ESG', 0.004402798600494862)"
Line 1242,"We comply with applicable employment and human rights laws and regulations wherever we have operations; we expect our suppliers to do the same.
","('Human_Rights_And_Community_Relations', 0.4958480894565582)","('Labor_Practices', 0.29430586099624634)","('Management_Of_Legal_And_Regulatory_Framework', 0.05430653318762779)","('NON-ESG', 0.4958480894565582)","('NON-ESG', 0.29430586099624634)","('NON-ESG', 0.05430653318762779)"
Line 1243,"In all of our operations: •  W e provide a safe and healthy workplace for our associates.
","('Employee_Health_And_Safety', 0.787082850933075)","('Employee_Engagement_Inclusion_And_Diversity', 0.047599852085113525)","('Product_Design_And_Lifecycle_Management', 0.027543243020772934)","(['Operational Eco-Efficiency'], 0.787082850933075)","('NON-ESG', 0.047599852085113525)","('NON-ESG', 0.027543243020772934)"
Line 1244,"•  W e do not use child labor.
","('Labor_Practices', 0.9711622595787048)","('Director_Removal', 0.002718525007367134)","('Waste_And_Hazardous_Materials_Management', 0.002624663757160306)","(['Labor Practice Indicators'], 0.9711622595787048)","('NON-ESG', 0.002718525007367134)","('NON-ESG', 0.002624663757160306)"
Line 1245,"•  W e do not use forced, prison, indentured, bonded or  involuntary labor.
","('Labor_Practices', 0.9747363328933716)","('Director_Removal', 0.0024155606515705585)","('Waste_And_Hazardous_Materials_Management', 0.0019223344279453158)","(['Labor Practice Indicators'], 0.9747363328933716)","('NON-ESG', 0.0024155606515705585)","('NON-ESG', 0.0019223344279453158)"
Line 1246,"•  W e prohibit discrimination in our hiring and employment  practices.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9035154581069946)","('Labor_Practices', 0.04105692729353905)","('Employee_Health_And_Safety', 0.005133321043103933)","(['Human Capital Development'], 0.9035154581069946)","('NON-ESG', 0.04105692729353905)","('NON-ESG', 0.005133321043103933)"
Line 1247,"•  W e prohibit physical abuse and harassment of associates, as  well as the threat of either.
","('Business_Ethics', 0.3151536285877228)","('Employee_Health_And_Safety', 0.27635258436203003)","('Labor_Practices', 0.09838517010211945)","('NON-ESG', 0.3151536285877228)","('NON-ESG', 0.27635258436203003)","('NON-ESG', 0.09838517010211945)"
Line 1248,"•  W e support the freedom of association and the rights of  workers and employers to bargain collectively.
","('Labor_Practices', 0.9768714308738708)","('Director_Removal', 0.002655234420672059)","('Human_Rights_And_Community_Relations', 0.0018242293735966086)","(['Labor Practice Indicators'], 0.9768714308738708)","('NON-ESG', 0.002655234420672059)","('NON-ESG', 0.0018242293735966086)"
Line 1249,"The central S&EHS team is responsible for monitoring and coordinating efforts to provide  awareness of human rights compliance obligations.
","('Human_Rights_And_Community_Relations', 0.9492877125740051)","('Labor_Practices', 0.004709215834736824)","('Access_And_Affordability', 0.004541134927421808)","(['Community Relations'], 0.9492877125740051)","('NON-ESG', 0.004709215834736824)","('NON-ESG', 0.004541134927421808)"
Line 1250,"Human rights management is embedded in our integrated supply chain (including Operations, Supply Chain, Procurement and Sustainability & EHS) and human resources functions, to foster compliance with our policies prohibiting forced labor, human trafficking and modern slavery across all of our operations.
","('Labor_Practices', 0.8650031685829163)","('Supply_Chain_Management', 0.03485613316297531)","('Employee_Health_And_Safety', 0.01839987188577652)","(['Labor Practice Indicators'], 0.8650031685829163)","('NON-ESG', 0.03485613316297531)","('NON-ESG', 0.01839987188577652)"
Line 1251,"As important matters relating to human rights issues arise, the VP S&EHS will brief the ERC  as needed; the ERC will brief the relevant Board committee and the full Board if applicable.BD has programs in place to monitor and advance human rights efforts throughout the company.
","('Human_Rights_And_Community_Relations', 0.9536342024803162)","('Labor_Practices', 0.003983767703175545)","('Critical_Incident_Risk_Management', 0.0036821505054831505)","(['Community Relations'], 0.9536342024803162)","('NON-ESG', 0.003983767703175545)","('NON-ESG', 0.0036821505054831505)"
Line 1252,"These include: •  A dditional policies •  T he BD Code of Conduct, which reinforces our commitment to human rights and  details how to report suspected violations anywhere in our supply chain.
","('Supply_Chain_Management', 0.8477627038955688)","('Labor_Practices', 0.02976992540061474)","('Human_Rights_And_Community_Relations', 0.015853185206651688)","(['Supply Chain Management'], 0.8477627038955688)","('NON-ESG', 0.02976992540061474)","('NON-ESG', 0.015853185206651688)"
Line 1253,"All of our  associates are trained annually on our Code of Conduct.
","('Business_Ethics', 0.7025862336158752)","('Management_Of_Legal_And_Regulatory_Framework', 0.11074721068143845)","('Director_Removal', 0.034372955560684204)","(['Business Ethics'], 0.7025862336158752)","('NON-ESG', 0.11074721068143845)","('NON-ESG', 0.034372955560684204)"
Line 1254,"•  BD Expect ations for Suppliers, our Code of Conduct designed for our thousands  of suppliers.
","('Supply_Chain_Management', 0.9171238541603088)","('Labor_Practices', 0.009954738430678844)","('Waste_And_Hazardous_Materials_Management', 0.006121979560703039)","(['Supply Chain Management'], 0.9171238541603088)","('NON-ESG', 0.009954738430678844)","('NON-ESG', 0.006121979560703039)"
Line 1255,"•  Pr actices geared toward ensuring that modern slavery and human trafficking do not exist  in our workforce or those of our suppliers •  W e do not charge any of our associates recruitment fees, and do not work with  recruitment agencies that engage in this practice.
","('Labor_Practices', 0.36235928535461426)","('Employee_Engagement_Inclusion_And_Diversity', 0.3364246189594269)","('Employee_Health_And_Safety', 0.08770855516195297)","('NON-ESG', 0.36235928535461426)","('NON-ESG', 0.3364246189594269)","('NON-ESG', 0.08770855516195297)"
Line 1256,"•  W e do not withhold identity documents, immigration documents or any other personal  documentation of our associates.
","('Customer_Privacy', 0.9296677708625793)","('Labor_Practices', 0.00762720825150609)","('Employee_Engagement_Inclusion_And_Diversity', 0.006047919858247042)","(['Privacy Protection'], 0.9296677708625793)","('NON-ESG', 0.00762720825150609)","('NON-ESG', 0.006047919858247042)"
Line 1257,"•  W e encourage our associates to report, without fear of retaliation, any matters related  to human trafficking, modern slavery or any other human rights violations.
","('Human_Rights_And_Community_Relations', 0.808256208896637)","('Business_Ethics', 0.04160883650183678)","('Labor_Practices', 0.02275550179183483)","(['Community Relations'], 0.808256208896637)","('NON-ESG', 0.04160883650183678)","('NON-ESG', 0.02275550179183483)"
Line 1258,"•  W e provide BD associates with forced labor and human trafficking training each  year, developed by a third party and administered online.
","('Labor_Practices', 0.9122361540794373)","('Human_Rights_And_Community_Relations', 0.01667184941470623)","('Employee_Health_And_Safety', 0.010409075766801834)","(['Labor Practice Indicators'], 0.9122361540794373)","('NON-ESG', 0.01667184941470623)","('NON-ESG', 0.010409075766801834)"
Line 1259,"This course is taken by  any associate that interacts directly or indirectly with our suppliers.
","('Supply_Chain_Management', 0.8888596892356873)","('Labor_Practices', 0.012823122553527355)","('Water_And_Wastewater_Management', 0.010610580444335938)","(['Supply Chain Management'], 0.8888596892356873)","('NON-ESG', 0.012823122553527355)","('NON-ESG', 0.010610580444335938)"
Line 1260,"This includes the sourcing, managing and/or advising on the selection of our suppliers.
","('Supply_Chain_Management', 0.8492440581321716)","('Product_Design_And_Lifecycle_Management', 0.042005158960819244)","('Customer_Welfare', 0.013984031975269318)","(['Supply Chain Management'], 0.8492440581321716)","('NON-ESG', 0.042005158960819244)","('NON-ESG', 0.013984031975269318)"
Line 1261,"•  W e are committed to due diligence, including initial assessments of suppliers against  12 risk factors (including ESG risk and desktop audits of prioritized suppliers).
","('Supply_Chain_Management', 0.9336175918579102)","('Systemic_Risk_Management', 0.012238423340022564)","('Physical_Impacts_Of_Climate_Change', 0.005506770685315132)","(['Supply Chain Management'], 0.9336175918579102)","('NON-ESG', 0.012238423340022564)","('NON-ESG', 0.005506770685315132)"
Line 1262,"•  W e employ risk management efforts to enhance compliance with related policies  throughout our operations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9055929780006409)","('Business_Ethics', 0.02434566430747509)","('Systemic_Risk_Management', 0.007324866019189358)","(['Corporate Governance'], 0.9055929780006409)","('NON-ESG', 0.02434566430747509)","('NON-ESG', 0.007324866019189358)"
Line 1263,"For example, our Global Operations and Human Resources teams work to promote compliance with our policies prohibiting forced labor, human trafficking and modern slavery across all of our operations, including manufacturing operations.
","('Labor_Practices', 0.9475440979003906)","('Employee_Health_And_Safety', 0.008166867308318615)","('Employee_Engagement_Inclusion_And_Diversity', 0.007337071001529694)","(['Labor Practice Indicators'], 0.9475440979003906)","('NON-ESG', 0.008166867308318615)","('NON-ESG', 0.007337071001529694)"
Line 1264,"•  W e provide training and capacity-building, both internally and for key suppliers.
","('Supply_Chain_Management', 0.8973603248596191)","('Product_Design_And_Lifecycle_Management', 0.00986677035689354)","('Energy_Management', 0.006733983755111694)","(['Supply Chain Management'], 0.8973603248596191)","('NON-ESG', 0.00986677035689354)","('NON-ESG', 0.006733983755111694)"
Line 1265,"BD takes steps to educate associates and third parties so they can identify modern slavery and other human rights abuses and take steps to eliminate them—both in our own operations and within our supply chain.
","('Human_Rights_And_Community_Relations', 0.33179008960723877)","('Labor_Practices', 0.15694892406463623)","('Business_Ethics', 0.15451820194721222)","('NON-ESG', 0.33179008960723877)","('NON-ESG', 0.15694892406463623)","('NON-ESG', 0.15451820194721222)"
Line 1266,"Further details about our supplier human rights due diligence process can be found in the  Responsible Supply Chain section of this report.
","('Supply_Chain_Management', 0.9464074969291687)","('Labor_Practices', 0.005971268285065889)","('Physical_Impacts_Of_Climate_Change', 0.003723533358424902)","(['Supply Chain Management'], 0.9464074969291687)","('NON-ESG', 0.005971268285065889)","('NON-ESG', 0.003723533358424902)"
Line 1267,"BD strives to continuously improve its programs to promote compliance with applicable  laws and high ethical standards to meet the expectations of our customers, shareholders, associates, communities and other stakeholders.2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Cybersecurity program BD products and systems are  designed to be secure and are developed using industry-leading cybersecurity standards, including those from ISO and NIST .
","('Business_Ethics', 0.3378596305847168)","('Data_Security', 0.20287948846817017)","('Systemic_Risk_Management', 0.15085335075855255)","('NON-ESG', 0.3378596305847168)","('NON-ESG', 0.20287948846817017)","('NON-ESG', 0.15085335075855255)"
Line 1268,"BD strives to continuously improve its programs to promote compliance with applicable  laws and high ethical standards to meet the expectations of our customers, shareholders, associates, communities and other stakeholders.2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Cybersecurity program BD products and systems are  designed to be secure and are developed using industry-leading cybersecurity standards, including those from ISO and NIST .
","('Management_Of_Legal_And_Regulatory_Framework', 0.4275622069835663)","('Product_Quality_And_Safety', 0.1627289354801178)","('Competitive_Behavior', 0.07581054419279099)","('NON-ESG', 0.4275622069835663)","('NON-ESG', 0.1627289354801178)","('NON-ESG', 0.07581054419279099)"
Line 1269,"BD products and systems are  secured and maintained throughout their intended life cycle, across all technologies and sites.
","('Product_Design_And_Lifecycle_Management', 0.9106494784355164)","('Product_Quality_And_Safety', 0.008578553795814514)","('Data_Security', 0.008534489199519157)","(['Product Stewardship'], 0.9106494784355164)","('NON-ESG', 0.008578553795814514)","('NON-ESG', 0.008534489199519157)"
Line 1270,"BD maintains a culture of  transparency and collaboration with customers and industry stakeholders to establish industry best practices.Security  by design Security   in use Security through partnership“In healthcare, the cybersecurity threat landscape is  dynamic and interconnected.
","('Business_Ethics', 0.723818302154541)","('Data_Security', 0.1795807033777237)","('Systemic_Risk_Management', 0.013331245630979538)","(['Business Ethics'], 0.723818302154541)","('NON-ESG', 0.1795807033777237)","('NON-ESG', 0.013331245630979538)"
Line 1271,"We strive to protect BD products from vulnerabilities and risks that could impact patient safety and privacy, while also safeguarding the company’s ability to manufacture and distribute quality medical technologies.
","('Product_Quality_And_Safety', 0.8771013021469116)","('Product_Design_And_Lifecycle_Management', 0.02693869173526764)","('Employee_Health_And_Safety', 0.01609947718679905)","(['Product Quality & Recall Management'], 0.8771013021469116)","('NON-ESG', 0.02693869173526764)","('NON-ESG', 0.01609947718679905)"
Line 1272,"By protecting the confidentiality, integrity and availability of our products, manufacturing and IT systems, BD is helping to improve the resilience of healthcare around the world.” Rob Suárez  Vice President, Chief Information Security Officer Our commitment to cybersecurity includes the protection and resilience of BD  products, manufacturing operational technology and enterprise information technology.
","('Data_Security', 0.927055299282074)","('Business_Ethics', 0.015216671861708164)","('Customer_Privacy', 0.012243497185409069)","(['Information Security/Cybersecurity & System Availability'], 0.927055299282074)","('NON-ESG', 0.015216671861708164)","('NON-ESG', 0.012243497185409069)"
Line 1273,"BD Information Security, which is part of the company’s risk management organization, is responsible for our: •  Global c ybersecurity strategy •  C ybersecurity governance •  C ybersecurity operations •  C ybersecurity engineering •  Pr oduct cybersecurity •  R egional cybersecurity  •  C ybersecurity awareness training Cybersecurity strategy Our strategic approach to cybersecurity incorporates regulatory requirements for  medical device cybersecurity, including the U.S. Food and Drug Administration’s pre- and post-market cybersecurity guidance, as well as emerging cybersecurity reporting and disclosure requirements pursuant to Executive Order 14028 on Improving the Nation’s Cybersecurity , which was issued in May 2021 by U.S.  President Joe Biden.
","('Data_Security', 0.935127317905426)","('Systemic_Risk_Management', 0.01443097647279501)","('Physical_Impacts_Of_Climate_Change', 0.004162999335676432)","(['Information Security/Cybersecurity & System Availability'], 0.935127317905426)","('NON-ESG', 0.01443097647279501)","('NON-ESG', 0.004162999335676432)"
Line 1274,"BD Information Security, which is part of the company’s risk management organization, is responsible for our: •  Global c ybersecurity strategy •  C ybersecurity governance •  C ybersecurity operations •  C ybersecurity engineering •  Pr oduct cybersecurity •  R egional cybersecurity  •  C ybersecurity awareness training Cybersecurity strategy Our strategic approach to cybersecurity incorporates regulatory requirements for  medical device cybersecurity, including the U.S. Food and Drug Administration’s pre- and post-market cybersecurity guidance, as well as emerging cybersecurity reporting and disclosure requirements pursuant to Executive Order 14028 on Improving the Nation’s Cybersecurity , which was issued in May 2021 by U.S.  President Joe Biden.
","('Data_Security', 0.8301810026168823)","('Systemic_Risk_Management', 0.059351567178964615)","('Business_Model_Resilience', 0.01816721260547638)","(['Information Security/Cybersecurity & System Availability'], 0.8301810026168823)","('NON-ESG', 0.059351567178964615)","('NON-ESG', 0.01816721260547638)"
Line 1275,"We also incorporate threat intelligence from organizations like the U.S. Department of Homeland Security Cybersecurity and Infrastructure Security Agency (CISA), which issued numerous communications in 2021 about potential cyber threats aimed at critical infrastructure.
","('Data_Security', 0.9545196890830994)","('Physical_Impacts_Of_Climate_Change', 0.004794513341039419)","('Systemic_Risk_Management', 0.0042878687381744385)","(['Information Security/Cybersecurity & System Availability'], 0.9545196890830994)","('NON-ESG', 0.004794513341039419)","('NON-ESG', 0.0042878687381744385)"
Line 1276,"To protect the cybersecurity and resilience of BD and our products, our  cybersecurity strategy is built on three guiding principles:2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Design Requirements Cybersecurity Requirements System Requirements Hardening Standards Software Requirements Secure Coding  Standards Regional and Market Cyberse curity Req uirementsCode AnalysisVulnerability ScanningUser ComplaintsIdentity Access Management Logging and Monitoring Incident ResponseVulnerability and Patch Management DecommissioningInventory Management Governance and Compliance ReportingService Design Idea Planning Development QualiﬁcationService Transition  LaunchService Operation Complaint Handling Desig n Control Risk Management Penetration Testing  Training and Awareness Management PlanInformation SecurityRisk AssessmentInformation Security Cybersecurity White Paper Asset, Vulnerability and Patch ManagementIn addition, the BD Cybersecurity Framework serves as a blueprint for managing cybersecurity risk across BD products, manufacturing operational technology and information technology.
","('Business_Model_Resilience', 0.43452194333076477)","('Systemic_Risk_Management', 0.20723101496696472)","('Data_Security', 0.10105816274881363)","('NON-ESG', 0.43452194333076477)","('NON-ESG', 0.20723101496696472)","('NON-ESG', 0.10105816274881363)"
Line 1277,"To protect the cybersecurity and resilience of BD and our products, our  cybersecurity strategy is built on three guiding principles:2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Design Requirements Cybersecurity Requirements System Requirements Hardening Standards Software Requirements Secure Coding  Standards Regional and Market Cyberse curity Req uirementsCode AnalysisVulnerability ScanningUser ComplaintsIdentity Access Management Logging and Monitoring Incident ResponseVulnerability and Patch Management DecommissioningInventory Management Governance and Compliance ReportingService Design Idea Planning Development QualiﬁcationService Transition  LaunchService Operation Complaint Handling Desig n Control Risk Management Penetration Testing  Training and Awareness Management PlanInformation SecurityRisk AssessmentInformation Security Cybersecurity White Paper Asset, Vulnerability and Patch ManagementIn addition, the BD Cybersecurity Framework serves as a blueprint for managing cybersecurity risk across BD products, manufacturing operational technology and information technology.
","('Data_Security', 0.9019271731376648)","('Systemic_Risk_Management', 0.02721860632300377)","('Business_Ethics', 0.011096533387899399)","(['Information Security/Cybersecurity & System Availability'], 0.9019271731376648)","('NON-ESG', 0.02721860632300377)","('NON-ESG', 0.011096533387899399)"
Line 1278,"To protect the cybersecurity and resilience of BD and our products, our  cybersecurity strategy is built on three guiding principles:2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Design Requirements Cybersecurity Requirements System Requirements Hardening Standards Software Requirements Secure Coding  Standards Regional and Market Cyberse curity Req uirementsCode AnalysisVulnerability ScanningUser ComplaintsIdentity Access Management Logging and Monitoring Incident ResponseVulnerability and Patch Management DecommissioningInventory Management Governance and Compliance ReportingService Design Idea Planning Development QualiﬁcationService Transition  LaunchService Operation Complaint Handling Desig n Control Risk Management Penetration Testing  Training and Awareness Management PlanInformation SecurityRisk AssessmentInformation Security Cybersecurity White Paper Asset, Vulnerability and Patch ManagementIn addition, the BD Cybersecurity Framework serves as a blueprint for managing cybersecurity risk across BD products, manufacturing operational technology and information technology.
","('Data_Security', 0.6998689770698547)","('Systemic_Risk_Management', 0.17134054005146027)","('Business_Model_Resilience', 0.017293507233262062)","(['Information Security/Cybersecurity & System Availability'], 0.6998689770698547)","('NON-ESG', 0.17134054005146027)","('NON-ESG', 0.017293507233262062)"
Line 1279,"The framework has 33 high-level design requirements including identity  and access management, platform hardening, application security, cloud security and patch management.
","('Data_Security', 0.9541511535644531)","('Customer_Privacy', 0.004997572861611843)","('Systemic_Risk_Management', 0.003699377179145813)","(['Information Security/Cybersecurity & System Availability'], 0.9541511535644531)","('NON-ESG', 0.004997572861611843)","('NON-ESG', 0.003699377179145813)"
Line 1280,"It is aligned to multiple industry standards and work products including the International Organization for Standardization (ISO) 27001 standards, the Healthcare & Public Health Sector Coordinating Council’s (HSCC’s) Medical Device and Health IT Joint Security Plan, the National Institute of Standards and Technology (NIST) Cybersecurity Framework, Underwriters’ Laboratories’ ((UL’s) 2900 Standard for Software Cybersecurity for Network-Connectable Products and the standards of the International Society of Automation (ISA) 62443.2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Cybersecurity governance Our approach to cybersecurity governance includes aligning cybersecurity risk  management, policy and compliance initiatives with business objectives so that information assets and technologies used in BD products, manufacturing, service, enterprise IT and third-party components are secure, resilient and compliant with applicable regulatory and industry standards.
","('Data_Security', 0.9108453392982483)","('Systemic_Risk_Management', 0.013448871672153473)","('Management_Of_Legal_And_Regulatory_Framework', 0.007196513470262289)","(['Information Security/Cybersecurity & System Availability'], 0.9108453392982483)","('NON-ESG', 0.013448871672153473)","('NON-ESG', 0.007196513470262289)"
Line 1281,"It is aligned to multiple industry standards and work products including the International Organization for Standardization (ISO) 27001 standards, the Healthcare & Public Health Sector Coordinating Council’s (HSCC’s) Medical Device and Health IT Joint Security Plan, the National Institute of Standards and Technology (NIST) Cybersecurity Framework, Underwriters’ Laboratories’ ((UL’s) 2900 Standard for Software Cybersecurity for Network-Connectable Products and the standards of the International Society of Automation (ISA) 62443.2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Cybersecurity governance Our approach to cybersecurity governance includes aligning cybersecurity risk  management, policy and compliance initiatives with business objectives so that information assets and technologies used in BD products, manufacturing, service, enterprise IT and third-party components are secure, resilient and compliant with applicable regulatory and industry standards.
","('Physical_Impacts_Of_Climate_Change', 0.587731122970581)","('Business_Model_Resilience', 0.13545243442058563)","('Supply_Chain_Management', 0.11610321700572968)","(['Climate Change'], 0.587731122970581)","('NON-ESG', 0.13545243442058563)","('NON-ESG', 0.11610321700572968)"
Line 1282,"It is aligned to multiple industry standards and work products including the International Organization for Standardization (ISO) 27001 standards, the Healthcare & Public Health Sector Coordinating Council’s (HSCC’s) Medical Device and Health IT Joint Security Plan, the National Institute of Standards and Technology (NIST) Cybersecurity Framework, Underwriters’ Laboratories’ ((UL’s) 2900 Standard for Software Cybersecurity for Network-Connectable Products and the standards of the International Society of Automation (ISA) 62443.2021 ESG Report Healthy workforce and communities Appendices Responsible supply chain Product impact Climate change Introduction Transparency Cybersecurity governance Our approach to cybersecurity governance includes aligning cybersecurity risk  management, policy and compliance initiatives with business objectives so that information assets and technologies used in BD products, manufacturing, service, enterprise IT and third-party components are secure, resilient and compliant with applicable regulatory and industry standards.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8050720691680908)","('Business_Ethics', 0.03698502853512764)","('Product_Quality_And_Safety', 0.03447328880429268)","(['Corporate Governance'], 0.8050720691680908)","('NON-ESG', 0.03698502853512764)","('NON-ESG', 0.03447328880429268)"
Line 1283,"This includes cybersecurity due diligence for BD mergers, acquisitions and divestitures.
","('Systemic_Risk_Management', 0.6800668239593506)","('Business_Ethics', 0.07149701565504074)","('Management_Of_Legal_And_Regulatory_Framework', 0.047316260635852814)","(['Risk & Crisis Management'], 0.6800668239593506)","('NON-ESG', 0.07149701565504074)","('NON-ESG', 0.047316260635852814)"
Line 1284,"BD Information Security policies and procedures are reviewed annually by cross- functional stakeholders specializing in information security, integrated supply chain, enterprise IT and quality.
","('Data_Security', 0.939241886138916)","('Supply_Chain_Management', 0.0060686757788062096)","('Systemic_Risk_Management', 0.004804709460586309)","(['Information Security/Cybersecurity & System Availability'], 0.939241886138916)","('NON-ESG', 0.0060686757788062096)","('NON-ESG', 0.004804709460586309)"
Line 1285,"Additionally, cybersecurity risks and their potential impact on BD, customers and patients are reviewed by the company’s central, regional and business teams, and information security provides guidance for identifying, prioritizing and mitigating such risks.
","('Data_Security', 0.903184711933136)","('Systemic_Risk_Management', 0.03736124187707901)","('Physical_Impacts_Of_Climate_Change', 0.006536847911775112)","(['Information Security/Cybersecurity & System Availability'], 0.903184711933136)","('NON-ESG', 0.03736124187707901)","('NON-ESG', 0.006536847911775112)"
Line 1286,"Cybersecurity risks are also integrated into our approach to enterprise risk management, and significant cybersecurity risks are communicated to the Executive Leadership team and the Board of Directors through the Audit Committee and the Quality and Regulatory Committee.
","('Systemic_Risk_Management', 0.6442040801048279)","('Data_Security', 0.20709258317947388)","('Business_Ethics', 0.02569841593503952)","(['Risk & Crisis Management'], 0.6442040801048279)","('NON-ESG', 0.20709258317947388)","('NON-ESG', 0.02569841593503952)"
Line 1287,"In addition, BD provides the Board of Directors and the Executive Leadership  team with cybersecurity training.
","('Business_Model_Resilience', 0.16343003511428833)","('Director_Removal', 0.13583610951900482)","('Systemic_Risk_Management', 0.10827570408582687)","('NON-ESG', 0.16343003511428833)","('NON-ESG', 0.13583610951900482)","('NON-ESG', 0.10827570408582687)"
Line 1288,"This includes annual scenario-based cybersecurity training in providing effective oversight in the event of a significant cybersecurity incident, and targeted cybersecurity training opportunities such as the National Association of Corporate Directors (NACD) Cyber-risk Oversight Certificate program, which is designed to enhance participants’ understanding of the cybersecurity threat landscape, cyber-risk oversight responsibilities and organizational preparedness for cybersecurity crises.
","('Data_Security', 0.8005884289741516)","('Systemic_Risk_Management', 0.05282967910170555)","('Physical_Impacts_Of_Climate_Change', 0.019973961636424065)","(['Information Security/Cybersecurity & System Availability'], 0.8005884289741516)","('NON-ESG', 0.05282967910170555)","('NON-ESG', 0.019973961636424065)"
Line 1289,"We also provide annual cybersecurity awareness training for our 75,000  associates, comprising online cybersecurity training modules; in-person and virtual cybersecurity bootcamp classes; contextual phishing simulation exercises; mock incident response exercises; and intranet resources aimed at enhancing associates’ ongoing cyber-awareness.Cybersecurity risk management BD proactively monitors for suspicious activity, including phishing attacks, malware and ransomware attacks, insider threats and human error.
","('Data_Security', 0.9618061780929565)","('Systemic_Risk_Management', 0.0037534560542553663)","('Business_Ethics', 0.0035444064997136593)","(['Information Security/Cybersecurity & System Availability'], 0.9618061780929565)","('NON-ESG', 0.0037534560542553663)","('NON-ESG', 0.0035444064997136593)"
Line 1290,"We also provide annual cybersecurity awareness training for our 75,000  associates, comprising online cybersecurity training modules; in-person and virtual cybersecurity bootcamp classes; contextual phishing simulation exercises; mock incident response exercises; and intranet resources aimed at enhancing associates’ ongoing cyber-awareness.Cybersecurity risk management BD proactively monitors for suspicious activity, including phishing attacks, malware and ransomware attacks, insider threats and human error.
","('Product_Design_And_Lifecycle_Management', 0.07696884870529175)","('Competitive_Behavior', 0.06801982969045639)","('Energy_Management', 0.06453041732311249)","('NON-ESG', 0.07696884870529175)","('NON-ESG', 0.06801982969045639)","('NON-ESG', 0.06453041732311249)"
Line 1291,"Our monitoring and detection systems block an average of 14.4 million malicious activities per month.
","('Data_Security', 0.9490458965301514)","('Business_Ethics', 0.005570744164288044)","('Systemic_Risk_Management', 0.004308314993977547)","(['Information Security/Cybersecurity & System Availability'], 0.9490458965301514)","('NON-ESG', 0.005570744164288044)","('NON-ESG', 0.004308314993977547)"
Line 1292,"Our cybersecurity program also includes regular internal and external security  audits and vulnerability assessments; penetration testing of the company’s systems, products and practices; third-party risk assessments; threat intelligence investigations; vulnerability scanning and management; and incident management.
","('Data_Security', 0.960303008556366)","('Systemic_Risk_Management', 0.004029839765280485)","('Business_Ethics', 0.003130930010229349)","(['Information Security/Cybersecurity & System Availability'], 0.960303008556366)","('NON-ESG', 0.004029839765280485)","('NON-ESG', 0.003130930010229349)"
Line 1293,"We also leverage threat modeling to uncover and examine potential cybersecurity risks during the design process and beyond.
","('Data_Security', 0.847321629524231)","('Systemic_Risk_Management', 0.06622355431318283)","('Physical_Impacts_Of_Climate_Change', 0.010687878355383873)","(['Information Security/Cybersecurity & System Availability'], 0.847321629524231)","('NON-ESG', 0.06622355431318283)","('NON-ESG', 0.010687878355383873)"
Line 1294,"BD maintains consistent practices for reporting cybersecurity incidents to the  U.S. government, including the Cybersecurity and Infrastructure Security Agency (CISA) and/or the Federal Bureau of Investigation (FBI).
","('Data_Security', 0.9457246661186218)","('Systemic_Risk_Management', 0.00923136156052351)","('Physical_Impacts_Of_Climate_Change', 0.004947460722178221)","(['Information Security/Cybersecurity & System Availability'], 0.9457246661186218)","('NON-ESG', 0.00923136156052351)","('NON-ESG', 0.004947460722178221)"
Line 1295,"In addition, BD welcomes vulnerability reports from customers, security researchers, third-party component vendors and other external groups that wish to report a potential vulnerability in a BD software-enabled device.
","('Data_Security', 0.9555474519729614)","('Systemic_Risk_Management', 0.00448317127302289)","('Director_Removal', 0.00363368121907115)","(['Information Security/Cybersecurity & System Availability'], 0.9555474519729614)","('NON-ESG', 0.00448317127302289)","('NON-ESG', 0.00363368121907115)"
Line 1296,"Our approach to vulnerability reporting and disclosure is publicly available at the BD Cybersecurity Trust Center and noted in the BD 2021 Cybersecurity Annual Report.2021 ESG Report Appendices Responsible supply chain Product impact Climate change Introduction Transparency Healthy workforce and communities ® • FT SE4 Good Index since •  Member of DJSI •  Ne wsweek’s America’s Most Responsible  Companies List •  Ne wsweek’s America’s Most Trusted  Companies list •  Americ a’s Most Just Companies, JUST 100  2022, •  T he Wall Street Journal Management Top  250 list, as ranked by The Drucker Institute  for fifth consecutive year •  E covadis Sustainability Rating, Silver •  R apid Ratings Innovation Award •  F rost & Sullivan 2020 Global Technology  Innovation Award •  T op 100 Global Innovator – Clarivate, •  Chemic al Footprint Project – Disclosure  leader •  U .S.
","('Supply_Chain_Management', 0.4909161329269409)","('Physical_Impacts_Of_Climate_Change', 0.29891133308410645)","('Systemic_Risk_Management', 0.05491228401660919)","('NON-ESG', 0.4909161329269409)","('NON-ESG', 0.29891133308410645)","('NON-ESG', 0.05491228401660919)"
Line 1297,"Our approach to vulnerability reporting and disclosure is publicly available at the BD Cybersecurity Trust Center and noted in the BD 2021 Cybersecurity Annual Report.2021 ESG Report Appendices Responsible supply chain Product impact Climate change Introduction Transparency Healthy workforce and communities ® • FT SE4 Good Index since •  Member of DJSI •  Ne wsweek’s America’s Most Responsible  Companies List •  Ne wsweek’s America’s Most Trusted  Companies list •  Americ a’s Most Just Companies, JUST 100  2022, •  T he Wall Street Journal Management Top  250 list, as ranked by The Drucker Institute  for fifth consecutive year •  E covadis Sustainability Rating, Silver •  R apid Ratings Innovation Award •  F rost & Sullivan 2020 Global Technology  Innovation Award •  T op 100 Global Innovator – Clarivate, •  Chemic al Footprint Project – Disclosure  leader •  U .S.
","('Business_Model_Resilience', 0.24955596029758453)","('Product_Design_And_Lifecycle_Management', 0.2079262137413025)","('Systemic_Risk_Management', 0.09741201996803284)","('NON-ESG', 0.24955596029758453)","('NON-ESG', 0.2079262137413025)","('NON-ESG', 0.09741201996803284)"
Line 1298,"EPA Green Power partner •  U .S.
","('Ecological_Impacts', 0.2267419546842575)","('Management_Of_Legal_And_Regulatory_Framework', 0.2058873474597931)","('GHG_Emissions', 0.13691067695617676)","('NON-ESG', 0.2267419546842575)","('NON-ESG', 0.2058873474597931)","('NON-ESG', 0.13691067695617676)"
Line 1299,"EPA Smartway(R) Transport partner•  Americ a’s Best Large Employers List by Forbes:  No. 1 Best Large Employer in Health Care Equipment & Services Industry •  Bloomber g Gender Equality Index 2022 –   third consecutive year •  Disability E quality Index 2021—Best Place to  Work for Disability Inclusion, 3rd year in a row •  Div ersity Inc •  T he Human Rights Campaign (HRC)  Foundation’s Best Places to Work for LGBTQ Equality list.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9273293018341064)","('Employee_Health_And_Safety', 0.01705787517130375)","('Human_Rights_And_Community_Relations', 0.010293777100741863)","(['Human Capital Development'], 0.9273293018341064)","('NON-ESG', 0.01705787517130375)","('NON-ESG', 0.010293777100741863)"
Line 1300,"– 100% score on Corporate Equality Index for fifth consecutive year •  F orbes 2022 List of Best Employers for DiversityAwards and  recognitions2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities ESG issues Text in blue italics indicates feedback from stakeholder interviews that were carried out as part of the ESG assessment.
","('Supply_Chain_Management', 0.48931872844696045)","('Physical_Impacts_Of_Climate_Change', 0.22560328245162964)","('Systemic_Risk_Management', 0.07618053257465363)","('NON-ESG', 0.48931872844696045)","('NON-ESG', 0.22560328245162964)","('NON-ESG', 0.07618053257465363)"
Line 1301,"– 100% score on Corporate Equality Index for fifth consecutive year •  F orbes 2022 List of Best Employers for DiversityAwards and  recognitions2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Appendices2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities ESG issues Text in blue italics indicates feedback from stakeholder interviews that were carried out as part of the ESG assessment.
","('Business_Model_Resilience', 0.1960977464914322)","('Management_Of_Legal_And_Regulatory_Framework', 0.18270176649093628)","('Systemic_Risk_Management', 0.16869275271892548)","('NON-ESG', 0.1960977464914322)","('NON-ESG', 0.18270176649093628)","('NON-ESG', 0.16869275271892548)"
Line 1302,"ESG issue Definition How we manage this issue Accessibility •  Expanding ac cess to BD products and services to low-income patients and underserved  populations around the world.
","('Access_And_Affordability', 0.9470034837722778)","('Product_Quality_And_Safety', 0.004840364214032888)","('Human_Rights_And_Community_Relations', 0.004065375775098801)","(['Health Outcome Contribution'], 0.9470034837722778)","('NON-ESG', 0.004840364214032888)","('NON-ESG', 0.004065375775098801)"
Line 1303,"Stakeholders see BD as a leader in improving accessibility for underserved populations.
","('Access_And_Affordability', 0.9461858868598938)","('Critical_Incident_Risk_Management', 0.0048980507999658585)","('Product_Quality_And_Safety', 0.004767406731843948)","(['Health Outcome Contribution'], 0.9461858868598938)","('NON-ESG', 0.0048980507999658585)","('NON-ESG', 0.004767406731843948)"
Line 1304,"For more details, refer to the Access to health section.
","('Access_And_Affordability', 0.8866669535636902)","('Product_Quality_And_Safety', 0.015079936943948269)","('Employee_Health_And_Safety', 0.008785502053797245)","(['Health Outcome Contribution'], 0.8866669535636902)","('NON-ESG', 0.015079936943948269)","('NON-ESG', 0.008785502053797245)"
Line 1305,"Advancing Medical Analytics  and Automation•  Driving c ontinuous development of new approaches to information and knowledge  management in order to improve solutions for biomedical science, quality patient care and public health needs.Automation and analytics are central to the use of data to improve health outcomes, manufacturing, the changing nature of work and cybersecurity.
","('Data_Security', 0.29801228642463684)","('Access_And_Affordability', 0.1812865138053894)","('Energy_Management', 0.0505538247525692)","('NON-ESG', 0.29801228642463684)","('NON-ESG', 0.1812865138053894)","('NON-ESG', 0.0505538247525692)"
Line 1306,"Stakeholders want to see how BD will continue to lead in these areas and optimize existing data sources to improve health outcomes.
","('Employee_Health_And_Safety', 0.7263243794441223)","('Access_And_Affordability', 0.0840521901845932)","('Product_Quality_And_Safety', 0.030091265216469765)","(['Operational Eco-Efficiency'], 0.7263243794441223)","('NON-ESG', 0.0840521901845932)","('NON-ESG', 0.030091265216469765)"
Line 1307,"The future of healthcare is changing, and we see three irreversible forces that are going to be shaping healthcare  in new way: •  Smart c onnected care •  A shift t o new care settings •  Chr onic disease outcomes For details on how we are approaching our two axes of growth—Durable Core and Transformative Solutions—see  About our business.
","('Business_Model_Resilience', 0.35290420055389404)","('Systemic_Risk_Management', 0.13732090592384338)","('Access_And_Affordability', 0.08919338136911392)","('NON-ESG', 0.35290420055389404)","('NON-ESG', 0.13732090592384338)","('NON-ESG', 0.08919338136911392)"
Line 1308,"Affordability •  Expanding the quality and aff ordability of healthcare, especially in emerging and  developing economies.
","('Access_And_Affordability', 0.33940231800079346)","('Energy_Management', 0.14677610993385315)","('Customer_Welfare', 0.08557899296283722)","('NON-ESG', 0.33940231800079346)","('NON-ESG', 0.14677610993385315)","('NON-ESG', 0.08557899296283722)"
Line 1309,"•  De veloping a transparent pricing strategy for key geographic areas, including tiered  developed and emerging market pricing, and engaging with customers to improve product pricing transparency, reimbursement and affordability.Stakeholders would like to see BD leading on low-cost products for emerging markets and passing along cost savings to patients.
","('Competitive_Behavior', 0.39674678444862366)","('Product_Design_And_Lifecycle_Management', 0.23674723505973816)","('Customer_Welfare', 0.10044582933187485)","('NON-ESG', 0.39674678444862366)","('NON-ESG', 0.23674723505973816)","('NON-ESG', 0.10044582933187485)"
Line 1310,"Our Global Public Health team works to strengthen healthcare systems across the world by developing and  deploying market-appropriate solutions.
","('Access_And_Affordability', 0.5382733941078186)","('Critical_Incident_Risk_Management', 0.05381489172577858)","('Customer_Welfare', 0.0509818010032177)","(['Health Outcome Contribution'], 0.5382733941078186)","('NON-ESG', 0.05381489172577858)","('NON-ESG', 0.0509818010032177)"
Line 1311,"For more details, refer to the Access to health section and the Global Public Health website.
","('Access_And_Affordability', 0.7465289831161499)","('Product_Quality_And_Safety', 0.02990744821727276)","('Human_Rights_And_Community_Relations', 0.0230385884642601)","(['Health Outcome Contribution'], 0.7465289831161499)","('NON-ESG', 0.02990744821727276)","('NON-ESG', 0.0230385884642601)"
Line 1312,"Availability •  Supporting av ailability of treatments to address significant disease burden, including those  currently unaddressed, through innovation, research and development of new technologies.
","('Access_And_Affordability', 0.195448100566864)","('Customer_Welfare', 0.13388222455978394)","('Systemic_Risk_Management', 0.10369668155908585)","('NON-ESG', 0.195448100566864)","('NON-ESG', 0.13388222455978394)","('NON-ESG', 0.10369668155908585)"
Line 1313,"•  C ollaborating with customers to improve clinical outcomes and scientific cooperation.For further details on our approach in this area, refer to the Innovation at BD section.
","('Access_And_Affordability', 0.15666043758392334)","('Customer_Welfare', 0.15633709728717804)","('Competitive_Behavior', 0.10019106417894363)","('NON-ESG', 0.15666043758392334)","('NON-ESG', 0.15633709728717804)","('NON-ESG', 0.10019106417894363)"
Line 1314,"Collaboration and Partnerships •  W orking with diverse stakeholders and multi-stakeholder partnerships to tackle global  sustainability and health challenges and drive positive innovations, including through public policy engagement.
","('Human_Rights_And_Community_Relations', 0.5379363894462585)","('Access_And_Affordability', 0.163524329662323)","('Management_Of_Legal_And_Regulatory_Framework', 0.049437712877988815)","(['Community Relations'], 0.5379363894462585)","('NON-ESG', 0.163524329662323)","('NON-ESG', 0.049437712877988815)"
Line 1315,"We aim to build on existing partnership successes and develop new strategic partnerships that work across the value chain.
","('Business_Model_Resilience', 0.49088412523269653)","('Supply_Chain_Management', 0.12407059967517853)","('Systemic_Risk_Management', 0.08659692853689194)","('NON-ESG', 0.49088412523269653)","('NON-ESG', 0.12407059967517853)","('NON-ESG', 0.08659692853689194)"
Line 1316,"An example of this is our 2030+ goal to expand partnerships to address the impact of plastics.
","('Access_And_Affordability', 0.1900305449962616)","('Business_Model_Resilience', 0.1347564160823822)","('Human_Rights_And_Community_Relations', 0.09908944368362427)","('NON-ESG', 0.1900305449962616)","('NON-ESG', 0.1347564160823822)","('NON-ESG', 0.09908944368362427)"
Line 1317,"Partnerships are central to our social investing activities and access to health programs.
","('Access_And_Affordability', 0.8854483962059021)","('Human_Rights_And_Community_Relations', 0.017192739993333817)","('Employee_Health_And_Safety', 0.011597946286201477)","(['Health Outcome Contribution'], 0.8854483962059021)","('NON-ESG', 0.017192739993333817)","('NON-ESG', 0.011597946286201477)"
Line 1318,"2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities ESG issue Definition How we manage this issue Customer-Centric Care  (including Product Innovation)  •  Driving c ontinuous development of new products, solutions and services to meet customer  and public health needs.
","('Product_Design_And_Lifecycle_Management', 0.769800066947937)","('Supply_Chain_Management', 0.09426648169755936)","('Business_Model_Resilience', 0.01739971525967121)","(['Product Stewardship'], 0.769800066947937)","('NON-ESG', 0.09426648169755936)","('NON-ESG', 0.01739971525967121)"
Line 1319,"•  Helping t o address global chronic disease and acute care challenges while demonstrating  value-based outcomes.
","('Employee_Health_And_Safety', 0.27094534039497375)","('Access_And_Affordability', 0.1734531670808792)","('Critical_Incident_Risk_Management', 0.07053599506616592)","('NON-ESG', 0.27094534039497375)","('NON-ESG', 0.1734531670808792)","('NON-ESG', 0.07053599506616592)"
Line 1320,"•  Identif ying unmet needs, delivering the right innovations and enabling best practices.
","('Product_Design_And_Lifecycle_Management', 0.38618484139442444)","('Business_Model_Resilience', 0.15587177872657776)","('Supply_Chain_Management', 0.09131555259227753)","('NON-ESG', 0.38618484139442444)","('NON-ESG', 0.15587177872657776)","('NON-ESG', 0.09131555259227753)"
Line 1321,"•  C ollaborating with customers and partners to develop comprehensive healthcare products  that meet emerging healthcare needs.Our stakeholders see BD as committed to customer-centric care and product innovation.
","('Product_Design_And_Lifecycle_Management', 0.9494178295135498)","('Customer_Welfare', 0.007621572352945805)","('Product_Quality_And_Safety', 0.005331709515303373)","(['Product Stewardship'], 0.9494178295135498)","('NON-ESG', 0.007621572352945805)","('NON-ESG', 0.005331709515303373)"
Line 1322,"Collaboration and partnership will be important to our strategies in these areas.
","('Human_Rights_And_Community_Relations', 0.3591161370277405)","('Management_Of_Legal_And_Regulatory_Framework', 0.12554676830768585)","('Access_And_Affordability', 0.12468494474887848)","('NON-ESG', 0.3591161370277405)","('NON-ESG', 0.12554676830768585)","('NON-ESG', 0.12468494474887848)"
Line 1323,"Category innovation and customer outcomes are two elements of our 2025 Strategy .
","('Business_Model_Resilience', 0.5854796767234802)","('Product_Design_And_Lifecycle_Management', 0.14757180213928223)","('Customer_Welfare', 0.03629255294799805)","(['Codes of Business Conduct'], 0.5854796767234802)","('NON-ESG', 0.14757180213928223)","('NON-ESG', 0.03629255294799805)"
Line 1324,"For further details about innovation at BD, refer to the Innovation at BD section.
","('Competitive_Behavior', 0.28236931562423706)","('Product_Design_And_Lifecycle_Management', 0.22304017841815948)","('Business_Ethics', 0.061133794486522675)","('NON-ESG', 0.28236931562423706)","('NON-ESG', 0.22304017841815948)","('NON-ESG', 0.061133794486522675)"
Line 1325,"Cybersecurity •  Sec uring the storage and access of product data and addressing medical data privacy  laws.
","('Data_Security', 0.9553664922714233)","('Customer_Privacy', 0.009738066233694553)","('Business_Ethics', 0.0030839163810014725)","(['Information Security/Cybersecurity & System Availability'], 0.9553664922714233)","('NON-ESG', 0.009738066233694553)","('NON-ESG', 0.0030839163810014725)"
Line 1326,"Preventing unauthorized access and improper use of product data and developing  robust customer privacy policies for biometric data.
","('Data_Security', 0.6384813189506531)","('Customer_Privacy', 0.27475816011428833)","('Business_Ethics', 0.012535112909972668)","(['Information Security/Cybersecurity & System Availability'], 0.6384813189506531)","('NON-ESG', 0.27475816011428833)","('NON-ESG', 0.012535112909972668)"
Line 1327,"Collaborating with industry partners to enhance security standards for medical devices and technologies.
","('Data_Security', 0.8970985412597656)","('Business_Ethics', 0.01525591779500246)","('Systemic_Risk_Management', 0.010524575598537922)","(['Information Security/Cybersecurity & System Availability'], 0.8970985412597656)","('NON-ESG', 0.01525591779500246)","('NON-ESG', 0.010524575598537922)"
Line 1328,"•  Sec uring company information and data storage and preventing unauthorized access to  company computers, databases and websites.For information about how we manage cybersecurity, please refer to the cybersecurity program section of this report and the BD 2021 Cybersecurity Annual Report.
","('Data_Security', 0.9627470970153809)","('Customer_Privacy', 0.005323326215147972)","('Business_Ethics', 0.0034046501386910677)","(['Information Security/Cybersecurity & System Availability'], 0.9627470970153809)","('NON-ESG', 0.005323326215147972)","('NON-ESG', 0.0034046501386910677)"
Line 1329,"Employee and Worker Health and Safety•  Impr oving associate safety by minimizing hazards in production facilities and other  locations where BD associates work.
","('Employee_Health_And_Safety', 0.9837734699249268)","('Critical_Incident_Risk_Management', 0.002669799141585827)","('Employee_Engagement_Inclusion_And_Diversity', 0.0013140509836375713)","(['Operational Eco-Efficiency'], 0.9837734699249268)","('NON-ESG', 0.002669799141585827)","('NON-ESG', 0.0013140509836375713)"
Line 1330,"•  Pr omoting associate health, safety, security, privacy and well-being.We have established a 2030+ commitment with goals intended to maintain a healthy and thriving workforce that cultivates our culture of inclusion, safety and well-being.
","('Employee_Health_And_Safety', 0.9710993766784668)","('Employee_Engagement_Inclusion_And_Diversity', 0.006122848019003868)","('Access_And_Affordability', 0.002300436142832041)","(['Operational Eco-Efficiency'], 0.9710993766784668)","('NON-ESG', 0.006122848019003868)","('NON-ESG', 0.002300436142832041)"
Line 1331,"Refer to the Health and safety section for further details on how we manage this area.
","('Employee_Health_And_Safety', 0.7993160486221313)","('Product_Quality_And_Safety', 0.11070533841848373)","('Product_Design_And_Lifecycle_Management', 0.01111429650336504)","(['Operational Eco-Efficiency'], 0.7993160486221313)","('NON-ESG', 0.11070533841848373)","('NON-ESG', 0.01111429650336504)"
Line 1332,"Energy and Emissions from  Our Operations•  R educing energy consumption and increasing percentage of renewable energy.
","('Energy_Management', 0.980290412902832)","('Management_Of_Legal_And_Regulatory_Framework', 0.002501841401681304)","('Air_Quality', 0.0016933964798226953)","(['Operational Eco-Efficiency'], 0.980290412902832)","('NON-ESG', 0.002501841401681304)","('NON-ESG', 0.0016933964798226953)"
Line 1333,"•  R educing greenhouse gases, hazardous air pollutants and other air emissions impacts  caused by BD’s operations.
","('Air_Quality', 0.9738290309906006)","('GHG_Emissions', 0.005060519557446241)","('Critical_Incident_Risk_Management', 0.0015987250953912735)","(['Operational Eco-Efficiency'], 0.9738290309906006)","('NON-ESG', 0.005060519557446241)","('NON-ESG', 0.0015987250953912735)"
Line 1334,"•  A ddressing the risks and opportunities resulting from the existing and emerging impacts  that the climate has on the business.
","('Physical_Impacts_Of_Climate_Change', 0.9367111325263977)","('Business_Model_Resilience', 0.014653016813099384)","('Systemic_Risk_Management', 0.006895590107887983)","(['Climate Change'], 0.9367111325263977)","('NON-ESG', 0.014653016813099384)","('NON-ESG', 0.006895590107887983)"
Line 1335,"•  R eporting the company’s performance on prevention, management and mitigation  of impacts.
","('Business_Model_Resilience', 0.5289369821548462)","('Ecological_Impacts', 0.10159260779619217)","('Physical_Impacts_Of_Climate_Change', 0.0680847316980362)","(['Codes of Business Conduct'], 0.5289369821548462)","('NON-ESG', 0.10159260779619217)","('NON-ESG', 0.0680847316980362)"
Line 1336,"Details on how we manage energy usage, emissions and impacts from climate change can be found in the Climate change section.
","('Physical_Impacts_Of_Climate_Change', 0.9491273760795593)","('Business_Model_Resilience', 0.0084949666634202)","('GHG_Emissions', 0.007562561426311731)","(['Climate Change'], 0.9491273760795593)","('NON-ESG', 0.0084949666634202)","('NON-ESG', 0.007562561426311731)"
Line 1337,"2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities ESG issue Definition How we manage this issue Ethical Business Practices •  Upholding and pr omoting high standards of ethics in business behavior.
","('Business_Ethics', 0.9669731259346008)","('Systemic_Risk_Management', 0.003342193551361561)","('Data_Security', 0.0030904458835721016)","(['Business Ethics'], 0.9669731259346008)","('NON-ESG', 0.003342193551361561)","('NON-ESG', 0.0030904458835721016)"
Line 1338,"•  Pr omoting ethical brand management and promotion, ethical marketing, and prevention of  anti-competitive practices.
","('Competitive_Behavior', 0.8466982841491699)","('Business_Ethics', 0.042815472930669785)","('Customer_Welfare', 0.013677859678864479)","(['Business Ethics'], 0.8466982841491699)","('NON-ESG', 0.042815472930669785)","('NON-ESG', 0.013677859678864479)"
Line 1339,"•  T raining associates on responsible interactions between company staff and  healthcare professionals.
","('Employee_Health_And_Safety', 0.2802697420120239)","('Human_Rights_And_Community_Relations', 0.1278044581413269)","('Employee_Engagement_Inclusion_And_Diversity', 0.08436443656682968)","('NON-ESG', 0.2802697420120239)","('NON-ESG', 0.1278044581413269)","('NON-ESG', 0.08436443656682968)"
Line 1340,"•  Engaging in sales and mark eting practices that incentivize ethical behaviors and promote  truthful, non-misleading information in sales interactions with customers and the medical/ scientific community.
","('Business_Ethics', 0.9342801570892334)","('Competitive_Behavior', 0.009141035377979279)","('Customer_Privacy', 0.008313745260238647)","(['Business Ethics'], 0.9342801570892334)","('NON-ESG', 0.009141035377979279)","('NON-ESG', 0.008313745260238647)"
Line 1341,"•  Impr oving Board structure and independence, executive compensation and accountability.
","('Director_Removal', 0.49063143134117126)","('Management_Of_Legal_And_Regulatory_Framework', 0.15028999745845795)","('Business_Ethics', 0.08349043130874634)","('NON-ESG', 0.49063143134117126)","('NON-ESG', 0.15028999745845795)","('NON-ESG', 0.08349043130874634)"
Line 1342,"Measuring sustainability strategy and business performance.
","('Business_Model_Resilience', 0.7670875191688538)","('Supply_Chain_Management', 0.038165152072906494)","('Product_Design_And_Lifecycle_Management', 0.03430837392807007)","(['Codes of Business Conduct'], 0.7670875191688538)","('NON-ESG', 0.038165152072906494)","('NON-ESG', 0.03430837392807007)"
Line 1343,"•  C omplying with state, federal and international laws pertaining to corruption and abuse,  including anti-kickback laws and the U.S. Foreign Corrupt Practices Act.Refer to the Transparency section for further details on our Ethical Business Practice programs.
","('Business_Ethics', 0.9757895469665527)","('Management_Of_Legal_And_Regulatory_Framework', 0.003250177251175046)","('Systemic_Risk_Management', 0.0017390691209584475)","(['Business Ethics'], 0.9757895469665527)","('NON-ESG', 0.003250177251175046)","('NON-ESG', 0.0017390691209584475)"
Line 1344,"Global Systemic Health Challenges•  De veloping of treatments and medical devices that address widespread critical disease  areas where there is unmet need and opportunity to prevent, diagnose and mitigate the impacts of global disease burdens, including delivering HIV/AIDS, malaria, maternal infant mortality and diabetes solutions.
","('Employee_Health_And_Safety', 0.33091041445732117)","('Critical_Incident_Risk_Management', 0.2560913860797882)","('Access_And_Affordability', 0.10072341561317444)","('NON-ESG', 0.33091041445732117)","('NON-ESG', 0.2560913860797882)","('NON-ESG', 0.10072341561317444)"
Line 1345,"•  A ddressing risks and opportunities that result from impacts caused by antimicrobial  resistance (AMR) and continuing to prioritize AMR research and treatments with a focus on prevention, management and mitigation of disease impact.
","('Systemic_Risk_Management', 0.14837710559368134)","('Access_And_Affordability', 0.11871474236249924)","('Product_Quality_And_Safety', 0.09003308415412903)","('NON-ESG', 0.14837710559368134)","('NON-ESG', 0.11871474236249924)","('NON-ESG', 0.09003308415412903)"
Line 1346,"•  A ddressing the risks and opportunities posed by the existing and emerging impacts that the  climate has on human health.For details on how we are helping to address global systemic health challenges, including AMR, please refer to the Access to health section In March 2022, we launched BD Infectious Disease Insights to dig deeper into today’s most prominent infectious- disease trends.
","('Systemic_Risk_Management', 0.7028504014015198)","('Physical_Impacts_Of_Climate_Change', 0.09723841398954391)","('Business_Model_Resilience', 0.03927326202392578)","(['Risk & Crisis Management'], 0.7028504014015198)","('NON-ESG', 0.09723841398954391)","('NON-ESG', 0.03927326202392578)"
Line 1347,"As part of our 2030+ commitments, we have set a goal to use our capabilities to contribute to solutions that  address unmet climate-related health needs.
","('Physical_Impacts_Of_Climate_Change', 0.7477629780769348)","('Critical_Incident_Risk_Management', 0.07641896605491638)","('Supply_Chain_Management', 0.026265012100338936)","(['Climate Change'], 0.7477629780769348)","('NON-ESG', 0.07641896605491638)","('NON-ESG', 0.026265012100338936)"
Line 1348,"We will provide details of progress in this area in future reports.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7544530034065247)","('Human_Rights_And_Community_Relations', 0.02627382054924965)","('Physical_Impacts_Of_Climate_Change', 0.02596316486597061)","(['Corporate Governance'], 0.7544530034065247)","('NON-ESG', 0.02627382054924965)","('NON-ESG', 0.02596316486597061)"
Line 1349,"Health Literacy and Adherence •  P artnering with patients to promote their understanding of medical conditions or diseases  and the reasons they are being treated, in order to improve patient outcomes through adherence to medication/treatment regimens.We provide various materials to help patients understand and manage their conditions, including web-based tools from: BD Life Sciences: Information is provided to patients about the BD Veritor™ At-Home COVID-19 Test at  www.bdveritorathome.com.
","('Access_And_Affordability', 0.27819016575813293)","('Employee_Health_And_Safety', 0.26300758123397827)","('Product_Quality_And_Safety', 0.10464125126600266)","('NON-ESG', 0.27819016575813293)","('NON-ESG', 0.26300758123397827)","('NON-ESG', 0.10464125126600266)"
Line 1350,"BD Interventional: Patients can understand and manage their Urinary Retention condition from the following  websites: www.liberatormedical.com – This website provides consumers with tools to both understand their condition and  choose the right product.
","('Employee_Health_And_Safety', 0.21087142825126648)","('Product_Quality_And_Safety', 0.16915179789066315)","('Customer_Welfare', 0.1111147403717041)","('NON-ESG', 0.21087142825126648)","('NON-ESG', 0.16915179789066315)","('NON-ESG', 0.1111147403717041)"
Line 1351,"www.purewickathome.com/ispurewickrightforme.html – This site includes information to help women who are  suffering from urinary incontinence understand whether if the PureWick TM System is the right product for them.
","('Employee_Health_And_Safety', 0.46176502108573914)","('Access_And_Affordability', 0.12263104319572449)","('Product_Quality_And_Safety', 0.06350751221179962)","('NON-ESG', 0.46176502108573914)","('NON-ESG', 0.12263104319572449)","('NON-ESG', 0.06350751221179962)"
Line 1352,"www.bardcare.com/consumers/get-answers/conditions/ – This site provides information for consumers on various conditions that the people we serve deal with on a daily basis.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities ESG issue Definition How we manage this issue Healthcare Market  Transformation•  A ddressing the risks and opportunities posed by the transformation of healthcare delivery  at a country, regional and/or global level.
","('Supply_Chain_Management', 0.5507411956787109)","('Physical_Impacts_Of_Climate_Change', 0.25142619013786316)","('Systemic_Risk_Management', 0.04809567704796791)","(['Supply Chain Management'], 0.5507411956787109)","('NON-ESG', 0.25142619013786316)","('NON-ESG', 0.04809567704796791)"
Line 1353,"www.bardcare.com/consumers/get-answers/conditions/ – This site provides information for consumers on various conditions that the people we serve deal with on a daily basis.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities ESG issue Definition How we manage this issue Healthcare Market  Transformation•  A ddressing the risks and opportunities posed by the transformation of healthcare delivery  at a country, regional and/or global level.
","('Systemic_Risk_Management', 0.3143582046031952)","('Management_Of_Legal_And_Regulatory_Framework', 0.10319378226995468)","('Competitive_Behavior', 0.07268142700195312)","('NON-ESG', 0.3143582046031952)","('NON-ESG', 0.10319378226995468)","('NON-ESG', 0.07268142700195312)"
Line 1354,"•  A ddressing the market shifts from in-patient to out-patient healthcare facilities and chronic  disease management.
","('Access_And_Affordability', 0.4368021488189697)","('Employee_Health_And_Safety', 0.13424666225910187)","('Customer_Welfare', 0.05348770692944527)","('NON-ESG', 0.4368021488189697)","('NON-ESG', 0.13424666225910187)","('NON-ESG', 0.05348770692944527)"
Line 1355,"Healthcare market transformation requires more intensive innovation to meet customer demands, advance data solutions and offer customized products for different market segments.
","('Product_Design_And_Lifecycle_Management', 0.8925371766090393)","('Customer_Welfare', 0.02316734939813614)","('Business_Model_Resilience', 0.013739564456045628)","(['Product Stewardship'], 0.8925371766090393)","('NON-ESG', 0.02316734939813614)","('NON-ESG', 0.013739564456045628)"
Line 1356,"Our stakeholders indicated that future success is based on our ability to stay abreast of, and be a part of, the market transformation.
","('Business_Model_Resilience', 0.8746039271354675)","('Systemic_Risk_Management', 0.03546549379825592)","('Supply_Chain_Management', 0.011504835449159145)","(['Codes of Business Conduct'], 0.8746039271354675)","('NON-ESG', 0.03546549379825592)","('NON-ESG', 0.011504835449159145)"
Line 1357,"Further details about our growth strategy can be found in the About our business section.
","('Business_Model_Resilience', 0.8664475083351135)","('Systemic_Risk_Management', 0.020183559507131577)","('Supply_Chain_Management', 0.011700505390763283)","(['Codes of Business Conduct'], 0.8664475083351135)","('NON-ESG', 0.020183559507131577)","('NON-ESG', 0.011700505390763283)"
Line 1358,"Human Rights •  R especting the human rights of various stakeholders, including suppliers, associates,  customers and patients and surrounding communities.BD is committed to operating in a way that respects human rights.
","('Human_Rights_And_Community_Relations', 0.9549568891525269)","('Access_And_Affordability', 0.004113959148526192)","('Labor_Practices', 0.0038203191943466663)","(['Community Relations'], 0.9549568891525269)","('NON-ESG', 0.004113959148526192)","('NON-ESG', 0.0038203191943466663)"
Line 1359,"Our commitment is detailed in our Global  human rights policy.
","('Human_Rights_And_Community_Relations', 0.9471551179885864)","('Labor_Practices', 0.0059067122638225555)","('Access_And_Affordability', 0.005062933545559645)","(['Community Relations'], 0.9471551179885864)","('NON-ESG', 0.0059067122638225555)","('NON-ESG', 0.005062933545559645)"
Line 1360,"For further details, refer to the Human rights section.
","('Human_Rights_And_Community_Relations', 0.9513364434242249)","('Labor_Practices', 0.005362587980926037)","('Access_And_Affordability', 0.003864841302856803)","(['Community Relations'], 0.9513364434242249)","('NON-ESG', 0.005362587980926037)","('NON-ESG', 0.003864841302856803)"
Line 1361,"Inclusion, Diversity and Talent •  R especting and promoting associates and suppliers of all different backgrounds  and identities, including gender, age, ethnicity/race, physical abilities/qualities and  sexual orientation.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9748886823654175)","('Employee_Health_And_Safety', 0.002391356974840164)","('Human_Rights_And_Community_Relations', 0.001590226893313229)","(['Human Capital Development'], 0.9748886823654175)","('NON-ESG', 0.002391356974840164)","('NON-ESG', 0.001590226893313229)"
Line 1362,"•  T raining associates and suppliers to prevent discriminatory behaviors and attitudes and  develop diversity and inclusion policies.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9742204546928406)","('Employee_Health_And_Safety', 0.00198445119895041)","('Labor_Practices', 0.0019571043085306883)","(['Human Capital Development'], 0.9742204546928406)","('NON-ESG', 0.00198445119895041)","('NON-ESG', 0.0019571043085306883)"
Line 1363,"•  Cr eating a stimulating work environment that offers opportunities for development and  promotion that attract and retain diverse top talent.The acquisitions of CareFusion and C.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9255385994911194)","('Employee_Health_And_Safety', 0.006086556240916252)","('Business_Model_Resilience', 0.005832474213093519)","(['Human Capital Development'], 0.9255385994911194)","('NON-ESG', 0.006086556240916252)","('NON-ESG', 0.005832474213093519)"
Line 1364,"R.
","('Management_Of_Legal_And_Regulatory_Framework', 0.16864672303199768)","('Human_Rights_And_Community_Relations', 0.08567094802856445)","('Ecological_Impacts', 0.06714435666799545)","('NON-ESG', 0.16864672303199768)","('NON-ESG', 0.08567094802856445)","('NON-ESG', 0.06714435666799545)"
Line 1365,"Bard changed the culture at BD.
","('Employee_Engagement_Inclusion_And_Diversity', 0.3618422746658325)","('Access_And_Affordability', 0.08985034376382828)","('Business_Model_Resilience', 0.07636632025241852)","('NON-ESG', 0.3618422746658325)","('NON-ESG', 0.08985034376382828)","('NON-ESG', 0.07636632025241852)"
Line 1366,"The ongoing pandemic has also changed how and where associates work.
","('Physical_Impacts_Of_Climate_Change', 0.3832208514213562)","('Critical_Incident_Risk_Management', 0.19469867646694183)","('Air_Quality', 0.0865902230143547)","('NON-ESG', 0.3832208514213562)","('NON-ESG', 0.19469867646694183)","('NON-ESG', 0.0865902230143547)"
Line 1367,"BD’s culture is a priority for associates, and our stakeholders have noted that investment in company culture will help retain and recruit top talent.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9343283176422119)","('Business_Model_Resilience', 0.007414046209305525)","('Employee_Health_And_Safety', 0.004633401520550251)","(['Human Capital Development'], 0.9343283176422119)","('NON-ESG', 0.007414046209305525)","('NON-ESG', 0.004633401520550251)"
Line 1368,"Our associates have also indicated that BD would benefit from further communication internally about its sustainability efforts.
","('Business_Model_Resilience', 0.219106525182724)","('Product_Design_And_Lifecycle_Management', 0.15228992700576782)","('Management_Of_Legal_And_Regulatory_Framework', 0.09095459431409836)","('NON-ESG', 0.219106525182724)","('NON-ESG', 0.15228992700576782)","('NON-ESG', 0.09095459431409836)"
Line 1369,"We have established 2030+ commitments and goals intended to maintain a healthy and thriving workforce  that cultivates our culture of inclusion, safety and well-being.
","('Employee_Engagement_Inclusion_And_Diversity', 0.7308847308158875)","('Employee_Health_And_Safety', 0.1488168090581894)","('Human_Rights_And_Community_Relations', 0.021218344569206238)","(['Human Capital Development'], 0.7308847308158875)","('NON-ESG', 0.1488168090581894)","('NON-ESG', 0.021218344569206238)"
Line 1370,"Details on our human capital programs, including inclusion and diversity, can be found in the Healthy workforce and communities section.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9757322072982788)","('Human_Rights_And_Community_Relations', 0.00210120459087193)","('Employee_Health_And_Safety', 0.001868855208158493)","(['Human Capital Development'], 0.9757322072982788)","('NON-ESG', 0.00210120459087193)","('NON-ESG', 0.001868855208158493)"
Line 1371,"We leverage internal communication platforms to communicate sustainability programs and performance— including publication of external ESG disclosures.
","('Business_Model_Resilience', 0.4925837814807892)","('Systemic_Risk_Management', 0.14739398658275604)","('Management_Of_Legal_And_Regulatory_Framework', 0.06834811717271805)","('NON-ESG', 0.4925837814807892)","('NON-ESG', 0.14739398658275604)","('NON-ESG', 0.06834811717271805)"
Line 1372,"The central Sustainability team engages with various central, regional and business teams, as well as our associate  resource groups and leadership development cohorts, to communicate our ESG strategy and 2030+ commitment and goals.
","('Business_Model_Resilience', 0.6602981090545654)","('Human_Rights_And_Community_Relations', 0.05793646723031998)","('Employee_Engagement_Inclusion_And_Diversity', 0.034906674176454544)","(['Codes of Business Conduct'], 0.6602981090545654)","('NON-ESG', 0.05793646723031998)","('NON-ESG', 0.034906674176454544)"
Line 1373,"In April 2022, we launched a week-long series of events leading up to Earth Day.
","('Human_Rights_And_Community_Relations', 0.2769968807697296)","('Ecological_Impacts', 0.09343810379505157)","('Access_And_Affordability', 0.0772278755903244)","('NON-ESG', 0.2769968807697296)","('NON-ESG', 0.09343810379505157)","('NON-ESG', 0.0772278755903244)"
Line 1374,"This included messages and  panel discussions with senior leaders from around the company, covering stakeholders’ expectations relating to sustainability and how BD is meeting those expectations through our ESG strategy and 2030+ commitment and goals.
","('Business_Model_Resilience', 0.7089480757713318)","('Human_Rights_And_Community_Relations', 0.04175766929984093)","('Director_Removal', 0.029856879264116287)","(['Codes of Business Conduct'], 0.7089480757713318)","('NON-ESG', 0.04175766929984093)","('NON-ESG', 0.029856879264116287)"
Line 1375,"Intellectual Property Rights and Product Integrity•  De veloping policies to protect patent rights and flexibility, as well as licensing agreements.
","('Competitive_Behavior', 0.8735488057136536)","('Business_Ethics', 0.020036140456795692)","('Management_Of_Legal_And_Regulatory_Framework', 0.01860051043331623)","(['Business Ethics'], 0.8735488057136536)","('NON-ESG', 0.020036140456795692)","('NON-ESG', 0.01860051043331623)"
Line 1376,"•  Pr otecting product integrity and training customers on proper product use through  monitoring, evaluation and chain-of-custody technologies.
","('Product_Design_And_Lifecycle_Management', 0.7978219389915466)","('Product_Quality_And_Safety', 0.0696311742067337)","('Selling_Practices_And_Product_Labeling', 0.04802699387073517)","(['Product Stewardship'], 0.7978219389915466)","('NON-ESG', 0.0696311742067337)","('NON-ESG', 0.04802699387073517)"
Line 1377,"For information about our approach to safeguarding confidential information and intellectual property, please refer to our Code of Conduct.
","('Customer_Privacy', 0.8309807777404785)","('Data_Security', 0.07588212937116623)","('Business_Ethics', 0.020906668156385422)","(['Privacy Protection'], 0.8309807777404785)","('NON-ESG', 0.07588212937116623)","('NON-ESG', 0.020906668156385422)"
Line 1378,"Pricing Pressure •  Impr oving company R&D productivity and resource efficiency in order to deliver value- added healthcare services that comply with regulations, evidence-based outcome requirements and changing point-of-care policies, and that address reimbursement pricing constraints.For further details on our approach in this area, refer to the Innovation at BD section.
","('Competitive_Behavior', 0.6705771088600159)","('Management_Of_Legal_And_Regulatory_Framework', 0.16610576212406158)","('Systemic_Risk_Management', 0.021905070170760155)","(['Business Ethics'], 0.6705771088600159)","('NON-ESG', 0.16610576212406158)","('NON-ESG', 0.021905070170760155)"
Line 1379,"2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities ESG issue Definition How we manage this issue Product Impacts on Human  Health and the Environment•  R educing waste and optimizing opportunities for recovery, reuse or recycling of products  and by-products and appropriate waste disposal.
","('Product_Design_And_Lifecycle_Management', 0.8224169611930847)","('Waste_And_Hazardous_Materials_Management', 0.08311215788125992)","('Product_Quality_And_Safety', 0.017407868057489395)","(['Product Stewardship'], 0.8224169611930847)","('NON-ESG', 0.08311215788125992)","('NON-ESG', 0.017407868057489395)"
Line 1380,"•  R eporting performance against waste targets.
","('Waste_And_Hazardous_Materials_Management', 0.9796573519706726)","('Water_And_Wastewater_Management', 0.001957493368536234)","('Air_Quality', 0.0016522740479558706)","(['Operational Eco-Efficiency'], 0.9796573519706726)","('NON-ESG', 0.001957493368536234)","('NON-ESG', 0.0016522740479558706)"
Line 1381,"•  Designing pr oducts to extract maximum value over their lifetime through longevity, reuse  and recycling.
","('Product_Design_And_Lifecycle_Management', 0.9312564134597778)","('Energy_Management', 0.01048128679394722)","('Supply_Chain_Management', 0.006924810819327831)","(['Product Stewardship'], 0.9312564134597778)","('NON-ESG', 0.01048128679394722)","('NON-ESG', 0.006924810819327831)"
Line 1382,"•  Mitigating en vironmental and human health impacts (e.g., from chemicals, energy, water  and waste) across the life cycle of BD products.
","('Product_Design_And_Lifecycle_Management', 0.4726340174674988)","('Waste_And_Hazardous_Materials_Management', 0.3777671456336975)","('Product_Quality_And_Safety', 0.020805377513170242)","('NON-ESG', 0.4726340174674988)","('NON-ESG', 0.3777671456336975)","('NON-ESG', 0.020805377513170242)"
Line 1383,"Stakeholders are particularly concerned with waste in the healthcare ecosystem and would like to see more transparency about BD’s efforts to address it, including collaborations and partnerships.
","('Waste_And_Hazardous_Materials_Management', 0.9830728769302368)","('Water_And_Wastewater_Management', 0.001533038099296391)","('Air_Quality', 0.0013780188746750355)","(['Operational Eco-Efficiency'], 0.9830728769302368)","('NON-ESG', 0.001533038099296391)","('NON-ESG', 0.0013780188746750355)"
Line 1384,"We have established 2030+ commitments and goals intended to reduce the environmental impact of our portfolio  and to address the sustainability needs of our customers.
","('Product_Design_And_Lifecycle_Management', 0.7897915244102478)","('Business_Model_Resilience', 0.049117397516965866)","('Supply_Chain_Management', 0.028257571160793304)","(['Product Stewardship'], 0.7897915244102478)","('NON-ESG', 0.049117397516965866)","('NON-ESG', 0.028257571160793304)"
Line 1385,"Refer to the section on Product impact.
","('Product_Design_And_Lifecycle_Management', 0.943119466304779)","('Product_Quality_And_Safety', 0.008600755594670773)","('Customer_Welfare', 0.005204174667596817)","(['Product Stewardship'], 0.943119466304779)","('NON-ESG', 0.008600755594670773)","('NON-ESG', 0.005204174667596817)"
Line 1386,"For details on how we manage waste from our operations and performance against targets, refer to  Waste management.
","('Waste_And_Hazardous_Materials_Management', 0.9845751523971558)","('Water_And_Wastewater_Management', 0.0012152836425229907)","('Data_Security', 0.001192681840620935)","(['Operational Eco-Efficiency'], 0.9845751523971558)","('NON-ESG', 0.0012152836425229907)","('NON-ESG', 0.001192681840620935)"
Line 1387,"Product Quality and Safety  •  Supporting r obust quality and regulatory management, including communicating quality  and safety standards to our suppliers.
","('Product_Quality_And_Safety', 0.9301766157150269)","('Product_Design_And_Lifecycle_Management', 0.007762886583805084)","('Selling_Practices_And_Product_Labeling', 0.0070132301189005375)","(['Product Quality & Recall Management'], 0.9301766157150269)","('NON-ESG', 0.007762886583805084)","('NON-ESG', 0.0070132301189005375)"
Line 1388,"Conducting supplier audits and product monitoring and evaluations.For further details about our programs in this area, refer to Product safety .
","('Product_Quality_And_Safety', 0.8871980905532837)","('Product_Design_And_Lifecycle_Management', 0.02376086264848709)","('Selling_Practices_And_Product_Labeling', 0.01797441951930523)","(['Product Quality & Recall Management'], 0.8871980905532837)","('NON-ESG', 0.02376086264848709)","('NON-ESG', 0.01797441951930523)"
Line 1389,"Regulatory Compliance •  A dhering to local laws and regulations for product design, manufacturing and quality in the  countries where BD operates.In accordance with our Code of Conduct, we follow the laws, rules and company policies that apply to us.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8907839059829712)","('Product_Quality_And_Safety', 0.029719170182943344)","('Business_Ethics', 0.010572293773293495)","(['Corporate Governance'], 0.8907839059829712)","('NON-ESG', 0.029719170182943344)","('NON-ESG', 0.010572293773293495)"
Line 1390,"Details of how we manage compliance with specific laws are detailed throughout this report.
","('Management_Of_Legal_And_Regulatory_Framework', 0.95742267370224)","('Human_Rights_And_Community_Relations', 0.004394607152789831)","('Director_Removal', 0.0027906130999326706)","(['Corporate Governance'], 0.95742267370224)","('NON-ESG', 0.004394607152789831)","('NON-ESG', 0.0027906130999326706)"
Line 1391,"Social Impact •  Driving and measuring in vestments in healthcare innovation and community development  and engaging associates in community service and capacity training.Social impact is an element of our 2030+ commitment to build Healthy workforce and communities.
","('Human_Rights_And_Community_Relations', 0.953156590461731)","('Access_And_Affordability', 0.00781176146119833)","('Critical_Incident_Risk_Management', 0.0032382234930992126)","(['Community Relations'], 0.953156590461731)","('NON-ESG', 0.00781176146119833)","('NON-ESG', 0.0032382234930992126)"
Line 1392,"Supply Chain Continuity and Sustainability•  Supporting c ontinuity of product supply including assurance of manufacturing, inventory  tracking and pandemic readiness.
","('Supply_Chain_Management', 0.6452475190162659)","('Product_Design_And_Lifecycle_Management', 0.21998055279254913)","('Product_Quality_And_Safety', 0.013011960312724113)","(['Supply Chain Management'], 0.6452475190162659)","('NON-ESG', 0.21998055279254913)","('NON-ESG', 0.013011960312724113)"
Line 1393,"•  De veloping supply resilience strategies to help meet customer needs when natural disasters,  political disruption or healthcare policy changes occur.
","('Supply_Chain_Management', 0.40696004033088684)","('Business_Model_Resilience', 0.39781421422958374)","('Physical_Impacts_Of_Climate_Change', 0.03716016560792923)","('NON-ESG', 0.40696004033088684)","('NON-ESG', 0.39781421422958374)","('NON-ESG', 0.03716016560792923)"
Line 1394,"•  Sour cing materials responsibly with minimal negative environmental and social impacts  and seeking to establish a sustainable upstream supply chain via climate resilience, supply chain diversity and responsible sourcing.Given our role in healthcare ecosystem, supply chain and business continuity—including climate resilience—are key to our ability to meet customer needs.
","('Supply_Chain_Management', 0.939918041229248)","('Business_Model_Resilience', 0.009159260429441929)","('Product_Design_And_Lifecycle_Management', 0.008987837471067905)","(['Supply Chain Management'], 0.939918041229248)","('NON-ESG', 0.009159260429441929)","('NON-ESG', 0.008987837471067905)"
Line 1395,"Stakeholders have indicated that BD has an opportunity to encourage more sustainability in the industry given our leadership position.
","('Business_Model_Resilience', 0.45098674297332764)","('Systemic_Risk_Management', 0.09145863354206085)","('Supply_Chain_Management', 0.07088353484869003)","('NON-ESG', 0.45098674297332764)","('NON-ESG', 0.09145863354206085)","('NON-ESG', 0.07088353484869003)"
Line 1396,"We have established 2030+ commitments and goals intended to create a supply chain that is adaptable to  disruption and able to contribute to strong environmental and social performance.
","('Supply_Chain_Management', 0.947403609752655)","('Product_Design_And_Lifecycle_Management', 0.006708269938826561)","('Physical_Impacts_Of_Climate_Change', 0.004080053418874741)","(['Supply Chain Management'], 0.947403609752655)","('NON-ESG', 0.006708269938826561)","('NON-ESG', 0.004080053418874741)"
Line 1397,"Please refer to the section on Responsible supply chain.
","('Supply_Chain_Management', 0.9288946390151978)","('Energy_Management', 0.0061536929570138454)","('Physical_Impacts_Of_Climate_Change', 0.0058893077075481415)","(['Supply Chain Management'], 0.9288946390151978)","('NON-ESG', 0.0061536929570138454)","('NON-ESG', 0.0058893077075481415)"
Line 1398,"Transparency •  Maint aining overall transparency with key stakeholders, including disclosures on  sustainability strategy and programs.It is our commitment to invite trust across stakeholder groups through transparent reporting of our performance on ESG issues relevant to our business.
","('Business_Ethics', 0.9659797549247742)","('Management_Of_Legal_And_Regulatory_Framework', 0.0044663636945188046)","('Systemic_Risk_Management', 0.0032057827338576317)","(['Business Ethics'], 0.9659797549247742)","('NON-ESG', 0.0044663636945188046)","('NON-ESG', 0.0032057827338576317)"
Line 1399,"We have set 2030+ commitments and goals to provide our stakeholders with regular disclosures about our  ESG performance and programs.
","('Business_Model_Resilience', 0.49025022983551025)","('Human_Rights_And_Community_Relations', 0.13841329514980316)","('Management_Of_Legal_And_Regulatory_Framework', 0.06195481866598129)","('NON-ESG', 0.49025022983551025)","('NON-ESG', 0.13841329514980316)","('NON-ESG', 0.06195481866598129)"
Line 1400,"We will do so by aligning with relevant and recognized external ESG reporting frameworks and providing issue-specific information.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2999017536640167)","('Systemic_Risk_Management', 0.2363334596157074)","('Business_Model_Resilience', 0.13336655497550964)","('NON-ESG', 0.2999017536640167)","('NON-ESG', 0.2363334596157074)","('NON-ESG', 0.13336655497550964)"
Line 1401,"This report provides the foundation for our goal to provide information about our ESG programs and performance.
","('Business_Model_Resilience', 0.2661062777042389)","('Management_Of_Legal_And_Regulatory_Framework', 0.1956866979598999)","('Systemic_Risk_Management', 0.1273399293422699)","('NON-ESG', 0.2661062777042389)","('NON-ESG', 0.1956866979598999)","('NON-ESG', 0.1273399293422699)"
Line 1402,"Water •  Optimizing the use of w ater and reducing and reusing of wastewater  throughout operations.
","('Water_And_Wastewater_Management', 0.9760318398475647)","('GHG_Emissions', 0.0024788181763142347)","('Energy_Management', 0.0023529038298875093)","(['Operational Eco-Efficiency'], 0.9760318398475647)","('NON-ESG', 0.0024788181763142347)","('NON-ESG', 0.0023529038298875093)"
Line 1403,"•  R educing potable water use and improving water disposal and discharge.
","('Water_And_Wastewater_Management', 0.9772323966026306)","('Waste_And_Hazardous_Materials_Management', 0.001910595572553575)","('GHG_Emissions', 0.0018656756728887558)","(['Operational Eco-Efficiency'], 0.9772323966026306)","('NON-ESG', 0.001910595572553575)","('NON-ESG', 0.0018656756728887558)"
Line 1404,"•  R eporting performance against water targets.For details on how we manage water usage in our operations and performance against targets, refer to  Water management.
","('Water_And_Wastewater_Management', 0.9762336611747742)","('GHG_Emissions', 0.002509128302335739)","('Energy_Management', 0.002041788771748543)","(['Operational Eco-Efficiency'], 0.9762336611747742)","('NON-ESG', 0.002509128302335739)","('NON-ESG', 0.002041788771748543)"
Line 1405,"2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities UN Sustainable Development Goals (SDGs) The following table provides an outline of how we contribute to the achievement of each SDG, how directly BD can impact the SDG through core business activities (degree of control) and which stages of BD’s value chain are most relevant to the SDG.
","('Supply_Chain_Management', 0.6438212394714355)","('Physical_Impacts_Of_Climate_Change', 0.1965322196483612)","('Business_Model_Resilience', 0.040457241237163544)","(['Supply Chain Management'], 0.6438212394714355)","('NON-ESG', 0.1965322196483612)","('NON-ESG', 0.040457241237163544)"
Line 1406,"Sustainable Development Goal How we contribute to the achievement of the SDG23Degree of control24Value chainGoal 1.
","('Business_Model_Resilience', 0.4129016697406769)","('Ecological_Impacts', 0.12617459893226624)","('Supply_Chain_Management', 0.07505550235509872)","('NON-ESG', 0.4129016697406769)","('NON-ESG', 0.12617459893226624)","('NON-ESG', 0.07505550235509872)"
Line 1407,"End poverty in all its forms everywhere We can contribute to the achievement of this SDG by ensuring that workers within our operations  and our value chain are paid a living wage.
","('Labor_Practices', 0.963601291179657)","('Supply_Chain_Management', 0.0032513525802642107)","('Human_Rights_And_Community_Relations', 0.003148492192849517)","(['Labor Practice Indicators'], 0.963601291179657)","('NON-ESG', 0.0032513525802642107)","('NON-ESG', 0.003148492192849517)"
Line 1408,"For example, under our 2030+ goals, we are committed to paying competitive market rates and utilizing living-wage assessments.
","('Management_Of_Legal_And_Regulatory_Framework', 0.34017375111579895)","('Labor_Practices', 0.26373904943466187)","('Competitive_Behavior', 0.22623856365680695)","('NON-ESG', 0.34017375111579895)","('NON-ESG', 0.26373904943466187)","('NON-ESG', 0.22623856365680695)"
Line 1409,"Through our social investing, we support programs to build community resilience.
","('Business_Model_Resilience', 0.8693843483924866)","('Physical_Impacts_Of_Climate_Change', 0.019794417545199394)","('Human_Rights_And_Community_Relations', 0.016203276813030243)","(['Codes of Business Conduct'], 0.8693843483924866)","('NON-ESG', 0.019794417545199394)","('NON-ESG', 0.016203276813030243)"
Line 1410,"Moderately direct for  our own operations, less direct in our value chainRaw materials, Suppliers, Operations, Distribution Goal 2.
","('Supply_Chain_Management', 0.8890747427940369)","('Product_Design_And_Lifecycle_Management', 0.03304968401789665)","('Energy_Management', 0.008146782405674458)","(['Supply Chain Management'], 0.8890747427940369)","('NON-ESG', 0.03304968401789665)","('NON-ESG', 0.008146782405674458)"
Line 1411,"End hunger, achieve food security and improved nutrition and promote sustainable agricultureWe have determined that BD’s impact on, or contribution to achievement of, this goal is negligible.
","('Customer_Welfare', 0.5601378083229065)","('Selling_Practices_And_Product_Labeling', 0.07933750003576279)","('Access_And_Affordability', 0.07271257787942886)","(['Customer Relationship Management'], 0.5601378083229065)","('NON-ESG', 0.07933750003576279)","('NON-ESG', 0.07271257787942886)"
Line 1412,"Moderately direct for our own operations, less direct in our value chainRaw materials, Suppliers, Operations, Distribution Goal 3.
","('Supply_Chain_Management', 0.8892546892166138)","('Product_Design_And_Lifecycle_Management', 0.03247891739010811)","('Energy_Management', 0.008285535499453545)","(['Supply Chain Management'], 0.8892546892166138)","('NON-ESG', 0.03247891739010811)","('NON-ESG', 0.008285535499453545)"
Line 1413,"Ensure healthy lives and promote well-being for all at all ages Details of how we are contributing to the achievement of this SDG are provided throughout this report.
","('Access_And_Affordability', 0.6941242814064026)","('Employee_Health_And_Safety', 0.08283049613237381)","('Human_Rights_And_Community_Relations', 0.051855120807886124)","(['Health Outcome Contribution'], 0.6941242814064026)","('NON-ESG', 0.08283049613237381)","('NON-ESG', 0.051855120807886124)"
Line 1414,"Other examples include women-focused philanthropic investments and our work on hospital infection prevention efforts.
","('Access_And_Affordability', 0.36235204339027405)","('Employee_Health_And_Safety', 0.22375474870204926)","('Critical_Incident_Risk_Management', 0.05494386702775955)","('NON-ESG', 0.36235204339027405)","('NON-ESG', 0.22375474870204926)","('NON-ESG', 0.05494386702775955)"
Line 1415,"Goal 3.9 requires that the number of deaths and illnesses from hazardous chemicals and air, water and  soil pollution and contamination is substantially reduced by 2030.
","('Employee_Health_And_Safety', 0.8265627026557922)","('Waste_And_Hazardous_Materials_Management', 0.07297047972679138)","('Ecological_Impacts', 0.013997156172990799)","(['Operational Eco-Efficiency'], 0.8265627026557922)","('NON-ESG', 0.07297047972679138)","('NON-ESG', 0.013997156172990799)"
Line 1416,"Our 2030+ commitments regarding climate change, product impact and responsible supply chain are aimed at reducing the impact of our operations, value chain and products on the environment, thereby reducing potential to undermine achievement of this goal.Very direct Raw materials, Suppliers, Inbound logistics, Operations, Distribution, Product use, End of life Goal 4.
","('Product_Design_And_Lifecycle_Management', 0.7333536744117737)","('Supply_Chain_Management', 0.1505572646856308)","('Business_Model_Resilience', 0.01502552442252636)","(['Product Stewardship'], 0.7333536744117737)","('NON-ESG', 0.1505572646856308)","('NON-ESG', 0.01502552442252636)"
Line 1417,"Ensure inclusive and equitable quality education and promote lifelong learning opportunities for all We are supporting achievement of this goal through our 2030+ commitment to proactively manage the needs of our future workforce through training, development and re-skilling strategies.
","('Employee_Engagement_Inclusion_And_Diversity', 0.5516362190246582)","('Access_And_Affordability', 0.23435266315937042)","('Employee_Health_And_Safety', 0.02326306141912937)","(['Human Capital Development'], 0.5516362190246582)","('NON-ESG', 0.23435266315937042)","('NON-ESG', 0.02326306141912937)"
Line 1418,"Details of how we enable our associates to grow can be found here.
","('Business_Model_Resilience', 0.5258327722549438)","('Systemic_Risk_Management', 0.11030150949954987)","('Employee_Engagement_Inclusion_And_Diversity', 0.04449416324496269)","(['Codes of Business Conduct'], 0.5258327722549438)","('NON-ESG', 0.11030150949954987)","('NON-ESG', 0.04449416324496269)"
Line 1419,"We collaborate with agencies around the world, providing training to assist in the strengthening of  health systems.
","('Employee_Health_And_Safety', 0.4830687642097473)","('Access_And_Affordability', 0.2823251485824585)","('Critical_Incident_Risk_Management', 0.06553133577108383)","('NON-ESG', 0.4830687642097473)","('NON-ESG', 0.2823251485824585)","('NON-ESG', 0.06553133577108383)"
Line 1420,"Moderately direct Operations, Product use  Goal 5.
","('Product_Design_And_Lifecycle_Management', 0.9358980059623718)","('Customer_Welfare', 0.011304490268230438)","('Selling_Practices_And_Product_Labeling', 0.006042723543941975)","(['Product Stewardship'], 0.9358980059623718)","('NON-ESG', 0.011304490268230438)","('NON-ESG', 0.006042723543941975)"
Line 1421,"Achieve gender equality and empower all women and girls In accordance with our Code of Conduct, we believe everyone deserves to work in a supportive, inclusive and safe environment, and we will never discriminate against anyone on the basis of “protected characteristics,” including gender.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9156804084777832)","('Labor_Practices', 0.02284366637468338)","('Human_Rights_And_Community_Relations', 0.01099334191530943)","(['Human Capital Development'], 0.9156804084777832)","('NON-ESG', 0.02284366637468338)","('NON-ESG', 0.01099334191530943)"
Line 1422,"This extends to our Expectations for Suppliers.
","('Supply_Chain_Management', 0.9113385677337646)","('Product_Design_And_Lifecycle_Management', 0.00863034650683403)","('GHG_Emissions', 0.00814281776547432)","(['Supply Chain Management'], 0.9113385677337646)","('NON-ESG', 0.00863034650683403)","('NON-ESG', 0.00814281776547432)"
Line 1423,"Details on how we build inclusion, diversity and equity can be found here and in our ID&E Report.Moderately direct Suppliers, Inbound logistics, Operations, Distribution,  Product use 23The rationale is based on a review of BD’s current activities and strategies, considering (a) the risks to people and the environment linked to our company’s operations and value chain; and (b) actual and potential positive impacts or benefits of products, services and investments related to the SDGs. 24 Degree of control is assessed by determining how directly BD can impact the SDG through its core business activities.
","('Employee_Engagement_Inclusion_And_Diversity', 0.40405333042144775)","('Product_Design_And_Lifecycle_Management', 0.2573258578777313)","('Product_Quality_And_Safety', 0.04812796786427498)","('NON-ESG', 0.40405333042144775)","('NON-ESG', 0.2573258578777313)","('NON-ESG', 0.04812796786427498)"
Line 1424,"Details on how we build inclusion, diversity and equity can be found here and in our ID&E Report.Moderately direct Suppliers, Inbound logistics, Operations, Distribution,  Product use 23The rationale is based on a review of BD’s current activities and strategies, considering (a) the risks to people and the environment linked to our company’s operations and value chain; and (b) actual and potential positive impacts or benefits of products, services and investments related to the SDGs. 24 Degree of control is assessed by determining how directly BD can impact the SDG through its core business activities.
","('Business_Model_Resilience', 0.5552088022232056)","('Systemic_Risk_Management', 0.10218101739883423)","('Supply_Chain_Management', 0.057635124772787094)","(['Codes of Business Conduct'], 0.5552088022232056)","('NON-ESG', 0.10218101739883423)","('NON-ESG', 0.057635124772787094)"
Line 1425,"While some targets will benefit from BD’s direct involvement, others are more relational and will benefit from BD’s overall influence or through parties and stakeholders other than BD itself.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4896010458469391)","('Competitive_Behavior', 0.16065233945846558)","('Business_Ethics', 0.07466185837984085)","('NON-ESG', 0.4896010458469391)","('NON-ESG', 0.16065233945846558)","('NON-ESG', 0.07466185837984085)"
Line 1426,"The degree of  control is considered either “very direct,” “moderately direct,” or “less direct.” 25 Value-chain impacts were assessed based on where in BD’s value chain the SDG is most relevant.
","('Systemic_Risk_Management', 0.4356987774372101)","('Business_Model_Resilience', 0.2525019347667694)","('Supply_Chain_Management', 0.1346316635608673)","('NON-ESG', 0.4356987774372101)","('NON-ESG', 0.2525019347667694)","('NON-ESG', 0.1346316635608673)"
Line 1427,"The greatest social and environmental impact that BD has on the SDGs may be beyond the scope of the assets it owns or controls, with the greatest business opportunities being potentially further upstream or downstream in the value chain.
","('Business_Model_Resilience', 0.41719648241996765)","('Human_Rights_And_Community_Relations', 0.17654822766780853)","('Supply_Chain_Management', 0.07703520357608795)","('NON-ESG', 0.41719648241996765)","('NON-ESG', 0.17654822766780853)","('NON-ESG', 0.07703520357608795)"
Line 1428,"This is a high-level mapping of BD’s value chain to identify areas with high likelihood of either negative or positive impacts on the issues that the SDGs represent.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Sustainable Development Goal How we contribute to the achievement of the SDG Degree of control Value chain Goal 6.
","('Supply_Chain_Management', 0.8557817339897156)","('Physical_Impacts_Of_Climate_Change', 0.05003741383552551)","('Business_Model_Resilience', 0.01788463070988655)","(['Supply Chain Management'], 0.8557817339897156)","('NON-ESG', 0.05003741383552551)","('NON-ESG', 0.01788463070988655)"
Line 1429,"Ensure availability and sustainable  management of water and sanitation for allWe believe that access to water, sanitation and hygiene is a human right.
","('Water_And_Wastewater_Management', 0.9598627090454102)","('Energy_Management', 0.004254139959812164)","('Critical_Incident_Risk_Management', 0.0031677703373134136)","(['Operational Eco-Efficiency'], 0.9598627090454102)","('NON-ESG', 0.004254139959812164)","('NON-ESG', 0.0031677703373134136)"
Line 1430,"Our 2030+ commitments regarding climate change, product impact and responsible supply chain are  aimed at reducing the impact of our operations, value chain and products on water, thereby reducing potential to undermine achievement of this goal.
","('Supply_Chain_Management', 0.5183007717132568)","('Physical_Impacts_Of_Climate_Change', 0.14687803387641907)","('Product_Design_And_Lifecycle_Management', 0.13553455471992493)","(['Supply Chain Management'], 0.5183007717132568)","('NON-ESG', 0.14687803387641907)","('NON-ESG', 0.13553455471992493)"
Line 1431,"Details on how we manage water use can be found here.
","('Water_And_Wastewater_Management', 0.9758145213127136)","('Ecological_Impacts', 0.0022302442230284214)","('GHG_Emissions', 0.0022285133600234985)","(['Operational Eco-Efficiency'], 0.9758145213127136)","('NON-ESG', 0.0022302442230284214)","('NON-ESG', 0.0022285133600234985)"
Line 1432,"Very direct Raw materials, Suppliers, Operations, Product use,  End of life Goal 7.
","('Product_Design_And_Lifecycle_Management', 0.9536654353141785)","('Supply_Chain_Management', 0.006902642548084259)","('Selling_Practices_And_Product_Labeling', 0.004629821982234716)","(['Product Stewardship'], 0.9536654353141785)","('NON-ESG', 0.006902642548084259)","('NON-ESG', 0.004629821982234716)"
Line 1433,"Ensure access to affordable, reliable, sustainable and modern energy for all Our contribution to achievement of this SDG is neutral.
","('Energy_Management', 0.9258968830108643)","('Product_Design_And_Lifecycle_Management', 0.020880674943327904)","('Access_And_Affordability', 0.008385359309613705)","(['Operational Eco-Efficiency'], 0.9258968830108643)","('NON-ESG', 0.020880674943327904)","('NON-ESG', 0.008385359309613705)"
Line 1434,"Details on how we manage our energy usage can be found here.Moderately direct Suppliers, Inbound logistics, Operations, Distribution Goal 8.
","('Energy_Management', 0.9500116109848022)","('Supply_Chain_Management', 0.010112053714692593)","('Water_And_Wastewater_Management', 0.0048464080318808556)","(['Operational Eco-Efficiency'], 0.9500116109848022)","('NON-ESG', 0.010112053714692593)","('NON-ESG', 0.0048464080318808556)"
Line 1435,"Promote sustained, inclusive and sustainable  economic growth, full and productive employment and decent work for allOur Global Human Rights Policy is guided by the principles outlined in the UN Declaration of Human Rights and International Labor Organization’s Declaration on Fundamental Principles and Rights at Work.
","('Labor_Practices', 0.7073282599449158)","('Human_Rights_And_Community_Relations', 0.19177478551864624)","('Employee_Health_And_Safety', 0.01194069068878889)","(['Labor Practice Indicators'], 0.7073282599449158)","('NON-ESG', 0.19177478551864624)","('NON-ESG', 0.01194069068878889)"
Line 1436,"This commitment extends beyond BD processes and practices to those in our supply chains.
","('Supply_Chain_Management', 0.9471721053123474)","('Labor_Practices', 0.005586482118815184)","('Product_Design_And_Lifecycle_Management', 0.003768204478546977)","(['Supply Chain Management'], 0.9471721053123474)","('NON-ESG', 0.005586482118815184)","('NON-ESG', 0.003768204478546977)"
Line 1437,"We are also supporting achievement of this SDG through our 2030+ commitments to a healthy  workforce and community and programs such as our Good Jobs Strategy.
","('Human_Rights_And_Community_Relations', 0.4712877869606018)","('Employee_Engagement_Inclusion_And_Diversity', 0.3382074236869812)","('Access_And_Affordability', 0.04526904597878456)","('NON-ESG', 0.4712877869606018)","('NON-ESG', 0.3382074236869812)","('NON-ESG', 0.04526904597878456)"
Line 1438,"Our 2030+ commitments regarding Product Impact are aimed at addressing plastic and packaging  consumption in our product portfolio, thereby reducing potential to undermine achievement of this goal, specifically the target to improve resource efficiency and decouple growth from environmental degradation.Very direct Suppliers, Inbound logistics, Operations, Distribution, Product use Goal 9.
","('Product_Design_And_Lifecycle_Management', 0.9658305048942566)","('Energy_Management', 0.0035966013092547655)","('Selling_Practices_And_Product_Labeling', 0.0034570256248116493)","(['Product Stewardship'], 0.9658305048942566)","('NON-ESG', 0.0035966013092547655)","('NON-ESG', 0.0034570256248116493)"
Line 1439,"Build resilient infrastructure, promote inclusive and sustainable industrialization and foster innovation We support the achievement of this SDG through our development of products and services related to healthcare and medical research.
","('Product_Design_And_Lifecycle_Management', 0.7530529499053955)","('Business_Model_Resilience', 0.1237226128578186)","('Supply_Chain_Management', 0.016894131898880005)","(['Product Stewardship'], 0.7530529499053955)","('NON-ESG', 0.1237226128578186)","('NON-ESG', 0.016894131898880005)"
Line 1440,"Details of our investment in R&D can be found here.Very direct Operations, Product use Goal 10.
","('Product_Design_And_Lifecycle_Management', 0.9332115650177002)","('Customer_Welfare', 0.009952153079211712)","('Supply_Chain_Management', 0.008698156103491783)","(['Product Stewardship'], 0.9332115650177002)","('NON-ESG', 0.009952153079211712)","('NON-ESG', 0.008698156103491783)"
Line 1441,"Reduce inequality within and  among countriesIn accordance with our Code of Conduct, we believe everyone deserves to work in a supportive, inclusive and safe environment, and we will never against anyone on the basis of “protected characteristics.” This extends to our Expectations for Suppliers.Very direct Suppliers, Operations Goal 11.
","('Supply_Chain_Management', 0.9097388982772827)","('Labor_Practices', 0.0106269009411335)","('Product_Design_And_Lifecycle_Management', 0.006200192030519247)","(['Supply Chain Management'], 0.9097388982772827)","('NON-ESG', 0.0106269009411335)","('NON-ESG', 0.006200192030519247)"
Line 1442,"Make cities and human settlements inclusive, safe, resilient and sustainable Our 2030+ commitments regarding climate change, product impact and responsible supply chain are aimed at reducing the impact of our operations, value chain and products on the environment, thereby reducing potential to undermine achievement of this goal.
","('Supply_Chain_Management', 0.4405955672264099)","('Product_Design_And_Lifecycle_Management', 0.3088044226169586)","('Business_Model_Resilience', 0.07285749167203903)","('NON-ESG', 0.4405955672264099)","('NON-ESG', 0.3088044226169586)","('NON-ESG', 0.07285749167203903)"
Line 1443,"Details on our waste management and air emissions programs can be found here.
","('Air_Quality', 0.9757879376411438)","('Energy_Management', 0.0023817268665879965)","('Waste_And_Hazardous_Materials_Management', 0.0023772811982780695)","(['Operational Eco-Efficiency'], 0.9757879376411438)","('NON-ESG', 0.0023817268665879965)","('NON-ESG', 0.0023772811982780695)"
Line 1444,"Very direct Suppliers, Inbound logistics, Operations, Distribution,  Product use, End of life2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Sustainable Development Goal How we contribute to the achievement of the SDG Degree of control Value chain Goal 12.
","('Supply_Chain_Management', 0.516177773475647)","('Product_Design_And_Lifecycle_Management', 0.34199538826942444)","('Business_Model_Resilience', 0.01655208319425583)","(['Supply Chain Management'], 0.516177773475647)","('NON-ESG', 0.34199538826942444)","('NON-ESG', 0.01655208319425583)"
Line 1445,"Ensure sustainable consumption and  production patternsOur 2030+ commitments regarding climate change, product impact and responsible supply chain are aimed at reducing the impact of our operations, value chain and products on the environment, thereby reducing potential to undermine achievement of this goal.
","('Product_Design_And_Lifecycle_Management', 0.8913049101829529)","('Supply_Chain_Management', 0.040026430040597916)","('Energy_Management', 0.008171155117452145)","(['Product Stewardship'], 0.8913049101829529)","('NON-ESG', 0.040026430040597916)","('NON-ESG', 0.008171155117452145)"
Line 1446,"Our 2030+ commitment to transparency supports achievement goal 12.6.Very direct Raw materials, Suppliers, Inbound logistics,  Operations, Distribution, Product use, End of life Goal 13.
","('Product_Design_And_Lifecycle_Management', 0.8924739360809326)","('Supply_Chain_Management', 0.03458505868911743)","('Selling_Practices_And_Product_Labeling', 0.00925394520163536)","(['Product Stewardship'], 0.8924739360809326)","('NON-ESG', 0.03458505868911743)","('NON-ESG', 0.00925394520163536)"
Line 1447,"Take urgent action to combat climate change and its impacts In September 2021, we strengthened our commitment to reducing emissions by joining the UN Race to Zero, via the Business Ambition for 1.5°C and Science Based Targets initiative (SBTi).
","('Physical_Impacts_Of_Climate_Change', 0.9193821549415588)","('GHG_Emissions', 0.023391783237457275)","('Business_Model_Resilience', 0.012618270702660084)","(['Climate Change'], 0.9193821549415588)","('NON-ESG', 0.023391783237457275)","('NON-ESG', 0.012618270702660084)"
Line 1448,"Our goal to set and achieve science-based targets, and our 2030+ goal to use our capabilities to contribute to solutions that address unmet climate-related health needs, contribute to achievement of this SDG.
","('Physical_Impacts_Of_Climate_Change', 0.8488031625747681)","('Business_Model_Resilience', 0.02392459847033024)","('Supply_Chain_Management', 0.022638559341430664)","(['Climate Change'], 0.8488031625747681)","('NON-ESG', 0.02392459847033024)","('NON-ESG', 0.022638559341430664)"
Line 1449,"Details of our approach to climate change management can be found here.Very direct Raw materials, Suppliers, Inbound logistics,  Operations, Distribution, Product use, End of life Goal 14.
","('Physical_Impacts_Of_Climate_Change', 0.6974110007286072)","('Supply_Chain_Management', 0.11817814409732819)","('Business_Model_Resilience', 0.041662268340587616)","(['Climate Change'], 0.6974110007286072)","('NON-ESG', 0.11817814409732819)","('NON-ESG', 0.041662268340587616)"
Line 1450,"Conserve and sustainably use the oceans, seas and marine resources for sustainable developmentOur 2030+ commitments regarding climate change, product impact and responsible supply chain are aimed at reducing the impact of our operations, value chain and products on the environment, thereby reducing potential to undermine achievement of this goal.Less direct Raw materials, Suppliers, Inbound logistics, Operations, Distribution, End of life Goal 15.
","('Supply_Chain_Management', 0.4864038825035095)","('Product_Design_And_Lifecycle_Management', 0.37822097539901733)","('Business_Model_Resilience', 0.014674130827188492)","('NON-ESG', 0.4864038825035095)","('NON-ESG', 0.37822097539901733)","('NON-ESG', 0.014674130827188492)"
Line 1451,"Protect, restore and promote sustainable use of terrestrial ecosystems, sustainably manage forests, combat desertification, and halt and reverse land degradation and halt biodiversity lossOur 2030+ commitments regarding climate change, product impact and responsible supply chain are aimed at reducing the impact of our operations, value chain and products on the environment, thereby reducing potential to undermine achievement of this goal.Less direct Raw materials, Suppliers, Inbound logistics, Operations, Distribution, End of life Goal 16.
","('Ecological_Impacts', 0.9247876405715942)","('Supply_Chain_Management', 0.012788482010364532)","('Product_Design_And_Lifecycle_Management', 0.009401687420904636)","(['Natural Capital'], 0.9247876405715942)","('NON-ESG', 0.012788482010364532)","('NON-ESG', 0.009401687420904636)"
Line 1452,"Protect, restore and promote sustainable use of terrestrial ecosystems, sustainably manage forests, combat desertification, and halt and reverse land degradation and halt biodiversity lossOur 2030+ commitments regarding climate change, product impact and responsible supply chain are aimed at reducing the impact of our operations, value chain and products on the environment, thereby reducing potential to undermine achievement of this goal.Less direct Raw materials, Suppliers, Inbound logistics, Operations, Distribution, End of life Goal 16.
","('Product_Design_And_Lifecycle_Management', 0.2757887542247772)","('Business_Model_Resilience', 0.16685432195663452)","('Ecological_Impacts', 0.110247902572155)","('NON-ESG', 0.2757887542247772)","('NON-ESG', 0.16685432195663452)","('NON-ESG', 0.110247902572155)"
Line 1453,"Promote peaceful and inclusive societies for sustainable development, provide access to justice for all and build effective, accountable and inclusive institutions at all levelsIn accordance with our Code of Conduct, we are fair and honest when we do business and follow all the laws that govern how companies compete and behave with each other.
","('Management_Of_Legal_And_Regulatory_Framework', 0.44299718737602234)","('Business_Ethics', 0.20884963870048523)","('Human_Rights_And_Community_Relations', 0.1004686951637268)","('NON-ESG', 0.44299718737602234)","('NON-ESG', 0.20884963870048523)","('NON-ESG', 0.1004686951637268)"
Line 1454,"Details of how we support achievement of this goal through ethical business practices can be found in  the Transparency section of this report.
","('Business_Ethics', 0.9687541723251343)","('Data_Security', 0.002858909545466304)","('Management_Of_Legal_And_Regulatory_Framework', 0.0025866758078336716)","(['Business Ethics'], 0.9687541723251343)","('NON-ESG', 0.002858909545466304)","('NON-ESG', 0.0025866758078336716)"
Line 1455,"Very direct Raw materials, Suppliers, Inbound logistics, Operations, Distribution Goal 17.
","('Supply_Chain_Management', 0.8754507899284363)","('Energy_Management', 0.017116235569119453)","('Product_Design_And_Lifecycle_Management', 0.01129081379622221)","(['Supply Chain Management'], 0.8754507899284363)","('NON-ESG', 0.017116235569119453)","('NON-ESG', 0.01129081379622221)"
Line 1456,"Strengthen the means of implementation and revitalize the Global Partnership for Sustainable Development We support achievement of this SDG by partnering with agencies and NGOs around the world to build capacity and strengthen health systems.
","('Access_And_Affordability', 0.657006561756134)","('Human_Rights_And_Community_Relations', 0.1031867191195488)","('Critical_Incident_Risk_Management', 0.039439477026462555)","(['Health Outcome Contribution'], 0.657006561756134)","('NON-ESG', 0.1031867191195488)","('NON-ESG', 0.039439477026462555)"
Line 1457,"Moderately direct Operations, Product use2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goal: Reduce Scope 1 and  2 emissions by 46% by 2030 (from 2019 baseline, absolute) Carbon-neutral  across direct operations by 2040Current status: Decreased by 7% (market-based, excluding unbundled REC purchase) in FY 2019, increased by 23% (market-based, including unbundled REC purchase) in FY 2019,  In previous years, we have purchased additional unbundled Renewable Energy  Credits (RECs) to offset greenhouse gas (GHG) emissions at our U.S. facilities.
","('Supply_Chain_Management', 0.4338952898979187)","('Product_Design_And_Lifecycle_Management', 0.2378910481929779)","('Physical_Impacts_Of_Climate_Change', 0.08251120150089264)","('NON-ESG', 0.4338952898979187)","('NON-ESG', 0.2378910481929779)","('NON-ESG', 0.08251120150089264)"
Line 1458,"Moderately direct Operations, Product use2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goal: Reduce Scope 1 and  2 emissions by 46% by 2030 (from 2019 baseline, absolute) Carbon-neutral  across direct operations by 2040Current status: Decreased by 7% (market-based, excluding unbundled REC purchase) in FY 2019, increased by 23% (market-based, including unbundled REC purchase) in FY 2019,  In previous years, we have purchased additional unbundled Renewable Energy  Credits (RECs) to offset greenhouse gas (GHG) emissions at our U.S. facilities.
","('GHG_Emissions', 0.9702605605125427)","('Ecological_Impacts', 0.003763534827157855)","('Management_Of_Legal_And_Regulatory_Framework', 0.0030433391220867634)","(['Climate Change'], 0.9702605605125427)","('NON-ESG', 0.003763534827157855)","('NON-ESG', 0.0030433391220867634)"
Line 1459,"However, due to the significant increase in the market price for RECs in FY 2020, we purchased and retired nearly 150,000 metric tonnes CO 2e of carbon  offsets.
","('Management_Of_Legal_And_Regulatory_Framework', 0.46180692315101624)","('Energy_Management', 0.08901485800743103)","('GHG_Emissions', 0.08212155103683472)","('NON-ESG', 0.46180692315101624)","('NON-ESG', 0.08901485800743103)","('NON-ESG', 0.08212155103683472)"
Line 1460,"(These offsets are not reflected in the data provided above).
","('Systemic_Risk_Management', 0.3253684639930725)","('Management_Of_Legal_And_Regulatory_Framework', 0.27763640880584717)","('Business_Model_Resilience', 0.042876120656728745)","('NON-ESG', 0.3253684639930725)","('NON-ESG', 0.27763640880584717)","('NON-ESG', 0.042876120656728745)"
Line 1461,"In FY 2021, we chose to divert funds set aside for the purchase of RECs to  activities to establish baseline emissions for our significant sources of Scope 3 emissions.
","('GHG_Emissions', 0.8139050602912903)","('Air_Quality', 0.10607801377773285)","('Management_Of_Legal_And_Regulatory_Framework', 0.012331834994256496)","(['Climate Change'], 0.8139050602912903)","('NON-ESG', 0.10607801377773285)","('NON-ESG', 0.012331834994256496)"
Line 1462,"Over the coming years we will continue to develop our strategy for achieving our stated commitments to carbon neutrality.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3977172374725342)","('GHG_Emissions', 0.25506025552749634)","('Competitive_Behavior', 0.06534867733716965)","('NON-ESG', 0.3977172374725342)","('NON-ESG', 0.25506025552749634)","('NON-ESG', 0.06534867733716965)"
Line 1463,"Data tables Scope 1 and GHG emissions — Scope 1 and 2 (market-based*) FY 2019 baseline FY 2020 FY Metric tonnes CO2e, absolute emissions Scope 1* 147,434 144,005 152,Scope 2 254,961 346,603 342,Total Scope 1 and 2 402,395 490,609 494,reduction from baseline 22% (increase) 23% (increase) GHG emissions – Scope 1 and 2 (market-based) excluding FY 2019 unbundled RECs FY 2019 baseline FY 2020 FY Metric tonnes CO2e, absolute emissions Scope 1 147,434 144,005 152,Scope 2 382,377 346,603 342,Total Scope 1 and 2 529,811 490,609 494,reduction from baseline 7% 7% *  Mark et-based (MB): quantifies Scope 2 GHG emissions based on GHG emissions emitted by the generators from which the reporter contractually purchases  electricity bundled with contractual instruments, or contractual instruments on their own (e.g., utility-specific emission factors, renewable energy certificates).
","('GHG_Emissions', 0.9656805396080017)","('Air_Quality', 0.006486889906227589)","('Ecological_Impacts', 0.0035464197862893343)","(['Climate Change'], 0.9656805396080017)","('NON-ESG', 0.006486889906227589)","('NON-ESG', 0.0035464197862893343)"
Line 1464,"Data tables Scope 1 and GHG emissions — Scope 1 and 2 (market-based*) FY 2019 baseline FY 2020 FY Metric tonnes CO2e, absolute emissions Scope 1* 147,434 144,005 152,Scope 2 254,961 346,603 342,Total Scope 1 and 2 402,395 490,609 494,reduction from baseline 22% (increase) 23% (increase) GHG emissions – Scope 1 and 2 (market-based) excluding FY 2019 unbundled RECs FY 2019 baseline FY 2020 FY Metric tonnes CO2e, absolute emissions Scope 1 147,434 144,005 152,Scope 2 382,377 346,603 342,Total Scope 1 and 2 529,811 490,609 494,reduction from baseline 7% 7% *  Mark et-based (MB): quantifies Scope 2 GHG emissions based on GHG emissions emitted by the generators from which the reporter contractually purchases  electricity bundled with contractual instruments, or contractual instruments on their own (e.g., utility-specific emission factors, renewable energy certificates).
","('GHG_Emissions', 0.958773136138916)","('Air_Quality', 0.011049584485590458)","('Management_Of_Legal_And_Regulatory_Framework', 0.0032507614232599735)","(['Climate Change'], 0.958773136138916)","('NON-ESG', 0.011049584485590458)","('NON-ESG', 0.0032507614232599735)"
Line 1465,"**  Emissions r elated to our sales fleet were previously included in Scope 3 Category 6; it is now included in Scope 1.
","('GHG_Emissions', 0.4804317355155945)","('Energy_Management', 0.2347637563943863)","('Air_Quality', 0.11523988097906113)","('NON-ESG', 0.4804317355155945)","('NON-ESG', 0.2347637563943863)","('NON-ESG', 0.11523988097906113)"
Line 1466,"Data for FY 2019 and FY 2020 has been  restated accordingly.Method of calculation Data represents Scope 1 (direct) and Scope 2 (indirect from electricity) energy sources.
","('Energy_Management', 0.9763245582580566)","('Management_Of_Legal_And_Regulatory_Framework', 0.003640801180154085)","('Water_And_Wastewater_Management', 0.0019299901323392987)","(['Operational Eco-Efficiency'], 0.9763245582580566)","('NON-ESG', 0.003640801180154085)","('NON-ESG', 0.0019299901323392987)"
Line 1467,"BD has used emission factors  that are temporally, geographically and technologically accurate for each site and source within its operational boundary as specified by the WRI/WBCSD GHG Protocol.
","('GHG_Emissions', 0.9419246912002563)","('Air_Quality', 0.020249636843800545)","('Energy_Management', 0.004414099268615246)","(['Climate Change'], 0.9419246912002563)","('NON-ESG', 0.020249636843800545)","('NON-ESG', 0.004414099268615246)"
Line 1468,"This includes updating electric power emission factors to reflect changes in the grid mix for areas in which BD operates.
","('Air_Quality', 0.9431355595588684)","('Energy_Management', 0.013641816563904285)","('Critical_Incident_Risk_Management', 0.005777369253337383)","(['Operational Eco-Efficiency'], 0.9431355595588684)","('NON-ESG', 0.013641816563904285)","('NON-ESG', 0.005777369253337383)"
Line 1469,"As many utilities have ceased publishing emission factors, we have used regional emission factors and restated across all years to ensure consistency.
","('Air_Quality', 0.9693840146064758)","('Critical_Incident_Risk_Management', 0.004814608953893185)","('Energy_Management', 0.002815880347043276)","(['Operational Eco-Efficiency'], 0.9693840146064758)","('NON-ESG', 0.004814608953893185)","('NON-ESG', 0.002815880347043276)"
Line 1470,"In general, historical emission factors remain consistent with the publication that was most recent at the time of  original reporting.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goal: Scope 3 emissions targets for material Scope 3 categories to be set by September 2023Current status: Baselines established for category 1, 4 and 9.
","('Air_Quality', 0.4575277268886566)","('GHG_Emissions', 0.32929134368896484)","('Physical_Impacts_Of_Climate_Change', 0.056235507130622864)","('NON-ESG', 0.4575277268886566)","('NON-ESG', 0.32929134368896484)","('NON-ESG', 0.056235507130622864)"
Line 1471,"Project underway  to calculate baseline for category 11 and 12.Scope Metric tonnes CO2e, absolute emissions FY 2019 FY 2020 FY 2021Percentage of total  reported Scope 3 emissions Method of calculation Category 1 Purchased goods and services — — 3,007,771 85% In FY 2021, we changed our approach to calculating category 1 and 2 emissions in preparation for setting science-based targets.
","('GHG_Emissions', 0.7985128164291382)","('Air_Quality', 0.12442754954099655)","('Energy_Management', 0.013214010745286942)","(['Climate Change'], 0.7985128164291382)","('NON-ESG', 0.12442754954099655)","('NON-ESG', 0.013214010745286942)"
Line 1472,"In the first phase, we calculated emissions using the Environmentally Extended Input-Output (EEIO) method.
","('GHG_Emissions', 0.727278470993042)","('Air_Quality', 0.1277882307767868)","('Energy_Management', 0.046404045075178146)","(['Climate Change'], 0.727278470993042)","('NON-ESG', 0.1277882307767868)","('NON-ESG', 0.046404045075178146)"
Line 1473,"With this approach, GHG emissions are estimated using a spend-based method and the emissions factors are based on emissions allocated to industry categories.
","('GHG_Emissions', 0.9626717567443848)","('Air_Quality', 0.008385496214032173)","('Management_Of_Legal_And_Regulatory_Framework', 0.0035341870971024036)","(['Climate Change'], 0.9626717567443848)","('NON-ESG', 0.008385496214032173)","('NON-ESG', 0.0035341870971024036)"
Line 1474,"While this method provides a reasonable estimate to enable prioritization of actions, the associated error margin is high and does not provide data that is sufficiently granular for prioritizing reduction initiatives.
","('Management_Of_Legal_And_Regulatory_Framework', 0.44300204515457153)","('Business_Model_Resilience', 0.13420480489730835)","('Systemic_Risk_Management', 0.07768803834915161)","('NON-ESG', 0.44300204515457153)","('NON-ESG', 0.13420480489730835)","('NON-ESG', 0.07768803834915161)"
Line 1475,"FY 2021 reported emissions were estimated using a composite approach, whereby average material GHG emission factors were  applied to purchases of the highest-volume goods, and company-specific GHG emissions data was used for the highest-volume services.
","('GHG_Emissions', 0.9596824049949646)","('Air_Quality', 0.010948842391371727)","('Management_Of_Legal_And_Regulatory_Framework', 0.003033327404409647)","(['Climate Change'], 0.9596824049949646)","('NON-ESG', 0.010948842391371727)","('NON-ESG', 0.003033327404409647)"
Line 1476,"Spend-based data and assumptions were then used to fill gaps.
","('Systemic_Risk_Management', 0.2278519868850708)","('Competitive_Behavior', 0.15916132926940918)","('Business_Ethics', 0.08649393916130066)","('NON-ESG', 0.2278519868850708)","('NON-ESG', 0.15916132926940918)","('NON-ESG', 0.08649393916130066)"
Line 1477,"This method delivers a more accurate estimate of GHG emissions than EEIO alone, and provides the necessary granularity needed to inform and focus reduction activities.
","('GHG_Emissions', 0.9690163731575012)","('Ecological_Impacts', 0.003362910822033882)","('Air_Quality', 0.003109765937551856)","(['Climate Change'], 0.9690163731575012)","('NON-ESG', 0.003362910822033882)","('NON-ESG', 0.003109765937551856)"
Line 1478,"Data for FY 2019 and FY 2020 has not been included due to the change in methodology used in FY 2021.
","('Physical_Impacts_Of_Climate_Change', 0.21189293265342712)","('Business_Model_Resilience', 0.17874865233898163)","('Management_Of_Legal_And_Regulatory_Framework', 0.12698525190353394)","('NON-ESG', 0.21189293265342712)","('NON-ESG', 0.17874865233898163)","('NON-ESG', 0.12698525190353394)"
Line 1479,"Category 2 Capital goods — — — These emissions are included in category 1.
","('GHG_Emissions', 0.7841693758964539)","('Air_Quality', 0.08859408646821976)","('Energy_Management', 0.034068211913108826)","(['Climate Change'], 0.7841693758964539)","('NON-ESG', 0.08859408646821976)","('NON-ESG', 0.034068211913108826)"
Line 1480,"Category 3 Fuel- and energy-related activities  (not included in Scope 1 or 2)101,392 97,464 148,597 4% Fuel- and Energy-related activities were calculated using BD Scope 1 and 2 data and applying electricity and fuel transmission and  distribution loss and well-to-tank factors from DEFRA.
","('Energy_Management', 0.9791800379753113)","('Management_Of_Legal_And_Regulatory_Framework', 0.0030835866928100586)","('Air_Quality', 0.001682698493823409)","(['Operational Eco-Efficiency'], 0.9791800379753113)","('NON-ESG', 0.0030835866928100586)","('NON-ESG', 0.001682698493823409)"
Line 1481,"Category 4 Upstream transportation and  distribution— — 317,324 9% In FY 2021, we aligned our GHG accounting practices for transportation activities with those of the Global Logistics Emissions Council  (GLEC) Framework.
","('GHG_Emissions', 0.9689207673072815)","('Air_Quality', 0.0035901954397559166)","('Ecological_Impacts', 0.00320184463635087)","(['Climate Change'], 0.9689207673072815)","('NON-ESG', 0.0035901954397559166)","('NON-ESG', 0.00320184463635087)"
Line 1482,"Specifically, GLEC Framework default emission-intensity factors in grams (g) carbon dioxide equivalent (CO 2e) per  tonne-kilometer (t-km) (g CO2e/t-km) were utilized to estimate emissions from air, rail, road and sea transportation of finished products  to the customer.
","('Air_Quality', 0.8362289071083069)","('GHG_Emissions', 0.09147783368825912)","('Energy_Management', 0.012455164454877377)","(['Operational Eco-Efficiency'], 0.8362289071083069)","('NON-ESG', 0.09147783368825912)","('NON-ESG', 0.012455164454877377)"
Line 1483,"BD assumes that it is rresponsible for the cost of this outbound transportation, and therefore the emissions are  categorized as Scope 3, category 4.
","('GHG_Emissions', 0.6277275085449219)","('Air_Quality', 0.22998261451721191)","('Energy_Management', 0.04466140270233154)","(['Climate Change'], 0.6277275085449219)","('NON-ESG', 0.22998261451721191)","('NON-ESG', 0.04466140270233154)"
Line 1484,"This category also includes leased square footage information combined with average intensities for energy consumption by each  asset type to obtain total consumption by energy source for each asset class.
","('Energy_Management', 0.9817147254943848)","('Air_Quality', 0.0016467859968543053)","('Water_And_Wastewater_Management', 0.001636194996535778)","(['Operational Eco-Efficiency'], 0.9817147254943848)","('NON-ESG', 0.0016467859968543053)","('NON-ESG', 0.001636194996535778)"
Line 1485,"This represents the warehouses that are under BD’s materiality threshold in terms of floor area.
","('Systemic_Risk_Management', 0.13786961138248444)","('Business_Model_Resilience', 0.13433361053466797)","('Energy_Management', 0.11825068295001984)","('NON-ESG', 0.13786961138248444)","('NON-ESG', 0.13433361053466797)","('NON-ESG', 0.11825068295001984)"
Line 1486,"Emission factors from IEA were then applied to different energy sources to calculate GHG emissions.
","('GHG_Emissions', 0.909046471118927)","('Air_Quality', 0.045745693147182465)","('Management_Of_Legal_And_Regulatory_Framework', 0.005178928840905428)","(['Climate Change'], 0.909046471118927)","('NON-ESG', 0.045745693147182465)","('NON-ESG', 0.005178928840905428)"
Line 1487,"Data for FY 2019 and FY 2020 has not been included due to the change in methodology used in FY 2021.
","('Physical_Impacts_Of_Climate_Change', 0.21189293265342712)","('Business_Model_Resilience', 0.17874865233898163)","('Management_Of_Legal_And_Regulatory_Framework', 0.12698525190353394)","('NON-ESG', 0.21189293265342712)","('NON-ESG', 0.17874865233898163)","('NON-ESG', 0.12698525190353394)"
Line 1488,"Category 5 Waste generated in operations 19,359 18,717 17,675 <1% Primary waste data (recyclables, plus solid waste including both incinerated and sent to landfill), were used with the EPA Waste  Reduction Model (WARM) emission factors.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Metric tonnes CO2e, absolute emissions FY 2019 FY 2020 FY 2021Percentage of total  reported Scope 3 emissions Method of calculation Category 6 Business travel 107,392 50,032 36,612 1% Air travel was calculated from reports received from BD’s vendors, with each flight segment categorized into specific flight haul lengths  and then multiplied by DEFRA’s published emission factors for those flights.
","('Waste_And_Hazardous_Materials_Management', 0.9840049743652344)","('Water_And_Wastewater_Management', 0.0014721829211339355)","('Air_Quality', 0.0013741857837885618)","(['Operational Eco-Efficiency'], 0.9840049743652344)","('NON-ESG', 0.0014721829211339355)","('NON-ESG', 0.0013741857837885618)"
Line 1489,"Category 5 Waste generated in operations 19,359 18,717 17,675 <1% Primary waste data (recyclables, plus solid waste including both incinerated and sent to landfill), were used with the EPA Waste  Reduction Model (WARM) emission factors.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Metric tonnes CO2e, absolute emissions FY 2019 FY 2020 FY 2021Percentage of total  reported Scope 3 emissions Method of calculation Category 6 Business travel 107,392 50,032 36,612 1% Air travel was calculated from reports received from BD’s vendors, with each flight segment categorized into specific flight haul lengths  and then multiplied by DEFRA’s published emission factors for those flights.
","('Air_Quality', 0.9705298542976379)","('Energy_Management', 0.003630809485912323)","('Critical_Incident_Risk_Management', 0.0030051234643906355)","(['Operational Eco-Efficiency'], 0.9705298542976379)","('NON-ESG', 0.003630809485912323)","('NON-ESG', 0.0030051234643906355)"
Line 1490,"Rental car emissions were calculated based on reports from  BD’s vendors.
","('Air_Quality', 0.9214106202125549)","('GHG_Emissions', 0.0213853158056736)","('Energy_Management', 0.017377005890011787)","(['Operational Eco-Efficiency'], 0.9214106202125549)","('NON-ESG', 0.0213853158056736)","('NON-ESG', 0.017377005890011787)"
Line 1491,"These reports included total miles driven with the calculation based on DEFRA emission factors.
","('Air_Quality', 0.9632070660591125)","('Energy_Management', 0.005769368261098862)","('Critical_Incident_Risk_Management', 0.005552089307457209)","(['Operational Eco-Efficiency'], 0.9632070660591125)","('NON-ESG', 0.005769368261098862)","('NON-ESG', 0.005552089307457209)"
Line 1492,"For hotel stays, total room nights by each country were multiplied by the DEFRA hotel stay emissions factors for that country.
","('Energy_Management', 0.43427956104278564)","('Labor_Practices', 0.07211174815893173)","('Management_Of_Legal_And_Regulatory_Framework', 0.05626997351646423)","('NON-ESG', 0.43427956104278564)","('NON-ESG', 0.07211174815893173)","('NON-ESG', 0.05626997351646423)"
Line 1493,"Rail travel was based on city-pair distances and vendor reports that show the origin station and destination station for each trip.
","('Energy_Management', 0.16628170013427734)","('Management_Of_Legal_And_Regulatory_Framework', 0.08753371238708496)","('Competitive_Behavior', 0.08387725800275803)","('NON-ESG', 0.16628170013427734)","('NON-ESG', 0.08753371238708496)","('NON-ESG', 0.08387725800275803)"
Line 1494,"The total distances traveled from both reports were calculated and then converted to emissions with DEFRA Rail Factors by rail type.
","('Air_Quality', 0.7844919562339783)","('GHG_Emissions', 0.10840214043855667)","('Energy_Management', 0.030482610687613487)","(['Operational Eco-Efficiency'], 0.7844919562339783)","('NON-ESG', 0.10840214043855667)","('NON-ESG', 0.030482610687613487)"
Line 1495,"Reimbursed car included mileage data, which was converted to emissions by using DEFRA factors by vehicle and fuel type.
","('Air_Quality', 0.8030149936676025)","('Energy_Management', 0.06124807149171829)","('GHG_Emissions', 0.060258470475673676)","(['Operational Eco-Efficiency'], 0.8030149936676025)","('NON-ESG', 0.06124807149171829)","('NON-ESG', 0.060258470475673676)"
Line 1496,"Emissions related to our sales fleet were previously included in this category; they are now included in Scope 1.
","('GHG_Emissions', 0.5362096428871155)","('Energy_Management', 0.15537625551223755)","('Air_Quality', 0.14946606755256653)","(['Climate Change'], 0.5362096428871155)","('NON-ESG', 0.15537625551223755)","('NON-ESG', 0.14946606755256653)"
Line 1497,"Data for FY 2019 and  FY 2020 has been restated accordingly.
","('Business_Model_Resilience', 0.3186775743961334)","('Physical_Impacts_Of_Climate_Change', 0.17453233897686005)","('Systemic_Risk_Management', 0.0631769523024559)","('NON-ESG', 0.3186775743961334)","('NON-ESG', 0.17453233897686005)","('NON-ESG', 0.0631769523024559)"
Line 1498,"Category 7 Employee commuting 20,400 20,400 20,400 1% Employee commuting was estimated using the Quantis Scope 3 evaluator with total employee headcount being the input.
","('Labor_Practices', 0.32543009519577026)","('Employee_Health_And_Safety', 0.2274882197380066)","('Employee_Engagement_Inclusion_And_Diversity', 0.13284792006015778)","('NON-ESG', 0.32543009519577026)","('NON-ESG', 0.2274882197380066)","('NON-ESG', 0.13284792006015778)"
Line 1499,"However, it  does not account for BD associates who worked from home during the pandemic.
","('Employee_Health_And_Safety', 0.2435341477394104)","('Labor_Practices', 0.12251584231853485)","('Critical_Incident_Risk_Management', 0.1211562231183052)","('NON-ESG', 0.2435341477394104)","('NON-ESG', 0.12251584231853485)","('NON-ESG', 0.1211562231183052)"
Line 1500,"Category 8 Upstream leased assets 877 1,031 754 <1% Leased square footage information was combined with average intensities for energy consumption by each asset type to obtain total  consumption by energy source for each asset class.
","('Energy_Management', 0.9807298183441162)","('Water_And_Wastewater_Management', 0.001953698694705963)","('Air_Quality', 0.001885136472992599)","(['Operational Eco-Efficiency'], 0.9807298183441162)","('NON-ESG', 0.001953698694705963)","('NON-ESG', 0.001885136472992599)"
Line 1501,"This represents the offices and labs that are under BD’s materiality threshold in terms of floor area.
","('Energy_Management', 0.1307448148727417)","('Competitive_Behavior', 0.0925166979432106)","('Business_Model_Resilience', 0.08835868537425995)","('NON-ESG', 0.1307448148727417)","('NON-ESG', 0.0925166979432106)","('NON-ESG', 0.08835868537425995)"
Line 1502,"Emission factors from the IEA were then applied to different energy sources to calculate GHG emissions.
","('GHG_Emissions', 0.9285142421722412)","('Air_Quality', 0.031047867611050606)","('Management_Of_Legal_And_Regulatory_Framework', 0.004657082259654999)","(['Climate Change'], 0.9285142421722412)","('NON-ESG', 0.031047867611050606)","('NON-ESG', 0.004657082259654999)"
Line 1503,"Category 9 Downstream transportation and  distribution— — — See category 4 above.
","('Water_And_Wastewater_Management', 0.24021685123443604)","('Energy_Management', 0.10795120894908905)","('Competitive_Behavior', 0.09684734046459198)","('NON-ESG', 0.24021685123443604)","('NON-ESG', 0.10795120894908905)","('NON-ESG', 0.09684734046459198)"
Line 1504,"Category 10 Processing of sold products — — — Not relevant  Category 11 Use of sold products — — — Our FY 2021 baseline is being calculated using a new methodology and expanded data set, and will be provided in future reports.
","('Product_Design_And_Lifecycle_Management', 0.9205788373947144)","('Selling_Practices_And_Product_Labeling', 0.02141423523426056)","('Product_Quality_And_Safety', 0.009567850269377232)","(['Product Stewardship'], 0.9205788373947144)","('NON-ESG', 0.02141423523426056)","('NON-ESG', 0.009567850269377232)"
Line 1505,"Category 12 End-of-life treatment of sold  products— — — Our FY 2021 baseline is being calculated using a new methodology and expanded data set, and will be provided in future reports.
","('Product_Design_And_Lifecycle_Management', 0.9557947516441345)","('Selling_Practices_And_Product_Labeling', 0.007387002930045128)","('Product_Quality_And_Safety', 0.005122505594044924)","(['Product Stewardship'], 0.9557947516441345)","('NON-ESG', 0.007387002930045128)","('NON-ESG', 0.005122505594044924)"
Line 1506,"Category 13 Downstream leased assets — 1,501 3,134 <1% Leased square footage information was combined with average intensities for energy consumption by each asset type to obtain total  consumption by energy source for each asset class.
","('Energy_Management', 0.9808682799339294)","('Water_And_Wastewater_Management', 0.0018592583946883678)","('Air_Quality', 0.0018514067633077502)","(['Operational Eco-Efficiency'], 0.9808682799339294)","('NON-ESG', 0.0018592583946883678)","('NON-ESG', 0.0018514067633077502)"
Line 1507,"This represents all the third-party distribution centers and data centers.
","('Supply_Chain_Management', 0.16727901995182037)","('Data_Security', 0.16560465097427368)","('Customer_Privacy', 0.10730023682117462)","('NON-ESG', 0.16727901995182037)","('NON-ESG', 0.16560465097427368)","('NON-ESG', 0.10730023682117462)"
Line 1508,"Emission factors from the IEA were then applied to different energy sources to calculate GHG emissions.
","('GHG_Emissions', 0.9285142421722412)","('Air_Quality', 0.031047867611050606)","('Management_Of_Legal_And_Regulatory_Framework', 0.004657082259654999)","(['Climate Change'], 0.9285142421722412)","('NON-ESG', 0.031047867611050606)","('NON-ESG', 0.004657082259654999)"
Line 1509,"Category 14 Franchises — — — Not relevant  Category 15 Investments — — — Not relevant  Total Scope 3 emissions 3,552,2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goal: Reduce energy consumption by 25% by 2030 (from 2019 baseline, normalized to COPS)Current status: Reduced by 14%Energy Energy consumption (GJ) FY 2019 baseline FY 2020 FY Scope 1, absolute 2,269,013 2,250,019 2,358,Scope 2, absolute 4,264,033 4,227,975 4,388,Total energy, absolute 6,533,046 6,477,994 6,746,Total energy, normalized (GJ per $M COPS) 726 679 % reduction from baseline, normalized 6% 14% Renewable energy consumption (GJ) Green Electric Power Consumed 620,491 686,801 716,Renewable Energy Credits (RECs) purchased 1,430,286 459,715 434,Renewable Energy Offsite – Direct (Physical) power purchase  agreements (PPA) — 50,345 61,Renewable Power – on-site 5,457 5,294 10,Total Renewable Energy 2,056,234 1,202,156 1,222,369Renewables as % of electric power consumption FY 2019 baseline FY 2020 FY Electric power consumption (GJ) 4,264,033 4,218,194 4,374,787  % of electric power via REC purchases 34% 11% 10% % of electric power sourced from green electric power 15% 16% 16% % of electric power sourced from direct PPA 0% 1% 1% % of electric power generated on-site 0% 0% 0% % of electric power from renewable energy 48% 28% 28% Data represents Scope 1 (direct) and Scope 2 (indirect from electricity) energy sources.
","('Energy_Management', 0.9746691584587097)","('Management_Of_Legal_And_Regulatory_Framework', 0.002103480976074934)","('GHG_Emissions', 0.0019387953216210008)","(['Operational Eco-Efficiency'], 0.9746691584587097)","('NON-ESG', 0.002103480976074934)","('NON-ESG', 0.0019387953216210008)"
Line 1510,"Category 14 Franchises — — — Not relevant  Category 15 Investments — — — Not relevant  Total Scope 3 emissions 3,552,2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goal: Reduce energy consumption by 25% by 2030 (from 2019 baseline, normalized to COPS)Current status: Reduced by 14%Energy Energy consumption (GJ) FY 2019 baseline FY 2020 FY Scope 1, absolute 2,269,013 2,250,019 2,358,Scope 2, absolute 4,264,033 4,227,975 4,388,Total energy, absolute 6,533,046 6,477,994 6,746,Total energy, normalized (GJ per $M COPS) 726 679 % reduction from baseline, normalized 6% 14% Renewable energy consumption (GJ) Green Electric Power Consumed 620,491 686,801 716,Renewable Energy Credits (RECs) purchased 1,430,286 459,715 434,Renewable Energy Offsite – Direct (Physical) power purchase  agreements (PPA) — 50,345 61,Renewable Power – on-site 5,457 5,294 10,Total Renewable Energy 2,056,234 1,202,156 1,222,369Renewables as % of electric power consumption FY 2019 baseline FY 2020 FY Electric power consumption (GJ) 4,264,033 4,218,194 4,374,787  % of electric power via REC purchases 34% 11% 10% % of electric power sourced from green electric power 15% 16% 16% % of electric power sourced from direct PPA 0% 1% 1% % of electric power generated on-site 0% 0% 0% % of electric power from renewable energy 48% 28% 28% Data represents Scope 1 (direct) and Scope 2 (indirect from electricity) energy sources.
","('Energy_Management', 0.9796243906021118)","('Management_Of_Legal_And_Regulatory_Framework', 0.0025154503528028727)","('Air_Quality', 0.001664193463511765)","(['Operational Eco-Efficiency'], 0.9796243906021118)","('NON-ESG', 0.0025154503528028727)","('NON-ESG', 0.001664193463511765)"
Line 1511,"Category 14 Franchises — — — Not relevant  Category 15 Investments — — — Not relevant  Total Scope 3 emissions 3,552,2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goal: Reduce energy consumption by 25% by 2030 (from 2019 baseline, normalized to COPS)Current status: Reduced by 14%Energy Energy consumption (GJ) FY 2019 baseline FY 2020 FY Scope 1, absolute 2,269,013 2,250,019 2,358,Scope 2, absolute 4,264,033 4,227,975 4,388,Total energy, absolute 6,533,046 6,477,994 6,746,Total energy, normalized (GJ per $M COPS) 726 679 % reduction from baseline, normalized 6% 14% Renewable energy consumption (GJ) Green Electric Power Consumed 620,491 686,801 716,Renewable Energy Credits (RECs) purchased 1,430,286 459,715 434,Renewable Energy Offsite – Direct (Physical) power purchase  agreements (PPA) — 50,345 61,Renewable Power – on-site 5,457 5,294 10,Total Renewable Energy 2,056,234 1,202,156 1,222,369Renewables as % of electric power consumption FY 2019 baseline FY 2020 FY Electric power consumption (GJ) 4,264,033 4,218,194 4,374,787  % of electric power via REC purchases 34% 11% 10% % of electric power sourced from green electric power 15% 16% 16% % of electric power sourced from direct PPA 0% 1% 1% % of electric power generated on-site 0% 0% 0% % of electric power from renewable energy 48% 28% 28% Data represents Scope 1 (direct) and Scope 2 (indirect from electricity) energy sources.
","('Energy_Management', 0.9768561720848083)","('Management_Of_Legal_And_Regulatory_Framework', 0.0024969815276563168)","('Critical_Incident_Risk_Management', 0.0021235141903162003)","(['Operational Eco-Efficiency'], 0.9768561720848083)","('NON-ESG', 0.0024969815276563168)","('NON-ESG', 0.0021235141903162003)"
Line 1512,"Breakdown of energy sources can be found in our annual CDP submission.Reduction in percentage of electric power from renewable energy is due to the shift from our reliance on unbundled RECs to a focused reliance on on-site solar  and sourcing of renewable energy sources.
","('Energy_Management', 0.980630099773407)","('Management_Of_Legal_And_Regulatory_Framework', 0.0021210890263319016)","('Critical_Incident_Risk_Management', 0.0016413278644904494)","(['Operational Eco-Efficiency'], 0.980630099773407)","('NON-ESG', 0.0021210890263319016)","('NON-ESG', 0.0016413278644904494)"
Line 1513,"We continue to purchase a certain amount of RECs in the U.S., as part of long-term contracts.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3744031488895416)","('Competitive_Behavior', 0.31396546959877014)","('Systemic_Risk_Management', 0.04206022620201111)","('NON-ESG', 0.3744031488895416)","('NON-ESG', 0.31396546959877014)","('NON-ESG', 0.04206022620201111)"
Line 1514,"These RECs are used to offset a portion of electrical power usage at our manufacturing facilities.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goal: Reduce water consumption by 40% by 2030 (from 2019 baseline, normalized to COPS)Current status: Reduced by 23%Water Water consumption (m3) FY 2019 baseline FY 2020 FY Water – purchased from local utility 4,673,866 4,077,574 4,270,Water – groundwater 285,019 305,910 292,Water – rainwater 1,629 777 Water – recycled 3,174 3,850 3,Water – surface water 129,714 154,073 166,Total water use 5,093,402 4,532,183 4,734,Total water use, normalized (cubic meters per $M COPS) 566 475 438  % reduction from baseline, normalized 16% 23%Wastewater disposal (m3) FY 2019 baseline FY 2020 FY Total wastewater disposed 4,603,955 4,235,640 3,943,Total wastewater disposed, normalized (cubic meters per $M COPS) 511 443 % wastewater discharged 90% 93% 83%2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goals: Current status: Reduce nonhazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS) Reduced by 16% Increase landfill diversion to 90% by 2030 (from 2019 baseline, absolute) Diversion rate of 79% Increase recycling to 80% by 2030 (from 2019 baseline, absolute) Recycling rate of 63% Reduce hazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS) Reduced by 6%Waste Nonhazardous waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste generated 67,462 71,564 68,Total nonhazardous waste generated, normalized   (metric tonnes per $M COPS) 7.49 7.50 6.% reduction from baseline, normalized 0% 16% Waste diverted from landfill (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste disposed via landfill 15,695 14,562 14,% nonhazardous waste diverted from landfill 77% 80% 79% Waste recycled (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste recycled 41,852 44,422 42,% nonhazardous waste recycled 62% 62% 63% Waste disposed of via incineration (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste disposed via incineration 9,915 12,580 10,% nonhazardous waste incinerated 15% 18% 16%Hazardous waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total hazardous waste generated 2,686 2,962 3,Total hazardous waste generated, normalized (metric tonnes per $M COPS) 0.30 0.31 0.% reduction from baseline, normalized 4% (increase) 6% Regulated (biohazardous and controlled) waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total regulated waste generated 1,321 1,559 1,Total regulated waste generated, normalized (metric tonnes per $M COPS) 0.15 0.16 0.% reduction from baseline, normalized 11% (increase) 27%2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities BD EHS Corporate standards define categories of waste as follows.
","('Water_And_Wastewater_Management', 0.9714084267616272)","('Energy_Management', 0.004808767698705196)","('GHG_Emissions', 0.002537240507081151)","(['Operational Eco-Efficiency'], 0.9714084267616272)","('NON-ESG', 0.004808767698705196)","('NON-ESG', 0.002537240507081151)"
Line 1515,"These RECs are used to offset a portion of electrical power usage at our manufacturing facilities.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goal: Reduce water consumption by 40% by 2030 (from 2019 baseline, normalized to COPS)Current status: Reduced by 23%Water Water consumption (m3) FY 2019 baseline FY 2020 FY Water – purchased from local utility 4,673,866 4,077,574 4,270,Water – groundwater 285,019 305,910 292,Water – rainwater 1,629 777 Water – recycled 3,174 3,850 3,Water – surface water 129,714 154,073 166,Total water use 5,093,402 4,532,183 4,734,Total water use, normalized (cubic meters per $M COPS) 566 475 438  % reduction from baseline, normalized 16% 23%Wastewater disposal (m3) FY 2019 baseline FY 2020 FY Total wastewater disposed 4,603,955 4,235,640 3,943,Total wastewater disposed, normalized (cubic meters per $M COPS) 511 443 % wastewater discharged 90% 93% 83%2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goals: Current status: Reduce nonhazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS) Reduced by 16% Increase landfill diversion to 90% by 2030 (from 2019 baseline, absolute) Diversion rate of 79% Increase recycling to 80% by 2030 (from 2019 baseline, absolute) Recycling rate of 63% Reduce hazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS) Reduced by 6%Waste Nonhazardous waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste generated 67,462 71,564 68,Total nonhazardous waste generated, normalized   (metric tonnes per $M COPS) 7.49 7.50 6.% reduction from baseline, normalized 0% 16% Waste diverted from landfill (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste disposed via landfill 15,695 14,562 14,% nonhazardous waste diverted from landfill 77% 80% 79% Waste recycled (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste recycled 41,852 44,422 42,% nonhazardous waste recycled 62% 62% 63% Waste disposed of via incineration (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste disposed via incineration 9,915 12,580 10,% nonhazardous waste incinerated 15% 18% 16%Hazardous waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total hazardous waste generated 2,686 2,962 3,Total hazardous waste generated, normalized (metric tonnes per $M COPS) 0.30 0.31 0.% reduction from baseline, normalized 4% (increase) 6% Regulated (biohazardous and controlled) waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total regulated waste generated 1,321 1,559 1,Total regulated waste generated, normalized (metric tonnes per $M COPS) 0.15 0.16 0.% reduction from baseline, normalized 11% (increase) 27%2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities BD EHS Corporate standards define categories of waste as follows.
","('Water_And_Wastewater_Management', 0.9663636684417725)","('Waste_And_Hazardous_Materials_Management', 0.007786009460687637)","('GHG_Emissions', 0.0019157415954396129)","(['Operational Eco-Efficiency'], 0.9663636684417725)","('NON-ESG', 0.007786009460687637)","('NON-ESG', 0.0019157415954396129)"
Line 1516,"These RECs are used to offset a portion of electrical power usage at our manufacturing facilities.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goal: Reduce water consumption by 40% by 2030 (from 2019 baseline, normalized to COPS)Current status: Reduced by 23%Water Water consumption (m3) FY 2019 baseline FY 2020 FY Water – purchased from local utility 4,673,866 4,077,574 4,270,Water – groundwater 285,019 305,910 292,Water – rainwater 1,629 777 Water – recycled 3,174 3,850 3,Water – surface water 129,714 154,073 166,Total water use 5,093,402 4,532,183 4,734,Total water use, normalized (cubic meters per $M COPS) 566 475 438  % reduction from baseline, normalized 16% 23%Wastewater disposal (m3) FY 2019 baseline FY 2020 FY Total wastewater disposed 4,603,955 4,235,640 3,943,Total wastewater disposed, normalized (cubic meters per $M COPS) 511 443 % wastewater discharged 90% 93% 83%2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goals: Current status: Reduce nonhazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS) Reduced by 16% Increase landfill diversion to 90% by 2030 (from 2019 baseline, absolute) Diversion rate of 79% Increase recycling to 80% by 2030 (from 2019 baseline, absolute) Recycling rate of 63% Reduce hazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS) Reduced by 6%Waste Nonhazardous waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste generated 67,462 71,564 68,Total nonhazardous waste generated, normalized   (metric tonnes per $M COPS) 7.49 7.50 6.% reduction from baseline, normalized 0% 16% Waste diverted from landfill (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste disposed via landfill 15,695 14,562 14,% nonhazardous waste diverted from landfill 77% 80% 79% Waste recycled (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste recycled 41,852 44,422 42,% nonhazardous waste recycled 62% 62% 63% Waste disposed of via incineration (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste disposed via incineration 9,915 12,580 10,% nonhazardous waste incinerated 15% 18% 16%Hazardous waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total hazardous waste generated 2,686 2,962 3,Total hazardous waste generated, normalized (metric tonnes per $M COPS) 0.30 0.31 0.% reduction from baseline, normalized 4% (increase) 6% Regulated (biohazardous and controlled) waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total regulated waste generated 1,321 1,559 1,Total regulated waste generated, normalized (metric tonnes per $M COPS) 0.15 0.16 0.% reduction from baseline, normalized 11% (increase) 27%2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities BD EHS Corporate standards define categories of waste as follows.
","('Waste_And_Hazardous_Materials_Management', 0.9799913167953491)","('Product_Design_And_Lifecycle_Management', 0.0020297467708587646)","('Water_And_Wastewater_Management', 0.0017825474496930838)","(['Operational Eco-Efficiency'], 0.9799913167953491)","('NON-ESG', 0.0020297467708587646)","('NON-ESG', 0.0017825474496930838)"
Line 1517,"These RECs are used to offset a portion of electrical power usage at our manufacturing facilities.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goal: Reduce water consumption by 40% by 2030 (from 2019 baseline, normalized to COPS)Current status: Reduced by 23%Water Water consumption (m3) FY 2019 baseline FY 2020 FY Water – purchased from local utility 4,673,866 4,077,574 4,270,Water – groundwater 285,019 305,910 292,Water – rainwater 1,629 777 Water – recycled 3,174 3,850 3,Water – surface water 129,714 154,073 166,Total water use 5,093,402 4,532,183 4,734,Total water use, normalized (cubic meters per $M COPS) 566 475 438  % reduction from baseline, normalized 16% 23%Wastewater disposal (m3) FY 2019 baseline FY 2020 FY Total wastewater disposed 4,603,955 4,235,640 3,943,Total wastewater disposed, normalized (cubic meters per $M COPS) 511 443 % wastewater discharged 90% 93% 83%2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goals: Current status: Reduce nonhazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS) Reduced by 16% Increase landfill diversion to 90% by 2030 (from 2019 baseline, absolute) Diversion rate of 79% Increase recycling to 80% by 2030 (from 2019 baseline, absolute) Recycling rate of 63% Reduce hazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS) Reduced by 6%Waste Nonhazardous waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste generated 67,462 71,564 68,Total nonhazardous waste generated, normalized   (metric tonnes per $M COPS) 7.49 7.50 6.% reduction from baseline, normalized 0% 16% Waste diverted from landfill (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste disposed via landfill 15,695 14,562 14,% nonhazardous waste diverted from landfill 77% 80% 79% Waste recycled (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste recycled 41,852 44,422 42,% nonhazardous waste recycled 62% 62% 63% Waste disposed of via incineration (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste disposed via incineration 9,915 12,580 10,% nonhazardous waste incinerated 15% 18% 16%Hazardous waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total hazardous waste generated 2,686 2,962 3,Total hazardous waste generated, normalized (metric tonnes per $M COPS) 0.30 0.31 0.% reduction from baseline, normalized 4% (increase) 6% Regulated (biohazardous and controlled) waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total regulated waste generated 1,321 1,559 1,Total regulated waste generated, normalized (metric tonnes per $M COPS) 0.15 0.16 0.% reduction from baseline, normalized 11% (increase) 27%2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities BD EHS Corporate standards define categories of waste as follows.
","('Waste_And_Hazardous_Materials_Management', 0.9836727976799011)","('Water_And_Wastewater_Management', 0.0016563439276069403)","('Data_Security', 0.0013512098230421543)","(['Operational Eco-Efficiency'], 0.9836727976799011)","('NON-ESG', 0.0016563439276069403)","('NON-ESG', 0.0013512098230421543)"
Line 1518,"These RECs are used to offset a portion of electrical power usage at our manufacturing facilities.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goal: Reduce water consumption by 40% by 2030 (from 2019 baseline, normalized to COPS)Current status: Reduced by 23%Water Water consumption (m3) FY 2019 baseline FY 2020 FY Water – purchased from local utility 4,673,866 4,077,574 4,270,Water – groundwater 285,019 305,910 292,Water – rainwater 1,629 777 Water – recycled 3,174 3,850 3,Water – surface water 129,714 154,073 166,Total water use 5,093,402 4,532,183 4,734,Total water use, normalized (cubic meters per $M COPS) 566 475 438  % reduction from baseline, normalized 16% 23%Wastewater disposal (m3) FY 2019 baseline FY 2020 FY Total wastewater disposed 4,603,955 4,235,640 3,943,Total wastewater disposed, normalized (cubic meters per $M COPS) 511 443 % wastewater discharged 90% 93% 83%2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goals: Current status: Reduce nonhazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS) Reduced by 16% Increase landfill diversion to 90% by 2030 (from 2019 baseline, absolute) Diversion rate of 79% Increase recycling to 80% by 2030 (from 2019 baseline, absolute) Recycling rate of 63% Reduce hazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS) Reduced by 6%Waste Nonhazardous waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste generated 67,462 71,564 68,Total nonhazardous waste generated, normalized   (metric tonnes per $M COPS) 7.49 7.50 6.% reduction from baseline, normalized 0% 16% Waste diverted from landfill (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste disposed via landfill 15,695 14,562 14,% nonhazardous waste diverted from landfill 77% 80% 79% Waste recycled (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste recycled 41,852 44,422 42,% nonhazardous waste recycled 62% 62% 63% Waste disposed of via incineration (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste disposed via incineration 9,915 12,580 10,% nonhazardous waste incinerated 15% 18% 16%Hazardous waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total hazardous waste generated 2,686 2,962 3,Total hazardous waste generated, normalized (metric tonnes per $M COPS) 0.30 0.31 0.% reduction from baseline, normalized 4% (increase) 6% Regulated (biohazardous and controlled) waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total regulated waste generated 1,321 1,559 1,Total regulated waste generated, normalized (metric tonnes per $M COPS) 0.15 0.16 0.% reduction from baseline, normalized 11% (increase) 27%2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities BD EHS Corporate standards define categories of waste as follows.
","('Waste_And_Hazardous_Materials_Management', 0.9846872687339783)","('Data_Security', 0.0012109994422644377)","('Water_And_Wastewater_Management', 0.00115942710544914)","(['Operational Eco-Efficiency'], 0.9846872687339783)","('NON-ESG', 0.0012109994422644377)","('NON-ESG', 0.00115942710544914)"
Line 1519,"These RECs are used to offset a portion of electrical power usage at our manufacturing facilities.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goal: Reduce water consumption by 40% by 2030 (from 2019 baseline, normalized to COPS)Current status: Reduced by 23%Water Water consumption (m3) FY 2019 baseline FY 2020 FY Water – purchased from local utility 4,673,866 4,077,574 4,270,Water – groundwater 285,019 305,910 292,Water – rainwater 1,629 777 Water – recycled 3,174 3,850 3,Water – surface water 129,714 154,073 166,Total water use 5,093,402 4,532,183 4,734,Total water use, normalized (cubic meters per $M COPS) 566 475 438  % reduction from baseline, normalized 16% 23%Wastewater disposal (m3) FY 2019 baseline FY 2020 FY Total wastewater disposed 4,603,955 4,235,640 3,943,Total wastewater disposed, normalized (cubic meters per $M COPS) 511 443 % wastewater discharged 90% 93% 83%2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goals: Current status: Reduce nonhazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS) Reduced by 16% Increase landfill diversion to 90% by 2030 (from 2019 baseline, absolute) Diversion rate of 79% Increase recycling to 80% by 2030 (from 2019 baseline, absolute) Recycling rate of 63% Reduce hazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS) Reduced by 6%Waste Nonhazardous waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste generated 67,462 71,564 68,Total nonhazardous waste generated, normalized   (metric tonnes per $M COPS) 7.49 7.50 6.% reduction from baseline, normalized 0% 16% Waste diverted from landfill (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste disposed via landfill 15,695 14,562 14,% nonhazardous waste diverted from landfill 77% 80% 79% Waste recycled (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste recycled 41,852 44,422 42,% nonhazardous waste recycled 62% 62% 63% Waste disposed of via incineration (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste disposed via incineration 9,915 12,580 10,% nonhazardous waste incinerated 15% 18% 16%Hazardous waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total hazardous waste generated 2,686 2,962 3,Total hazardous waste generated, normalized (metric tonnes per $M COPS) 0.30 0.31 0.% reduction from baseline, normalized 4% (increase) 6% Regulated (biohazardous and controlled) waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total regulated waste generated 1,321 1,559 1,Total regulated waste generated, normalized (metric tonnes per $M COPS) 0.15 0.16 0.% reduction from baseline, normalized 11% (increase) 27%2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities BD EHS Corporate standards define categories of waste as follows.
","('Waste_And_Hazardous_Materials_Management', 0.9843758940696716)","('Water_And_Wastewater_Management', 0.0013834708370268345)","('Data_Security', 0.001139304367825389)","(['Operational Eco-Efficiency'], 0.9843758940696716)","('NON-ESG', 0.0013834708370268345)","('NON-ESG', 0.001139304367825389)"
Line 1520,"These RECs are used to offset a portion of electrical power usage at our manufacturing facilities.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goal: Reduce water consumption by 40% by 2030 (from 2019 baseline, normalized to COPS)Current status: Reduced by 23%Water Water consumption (m3) FY 2019 baseline FY 2020 FY Water – purchased from local utility 4,673,866 4,077,574 4,270,Water – groundwater 285,019 305,910 292,Water – rainwater 1,629 777 Water – recycled 3,174 3,850 3,Water – surface water 129,714 154,073 166,Total water use 5,093,402 4,532,183 4,734,Total water use, normalized (cubic meters per $M COPS) 566 475 438  % reduction from baseline, normalized 16% 23%Wastewater disposal (m3) FY 2019 baseline FY 2020 FY Total wastewater disposed 4,603,955 4,235,640 3,943,Total wastewater disposed, normalized (cubic meters per $M COPS) 511 443 % wastewater discharged 90% 93% 83%2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goals: Current status: Reduce nonhazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS) Reduced by 16% Increase landfill diversion to 90% by 2030 (from 2019 baseline, absolute) Diversion rate of 79% Increase recycling to 80% by 2030 (from 2019 baseline, absolute) Recycling rate of 63% Reduce hazardous waste by 50% by 2030 (from 2019 baseline, normalized to COPS) Reduced by 6%Waste Nonhazardous waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste generated 67,462 71,564 68,Total nonhazardous waste generated, normalized   (metric tonnes per $M COPS) 7.49 7.50 6.% reduction from baseline, normalized 0% 16% Waste diverted from landfill (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste disposed via landfill 15,695 14,562 14,% nonhazardous waste diverted from landfill 77% 80% 79% Waste recycled (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste recycled 41,852 44,422 42,% nonhazardous waste recycled 62% 62% 63% Waste disposed of via incineration (metric tonnes) FY 2019 baseline FY 2020 FY Total nonhazardous waste disposed via incineration 9,915 12,580 10,% nonhazardous waste incinerated 15% 18% 16%Hazardous waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total hazardous waste generated 2,686 2,962 3,Total hazardous waste generated, normalized (metric tonnes per $M COPS) 0.30 0.31 0.% reduction from baseline, normalized 4% (increase) 6% Regulated (biohazardous and controlled) waste generated (metric tonnes) FY 2019 baseline FY 2020 FY Total regulated waste generated 1,321 1,559 1,Total regulated waste generated, normalized (metric tonnes per $M COPS) 0.15 0.16 0.% reduction from baseline, normalized 11% (increase) 27%2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities BD EHS Corporate standards define categories of waste as follows.
","('Competitive_Behavior', 0.12259964644908905)","('Business_Ethics', 0.0945313572883606)","('Data_Security', 0.08243986964225769)","('NON-ESG', 0.12259964644908905)","('NON-ESG', 0.0945313572883606)","('NON-ESG', 0.08243986964225769)"
Line 1521,"Nonhazardous waste – Any garbage, refuse, solid, liquid, semi-solid or contained gaseous substance, object or material that  is not harmful to humans or the environment that is discarded, inherently waste-like, disposed of or intended to be recycled.
","('Waste_And_Hazardous_Materials_Management', 0.9838404059410095)","('Water_And_Wastewater_Management', 0.001224371138960123)","('Data_Security', 0.0011547954054549336)","(['Operational Eco-Efficiency'], 0.9838404059410095)","('NON-ESG', 0.001224371138960123)","('NON-ESG', 0.0011547954054549336)"
Line 1522,"Hazardous Waste – Any solid, liquid, semi-solid or contained gaseous substance, object or material that is harmful to humans  or the environment that is abandoned, discarded, inherently waste-like, disposed of or intended to be disposed of.
","('Waste_And_Hazardous_Materials_Management', 0.9843828082084656)","('Data_Security', 0.0011618452845141292)","('Water_And_Wastewater_Management', 0.0011366783874109387)","(['Operational Eco-Efficiency'], 0.9843828082084656)","('NON-ESG', 0.0011618452845141292)","('NON-ESG', 0.0011366783874109387)"
Line 1523,"Regulated Medical Waste (RMW) – Wastes that are regulated by specific federal (national), state and local guidelines and  regulations which specify the categories of biohazardous waste that are subject to regulation and outline the requirements  associated with treatment and disposal.
","('Waste_And_Hazardous_Materials_Management', 0.9847431182861328)","('Data_Security', 0.0012563677737489343)","('Water_And_Wastewater_Management', 0.0012485615443438292)","(['Operational Eco-Efficiency'], 0.9847431182861328)","('NON-ESG', 0.0012563677737489343)","('NON-ESG', 0.0012485615443438292)"
Line 1524,"Biohazardous Waste – Sometimes called medical waste, refers to waste that has the risk of carrying infectious diseases.
","('Waste_And_Hazardous_Materials_Management', 0.983864426612854)","('Data_Security', 0.001411822042427957)","('Water_And_Wastewater_Management', 0.0011818887433037162)","(['Operational Eco-Efficiency'], 0.983864426612854)","('NON-ESG', 0.001411822042427957)","('NON-ESG', 0.0011818887433037162)"
Line 1525,"Biohazardous waste may include, but is not limited to these broad categories:  •  c ultures and stocks of infectious agents and associated biologicals – specimens from medical and pathology laboratories;  cultures and stocks of infectious agents from clinical, research and industrial laboratories; disposable culture dishes  and devices used to transfer, inoculate and mix cultures; waste from the production of biologicals; discarded live and attenuated vaccines •  human blood and blood pr oducts – waste blood, serum, plasma and blood products •  pathologic al waste – tissue, organs, body parts, blood and body fluid •  sharps – c ontaminated hypodermic needles, syringes, scalpel blades, Pasteur pipettes and broken glass •  c ontaminated animal carcasses, body parts and bedding – contaminated animal carcasses, body parts and bedding of  animals that were intentionally exposed to pathogens •  misc ellaneous laboratory waste – contaminated specimen containers, slides, cover slips, disposable gloves, lab coats, aprons,  towels, padding, equipment and tubing Controlled Waste – A waste that requires special handling due to its physical, chemical or biological characteristics or  local regulations.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goals: Current status: Reduce VOCs and HAPs by 30% by 2030 (from 2019  baseline, normalized to COPS)Reduced by 32% Reduce ozone-depleting substances (ODSs) by 50% by   2030 (from 2019 baseline, normalized to COPS)Reduced by 87% As part of ongoing programs, we have achieved further reductions in ODS emissions at our BD Medical manufacturing facilities.
","('Waste_And_Hazardous_Materials_Management', 0.9842736721038818)","('Water_And_Wastewater_Management', 0.0014913491904735565)","('Data_Security', 0.001138318912126124)","(['Operational Eco-Efficiency'], 0.9842736721038818)","('NON-ESG', 0.0014913491904735565)","('NON-ESG', 0.001138318912126124)"
Line 1526,"Biohazardous waste may include, but is not limited to these broad categories:  •  c ultures and stocks of infectious agents and associated biologicals – specimens from medical and pathology laboratories;  cultures and stocks of infectious agents from clinical, research and industrial laboratories; disposable culture dishes  and devices used to transfer, inoculate and mix cultures; waste from the production of biologicals; discarded live and attenuated vaccines •  human blood and blood pr oducts – waste blood, serum, plasma and blood products •  pathologic al waste – tissue, organs, body parts, blood and body fluid •  sharps – c ontaminated hypodermic needles, syringes, scalpel blades, Pasteur pipettes and broken glass •  c ontaminated animal carcasses, body parts and bedding – contaminated animal carcasses, body parts and bedding of  animals that were intentionally exposed to pathogens •  misc ellaneous laboratory waste – contaminated specimen containers, slides, cover slips, disposable gloves, lab coats, aprons,  towels, padding, equipment and tubing Controlled Waste – A waste that requires special handling due to its physical, chemical or biological characteristics or  local regulations.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goals: Current status: Reduce VOCs and HAPs by 30% by 2030 (from 2019  baseline, normalized to COPS)Reduced by 32% Reduce ozone-depleting substances (ODSs) by 50% by   2030 (from 2019 baseline, normalized to COPS)Reduced by 87% As part of ongoing programs, we have achieved further reductions in ODS emissions at our BD Medical manufacturing facilities.
","('Waste_And_Hazardous_Materials_Management', 0.973609209060669)","('Employee_Health_And_Safety', 0.0026500229723751545)","('Selling_Practices_And_Product_Labeling', 0.0021063757594674826)","(['Operational Eco-Efficiency'], 0.973609209060669)","('NON-ESG', 0.0026500229723751545)","('NON-ESG', 0.0021063757594674826)"
Line 1527,"Biohazardous waste may include, but is not limited to these broad categories:  •  c ultures and stocks of infectious agents and associated biologicals – specimens from medical and pathology laboratories;  cultures and stocks of infectious agents from clinical, research and industrial laboratories; disposable culture dishes  and devices used to transfer, inoculate and mix cultures; waste from the production of biologicals; discarded live and attenuated vaccines •  human blood and blood pr oducts – waste blood, serum, plasma and blood products •  pathologic al waste – tissue, organs, body parts, blood and body fluid •  sharps – c ontaminated hypodermic needles, syringes, scalpel blades, Pasteur pipettes and broken glass •  c ontaminated animal carcasses, body parts and bedding – contaminated animal carcasses, body parts and bedding of  animals that were intentionally exposed to pathogens •  misc ellaneous laboratory waste – contaminated specimen containers, slides, cover slips, disposable gloves, lab coats, aprons,  towels, padding, equipment and tubing Controlled Waste – A waste that requires special handling due to its physical, chemical or biological characteristics or  local regulations.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goals: Current status: Reduce VOCs and HAPs by 30% by 2030 (from 2019  baseline, normalized to COPS)Reduced by 32% Reduce ozone-depleting substances (ODSs) by 50% by   2030 (from 2019 baseline, normalized to COPS)Reduced by 87% As part of ongoing programs, we have achieved further reductions in ODS emissions at our BD Medical manufacturing facilities.
","('Waste_And_Hazardous_Materials_Management', 0.9826618432998657)","('Product_Design_And_Lifecycle_Management', 0.0014358155895024538)","('Water_And_Wastewater_Management', 0.0013694481458514929)","(['Operational Eco-Efficiency'], 0.9826618432998657)","('NON-ESG', 0.0014358155895024538)","('NON-ESG', 0.0013694481458514929)"
Line 1528,"Biohazardous waste may include, but is not limited to these broad categories:  •  c ultures and stocks of infectious agents and associated biologicals – specimens from medical and pathology laboratories;  cultures and stocks of infectious agents from clinical, research and industrial laboratories; disposable culture dishes  and devices used to transfer, inoculate and mix cultures; waste from the production of biologicals; discarded live and attenuated vaccines •  human blood and blood pr oducts – waste blood, serum, plasma and blood products •  pathologic al waste – tissue, organs, body parts, blood and body fluid •  sharps – c ontaminated hypodermic needles, syringes, scalpel blades, Pasteur pipettes and broken glass •  c ontaminated animal carcasses, body parts and bedding – contaminated animal carcasses, body parts and bedding of  animals that were intentionally exposed to pathogens •  misc ellaneous laboratory waste – contaminated specimen containers, slides, cover slips, disposable gloves, lab coats, aprons,  towels, padding, equipment and tubing Controlled Waste – A waste that requires special handling due to its physical, chemical or biological characteristics or  local regulations.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities 2030+ goals: Current status: Reduce VOCs and HAPs by 30% by 2030 (from 2019  baseline, normalized to COPS)Reduced by 32% Reduce ozone-depleting substances (ODSs) by 50% by   2030 (from 2019 baseline, normalized to COPS)Reduced by 87% As part of ongoing programs, we have achieved further reductions in ODS emissions at our BD Medical manufacturing facilities.
","('Air_Quality', 0.7567460536956787)","('GHG_Emissions', 0.11214803159236908)","('Energy_Management', 0.04870446398854256)","(['Operational Eco-Efficiency'], 0.7567460536956787)","('NON-ESG', 0.11214803159236908)","('NON-ESG', 0.04870446398854256)"
Line 1529,"A large proportion of the reduction was made in FY 2019 and FY 2020 through elimination projects at one of our manufacturing facilities.
","('Product_Design_And_Lifecycle_Management', 0.5062902569770813)","('Energy_Management', 0.11905042827129364)","('Supply_Chain_Management', 0.10949910432100296)","(['Product Stewardship'], 0.5062902569770813)","('NON-ESG', 0.11905042827129364)","('NON-ESG', 0.10949910432100296)"
Line 1530,"Two additional manufacturing facilities  accounted for a significant proportion of the reduction in FY 2021.
","('Supply_Chain_Management', 0.4974988102912903)","('Product_Design_And_Lifecycle_Management', 0.17582102119922638)","('Energy_Management', 0.0706937238574028)","('NON-ESG', 0.4974988102912903)","('NON-ESG', 0.17582102119922638)","('NON-ESG', 0.0706937238574028)"
Line 1531,"Eliminate use of R22 by 2030 (absolute) R22 refrigerant (also known as R22 freon and HCFC-22 freon) is a chemical used in both air conditioners and heat pumps.
","('Air_Quality', 0.6678518056869507)","('Energy_Management', 0.2045411765575409)","('Water_And_Wastewater_Management', 0.015454121865332127)","(['Operational Eco-Efficiency'], 0.6678518056869507)","('NON-ESG', 0.2045411765575409)","('NON-ESG', 0.015454121865332127)"
Line 1532,"It has a harmful impact on the ozone layer when released into the air and therefore has subsequently been banned from manufacture or import in many jurisdictions where BD operates.
","('Air_Quality', 0.42506876587867737)","('Waste_And_Hazardous_Materials_Management', 0.15454325079917908)","('GHG_Emissions', 0.11755001544952393)","('NON-ESG', 0.42506876587867737)","('NON-ESG', 0.15454325079917908)","('NON-ESG', 0.11755001544952393)"
Line 1533,"Throughout FY 2021 and FY 2022, we are carrying out an audit of all our locations worldwide in order to capture the number and type of R22 units in use.
","('Product_Design_And_Lifecycle_Management', 0.24013324081897736)","('Product_Quality_And_Safety', 0.11474987119436264)","('Supply_Chain_Management', 0.09649571776390076)","('NON-ESG', 0.24013324081897736)","('NON-ESG', 0.11474987119436264)","('NON-ESG', 0.09649571776390076)"
Line 1534,"For sites with multiple  R22 units, we are working with external partners to conduct these studies.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3313017189502716)","('GHG_Emissions', 0.13267722725868225)","('Access_And_Affordability', 0.11491214483976364)","('NON-ESG', 0.3313017189502716)","('NON-ESG', 0.13267722725868225)","('NON-ESG', 0.11491214483976364)"
Line 1535,"Using our “Replace with a Purpose” approach, site-level plans will be developed that focus on compliance, reliability, redundancy and long-term capacity while optimizing  efficiency.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3255263566970825)","('Energy_Management', 0.197828009724617)","('Business_Model_Resilience', 0.1316954344511032)","('NON-ESG', 0.3255263566970825)","('NON-ESG', 0.197828009724617)","('NON-ESG', 0.1316954344511032)"
Line 1536,"By avoiding like-for-like replacements, our Replace with a Purpose approach will ensure that the long-term needs of our sites are met.Air FY 2019 baseline FY 2020 FY Total VOCs emitted 356 408 Total VOCs emitted, normalized (metric tonnes per $M COPS) 0.04 0.04 0.Total HAPs emitted 106 82 Total HAPs emitted normalized (metric tonnes per $M COPS) 0.01 0.01 0.Total VOCs + HAP emitted 463 490 Total VOCs + HAP emitted, normalized (metric tonnes per $M COPS) 0.051 0.051 0.% reduction from baseline, normalized 0% 32% VOCs – volatile organic compounds HAPs – hazardous air pollutantsFY 2019 baseline FY 2020 FY Total ODS emitted 104 26 Total ODS emitted, normalized (metric tonnes per $M COPS) 0.011 0.003 0.% reduction from baseline, normalized 77% 87% ODS – ozone depleting substances2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Diversity Gender breakdown of Board of Directors and Executive Officers *Information regarding Board of Directors, Executive Officers and Officers is current as of April 26, 2022.
","('GHG_Emissions', 0.437531054019928)","('Air_Quality', 0.20761309564113617)","('Energy_Management', 0.1216331347823143)","('NON-ESG', 0.437531054019928)","('NON-ESG', 0.20761309564113617)","('NON-ESG', 0.1216331347823143)"
Line 1537,"By avoiding like-for-like replacements, our Replace with a Purpose approach will ensure that the long-term needs of our sites are met.Air FY 2019 baseline FY 2020 FY Total VOCs emitted 356 408 Total VOCs emitted, normalized (metric tonnes per $M COPS) 0.04 0.04 0.Total HAPs emitted 106 82 Total HAPs emitted normalized (metric tonnes per $M COPS) 0.01 0.01 0.Total VOCs + HAP emitted 463 490 Total VOCs + HAP emitted, normalized (metric tonnes per $M COPS) 0.051 0.051 0.% reduction from baseline, normalized 0% 32% VOCs – volatile organic compounds HAPs – hazardous air pollutantsFY 2019 baseline FY 2020 FY Total ODS emitted 104 26 Total ODS emitted, normalized (metric tonnes per $M COPS) 0.011 0.003 0.% reduction from baseline, normalized 77% 87% ODS – ozone depleting substances2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Diversity Gender breakdown of Board of Directors and Executive Officers *Information regarding Board of Directors, Executive Officers and Officers is current as of April 26, 2022.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8505393266677856)","('Business_Model_Resilience', 0.021238675341010094)","('Human_Rights_And_Community_Relations', 0.010766995139420033)","(['Human Capital Development'], 0.8505393266677856)","('NON-ESG', 0.021238675341010094)","('NON-ESG', 0.010766995139420033)"
Line 1538,"By avoiding like-for-like replacements, our Replace with a Purpose approach will ensure that the long-term needs of our sites are met.Air FY 2019 baseline FY 2020 FY Total VOCs emitted 356 408 Total VOCs emitted, normalized (metric tonnes per $M COPS) 0.04 0.04 0.Total HAPs emitted 106 82 Total HAPs emitted normalized (metric tonnes per $M COPS) 0.01 0.01 0.Total VOCs + HAP emitted 463 490 Total VOCs + HAP emitted, normalized (metric tonnes per $M COPS) 0.051 0.051 0.% reduction from baseline, normalized 0% 32% VOCs – volatile organic compounds HAPs – hazardous air pollutantsFY 2019 baseline FY 2020 FY Total ODS emitted 104 26 Total ODS emitted, normalized (metric tonnes per $M COPS) 0.011 0.003 0.% reduction from baseline, normalized 77% 87% ODS – ozone depleting substances2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Diversity Gender breakdown of Board of Directors and Executive Officers *Information regarding Board of Directors, Executive Officers and Officers is current as of April 26, 2022.
","('Director_Removal', 0.7547554969787598)","('Management_Of_Legal_And_Regulatory_Framework', 0.025555728003382683)","('Business_Ethics', 0.022784849628806114)","(['Anti-Crime Policy & Measures'], 0.7547554969787598)","('NON-ESG', 0.025555728003382683)","('NON-ESG', 0.022784849628806114)"
Line 1539,"**Total number of Officers includes Executive Officers Female Male Board of Directors 3 Executive Officers 1 Officers 5 Board of Directors, Ethnicity White Black or African American Hispanic, Latino or Spanish Origin Executives *We define “executives” as associates in positions of vice president and above.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9563115239143372)","('Director_Removal', 0.0043557919561862946)","('Business_Model_Resilience', 0.0030192385893315077)","(['Human Capital Development'], 0.9563115239143372)","('NON-ESG', 0.0043557919561862946)","('NON-ESG', 0.0030192385893315077)"
Line 1540,"**Information regarding race and gender is based on information provided by associates.***Ethnicity data reflects that of the U.S. workforce including Alaska and Hawaii, and Puerto Rico but excludes any other U.S. territories.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9677626490592957)","('Customer_Privacy', 0.0032417625188827515)","('Employee_Health_And_Safety', 0.002379833022132516)","(['Human Capital Development'], 0.9677626490592957)","('NON-ESG', 0.0032417625188827515)","('NON-ESG', 0.002379833022132516)"
Line 1541,"Gender, global FY 2019 FY 2020 FY Female 25% 27% 30% Male 75% 73% 70% Total number 354 364 Age, global FY2019 FY2020 FY0 – 34 0% 0% 0% 35 – 54 72% 70% 69% 55 + 28% 30% 31% Total number 354 364 381Ethnicity, U.S. FY 2019 FY 2020 FY Asian 10% 11% 11% Black or African American 3% 4% 4% Hispanic or Latino 4% 5% 5% Other 1% 1% 1% White 78% 75% 75% Unknown 3% 5% 5% Total 291 293 Management *“Management” positions are defined as those in manager, director or equivalent roles.**Information regarding race and gender is based on information provided by associates.***Ethnicity data reflects that of the U.S. workforce including Alaska and Hawaii, and Puerto Rico but excludes any other U.S. territories.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9685077667236328)","('Customer_Privacy', 0.002047198824584484)","('Employee_Health_And_Safety', 0.0020181844010949135)","(['Human Capital Development'], 0.9685077667236328)","('NON-ESG', 0.002047198824584484)","('NON-ESG', 0.0020181844010949135)"
Line 1542,"Gender, global FY 2019 FY 2020 FY Female 25% 27% 30% Male 75% 73% 70% Total number 354 364 Age, global FY2019 FY2020 FY0 – 34 0% 0% 0% 35 – 54 72% 70% 69% 55 + 28% 30% 31% Total number 354 364 381Ethnicity, U.S. FY 2019 FY 2020 FY Asian 10% 11% 11% Black or African American 3% 4% 4% Hispanic or Latino 4% 5% 5% Other 1% 1% 1% White 78% 75% 75% Unknown 3% 5% 5% Total 291 293 Management *“Management” positions are defined as those in manager, director or equivalent roles.**Information regarding race and gender is based on information provided by associates.***Ethnicity data reflects that of the U.S. workforce including Alaska and Hawaii, and Puerto Rico but excludes any other U.S. territories.
","('Employee_Engagement_Inclusion_And_Diversity', 0.956990659236908)","('Customer_Privacy', 0.00632284302264452)","('Employee_Health_And_Safety', 0.0029265161138027906)","(['Human Capital Development'], 0.956990659236908)","('NON-ESG', 0.00632284302264452)","('NON-ESG', 0.0029265161138027906)"
Line 1543,"Gender, global FY 2019 FY 2020 FY Female 39% 39% 40% Male 61% 61% 60% Total number 10,086 10,390 11,Age, global FY 2019 FY 2020 FY 0 – 34 11% 11% 11% 35 – 54 72% 72% 71% 55 + 17% 17% 18% Total number 10,086 10,390 11,Ethnicity, U.S. FY 2019 FY 2020 FY Asian 14% 14% 14% Black or African American 3% 4% 4% Hispanic or Latino 8% 8% 9% Other 2% 2% 2% White 69% 67% 66% Unknown 4% 5% 5% Total number 6,028 6,172 6,2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities All Associates *Workforce includes all associates, both management and nonmanagement.
","('Physical_Impacts_Of_Climate_Change', 0.5134913325309753)","('Supply_Chain_Management', 0.2990732789039612)","('Business_Model_Resilience', 0.03351610526442528)","(['Climate Change'], 0.5134913325309753)","('NON-ESG', 0.2990732789039612)","('NON-ESG', 0.03351610526442528)"
Line 1544,"Gender, global FY 2019 FY 2020 FY Female 39% 39% 40% Male 61% 61% 60% Total number 10,086 10,390 11,Age, global FY 2019 FY 2020 FY 0 – 34 11% 11% 11% 35 – 54 72% 72% 71% 55 + 17% 17% 18% Total number 10,086 10,390 11,Ethnicity, U.S. FY 2019 FY 2020 FY Asian 14% 14% 14% Black or African American 3% 4% 4% Hispanic or Latino 8% 8% 9% Other 2% 2% 2% White 69% 67% 66% Unknown 4% 5% 5% Total number 6,028 6,172 6,2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities All Associates *Workforce includes all associates, both management and nonmanagement.
","('Employee_Engagement_Inclusion_And_Diversity', 0.8842891454696655)","('Labor_Practices', 0.021864918991923332)","('Employee_Health_And_Safety', 0.01881866529583931)","(['Human Capital Development'], 0.8842891454696655)","('NON-ESG', 0.021864918991923332)","('NON-ESG', 0.01881866529583931)"
Line 1545,"**Information regarding race and gender is based on information provided by associates.***Ethnicity data reflects that of the U.S. workforce including Alaska and Hawaii, and Puerto Rico but excludes any other U.S. territories.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9677626490592957)","('Customer_Privacy', 0.0032417625188827515)","('Employee_Health_And_Safety', 0.002379833022132516)","(['Human Capital Development'], 0.9677626490592957)","('NON-ESG', 0.0032417625188827515)","('NON-ESG', 0.002379833022132516)"
Line 1546,"Gender, global FY 2019 FY 2020 FY Female 49% 49% 49% Male 50% 51% 51% Total 70,193 72,077 75,In FY 2019, gender was not disclosed for 1 percent of the data set.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9017320871353149)","('Labor_Practices', 0.012079610489308834)","('Customer_Privacy', 0.009951746091246605)","(['Human Capital Development'], 0.9017320871353149)","('NON-ESG', 0.012079610489308834)","('NON-ESG', 0.009951746091246605)"
Line 1547,"Age, global FY 2019 FY 2020 FY 0 – 34 38% 37% 38% 35 – 54 50% 50% 50% 55 + 12% 13% 13% Total 70,200 72,077 75,Ethnicity, U.S. FY 2019 FY 2020 FY Asian 11% 11% 11% Black or African American 9% 9% 9% Hispanic or Latino 16% 16% 16% Other 2% 2% 2% White 55% 53% 52% Unknown 8% 9% 10% Total 24,220 24,624 25,New-Hire rate *New-hire rate is calculated as the number of associates who started working for BD during the fiscal year, divided by the average headcount for the fiscal year.
","('Employee_Engagement_Inclusion_And_Diversity', 0.6944895386695862)","('Labor_Practices', 0.07236199826002121)","('Director_Removal', 0.0339396670460701)","(['Human Capital Development'], 0.6944895386695862)","('NON-ESG', 0.07236199826002121)","('NON-ESG', 0.0339396670460701)"
Line 1548,"Gender, global FY 2019 FY 2020 FY Female 31% 27% 29% Male 28% 26% 25% Age, global FY 2019 FY 2020 FY 0 – 34 56% 50% 52% 35 – 54 15% 13% 14% 55 + 7% 6% 6%Turnover rate * T urnover is calculated as the number of associates who exited during the fiscal year, both voluntarily and involuntarily, divided by the average headcount for  the fiscal year.
","('Systemic_Risk_Management', 0.19189469516277313)","('Employee_Engagement_Inclusion_And_Diversity', 0.1723785549402237)","('Director_Removal', 0.16370204091072083)","('NON-ESG', 0.19189469516277313)","('NON-ESG', 0.1723785549402237)","('NON-ESG', 0.16370204091072083)"
Line 1549,"Gender, global FY 2019 FY 2020 FY Female 26% 26% 25% Male 23% 23% 21% Age, global FY 2019 FY 2020 FY 0 – 34 41% 43% 40% 35 – 54 15% 13% 13% 55 + 14% 13% 13% Safety FY 2019 FY 2020 FY LTIFR (per 200,000 hours): 0.24 0.17 0.OIFR (per 200,000 hours): 0.00 0.00 0.IIR (per 200,000 hours): 0.51 0.42 0.Fatalities 0 0 Data includes associates in our manufacturing and supply chain operations only.
","('Supply_Chain_Management', 0.9218799471855164)","('Energy_Management', 0.006739824078977108)","('Labor_Practices', 0.006543416529893875)","(['Supply Chain Management'], 0.9218799471855164)","('NON-ESG', 0.006739824078977108)","('NON-ESG', 0.006543416529893875)"
Line 1550,"It does not include associates in office locations.
","('Director_Removal', 0.22310678660869598)","('Business_Ethics', 0.11681847274303436)","('Competitive_Behavior', 0.08856888115406036)","('NON-ESG', 0.22310678660869598)","('NON-ESG', 0.11681847274303436)","('NON-ESG', 0.08856888115406036)"
Line 1551,"LTIFR  – Lost time injury frequency rate OIFR – Occupational illness frequency rate IIR – Injury and illness rate2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI index GRI Disclosure Disclosure requirement Response or disclosure location 102-1 Name of the organization Becton, Dickinson and Company (BD) 102-2 Activities, brands, products and services About our business 2021 Form 10-K 102-3 Location of headquarters 1 Becton Drive, Franklin Lakes, NJ 07417 USA 102-4 Location of operations About our business 2021 Form 10-K 102-5 Ownership and legal form Publicly traded on the New York Stock Exchange as BDX 102-6 Markets served About our business2021 Form 10-K 102-7 Scale of the organization About BD2021 Form 10-K 102-8 Information on employees and other workers Healthy workforce and communities – Inclusion, diversity  and equity and data tables 102-9 Supply chain 2021 Form 10-K 102-10 Significant changes to the organization and  its supply chain2021 Form 10-K In May 2021, we announced our intention to spin off  our Diabetes Care business into a new independent, publicly traded company called embecta.
","('Employee_Health_And_Safety', 0.9831303358078003)","('Employee_Engagement_Inclusion_And_Diversity', 0.001528121531009674)","('Product_Design_And_Lifecycle_Management', 0.001405204995535314)","(['Operational Eco-Efficiency'], 0.9831303358078003)","('NON-ESG', 0.001528121531009674)","('NON-ESG', 0.001405204995535314)"
Line 1552,"LTIFR  – Lost time injury frequency rate OIFR – Occupational illness frequency rate IIR – Injury and illness rate2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI index GRI Disclosure Disclosure requirement Response or disclosure location 102-1 Name of the organization Becton, Dickinson and Company (BD) 102-2 Activities, brands, products and services About our business 2021 Form 10-K 102-3 Location of headquarters 1 Becton Drive, Franklin Lakes, NJ 07417 USA 102-4 Location of operations About our business 2021 Form 10-K 102-5 Ownership and legal form Publicly traded on the New York Stock Exchange as BDX 102-6 Markets served About our business2021 Form 10-K 102-7 Scale of the organization About BD2021 Form 10-K 102-8 Information on employees and other workers Healthy workforce and communities – Inclusion, diversity  and equity and data tables 102-9 Supply chain 2021 Form 10-K 102-10 Significant changes to the organization and  its supply chain2021 Form 10-K In May 2021, we announced our intention to spin off  our Diabetes Care business into a new independent, publicly traded company called embecta.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9482987523078918)","('Labor_Practices', 0.010050342418253422)","('Employee_Health_And_Safety', 0.006719517987221479)","(['Human Capital Development'], 0.9482987523078918)","('NON-ESG', 0.010050342418253422)","('NON-ESG', 0.006719517987221479)"
Line 1553,"LTIFR  – Lost time injury frequency rate OIFR – Occupational illness frequency rate IIR – Injury and illness rate2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI index GRI Disclosure Disclosure requirement Response or disclosure location 102-1 Name of the organization Becton, Dickinson and Company (BD) 102-2 Activities, brands, products and services About our business 2021 Form 10-K 102-3 Location of headquarters 1 Becton Drive, Franklin Lakes, NJ 07417 USA 102-4 Location of operations About our business 2021 Form 10-K 102-5 Ownership and legal form Publicly traded on the New York Stock Exchange as BDX 102-6 Markets served About our business2021 Form 10-K 102-7 Scale of the organization About BD2021 Form 10-K 102-8 Information on employees and other workers Healthy workforce and communities – Inclusion, diversity  and equity and data tables 102-9 Supply chain 2021 Form 10-K 102-10 Significant changes to the organization and  its supply chain2021 Form 10-K In May 2021, we announced our intention to spin off  our Diabetes Care business into a new independent, publicly traded company called embecta.
","('Supply_Chain_Management', 0.9528560042381287)","('Physical_Impacts_Of_Climate_Change', 0.00428954279050231)","('Product_Design_And_Lifecycle_Management', 0.003417929634451866)","(['Supply Chain Management'], 0.9528560042381287)","('NON-ESG', 0.00428954279050231)","('NON-ESG', 0.003417929634451866)"
Line 1554,"The spin-off was completed in April 2022.
","('Business_Model_Resilience', 0.31073474884033203)","('Management_Of_Legal_And_Regulatory_Framework', 0.1756291389465332)","('Physical_Impacts_Of_Climate_Change', 0.06870197504758835)","('NON-ESG', 0.31073474884033203)","('NON-ESG', 0.1756291389465332)","('NON-ESG', 0.06870197504758835)"
Line 1555,"102-11 Precautionary principle or approach Product impact – Management of materials of concern TCFD disclosures 102-12 External initiatives Alignment with the SDGsClimate change Product impact – Laboratory animal welfareTransparency – Human rights 102-13 Membership of associations Product impact – Strategic partnershipsProduct impact – Inspiring quality in industryGRI Disclosure Disclosure requirement Response or disclosure location 102-14 Statement from senior decision-maker To our stakeholders 102-15 Key impacts, risks and opportunities ESG IssuesTCFD disclosures 102-16 Values, principles, standards and norms of  behavior About BD  102-17 Mechanisms for advice and concerns about ethicsEthics and compliance BD Code of Conduct 102-18 Governance structure ESG strategy2022 Proxy Statement 102-19 Delegating authority ESG strategy2022 Proxy Statement 102-20 Executive-level responsibility for economic,  environmental, and social topics ESG strategy  102-21 Consulting stakeholders on economic, environmental and social topics Stakeholder engagement 102-22 Composition of the highest governance body and its committees 2022 Proxy Statement 102-23 Chair of the highest governance body Tom Polen is Chair of the Board and CEO of BD.
","('Product_Design_And_Lifecycle_Management', 0.9228443503379822)","('Product_Quality_And_Safety', 0.016110215336084366)","('Selling_Practices_And_Product_Labeling', 0.010926340706646442)","(['Product Stewardship'], 0.9228443503379822)","('NON-ESG', 0.016110215336084366)","('NON-ESG', 0.010926340706646442)"
Line 1556,"102-11 Precautionary principle or approach Product impact – Management of materials of concern TCFD disclosures 102-12 External initiatives Alignment with the SDGsClimate change Product impact – Laboratory animal welfareTransparency – Human rights 102-13 Membership of associations Product impact – Strategic partnershipsProduct impact – Inspiring quality in industryGRI Disclosure Disclosure requirement Response or disclosure location 102-14 Statement from senior decision-maker To our stakeholders 102-15 Key impacts, risks and opportunities ESG IssuesTCFD disclosures 102-16 Values, principles, standards and norms of  behavior About BD  102-17 Mechanisms for advice and concerns about ethicsEthics and compliance BD Code of Conduct 102-18 Governance structure ESG strategy2022 Proxy Statement 102-19 Delegating authority ESG strategy2022 Proxy Statement 102-20 Executive-level responsibility for economic,  environmental, and social topics ESG strategy  102-21 Consulting stakeholders on economic, environmental and social topics Stakeholder engagement 102-22 Composition of the highest governance body and its committees 2022 Proxy Statement 102-23 Chair of the highest governance body Tom Polen is Chair of the Board and CEO of BD.
","('Business_Ethics', 0.7673354744911194)","('Management_Of_Legal_And_Regulatory_Framework', 0.0847538486123085)","('Systemic_Risk_Management', 0.03217405825853348)","(['Business Ethics'], 0.7673354744911194)","('NON-ESG', 0.0847538486123085)","('NON-ESG', 0.03217405825853348)"
Line 1557,"102-11 Precautionary principle or approach Product impact – Management of materials of concern TCFD disclosures 102-12 External initiatives Alignment with the SDGsClimate change Product impact – Laboratory animal welfareTransparency – Human rights 102-13 Membership of associations Product impact – Strategic partnershipsProduct impact – Inspiring quality in industryGRI Disclosure Disclosure requirement Response or disclosure location 102-14 Statement from senior decision-maker To our stakeholders 102-15 Key impacts, risks and opportunities ESG IssuesTCFD disclosures 102-16 Values, principles, standards and norms of  behavior About BD  102-17 Mechanisms for advice and concerns about ethicsEthics and compliance BD Code of Conduct 102-18 Governance structure ESG strategy2022 Proxy Statement 102-19 Delegating authority ESG strategy2022 Proxy Statement 102-20 Executive-level responsibility for economic,  environmental, and social topics ESG strategy  102-21 Consulting stakeholders on economic, environmental and social topics Stakeholder engagement 102-22 Composition of the highest governance body and its committees 2022 Proxy Statement 102-23 Chair of the highest governance body Tom Polen is Chair of the Board and CEO of BD.
","('Business_Model_Resilience', 0.2542804181575775)","('Human_Rights_And_Community_Relations', 0.11785904318094254)","('Director_Removal', 0.11005070805549622)","('NON-ESG', 0.2542804181575775)","('NON-ESG', 0.11785904318094254)","('NON-ESG', 0.11005070805549622)"
Line 1558,"2022 Proxy Statement 102-24 Nominating and selecting the highest governance body 2022 Proxy Statement 102-25 Conflicts of interest 2022 Proxy Statement 102-26 Role of highest governance body in setting purpose, values and strategy2022 Proxy Statement ESG strategy 102-27 Collective knowledge of highest governance  body2022 Proxy Statement 102-28 Evaluating the highest governance body’s performance 2022 Proxy Statement 102-29 Identifying and managing economic, environmental and social impacts2022 Proxy Statement 102-30 Effectiveness of risk management processes 2022 Proxy Statement2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location 102-31 Review of economic, environmental and  social topics2022 Proxy Statement 102-32 Highest governance body’s role in sustainability reporting 2022 Proxy Statement 102-33 Communicating critical concerns 2022 Proxy Statement 102-35 Remuneration policies 2022 Proxy Statement 102-36 Process for determining remuneration 2022 Proxy Statement 102-40 List of stakeholder groups Stakeholder engagement 102-41 Collective bargaining agreements Our Global Human Rights Policy states that we are committed to supporting the freedom of association and the rights of workers and employers to bargain collectively in all of our operations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.422385573387146)","('Business_Model_Resilience', 0.15714725852012634)","('Business_Ethics', 0.06196976453065872)","('NON-ESG', 0.422385573387146)","('NON-ESG', 0.15714725852012634)","('NON-ESG', 0.06196976453065872)"
Line 1559,"2022 Proxy Statement 102-24 Nominating and selecting the highest governance body 2022 Proxy Statement 102-25 Conflicts of interest 2022 Proxy Statement 102-26 Role of highest governance body in setting purpose, values and strategy2022 Proxy Statement ESG strategy 102-27 Collective knowledge of highest governance  body2022 Proxy Statement 102-28 Evaluating the highest governance body’s performance 2022 Proxy Statement 102-29 Identifying and managing economic, environmental and social impacts2022 Proxy Statement 102-30 Effectiveness of risk management processes 2022 Proxy Statement2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location 102-31 Review of economic, environmental and  social topics2022 Proxy Statement 102-32 Highest governance body’s role in sustainability reporting 2022 Proxy Statement 102-33 Communicating critical concerns 2022 Proxy Statement 102-35 Remuneration policies 2022 Proxy Statement 102-36 Process for determining remuneration 2022 Proxy Statement 102-40 List of stakeholder groups Stakeholder engagement 102-41 Collective bargaining agreements Our Global Human Rights Policy states that we are committed to supporting the freedom of association and the rights of workers and employers to bargain collectively in all of our operations.
","('Physical_Impacts_Of_Climate_Change', 0.7233082056045532)","('Supply_Chain_Management', 0.09900552034378052)","('Business_Model_Resilience', 0.04510108754038811)","(['Climate Change'], 0.7233082056045532)","('NON-ESG', 0.09900552034378052)","('NON-ESG', 0.04510108754038811)"
Line 1560,"2022 Proxy Statement 102-24 Nominating and selecting the highest governance body 2022 Proxy Statement 102-25 Conflicts of interest 2022 Proxy Statement 102-26 Role of highest governance body in setting purpose, values and strategy2022 Proxy Statement ESG strategy 102-27 Collective knowledge of highest governance  body2022 Proxy Statement 102-28 Evaluating the highest governance body’s performance 2022 Proxy Statement 102-29 Identifying and managing economic, environmental and social impacts2022 Proxy Statement 102-30 Effectiveness of risk management processes 2022 Proxy Statement2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location 102-31 Review of economic, environmental and  social topics2022 Proxy Statement 102-32 Highest governance body’s role in sustainability reporting 2022 Proxy Statement 102-33 Communicating critical concerns 2022 Proxy Statement 102-35 Remuneration policies 2022 Proxy Statement 102-36 Process for determining remuneration 2022 Proxy Statement 102-40 List of stakeholder groups Stakeholder engagement 102-41 Collective bargaining agreements Our Global Human Rights Policy states that we are committed to supporting the freedom of association and the rights of workers and employers to bargain collectively in all of our operations.
","('Labor_Practices', 0.9781811833381653)","('Director_Removal', 0.0021857228130102158)","('Employee_Health_And_Safety', 0.0015324641717597842)","(['Labor Practice Indicators'], 0.9781811833381653)","('NON-ESG', 0.0021857228130102158)","('NON-ESG', 0.0015324641717597842)"
Line 1561,"102-42 Identifying and selecting stakeholders Stakeholder engagement 102-43 Approach to stakeholder engagement Stakeholder engagement 102-44 Key topics and concerns raised Stakeholder engagement 102-46 Defining report content and topic boundaries About this report ESG assessment 102-47 List of material topics ESG issues  102-49 Changes in reporting About this report 102-50 Reporting period About this report 102-51 Date of most recent report About this report 102-52 Reporting cycle About this report 102-53 Contact point for questions regarding the  report BD_Sustainability_Office@bd.com 102-54 Claims of reporting in accordance with the GRI StandardsThis report was prepared with reference to GRI Standards.
","('Human_Rights_And_Community_Relations', 0.48716896772384644)","('Business_Model_Resilience', 0.19369222223758698)","('Management_Of_Legal_And_Regulatory_Framework', 0.031028367578983307)","('NON-ESG', 0.48716896772384644)","('NON-ESG', 0.19369222223758698)","('NON-ESG', 0.031028367578983307)"
Line 1562,"102-42 Identifying and selecting stakeholders Stakeholder engagement 102-43 Approach to stakeholder engagement Stakeholder engagement 102-44 Key topics and concerns raised Stakeholder engagement 102-46 Defining report content and topic boundaries About this report ESG assessment 102-47 List of material topics ESG issues  102-49 Changes in reporting About this report 102-50 Reporting period About this report 102-51 Date of most recent report About this report 102-52 Reporting cycle About this report 102-53 Contact point for questions regarding the  report BD_Sustainability_Office@bd.com 102-54 Claims of reporting in accordance with the GRI StandardsThis report was prepared with reference to GRI Standards.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7232500910758972)","('Product_Quality_And_Safety', 0.06347070634365082)","('Director_Removal', 0.01942410133779049)","(['Corporate Governance'], 0.7232500910758972)","('NON-ESG', 0.06347070634365082)","('NON-ESG', 0.01942410133779049)"
Line 1563,"About this report 102-56 External assurance Data in this FY 2021 ESG report has not been externally  assured.GRI Disclosure Disclosure requirement Response or disclosure location 103-1 Explanation of the material topic and its boundaryESG assessment The UN SDGs and our contribution to their achievement  was included in our assessment of ESG issues.
","('Business_Model_Resilience', 0.2339743673801422)","('Management_Of_Legal_And_Regulatory_Framework', 0.17307335138320923)","('Human_Rights_And_Community_Relations', 0.1087348610162735)","('NON-ESG', 0.2339743673801422)","('NON-ESG', 0.17307335138320923)","('NON-ESG', 0.1087348610162735)"
Line 1564,"Further details on our contribution, degree of control and where in the value chain impacts occur can be found in the Appendices – UN Sustainable Development Goals.
","('Business_Model_Resilience', 0.5192896127700806)","('Supply_Chain_Management', 0.08819223940372467)","('Ecological_Impacts', 0.07659803330898285)","(['Codes of Business Conduct'], 0.5192896127700806)","('NON-ESG', 0.08819223940372467)","('NON-ESG', 0.07659803330898285)"
Line 1565,"The inclusion of information in this report should not be  construed as a characterization regarding the materiality or financial impact of that information.
","('Management_Of_Legal_And_Regulatory_Framework', 0.45218491554260254)","('Business_Model_Resilience', 0.11643796414136887)","('Systemic_Risk_Management', 0.08968594670295715)","('NON-ESG', 0.45218491554260254)","('NON-ESG', 0.11643796414136887)","('NON-ESG', 0.08968594670295715)"
Line 1566,"For additional information regarding BD, please see our current and periodic reports with the Securities and Exchange Commission, including our Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9315676093101501)","('Director_Removal', 0.008140225894749165)","('Business_Ethics', 0.007920200936496258)","(['Corporate Governance'], 0.9315676093101501)","('NON-ESG', 0.008140225894749165)","('NON-ESG', 0.007920200936496258)"
Line 1567,"103-2 The management approach and its components  ESG issues 103-3 Evaluation of the management approach ESG governance Economic Performance 201-1 Direct economic value generated and  distributed2021 Form 10-K 201-2 Financial implications and other risks and opportunities due to climate changeTCFD disclosures 201-3 Defined benefit plan obligations and other retirement plans2021 Form 10-K 201-4 Financial assistance received from government2021 Form 10-K Procurement Practices 204-1 Proportion of spending on local suppliers Responsible supply chain – Supplier diversity Anti-Corruption205-2 Communication and training about  anti-corruption policies and proceduresTransparency – Ethics and compliance2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location 205-3 Confirmed incidents of corruption and  actions takenWhile we have implemented, and continue to improve upon, programs and management systems around ethics and compliance, we may, on occasion, be subject to legal actions.
","('Physical_Impacts_Of_Climate_Change', 0.8980903029441833)","('Business_Model_Resilience', 0.03282320871949196)","('Systemic_Risk_Management', 0.018367532640695572)","(['Climate Change'], 0.8980903029441833)","('NON-ESG', 0.03282320871949196)","('NON-ESG', 0.018367532640695572)"
Line 1568,"103-2 The management approach and its components  ESG issues 103-3 Evaluation of the management approach ESG governance Economic Performance 201-1 Direct economic value generated and  distributed2021 Form 10-K 201-2 Financial implications and other risks and opportunities due to climate changeTCFD disclosures 201-3 Defined benefit plan obligations and other retirement plans2021 Form 10-K 201-4 Financial assistance received from government2021 Form 10-K Procurement Practices 204-1 Proportion of spending on local suppliers Responsible supply chain – Supplier diversity Anti-Corruption205-2 Communication and training about  anti-corruption policies and proceduresTransparency – Ethics and compliance2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location 205-3 Confirmed incidents of corruption and  actions takenWhile we have implemented, and continue to improve upon, programs and management systems around ethics and compliance, we may, on occasion, be subject to legal actions.
","('Business_Ethics', 0.9465771913528442)","('Labor_Practices', 0.00606480473652482)","('Data_Security', 0.0048883166164159775)","(['Business Ethics'], 0.9465771913528442)","('NON-ESG', 0.00606480473652482)","('NON-ESG', 0.0048883166164159775)"
Line 1569,"103-2 The management approach and its components  ESG issues 103-3 Evaluation of the management approach ESG governance Economic Performance 201-1 Direct economic value generated and  distributed2021 Form 10-K 201-2 Financial implications and other risks and opportunities due to climate changeTCFD disclosures 201-3 Defined benefit plan obligations and other retirement plans2021 Form 10-K 201-4 Financial assistance received from government2021 Form 10-K Procurement Practices 204-1 Proportion of spending on local suppliers Responsible supply chain – Supplier diversity Anti-Corruption205-2 Communication and training about  anti-corruption policies and proceduresTransparency – Ethics and compliance2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location 205-3 Confirmed incidents of corruption and  actions takenWhile we have implemented, and continue to improve upon, programs and management systems around ethics and compliance, we may, on occasion, be subject to legal actions.
","('Business_Ethics', 0.9686578512191772)","('Management_Of_Legal_And_Regulatory_Framework', 0.0043548839166760445)","('Product_Quality_And_Safety', 0.0027609430253505707)","(['Business Ethics'], 0.9686578512191772)","('NON-ESG', 0.0043548839166760445)","('NON-ESG', 0.0027609430253505707)"
Line 1570,"For a description of certain legal actions, see our Annual Report on Form 10-K for our 2021 fiscal year and our subsequent SEC filings.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8197813034057617)","('Business_Ethics', 0.07234359532594681)","('Competitive_Behavior', 0.0175864826887846)","(['Corporate Governance'], 0.8197813034057617)","('NON-ESG', 0.07234359532594681)","('NON-ESG', 0.0175864826887846)"
Line 1571,"For further information about antibribery and  anticorruption, see Transparency – Ethics and compliance.
","('Business_Ethics', 0.9700297713279724)","('Management_Of_Legal_And_Regulatory_Framework', 0.004486332181841135)","('Director_Removal', 0.002181645017117262)","(['Business Ethics'], 0.9700297713279724)","('NON-ESG', 0.004486332181841135)","('NON-ESG', 0.002181645017117262)"
Line 1572,"Anti-Competitive Behavior 206-1 Legal actions for anti-competitive behavior,  antitrust and monopoly practicesWhile we have implemented, and continue to improve upon, programs and management systems around ethics and compliance, we may, on occasion, be subject to legal actions.
","('Business_Ethics', 0.866972029209137)","('Competitive_Behavior', 0.07233384996652603)","('Management_Of_Legal_And_Regulatory_Framework', 0.009853786788880825)","(['Business Ethics'], 0.866972029209137)","('NON-ESG', 0.07233384996652603)","('NON-ESG', 0.009853786788880825)"
Line 1573,"For a description of certain legal actions, see our Annual Report on Form 10-K for our 2021 fiscal year and our subsequent SEC filings.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8197813034057617)","('Business_Ethics', 0.07234359532594681)","('Competitive_Behavior', 0.0175864826887846)","(['Corporate Governance'], 0.8197813034057617)","('NON-ESG', 0.07234359532594681)","('NON-ESG', 0.0175864826887846)"
Line 1574,"For further information about antibribery and  anticorruption, see Transparency – Ethics and compliance.
","('Business_Ethics', 0.9700297713279724)","('Management_Of_Legal_And_Regulatory_Framework', 0.004486332181841135)","('Director_Removal', 0.002181645017117262)","(['Business Ethics'], 0.9700297713279724)","('NON-ESG', 0.004486332181841135)","('NON-ESG', 0.002181645017117262)"
Line 1575,"Materials 301-2 Recycled input materials used Due to the nature of our products and the need for  consistency and traceability in order to adhere to stringent quality and performance criteria, we are unable to use recycled materials in the majority of our products and packaging.
","('Product_Design_And_Lifecycle_Management', 0.960520327091217)","('Product_Quality_And_Safety', 0.005340925417840481)","('Selling_Practices_And_Product_Labeling', 0.00414909515529871)","(['Product Stewardship'], 0.960520327091217)","('NON-ESG', 0.005340925417840481)","('NON-ESG', 0.00414909515529871)"
Line 1576,"However, a number of our sharps disposal solutions do utilize recycled content.
","('Waste_And_Hazardous_Materials_Management', 0.5212596654891968)","('Product_Design_And_Lifecycle_Management', 0.13747768104076385)","('Water_And_Wastewater_Management', 0.11196769028902054)","(['Operational Eco-Efficiency'], 0.5212596654891968)","('NON-ESG', 0.13747768104076385)","('NON-ESG', 0.11196769028902054)"
Line 1577,"301-3 Reclaimed products and their packaging materialsProduct impact – Product takeback Energy 302-1 Energy consumption within the organization Data tables – Energy    302-3 Energy-intensity Data tables – Energy    302-4 Reduction of energy consumption Data tables – Energy  GRI Disclosure Disclosure requirement Response or disclosure location Water and Effluents 303-1 Interactions with water as a shared resource Climate change – Water management  303-3 Water withdrawal Data tables – Water    303-4 Water discharge Data tables – Water   303-5 Water consumption  Emissions 305-1 Direct (Scope 1) GHG emissions Data tables – Scope 1 and 2  305-2 Energy indirect (Scope 2) GHG emissions Data tables – Scope 1 and 2  305-3 Other indirect (Scope 3) GHG emissions Data tables – Scope 3  305-4 GHG emissions intensity Our emission reduction targets are absolute, therefore we  do not routinely track intensity.
","('Energy_Management', 0.5582329034805298)","('Water_And_Wastewater_Management', 0.33222687244415283)","('Product_Design_And_Lifecycle_Management', 0.013845962472259998)","(['Operational Eco-Efficiency'], 0.5582329034805298)","('NON-ESG', 0.33222687244415283)","('NON-ESG', 0.013845962472259998)"
Line 1578,"301-3 Reclaimed products and their packaging materialsProduct impact – Product takeback Energy 302-1 Energy consumption within the organization Data tables – Energy    302-3 Energy-intensity Data tables – Energy    302-4 Reduction of energy consumption Data tables – Energy  GRI Disclosure Disclosure requirement Response or disclosure location Water and Effluents 303-1 Interactions with water as a shared resource Climate change – Water management  303-3 Water withdrawal Data tables – Water    303-4 Water discharge Data tables – Water   303-5 Water consumption  Emissions 305-1 Direct (Scope 1) GHG emissions Data tables – Scope 1 and 2  305-2 Energy indirect (Scope 2) GHG emissions Data tables – Scope 1 and 2  305-3 Other indirect (Scope 3) GHG emissions Data tables – Scope 3  305-4 GHG emissions intensity Our emission reduction targets are absolute, therefore we  do not routinely track intensity.
","('GHG_Emissions', 0.9574103951454163)","('Air_Quality', 0.012328238226473331)","('Management_Of_Legal_And_Regulatory_Framework', 0.0032603491563349962)","(['Climate Change'], 0.9574103951454163)","('NON-ESG', 0.012328238226473331)","('NON-ESG', 0.0032603491563349962)"
Line 1579,"In previous years, Scope 1 and 2 emissions intensity was calculated using COPS.
","('GHG_Emissions', 0.8463504910469055)","('Air_Quality', 0.06151791661977768)","('Management_Of_Legal_And_Regulatory_Framework', 0.016341432929039)","(['Climate Change'], 0.8463504910469055)","('NON-ESG', 0.06151791661977768)","('NON-ESG', 0.016341432929039)"
Line 1580,"FY 2019.
","('Physical_Impacts_Of_Climate_Change', 0.23544135689735413)","('Business_Model_Resilience', 0.21033340692520142)","('Systemic_Risk_Management', 0.04638895392417908)","('NON-ESG', 0.23544135689735413)","('NON-ESG', 0.21033340692520142)","('NON-ESG', 0.04638895392417908)"
Line 1581,"Absolute – 402,395 tonnes CO 2e, normalized to  COPS - 44.7  FY 2020.
","('Energy_Management', 0.414236456155777)","('GHG_Emissions', 0.22316516935825348)","('Management_Of_Legal_And_Regulatory_Framework', 0.09652332961559296)","('NON-ESG', 0.414236456155777)","('NON-ESG', 0.22316516935825348)","('NON-ESG', 0.09652332961559296)"
Line 1582,"Absolute – 490,609 tonnes CO 2e, normalized to  COPS - 51.4  FY 2021.
","('GHG_Emissions', 0.3525865972042084)","('Energy_Management', 0.28667575120925903)","('Management_Of_Legal_And_Regulatory_Framework', 0.10358352959156036)","('NON-ESG', 0.3525865972042084)","('NON-ESG', 0.28667575120925903)","('NON-ESG', 0.10358352959156036)"
Line 1583,"Absolute – 494,501 tonnes CO 2e, normalized to  COPS - 45.7   We do not currently measure intensity for Scope 3 emissions.
","('GHG_Emissions', 0.9087837338447571)","('Air_Quality', 0.019629573449492455)","('Management_Of_Legal_And_Regulatory_Framework', 0.013875750824809074)","(['Climate Change'], 0.9087837338447571)","('NON-ESG', 0.019629573449492455)","('NON-ESG', 0.013875750824809074)"
Line 1584,"305-5 Reduction of GHG emissions Data tables – Scope 1 and 2, Scope 3  305-6 Emissions of ozone-depleting substances (ODS)Data tables – Air emissions 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX), and other significant air emissionsData tables – Air emissions2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location Waste 306-2 Management of significant waste-related  impactsClimate change – Waste management 306-3 Waste generated Climate change – Waste management Data tables – Waste 306-4 Waste diverted from disposal Climate change – Waste management Data tables – Waste 306-5 Waste directed to disposal Climate change – Waste management Data tables – Waste Environmental Compliance 307-1 Non-compliance with environmental laws  and regulationsWhile we have implemented, and continue to improve upon, programs and management systems around environmental management, we may, on occasion, be subject to legal actions.
","('Air_Quality', 0.9417682886123657)","('GHG_Emissions', 0.02424376644194126)","('Physical_Impacts_Of_Climate_Change', 0.0038746322970837355)","(['Operational Eco-Efficiency'], 0.9417682886123657)","('NON-ESG', 0.02424376644194126)","('NON-ESG', 0.0038746322970837355)"
Line 1585,"305-5 Reduction of GHG emissions Data tables – Scope 1 and 2, Scope 3  305-6 Emissions of ozone-depleting substances (ODS)Data tables – Air emissions 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX), and other significant air emissionsData tables – Air emissions2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location Waste 306-2 Management of significant waste-related  impactsClimate change – Waste management 306-3 Waste generated Climate change – Waste management Data tables – Waste 306-4 Waste diverted from disposal Climate change – Waste management Data tables – Waste 306-5 Waste directed to disposal Climate change – Waste management Data tables – Waste Environmental Compliance 307-1 Non-compliance with environmental laws  and regulationsWhile we have implemented, and continue to improve upon, programs and management systems around environmental management, we may, on occasion, be subject to legal actions.
","('Waste_And_Hazardous_Materials_Management', 0.9836222529411316)","('Water_And_Wastewater_Management', 0.0012847718317061663)","('Data_Security', 0.001200864790007472)","(['Operational Eco-Efficiency'], 0.9836222529411316)","('NON-ESG', 0.0012847718317061663)","('NON-ESG', 0.001200864790007472)"
Line 1586,"305-5 Reduction of GHG emissions Data tables – Scope 1 and 2, Scope 3  305-6 Emissions of ozone-depleting substances (ODS)Data tables – Air emissions 305-7 Nitrogen oxides (NOX), sulfur oxides (SOX), and other significant air emissionsData tables – Air emissions2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location Waste 306-2 Management of significant waste-related  impactsClimate change – Waste management 306-3 Waste generated Climate change – Waste management Data tables – Waste 306-4 Waste diverted from disposal Climate change – Waste management Data tables – Waste 306-5 Waste directed to disposal Climate change – Waste management Data tables – Waste Environmental Compliance 307-1 Non-compliance with environmental laws  and regulationsWhile we have implemented, and continue to improve upon, programs and management systems around environmental management, we may, on occasion, be subject to legal actions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7688356637954712)","('Business_Ethics', 0.10253696143627167)","('Competitive_Behavior', 0.02649420127272606)","(['Corporate Governance'], 0.7688356637954712)","('NON-ESG', 0.10253696143627167)","('NON-ESG', 0.02649420127272606)"
Line 1587,"For a description of certain legal actions, see our Annual Report on Form 10-K for our 2021 fiscal year and our subsequent SEC filings.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8197813034057617)","('Business_Ethics', 0.07234359532594681)","('Competitive_Behavior', 0.0175864826887846)","(['Corporate Governance'], 0.8197813034057617)","('NON-ESG', 0.07234359532594681)","('NON-ESG', 0.0175864826887846)"
Line 1588,"For further information about environmental  management, see Climate Change – EHS Management.
","('Physical_Impacts_Of_Climate_Change', 0.9492215514183044)","('Business_Model_Resilience', 0.009191944263875484)","('GHG_Emissions', 0.006723068654537201)","(['Climate Change'], 0.9492215514183044)","('NON-ESG', 0.009191944263875484)","('NON-ESG', 0.006723068654537201)"
Line 1589,"Supplier Environmental Assessment 308-1 New suppliers that were screened using  environmental criteriaResponsible supply chain – Responsible sourcing 308-2 Negative environmental impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Employment 401-1 New employee hires and employee turnover Healthy workforce & communities – ID&E  Data tables – ID&E 401-2 Benefits provided to full-time employees that  are not provided to temporary or part-time employeesHealthy workforce & communities – Compensation, benefits and well-beingGRI Disclosure Disclosure requirement Response or disclosure location Occupational Health and Safety 403-1 Occupational health and safety  management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-2 Hazard identification, risk assessment, and incident investigation Climate change – EHS management Healthy workforce & communities – Health & safety 403-3 Occupational health services Healthy workforce & communities – Health & safety 403-4 Worker participation, consultation, and communication on occupational health and safety Healthy workforce & communities – Health & safety 403-5 Worker training on occupational health and safety Climate change – EHS management Healthy workforce & communities – Health & safety 403-6 Promotion of worker health Healthy workforce & communities – Compensation, benefits and well-being 403-7 Prevention and mitigation of occupational health and safety impacts directly linked by business relationships Climate change – EHS management Healthy workforce & communities – Health & safety 403-8 Workers covered by an occupational health and safety management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-9 Work-related injuries Healthy workforce & communities – Health & safety Diversity and Equal Opportunity 405-1 Diversity of governance bodies and  employeesHealthy workforce & communities – ID&E Data tables – ID&E 405-2 Ratio of basic salary and remuneration of women to menHealthy workforce & communities – ID&E Human Rights Assessment 412-2 Employee training on human rights policies  and proceduresResponsible supply chain – Responsible sourcing2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location Local Communities 413-2 Operations with significant actual and  potential negative impacts on local communitiesClimate change – Environmental justice Supplier Social Assessment 414-1 New suppliers that were screened using  social criteriaResponsible supply chain – Responsible sourcing 414-2 Negative social impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Public Policy 415-1 Political contributions Transparency – Participation in the policymaking process Customer Health and Safety416-1 Assessment of the health and safety impacts  of product and service categoriesProduct impact – Product safety 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesProduct impact – Product safety Marketing and Labeling 417-1 Requirements for product and service  information and labelingProduct impact – Management of materials of concern Transparency – Ethics in sales and marketingGRI Disclosure Disclosure requirement Response or disclosure location 417-2 Incidents of noncompliance concerning  product and service information and labelingWhile we have implemented, and continue to improve upon, programs and management systems around product labeling, we may, on occasion, be subject to legal actions.
","('Supply_Chain_Management', 0.8908116221427917)","('Labor_Practices', 0.03476633131504059)","('Employee_Health_And_Safety', 0.006229120772331953)","(['Supply Chain Management'], 0.8908116221427917)","('NON-ESG', 0.03476633131504059)","('NON-ESG', 0.006229120772331953)"
Line 1590,"Supplier Environmental Assessment 308-1 New suppliers that were screened using  environmental criteriaResponsible supply chain – Responsible sourcing 308-2 Negative environmental impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Employment 401-1 New employee hires and employee turnover Healthy workforce & communities – ID&E  Data tables – ID&E 401-2 Benefits provided to full-time employees that  are not provided to temporary or part-time employeesHealthy workforce & communities – Compensation, benefits and well-beingGRI Disclosure Disclosure requirement Response or disclosure location Occupational Health and Safety 403-1 Occupational health and safety  management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-2 Hazard identification, risk assessment, and incident investigation Climate change – EHS management Healthy workforce & communities – Health & safety 403-3 Occupational health services Healthy workforce & communities – Health & safety 403-4 Worker participation, consultation, and communication on occupational health and safety Healthy workforce & communities – Health & safety 403-5 Worker training on occupational health and safety Climate change – EHS management Healthy workforce & communities – Health & safety 403-6 Promotion of worker health Healthy workforce & communities – Compensation, benefits and well-being 403-7 Prevention and mitigation of occupational health and safety impacts directly linked by business relationships Climate change – EHS management Healthy workforce & communities – Health & safety 403-8 Workers covered by an occupational health and safety management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-9 Work-related injuries Healthy workforce & communities – Health & safety Diversity and Equal Opportunity 405-1 Diversity of governance bodies and  employeesHealthy workforce & communities – ID&E Data tables – ID&E 405-2 Ratio of basic salary and remuneration of women to menHealthy workforce & communities – ID&E Human Rights Assessment 412-2 Employee training on human rights policies  and proceduresResponsible supply chain – Responsible sourcing2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location Local Communities 413-2 Operations with significant actual and  potential negative impacts on local communitiesClimate change – Environmental justice Supplier Social Assessment 414-1 New suppliers that were screened using  social criteriaResponsible supply chain – Responsible sourcing 414-2 Negative social impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Public Policy 415-1 Political contributions Transparency – Participation in the policymaking process Customer Health and Safety416-1 Assessment of the health and safety impacts  of product and service categoriesProduct impact – Product safety 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesProduct impact – Product safety Marketing and Labeling 417-1 Requirements for product and service  information and labelingProduct impact – Management of materials of concern Transparency – Ethics in sales and marketingGRI Disclosure Disclosure requirement Response or disclosure location 417-2 Incidents of noncompliance concerning  product and service information and labelingWhile we have implemented, and continue to improve upon, programs and management systems around product labeling, we may, on occasion, be subject to legal actions.
","('Employee_Health_And_Safety', 0.9841794371604919)","('Critical_Incident_Risk_Management', 0.002450248459354043)","('Employee_Engagement_Inclusion_And_Diversity', 0.001490150112658739)","(['Operational Eco-Efficiency'], 0.9841794371604919)","('NON-ESG', 0.002450248459354043)","('NON-ESG', 0.001490150112658739)"
Line 1591,"Supplier Environmental Assessment 308-1 New suppliers that were screened using  environmental criteriaResponsible supply chain – Responsible sourcing 308-2 Negative environmental impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Employment 401-1 New employee hires and employee turnover Healthy workforce & communities – ID&E  Data tables – ID&E 401-2 Benefits provided to full-time employees that  are not provided to temporary or part-time employeesHealthy workforce & communities – Compensation, benefits and well-beingGRI Disclosure Disclosure requirement Response or disclosure location Occupational Health and Safety 403-1 Occupational health and safety  management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-2 Hazard identification, risk assessment, and incident investigation Climate change – EHS management Healthy workforce & communities – Health & safety 403-3 Occupational health services Healthy workforce & communities – Health & safety 403-4 Worker participation, consultation, and communication on occupational health and safety Healthy workforce & communities – Health & safety 403-5 Worker training on occupational health and safety Climate change – EHS management Healthy workforce & communities – Health & safety 403-6 Promotion of worker health Healthy workforce & communities – Compensation, benefits and well-being 403-7 Prevention and mitigation of occupational health and safety impacts directly linked by business relationships Climate change – EHS management Healthy workforce & communities – Health & safety 403-8 Workers covered by an occupational health and safety management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-9 Work-related injuries Healthy workforce & communities – Health & safety Diversity and Equal Opportunity 405-1 Diversity of governance bodies and  employeesHealthy workforce & communities – ID&E Data tables – ID&E 405-2 Ratio of basic salary and remuneration of women to menHealthy workforce & communities – ID&E Human Rights Assessment 412-2 Employee training on human rights policies  and proceduresResponsible supply chain – Responsible sourcing2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location Local Communities 413-2 Operations with significant actual and  potential negative impacts on local communitiesClimate change – Environmental justice Supplier Social Assessment 414-1 New suppliers that were screened using  social criteriaResponsible supply chain – Responsible sourcing 414-2 Negative social impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Public Policy 415-1 Political contributions Transparency – Participation in the policymaking process Customer Health and Safety416-1 Assessment of the health and safety impacts  of product and service categoriesProduct impact – Product safety 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesProduct impact – Product safety Marketing and Labeling 417-1 Requirements for product and service  information and labelingProduct impact – Management of materials of concern Transparency – Ethics in sales and marketingGRI Disclosure Disclosure requirement Response or disclosure location 417-2 Incidents of noncompliance concerning  product and service information and labelingWhile we have implemented, and continue to improve upon, programs and management systems around product labeling, we may, on occasion, be subject to legal actions.
","('Employee_Health_And_Safety', 0.9846740961074829)","('Employee_Engagement_Inclusion_And_Diversity', 0.00180018728133291)","('Critical_Incident_Risk_Management', 0.0012903049355372787)","(['Operational Eco-Efficiency'], 0.9846740961074829)","('NON-ESG', 0.00180018728133291)","('NON-ESG', 0.0012903049355372787)"
Line 1592,"Supplier Environmental Assessment 308-1 New suppliers that were screened using  environmental criteriaResponsible supply chain – Responsible sourcing 308-2 Negative environmental impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Employment 401-1 New employee hires and employee turnover Healthy workforce & communities – ID&E  Data tables – ID&E 401-2 Benefits provided to full-time employees that  are not provided to temporary or part-time employeesHealthy workforce & communities – Compensation, benefits and well-beingGRI Disclosure Disclosure requirement Response or disclosure location Occupational Health and Safety 403-1 Occupational health and safety  management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-2 Hazard identification, risk assessment, and incident investigation Climate change – EHS management Healthy workforce & communities – Health & safety 403-3 Occupational health services Healthy workforce & communities – Health & safety 403-4 Worker participation, consultation, and communication on occupational health and safety Healthy workforce & communities – Health & safety 403-5 Worker training on occupational health and safety Climate change – EHS management Healthy workforce & communities – Health & safety 403-6 Promotion of worker health Healthy workforce & communities – Compensation, benefits and well-being 403-7 Prevention and mitigation of occupational health and safety impacts directly linked by business relationships Climate change – EHS management Healthy workforce & communities – Health & safety 403-8 Workers covered by an occupational health and safety management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-9 Work-related injuries Healthy workforce & communities – Health & safety Diversity and Equal Opportunity 405-1 Diversity of governance bodies and  employeesHealthy workforce & communities – ID&E Data tables – ID&E 405-2 Ratio of basic salary and remuneration of women to menHealthy workforce & communities – ID&E Human Rights Assessment 412-2 Employee training on human rights policies  and proceduresResponsible supply chain – Responsible sourcing2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location Local Communities 413-2 Operations with significant actual and  potential negative impacts on local communitiesClimate change – Environmental justice Supplier Social Assessment 414-1 New suppliers that were screened using  social criteriaResponsible supply chain – Responsible sourcing 414-2 Negative social impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Public Policy 415-1 Political contributions Transparency – Participation in the policymaking process Customer Health and Safety416-1 Assessment of the health and safety impacts  of product and service categoriesProduct impact – Product safety 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesProduct impact – Product safety Marketing and Labeling 417-1 Requirements for product and service  information and labelingProduct impact – Management of materials of concern Transparency – Ethics in sales and marketingGRI Disclosure Disclosure requirement Response or disclosure location 417-2 Incidents of noncompliance concerning  product and service information and labelingWhile we have implemented, and continue to improve upon, programs and management systems around product labeling, we may, on occasion, be subject to legal actions.
","('Employee_Health_And_Safety', 0.8527238965034485)","('Employee_Engagement_Inclusion_And_Diversity', 0.08293362706899643)","('Labor_Practices', 0.00915828999131918)","(['Operational Eco-Efficiency'], 0.8527238965034485)","('NON-ESG', 0.08293362706899643)","('NON-ESG', 0.00915828999131918)"
Line 1593,"Supplier Environmental Assessment 308-1 New suppliers that were screened using  environmental criteriaResponsible supply chain – Responsible sourcing 308-2 Negative environmental impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Employment 401-1 New employee hires and employee turnover Healthy workforce & communities – ID&E  Data tables – ID&E 401-2 Benefits provided to full-time employees that  are not provided to temporary or part-time employeesHealthy workforce & communities – Compensation, benefits and well-beingGRI Disclosure Disclosure requirement Response or disclosure location Occupational Health and Safety 403-1 Occupational health and safety  management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-2 Hazard identification, risk assessment, and incident investigation Climate change – EHS management Healthy workforce & communities – Health & safety 403-3 Occupational health services Healthy workforce & communities – Health & safety 403-4 Worker participation, consultation, and communication on occupational health and safety Healthy workforce & communities – Health & safety 403-5 Worker training on occupational health and safety Climate change – EHS management Healthy workforce & communities – Health & safety 403-6 Promotion of worker health Healthy workforce & communities – Compensation, benefits and well-being 403-7 Prevention and mitigation of occupational health and safety impacts directly linked by business relationships Climate change – EHS management Healthy workforce & communities – Health & safety 403-8 Workers covered by an occupational health and safety management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-9 Work-related injuries Healthy workforce & communities – Health & safety Diversity and Equal Opportunity 405-1 Diversity of governance bodies and  employeesHealthy workforce & communities – ID&E Data tables – ID&E 405-2 Ratio of basic salary and remuneration of women to menHealthy workforce & communities – ID&E Human Rights Assessment 412-2 Employee training on human rights policies  and proceduresResponsible supply chain – Responsible sourcing2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location Local Communities 413-2 Operations with significant actual and  potential negative impacts on local communitiesClimate change – Environmental justice Supplier Social Assessment 414-1 New suppliers that were screened using  social criteriaResponsible supply chain – Responsible sourcing 414-2 Negative social impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Public Policy 415-1 Political contributions Transparency – Participation in the policymaking process Customer Health and Safety416-1 Assessment of the health and safety impacts  of product and service categoriesProduct impact – Product safety 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesProduct impact – Product safety Marketing and Labeling 417-1 Requirements for product and service  information and labelingProduct impact – Management of materials of concern Transparency – Ethics in sales and marketingGRI Disclosure Disclosure requirement Response or disclosure location 417-2 Incidents of noncompliance concerning  product and service information and labelingWhile we have implemented, and continue to improve upon, programs and management systems around product labeling, we may, on occasion, be subject to legal actions.
","('Supply_Chain_Management', 0.8020527362823486)","('Human_Rights_And_Community_Relations', 0.05410526320338249)","('Physical_Impacts_Of_Climate_Change', 0.03229449316859245)","(['Supply Chain Management'], 0.8020527362823486)","('NON-ESG', 0.05410526320338249)","('NON-ESG', 0.03229449316859245)"
Line 1594,"Supplier Environmental Assessment 308-1 New suppliers that were screened using  environmental criteriaResponsible supply chain – Responsible sourcing 308-2 Negative environmental impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Employment 401-1 New employee hires and employee turnover Healthy workforce & communities – ID&E  Data tables – ID&E 401-2 Benefits provided to full-time employees that  are not provided to temporary or part-time employeesHealthy workforce & communities – Compensation, benefits and well-beingGRI Disclosure Disclosure requirement Response or disclosure location Occupational Health and Safety 403-1 Occupational health and safety  management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-2 Hazard identification, risk assessment, and incident investigation Climate change – EHS management Healthy workforce & communities – Health & safety 403-3 Occupational health services Healthy workforce & communities – Health & safety 403-4 Worker participation, consultation, and communication on occupational health and safety Healthy workforce & communities – Health & safety 403-5 Worker training on occupational health and safety Climate change – EHS management Healthy workforce & communities – Health & safety 403-6 Promotion of worker health Healthy workforce & communities – Compensation, benefits and well-being 403-7 Prevention and mitigation of occupational health and safety impacts directly linked by business relationships Climate change – EHS management Healthy workforce & communities – Health & safety 403-8 Workers covered by an occupational health and safety management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-9 Work-related injuries Healthy workforce & communities – Health & safety Diversity and Equal Opportunity 405-1 Diversity of governance bodies and  employeesHealthy workforce & communities – ID&E Data tables – ID&E 405-2 Ratio of basic salary and remuneration of women to menHealthy workforce & communities – ID&E Human Rights Assessment 412-2 Employee training on human rights policies  and proceduresResponsible supply chain – Responsible sourcing2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location Local Communities 413-2 Operations with significant actual and  potential negative impacts on local communitiesClimate change – Environmental justice Supplier Social Assessment 414-1 New suppliers that were screened using  social criteriaResponsible supply chain – Responsible sourcing 414-2 Negative social impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Public Policy 415-1 Political contributions Transparency – Participation in the policymaking process Customer Health and Safety416-1 Assessment of the health and safety impacts  of product and service categoriesProduct impact – Product safety 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesProduct impact – Product safety Marketing and Labeling 417-1 Requirements for product and service  information and labelingProduct impact – Management of materials of concern Transparency – Ethics in sales and marketingGRI Disclosure Disclosure requirement Response or disclosure location 417-2 Incidents of noncompliance concerning  product and service information and labelingWhile we have implemented, and continue to improve upon, programs and management systems around product labeling, we may, on occasion, be subject to legal actions.
","('Product_Design_And_Lifecycle_Management', 0.5354479551315308)","('Supply_Chain_Management', 0.1628168374300003)","('Product_Quality_And_Safety', 0.13299879431724548)","(['Product Stewardship'], 0.5354479551315308)","('NON-ESG', 0.1628168374300003)","('NON-ESG', 0.13299879431724548)"
Line 1595,"Supplier Environmental Assessment 308-1 New suppliers that were screened using  environmental criteriaResponsible supply chain – Responsible sourcing 308-2 Negative environmental impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Employment 401-1 New employee hires and employee turnover Healthy workforce & communities – ID&E  Data tables – ID&E 401-2 Benefits provided to full-time employees that  are not provided to temporary or part-time employeesHealthy workforce & communities – Compensation, benefits and well-beingGRI Disclosure Disclosure requirement Response or disclosure location Occupational Health and Safety 403-1 Occupational health and safety  management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-2 Hazard identification, risk assessment, and incident investigation Climate change – EHS management Healthy workforce & communities – Health & safety 403-3 Occupational health services Healthy workforce & communities – Health & safety 403-4 Worker participation, consultation, and communication on occupational health and safety Healthy workforce & communities – Health & safety 403-5 Worker training on occupational health and safety Climate change – EHS management Healthy workforce & communities – Health & safety 403-6 Promotion of worker health Healthy workforce & communities – Compensation, benefits and well-being 403-7 Prevention and mitigation of occupational health and safety impacts directly linked by business relationships Climate change – EHS management Healthy workforce & communities – Health & safety 403-8 Workers covered by an occupational health and safety management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-9 Work-related injuries Healthy workforce & communities – Health & safety Diversity and Equal Opportunity 405-1 Diversity of governance bodies and  employeesHealthy workforce & communities – ID&E Data tables – ID&E 405-2 Ratio of basic salary and remuneration of women to menHealthy workforce & communities – ID&E Human Rights Assessment 412-2 Employee training on human rights policies  and proceduresResponsible supply chain – Responsible sourcing2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location Local Communities 413-2 Operations with significant actual and  potential negative impacts on local communitiesClimate change – Environmental justice Supplier Social Assessment 414-1 New suppliers that were screened using  social criteriaResponsible supply chain – Responsible sourcing 414-2 Negative social impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Public Policy 415-1 Political contributions Transparency – Participation in the policymaking process Customer Health and Safety416-1 Assessment of the health and safety impacts  of product and service categoriesProduct impact – Product safety 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesProduct impact – Product safety Marketing and Labeling 417-1 Requirements for product and service  information and labelingProduct impact – Management of materials of concern Transparency – Ethics in sales and marketingGRI Disclosure Disclosure requirement Response or disclosure location 417-2 Incidents of noncompliance concerning  product and service information and labelingWhile we have implemented, and continue to improve upon, programs and management systems around product labeling, we may, on occasion, be subject to legal actions.
","('Product_Quality_And_Safety', 0.8172745108604431)","('Selling_Practices_And_Product_Labeling', 0.07802434265613556)","('Product_Design_And_Lifecycle_Management', 0.015234306454658508)","(['Product Quality & Recall Management'], 0.8172745108604431)","('NON-ESG', 0.07802434265613556)","('NON-ESG', 0.015234306454658508)"
Line 1596,"Supplier Environmental Assessment 308-1 New suppliers that were screened using  environmental criteriaResponsible supply chain – Responsible sourcing 308-2 Negative environmental impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Employment 401-1 New employee hires and employee turnover Healthy workforce & communities – ID&E  Data tables – ID&E 401-2 Benefits provided to full-time employees that  are not provided to temporary or part-time employeesHealthy workforce & communities – Compensation, benefits and well-beingGRI Disclosure Disclosure requirement Response or disclosure location Occupational Health and Safety 403-1 Occupational health and safety  management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-2 Hazard identification, risk assessment, and incident investigation Climate change – EHS management Healthy workforce & communities – Health & safety 403-3 Occupational health services Healthy workforce & communities – Health & safety 403-4 Worker participation, consultation, and communication on occupational health and safety Healthy workforce & communities – Health & safety 403-5 Worker training on occupational health and safety Climate change – EHS management Healthy workforce & communities – Health & safety 403-6 Promotion of worker health Healthy workforce & communities – Compensation, benefits and well-being 403-7 Prevention and mitigation of occupational health and safety impacts directly linked by business relationships Climate change – EHS management Healthy workforce & communities – Health & safety 403-8 Workers covered by an occupational health and safety management system Climate change – EHS management Healthy workforce & communities – Health & safety 403-9 Work-related injuries Healthy workforce & communities – Health & safety Diversity and Equal Opportunity 405-1 Diversity of governance bodies and  employeesHealthy workforce & communities – ID&E Data tables – ID&E 405-2 Ratio of basic salary and remuneration of women to menHealthy workforce & communities – ID&E Human Rights Assessment 412-2 Employee training on human rights policies  and proceduresResponsible supply chain – Responsible sourcing2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities GRI Disclosure Disclosure requirement Response or disclosure location Local Communities 413-2 Operations with significant actual and  potential negative impacts on local communitiesClimate change – Environmental justice Supplier Social Assessment 414-1 New suppliers that were screened using  social criteriaResponsible supply chain – Responsible sourcing 414-2 Negative social impacts in the supply chain and actions takenResponsible supply chain – Responsible sourcing Public Policy 415-1 Political contributions Transparency – Participation in the policymaking process Customer Health and Safety416-1 Assessment of the health and safety impacts  of product and service categoriesProduct impact – Product safety 416-2 Incidents of noncompliance concerning the health and safety impacts of products and servicesProduct impact – Product safety Marketing and Labeling 417-1 Requirements for product and service  information and labelingProduct impact – Management of materials of concern Transparency – Ethics in sales and marketingGRI Disclosure Disclosure requirement Response or disclosure location 417-2 Incidents of noncompliance concerning  product and service information and labelingWhile we have implemented, and continue to improve upon, programs and management systems around product labeling, we may, on occasion, be subject to legal actions.
","('Selling_Practices_And_Product_Labeling', 0.8610513806343079)","('Product_Quality_And_Safety', 0.031452786177396774)","('Product_Design_And_Lifecycle_Management', 0.02611507475376129)","(['Marketing Practices'], 0.8610513806343079)","('NON-ESG', 0.031452786177396774)","('NON-ESG', 0.02611507475376129)"
Line 1597,"For a description of certain legal actions, see our Annual Report on Form 10-K for our 2021 fiscal year and our subsequent SEC filings.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8197813034057617)","('Business_Ethics', 0.07234359532594681)","('Competitive_Behavior', 0.0175864826887846)","(['Corporate Governance'], 0.8197813034057617)","('NON-ESG', 0.07234359532594681)","('NON-ESG', 0.0175864826887846)"
Line 1598,"417-3 Incidents of noncompliance concerning marketing communicationsWhile we have implemented, and continue to improve upon, programs and management systems around product marketing, we may, on occasion, be subject to legal actions.
","('Selling_Practices_And_Product_Labeling', 0.6127288937568665)","('Product_Quality_And_Safety', 0.07966752350330353)","('Customer_Welfare', 0.07556971907615662)","(['Marketing Practices'], 0.6127288937568665)","('NON-ESG', 0.07966752350330353)","('NON-ESG', 0.07556971907615662)"
Line 1599,"For a description of certain legal actions, see our Annual Report on Form 10-K for our 2021 fiscal year and our subsequent SEC filings.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8197813034057617)","('Business_Ethics', 0.07234359532594681)","('Competitive_Behavior', 0.0175864826887846)","(['Corporate Governance'], 0.8197813034057617)","('NON-ESG', 0.07234359532594681)","('NON-ESG', 0.0175864826887846)"
Line 1600,"Socioeconomic Compliance 419-1 Noncompliance with laws and regulations in  the social and economic areaWhile we have implemented, and continue to improve upon, programs and management systems around relevant social and economic issues in relation to which we are subject to laws and/or regulations, we may, on occasion, be subject to legal actions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9412611722946167)","('Human_Rights_And_Community_Relations', 0.01572587341070175)","('Ecological_Impacts', 0.004915957804769278)","(['Corporate Governance'], 0.9412611722946167)","('NON-ESG', 0.01572587341070175)","('NON-ESG', 0.004915957804769278)"
Line 1601,"For a description of certain legal actions, see our Annual Report on Form 10-K for our 2021 fiscal year and our subsequent SEC filings.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities SASB index SASB Disclosure Disclosure requirement Response or disclosure location HC-MS-250a.1 Number of recalls issued, total units recalled Product Impact – Product safety HC-MS-250a.2 List of products listed in the FDA’s MedWatch  Safety Alerts for Human Medical Products  databaseProduct Impact – Product safety HC-MS-250a.3 Number of fatalities related to products as  reported in the FDA Manufacturer and User Facility Device ExperienceProduct Impact – Product safety HC-MS-250a.4 Number of FDA enforcement actions taken  in response to violations of current Good Manufacturing Practices (cGMPs), by typeProduct Impact – Product safety HC-MS-270a.1 Total amount of monetary losses as a result  of legal proceedings associated with false marketing claimsWhile we have implemented, and continue to improve upon, programs and management systems around product marketing, we may, on occasion, be subject to legal actions.
","('Product_Quality_And_Safety', 0.8340266346931458)","('Selling_Practices_And_Product_Labeling', 0.03814450278878212)","('Product_Design_And_Lifecycle_Management', 0.018711717799305916)","(['Product Quality & Recall Management'], 0.8340266346931458)","('NON-ESG', 0.03814450278878212)","('NON-ESG', 0.018711717799305916)"
Line 1602,"For a description of certain legal actions, see our Annual Report on Form 10-K for our 2021 fiscal year and our subsequent SEC filings.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities SASB index SASB Disclosure Disclosure requirement Response or disclosure location HC-MS-250a.1 Number of recalls issued, total units recalled Product Impact – Product safety HC-MS-250a.2 List of products listed in the FDA’s MedWatch  Safety Alerts for Human Medical Products  databaseProduct Impact – Product safety HC-MS-250a.3 Number of fatalities related to products as  reported in the FDA Manufacturer and User Facility Device ExperienceProduct Impact – Product safety HC-MS-250a.4 Number of FDA enforcement actions taken  in response to violations of current Good Manufacturing Practices (cGMPs), by typeProduct Impact – Product safety HC-MS-270a.1 Total amount of monetary losses as a result  of legal proceedings associated with false marketing claimsWhile we have implemented, and continue to improve upon, programs and management systems around product marketing, we may, on occasion, be subject to legal actions.
","('Product_Quality_And_Safety', 0.9117075800895691)","('Selling_Practices_And_Product_Labeling', 0.013178488239645958)","('Employee_Health_And_Safety', 0.010582631453871727)","(['Product Quality & Recall Management'], 0.9117075800895691)","('NON-ESG', 0.013178488239645958)","('NON-ESG', 0.010582631453871727)"
Line 1603,"For a description of certain legal actions, see our Annual Report on Form 10-K for our 2021 fiscal year and our subsequent SEC filings.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities SASB index SASB Disclosure Disclosure requirement Response or disclosure location HC-MS-250a.1 Number of recalls issued, total units recalled Product Impact – Product safety HC-MS-250a.2 List of products listed in the FDA’s MedWatch  Safety Alerts for Human Medical Products  databaseProduct Impact – Product safety HC-MS-250a.3 Number of fatalities related to products as  reported in the FDA Manufacturer and User Facility Device ExperienceProduct Impact – Product safety HC-MS-250a.4 Number of FDA enforcement actions taken  in response to violations of current Good Manufacturing Practices (cGMPs), by typeProduct Impact – Product safety HC-MS-270a.1 Total amount of monetary losses as a result  of legal proceedings associated with false marketing claimsWhile we have implemented, and continue to improve upon, programs and management systems around product marketing, we may, on occasion, be subject to legal actions.
","('Selling_Practices_And_Product_Labeling', 0.6568370461463928)","('Product_Quality_And_Safety', 0.08027290552854538)","('Customer_Welfare', 0.07186972349882126)","(['Marketing Practices'], 0.6568370461463928)","('NON-ESG', 0.08027290552854538)","('NON-ESG', 0.07186972349882126)"
Line 1604,"For a description of certain legal actions, see our Annual Report on Form 10-K for our 2021 fiscal year and our subsequent SEC filings.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8197813034057617)","('Business_Ethics', 0.07234359532594681)","('Competitive_Behavior', 0.0175864826887846)","(['Corporate Governance'], 0.8197813034057617)","('NON-ESG', 0.07234359532594681)","('NON-ESG', 0.0175864826887846)"
Line 1605,"HC-MS-270a.2 Description of code of ethics governing  promotion of off-label use of productsTransparency – Ethics in sales and marketing HC-MS-410a.1 Discussion of process to assess and  manage environmental and human health considerations associated with chemicals in products, and meet demand for sustainable productsProduct Impact – 2030+ commitments; Management of materials of concern HC-MS-410a.2 Total amount of products accepted for  takeback and reused, recycled or donated, broken down by (1) devices and equipment and (2) suppliesProduct Impact – Product takeback Healthy workforce & Communities – Healthy communitiesSASB Disclosure Disclosure requirement Response or disclosure location HC-MS-430a.1 Percentage of (1) entity’s facilities and (2)  Tier I suppliers’ facilities participating in third- party audit programs for manufacturing and product quality95 percent of manufacturing sites and 91 percent of design centers have quality management systems externally certified to either ISO 13485, ISO 9001or ISO 17025.
","('Product_Design_And_Lifecycle_Management', 0.9234721064567566)","('Product_Quality_And_Safety', 0.017189018428325653)","('Selling_Practices_And_Product_Labeling', 0.01589074544608593)","(['Product Stewardship'], 0.9234721064567566)","('NON-ESG', 0.017189018428325653)","('NON-ESG', 0.01589074544608593)"
Line 1606,"HC-MS-270a.2 Description of code of ethics governing  promotion of off-label use of productsTransparency – Ethics in sales and marketing HC-MS-410a.1 Discussion of process to assess and  manage environmental and human health considerations associated with chemicals in products, and meet demand for sustainable productsProduct Impact – 2030+ commitments; Management of materials of concern HC-MS-410a.2 Total amount of products accepted for  takeback and reused, recycled or donated, broken down by (1) devices and equipment and (2) suppliesProduct Impact – Product takeback Healthy workforce & Communities – Healthy communitiesSASB Disclosure Disclosure requirement Response or disclosure location HC-MS-430a.1 Percentage of (1) entity’s facilities and (2)  Tier I suppliers’ facilities participating in third- party audit programs for manufacturing and product quality95 percent of manufacturing sites and 91 percent of design centers have quality management systems externally certified to either ISO 13485, ISO 9001or ISO 17025.
","('Product_Design_And_Lifecycle_Management', 0.8767454028129578)","('Product_Quality_And_Safety', 0.05083523318171501)","('Customer_Welfare', 0.0100322924554348)","(['Product Stewardship'], 0.8767454028129578)","('NON-ESG', 0.05083523318171501)","('NON-ESG', 0.0100322924554348)"
Line 1607,"HC-MS-270a.2 Description of code of ethics governing  promotion of off-label use of productsTransparency – Ethics in sales and marketing HC-MS-410a.1 Discussion of process to assess and  manage environmental and human health considerations associated with chemicals in products, and meet demand for sustainable productsProduct Impact – 2030+ commitments; Management of materials of concern HC-MS-410a.2 Total amount of products accepted for  takeback and reused, recycled or donated, broken down by (1) devices and equipment and (2) suppliesProduct Impact – Product takeback Healthy workforce & Communities – Healthy communitiesSASB Disclosure Disclosure requirement Response or disclosure location HC-MS-430a.1 Percentage of (1) entity’s facilities and (2)  Tier I suppliers’ facilities participating in third- party audit programs for manufacturing and product quality95 percent of manufacturing sites and 91 percent of design centers have quality management systems externally certified to either ISO 13485, ISO 9001or ISO 17025.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6701440811157227)","('Data_Security', 0.027204830199480057)","('Business_Ethics', 0.02603192813694477)","(['Corporate Governance'], 0.6701440811157227)","('NON-ESG', 0.027204830199480057)","('NON-ESG', 0.02603192813694477)"
Line 1608,"These locations will receive audits of their management systems as part of the ongoing certification process.
","('Product_Quality_And_Safety', 0.2786150872707367)","('Management_Of_Legal_And_Regulatory_Framework', 0.20846524834632874)","('Business_Ethics', 0.1671680063009262)","('NON-ESG', 0.2786150872707367)","('NON-ESG', 0.20846524834632874)","('NON-ESG', 0.1671680063009262)"
Line 1609,"Supplier quality audits are carried out by an internal BD team  using a risk-based approach determined by the goods or service.
","('Supply_Chain_Management', 0.882964551448822)","('Labor_Practices', 0.014757541939616203)","('Product_Quality_And_Safety', 0.010769869200885296)","(['Supply Chain Management'], 0.882964551448822)","('NON-ESG', 0.014757541939616203)","('NON-ESG', 0.010769869200885296)"
Line 1610,"Supplier quality audits are part of a comprehensive supplier management approach that also includes monitoring of key metrics and supplier corrective action as required.
","('Supply_Chain_Management', 0.9334007501602173)","('Labor_Practices', 0.009911416098475456)","('Waste_And_Hazardous_Materials_Management', 0.004594199359416962)","(['Supply Chain Management'], 0.9334007501602173)","('NON-ESG', 0.009911416098475456)","('NON-ESG', 0.004594199359416962)"
Line 1611,"Product Impact – Product safety HC-MS-430a.2 Description of efforts to maintain  traceability within the distribution chainBD has implemented a series of procedures and technology  solutions to ensure end-to-end identification and traceability of materials and products throughout the supply chain.
","('Product_Quality_And_Safety', 0.43714362382888794)","('Product_Design_And_Lifecycle_Management', 0.4018948972225189)","('Selling_Practices_And_Product_Labeling', 0.034239742904901505)","('NON-ESG', 0.43714362382888794)","('NON-ESG', 0.4018948972225189)","('NON-ESG', 0.034239742904901505)"
Line 1612,"Our procedures describe assignment of stock keeping unit (SKU) level material, product and batch unique identifiers, as well as how these identifiers are managed within our enterprise resource planning (ERP) systems.
","('Product_Design_And_Lifecycle_Management', 0.3433234691619873)","('Selling_Practices_And_Product_Labeling', 0.1414882391691208)","('Product_Quality_And_Safety', 0.11996733397245407)","('NON-ESG', 0.3433234691619873)","('NON-ESG', 0.1414882391691208)","('NON-ESG', 0.11996733397245407)"
Line 1613,"These traceability and identification principles also include BD’s purchased finished goods.
","('Customer_Privacy', 0.3421802222728729)","('Data_Security', 0.21198931336402893)","('Waste_And_Hazardous_Materials_Management', 0.08365711569786072)","('NON-ESG', 0.3421802222728729)","('NON-ESG', 0.21198931336402893)","('NON-ESG', 0.08365711569786072)"
Line 1614,"Traceability is maintained throughout all stages of manufacturing, storage and distribution, from receipt through and including installation, return and repair (where applicable).
","('Waste_And_Hazardous_Materials_Management', 0.5127685070037842)","('Water_And_Wastewater_Management', 0.11659970879554749)","('Product_Design_And_Lifecycle_Management', 0.07921881228685379)","(['Operational Eco-Efficiency'], 0.5127685070037842)","('NON-ESG', 0.11659970879554749)","('NON-ESG', 0.07921881228685379)"
Line 1615,"Additionally, BD has acquired and deployed a control tower solution which monitors and tracks real-time shipments across ocean, air and ground to internal and customer ship-to addresses.
","('Waste_And_Hazardous_Materials_Management', 0.39903485774993896)","('Supply_Chain_Management', 0.14352142810821533)","('Product_Design_And_Lifecycle_Management', 0.04628089442849159)","('NON-ESG', 0.39903485774993896)","('NON-ESG', 0.14352142810821533)","('NON-ESG', 0.04628089442849159)"
Line 1616,"HC-MS-430a.3 Description of the management of risks  associated with the use of critical materialsResponsible Supply Chain – Responsible sourcing HC-MS-510a.1 Total amount of monetary losses as a result  of legal proceedings associated with bribery or corruptionWhile we have implemented, and continue to improve upon, programs and management systems around ethics and compliance, we may, on occasion, be subject to legal actions.
","('Business_Ethics', 0.9743524789810181)","('Data_Security', 0.0020289679523557425)","('Product_Quality_And_Safety', 0.001846667961217463)","(['Business Ethics'], 0.9743524789810181)","('NON-ESG', 0.0020289679523557425)","('NON-ESG', 0.001846667961217463)"
Line 1617,"For a description of certain legal actions, see our Annual Report on Form 10-K for our 2021 fiscal year and our subsequent SEC filings.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8197813034057617)","('Business_Ethics', 0.07234359532594681)","('Competitive_Behavior', 0.0175864826887846)","(['Corporate Governance'], 0.8197813034057617)","('NON-ESG', 0.07234359532594681)","('NON-ESG', 0.0175864826887846)"
Line 1618,"For further information about antibribery and anticorruption,  see Transparency – Ethics and compliance.
","('Business_Ethics', 0.9700297713279724)","('Management_Of_Legal_And_Regulatory_Framework', 0.004486332181841135)","('Director_Removal', 0.002181645017117262)","(['Business Ethics'], 0.9700297713279724)","('NON-ESG', 0.004486332181841135)","('NON-ESG', 0.002181645017117262)"
Line 1619,"HC-MS-510a.2 Description of code of ethics governing  interactions with healthcare professionalsTransparency – Ethics in sales and marketing2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities TCFD disclosures The disclosures in this report follow the recommendations and guidance set out in “Implementing the Recommendations of the Task Force on Climate-related Financial Disclosures” (October 2021).
","('Physical_Impacts_Of_Climate_Change', 0.8996474742889404)","('Supply_Chain_Management', 0.014170525595545769)","('Business_Model_Resilience', 0.010454905219376087)","(['Climate Change'], 0.8996474742889404)","('NON-ESG', 0.014170525595545769)","('NON-ESG', 0.010454905219376087)"
Line 1620,"Governance At the Board level, the Corporate Governance and Nominating Committee  has oversight responsibility for the processes, policies and practices related to climate change, and will receive updates on topics concerning climate change at least annually.
","('Physical_Impacts_Of_Climate_Change', 0.9534165859222412)","('Business_Model_Resilience', 0.009908689185976982)","('GHG_Emissions', 0.003910284489393234)","(['Climate Change'], 0.9534165859222412)","('NON-ESG', 0.009908689185976982)","('NON-ESG', 0.003910284489393234)"
Line 1621,"The full Board also receives reports on topics concerning climate change at  least annually.
","('Physical_Impacts_Of_Climate_Change', 0.9538278579711914)","('Business_Model_Resilience', 0.008061918430030346)","('GHG_Emissions', 0.005014464724808931)","(['Climate Change'], 0.9538278579711914)","('NON-ESG', 0.008061918430030346)","('NON-ESG', 0.005014464724808931)"
Line 1622,"At the management level, the ERC provides oversight of our enterprise risk  management (ERM) program, our 2030+ commitments and goals, and other ESG priority matters—these include climate change.
","('Physical_Impacts_Of_Climate_Change', 0.9521383047103882)","('Business_Model_Resilience', 0.010073544457554817)","('Systemic_Risk_Management', 0.0046831280924379826)","(['Climate Change'], 0.9521383047103882)","('NON-ESG', 0.010073544457554817)","('NON-ESG', 0.0046831280924379826)"
Line 1623,"The ERC is responsible for reporting to the Board and its committees on management of ESG risks and overseeing external and internal reporting on climate change.
","('Physical_Impacts_Of_Climate_Change', 0.9542145729064941)","('Business_Model_Resilience', 0.008799955248832703)","('Systemic_Risk_Management', 0.004689193330705166)","(['Climate Change'], 0.9542145729064941)","('NON-ESG', 0.008799955248832703)","('NON-ESG', 0.004689193330705166)"
Line 1624,"Further details about Board oversight of ESG matters and the ERC can be  found here.
","('Director_Removal', 0.487945556640625)","('Management_Of_Legal_And_Regulatory_Framework', 0.2119794487953186)","('Business_Ethics', 0.0380585752427578)","('NON-ESG', 0.487945556640625)","('NON-ESG', 0.2119794487953186)","('NON-ESG', 0.0380585752427578)"
Line 1625,"The VP S&EHS leads the company’s strategy around climate change.
","('Physical_Impacts_Of_Climate_Change', 0.9533246755599976)","('Business_Model_Resilience', 0.008765343576669693)","('GHG_Emissions', 0.005096381064504385)","(['Climate Change'], 0.9533246755599976)","('NON-ESG', 0.008765343576669693)","('NON-ESG', 0.005096381064504385)"
Line 1626,"The VP  S&EHS reports to the company’s EVP ISC.
","('Management_Of_Legal_And_Regulatory_Framework', 0.909860372543335)","('Business_Ethics', 0.011032438836991787)","('Competitive_Behavior', 0.009045248851180077)","(['Corporate Governance'], 0.909860372543335)","('NON-ESG', 0.011032438836991787)","('NON-ESG', 0.009045248851180077)"
Line 1627,"This position reports to the CEO and is part of the company’s Executive Leadership team.
","('Director_Removal', 0.5997492074966431)","('Business_Model_Resilience', 0.06801282614469528)","('Employee_Engagement_Inclusion_And_Diversity', 0.06439246237277985)","(['Anti-Crime Policy & Measures'], 0.5997492074966431)","('NON-ESG', 0.06801282614469528)","('NON-ESG', 0.06439246237277985)"
Line 1628,"The CEO is also chair of our Board of Directors.
","('Director_Removal', 0.7255454063415527)","('Business_Model_Resilience', 0.031759537756443024)","('Employee_Engagement_Inclusion_And_Diversity', 0.028313439339399338)","(['Anti-Crime Policy & Measures'], 0.7255454063415527)","('NON-ESG', 0.031759537756443024)","('NON-ESG', 0.028313439339399338)"
Line 1629,"As important matters arise, such as climate issues impacting business continuity  or regulatory updates that could impact the company’s strategy, the VP S&EHS will brief the ERC as needed; the ERC chairperson will brief the relevant Board committee and the full Board if applicable.
","('Physical_Impacts_Of_Climate_Change', 0.9078125357627869)","('Business_Model_Resilience', 0.02546905167400837)","('Systemic_Risk_Management', 0.007817847654223442)","(['Climate Change'], 0.9078125357627869)","('NON-ESG', 0.02546905167400837)","('NON-ESG', 0.007817847654223442)"
Line 1630,"The following central teams have responsibility for management of climate  change emissions and the identification and management of risks related to specific areas of our value chain.
","('Physical_Impacts_Of_Climate_Change', 0.9513565301895142)","('Business_Model_Resilience', 0.010336262173950672)","('GHG_Emissions', 0.005231951829046011)","(['Climate Change'], 0.9513565301895142)","('NON-ESG', 0.010336262173950672)","('NON-ESG', 0.005231951829046011)"
Line 1631,"The S&EHS team is resourced to address a number of broad areas of focus  regarding climate change, including: •  st akeholder engagement and reporting; •  human rights; and •  sust ainable operations.
","('Physical_Impacts_Of_Climate_Change', 0.9229492545127869)","('Human_Rights_And_Community_Relations', 0.012936001643538475)","('Business_Model_Resilience', 0.010491029359400272)","(['Climate Change'], 0.9229492545127869)","('NON-ESG', 0.012936001643538475)","('NON-ESG', 0.010491029359400272)"
Line 1632,"This team is responsible for compiling our greenhouse gas (GHG) inventory and  working with BD sites to reduce emissions through energy reduction and renewable energy projects.
","('GHG_Emissions', 0.9705660343170166)","('Ecological_Impacts', 0.0036165097262710333)","('Air_Quality', 0.003305434249341488)","(['Climate Change'], 0.9705660343170166)","('NON-ESG', 0.0036165097262710333)","('NON-ESG', 0.003305434249341488)"
Line 1633,"This team also partners with central and business teams to incorporate climate risks, such as extreme weather, into business continuity planning programs.
","('Physical_Impacts_Of_Climate_Change', 0.9188307523727417)","('Business_Model_Resilience', 0.027982033789157867)","('Systemic_Risk_Management', 0.006302444264292717)","(['Climate Change'], 0.9188307523727417)","('NON-ESG', 0.027982033789157867)","('NON-ESG', 0.006302444264292717)"
Line 1634,"The S&EHS team also works with the ERM team to provide input on risks and opportunities related to climate change through our company’s ERM program.
","('Physical_Impacts_Of_Climate_Change', 0.9526549577713013)","('Business_Model_Resilience', 0.009137348271906376)","('Systemic_Risk_Management', 0.005281457211822271)","(['Climate Change'], 0.9526549577713013)","('NON-ESG', 0.009137348271906376)","('NON-ESG', 0.005281457211822271)"
Line 1635,"The central S&EHS team also oversees the Sustainability Operations Council.
","('Business_Model_Resilience', 0.2595526874065399)","('Management_Of_Legal_And_Regulatory_Framework', 0.11116848886013031)","('Director_Removal', 0.09778435528278351)","('NON-ESG', 0.2595526874065399)","('NON-ESG', 0.11116848886013031)","('NON-ESG', 0.09778435528278351)"
Line 1636,"Sponsored by the VP S&EHS and chaired by the senior director, sustainability operations, the Council consists of representatives from each business team on behalf of our manufacturing facilities, distribution center and large campus locations.
","('Supply_Chain_Management', 0.2837720215320587)","('Product_Design_And_Lifecycle_Management', 0.14125853776931763)","('Business_Model_Resilience', 0.12875895202159882)","('NON-ESG', 0.2837720215320587)","('NON-ESG', 0.14125853776931763)","('NON-ESG', 0.12875895202159882)"
Line 1637,"The Council tracks performance against Scope 1 and 2 targets and aligns resources to build a multiyear pipeline of sustainability projects to achieve our 2030+ climate change management goals.
","('Physical_Impacts_Of_Climate_Change', 0.9221327304840088)","('Business_Model_Resilience', 0.01884833164513111)","('GHG_Emissions', 0.013970048166811466)","(['Climate Change'], 0.9221327304840088)","('NON-ESG', 0.01884833164513111)","('NON-ESG', 0.013970048166811466)"
Line 1638,"The central Procurement team is responsible for tracking Scope 3, category 1  emissions from Purchased Goods and Services and partnering with our suppliers to lower those emissions.
","('Product_Design_And_Lifecycle_Management', 0.2395220696926117)","('Supply_Chain_Management', 0.237979918718338)","('Energy_Management', 0.140874981880188)","('NON-ESG', 0.2395220696926117)","('NON-ESG', 0.237979918718338)","('NON-ESG', 0.140874981880188)"
Line 1639,"The S&EHS team also partners with the central Procurement team on the development and implementation of our energy demand reduction and renewables strategy.The central Procurement team also oversees the Responsible Sourcing Operating Committee, which has been established to guide and facilitate the human rights supplier due diligence and reduction efforts of our Scope 3, category 1 emissions.
","('Supply_Chain_Management', 0.9367848634719849)","('Product_Design_And_Lifecycle_Management', 0.009459742344915867)","('Business_Model_Resilience', 0.004400302655994892)","(['Supply Chain Management'], 0.9367848634719849)","('NON-ESG', 0.009459742344915867)","('NON-ESG', 0.004400302655994892)"
Line 1640,"The Committee is chaired by the director, procurement effectiveness.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5108729004859924)","('Supply_Chain_Management', 0.08370552211999893)","('Competitive_Behavior', 0.037728987634181976)","(['Corporate Governance'], 0.5108729004859924)","('NON-ESG', 0.08370552211999893)","('NON-ESG', 0.037728987634181976)"
Line 1641,"Overall progress and major action items are reported to the SVP of global procurement and to the VP S&EHS on a quarterly basis.
","('Management_Of_Legal_And_Regulatory_Framework', 0.42594674229621887)","('Supply_Chain_Management', 0.19588620960712433)","('Product_Design_And_Lifecycle_Management', 0.05049806460738182)","('NON-ESG', 0.42594674229621887)","('NON-ESG', 0.19588620960712433)","('NON-ESG', 0.05049806460738182)"
Line 1642,"Further details on Scope 3, category 1 emission reduction programs can be found  in the Responsible Supply Chain section.
","('Air_Quality', 0.8520119190216064)","('Energy_Management', 0.04541381821036339)","('GHG_Emissions', 0.04237664118409157)","(['Operational Eco-Efficiency'], 0.8520119190216064)","('NON-ESG', 0.04541381821036339)","('NON-ESG', 0.04237664118409157)"
Line 1643,"The central Supply Chain team is responsible for tracking Scope 3, category  4 and 9 emissions from upstream and downstream transportation and distribution, and reducing those emissions.
","('Supply_Chain_Management', 0.9024704098701477)","('GHG_Emissions', 0.019429195672273636)","('Physical_Impacts_Of_Climate_Change', 0.008495135232806206)","(['Supply Chain Management'], 0.9024704098701477)","('NON-ESG', 0.019429195672273636)","('NON-ESG', 0.008495135232806206)"
Line 1644,"This team is also responsible for reducing Scope 1 and 2 emissions from our distribution centers.
","('GHG_Emissions', 0.678933322429657)","('Air_Quality', 0.158604696393013)","('Energy_Management', 0.05012008920311928)","(['Climate Change'], 0.678933322429657)","('NON-ESG', 0.158604696393013)","('NON-ESG', 0.05012008920311928)"
Line 1645,"Further details on category 4 and 9 emission reduction programs can be found in the Responsible Supply Chain section.
","('Air_Quality', 0.876807451248169)","('Energy_Management', 0.04090151935815811)","('GHG_Emissions', 0.02431362308561802)","(['Operational Eco-Efficiency'], 0.876807451248169)","('NON-ESG', 0.04090151935815811)","('NON-ESG', 0.02431362308561802)"
Line 1646,"The central R&D team is responsible for establishing and tracking emissions for  Scope 3, category 11 and 12 emissions from use of and end-of-life disposal of products.
","('Product_Design_And_Lifecycle_Management', 0.9506133794784546)","('Energy_Management', 0.007278727367520332)","('Product_Quality_And_Safety', 0.0054085287265479565)","(['Product Stewardship'], 0.9506133794784546)","('NON-ESG', 0.007278727367520332)","('NON-ESG', 0.0054085287265479565)"
Line 1647,"The central R&D team will coordinate with business teams on this work via the Sustainable Medical Technology Institute.
","('Product_Design_And_Lifecycle_Management', 0.2596209645271301)","('Supply_Chain_Management', 0.12263555824756622)","('Access_And_Affordability', 0.11654584109783173)","('NON-ESG', 0.2596209645271301)","('NON-ESG', 0.12263555824756622)","('NON-ESG', 0.11654584109783173)"
Line 1648,"The central R&D team also partners with business teams on life cycle assessments of products.
","('Product_Design_And_Lifecycle_Management', 0.9620357155799866)","('Supply_Chain_Management', 0.004039861261844635)","('Product_Quality_And_Safety', 0.003622589632868767)","(['Product Stewardship'], 0.9620357155799866)","('NON-ESG', 0.004039861261844635)","('NON-ESG', 0.003622589632868767)"
Line 1649,"The central R&D and S&EHS teams have established a Product Impacts Council  to support and track progress toward achieving our 2030+ product impact goals.
","('Product_Design_And_Lifecycle_Management', 0.9508152008056641)","('Product_Quality_And_Safety', 0.00791292916983366)","('Business_Model_Resilience', 0.004308705218136311)","(['Product Stewardship'], 0.9508152008056641)","('NON-ESG', 0.00791292916983366)","('NON-ESG', 0.004308705218136311)"
Line 1650,"This includes establishing baselines and targets for Scope 3, category 11 and 12 emissions and establishing a life cycle assessment community of practice to support the business teams.
","('GHG_Emissions', 0.9082323908805847)","('Air_Quality', 0.013775237835943699)","('Management_Of_Legal_And_Regulatory_Framework', 0.011198712512850761)","(['Climate Change'], 0.9082323908805847)","('NON-ESG', 0.013775237835943699)","('NON-ESG', 0.011198712512850761)"
Line 1651,"The Council is sponsored by the executive vice president and chief technology officer, and the EVP ISC.
","('Management_Of_Legal_And_Regulatory_Framework', 0.33490094542503357)","('Director_Removal', 0.3307085633277893)","('Employee_Engagement_Inclusion_And_Diversity', 0.03506084159016609)","('NON-ESG', 0.33490094542503357)","('NON-ESG', 0.3307085633277893)","('NON-ESG', 0.03506084159016609)"
Line 1652,"The teams listed above report on progress at least annually to the ERC and on  specific risks as necessary.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Strategy A summary of climate risks and opportunities that could have a substantive impact  on our business is outlined below.
","('Physical_Impacts_Of_Climate_Change', 0.9185383319854736)","('Supply_Chain_Management', 0.020087292417883873)","('Business_Model_Resilience', 0.01210843026638031)","(['Climate Change'], 0.9185383319854736)","('NON-ESG', 0.020087292417883873)","('NON-ESG', 0.01210843026638031)"
Line 1653,"We define substantive strategic risk as climate-related risks that have more  variability and uncertainty over a longer time frame than is normally considered for financial risk.
","('Physical_Impacts_Of_Climate_Change', 0.919126033782959)","('Business_Model_Resilience', 0.022578079253435135)","('Systemic_Risk_Management', 0.0158248171210289)","(['Climate Change'], 0.919126033782959)","('NON-ESG', 0.022578079253435135)","('NON-ESG', 0.0158248171210289)"
Line 1654,"The majority of disclosures in this report fall under the category of substantive strategic risk.
","('Systemic_Risk_Management', 0.6628676652908325)","('Business_Model_Resilience', 0.19276972115039825)","('Supply_Chain_Management', 0.02540775015950203)","(['Risk & Crisis Management'], 0.6628676652908325)","('NON-ESG', 0.19276972115039825)","('NON-ESG', 0.02540775015950203)"
Line 1655,"Any risk or opportunity that could result in a change in business operations,  revenue or expenditure, thereby prompting disclosure in other company filings (e.g., 10-K) may be considered financially substantive for the purposes of TCFD-recommended and CDP disclosures.
","('Systemic_Risk_Management', 0.5200252532958984)","('Business_Model_Resilience', 0.2958500385284424)","('Physical_Impacts_Of_Climate_Change', 0.03149669989943504)","(['Risk & Crisis Management'], 0.5200252532958984)","('NON-ESG', 0.2958500385284424)","('NON-ESG', 0.03149669989943504)"
Line 1656,"This applies to both supply chain and direct operations.When considering climate-related risks and opportunities, we define the magnitude of potential impact as follows: •  Low – insignificant impact on revenues and/or minor disruption of operations.
","('Supply_Chain_Management', 0.9075552821159363)","('Physical_Impacts_Of_Climate_Change', 0.028303105384111404)","('Systemic_Risk_Management', 0.009073385037481785)","(['Supply Chain Management'], 0.9075552821159363)","('NON-ESG', 0.028303105384111404)","('NON-ESG', 0.009073385037481785)"
Line 1657,"•  Medium – some impact on r evenues and/or some disruption to operations, likely  limited to a geographic region and/or number of business units.
","('Business_Model_Resilience', 0.5730810761451721)","('Systemic_Risk_Management', 0.17778438329696655)","('Supply_Chain_Management', 0.04879717156291008)","(['Codes of Business Conduct'], 0.5730810761451721)","('NON-ESG', 0.17778438329696655)","('NON-ESG', 0.04879717156291008)"
Line 1658,"This may result  in disclosure in financial reports.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5176220536231995)","('Systemic_Risk_Management', 0.1591140478849411)","('Business_Model_Resilience', 0.05333765596151352)","(['Corporate Governance'], 0.5176220536231995)","('NON-ESG', 0.1591140478849411)","('NON-ESG', 0.05333765596151352)"
Line 1659,"•  High – signific ant impact on revenues and/or severe disruption to operations,  likely affecting multiple regions and/or business units.
","('Systemic_Risk_Management', 0.5201181769371033)","('Business_Model_Resilience', 0.2765309810638428)","('Supply_Chain_Management', 0.04610707238316536)","(['Risk & Crisis Management'], 0.5201181769371033)","('NON-ESG', 0.2765309810638428)","('NON-ESG', 0.04610707238316536)"
Line 1660,"This will likely result in disclosures in financial reports.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6125870943069458)","('Systemic_Risk_Management', 0.09064736217260361)","('Business_Model_Resilience', 0.056167714297771454)","(['Corporate Governance'], 0.6125870943069458)","('NON-ESG', 0.09064736217260361)","('NON-ESG', 0.056167714297771454)"
Line 1661,"We consider a short-term horizon to be up to three years in the context of climate-related risks and opportunities.
","('Physical_Impacts_Of_Climate_Change', 0.9113390445709229)","('Business_Model_Resilience', 0.02962200529873371)","('Systemic_Risk_Management', 0.011082181707024574)","(['Climate Change'], 0.9113390445709229)","('NON-ESG', 0.02962200529873371)","('NON-ESG', 0.011082181707024574)"
Line 1662,"This is in alignment with other general financial planning and business practices (such as financial planning for energy-efficiency projects).Medium-term time horizons are defined as three to 10 years in alignment with general financial planning and business processes with a medium-term outlook, such as power purchase agreements, which often have terms of around 10 years.
","('Energy_Management', 0.9347482323646545)","('Management_Of_Legal_And_Regulatory_Framework', 0.01794377528131008)","('Product_Design_And_Lifecycle_Management', 0.005435350351035595)","(['Operational Eco-Efficiency'], 0.9347482323646545)","('NON-ESG', 0.01794377528131008)","('NON-ESG', 0.005435350351035595)"
Line 1663,"Long-term time horizons are aligned with other business practices and long-term  goals.
","('Business_Model_Resilience', 0.7723588943481445)","('Supply_Chain_Management', 0.0426967553794384)","('Product_Design_And_Lifecycle_Management', 0.025706419721245766)","(['Codes of Business Conduct'], 0.7723588943481445)","('NON-ESG', 0.0426967553794384)","('NON-ESG', 0.025706419721245766)"
Line 1664,"For example, our company’s 2030+ goals with a 2019 baseline and carbon neutrality goals fit into a long-term time horizon.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Risks Where the risk occurs in the  value chainDirect operations Risk type Acute physical Climate-related driver Increased severity and frequency of extreme weather events such as cyclones and floods Potential financial impact Decreased revenues due to reduced production capacity Time horizon Medium-term Likelihood About as likely as not Magnitude of impact Low – medium Description There is evidence to suggest that climate change is already impacting the frequency and severity of tropical storms.
","('Physical_Impacts_Of_Climate_Change', 0.9231201410293579)","('Business_Model_Resilience', 0.019305318593978882)","('Supply_Chain_Management', 0.012575234286487103)","(['Climate Change'], 0.9231201410293579)","('NON-ESG', 0.019305318593978882)","('NON-ESG', 0.012575234286487103)"
Line 1665,"For example, our company’s 2030+ goals with a 2019 baseline and carbon neutrality goals fit into a long-term time horizon.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Risks Where the risk occurs in the  value chainDirect operations Risk type Acute physical Climate-related driver Increased severity and frequency of extreme weather events such as cyclones and floods Potential financial impact Decreased revenues due to reduced production capacity Time horizon Medium-term Likelihood About as likely as not Magnitude of impact Low – medium Description There is evidence to suggest that climate change is already impacting the frequency and severity of tropical storms.
","('Physical_Impacts_Of_Climate_Change', 0.9331833124160767)","('Business_Model_Resilience', 0.020631421357393265)","('GHG_Emissions', 0.005207710433751345)","(['Climate Change'], 0.9331833124160767)","('NON-ESG', 0.020631421357393265)","('NON-ESG', 0.005207710433751345)"
Line 1666,"The impact of an extreme weather event on healthcare was exemplified by hurricane Maria.
","('Physical_Impacts_Of_Climate_Change', 0.8785732984542847)","('Business_Model_Resilience', 0.04152659699320793)","('Critical_Incident_Risk_Management', 0.008166352286934853)","(['Climate Change'], 0.8785732984542847)","('NON-ESG', 0.04152659699320793)","('NON-ESG', 0.008166352286934853)"
Line 1667,"As reported  in the results for our first fiscal quarter in 2018, costs of $7 million were incurred as a result of hurricane-related damage to our production facilities in Puerto Rico from Hurricane Maria.
","('Physical_Impacts_Of_Climate_Change', 0.9214360117912292)","('Critical_Incident_Risk_Management', 0.013155222870409489)","('Business_Model_Resilience', 0.010893001221120358)","(['Climate Change'], 0.9214360117912292)","('NON-ESG', 0.013155222870409489)","('NON-ESG', 0.010893001221120358)"
Line 1668,"We have manufacturing sites all over the world.
","('Product_Design_And_Lifecycle_Management', 0.5194280743598938)","('Supply_Chain_Management', 0.20629987120628357)","('Waste_And_Hazardous_Materials_Management', 0.03865138441324234)","(['Product Stewardship'], 0.5194280743598938)","('NON-ESG', 0.20629987120628357)","('NON-ESG', 0.03865138441324234)"
Line 1669,"In some instances, the manufacturing of certain of our product lines is concentrated in one or more of our plants.
","('Product_Design_And_Lifecycle_Management', 0.9461367130279541)","('Selling_Practices_And_Product_Labeling', 0.007884659804403782)","('Customer_Welfare', 0.006770993582904339)","(['Product Stewardship'], 0.9461367130279541)","('NON-ESG', 0.007884659804403782)","('NON-ESG', 0.006770993582904339)"
Line 1670,"Interruptions to our manufacturing operations resulting from weather or natural disasters, regulatory requirements or issues in our manufacturing process, equipment failure or other factors, could adversely affect our ability to manufacture our products.
","('Product_Design_And_Lifecycle_Management', 0.9240576028823853)","('Product_Quality_And_Safety', 0.013078710064291954)","('Selling_Practices_And_Product_Labeling', 0.01022289413958788)","(['Product Stewardship'], 0.9240576028823853)","('NON-ESG', 0.013078710064291954)","('NON-ESG', 0.01022289413958788)"
Line 1671,"In some instances, we may not be able to transition manufacturing to other BD sites or a third party to replace the lost production.
","('Energy_Management', 0.24867276847362518)","('Supply_Chain_Management', 0.23974843323230743)","('Product_Design_And_Lifecycle_Management', 0.22783544659614563)","('NON-ESG', 0.24867276847362518)","('NON-ESG', 0.23974843323230743)","('NON-ESG', 0.22783544659614563)"
Line 1672,"A significant interruption of our manufacturing operations could result in lost revenues and damage to our relationship with customers.
","('Supply_Chain_Management', 0.19965460896492004)","('Product_Design_And_Lifecycle_Management', 0.19906027615070343)","('Business_Model_Resilience', 0.11357136815786362)","('NON-ESG', 0.19965460896492004)","('NON-ESG', 0.19906027615070343)","('NON-ESG', 0.11357136815786362)"
Line 1673,"In addition, many of our products require sterilization prior to sale, and we utilize both BD facilities and third parties for this process.
","('Product_Design_And_Lifecycle_Management', 0.33815237879753113)","('Product_Quality_And_Safety', 0.2970290184020996)","('Selling_Practices_And_Product_Labeling', 0.10488466918468475)","('NON-ESG', 0.33815237879753113)","('NON-ESG', 0.2970290184020996)","('NON-ESG', 0.10488466918468475)"
Line 1674,"In some instances, only a few facilities are qualified under applicable regulations to conduct this sterilization.
","('Employee_Health_And_Safety', 0.6777957677841187)","('Access_And_Affordability', 0.061557587236166)","('Waste_And_Hazardous_Materials_Management', 0.04233212769031525)","(['Operational Eco-Efficiency'], 0.6777957677841187)","('NON-ESG', 0.061557587236166)","('NON-ESG', 0.04233212769031525)"
Line 1675,"To the extent we or third parties are unable to sterilize our products, whether due to lack of capacity (e.g., caused by disruption from an extreme weather event), regulatory requirements (e.g., related to reducing greenhouse gas emissions) or otherwise, we may be unable to transition sterilization to other sites or modalities in a timeline- or cost-effective manner, or at all, which could have an adverse impact on our operating results.
","('Product_Design_And_Lifecycle_Management', 0.27555373311042786)","('Product_Quality_And_Safety', 0.2222372591495514)","('Selling_Practices_And_Product_Labeling', 0.11716123670339584)","('NON-ESG', 0.27555373311042786)","('NON-ESG', 0.2222372591495514)","('NON-ESG', 0.11716123670339584)"
Line 1676,"Our response Our 2030+ commitments and goals include targets to reduce GHG emissions across our value chain, in addition to a commitment to creating a supply chain that is adaptable to disruption and able to contribute to strong environmental and social performance; this includes a goal to incorporate climate risk into supply chain and network architecture strategies.
","('Supply_Chain_Management', 0.8136591911315918)","('GHG_Emissions', 0.07032103091478348)","('Physical_Impacts_Of_Climate_Change', 0.02227584458887577)","(['Supply Chain Management'], 0.8136591911315918)","('NON-ESG', 0.07032103091478348)","('NON-ESG', 0.02227584458887577)"
Line 1677,"Hurricane Maria demonstrated how important it is to continue our work in this area, in order to manage and reduce risk from future extreme-weather-related events around the world.
","('Physical_Impacts_Of_Climate_Change', 0.9111757874488831)","('Business_Model_Resilience', 0.021251868456602097)","('Critical_Incident_Risk_Management', 0.012127969413995743)","(['Climate Change'], 0.9111757874488831)","('NON-ESG', 0.021251868456602097)","('NON-ESG', 0.012127969413995743)"
Line 1678,"Risks to our operations, including  those caused by potential natural disasters, are identified as part of our Enterprise Risk Management process.
","('Physical_Impacts_Of_Climate_Change', 0.6025091409683228)","('Critical_Incident_Risk_Management', 0.25563758611679077)","('Supply_Chain_Management', 0.022013632580637932)","(['Climate Change'], 0.6025091409683228)","('NON-ESG', 0.25563758611679077)","('NON-ESG', 0.022013632580637932)"
Line 1679,"Each BD facility that is in an area of risk for natural disasters has a crisis/emergency plan specific to its location.
","('Critical_Incident_Risk_Management', 0.975373387336731)","('Physical_Impacts_Of_Climate_Change', 0.0022818068973720074)","('Air_Quality', 0.002264361595734954)","(['Risk & Crisis Management'], 0.975373387336731)","('NON-ESG', 0.0022818068973720074)","('NON-ESG', 0.002264361595734954)"
Line 1680,"If needed, we also implement projects that increase or improve our backup systems and resilience to physical extremes.
","('Business_Model_Resilience', 0.8985808491706848)","('Physical_Impacts_Of_Climate_Change', 0.014365307055413723)","('Product_Design_And_Lifecycle_Management', 0.010064606554806232)","(['Codes of Business Conduct'], 0.8985808491706848)","('NON-ESG', 0.014365307055413723)","('NON-ESG', 0.010064606554806232)"
Line 1681,"Case study: We are continuously increasing the resilience of our facilities by investing in resilience projects.
","('Business_Model_Resilience', 0.9020683765411377)","('Product_Design_And_Lifecycle_Management', 0.012203458696603775)","('Physical_Impacts_Of_Climate_Change', 0.011502111330628395)","(['Codes of Business Conduct'], 0.9020683765411377)","('NON-ESG', 0.012203458696603775)","('NON-ESG', 0.011502111330628395)"
Line 1682,"For example, a CHP unit in our Drogheda, Ireland, location will reduce reliance on the power grid and increase  resilience; by producing our own energy on-site, we are able to continue to operate in situations causing energy outages, such as extreme weather.
","('Energy_Management', 0.9506563544273376)","('Physical_Impacts_Of_Climate_Change', 0.004343452863395214)","('Air_Quality', 0.004270233679562807)","(['Operational Eco-Efficiency'], 0.9506563544273376)","('NON-ESG', 0.004343452863395214)","('NON-ESG', 0.004270233679562807)"
Line 1683,"We are also updating our strategy to incorporate climate-change considerations.
","('Physical_Impacts_Of_Climate_Change', 0.9431524276733398)","('Business_Model_Resilience', 0.013864155858755112)","('GHG_Emissions', 0.0076691643334925175)","(['Climate Change'], 0.9431524276733398)","('NON-ESG', 0.013864155858755112)","('NON-ESG', 0.0076691643334925175)"
Line 1684,"BD undertook climate scenario analysis to better understand how climate-related risks (such as climate-induced water scarcity) and opportunities could impact the business.
","('Physical_Impacts_Of_Climate_Change', 0.8728193044662476)","('Supply_Chain_Management', 0.024897703900933266)","('Business_Model_Resilience', 0.024712489917874336)","(['Climate Change'], 0.8728193044662476)","('NON-ESG', 0.024897703900933266)","('NON-ESG', 0.024712489917874336)"
Line 1685,"BD partnered with BSR, a global nonprofit organization of sustainable business experts that works with its global network of the world’s leading companies to build a just and sustainable world, to develop four scenarios corresponding to warming by 2100 that explored climate-related risks and opportunities, and other key uncertainties for BD’s business.
","('Physical_Impacts_Of_Climate_Change', 0.9391561150550842)","('Business_Model_Resilience', 0.012838209979236126)","('Systemic_Risk_Management', 0.006345975212752819)","(['Climate Change'], 0.9391561150550842)","('NON-ESG', 0.012838209979236126)","('NON-ESG', 0.006345975212752819)"
Line 1686,"These scenarios incorporated credible and publicly available climate projections for emissions reductions and climate impacts.
","('Physical_Impacts_Of_Climate_Change', 0.8415022492408752)","('GHG_Emissions', 0.05540584772825241)","('Business_Model_Resilience', 0.027048058807849884)","(['Climate Change'], 0.8415022492408752)","('NON-ESG', 0.05540584772825241)","('NON-ESG', 0.027048058807849884)"
Line 1687,"These scenarios were reviewed by BD’s management in early 2020 and insights from the scenario analysis were incorporated into the development of BD’s 2030+ commitments and goals.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Where the risk occurs in the  value chainDirect operations Risk type Emerging regulation Climate-related driver Carbon-pricing mechanisms Potential financial impact Increased indirect (operating) costs Time horizon Medium-term Likelihood Exceptionally unlikely Magnitude of impact Low Description Our operations are global and are affected by complex state, federal and international laws relating to various areas, including environmental protection.
","('Physical_Impacts_Of_Climate_Change', 0.9126158356666565)","('Supply_Chain_Management', 0.020794445648789406)","('Business_Model_Resilience', 0.01575421541929245)","(['Climate Change'], 0.9126158356666565)","('NON-ESG', 0.020794445648789406)","('NON-ESG', 0.01575421541929245)"
Line 1688,"These scenarios were reviewed by BD’s management in early 2020 and insights from the scenario analysis were incorporated into the development of BD’s 2030+ commitments and goals.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Where the risk occurs in the  value chainDirect operations Risk type Emerging regulation Climate-related driver Carbon-pricing mechanisms Potential financial impact Increased indirect (operating) costs Time horizon Medium-term Likelihood Exceptionally unlikely Magnitude of impact Low Description Our operations are global and are affected by complex state, federal and international laws relating to various areas, including environmental protection.
","('Ecological_Impacts', 0.821914792060852)","('Management_Of_Legal_And_Regulatory_Framework', 0.036365993320941925)","('Human_Rights_And_Community_Relations', 0.03232662007212639)","(['Natural Capital'], 0.821914792060852)","('NON-ESG', 0.036365993320941925)","('NON-ESG', 0.03232662007212639)"
Line 1689,"Violation of these laws can result in criminal or civil sanctions,  including substantial fines and, in some cases, exclusion from participation in healthcare programs.
","('Management_Of_Legal_And_Regulatory_Framework', 0.8648832440376282)","('Business_Ethics', 0.058940961956977844)","('Human_Rights_And_Community_Relations', 0.00874504167586565)","(['Corporate Governance'], 0.8648832440376282)","('NON-ESG', 0.058940961956977844)","('NON-ESG', 0.00874504167586565)"
Line 1690,"Environmental laws, particularly with respect to the emissions of greenhouse gases, are also becoming more stringent throughout the world, which may increase our costs of operations or necessitate the closures of or changes to our manufacturing plants or processes or those of our suppliers, or result in liability for BD.
","('GHG_Emissions', 0.9639279246330261)","('Ecological_Impacts', 0.005182695109397173)","('Air_Quality', 0.004152588080614805)","(['Climate Change'], 0.9639279246330261)","('NON-ESG', 0.005182695109397173)","('NON-ESG', 0.004152588080614805)"
Line 1691,"The enactment of additional laws in the future may increase our compliance costs or otherwise adversely impact our operations.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9690658450126648)","('Business_Ethics', 0.0027632073033601046)","('Director_Removal', 0.002487371675670147)","(['Corporate Governance'], 0.9690658450126648)","('NON-ESG', 0.0027632073033601046)","('NON-ESG', 0.002487371675670147)"
Line 1692,"Additionally, new laws or regulations adopted in response to climate change could also increase energy and transportation costs, as well as the costs of certain raw materials and components.
","('Physical_Impacts_Of_Climate_Change', 0.9295597076416016)","('Business_Model_Resilience', 0.01252735871821642)","('Supply_Chain_Management', 0.00870829913765192)","(['Climate Change'], 0.9295597076416016)","('NON-ESG', 0.01252735871821642)","('NON-ESG', 0.00870829913765192)"
Line 1693,"In particular, we purchase supplies of resins, which are oil-based components used in the manufacture of certain products, and any significant increases in resin costs could adversely impact future operating results.
","('Product_Design_And_Lifecycle_Management', 0.9560922384262085)","('Customer_Welfare', 0.006080996245145798)","('Product_Quality_And_Safety', 0.00515317777171731)","(['Product Stewardship'], 0.9560922384262085)","('NON-ESG', 0.006080996245145798)","('NON-ESG', 0.00515317777171731)"
Line 1694,"Increases in oil prices can also increase our packaging and transportation costs.
","('Product_Design_And_Lifecycle_Management', 0.8341987729072571)","('Energy_Management', 0.0325520820915699)","('Selling_Practices_And_Product_Labeling', 0.022467749193310738)","(['Product Stewardship'], 0.8341987729072571)","('NON-ESG', 0.0325520820915699)","('NON-ESG', 0.022467749193310738)"
Line 1695,"We may not be able to offset any increases in our operational costs.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5301463007926941)","('Energy_Management', 0.27160200476646423)","('Systemic_Risk_Management', 0.03107365407049656)","(['Corporate Governance'], 0.5301463007926941)","('NON-ESG', 0.27160200476646423)","('NON-ESG', 0.03107365407049656)"
Line 1696,"Local and national governments may implement taxes on fuel and energy to mitigate the impacts of climate change, and these taxes may increase over time in the areas where BD operates.
","('Physical_Impacts_Of_Climate_Change', 0.9228794574737549)","('Business_Model_Resilience', 0.01261228695511818)","('Management_Of_Legal_And_Regulatory_Framework', 0.008776669390499592)","(['Climate Change'], 0.9228794574737549)","('NON-ESG', 0.01261228695511818)","('NON-ESG', 0.008776669390499592)"
Line 1697,"BD is currently subject to regulatory programs in regions we operate, which impacts the cost of utilities, taxes and compliance fines in these regions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9751036763191223)","('Energy_Management', 0.002456790767610073)","('Business_Ethics', 0.0018143620109185576)","(['Corporate Governance'], 0.9751036763191223)","('NON-ESG', 0.002456790767610073)","('NON-ESG', 0.0018143620109185576)"
Line 1698,"While only carbon schemes such as the U.K. CRC have impacted our operations to date, we operate in 16 countries where there is existing carbon regulation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9459231495857239)","('GHG_Emissions', 0.008978147991001606)","('Energy_Management', 0.005920717027038336)","(['Corporate Governance'], 0.9459231495857239)","('NON-ESG', 0.008978147991001606)","('NON-ESG', 0.005920717027038336)"
Line 1699,"In a transition to a low-carbon economy, it is possible that these locations or our global operations may qualify for carbon pricing.
","('Energy_Management', 0.4531778395175934)","('Management_Of_Legal_And_Regulatory_Framework', 0.08242913335561752)","('Systemic_Risk_Management', 0.07617785036563873)","('NON-ESG', 0.4531778395175934)","('NON-ESG', 0.08242913335561752)","('NON-ESG', 0.07617785036563873)"
Line 1700,"We consider this scenario to be extremely unlikely in the medium-term, particularly as it applies to our global operations.
","('Business_Model_Resilience', 0.5979481935501099)","('Systemic_Risk_Management', 0.17536477744579315)","('Physical_Impacts_Of_Climate_Change', 0.040444258600473404)","(['Codes of Business Conduct'], 0.5979481935501099)","('NON-ESG', 0.17536477744579315)","('NON-ESG', 0.040444258600473404)"
Line 1701,"Our response In our climate change impact area, we have set goals to reduce our GHG emissions.
","('GHG_Emissions', 0.949748158454895)","('Physical_Impacts_Of_Climate_Change', 0.011776111088693142)","('Ecological_Impacts', 0.004801185801625252)","(['Climate Change'], 0.949748158454895)","('NON-ESG', 0.011776111088693142)","('NON-ESG', 0.004801185801625252)"
Line 1702,"We will achieve this reduction through two mechanisms – reduced energy demand and increased use of renewables.
","('Energy_Management', 0.9783390760421753)","('Management_Of_Legal_And_Regulatory_Framework', 0.002870870055630803)","('Product_Design_And_Lifecycle_Management', 0.0015983431367203593)","(['Operational Eco-Efficiency'], 0.9783390760421753)","('NON-ESG', 0.002870870055630803)","('NON-ESG', 0.0015983431367203593)"
Line 1703,"Each facility has identified a pipeline of projects aimed at reducing our GHG emissions and will utilize a traditional capital funding process to implement these projects.
","('GHG_Emissions', 0.9666649103164673)","('Air_Quality', 0.004445775877684355)","('Management_Of_Legal_And_Regulatory_Framework', 0.003098340705037117)","(['Climate Change'], 0.9666649103164673)","('NON-ESG', 0.004445775877684355)","('NON-ESG', 0.003098340705037117)"
Line 1704,"This process will continue to increase the number of  projects with potential sustainability benefits and associated cost savings and contribute to BD’s competitiveness both in the short- and long-term.
","('Competitive_Behavior', 0.6780046820640564)","('Business_Model_Resilience', 0.11556239426136017)","('Systemic_Risk_Management', 0.029879244044423103)","(['Business Ethics'], 0.6780046820640564)","('NON-ESG', 0.11556239426136017)","('NON-ESG', 0.029879244044423103)"
Line 1705,"Previous projects have included HVAC replacements, chiller upgrades, compressed-air upgrades and LED installations, in addition to larger projects such as the installation of cogeneration facilities and various major solar  installation projects.
","('Energy_Management', 0.9192700982093811)","('Air_Quality', 0.01809428632259369)","('Management_Of_Legal_And_Regulatory_Framework', 0.006159544922411442)","(['Operational Eco-Efficiency'], 0.9192700982093811)","('NON-ESG', 0.01809428632259369)","('NON-ESG', 0.006159544922411442)"
Line 1706,"As part of our procurement strategy, we evaluate all new energy deals for a green-energy option.
","('Management_Of_Legal_And_Regulatory_Framework', 0.37199848890304565)","('Energy_Management', 0.20243269205093384)","('Systemic_Risk_Management', 0.056994784623384476)","('NON-ESG', 0.37199848890304565)","('NON-ESG', 0.20243269205093384)","('NON-ESG', 0.056994784623384476)"
Line 1707,"We currently purchase green tariffs in Germany, Ireland, Spain, Belgium, the Netherlands and the U.K. In FY 2021, we  invested over $2.5 million in solar and wind energy through power purchase agreements (PPA) and RECs from existing contracts.
","('Energy_Management', 0.9209673404693604)","('Management_Of_Legal_And_Regulatory_Framework', 0.036220137029886246)","('GHG_Emissions', 0.005971209611743689)","(['Operational Eco-Efficiency'], 0.9209673404693604)","('NON-ESG', 0.036220137029886246)","('NON-ESG', 0.005971209611743689)"
Line 1708,"Case study: In FY 2021, we implemented 142 projects that include solar installations, updating building controls, HVAC replacements, lighting retrofits, machine replacements, process optimization and other efficiency  upgrades in the production process.
","('Energy_Management', 0.9471240043640137)","('Product_Design_And_Lifecycle_Management', 0.005836531054228544)","('Air_Quality', 0.005815370008349419)","(['Operational Eco-Efficiency'], 0.9471240043640137)","('NON-ESG', 0.005836531054228544)","('NON-ESG', 0.005815370008349419)"
Line 1709,"The projects were expected to generate a $5.1 million annual saving in energy cost and 19,266 metric tonnes of CO2e reduction starting throughout FY 2021 and into FY 2022.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Where the risk occurs in the  value chainDownstream Risk type Acute physical Climate-related driver Increased severity and frequency of extreme weather events such as cyclones and floods Potential financial impact Decreased revenues due to reduced demand for products and services Time horizon Medium-term Likelihood About as likely as not Magnitude of impact Low – medium Description We sell products to researchers at pharmaceutical and biotechnology companies, academic institutions, government laboratories and private foundations.
","('Physical_Impacts_Of_Climate_Change', 0.9230308532714844)","('Business_Model_Resilience', 0.015450494363904)","('Supply_Chain_Management', 0.013687355443835258)","(['Climate Change'], 0.9230308532714844)","('NON-ESG', 0.015450494363904)","('NON-ESG', 0.013687355443835258)"
Line 1710,"The projects were expected to generate a $5.1 million annual saving in energy cost and 19,266 metric tonnes of CO2e reduction starting throughout FY 2021 and into FY 2022.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Where the risk occurs in the  value chainDownstream Risk type Acute physical Climate-related driver Increased severity and frequency of extreme weather events such as cyclones and floods Potential financial impact Decreased revenues due to reduced demand for products and services Time horizon Medium-term Likelihood About as likely as not Magnitude of impact Low – medium Description We sell products to researchers at pharmaceutical and biotechnology companies, academic institutions, government laboratories and private foundations.
","('Product_Design_And_Lifecycle_Management', 0.8345836997032166)","('Customer_Welfare', 0.0489252507686615)","('Selling_Practices_And_Product_Labeling', 0.02081715501844883)","(['Product Stewardship'], 0.8345836997032166)","('NON-ESG', 0.0489252507686615)","('NON-ESG', 0.02081715501844883)"
Line 1711,"Research and development spending of our customers can  fluctuate based on spending priorities and general economic conditions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5059751272201538)","('Energy_Management', 0.27038392424583435)","('Competitive_Behavior', 0.0419582724571228)","(['Corporate Governance'], 0.5059751272201538)","('NON-ESG', 0.27038392424583435)","('NON-ESG', 0.0419582724571228)"
Line 1712,"A number of these customers are also dependent for their funding upon grants from U.S. government agencies, such as the U.S. National Institutes of Health (“NIH”) and agencies in other countries.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9004969596862793)","('Access_And_Affordability', 0.017513634636998177)","('GHG_Emissions', 0.01595151610672474)","(['Corporate Governance'], 0.9004969596862793)","('NON-ESG', 0.017513634636998177)","('NON-ESG', 0.01595151610672474)"
Line 1713,"Climate change could impact our customers as severe weather events increase in frequency and distribution.
","('Physical_Impacts_Of_Climate_Change', 0.9457988739013672)","('Business_Model_Resilience', 0.013649201020598412)","('GHG_Emissions', 0.004197263158857822)","(['Climate Change'], 0.9457988739013672)","('NON-ESG', 0.013649201020598412)","('NON-ESG', 0.004197263158857822)"
Line 1714,"Hospitals and other medical care facilities can be impacted by severe weather through reduced demand, where patients may cancel or defer elective treatments and procedures, and/or physical damage to infrastructure and facilities may require the suspension of operations.
","('Access_And_Affordability', 0.3012675642967224)","('Employee_Health_And_Safety', 0.18684569001197815)","('Critical_Incident_Risk_Management', 0.1300036758184433)","('NON-ESG', 0.3012675642967224)","('NON-ESG', 0.18684569001197815)","('NON-ESG', 0.1300036758184433)"
Line 1715,"Following natural disasters, the number of uninsured or underinsured patients can also increase, which can lead to lower rates of reimbursement for our U.S. customers.
","('Systemic_Risk_Management', 0.5870491862297058)","('Access_And_Affordability', 0.05546431243419647)","('Supply_Chain_Management', 0.05060887336730957)","(['Risk & Crisis Management'], 0.5870491862297058)","('NON-ESG', 0.05546431243419647)","('NON-ESG', 0.05060887336730957)"
Line 1716,"These factors may lead to budget restrictions for our customers, and potentially lower revenues for BD.
","('Management_Of_Legal_And_Regulatory_Framework', 0.3966480791568756)","('Competitive_Behavior', 0.24580149352550507)","('Systemic_Risk_Management', 0.08258263766765594)","('NON-ESG', 0.3966480791568756)","('NON-ESG', 0.24580149352550507)","('NON-ESG', 0.08258263766765594)"
Line 1717,"Though not related to severe weather, we have seen similar trends in the recent COVID-19 pandemic.
","('Physical_Impacts_Of_Climate_Change', 0.7671297192573547)","('Business_Model_Resilience', 0.06078598275780678)","('Critical_Incident_Risk_Management', 0.04581668972969055)","(['Climate Change'], 0.7671297192573547)","('NON-ESG', 0.06078598275780678)","('NON-ESG', 0.04581668972969055)"
Line 1718,"As a result of measures taken in response to the COVID-19 pandemic, we experienced significant reductions in the demand for certain of our products, resulting in reductions in elective and nonessential procedures, lower utilization of routine testing and related specimen collections, reduced capital spending by customers and a decrease in research activity due to laboratory closures and reduced clinical testing.
","('Customer_Welfare', 0.3963291645050049)","('Product_Quality_And_Safety', 0.10165385156869888)","('Product_Design_And_Lifecycle_Management', 0.08484936505556107)","('NON-ESG', 0.3963291645050049)","('NON-ESG', 0.10165385156869888)","('NON-ESG', 0.08484936505556107)"
Line 1719,"Our response We manage this risk through our 2030+ commitments, partnerships and scenario analyses.
","('Systemic_Risk_Management', 0.30157431960105896)","('Physical_Impacts_Of_Climate_Change', 0.27814173698425293)","('Business_Model_Resilience', 0.1543344110250473)","('NON-ESG', 0.30157431960105896)","('NON-ESG', 0.27814173698425293)","('NON-ESG', 0.1543344110250473)"
Line 1720,"Our 2030+ commitments and goals include targets to reduce GHG emissions across our value chain, in addition to a commitment to creating a supply chain that is adaptable to disruption and able to contribute to strong  environmental and social performance; this includes a goal to incorporate climate risk into supply chain and network architecture strategies  .
","('Supply_Chain_Management', 0.7664275169372559)","('GHG_Emissions', 0.10004778206348419)","('Physical_Impacts_Of_Climate_Change', 0.025774991139769554)","(['Supply Chain Management'], 0.7664275169372559)","('NON-ESG', 0.10004778206348419)","('NON-ESG', 0.025774991139769554)"
Line 1721,"As part of our 2030+ Pr oduct Impact commitment, we have to set a goal to work to address the impact of plastics through existing and new strategic partnerships that work across the value chain  .
","('Business_Model_Resilience', 0.6320388913154602)","('Supply_Chain_Management', 0.11381840705871582)","('Systemic_Risk_Management', 0.0507839098572731)","(['Codes of Business Conduct'], 0.6320388913154602)","('NON-ESG', 0.11381840705871582)","('NON-ESG', 0.0507839098572731)"
Line 1722,"T his includes our  membership in the Sustainable Healthcare Coalition, a healthcare sector-led group that looks for the greatest opportunities to inspire sustainable practices in healthcare through the collaboration of its members.
","('Product_Design_And_Lifecycle_Management', 0.2477036863565445)","('Access_And_Affordability', 0.1395377367734909)","('Business_Model_Resilience', 0.13284434378147125)","('NON-ESG', 0.2477036863565445)","('NON-ESG', 0.1395377367734909)","('NON-ESG', 0.13284434378147125)"
Line 1723,"We see the value of partnerships and evolving discussion with this and other coalitions.
","('Management_Of_Legal_And_Regulatory_Framework', 0.23440542817115784)","('Human_Rights_And_Community_Relations', 0.20689457654953003)","('Business_Model_Resilience', 0.09957058727741241)","('NON-ESG', 0.23440542817115784)","('NON-ESG', 0.20689457654953003)","('NON-ESG', 0.09957058727741241)"
Line 1724,"Scenario analysis can be a valuable tool to envision alternative scenarios and challenge conventional wisdom about the future.Case study: BD undertook climate scenario analysis to better understand how climate-related risks (such as climate-induced water scarcity) and opportunities could impact the business.
","('Physical_Impacts_Of_Climate_Change', 0.882533609867096)","('Business_Model_Resilience', 0.042879700660705566)","('GHG_Emissions', 0.015077117830514908)","(['Climate Change'], 0.882533609867096)","('NON-ESG', 0.042879700660705566)","('NON-ESG', 0.015077117830514908)"
Line 1725,"BD partnered with BSR, a global  nonprofit organization of sustainable business experts that works with its global network of the world’s leading companies to build a just and sustainable world, to develop four scenarios corresponding to warming by 2100, which explored climate-related risks and opportunities, and other key uncertainties for BD’s business.
","('Physical_Impacts_Of_Climate_Change', 0.937990665435791)","('Business_Model_Resilience', 0.013113081455230713)","('Systemic_Risk_Management', 0.0069921924732625484)","(['Climate Change'], 0.937990665435791)","('NON-ESG', 0.013113081455230713)","('NON-ESG', 0.0069921924732625484)"
Line 1726,"These scenarios incorporated credible and publicly available climate projections for emissions reductions and climate impacts.
","('Physical_Impacts_Of_Climate_Change', 0.8415022492408752)","('GHG_Emissions', 0.05540584772825241)","('Business_Model_Resilience', 0.027048058807849884)","(['Climate Change'], 0.8415022492408752)","('NON-ESG', 0.05540584772825241)","('NON-ESG', 0.027048058807849884)"
Line 1727,"These scenarios were reviewed by BD’s management in early 2020 and insights from the scenario analysis were incorporated into the development of BDs 2030+ commitments and goals.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Where the risk occurs in the  value chainUpstream Risk type Market Climate-related driver Increased cost of raw materials Potential financial impact Increased direct costs Time horizon Short-term Likelihood About as likely as not Magnitude of impact Medium Description BD has more than 900 critical-to-healthcare suppliers that provide many different types of raw materials and components, including plastics, glass, metals, textiles, paper products, agricultural products, electronic and  mechanical subassemblies, and various biological, chemical and petrochemical product.
","('Physical_Impacts_Of_Climate_Change', 0.750359058380127)","('Supply_Chain_Management', 0.12150096148252487)","('Business_Model_Resilience', 0.03068530187010765)","(['Climate Change'], 0.750359058380127)","('NON-ESG', 0.12150096148252487)","('NON-ESG', 0.03068530187010765)"
Line 1728,"These scenarios were reviewed by BD’s management in early 2020 and insights from the scenario analysis were incorporated into the development of BDs 2030+ commitments and goals.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Where the risk occurs in the  value chainUpstream Risk type Market Climate-related driver Increased cost of raw materials Potential financial impact Increased direct costs Time horizon Short-term Likelihood About as likely as not Magnitude of impact Medium Description BD has more than 900 critical-to-healthcare suppliers that provide many different types of raw materials and components, including plastics, glass, metals, textiles, paper products, agricultural products, electronic and  mechanical subassemblies, and various biological, chemical and petrochemical product.
","('Product_Design_And_Lifecycle_Management', 0.8919841647148132)","('Supply_Chain_Management', 0.02907378040254116)","('Customer_Welfare', 0.012610990554094315)","(['Product Stewardship'], 0.8919841647148132)","('NON-ESG', 0.02907378040254116)","('NON-ESG', 0.012610990554094315)"
Line 1729,"Our results of operations could be negatively impacted by volatility in the cost of raw materials, components, freight and energy, which, in turn, increases the costs of producing and distributing our products.
","('Product_Design_And_Lifecycle_Management', 0.9609273076057434)","('Energy_Management', 0.005270706955343485)","('Supply_Chain_Management', 0.003671281272545457)","(['Product Stewardship'], 0.9609273076057434)","('NON-ESG', 0.005270706955343485)","('NON-ESG', 0.003671281272545457)"
Line 1730,"New laws or regulations adopted in response to climate change could also increase energy and transportation costs, as well as costs of certain raw materials and components.
","('Physical_Impacts_Of_Climate_Change', 0.9268696904182434)","('Supply_Chain_Management', 0.010776327922940254)","('Business_Model_Resilience', 0.010729280300438404)","(['Climate Change'], 0.9268696904182434)","('NON-ESG', 0.010776327922940254)","('NON-ESG', 0.010729280300438404)"
Line 1731,"In particular, we purchase supplies of resins, which are oil-based components used in the manufacture of certain products, and any significant increases in resin costs could adversely impact future operating results.
","('Product_Design_And_Lifecycle_Management', 0.9560922384262085)","('Customer_Welfare', 0.006080996245145798)","('Product_Quality_And_Safety', 0.00515317777171731)","(['Product Stewardship'], 0.9560922384262085)","('NON-ESG', 0.006080996245145798)","('NON-ESG', 0.00515317777171731)"
Line 1732,"Increases in oil prices can also increase our packaging and transportation costs.
","('Product_Design_And_Lifecycle_Management', 0.8341987729072571)","('Energy_Management', 0.0325520820915699)","('Selling_Practices_And_Product_Labeling', 0.022467749193310738)","(['Product Stewardship'], 0.8341987729072571)","('NON-ESG', 0.0325520820915699)","('NON-ESG', 0.022467749193310738)"
Line 1733,"We may not be able to offset increases in these costs through other cost reductions.
","('Energy_Management', 0.4087963402271271)","('Management_Of_Legal_And_Regulatory_Framework', 0.36044779419898987)","('Systemic_Risk_Management', 0.02499305084347725)","('NON-ESG', 0.4087963402271271)","('NON-ESG', 0.36044779419898987)","('NON-ESG', 0.02499305084347725)"
Line 1734,"Our response This is managed through procurement and engineering expertise.
","('Product_Design_And_Lifecycle_Management', 0.24354591965675354)","('Supply_Chain_Management', 0.10808742791414261)","('Management_Of_Legal_And_Regulatory_Framework', 0.06869848817586899)","('NON-ESG', 0.24354591965675354)","('NON-ESG', 0.10808742791414261)","('NON-ESG', 0.06869848817586899)"
Line 1735,"BD’s strategic sourcing teams continuously assess our sole-sourced raw materials and maintain business continuity plans with our suppliers.
","('Supply_Chain_Management', 0.8699406385421753)","('Product_Design_And_Lifecycle_Management', 0.03876521438360214)","('Customer_Welfare', 0.008279119618237019)","(['Supply Chain Management'], 0.8699406385421753)","('NON-ESG', 0.03876521438360214)","('NON-ESG', 0.008279119618237019)"
Line 1736,"BD’s continuity plans may include securing secondary supply with alternative suppliers, qualification of alternative manufacturing facilities, maintaining contingency stock, internal development of supply and establishment of technology escrow accounts.
","('Supply_Chain_Management', 0.9466912150382996)","('Systemic_Risk_Management', 0.004427925683557987)","('Energy_Management', 0.0042815194465219975)","(['Supply Chain Management'], 0.9466912150382996)","('NON-ESG', 0.004427925683557987)","('NON-ESG', 0.0042815194465219975)"
Line 1737,"We also strive to increase our material efficiency through design and ongoing sustained engineering efforts.
","('Energy_Management', 0.781518280506134)","('Product_Design_And_Lifecycle_Management', 0.13094596564769745)","('Supply_Chain_Management', 0.007988505996763706)","(['Operational Eco-Efficiency'], 0.781518280506134)","('NON-ESG', 0.13094596564769745)","('NON-ESG', 0.007988505996763706)"
Line 1738,"Sustaining engineering teams work on material reduction, packaging reduction and product improvements in order to mitigate our exposure to these risks.
","('Product_Design_And_Lifecycle_Management', 0.9561669826507568)","('Product_Quality_And_Safety', 0.0061050960794091225)","('Supply_Chain_Management', 0.004305856302380562)","(['Product Stewardship'], 0.9561669826507568)","('NON-ESG', 0.0061050960794091225)","('NON-ESG', 0.004305856302380562)"
Line 1739,"In 2016, we refined our approach to supplier risk profiling by adding reputational risks into our Enterprise Supplier Risk Management process, for direct suppliers.
","('Supply_Chain_Management', 0.9421855807304382)","('Labor_Practices', 0.007353959139436483)","('Systemic_Risk_Management', 0.005227497313171625)","(['Supply Chain Management'], 0.9421855807304382)","('NON-ESG', 0.007353959139436483)","('NON-ESG', 0.005227497313171625)"
Line 1740,"An initial set of risks were identified, and mitigation plans are in progress.
","('Systemic_Risk_Management', 0.3627808392047882)","('Physical_Impacts_Of_Climate_Change', 0.21694087982177734)","('Business_Model_Resilience', 0.12198583036661148)","('NON-ESG', 0.3627808392047882)","('NON-ESG', 0.21694087982177734)","('NON-ESG', 0.12198583036661148)"
Line 1741,"We will continue to refine our risk model and adjust our top risks accordingly.
","('Systemic_Risk_Management', 0.8957923650741577)","('Business_Model_Resilience', 0.027498498558998108)","('Competitive_Behavior', 0.014366833493113518)","(['Risk & Crisis Management'], 0.8957923650741577)","('NON-ESG', 0.027498498558998108)","('NON-ESG', 0.014366833493113518)"
Line 1742,"As part of our 2030+ Product Impact commitment, we have to set a goal to work to address the impact of plastics through existing and new strategic partnerships that work across the value chain  .
","('Product_Design_And_Lifecycle_Management', 0.9624066948890686)","('Product_Quality_And_Safety', 0.0048240371979773045)","('Business_Model_Resilience', 0.0032415681052953005)","(['Product Stewardship'], 0.9624066948890686)","('NON-ESG', 0.0048240371979773045)","('NON-ESG', 0.0032415681052953005)"
Line 1743,"T his includes our  membership in the Healthcare Plastic Recycling Council, www.HPRC.org.
","('Waste_And_Hazardous_Materials_Management', 0.9074167013168335)","('Product_Design_And_Lifecycle_Management', 0.025813933461904526)","('Water_And_Wastewater_Management', 0.007483360823243856)","(['Operational Eco-Efficiency'], 0.9074167013168335)","('NON-ESG', 0.025813933461904526)","('NON-ESG', 0.007483360823243856)"
Line 1744,"2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Where the risk occurs in the  value chainUpstream Risk type Market Climate-related driver Availability of raw materials Potential financial impact Increased direct costs Time horizon Short-term Likelihood About as likely as not Magnitude of impact Medium Description A reduction or interruption in the supply of certain raw materials and components could adversely affect our operating results.
","('Supply_Chain_Management', 0.8389802575111389)","('Physical_Impacts_Of_Climate_Change', 0.051388535648584366)","('Product_Design_And_Lifecycle_Management', 0.017148716375231743)","(['Supply Chain Management'], 0.8389802575111389)","('NON-ESG', 0.051388535648584366)","('NON-ESG', 0.017148716375231743)"
Line 1745,"2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Where the risk occurs in the  value chainUpstream Risk type Market Climate-related driver Availability of raw materials Potential financial impact Increased direct costs Time horizon Short-term Likelihood About as likely as not Magnitude of impact Medium Description A reduction or interruption in the supply of certain raw materials and components could adversely affect our operating results.
","('Systemic_Risk_Management', 0.22330594062805176)","('Business_Model_Resilience', 0.20416131615638733)","('Data_Security', 0.09903903305530548)","('NON-ESG', 0.22330594062805176)","('NON-ESG', 0.20416131615638733)","('NON-ESG', 0.09903903305530548)"
Line 1746,"We purchase many different types of raw materials and components used in our products.
","('Product_Design_And_Lifecycle_Management', 0.9526073336601257)","('Selling_Practices_And_Product_Labeling', 0.006764853838831186)","('Supply_Chain_Management', 0.0041501191444695)","(['Product Stewardship'], 0.9526073336601257)","('NON-ESG', 0.006764853838831186)","('NON-ESG', 0.0041501191444695)"
Line 1747,"Certain raw materials and components are not available from multiple sources.
","('Product_Design_And_Lifecycle_Management', 0.49797767400741577)","('Supply_Chain_Management', 0.19903568923473358)","('Energy_Management', 0.07493875920772552)","('NON-ESG', 0.49797767400741577)","('NON-ESG', 0.19903568923473358)","('NON-ESG', 0.07493875920772552)"
Line 1748,"In addition, for quality assurance, cost effectiveness and other reasons, certain raw materials and components are purchased from sole suppliers.
","('Product_Design_And_Lifecycle_Management', 0.6042977571487427)","('Supply_Chain_Management', 0.2103414088487625)","('Product_Quality_And_Safety', 0.035138580948114395)","(['Product Stewardship'], 0.6042977571487427)","('NON-ESG', 0.2103414088487625)","('NON-ESG', 0.035138580948114395)"
Line 1749,"The price and supply of these materials and components may be impacted or disrupted for reasons beyond our control, such as extreme weather events.
","('Supply_Chain_Management', 0.6932950019836426)","('Product_Design_And_Lifecycle_Management', 0.14123870432376862)","('Business_Model_Resilience', 0.02441711165010929)","(['Supply Chain Management'], 0.6932950019836426)","('NON-ESG', 0.14123870432376862)","('NON-ESG', 0.02441711165010929)"
Line 1750,"While we work with suppliers to ensure continuity of supply, no assurance can be given that these efforts will be successful.
","('Supply_Chain_Management', 0.9330034852027893)","('Water_And_Wastewater_Management', 0.007546456530690193)","('Labor_Practices', 0.0074775852262973785)","(['Supply Chain Management'], 0.9330034852027893)","('NON-ESG', 0.007546456530690193)","('NON-ESG', 0.0074775852262973785)"
Line 1751,"In addition, due to regulatory requirements relating to the qualification of suppliers, we may not be able to establish additional or replacement sources on a timely basis or without excessive cost.
","('Supply_Chain_Management', 0.7904490828514099)","('Management_Of_Legal_And_Regulatory_Framework', 0.0370192751288414)","('Product_Design_And_Lifecycle_Management', 0.01548368576914072)","(['Supply Chain Management'], 0.7904490828514099)","('NON-ESG', 0.0370192751288414)","('NON-ESG', 0.01548368576914072)"
Line 1752,"The termination, reduction or interruption in supply of these raw materials and components could adversely impact our ability to manufacture and sell certain of our products.
","('Product_Design_And_Lifecycle_Management', 0.9610264897346497)","('Selling_Practices_And_Product_Labeling', 0.005247111432254314)","('Product_Quality_And_Safety', 0.0042051696218550205)","(['Product Stewardship'], 0.9610264897346497)","('NON-ESG', 0.005247111432254314)","('NON-ESG', 0.0042051696218550205)"
Line 1753,"Our response This is managed through procurement expertise.
","('Supply_Chain_Management', 0.38838931918144226)","('Product_Design_And_Lifecycle_Management', 0.11226370930671692)","('Management_Of_Legal_And_Regulatory_Framework', 0.08511850982904434)","('NON-ESG', 0.38838931918144226)","('NON-ESG', 0.11226370930671692)","('NON-ESG', 0.08511850982904434)"
Line 1754,"BD’s strategic sourcing teams continuously assess our sole-sourced raw materials and maintain business continuity plans with our suppliers.
","('Supply_Chain_Management', 0.8699406385421753)","('Product_Design_And_Lifecycle_Management', 0.03876521438360214)","('Customer_Welfare', 0.008279119618237019)","(['Supply Chain Management'], 0.8699406385421753)","('NON-ESG', 0.03876521438360214)","('NON-ESG', 0.008279119618237019)"
Line 1755,"BD’s continuity plans may include securing secondary supply with alternative suppliers, qualification of alternative manufacturing facilities, maintaining contingency stock, internal development of supply and establishment of technology escrow accounts.
","('Supply_Chain_Management', 0.9466912150382996)","('Systemic_Risk_Management', 0.004427925683557987)","('Energy_Management', 0.0042815194465219975)","(['Supply Chain Management'], 0.9466912150382996)","('NON-ESG', 0.004427925683557987)","('NON-ESG', 0.0042815194465219975)"
Line 1756,"In 2016, we refined our approach to supplier risk profiling by adding reputational risks into our Enterprise Supplier Risk Management process, for direct suppliers.
","('Supply_Chain_Management', 0.9421855807304382)","('Labor_Practices', 0.007353959139436483)","('Systemic_Risk_Management', 0.005227497313171625)","(['Supply Chain Management'], 0.9421855807304382)","('NON-ESG', 0.007353959139436483)","('NON-ESG', 0.005227497313171625)"
Line 1757,"An initial set of risks were identified, and mitigation plans are in progress.
","('Systemic_Risk_Management', 0.3627808392047882)","('Physical_Impacts_Of_Climate_Change', 0.21694087982177734)","('Business_Model_Resilience', 0.12198583036661148)","('NON-ESG', 0.3627808392047882)","('NON-ESG', 0.21694087982177734)","('NON-ESG', 0.12198583036661148)"
Line 1758,"We will continue to refine our risk model and adjust our top risks accordingly.In addition, our 2030+ commitment to creating a supply chain that is adaptable to disruption and able to contribute to strong environmental and social performance includes a goal to partner with strategic/preferred/ critical suppliers to evaluate risk in Tier 2 by 2030.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Opportunities Where the opportunity  occurs in the value chainDirect operations Opportunity type Resource efficiency Climate-related driver Use of more efficient production and distribution processes Potential financial impact Reduced indirect (operating) costs Time horizon Short-term Likelihood About as likely as not Magnitude of impact Low Description Increased cost for traditional energy as a result of climate change makes capital investments in renewable energy (or projects with a longer ROI) more feasible and saves more money over the lifetime of the project.
","('Supply_Chain_Management', 0.9492947459220886)","('Physical_Impacts_Of_Climate_Change', 0.008316353894770145)","('Systemic_Risk_Management', 0.0048053371720016)","(['Supply Chain Management'], 0.9492947459220886)","('NON-ESG', 0.008316353894770145)","('NON-ESG', 0.0048053371720016)"
Line 1759,"We will continue to refine our risk model and adjust our top risks accordingly.In addition, our 2030+ commitment to creating a supply chain that is adaptable to disruption and able to contribute to strong environmental and social performance includes a goal to partner with strategic/preferred/ critical suppliers to evaluate risk in Tier 2 by 2030.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Opportunities Where the opportunity  occurs in the value chainDirect operations Opportunity type Resource efficiency Climate-related driver Use of more efficient production and distribution processes Potential financial impact Reduced indirect (operating) costs Time horizon Short-term Likelihood About as likely as not Magnitude of impact Low Description Increased cost for traditional energy as a result of climate change makes capital investments in renewable energy (or projects with a longer ROI) more feasible and saves more money over the lifetime of the project.
","('Physical_Impacts_Of_Climate_Change', 0.9124642610549927)","('Business_Model_Resilience', 0.016344664618372917)","('GHG_Emissions', 0.008520172908902168)","(['Climate Change'], 0.9124642610549927)","('NON-ESG', 0.016344664618372917)","('NON-ESG', 0.008520172908902168)"
Line 1760,"We will continue to refine our risk model and adjust our top risks accordingly.In addition, our 2030+ commitment to creating a supply chain that is adaptable to disruption and able to contribute to strong environmental and social performance includes a goal to partner with strategic/preferred/ critical suppliers to evaluate risk in Tier 2 by 2030.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Opportunities Where the opportunity  occurs in the value chainDirect operations Opportunity type Resource efficiency Climate-related driver Use of more efficient production and distribution processes Potential financial impact Reduced indirect (operating) costs Time horizon Short-term Likelihood About as likely as not Magnitude of impact Low Description Increased cost for traditional energy as a result of climate change makes capital investments in renewable energy (or projects with a longer ROI) more feasible and saves more money over the lifetime of the project.
","('Product_Design_And_Lifecycle_Management', 0.1773006021976471)","('Management_Of_Legal_And_Regulatory_Framework', 0.12052217870950699)","('Ecological_Impacts', 0.08742596954107285)","('NON-ESG', 0.1773006021976471)","('NON-ESG', 0.12052217870950699)","('NON-ESG', 0.08742596954107285)"
Line 1761,"This is particularly relevant for BD, where rising costs from both our energy usage and a portion of our raw-material base (plastic resins), as well as competition from low-cost producers around the world, can reduce our competitive advantage.
","('Competitive_Behavior', 0.6201608180999756)","('Energy_Management', 0.17325982451438904)","('Product_Design_And_Lifecycle_Management', 0.034178413450717926)","(['Business Ethics'], 0.6201608180999756)","('NON-ESG', 0.17325982451438904)","('NON-ESG', 0.034178413450717926)"
Line 1762,"Strategy to realize  opportunityIn our climate change impact area, we have set goals to reduce our GHG emissions.
","('GHG_Emissions', 0.9517098069190979)","('Physical_Impacts_Of_Climate_Change', 0.011432874016463757)","('Ecological_Impacts', 0.004529346711933613)","(['Climate Change'], 0.9517098069190979)","('NON-ESG', 0.011432874016463757)","('NON-ESG', 0.004529346711933613)"
Line 1763,"We will achieve this reduction through two mechanisms—reduced energy demand and increased use of renewables.
","('Energy_Management', 0.9785252213478088)","('Management_Of_Legal_And_Regulatory_Framework', 0.0028462721966207027)","('Product_Design_And_Lifecycle_Management', 0.001595797366462648)","(['Operational Eco-Efficiency'], 0.9785252213478088)","('NON-ESG', 0.0028462721966207027)","('NON-ESG', 0.001595797366462648)"
Line 1764,"Each facility has identified a pipeline of projects aimed at reducing our GHG emissions and will utilize a traditional capital funding process to implement these projects.
","('GHG_Emissions', 0.9666649103164673)","('Air_Quality', 0.004445775877684355)","('Management_Of_Legal_And_Regulatory_Framework', 0.003098340705037117)","(['Climate Change'], 0.9666649103164673)","('NON-ESG', 0.004445775877684355)","('NON-ESG', 0.003098340705037117)"
Line 1765,"This process will continue to increase the number of  projects with sustainability benefits and associated cost savings and contribute to BD’s competitiveness in both the short- and the long-term.
","('Competitive_Behavior', 0.6891517639160156)","('Business_Model_Resilience', 0.12027326971292496)","('Systemic_Risk_Management', 0.027891874313354492)","(['Business Ethics'], 0.6891517639160156)","('NON-ESG', 0.12027326971292496)","('NON-ESG', 0.027891874313354492)"
Line 1766,"Previous projects have included HVAC replacements, chiller upgrades, compressed-air upgrades and LED installations, in addition to larger projects such as the installation of cogeneration facilities and various major solar  installation projects.
","('Energy_Management', 0.9192700982093811)","('Air_Quality', 0.01809428632259369)","('Management_Of_Legal_And_Regulatory_Framework', 0.006159544922411442)","(['Operational Eco-Efficiency'], 0.9192700982093811)","('NON-ESG', 0.01809428632259369)","('NON-ESG', 0.006159544922411442)"
Line 1767,"As part of our procurement strategy, we evaluate all new energy deals for a green-energy option.
","('Management_Of_Legal_And_Regulatory_Framework', 0.37199848890304565)","('Energy_Management', 0.20243269205093384)","('Systemic_Risk_Management', 0.056994784623384476)","('NON-ESG', 0.37199848890304565)","('NON-ESG', 0.20243269205093384)","('NON-ESG', 0.056994784623384476)"
Line 1768,"We currently purchase green tariffs in Germany, Ireland, Spain, Belgium, the Netherlands and the U.K. In FY 2021, we  invested over $2.5 million in solar and wind energy through power purchase agreements and RECs from existing contracts.
","('Energy_Management', 0.9326186180114746)","('Management_Of_Legal_And_Regulatory_Framework', 0.029064035043120384)","('GHG_Emissions', 0.004930567461997271)","(['Operational Eco-Efficiency'], 0.9326186180114746)","('NON-ESG', 0.029064035043120384)","('NON-ESG', 0.004930567461997271)"
Line 1769,"Case study: In FY 2021, we implemented 142 projects that include solar installations, updating building controls, HVAC replacements, lighting retrofits, machine replacements, process optimization and other efficiency  upgrades in the production process.
","('Energy_Management', 0.9471240043640137)","('Product_Design_And_Lifecycle_Management', 0.005836531054228544)","('Air_Quality', 0.005815370008349419)","(['Operational Eco-Efficiency'], 0.9471240043640137)","('NON-ESG', 0.005836531054228544)","('NON-ESG', 0.005815370008349419)"
Line 1770,"The projects were expected to generate a $5.1 million annual saving in energy costs and 19,266 metric tonnes of CO2e reduction starting throughout FY21 and into FY 2022.
","('Energy_Management', 0.9764977693557739)","('Management_Of_Legal_And_Regulatory_Framework', 0.002636427991092205)","('Product_Design_And_Lifecycle_Management', 0.0019766255281865597)","(['Operational Eco-Efficiency'], 0.9764977693557739)","('NON-ESG', 0.002636427991092205)","('NON-ESG', 0.0019766255281865597)"
Line 1771,"2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Where the opportunity  occurs in the value chainDirect operations Opportunity type Resource efficiency Climate-related driver Reduced water usage and consumption Potential financial impact Reduced indirect (operating) costs Time horizon Short-term Likelihood About as likely as not Magnitude of impact Low Description Reliable and high-quality water is particularly important to our business in order to maintain strict quality specifications.
","('Water_And_Wastewater_Management', 0.9235820174217224)","('Supply_Chain_Management', 0.01309412531554699)","('Physical_Impacts_Of_Climate_Change', 0.009398975409567356)","(['Operational Eco-Efficiency'], 0.9235820174217224)","('NON-ESG', 0.01309412531554699)","('NON-ESG', 0.009398975409567356)"
Line 1772,"2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Where the opportunity  occurs in the value chainDirect operations Opportunity type Resource efficiency Climate-related driver Reduced water usage and consumption Potential financial impact Reduced indirect (operating) costs Time horizon Short-term Likelihood About as likely as not Magnitude of impact Low Description Reliable and high-quality water is particularly important to our business in order to maintain strict quality specifications.
","('Product_Design_And_Lifecycle_Management', 0.7152374386787415)","('Product_Quality_And_Safety', 0.06380069255828857)","('Supply_Chain_Management', 0.06074890121817589)","(['Product Stewardship'], 0.7152374386787415)","('NON-ESG', 0.06380069255828857)","('NON-ESG', 0.06074890121817589)"
Line 1773,"There are many instances where projects have savings and efficiencies in multiple sustainability  categories—e.g., a project that reduces energy consumption may also have a significant water reduction associated with it.
","('Energy_Management', 0.9281066060066223)","('Water_And_Wastewater_Management', 0.03204367309808731)","('Air_Quality', 0.004176873713731766)","(['Operational Eco-Efficiency'], 0.9281066060066223)","('NON-ESG', 0.03204367309808731)","('NON-ESG', 0.004176873713731766)"
Line 1774,"For example, we have implemented water recovery processes (e.g., at water purification plants) that have both conserved water and reduced our energy consumption; similarly, optimizing process heating reduces the use of steam and water.
","('Water_And_Wastewater_Management', 0.969481885433197)","('Energy_Management', 0.004937482066452503)","('Waste_And_Hazardous_Materials_Management', 0.002391436602920294)","(['Operational Eco-Efficiency'], 0.969481885433197)","('NON-ESG', 0.004937482066452503)","('NON-ESG', 0.002391436602920294)"
Line 1775,"As water is still a relatively low-cost resource in most of the regions where we operate, water efficiency projects often do not have as favorable return on investment (ROI) as other sustainability or capital investment projects.
","('Water_And_Wastewater_Management', 0.9601248502731323)","('Energy_Management', 0.01086659450083971)","('GHG_Emissions', 0.0033669190015643835)","(['Operational Eco-Efficiency'], 0.9601248502731323)","('NON-ESG', 0.01086659450083971)","('NON-ESG', 0.0033669190015643835)"
Line 1776,"However, for facilities in water-stressed areas, reducing our consumption now will help build resilience over the long-term.
","('Water_And_Wastewater_Management', 0.9488083124160767)","('Energy_Management', 0.006608410272747278)","('GHG_Emissions', 0.005564844701439142)","(['Operational Eco-Efficiency'], 0.9488083124160767)","('NON-ESG', 0.006608410272747278)","('NON-ESG', 0.005564844701439142)"
Line 1777,"Managing this risk enables us to capitalize on more opportunities, such as reduced operational costs over the long-term.
","('Systemic_Risk_Management', 0.8260927200317383)","('Business_Model_Resilience', 0.04665978625416756)","('Supply_Chain_Management', 0.035391826182603836)","(['Risk & Crisis Management'], 0.8260927200317383)","('NON-ESG', 0.04665978625416756)","('NON-ESG', 0.035391826182603836)"
Line 1778,"Strategy to realize  opportunityAs part of our 2030+ commitments, we have set targets to reduce our water usage by 40 percent by 2030 (from a baseline of 2019 and normalized to COPS).
","('Water_And_Wastewater_Management', 0.9664790630340576)","('Energy_Management', 0.006524131633341312)","('GHG_Emissions', 0.004192277789115906)","(['Operational Eco-Efficiency'], 0.9664790630340576)","('NON-ESG', 0.006524131633341312)","('NON-ESG', 0.004192277789115906)"
Line 1779,"This opportunity is managed by implementing projects with  significant energy/water/waste savings.
","('Energy_Management', 0.9281205534934998)","('Water_And_Wastewater_Management', 0.028596358373761177)","('Management_Of_Legal_And_Regulatory_Framework', 0.004434726666659117)","(['Operational Eco-Efficiency'], 0.9281205534934998)","('NON-ESG', 0.028596358373761177)","('NON-ESG', 0.004434726666659117)"
Line 1780,"We utilize a traditional capital funding process at the facility level to implement projects that will reduce water usage and increase efficient use of water.
","('Water_And_Wastewater_Management', 0.9755101799964905)","('Energy_Management', 0.0029555908404290676)","('GHG_Emissions', 0.0028519597835838795)","(['Operational Eco-Efficiency'], 0.9755101799964905)","('NON-ESG', 0.0029555908404290676)","('NON-ESG', 0.0028519597835838795)"
Line 1781,"This process will continue to increase the number of projects with sustainability benefits and associated cost savings and contribute to BD’s competitiveness in both the short- and the long-term.
","('Competitive_Behavior', 0.6891517639160156)","('Business_Model_Resilience', 0.12027326971292496)","('Systemic_Risk_Management', 0.027891874313354492)","(['Business Ethics'], 0.6891517639160156)","('NON-ESG', 0.12027326971292496)","('NON-ESG', 0.027891874313354492)"
Line 1782,"These methods have contributed to more than $12 million in cost savings in both energy and water since FY 2019.
","('Water_And_Wastewater_Management', 0.4586063027381897)","('Energy_Management', 0.42644423246383667)","('GHG_Emissions', 0.019030330702662468)","('NON-ESG', 0.4586063027381897)","('NON-ESG', 0.42644423246383667)","('NON-ESG', 0.019030330702662468)"
Line 1783,"Case study: BD implemented or approved eight water-related projects in the United States, Puerto Rico, Mexico and China in FY21 that are projected to reduce annual water costs by $194,000 per year.
","('Water_And_Wastewater_Management', 0.9731221795082092)","('Energy_Management', 0.003918814472854137)","('GHG_Emissions', 0.002454387955367565)","(['Operational Eco-Efficiency'], 0.9731221795082092)","('NON-ESG', 0.003918814472854137)","('NON-ESG', 0.002454387955367565)"
Line 1784,"Increased cost for  water as a result of constrained availability makes capital investments in water conservation methods (or projects with a longer ROI) more feasible and saves more money over the lifetime of the project.
","('Water_And_Wastewater_Management', 0.9775962829589844)","('GHG_Emissions', 0.002149408683180809)","('Energy_Management', 0.0019041959894821048)","(['Operational Eco-Efficiency'], 0.9775962829589844)","('NON-ESG', 0.002149408683180809)","('NON-ESG', 0.0019041959894821048)"
Line 1785,"We will continue to identify and implement viable water reduction projects.
","('Water_And_Wastewater_Management', 0.9740366339683533)","('GHG_Emissions', 0.003209501039236784)","('Ecological_Impacts', 0.0025678419042378664)","(['Operational Eco-Efficiency'], 0.9740366339683533)","('NON-ESG', 0.003209501039236784)","('NON-ESG', 0.0025678419042378664)"
Line 1786,"2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Where the opportunity  occurs in the value chainDownstream Opportunity type Products and services Climate-related driver Shift in consumer preferences Potential financial impact Increased revenues resulting from increased demand for products and services Time horizon Medium-term Likelihood More likely than not Magnitude of impact Medium Description We face changing customer preferences and requirements, including increased customer demand for more environmentally preferable products as they become more concerned about climate change and its impacts.
","('Supply_Chain_Management', 0.3013007342815399)","('Physical_Impacts_Of_Climate_Change', 0.2686241567134857)","('Product_Design_And_Lifecycle_Management', 0.16088992357254028)","('NON-ESG', 0.3013007342815399)","('NON-ESG', 0.2686241567134857)","('NON-ESG', 0.16088992357254028)"
Line 1787,"2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Where the opportunity  occurs in the value chainDownstream Opportunity type Products and services Climate-related driver Shift in consumer preferences Potential financial impact Increased revenues resulting from increased demand for products and services Time horizon Medium-term Likelihood More likely than not Magnitude of impact Medium Description We face changing customer preferences and requirements, including increased customer demand for more environmentally preferable products as they become more concerned about climate change and its impacts.
","('Product_Design_And_Lifecycle_Management', 0.5418497323989868)","('Physical_Impacts_Of_Climate_Change', 0.1804129183292389)","('Supply_Chain_Management', 0.05500900745391846)","(['Product Stewardship'], 0.5418497323989868)","('NON-ESG', 0.1804129183292389)","('NON-ESG', 0.05500900745391846)"
Line 1788,"While climate change criteria are not currently used as a purchasing criterion by our customers, we receive a significant number of requests for sustainability information.
","('Physical_Impacts_Of_Climate_Change', 0.9150007367134094)","('Business_Model_Resilience', 0.022479314357042313)","('GHG_Emissions', 0.009972433559596539)","(['Climate Change'], 0.9150007367134094)","('NON-ESG', 0.022479314357042313)","('NON-ESG', 0.009972433559596539)"
Line 1789,"While no formal tracking mechanism exists, we estimate sustainability criteria to be included in most of the RFPs from European-based customers, some from Australia/New Zealand and a significant portion from U.S.-based customers as well.
","('Management_Of_Legal_And_Regulatory_Framework', 0.21023154258728027)","('Product_Design_And_Lifecycle_Management', 0.1195380687713623)","('Business_Model_Resilience', 0.1157149001955986)","('NON-ESG', 0.21023154258728027)","('NON-ESG', 0.1195380687713623)","('NON-ESG', 0.1157149001955986)"
Line 1790,"Particularly notable is the U.K.’s NHS, which in October 2020 became the world’s first health service to commit to reaching carbon net zero.
","('Access_And_Affordability', 0.1887318640947342)","('Energy_Management', 0.1554800122976303)","('Management_Of_Legal_And_Regulatory_Framework', 0.14630736410617828)","('NON-ESG', 0.1887318640947342)","('NON-ESG', 0.1554800122976303)","('NON-ESG', 0.14630736410617828)"
Line 1791,"The NHS’ Net Zero Supplier Roadmap will require suppliers to publish a carbon  reduction plan and to meet requirements for product carbon footprinting.
","('Supply_Chain_Management', 0.5332494974136353)","('Product_Design_And_Lifecycle_Management', 0.28556159138679504)","('Energy_Management', 0.02324005961418152)","(['Supply Chain Management'], 0.5332494974136353)","('NON-ESG', 0.28556159138679504)","('NON-ESG', 0.02324005961418152)"
Line 1792,"Also, from 2030, suppliers will be able to qualify for NHS contracts only if they can demonstrate their progress through published progress reports and continued carbon emissions reporting.
","('GHG_Emissions', 0.7778770923614502)","('Air_Quality', 0.041017331182956696)","('Management_Of_Legal_And_Regulatory_Framework', 0.03899645432829857)","(['Climate Change'], 0.7778770923614502)","('NON-ESG', 0.041017331182956696)","('NON-ESG', 0.03899645432829857)"
Line 1793,"We have also had increased interest from, and engagement with, our pharmaceutical customers around our carbon reduction plans and how we can assist in lowering carbon emissions across the pharmaceutical  value chain.
","('GHG_Emissions', 0.8343161344528198)","('Ecological_Impacts', 0.038114096969366074)","('Physical_Impacts_Of_Climate_Change', 0.020430373027920723)","(['Climate Change'], 0.8343161344528198)","('NON-ESG', 0.038114096969366074)","('NON-ESG', 0.020430373027920723)"
Line 1794,"As a company with a proven reputation for maintaining the quality and safety of our products while reducing our carbon footprint, we are strategically positioned to manage this opportunity.
","('Product_Quality_And_Safety', 0.5154584646224976)","('Product_Design_And_Lifecycle_Management', 0.3362269103527069)","('Selling_Practices_And_Product_Labeling', 0.024526778608560562)","(['Product Quality & Recall Management'], 0.5154584646224976)","('NON-ESG', 0.3362269103527069)","('NON-ESG', 0.024526778608560562)"
Line 1795,"We also benefit from  reducing the energy-related costs associated with a product as it increases our competitiveness in a market that increasingly looks toward low-cost solutions.
","('Product_Design_And_Lifecycle_Management', 0.8785811066627502)","('Energy_Management', 0.035895247012376785)","('Customer_Welfare', 0.013334590941667557)","(['Product Stewardship'], 0.8785811066627502)","('NON-ESG', 0.035895247012376785)","('NON-ESG', 0.013334590941667557)"
Line 1796,"Strategy to realize  opportunityAs part of our 2030+ commitment to climate change and product impact, we have set a number of goals to realize this opportunity.
","('Physical_Impacts_Of_Climate_Change', 0.9477748274803162)","('Business_Model_Resilience', 0.011052741669118404)","('GHG_Emissions', 0.005226791836321354)","(['Climate Change'], 0.9477748274803162)","('NON-ESG', 0.011052741669118404)","('NON-ESG', 0.005226791836321354)"
Line 1797,"First, we are committed to setting targets to reduce Scope 3 emissions that result from the use of, and end-of-life disposal of, our products.Second, we have set a number of goals to realize our commitment to reducing the environmental impact of our portfolio and addressing the sustainability needs of our customers.
","('Product_Design_And_Lifecycle_Management', 0.9696569442749023)","('Product_Quality_And_Safety', 0.00321020046249032)","('Selling_Practices_And_Product_Labeling', 0.00240556662902236)","(['Product Stewardship'], 0.9696569442749023)","('NON-ESG', 0.00321020046249032)","('NON-ESG', 0.00240556662902236)"
Line 1798,"T hese priorities led us to form the Sustainable Medical Technology Institute.
","('Product_Design_And_Lifecycle_Management', 0.6079643964767456)","('Access_And_Affordability', 0.04332861304283142)","('Energy_Management', 0.03499573469161987)","(['Product Stewardship'], 0.6079643964767456)","('NON-ESG', 0.04332861304283142)","('NON-ESG', 0.03499573469161987)"
Line 1799,"Case study: We see the value of partnerships and evolving discussion with coalitions.
","('Human_Rights_And_Community_Relations', 0.33239424228668213)","('Management_Of_Legal_And_Regulatory_Framework', 0.18213193118572235)","('Business_Model_Resilience', 0.056285079568624496)","('NON-ESG', 0.33239424228668213)","('NON-ESG', 0.18213193118572235)","('NON-ESG', 0.056285079568624496)"
Line 1800,"Our memberships in the Sustainable Healthcare Coalition and Healthcare Plastic Recycling Council have allowed us to gain insights  into developing and evolving customer expectations.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Where the opportunity  occurs in the value chainUpstream Opportunity type Products and services Climate-related driver Increased need for products and services Potential financial impact Increased revenues resulting from increased demand for products and services Time horizon Medium-term Likelihood More likely than not Magnitude of impact Medium Description With health-related impacts of climate change expected to increase, the need for products and solutions provided by BD, such as diagnostics and delivery systems, may increase as well.
","('Product_Design_And_Lifecycle_Management', 0.4510045051574707)","('Supply_Chain_Management', 0.2100788801908493)","('Physical_Impacts_Of_Climate_Change', 0.11459498852491379)","('NON-ESG', 0.4510045051574707)","('NON-ESG', 0.2100788801908493)","('NON-ESG', 0.11459498852491379)"
Line 1801,"Our memberships in the Sustainable Healthcare Coalition and Healthcare Plastic Recycling Council have allowed us to gain insights  into developing and evolving customer expectations.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Where the opportunity  occurs in the value chainUpstream Opportunity type Products and services Climate-related driver Increased need for products and services Potential financial impact Increased revenues resulting from increased demand for products and services Time horizon Medium-term Likelihood More likely than not Magnitude of impact Medium Description With health-related impacts of climate change expected to increase, the need for products and solutions provided by BD, such as diagnostics and delivery systems, may increase as well.
","('Physical_Impacts_Of_Climate_Change', 0.8471551537513733)","('Business_Model_Resilience', 0.028409650549292564)","('Supply_Chain_Management', 0.01877727545797825)","(['Climate Change'], 0.8471551537513733)","('NON-ESG', 0.028409650549292564)","('NON-ESG', 0.01877727545797825)"
Line 1802,"Health impacts could include:  an increase in vector-borne and infectious diseases; alterations in disease patterns requiring diagnostic and surveillance solutions; emergence of new diseases requiring BD technologies that enable medical research; an increase in antimicrobial resistance (exacerbated by climate change), potentially increasing demand for BD’s diagnostic and surveillance solutions; and disproportionate climate-related health impacts in developing countries, which may increase demand for BD’s low-cost innovations.
","('Physical_Impacts_Of_Climate_Change', 0.8555177450180054)","('Critical_Incident_Risk_Management', 0.03564385324716568)","('Business_Model_Resilience', 0.01703568361699581)","(['Climate Change'], 0.8555177450180054)","('NON-ESG', 0.03564385324716568)","('NON-ESG', 0.01703568361699581)"
Line 1803,"Health impacts could include:  an increase in vector-borne and infectious diseases; alterations in disease patterns requiring diagnostic and surveillance solutions; emergence of new diseases requiring BD technologies that enable medical research; an increase in antimicrobial resistance (exacerbated by climate change), potentially increasing demand for BD’s diagnostic and surveillance solutions; and disproportionate climate-related health impacts in developing countries, which may increase demand for BD’s low-cost innovations.
","('Product_Design_And_Lifecycle_Management', 0.3160984218120575)","('Energy_Management', 0.1831125169992447)","('Supply_Chain_Management', 0.105891153216362)","('NON-ESG', 0.3160984218120575)","('NON-ESG', 0.1831125169992447)","('NON-ESG', 0.105891153216362)"
Line 1804,"Strategy to realize  opportunityAs part of our 2030+ commitments to climate change, we have set a goal to use our capabilities to contribute to solutions that address unmet climate-related health needs, recognizing the connection between climate  change and human health.
","('Physical_Impacts_Of_Climate_Change', 0.9465744495391846)","('Business_Model_Resilience', 0.007619635667651892)","('Critical_Incident_Risk_Management', 0.006081519648432732)","(['Climate Change'], 0.9465744495391846)","('NON-ESG', 0.007619635667651892)","('NON-ESG', 0.006081519648432732)"
Line 1805,"Case study: BD undertook climate scenario analysis to better understand how climate-related risks (such as climate-induced water scarcity) and opportunities could impact the business.
","('Physical_Impacts_Of_Climate_Change', 0.9065951704978943)","('Business_Model_Resilience', 0.020197821781039238)","('Supply_Chain_Management', 0.013746642507612705)","(['Climate Change'], 0.9065951704978943)","('NON-ESG', 0.020197821781039238)","('NON-ESG', 0.013746642507612705)"
Line 1806,"BD partnered with BSR, a global  nonprofit organization of sustainable business experts that works with its global network of the world’s leading companies to build a just and sustainable world, to develop four scenarios corresponding to warming by 2100, which explored climate-related risks and opportunities, and other key uncertainties for BD’s business.
","('Physical_Impacts_Of_Climate_Change', 0.937990665435791)","('Business_Model_Resilience', 0.013113081455230713)","('Systemic_Risk_Management', 0.0069921924732625484)","(['Climate Change'], 0.937990665435791)","('NON-ESG', 0.013113081455230713)","('NON-ESG', 0.0069921924732625484)"
Line 1807,"These scenarios incorporated credible and publicly available climate projections for emissions reductions and climate impacts.
","('Physical_Impacts_Of_Climate_Change', 0.8415022492408752)","('GHG_Emissions', 0.05540584772825241)","('Business_Model_Resilience', 0.027048058807849884)","(['Climate Change'], 0.8415022492408752)","('NON-ESG', 0.05540584772825241)","('NON-ESG', 0.027048058807849884)"
Line 1808,"These scenarios were reviewed by BD’s management in early 2020 and insights from the scenario analysis were incorporated into the development of BDs 2030+ commitments and goals.
","('Business_Model_Resilience', 0.3875974416732788)","('Physical_Impacts_Of_Climate_Change', 0.1566580832004547)","('GHG_Emissions', 0.09827379137277603)","('NON-ESG', 0.3875974416732788)","('NON-ESG', 0.1566580832004547)","('NON-ESG', 0.09827379137277603)"
Line 1809,"2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities How risks and opportunities have influenced our  strategy and financial planning processes The aspects of climate change that have most influenced our strategy are: •  ph ysical risks to operations and supply chain; •  mark et risks due to increasing cost and/or availability of raw materials; •  av ailability of water for our operations; and •  the incr easing expectations of our customers, and reputational considerations in  both the short- and the long-term.
","('Physical_Impacts_Of_Climate_Change', 0.575515866279602)","('Supply_Chain_Management', 0.2744165360927582)","('Systemic_Risk_Management', 0.025952743366360664)","(['Climate Change'], 0.575515866279602)","('NON-ESG', 0.2744165360927582)","('NON-ESG', 0.025952743366360664)"
Line 1810,"2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities How risks and opportunities have influenced our  strategy and financial planning processes The aspects of climate change that have most influenced our strategy are: •  ph ysical risks to operations and supply chain; •  mark et risks due to increasing cost and/or availability of raw materials; •  av ailability of water for our operations; and •  the incr easing expectations of our customers, and reputational considerations in  both the short- and the long-term.
","('Competitive_Behavior', 0.3080141246318817)","('Business_Model_Resilience', 0.2829873263835907)","('Systemic_Risk_Management', 0.08062781393527985)","('NON-ESG', 0.3080141246318817)","('NON-ESG', 0.2829873263835907)","('NON-ESG', 0.08062781393527985)"
Line 1811,"These risks have translated into our 2030+ commitments and goals across the  areas of climate change, product impact and a responsible supply chain, and our public commitment to the UN Race to Zero.Opportunities such as customer preferences for environmentally preferable products have resulted in our 2030+ commitment to reducing the environmental impact of our portfolio and addressing the sustainability needs of our customers.
","('Product_Design_And_Lifecycle_Management', 0.9520183801651001)","('Supply_Chain_Management', 0.00845746323466301)","('Product_Quality_And_Safety', 0.00521613284945488)","(['Product Stewardship'], 0.9520183801651001)","('NON-ESG', 0.00845746323466301)","('NON-ESG', 0.00521613284945488)"
Line 1812,"While our 2030+ commitments and goals are managed at the corporate level  by various central teams, the integration of these goals into business strategy varies among our company’s segments because of diverse geographic locations and product portfolios.
","('Business_Model_Resilience', 0.43121981620788574)","('Product_Design_And_Lifecycle_Management', 0.2644559442996979)","('Supply_Chain_Management', 0.05602625757455826)","('NON-ESG', 0.43121981620788574)","('NON-ESG', 0.2644559442996979)","('NON-ESG', 0.05602625757455826)"
Line 1813,"All business segments work toward the same 2030+ commitments and goals to increase operational efficiency, but certain segments have a heavier emphasis on product sustainability.
","('Product_Design_And_Lifecycle_Management', 0.9593267440795898)","('Energy_Management', 0.005383152049034834)","('Product_Quality_And_Safety', 0.004932610783725977)","(['Product Stewardship'], 0.9593267440795898)","('NON-ESG', 0.005383152049034834)","('NON-ESG', 0.004932610783725977)"
Line 1814,"For example, the BD Medical segment produces drug delivery systems (such as needles, syringes and catheters) that are primarily single-use, in order to prevent the spread of infection.
","('Employee_Health_And_Safety', 0.46798965334892273)","('Data_Security', 0.04042148217558861)","('Systemic_Risk_Management', 0.040218841284513474)","('NON-ESG', 0.46798965334892273)","('NON-ESG', 0.04042148217558861)","('NON-ESG', 0.040218841284513474)"
Line 1815,"Therefore, environmentally preferable product considerations such as less material and recycled content (where possible) are a heavier area of focus for this segment.
","('Product_Design_And_Lifecycle_Management', 0.9593490958213806)","('Product_Quality_And_Safety', 0.004614570643752813)","('Selling_Practices_And_Product_Labeling', 0.004467243794351816)","(['Product Stewardship'], 0.9593490958213806)","('NON-ESG', 0.004614570643752813)","('NON-ESG', 0.004467243794351816)"
Line 1816,"In other business segments where instruments are part of the portfolio, the use phase has the greatest impact, and more consideration is given to the energy efficiency of products.
","('Product_Design_And_Lifecycle_Management', 0.7461130023002625)","('Energy_Management', 0.16902735829353333)","('Product_Quality_And_Safety', 0.008710923604667187)","(['Product Stewardship'], 0.7461130023002625)","('NON-ESG', 0.16902735829353333)","('NON-ESG', 0.008710923604667187)"
Line 1817,"Our work to establish baseline Scope 3 emissions from the use and end-of-life disposal of our products, as well as increased utilization of life-cycle assessments, will provide insights to identify areas of opportunity to reduce emissions and environmental impact across our portfolio.
","('Product_Design_And_Lifecycle_Management', 0.9655666947364807)","('Energy_Management', 0.0033752727322280407)","('Product_Quality_And_Safety', 0.003338857088238001)","(['Product Stewardship'], 0.9655666947364807)","('NON-ESG', 0.0033752727322280407)","('NON-ESG', 0.003338857088238001)"
Line 1818,"The following describes where and how specific risks and opportunities have  influenced our strategy and financial planning.
","('Systemic_Risk_Management', 0.9284694194793701)","('Business_Model_Resilience', 0.02103978395462036)","('Physical_Impacts_Of_Climate_Change', 0.008986255154013634)","(['Risk & Crisis Management'], 0.9284694194793701)","('NON-ESG', 0.02103978395462036)","('NON-ESG', 0.008986255154013634)"
Line 1819,"Part of the value chain Description of influence Products and  servicesHow our strategy has been influenced: Some suppliers, facilities or product lines could be impacted by the risk of climate-related issues in products and services.
","('Product_Design_And_Lifecycle_Management', 0.9422594308853149)","('Supply_Chain_Management', 0.012781443074345589)","('Selling_Practices_And_Product_Labeling', 0.005231998860836029)","(['Product Stewardship'], 0.9422594308853149)","('NON-ESG', 0.012781443074345589)","('NON-ESG', 0.005231998860836029)"
Line 1820,"Carbon regulation and the rise of raw-material costs due to acute  and chronic climate change events could impact the cost of products.
","('Physical_Impacts_Of_Climate_Change', 0.8448047041893005)","('Supply_Chain_Management', 0.032525114715099335)","('Business_Model_Resilience', 0.028449837118387222)","(['Climate Change'], 0.8448047041893005)","('NON-ESG', 0.032525114715099335)","('NON-ESG', 0.028449837118387222)"
Line 1821,"At BD, we view climate change as an issue affecting the health of the global population, which will likely disproportionately impact vulnerable populations such as those without access to healthcare.
","('Physical_Impacts_Of_Climate_Change', 0.9464348554611206)","('Critical_Incident_Risk_Management', 0.008118906058371067)","('Business_Model_Resilience', 0.005442734342068434)","(['Climate Change'], 0.9464348554611206)","('NON-ESG', 0.008118906058371067)","('NON-ESG', 0.005442734342068434)"
Line 1822,"The global greenhouse gas (GHG) emission trajectory is expected to increase the frequency and intensity of some extreme weather events and, along with increasing temperatures, these factors will bring about a range of health risks and population impacts.
","('GHG_Emissions', 0.9689561724662781)","('Air_Quality', 0.0040483130142092705)","('Ecological_Impacts', 0.003556569805368781)","(['Climate Change'], 0.9689561724662781)","('NON-ESG', 0.0040483130142092705)","('NON-ESG', 0.003556569805368781)"
Line 1823,"Heat-related fatalities and illnesses, such as heat stroke and respiratory illnesses, will increase due to rising temperatures and levels of air pollution.
","('Employee_Health_And_Safety', 0.8789142370223999)","('Air_Quality', 0.03740164637565613)","('Critical_Incident_Risk_Management', 0.030341658741235733)","(['Operational Eco-Efficiency'], 0.8789142370223999)","('NON-ESG', 0.03740164637565613)","('NON-ESG', 0.030341658741235733)"
Line 1824,"Increased flooding will affect waterborne illnesses and the spread of vector-borne diseases, such as malaria, Zika virus and West Nile virus.
","('Water_And_Wastewater_Management', 0.4552556574344635)","('Critical_Incident_Risk_Management', 0.24437358975410461)","('Physical_Impacts_Of_Climate_Change', 0.08690030127763748)","('NON-ESG', 0.4552556574344635)","('NON-ESG', 0.24437358975410461)","('NON-ESG', 0.08690030127763748)"
Line 1825,"These factors will place strain on the healthcare infrastructure, so we believe it is imperative that we take steps not only to reduce GHG emissions from our own operations, but also to manage—and where possible mitigate—the potential risks and negative impacts of climate change across our value chain.
","('GHG_Emissions', 0.7206604480743408)","('Physical_Impacts_Of_Climate_Change', 0.18634004890918732)","('Air_Quality', 0.010835343040525913)","(['Climate Change'], 0.7206604480743408)","('NON-ESG', 0.18634004890918732)","('NON-ESG', 0.010835343040525913)"
Line 1826,"Finally, improvements to our products and solutions to reduce their carbon footprint across their life cycle will support our customers in pursuit of their sustainability goals.
","('Product_Design_And_Lifecycle_Management', 0.9677237868309021)","('Product_Quality_And_Safety', 0.0032199749257415533)","('Business_Model_Resilience', 0.0026640056166797876)","(['Product Stewardship'], 0.9677237868309021)","('NON-ESG', 0.0032199749257415533)","('NON-ESG', 0.0026640056166797876)"
Line 1827,"This could include designing electrical equipment to be more energy-efficient, considering alternative materials and making our supply chain networks more efficient.
","('Energy_Management', 0.8535224199295044)","('Supply_Chain_Management', 0.056814949959516525)","('Product_Design_And_Lifecycle_Management', 0.023141920566558838)","(['Operational Eco-Efficiency'], 0.8535224199295044)","('NON-ESG', 0.056814949959516525)","('NON-ESG', 0.023141920566558838)"
Line 1828,"The magnitude of this impact has been small compared to revenue from other types of products and services in our portfolio.
","('Product_Design_And_Lifecycle_Management', 0.9548423290252686)","('Customer_Welfare', 0.005502810701727867)","('Product_Quality_And_Safety', 0.005431071389466524)","(['Product Stewardship'], 0.9548423290252686)","('NON-ESG', 0.005502810701727867)","('NON-ESG', 0.005431071389466524)"
Line 1829,"Time horizons covered include short- and medium-term.
","('Business_Model_Resilience', 0.18639273941516876)","('Physical_Impacts_Of_Climate_Change', 0.16570810973644257)","('GHG_Emissions', 0.12805236876010895)","('NON-ESG', 0.18639273941516876)","('NON-ESG', 0.16570810973644257)","('NON-ESG', 0.12805236876010895)"
Line 1830,"Case study of substantial strategic decisions: Inherent in our Purpose of advancing the world of health ™ is working to meet emerging or unmet health needs that our products, solutions and expertise can address.
","('Product_Design_And_Lifecycle_Management', 0.9568274617195129)","('Product_Quality_And_Safety', 0.0051850504241883755)","('Customer_Welfare', 0.004090477712452412)","(['Product Stewardship'], 0.9568274617195129)","('NON-ESG', 0.0051850504241883755)","('NON-ESG', 0.004090477712452412)"
Line 1831,"We have a  portfolio of solutions that can help detect and diagnose illnesses that will be exacerbated by climate change, such as antimicrobial resistance (AMR).
","('Physical_Impacts_Of_Climate_Change', 0.9410704374313354)","('Business_Model_Resilience', 0.01269642636179924)","('GHG_Emissions', 0.005316834896802902)","(['Climate Change'], 0.9410704374313354)","('NON-ESG', 0.01269642636179924)","('NON-ESG', 0.005316834896802902)"
Line 1832,"Additionally, chronic disease risks are likely to increase with climate change.
","('Physical_Impacts_Of_Climate_Change', 0.956345796585083)","('Business_Model_Resilience', 0.0072987996973097324)","('Critical_Incident_Risk_Management', 0.0038393645081669092)","(['Climate Change'], 0.956345796585083)","('NON-ESG', 0.0072987996973097324)","('NON-ESG', 0.0038393645081669092)"
Line 1833,"Our  growth strategy will focus on transformative solutions to positively impact the treatment of chronic disease.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Part of the value chain Description of influence Supply chain How our strategy has been influenced: The risks and opportunities in our supply chain are in the form of rising energy costs that would impact our process and cause a reduction or interruption in the supply of certain raw  materials and components that could adversely affect our operations.
","('Supply_Chain_Management', 0.9506961107254028)","('Physical_Impacts_Of_Climate_Change', 0.007543243933469057)","('Systemic_Risk_Management', 0.005173171870410442)","(['Supply Chain Management'], 0.9506961107254028)","('NON-ESG', 0.007543243933469057)","('NON-ESG', 0.005173171870410442)"
Line 1834,"Our  growth strategy will focus on transformative solutions to positively impact the treatment of chronic disease.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Part of the value chain Description of influence Supply chain How our strategy has been influenced: The risks and opportunities in our supply chain are in the form of rising energy costs that would impact our process and cause a reduction or interruption in the supply of certain raw  materials and components that could adversely affect our operations.
","('Supply_Chain_Management', 0.7982103228569031)","('Product_Design_And_Lifecycle_Management', 0.058047834783792496)","('Energy_Management', 0.026151835918426514)","(['Supply Chain Management'], 0.7982103228569031)","('NON-ESG', 0.058047834783792496)","('NON-ESG', 0.026151835918426514)"
Line 1835,"Severe weather that impacts our supply chain would increase our risk of disruption to customers.
","('Supply_Chain_Management', 0.9502654671669006)","('Physical_Impacts_Of_Climate_Change', 0.004797510337084532)","('Product_Design_And_Lifecycle_Management', 0.004649526905268431)","(['Supply Chain Management'], 0.9502654671669006)","('NON-ESG', 0.004797510337084532)","('NON-ESG', 0.004649526905268431)"
Line 1836,"This is managed through procurement expertise.
","('Supply_Chain_Management', 0.2893941402435303)","('Product_Design_And_Lifecycle_Management', 0.22669392824172974)","('Management_Of_Legal_And_Regulatory_Framework', 0.05823316425085068)","('NON-ESG', 0.2893941402435303)","('NON-ESG', 0.22669392824172974)","('NON-ESG', 0.05823316425085068)"
Line 1837,"BD’s strategic sourcing teams continuously assess our sole-sourced raw materials and maintain business continuity plans with our suppliers.
","('Supply_Chain_Management', 0.8699406385421753)","('Product_Design_And_Lifecycle_Management', 0.03876521438360214)","('Customer_Welfare', 0.008279119618237019)","(['Supply Chain Management'], 0.8699406385421753)","('NON-ESG', 0.03876521438360214)","('NON-ESG', 0.008279119618237019)"
Line 1838,"BD’s continuity plans may include securing secondary supply with alternative suppliers, qualification of alternative manufacturing facilities, maintaining contingency stock, internal development of supply and establishment of technology escrow accounts.
","('Supply_Chain_Management', 0.9466912150382996)","('Systemic_Risk_Management', 0.004427925683557987)","('Energy_Management', 0.0042815194465219975)","(['Supply Chain Management'], 0.9466912150382996)","('NON-ESG', 0.004427925683557987)","('NON-ESG', 0.0042815194465219975)"
Line 1839,"In 2016, we refined our approach to supplier risk profiling by adding reputation risks into our Enterprise Supplier Risk Management process, for direct suppliers.
","('Supply_Chain_Management', 0.943166196346283)","('Labor_Practices', 0.007131575606763363)","('Systemic_Risk_Management', 0.005221096333116293)","(['Supply Chain Management'], 0.943166196346283)","('NON-ESG', 0.007131575606763363)","('NON-ESG', 0.005221096333116293)"
Line 1840,"An initial set of risks were identified, and mitigation plans are in progress.
","('Systemic_Risk_Management', 0.3627808392047882)","('Physical_Impacts_Of_Climate_Change', 0.21694087982177734)","('Business_Model_Resilience', 0.12198583036661148)","('NON-ESG', 0.3627808392047882)","('NON-ESG', 0.21694087982177734)","('NON-ESG', 0.12198583036661148)"
Line 1841,"We will continue to refine our risk model and adjust our top risks accordingly.
","('Systemic_Risk_Management', 0.8957923650741577)","('Business_Model_Resilience', 0.027498498558998108)","('Competitive_Behavior', 0.014366833493113518)","(['Risk & Crisis Management'], 0.8957923650741577)","('NON-ESG', 0.027498498558998108)","('NON-ESG', 0.014366833493113518)"
Line 1842,"The magnitude of impacts on our supply chain from climate change has been small compared to other factors.
","('Physical_Impacts_Of_Climate_Change', 0.4845082461833954)","('Supply_Chain_Management', 0.36338871717453003)","('Business_Model_Resilience', 0.02581007033586502)","('NON-ESG', 0.4845082461833954)","('NON-ESG', 0.36338871717453003)","('NON-ESG', 0.02581007033586502)"
Line 1843,"However, if frequency of disruption increases, potential impacts could be significant as our supply chain is large and complex.
","('Supply_Chain_Management', 0.9507014155387878)","('Systemic_Risk_Management', 0.004447081126272678)","('Labor_Practices', 0.004270472098141909)","(['Supply Chain Management'], 0.9507014155387878)","('NON-ESG', 0.004447081126272678)","('NON-ESG', 0.004270472098141909)"
Line 1844,"Time horizons covered include short- and medium-term.
","('Business_Model_Resilience', 0.18639273941516876)","('Physical_Impacts_Of_Climate_Change', 0.16570810973644257)","('GHG_Emissions', 0.12805236876010895)","('NON-ESG', 0.18639273941516876)","('NON-ESG', 0.16570810973644257)","('NON-ESG', 0.12805236876010895)"
Line 1845,"Case study of substantial strategic decisions: As part of our 2030+ commitment to create a supply chain adaptable to disruption and able to contribute to strong environmental and social performance, we have set goals to  (1) complete ESG desktop audits for strategic, preferred and critical suppliers by 2023 and (2) have 90 percent of total spend reflected in completed supplier ESG desktop audits by 2025.
","('Supply_Chain_Management', 0.955008327960968)","('Product_Design_And_Lifecycle_Management', 0.0039167567156255245)","('Physical_Impacts_Of_Climate_Change', 0.0036143173929303885)","(['Supply Chain Management'], 0.955008327960968)","('NON-ESG', 0.0039167567156255245)","('NON-ESG', 0.0036143173929303885)"
Line 1846,"Using third-party survey platforms, such as Ecovadis, we are able to collect different environmental KPIs (GHG emissions, water usage, waste generated, etc.) and assess suppliers’ policies and processes to manage various  ESG issues.
","('GHG_Emissions', 0.9361701607704163)","('Water_And_Wastewater_Management', 0.007286180276423693)","('Management_Of_Legal_And_Regulatory_Framework', 0.005993185564875603)","(['Climate Change'], 0.9361701607704163)","('NON-ESG', 0.007286180276423693)","('NON-ESG', 0.005993185564875603)"
Line 1847,"Investment in R&D How our strategy has been influenced: At BD, we view climate change as an issue of public health.
","('Physical_Impacts_Of_Climate_Change', 0.9577469825744629)","('Business_Model_Resilience', 0.007469533011317253)","('GHG_Emissions', 0.0037355893291532993)","(['Climate Change'], 0.9577469825744629)","('NON-ESG', 0.007469533011317253)","('NON-ESG', 0.0037355893291532993)"
Line 1848,"The global greenhouse gas (GHG) emission trajectory is expected to increase the frequency and intensity of some extreme weather events, and along with increasing temperatures, these factors will bring about a range of health risks and population impacts.
","('GHG_Emissions', 0.9688500761985779)","('Air_Quality', 0.004088123794645071)","('Ecological_Impacts', 0.0035698777064681053)","(['Climate Change'], 0.9688500761985779)","('NON-ESG', 0.004088123794645071)","('NON-ESG', 0.0035698777064681053)"
Line 1849,"Heat-related fatalities and illnesses, such as heat stroke and respiratory illnesses, will increase due to rising temperatures and levels of air pollution.
","('Employee_Health_And_Safety', 0.8789142370223999)","('Air_Quality', 0.03740164637565613)","('Critical_Incident_Risk_Management', 0.030341658741235733)","(['Operational Eco-Efficiency'], 0.8789142370223999)","('NON-ESG', 0.03740164637565613)","('NON-ESG', 0.030341658741235733)"
Line 1850,"Increased flooding will affect waterborne illnesses and the spread of vector-borne diseases, such as malaria, Zika virus and West Nile virus.
","('Water_And_Wastewater_Management', 0.4552556574344635)","('Critical_Incident_Risk_Management', 0.24437358975410461)","('Physical_Impacts_Of_Climate_Change', 0.08690030127763748)","('NON-ESG', 0.4552556574344635)","('NON-ESG', 0.24437358975410461)","('NON-ESG', 0.08690030127763748)"
Line 1851,"These factors will place strain on the healthcare infrastructure, so we believe it is imperative that we take steps not only to reduce GHG emissions from our own operations, but also take steps to manage—and where possible mitigate—the potential risks and negative impacts of climate change across our value chain.
","('GHG_Emissions', 0.7778286933898926)","('Physical_Impacts_Of_Climate_Change', 0.13812094926834106)","('Air_Quality', 0.010621877387166023)","(['Climate Change'], 0.7778286933898926)","('NON-ESG', 0.13812094926834106)","('NON-ESG', 0.010621877387166023)"
Line 1852,"As part of our 2030+ commitment to minimize our contribution to global emissions, we have also set a goal to utilize our capabilities to address unmet health needs for climate-vulnerable populations.
","('Critical_Incident_Risk_Management', 0.2688797116279602)","('Physical_Impacts_Of_Climate_Change', 0.18671579658985138)","('Access_And_Affordability', 0.129830464720726)","('NON-ESG', 0.2688797116279602)","('NON-ESG', 0.18671579658985138)","('NON-ESG', 0.129830464720726)"
Line 1853,"While w e do not currently  have a specific program around investment in R&D for climate-related diseases, we see risks and opportunities related to the nexus of climate change and human health as something that would surface as part of our work to  address unmet health needs.
","('Physical_Impacts_Of_Climate_Change', 0.9417786598205566)","('Critical_Incident_Risk_Management', 0.00996466726064682)","('Business_Model_Resilience', 0.007097222376614809)","(['Climate Change'], 0.9417786598205566)","('NON-ESG', 0.00996466726064682)","('NON-ESG', 0.007097222376614809)"
Line 1854,"We would allocate investments through existing funding channels within the organization.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9159945845603943)","('Access_And_Affordability', 0.013230743817985058)","('Energy_Management', 0.009332114830613136)","(['Corporate Governance'], 0.9159945845603943)","('NON-ESG', 0.013230743817985058)","('NON-ESG', 0.009332114830613136)"
Line 1855,"The magnitude of this impact is expected to be small in relation to other R&D investments.
","('Systemic_Risk_Management', 0.3233194351196289)","('Business_Model_Resilience', 0.3164645731449127)","('Management_Of_Legal_And_Regulatory_Framework', 0.09962321072816849)","('NON-ESG', 0.3233194351196289)","('NON-ESG', 0.3164645731449127)","('NON-ESG', 0.09962321072816849)"
Line 1856,"Time horizons covered include medium and long-term.
","('Business_Model_Resilience', 0.30859267711639404)","('Physical_Impacts_Of_Climate_Change', 0.1766260415315628)","('Systemic_Risk_Management', 0.07299987971782684)","('NON-ESG', 0.30859267711639404)","('NON-ESG', 0.1766260415315628)","('NON-ESG', 0.07299987971782684)"
Line 1857,"Case study of substantial strategic decisions: Inherent in our Purpose of advancing the world of health ™ is working to meet emerging or unmet health needs that our products, solutions and expertise can support.
","('Product_Design_And_Lifecycle_Management', 0.9560185670852661)","('Product_Quality_And_Safety', 0.0053221965208649635)","('Customer_Welfare', 0.00418434152379632)","(['Product Stewardship'], 0.9560185670852661)","('NON-ESG', 0.0053221965208649635)","('NON-ESG', 0.00418434152379632)"
Line 1858,"We have  a portfolio of solutions that can help detect and diagnose illnesses that will be exacerbated by climate change, such as antimicrobial resistance (AMR).
","('Physical_Impacts_Of_Climate_Change', 0.9410704374313354)","('Business_Model_Resilience', 0.01269642636179924)","('GHG_Emissions', 0.005316834896802902)","(['Climate Change'], 0.9410704374313354)","('NON-ESG', 0.01269642636179924)","('NON-ESG', 0.005316834896802902)"
Line 1859,"Additionally chronic disease risks are likely to increase with climate change.
","('Physical_Impacts_Of_Climate_Change', 0.9573269486427307)","('Business_Model_Resilience', 0.006737280637025833)","('Critical_Incident_Risk_Management', 0.0041563427075743675)","(['Climate Change'], 0.9573269486427307)","('NON-ESG', 0.006737280637025833)","('NON-ESG', 0.0041563427075743675)"
Line 1860,"Our growth strategy will focus on transformative solutions to positively impact the treatment of chronic disease.
","('Employee_Health_And_Safety', 0.46170365810394287)","('Access_And_Affordability', 0.14132267236709595)","('Product_Quality_And_Safety', 0.073140949010849)","('NON-ESG', 0.46170365810394287)","('NON-ESG', 0.14132267236709595)","('NON-ESG', 0.073140949010849)"
Line 1861,"In FY 2022, BD announced the formation of the BD Sustainable Medical Technology Institute (BD SMTI), which will develop and support programs to achieve our 2030+ Product Impact goals.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Part of the value chain Description of influence Operations How our strategy has been influenced: Risks from climate change in operations are intensified for some suppliers, facilities or product lines.
","('Physical_Impacts_Of_Climate_Change', 0.6680200099945068)","('Supply_Chain_Management', 0.1581535041332245)","('Business_Model_Resilience', 0.03220033645629883)","(['Climate Change'], 0.6680200099945068)","('NON-ESG', 0.1581535041332245)","('NON-ESG', 0.03220033645629883)"
Line 1862,"In FY 2022, BD announced the formation of the BD Sustainable Medical Technology Institute (BD SMTI), which will develop and support programs to achieve our 2030+ Product Impact goals.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Part of the value chain Description of influence Operations How our strategy has been influenced: Risks from climate change in operations are intensified for some suppliers, facilities or product lines.
","('Product_Design_And_Lifecycle_Management', 0.8019850254058838)","('Selling_Practices_And_Product_Labeling', 0.04596783593297005)","('Customer_Welfare', 0.031998567283153534)","(['Product Stewardship'], 0.8019850254058838)","('NON-ESG', 0.04596783593297005)","('NON-ESG', 0.031998567283153534)"
Line 1863,"This could include carbon regulation increasing operational costs, acute and chronic  events such as an increase in extreme hurricanes impacting BD manufacturing facilities and/or supplier facilities, and chronic events such as prolonged drought increasing water costs in operations.
","('Water_And_Wastewater_Management', 0.7275413870811462)","('Supply_Chain_Management', 0.11367888748645782)","('Energy_Management', 0.026471178978681564)","(['Operational Eco-Efficiency'], 0.7275413870811462)","('NON-ESG', 0.11367888748645782)","('NON-ESG', 0.026471178978681564)"
Line 1864,"We have incorporated this risk into our business continuity planning for operations by evaluating where we manufacture products that are classified as critical to healthcare and pursuing redundant manufacturing capabilities  where appropriate.
","('Product_Design_And_Lifecycle_Management', 0.9445595741271973)","('Supply_Chain_Management', 0.009247031062841415)","('Product_Quality_And_Safety', 0.005270520690828562)","(['Product Stewardship'], 0.9445595741271973)","('NON-ESG', 0.009247031062841415)","('NON-ESG', 0.005270520690828562)"
Line 1865,"In addition to goals set for our climate change impact area, we have set a 2030+ goal to incorporate climate risk into supply chain and network architecture strategies  .
","('Physical_Impacts_Of_Climate_Change', 0.7652820944786072)","('Supply_Chain_Management', 0.11619394272565842)","('Business_Model_Resilience', 0.022098664194345474)","(['Climate Change'], 0.7652820944786072)","('NON-ESG', 0.11619394272565842)","('NON-ESG', 0.022098664194345474)"
Line 1866,"T he magnitude of this impact has been  small compared to other factors like operational expenditures and annual revenue.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7076174020767212)","('Energy_Management', 0.06829007714986801)","('Systemic_Risk_Management', 0.03814109042286873)","(['Corporate Governance'], 0.7076174020767212)","('NON-ESG', 0.06829007714986801)","('NON-ESG', 0.03814109042286873)"
Line 1867,"Time horizons covered include short- and medium-term.
","('Business_Model_Resilience', 0.18639273941516876)","('Physical_Impacts_Of_Climate_Change', 0.16570810973644257)","('GHG_Emissions', 0.12805236876010895)","('NON-ESG', 0.18639273941516876)","('NON-ESG', 0.16570810973644257)","('NON-ESG', 0.12805236876010895)"
Line 1868,"Case study of substantial strategic decisions: In our climate change impact area, we have set goals to reduce our GHG emissions.
","('GHG_Emissions', 0.9415244460105896)","('Physical_Impacts_Of_Climate_Change', 0.016627341508865356)","('Ecological_Impacts', 0.004688675981014967)","(['Climate Change'], 0.9415244460105896)","('NON-ESG', 0.016627341508865356)","('NON-ESG', 0.004688675981014967)"
Line 1869,"We will achieve this reduction through two mechanisms—reduced energy demand and  increased use of renewables.
","('Energy_Management', 0.9785252213478088)","('Management_Of_Legal_And_Regulatory_Framework', 0.0028462721966207027)","('Product_Design_And_Lifecycle_Management', 0.001595797366462648)","(['Operational Eco-Efficiency'], 0.9785252213478088)","('NON-ESG', 0.0028462721966207027)","('NON-ESG', 0.001595797366462648)"
Line 1870,"Each facility has identified a pipeline of projects aimed at reducing our GHG emissions and will utilize a traditional capital funding process to implement these projects.
","('GHG_Emissions', 0.9666649103164673)","('Air_Quality', 0.004445775877684355)","('Management_Of_Legal_And_Regulatory_Framework', 0.003098340705037117)","(['Climate Change'], 0.9666649103164673)","('NON-ESG', 0.004445775877684355)","('NON-ESG', 0.003098340705037117)"
Line 1871,"This process will continue to increase the number of projects  with sustainability benefits and associated cost savings and contribute to BD’s competitiveness in both the short- and the long-term.
","('Competitive_Behavior', 0.6891517639160156)","('Business_Model_Resilience', 0.12027326971292496)","('Systemic_Risk_Management', 0.027891874313354492)","(['Business Ethics'], 0.6891517639160156)","('NON-ESG', 0.12027326971292496)","('NON-ESG', 0.027891874313354492)"
Line 1872,"Previous projects have included HVAC replacements, chiller upgrades, compressed-air upgrades and LED installations, in addition to larger projects such as the installation of cogeneration facilities and various major solar  installation projects.
","('Energy_Management', 0.9192700982093811)","('Air_Quality', 0.01809428632259369)","('Management_Of_Legal_And_Regulatory_Framework', 0.006159544922411442)","(['Operational Eco-Efficiency'], 0.9192700982093811)","('NON-ESG', 0.01809428632259369)","('NON-ESG', 0.006159544922411442)"
Line 1873,"Indirect costs,   capital expenditures and assetsHow our strategy has been influenced: Risks and opportunities that would affect operating costs and capital expenditure/capital allocation are factored into our financial planning through normal budgeting processes for the  short-term.
","('Business_Model_Resilience', 0.515408456325531)","('Systemic_Risk_Management', 0.2249452769756317)","('Management_Of_Legal_And_Regulatory_Framework', 0.06290332973003387)","(['Codes of Business Conduct'], 0.515408456325531)","('NON-ESG', 0.2249452769756317)","('NON-ESG', 0.06290332973003387)"
Line 1874,"These risks include increased operational costs from regulation or rising energy costs.
","('Energy_Management', 0.9314973950386047)","('Management_Of_Legal_And_Regulatory_Framework', 0.029290221631526947)","('Air_Quality', 0.00339366658590734)","(['Operational Eco-Efficiency'], 0.9314973950386047)","('NON-ESG', 0.029290221631526947)","('NON-ESG', 0.00339366658590734)"
Line 1875,"Each facility has identified a pipeline of projects aimed at reducing our GHG emissions through demand reduction and increase in the use of renewables, and will utilize a traditional capital funding process to implement these projects.
","('GHG_Emissions', 0.966735303401947)","('Air_Quality', 0.003690661396831274)","('Management_Of_Legal_And_Regulatory_Framework', 0.0033833386842161417)","(['Climate Change'], 0.966735303401947)","('NON-ESG', 0.003690661396831274)","('NON-ESG', 0.0033833386842161417)"
Line 1876,"The magnitude of impact is relatively small (less than 5 percent of total operating costs).
","('Energy_Management', 0.4174914062023163)","('Supply_Chain_Management', 0.13459791243076324)","('Systemic_Risk_Management', 0.11519105732440948)","('NON-ESG', 0.4174914062023163)","('NON-ESG', 0.13459791243076324)","('NON-ESG', 0.11519105732440948)"
Line 1877,"Time horizons covered by financial planning are short- to medium-term.Risks and opportunities from climate change in asset financial planning are impacted for some suppliers, facilities and product lines.
","('Physical_Impacts_Of_Climate_Change', 0.9467211961746216)","('Business_Model_Resilience', 0.008302401751279831)","('Supply_Chain_Management', 0.005422940943390131)","(['Climate Change'], 0.9467211961746216)","('NON-ESG', 0.008302401751279831)","('NON-ESG', 0.005422940943390131)"
Line 1878,"Risks include property damage from acute physical impacts from increased severity of extreme  weather events—as seen through Hurricane Maria.
","('Physical_Impacts_Of_Climate_Change', 0.8592637777328491)","('Business_Model_Resilience', 0.056094832718372345)","('Critical_Incident_Risk_Management', 0.013137572444975376)","(['Climate Change'], 0.8592637777328491)","('NON-ESG', 0.056094832718372345)","('NON-ESG', 0.013137572444975376)"
Line 1879,"These risks are managed as part of general business continuity planning over the medium-term.
","('Systemic_Risk_Management', 0.9020134806632996)","('Business_Model_Resilience', 0.023646464571356773)","('Physical_Impacts_Of_Climate_Change', 0.01794738508760929)","(['Risk & Crisis Management'], 0.9020134806632996)","('NON-ESG', 0.023646464571356773)","('NON-ESG', 0.01794738508760929)"
Line 1880,"Case study of substantial strategic decisions: BD has entered into multiple power purchase agreements (PPAs) at various facilities to secure a supply of renewable energy for our operations.
","('Energy_Management', 0.9692614674568176)","('Management_Of_Legal_And_Regulatory_Framework', 0.004018988460302353)","('Product_Design_And_Lifecycle_Management', 0.0029135607182979584)","(['Operational Eco-Efficiency'], 0.9692614674568176)","('NON-ESG', 0.004018988460302353)","('NON-ESG', 0.0029135607182979584)"
Line 1881,"These PPAs range from on-site  renewable energy installations to indirect procurement of green energy off-site.
","('Energy_Management', 0.9782857894897461)","('Management_Of_Legal_And_Regulatory_Framework', 0.0029193044174462557)","('Product_Design_And_Lifecycle_Management', 0.0016247524181380868)","(['Operational Eco-Efficiency'], 0.9782857894897461)","('NON-ESG', 0.0029193044174462557)","('NON-ESG', 0.0016247524181380868)"
Line 1882,"By signing these agreements and fixing our energy costs over a long period of time, we are managing our operating costs as well as reducing climate impacts.
","('Energy_Management', 0.9510021209716797)","('Physical_Impacts_Of_Climate_Change', 0.007362730801105499)","('Management_Of_Legal_And_Regulatory_Framework', 0.006647592410445213)","(['Operational Eco-Efficiency'], 0.9510021209716797)","('NON-ESG', 0.007362730801105499)","('NON-ESG', 0.006647592410445213)"
Line 1883,"Time horizons covered by financial planning are short- to medium-term.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Scenario analysis In 2019, responding to the need for strategic resilience in a time of rapid change,  as well as a desire to assess and report to investors on climate risk in line with the TCFD Recommendations, BD undertook climate scenario analysis to better understand how climate-related risks and opportunities could impact the business.
","('Physical_Impacts_Of_Climate_Change', 0.9295065402984619)","('Business_Model_Resilience', 0.021455369889736176)","('Supply_Chain_Management', 0.0075504370033741)","(['Climate Change'], 0.9295065402984619)","('NON-ESG', 0.021455369889736176)","('NON-ESG', 0.0075504370033741)"
Line 1884,"Time horizons covered by financial planning are short- to medium-term.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Scenario analysis In 2019, responding to the need for strategic resilience in a time of rapid change,  as well as a desire to assess and report to investors on climate risk in line with the TCFD Recommendations, BD undertook climate scenario analysis to better understand how climate-related risks and opportunities could impact the business.
","('Business_Model_Resilience', 0.559654951095581)","('Systemic_Risk_Management', 0.22559338808059692)","('Supply_Chain_Management', 0.04617606848478317)","(['Codes of Business Conduct'], 0.559654951095581)","('NON-ESG', 0.22559338808059692)","('NON-ESG', 0.04617606848478317)"
Line 1885,"BD partnered with BSR, a global nonprofit organization of sustainable business experts that works with its global network of the world’s leading companies to build a just and sustainable world.
","('Business_Model_Resilience', 0.3890431225299835)","('Product_Design_And_Lifecycle_Management', 0.2689729630947113)","('Supply_Chain_Management', 0.04828527197241783)","('NON-ESG', 0.3890431225299835)","('NON-ESG', 0.2689729630947113)","('NON-ESG', 0.04828527197241783)"
Line 1886,"BSR and BD collaboratively developed qualitative scenarios, augmented them with information from relevant climate projections and completed a climate scenario to analyze and assess the resilience of BD’s corporate strategy to climate-related risks and opportunities, in line with the TCFD Recommendations.
","('Physical_Impacts_Of_Climate_Change', 0.6289916634559631)","('Business_Model_Resilience', 0.26395130157470703)","('Systemic_Risk_Management', 0.014924648217856884)","(['Climate Change'], 0.6289916634559631)","('NON-ESG', 0.26395130157470703)","('NON-ESG', 0.014924648217856884)"
Line 1887,"Four scenarios were developed that corresponded to warming by 2100 allowing  us to explore climate-related risks and opportunities, and other key uncertainties for our business.
","('Physical_Impacts_Of_Climate_Change', 0.9261586666107178)","('Business_Model_Resilience', 0.0163174606859684)","('Systemic_Risk_Management', 0.013527980074286461)","(['Climate Change'], 0.9261586666107178)","('NON-ESG', 0.0163174606859684)","('NON-ESG', 0.013527980074286461)"
Line 1888,"The time horizons covered included both the medium and the long-term (2030+).
","('Physical_Impacts_Of_Climate_Change', 0.31338751316070557)","('Business_Model_Resilience', 0.27835363149642944)","('GHG_Emissions', 0.10375940799713135)","('NON-ESG', 0.31338751316070557)","('NON-ESG', 0.27835363149642944)","('NON-ESG', 0.10375940799713135)"
Line 1889,"In order to incorporate information from climate projections into the scenarios, specific temperature increases and climate projections were assigned to each scenario.
","('Physical_Impacts_Of_Climate_Change', 0.6663920283317566)","('GHG_Emissions', 0.08180658519268036)","('Business_Model_Resilience', 0.07912252098321915)","(['Climate Change'], 0.6663920283317566)","('NON-ESG', 0.08180658519268036)","('NON-ESG', 0.07912252098321915)"
Line 1890,"Two of the resulting scenarios were created based on the RCP 2.6 scenarios with the 1.5°C trajectory by 2100; the remaining two were created based on RCP 8.5, which is also the business-as-usual scenario.
","('Business_Model_Resilience', 0.34874916076660156)","('Systemic_Risk_Management', 0.1795574575662613)","('GHG_Emissions', 0.1101592406630516)","('NON-ESG', 0.34874916076660156)","('NON-ESG', 0.1795574575662613)","('NON-ESG', 0.1101592406630516)"
Line 1891,"The areas that were considered as part of the scenario analysis include supply chain, business strategy, policy, market trends and technology.
","('Supply_Chain_Management', 0.9492607712745667)","('Physical_Impacts_Of_Climate_Change', 0.004618231672793627)","('Product_Design_And_Lifecycle_Management', 0.0034995560999959707)","(['Supply Chain Management'], 0.9492607712745667)","('NON-ESG', 0.004618231672793627)","('NON-ESG', 0.0034995560999959707)"
Line 1892,"A cross-functional workshop was held, in order for participants to explore the  strategic implications of the four future scenarios.
","('Business_Model_Resilience', 0.7068877816200256)","('Physical_Impacts_Of_Climate_Change', 0.07712572813034058)","('Systemic_Risk_Management', 0.027053391560912132)","(['Codes of Business Conduct'], 0.7068877816200256)","('NON-ESG', 0.07712572813034058)","('NON-ESG', 0.027053391560912132)"
Line 1893,"The results were used to determine (1) issues that are likely to increase in importance, regardless of scenario, and (2) highly dynamic issues that are very responsive to different scenarios and therefore require close monitoring and a foresight-driven management approach.
","('Systemic_Risk_Management', 0.48655861616134644)","('Physical_Impacts_Of_Climate_Change', 0.16524621844291687)","('Business_Model_Resilience', 0.15493126213550568)","('NON-ESG', 0.48655861616134644)","('NON-ESG', 0.16524621844291687)","('NON-ESG', 0.15493126213550568)"
Line 1894,"These insights were incorporated into the development of BD’s 2030+ commitments and goals, including the science-based target that was announced at the end of 2020.Under the business-as-usual scenarios, a number of issues increased in importance, including water and global systemic health challenges related to climate change.
","('Physical_Impacts_Of_Climate_Change', 0.7190912365913391)","('Systemic_Risk_Management', 0.15179194509983063)","('Business_Model_Resilience', 0.05084967240691185)","(['Climate Change'], 0.7190912365913391)","('NON-ESG', 0.15179194509983063)","('NON-ESG', 0.05084967240691185)"
Line 1895,"Under the remaining scenarios with the 1.5°C trajectory by 2100, energy and emissions from our operations; social impact and access for underserved populations; talent; diversity and inclusion; and global systemic health challenges related to climate change increased in importance.
","('Access_And_Affordability', 0.8908145427703857)","('Human_Rights_And_Community_Relations', 0.019784439355134964)","('Employee_Engagement_Inclusion_And_Diversity', 0.013212659396231174)","(['Health Outcome Contribution'], 0.8908145427703857)","('NON-ESG', 0.019784439355134964)","('NON-ESG', 0.013212659396231174)"
Line 1896,"These issues are addressed under our 2030+ commitments.
","('Human_Rights_And_Community_Relations', 0.4045465588569641)","('Management_Of_Legal_And_Regulatory_Framework', 0.18922321498394012)","('Access_And_Affordability', 0.0658809021115303)","('NON-ESG', 0.4045465588569641)","('NON-ESG', 0.18922321498394012)","('NON-ESG', 0.0658809021115303)"
Line 1897,"Further information about which of our ESG issues increased in importance and/or  were dynamic can be found in the material ESG issues section.
","('Business_Model_Resilience', 0.29019877314567566)","('Systemic_Risk_Management', 0.19180913269519806)","('Human_Rights_And_Community_Relations', 0.09790601581335068)","('NON-ESG', 0.29019877314567566)","('NON-ESG', 0.19180913269519806)","('NON-ESG', 0.09790601581335068)"
Line 1898,"Risk management At a company level, climate-related risks are identified by the central S&EHS team.
","('Physical_Impacts_Of_Climate_Change', 0.9454714059829712)","('Business_Model_Resilience', 0.009925146587193012)","('GHG_Emissions', 0.006001691333949566)","(['Climate Change'], 0.9454714059829712)","('NON-ESG', 0.009925146587193012)","('NON-ESG', 0.006001691333949566)"
Line 1899,"The process for identifying risks involves stakeholder engagement with our internal technical experts, customers, shareholders, BD associates, business partners (e.g., suppliers), communities, governments, international agencies and nongovernmental organizations.
","('Supply_Chain_Management', 0.6497953534126282)","('Systemic_Risk_Management', 0.1106889471411705)","('Business_Model_Resilience', 0.029206732288002968)","(['Supply Chain Management'], 0.6497953534126282)","('NON-ESG', 0.1106889471411705)","('NON-ESG', 0.029206732288002968)"
Line 1900,"Climate-related risks are identified and evaluated by the S&EHS team through  general sustainability materiality assessments and are informed by our ERM program and business continuity planning in areas such as disaster planning (including severe storms).
","('Critical_Incident_Risk_Management', 0.8347460627555847)","('Physical_Impacts_Of_Climate_Change', 0.09651798009872437)","('Air_Quality', 0.009453969076275826)","(['Risk & Crisis Management'], 0.8347460627555847)","('NON-ESG', 0.09651798009872437)","('NON-ESG', 0.009453969076275826)"
Line 1901,"Physical (operational) risks posed by climate change that could impact our direct  operations and/or supply chain and result in disruption to business continuity are identified and evaluated via processes established within the ISC team.
","('Physical_Impacts_Of_Climate_Change', 0.634850263595581)","('Supply_Chain_Management', 0.23007218539714813)","('Business_Model_Resilience', 0.02304733917117119)","(['Climate Change'], 0.634850263595581)","('NON-ESG', 0.23007218539714813)","('NON-ESG', 0.02304733917117119)"
Line 1902,"Risk teams within the ISC team partner with individual facilities, business teams and subject matter experts to identify and evaluate risks (which may include but are not confined to climate change impacts).
","('Physical_Impacts_Of_Climate_Change', 0.9574878811836243)","('Business_Model_Resilience', 0.007941275835037231)","('GHG_Emissions', 0.0038581625558435917)","(['Climate Change'], 0.9574878811836243)","('NON-ESG', 0.007941275835037231)","('NON-ESG', 0.0038581625558435917)"
Line 1903,"The central Risk Management team is responsible for monitoring compliance to property protection standards through which longer-term systematic risks can be evaluated.
","('Systemic_Risk_Management', 0.4120926856994629)","('Management_Of_Legal_And_Regulatory_Framework', 0.2156667709350586)","('Product_Quality_And_Safety', 0.09095493704080582)","('NON-ESG', 0.4120926856994629)","('NON-ESG', 0.2156667709350586)","('NON-ESG', 0.09095493704080582)"
Line 1904,"The process includes, but is not limited to, aggregation of insurance reports, sustainability risk assessments and third-party tools, such as water risk assessments.
","('Water_And_Wastewater_Management', 0.21916493773460388)","('Systemic_Risk_Management', 0.19075444340705872)","('Physical_Impacts_Of_Climate_Change', 0.18024960160255432)","('NON-ESG', 0.21916493773460388)","('NON-ESG', 0.19075444340705872)","('NON-ESG', 0.18024960160255432)"
Line 1905,"Examples of these physical risks include damage to facility and/or product from severe weather (such as Hurricane Maria’s impact on our facilities in Puerto Rico) and upstream fluctuations in the availability of materials (such as hurricanes in Texas impacting refineries and, by extension, resins.).
","('Supply_Chain_Management', 0.3304715156555176)","('Physical_Impacts_Of_Climate_Change', 0.19707560539245605)","('Product_Design_And_Lifecycle_Management', 0.1402529627084732)","('NON-ESG', 0.3304715156555176)","('NON-ESG', 0.19707560539245605)","('NON-ESG', 0.1402529627084732)"
Line 1906,"Transitional risks posed by climate change (financial, external, legal and  compliance, and strategic) are evaluated by the central S&EHS team.
","('Physical_Impacts_Of_Climate_Change', 0.9561412930488586)","('Business_Model_Resilience', 0.008362019434571266)","('Systemic_Risk_Management', 0.003906895872205496)","(['Climate Change'], 0.9561412930488586)","('NON-ESG', 0.008362019434571266)","('NON-ESG', 0.003906895872205496)"
Line 1907,"Both physical and transitional risks posed by climate change may also be reviewed within the ERM program, based on risk assessment and other procedures performed to identify and assess risks against established guidelines.
","('Physical_Impacts_Of_Climate_Change', 0.9594156742095947)","('Business_Model_Resilience', 0.00726835522800684)","('GHG_Emissions', 0.003208391135558486)","(['Climate Change'], 0.9594156742095947)","('NON-ESG', 0.00726835522800684)","('NON-ESG', 0.003208391135558486)"
Line 1908,"Though risks that are identified as part of our ERM program may be impacted by climate change (for example, supply chain disruption due to extreme weather), climate change may not be named as a specific individual risk.
","('Physical_Impacts_Of_Climate_Change', 0.8671663999557495)","('Supply_Chain_Management', 0.04959505423903465)","('Business_Model_Resilience', 0.015677589923143387)","(['Climate Change'], 0.8671663999557495)","('NON-ESG', 0.04959505423903465)","('NON-ESG', 0.015677589923143387)"
Line 1909,"Any climate-related risks that may be captured within our ERM program will be managed in accordance with the ERM program governance.
","('Physical_Impacts_Of_Climate_Change', 0.941329300403595)","('Business_Model_Resilience', 0.011748344637453556)","('Systemic_Risk_Management', 0.006997987162321806)","(['Climate Change'], 0.941329300403595)","('NON-ESG', 0.011748344637453556)","('NON-ESG', 0.006997987162321806)"
Line 1910,"For further information regarding management and Board oversight or our ERM  program, please refer to the ESG Governance section.
","('Director_Removal', 0.4223063886165619)","('Management_Of_Legal_And_Regulatory_Framework', 0.19184772670269012)","('Business_Ethics', 0.07052849978208542)","('NON-ESG', 0.4223063886165619)","('NON-ESG', 0.19184772670269012)","('NON-ESG', 0.07052849978208542)"
Line 1911,"Once risks and opportunities from climate change have been identified, they  are evaluated and prioritized by the central S&EHS team.
","('Physical_Impacts_Of_Climate_Change', 0.9555366039276123)","('Business_Model_Resilience', 0.008038002997636795)","('GHG_Emissions', 0.004415407311171293)","(['Climate Change'], 0.9555366039276123)","('NON-ESG', 0.008038002997636795)","('NON-ESG', 0.004415407311171293)"
Line 1912,"This includes assessing key risk areas, evaluating the likelihood and impact, and ranking these risks.
","('Systemic_Risk_Management', 0.9406152367591858)","('Business_Model_Resilience', 0.009423363953828812)","('Physical_Impacts_Of_Climate_Change', 0.006897627841681242)","(['Risk & Crisis Management'], 0.9406152367591858)","('NON-ESG', 0.009423363953828812)","('NON-ESG', 0.006897627841681242)"
Line 1913,"Key prioritization components include the magnitude of the event should it occur (financial or reputational), the probability of such an event happening and our direct control to mitigate the risk.
","('Systemic_Risk_Management', 0.9151836633682251)","('Business_Model_Resilience', 0.025646474212408066)","('Competitive_Behavior', 0.00744862575083971)","(['Risk & Crisis Management'], 0.9151836633682251)","('NON-ESG', 0.025646474212408066)","('NON-ESG', 0.00744862575083971)"
Line 1914,"Climate-related risks (including GHG emissions and water scarcity) were also  identified by the central S&EHS team as risks to the company as a part of the ESG issue materiality assessments.
","('GHG_Emissions', 0.9382050037384033)","('Physical_Impacts_Of_Climate_Change', 0.01566391997039318)","('Ecological_Impacts', 0.007773579563945532)","(['Climate Change'], 0.9382050037384033)","('NON-ESG', 0.01566391997039318)","('NON-ESG', 0.007773579563945532)"
Line 1915,"2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Our 2030+ commitments and goals were implemented to mitigate or manage  these risks.
","('Supply_Chain_Management', 0.5393836498260498)","('Physical_Impacts_Of_Climate_Change', 0.3130037188529968)","('Systemic_Risk_Management', 0.02435247041285038)","(['Supply Chain Management'], 0.5393836498260498)","('NON-ESG', 0.3130037188529968)","('NON-ESG', 0.02435247041285038)"
Line 1916,"Various central teams are responsible for collectively managing or mitigating climate change risk.
","('Physical_Impacts_Of_Climate_Change', 0.9570884108543396)","('Business_Model_Resilience', 0.008493427187204361)","('GHG_Emissions', 0.003622555872425437)","(['Climate Change'], 0.9570884108543396)","('NON-ESG', 0.008493427187204361)","('NON-ESG', 0.003622555872425437)"
Line 1917,"Details can be found throughout this report.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6182072758674622)","('Business_Ethics', 0.05738718807697296)","('Systemic_Risk_Management', 0.04305757209658623)","(['Corporate Governance'], 0.6182072758674622)","('NON-ESG', 0.05738718807697296)","('NON-ESG', 0.04305757209658623)"
Line 1918,"Updates on our progress against our 2030+ goals are reported internally to  management via the ERC and to the Board.
","('Human_Rights_And_Community_Relations', 0.26541590690612793)","('Management_Of_Legal_And_Regulatory_Framework', 0.21906688809394836)","('Business_Model_Resilience', 0.15066516399383545)","('NON-ESG', 0.26541590690612793)","('NON-ESG', 0.21906688809394836)","('NON-ESG', 0.15066516399383545)"
Line 1919,"Externally, progress is shared via our sustainability reporting (including annual reporting to the CDP).
","('Management_Of_Legal_And_Regulatory_Framework', 0.25308358669281006)","('Business_Model_Resilience', 0.11986766755580902)","('GHG_Emissions', 0.08911702036857605)","('NON-ESG', 0.25308358669281006)","('NON-ESG', 0.11986766755580902)","('NON-ESG', 0.08911702036857605)"
Line 1920,"External reporting is carried out to meet growing stakeholder expectation for transparency, and therefore it helps to manage any reputational risk.
","('Business_Ethics', 0.9626589417457581)","('Systemic_Risk_Management', 0.004881836008280516)","('Data_Security', 0.004330787807703018)","(['Business Ethics'], 0.9626589417457581)","('NON-ESG', 0.004881836008280516)","('NON-ESG', 0.004330787807703018)"
Line 1921,"BD has also developed a best-in-class Supply Base Resiliency program that  evaluates supplier risk against 14 different risk factors.
","('Supply_Chain_Management', 0.9166935682296753)","('Business_Model_Resilience', 0.021554870530962944)","('Product_Design_And_Lifecycle_Management', 0.007582484278827906)","(['Supply Chain Management'], 0.9166935682296753)","('NON-ESG', 0.021554870530962944)","('NON-ESG', 0.007582484278827906)"
Line 1922,"These factors include environmental risk (supplier practice and policy to account for their own climate-based risks and greenhouse gas emissions), location risk (including indicators such as a country’s reliance on fossil fuels and the emission of carbon dioxide), which accounts for hazardous environments/locations potentially caused by climate change and may also impact supplier operations, and geopolitical risk, which can account for potential risk brought on by environmental/sustainability policy (or lack thereof).
","('GHG_Emissions', 0.7481554746627808)","('Physical_Impacts_Of_Climate_Change', 0.0879143476486206)","('Supply_Chain_Management', 0.0435597188770771)","(['Climate Change'], 0.7481554746627808)","('NON-ESG', 0.0879143476486206)","('NON-ESG', 0.0435597188770771)"
Line 1923,"These factors include environmental risk (supplier practice and policy to account for their own climate-based risks and greenhouse gas emissions), location risk (including indicators such as a country’s reliance on fossil fuels and the emission of carbon dioxide), which accounts for hazardous environments/locations potentially caused by climate change and may also impact supplier operations, and geopolitical risk, which can account for potential risk brought on by environmental/sustainability policy (or lack thereof).
","('Management_Of_Legal_And_Regulatory_Framework', 0.14440125226974487)","('Competitive_Behavior', 0.1266164481639862)","('Business_Ethics', 0.08039667457342148)","('NON-ESG', 0.14440125226974487)","('NON-ESG', 0.1266164481639862)","('NON-ESG', 0.08039667457342148)"
Line 1924,"Suppliers included in this risk program are evaluated based on risk criteria and, if the risk rating is high, asked to develop an improvement plan to better account for that risk.
","('Supply_Chain_Management', 0.9053202867507935)","('Systemic_Risk_Management', 0.020697109401226044)","('Physical_Impacts_Of_Climate_Change', 0.007692825980484486)","(['Supply Chain Management'], 0.9053202867507935)","('NON-ESG', 0.020697109401226044)","('NON-ESG', 0.007692825980484486)"
Line 1925,"Metrics and targets Details of our metrics and targets can be found in the Climate Change section.
","('Physical_Impacts_Of_Climate_Change', 0.9396302103996277)","('Business_Model_Resilience', 0.011106596328318119)","('GHG_Emissions', 0.008796986192464828)","(['Climate Change'], 0.9396302103996277)","('NON-ESG', 0.011106596328318119)","('NON-ESG', 0.008796986192464828)"
Line 1926,"Performance data can be found in the data tables.The following paragraphs detail how various risks are considered in our climate-related risk assessments: Current regulation Current regulation is relevant and always included in climate-related risk assessments.
","('Physical_Impacts_Of_Climate_Change', 0.9433347582817078)","('Business_Model_Resilience', 0.010982958599925041)","('GHG_Emissions', 0.006384511012583971)","(['Climate Change'], 0.9433347582817078)","('NON-ESG', 0.010982958599925041)","('NON-ESG', 0.006384511012583971)"
Line 1927,"Specific risk assessments including monitoring of  local regulations such as carbon taxes and emission trading scheme applicability are reviewed.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9739156365394592)","('Energy_Management', 0.002161871176213026)","('Director_Removal', 0.0019894998986274004)","(['Corporate Governance'], 0.9739156365394592)","('NON-ESG', 0.002161871176213026)","('NON-ESG', 0.0019894998986274004)"
Line 1928,"These climate-related risks are assessed through strategy planning sessions, materiality assessments and business continuity planning.
","('Physical_Impacts_Of_Climate_Change', 0.9515441656112671)","('Business_Model_Resilience', 0.0095680458471179)","('Systemic_Risk_Management', 0.0043456293642520905)","(['Climate Change'], 0.9515441656112671)","('NON-ESG', 0.0095680458471179)","('NON-ESG', 0.0043456293642520905)"
Line 1929,"Emerging   regulationEmerging regulation is relevant and always included in climate-related risk assessments, where “emerging” is defined as regulation likely  to happen in the next 1 – 2 years.
","('Physical_Impacts_Of_Climate_Change', 0.856809139251709)","('Business_Model_Resilience', 0.029052963480353355)","('GHG_Emissions', 0.0266511682420969)","(['Climate Change'], 0.856809139251709)","('NON-ESG', 0.029052963480353355)","('NON-ESG', 0.0266511682420969)"
Line 1930,"Risks are monitored at the facility level as part of normal business continuity planning.
","('Systemic_Risk_Management', 0.7436356544494629)","('Critical_Incident_Risk_Management', 0.05221063271164894)","('Supply_Chain_Management', 0.027350617572665215)","(['Risk & Crisis Management'], 0.7436356544494629)","('NON-ESG', 0.05221063271164894)","('NON-ESG', 0.027350617572665215)"
Line 1931,"Specific risk assessments include monitoring of local regulations such as carbon taxes and emission-trading schemes.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9738557934761047)","('Energy_Management', 0.0021795749198645353)","('Director_Removal', 0.0020729354582726955)","(['Corporate Governance'], 0.9738557934761047)","('NON-ESG', 0.0021795749198645353)","('NON-ESG', 0.0020729354582726955)"
Line 1932,"We continue to review emerging regulation in Europe as part of the energy-efficiency schemes and anticipate undergoing audits as part of this regulation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.4666072428226471)","('Energy_Management', 0.443378746509552)","('Air_Quality', 0.010061247274279594)","('NON-ESG', 0.4666072428226471)","('NON-ESG', 0.443378746509552)","('NON-ESG', 0.010061247274279594)"
Line 1933,"New laws or regulations adopted in response to climate change could also increase energy costs as well as the costs of certain raw materials and components, which are evaluated on an ongoing basis.
","('Physical_Impacts_Of_Climate_Change', 0.9360010623931885)","('Business_Model_Resilience', 0.010746333748102188)","('Supply_Chain_Management', 0.008309922181069851)","(['Climate Change'], 0.9360010623931885)","('NON-ESG', 0.010746333748102188)","('NON-ESG', 0.008309922181069851)"
Line 1934,"We may not be able to offset increases in these costs through other cost reductions.
","('Energy_Management', 0.4087963402271271)","('Management_Of_Legal_And_Regulatory_Framework', 0.36044779419898987)","('Systemic_Risk_Management', 0.02499305084347725)","('NON-ESG', 0.4087963402271271)","('NON-ESG', 0.36044779419898987)","('NON-ESG', 0.02499305084347725)"
Line 1935,"Environmental laws, particularly with respect to the emission of greenhouse gases, are also becoming more stringent throughout the world, which may increase our costs of operations or necessitate changes in our manufacturing plants or processes or those of our suppliers, or result in liability to BD.
","('GHG_Emissions', 0.954470157623291)","('Air_Quality', 0.008360740728676319)","('Ecological_Impacts', 0.005960667040199041)","(['Climate Change'], 0.954470157623291)","('NON-ESG', 0.008360740728676319)","('NON-ESG', 0.005960667040199041)"
Line 1936,"These climate-related risks are assessed through strategy planning sessions, materiality assessments and business continuity planning.
","('Physical_Impacts_Of_Climate_Change', 0.9515441656112671)","('Business_Model_Resilience', 0.0095680458471179)","('Systemic_Risk_Management', 0.0043456293642520905)","(['Climate Change'], 0.9515441656112671)","('NON-ESG', 0.0095680458471179)","('NON-ESG', 0.0043456293642520905)"
Line 1937,"Technology Technology risk is relevant and sometimes included in climate-related risk assessments.
","('Physical_Impacts_Of_Climate_Change', 0.9393850564956665)","('Business_Model_Resilience', 0.012348642572760582)","('Systemic_Risk_Management', 0.007829141803085804)","(['Climate Change'], 0.9393850564956665)","('NON-ESG', 0.012348642572760582)","('NON-ESG', 0.007829141803085804)"
Line 1938,"Risks associated with a transition to a lower-carbon economic system on the operational side include the use of renewable energy.
","('Energy_Management', 0.9417631030082703)","('Management_Of_Legal_And_Regulatory_Framework', 0.019825154915452003)","('GHG_Emissions', 0.0037862255703657866)","(['Operational Eco-Efficiency'], 0.9417631030082703)","('NON-ESG', 0.019825154915452003)","('NON-ESG', 0.0037862255703657866)"
Line 1939,"Solar power, combined heat and power, and fuel cells are used at various BD facilities to reduce carbon and increase energy-efficiency to aid in achieving our 2030+ climate change commitment, which was developed to mitigate climate-related risks.
","('Physical_Impacts_Of_Climate_Change', 0.9258944392204285)","('GHG_Emissions', 0.011826940812170506)","('Business_Model_Resilience', 0.00997148547321558)","(['Climate Change'], 0.9258944392204285)","('NON-ESG', 0.011826940812170506)","('NON-ESG', 0.00997148547321558)"
Line 1940,"These climate-related risks are assessed through strategy planning sessions, materiality assessments and business continuity planning.
","('Physical_Impacts_Of_Climate_Change', 0.9515441656112671)","('Business_Model_Resilience', 0.0095680458471179)","('Systemic_Risk_Management', 0.0043456293642520905)","(['Climate Change'], 0.9515441656112671)","('NON-ESG', 0.0095680458471179)","('NON-ESG', 0.0043456293642520905)"
Line 1941,"Legal Legal risks are not relevant because no litigation claims linked to climate-related issues have been identified to date.
","('Physical_Impacts_Of_Climate_Change', 0.9544297456741333)","('Business_Model_Resilience', 0.007320106960833073)","('GHG_Emissions', 0.004702764563262463)","(['Climate Change'], 0.9544297456741333)","('NON-ESG', 0.007320106960833073)","('NON-ESG', 0.004702764563262463)"
Line 1942,"Market Market risks are relevant and sometimes included in climate-related risk assessments.
","('Physical_Impacts_Of_Climate_Change', 0.9359109401702881)","('Business_Model_Resilience', 0.01300137210637331)","('Systemic_Risk_Management', 0.008608651347458363)","(['Climate Change'], 0.9359109401702881)","('NON-ESG', 0.01300137210637331)","('NON-ESG', 0.008608651347458363)"
Line 1943,"Plastics are used extensively across our portfolio of products, therefore regulations on carbon and fossil fuels could result in fluctuating prices.
","('Product_Design_And_Lifecycle_Management', 0.9475385546684265)","('Selling_Practices_And_Product_Labeling', 0.008134394884109497)","('Product_Quality_And_Safety', 0.007288256660103798)","(['Product Stewardship'], 0.9475385546684265)","('NON-ESG', 0.008134394884109497)","('NON-ESG', 0.007288256660103798)"
Line 1944,"These climate-related risks are assessed through strategy planning sessions, materiality assessments and business continuity planning.
","('Physical_Impacts_Of_Climate_Change', 0.9515441656112671)","('Business_Model_Resilience', 0.0095680458471179)","('Systemic_Risk_Management', 0.0043456293642520905)","(['Climate Change'], 0.9515441656112671)","('NON-ESG', 0.0095680458471179)","('NON-ESG', 0.0043456293642520905)"
Line 1945,"Mitigation measures include projects to reduce material usage on products and packaging.
","('Product_Design_And_Lifecycle_Management', 0.95975661277771)","('Product_Quality_And_Safety', 0.004764177370816469)","('Selling_Practices_And_Product_Labeling', 0.0036567654460668564)","(['Product Stewardship'], 0.95975661277771)","('NON-ESG', 0.004764177370816469)","('NON-ESG', 0.0036567654460668564)"
Line 1946,"Reputation Reputation risks are relevant and sometimes included in climate-related risk assessments.
","('Physical_Impacts_Of_Climate_Change', 0.4176442325115204)","('Systemic_Risk_Management', 0.4130201041698456)","('Business_Model_Resilience', 0.05392619967460632)","('NON-ESG', 0.4176442325115204)","('NON-ESG', 0.4130201041698456)","('NON-ESG', 0.05392619967460632)"
Line 1947,"They are monitored from a general standpoint through customers that prioritize sustainability in their RFPs or purchasing specifications, as well as through ESG-oriented investors and analysis of BD from ESG ratings agencies.
","('Business_Model_Resilience', 0.3831945061683655)","('Systemic_Risk_Management', 0.20037293434143066)","('Competitive_Behavior', 0.1398683786392212)","('NON-ESG', 0.3831945061683655)","('NON-ESG', 0.20037293434143066)","('NON-ESG', 0.1398683786392212)"
Line 1948,"These climate-related risks are assessed through strategy planning sessions, materiality assessments and business continuity planning.
","('Physical_Impacts_Of_Climate_Change', 0.9515441656112671)","('Business_Model_Resilience', 0.0095680458471179)","('Systemic_Risk_Management', 0.0043456293642520905)","(['Climate Change'], 0.9515441656112671)","('NON-ESG', 0.0095680458471179)","('NON-ESG', 0.0043456293642520905)"
Line 1949,"Acute physical Acute physical risks are relevant and sometimes included in climate-related risk assessments.
","('Physical_Impacts_Of_Climate_Change', 0.8956604599952698)","('Critical_Incident_Risk_Management', 0.022725246846675873)","('Systemic_Risk_Management', 0.01655898429453373)","(['Climate Change'], 0.8956604599952698)","('NON-ESG', 0.022725246846675873)","('NON-ESG', 0.01655898429453373)"
Line 1950,"These assessments are generally performed at an asset level and incorporated into Business Continuity Plans.
","('Systemic_Risk_Management', 0.3617129623889923)","('Business_Model_Resilience', 0.21793200075626373)","('Management_Of_Legal_And_Regulatory_Framework', 0.13570284843444824)","('NON-ESG', 0.3617129623889923)","('NON-ESG', 0.21793200075626373)","('NON-ESG', 0.13570284843444824)"
Line 1951,"For example, the impact of Hurricane Maria in 2017 on our facilities in Puerto Rico resulted in updates to standard extreme weather evaluations and planned mitigation activities as part of business continuity planning.
","('Physical_Impacts_Of_Climate_Change', 0.8712462186813354)","('Business_Model_Resilience', 0.04620738700032234)","('GHG_Emissions', 0.00957623403519392)","(['Climate Change'], 0.8712462186813354)","('NON-ESG', 0.04620738700032234)","('NON-ESG', 0.00957623403519392)"
Line 1952,"These climate-related risks are assessed through strategy planning sessions, materiality assessments and business continuity planning.
","('Physical_Impacts_Of_Climate_Change', 0.9515441656112671)","('Business_Model_Resilience', 0.0095680458471179)","('Systemic_Risk_Management', 0.0043456293642520905)","(['Climate Change'], 0.9515441656112671)","('NON-ESG', 0.0095680458471179)","('NON-ESG', 0.0043456293642520905)"
Line 1953,"Chronic physical Chronic physical risks are relevant and sometimes included in climate-related risk assessments.
","('Physical_Impacts_Of_Climate_Change', 0.921734094619751)","('Critical_Incident_Risk_Management', 0.011933751404285431)","('Business_Model_Resilience', 0.010959896259009838)","(['Climate Change'], 0.921734094619751)","('NON-ESG', 0.011933751404285431)","('NON-ESG', 0.010959896259009838)"
Line 1954,"Risks evaluated include supply disruptions that may result from water scarcity in our direct operations.
","('Water_And_Wastewater_Management', 0.4992141127586365)","('Supply_Chain_Management', 0.34970176219940186)","('Energy_Management', 0.018078051507472992)","('NON-ESG', 0.4992141127586365)","('NON-ESG', 0.34970176219940186)","('NON-ESG', 0.018078051507472992)"
Line 1955,"These climate-related risks are assessed through strategy planning sessions, materiality assessments and business continuity planning.2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities Policies, guidelines and statements center The following list provides links to commonly referenced BD documents.
","('Physical_Impacts_Of_Climate_Change', 0.90081787109375)","('Supply_Chain_Management', 0.030070634558796883)","('Business_Model_Resilience', 0.012572083622217178)","(['Climate Change'], 0.90081787109375)","('NON-ESG', 0.030070634558796883)","('NON-ESG', 0.012572083622217178)"
Line 1956,"BD Websites bd.com About BD https://www.bd.com/en-us/about-bd/our-company Includes information about BD’s business segments, leadership, and ethics and compliance Careers website https://jobs.bd.com Career opportunities at BD Cybersecurity https://cybersecurity.bd.com Links to the Trust center, bulletins and patches, and vulnerability disclosures, plus the annual Cybersecurity report ESG https://www.bd.com/en-us/about-bd/esg Links to Sustainability (including report archive), Global Public Health and Social Investing Inclusion, diversity and equity https://investors.bd.com/esg/inclusion-diversity-inclusion Links to our ID&E report Investor Relations https://investors.bd.com Links to our financial reports and SEC filings; press releases, events and presentations, and corporate governance  information, including public policy positions and PAC and corporate contributions Newsroom https://news.bd.com Latest BD news, the BD blog and ESG news BD policies, guidelines and statements Australia Modern Slavery and Human Trafficking statement https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD-FY2021-AUS-Modern-Slavery-Statement.pdf California Transparency in Supply Chains Act https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/guidelines/BD_CA-Transparency-in-Supply-Chains_EN.pdf BD Code of Conduct https://www.bd.com/content/bd-com/na/us/en-us/about-bd/our-company.html?containerId=our-company-code-of-conduct&activeTab=4  Conflict Minerals Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/policies/bd_conflict-minerals-policy_en.pdf BD Expectations for Suppliers https://www.bd.com/en-us/about-bd/policies/expectations-for-suppliers-page  Global Human Rights Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Human-Rights-Policy.pdf U.K. Modern Slavery and Human Trafficking statement https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD-FY2021-UK-Modern-Slavery-Statement.pdf Global Antibribery and Anticorruption Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-ABAC_Policy.pdf Global EHS Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Environment-Health-Safety-Policy.pdf Global Humane Handling Care and Use of Animals Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Humane-Handling-Care-and-Use-of-Animals-Policy.pdf Materials of Concern list https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD_Materials-of-Concern_List_EN.pdf Privacy statement https://www.bd.com/en-us/about-bd/policies/privacy-policy-statement2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities The following is a non-exhaustive list of acronyms and terms used throughout this report that are included to provide clarity.
","('Data_Security', 0.8679946064949036)","('Business_Ethics', 0.040405984967947006)","('Systemic_Risk_Management', 0.017134785652160645)","(['Information Security/Cybersecurity & System Availability'], 0.8679946064949036)","('NON-ESG', 0.040405984967947006)","('NON-ESG', 0.017134785652160645)"
Line 1957,"BD Websites bd.com About BD https://www.bd.com/en-us/about-bd/our-company Includes information about BD’s business segments, leadership, and ethics and compliance Careers website https://jobs.bd.com Career opportunities at BD Cybersecurity https://cybersecurity.bd.com Links to the Trust center, bulletins and patches, and vulnerability disclosures, plus the annual Cybersecurity report ESG https://www.bd.com/en-us/about-bd/esg Links to Sustainability (including report archive), Global Public Health and Social Investing Inclusion, diversity and equity https://investors.bd.com/esg/inclusion-diversity-inclusion Links to our ID&E report Investor Relations https://investors.bd.com Links to our financial reports and SEC filings; press releases, events and presentations, and corporate governance  information, including public policy positions and PAC and corporate contributions Newsroom https://news.bd.com Latest BD news, the BD blog and ESG news BD policies, guidelines and statements Australia Modern Slavery and Human Trafficking statement https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD-FY2021-AUS-Modern-Slavery-Statement.pdf California Transparency in Supply Chains Act https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/guidelines/BD_CA-Transparency-in-Supply-Chains_EN.pdf BD Code of Conduct https://www.bd.com/content/bd-com/na/us/en-us/about-bd/our-company.html?containerId=our-company-code-of-conduct&activeTab=4  Conflict Minerals Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/policies/bd_conflict-minerals-policy_en.pdf BD Expectations for Suppliers https://www.bd.com/en-us/about-bd/policies/expectations-for-suppliers-page  Global Human Rights Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Human-Rights-Policy.pdf U.K. Modern Slavery and Human Trafficking statement https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD-FY2021-UK-Modern-Slavery-Statement.pdf Global Antibribery and Anticorruption Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-ABAC_Policy.pdf Global EHS Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Environment-Health-Safety-Policy.pdf Global Humane Handling Care and Use of Animals Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Humane-Handling-Care-and-Use-of-Animals-Policy.pdf Materials of Concern list https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD_Materials-of-Concern_List_EN.pdf Privacy statement https://www.bd.com/en-us/about-bd/policies/privacy-policy-statement2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities The following is a non-exhaustive list of acronyms and terms used throughout this report that are included to provide clarity.
","('Employee_Engagement_Inclusion_And_Diversity', 0.9688073396682739)","('Employee_Health_And_Safety', 0.0031445547938346863)","('Human_Rights_And_Community_Relations', 0.0025151281151920557)","(['Human Capital Development'], 0.9688073396682739)","('NON-ESG', 0.0031445547938346863)","('NON-ESG', 0.0025151281151920557)"
Line 1958,"BD Websites bd.com About BD https://www.bd.com/en-us/about-bd/our-company Includes information about BD’s business segments, leadership, and ethics and compliance Careers website https://jobs.bd.com Career opportunities at BD Cybersecurity https://cybersecurity.bd.com Links to the Trust center, bulletins and patches, and vulnerability disclosures, plus the annual Cybersecurity report ESG https://www.bd.com/en-us/about-bd/esg Links to Sustainability (including report archive), Global Public Health and Social Investing Inclusion, diversity and equity https://investors.bd.com/esg/inclusion-diversity-inclusion Links to our ID&E report Investor Relations https://investors.bd.com Links to our financial reports and SEC filings; press releases, events and presentations, and corporate governance  information, including public policy positions and PAC and corporate contributions Newsroom https://news.bd.com Latest BD news, the BD blog and ESG news BD policies, guidelines and statements Australia Modern Slavery and Human Trafficking statement https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD-FY2021-AUS-Modern-Slavery-Statement.pdf California Transparency in Supply Chains Act https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/guidelines/BD_CA-Transparency-in-Supply-Chains_EN.pdf BD Code of Conduct https://www.bd.com/content/bd-com/na/us/en-us/about-bd/our-company.html?containerId=our-company-code-of-conduct&activeTab=4  Conflict Minerals Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/policies/bd_conflict-minerals-policy_en.pdf BD Expectations for Suppliers https://www.bd.com/en-us/about-bd/policies/expectations-for-suppliers-page  Global Human Rights Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Human-Rights-Policy.pdf U.K. Modern Slavery and Human Trafficking statement https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD-FY2021-UK-Modern-Slavery-Statement.pdf Global Antibribery and Anticorruption Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-ABAC_Policy.pdf Global EHS Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Environment-Health-Safety-Policy.pdf Global Humane Handling Care and Use of Animals Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Humane-Handling-Care-and-Use-of-Animals-Policy.pdf Materials of Concern list https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD_Materials-of-Concern_List_EN.pdf Privacy statement https://www.bd.com/en-us/about-bd/policies/privacy-policy-statement2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities The following is a non-exhaustive list of acronyms and terms used throughout this report that are included to provide clarity.
","('Business_Ethics', 0.3345201015472412)","('Supply_Chain_Management', 0.2083296924829483)","('Labor_Practices', 0.10128495842218399)","('NON-ESG', 0.3345201015472412)","('NON-ESG', 0.2083296924829483)","('NON-ESG', 0.10128495842218399)"
Line 1959,"BD Websites bd.com About BD https://www.bd.com/en-us/about-bd/our-company Includes information about BD’s business segments, leadership, and ethics and compliance Careers website https://jobs.bd.com Career opportunities at BD Cybersecurity https://cybersecurity.bd.com Links to the Trust center, bulletins and patches, and vulnerability disclosures, plus the annual Cybersecurity report ESG https://www.bd.com/en-us/about-bd/esg Links to Sustainability (including report archive), Global Public Health and Social Investing Inclusion, diversity and equity https://investors.bd.com/esg/inclusion-diversity-inclusion Links to our ID&E report Investor Relations https://investors.bd.com Links to our financial reports and SEC filings; press releases, events and presentations, and corporate governance  information, including public policy positions and PAC and corporate contributions Newsroom https://news.bd.com Latest BD news, the BD blog and ESG news BD policies, guidelines and statements Australia Modern Slavery and Human Trafficking statement https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD-FY2021-AUS-Modern-Slavery-Statement.pdf California Transparency in Supply Chains Act https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/guidelines/BD_CA-Transparency-in-Supply-Chains_EN.pdf BD Code of Conduct https://www.bd.com/content/bd-com/na/us/en-us/about-bd/our-company.html?containerId=our-company-code-of-conduct&activeTab=4  Conflict Minerals Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/policies/bd_conflict-minerals-policy_en.pdf BD Expectations for Suppliers https://www.bd.com/en-us/about-bd/policies/expectations-for-suppliers-page  Global Human Rights Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Human-Rights-Policy.pdf U.K. Modern Slavery and Human Trafficking statement https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD-FY2021-UK-Modern-Slavery-Statement.pdf Global Antibribery and Anticorruption Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-ABAC_Policy.pdf Global EHS Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Environment-Health-Safety-Policy.pdf Global Humane Handling Care and Use of Animals Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Humane-Handling-Care-and-Use-of-Animals-Policy.pdf Materials of Concern list https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD_Materials-of-Concern_List_EN.pdf Privacy statement https://www.bd.com/en-us/about-bd/policies/privacy-policy-statement2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities The following is a non-exhaustive list of acronyms and terms used throughout this report that are included to provide clarity.
","('Human_Rights_And_Community_Relations', 0.9146056771278381)","('Supply_Chain_Management', 0.008639869280159473)","('Labor_Practices', 0.007212364114820957)","(['Community Relations'], 0.9146056771278381)","('NON-ESG', 0.008639869280159473)","('NON-ESG', 0.007212364114820957)"
Line 1960,"BD Websites bd.com About BD https://www.bd.com/en-us/about-bd/our-company Includes information about BD’s business segments, leadership, and ethics and compliance Careers website https://jobs.bd.com Career opportunities at BD Cybersecurity https://cybersecurity.bd.com Links to the Trust center, bulletins and patches, and vulnerability disclosures, plus the annual Cybersecurity report ESG https://www.bd.com/en-us/about-bd/esg Links to Sustainability (including report archive), Global Public Health and Social Investing Inclusion, diversity and equity https://investors.bd.com/esg/inclusion-diversity-inclusion Links to our ID&E report Investor Relations https://investors.bd.com Links to our financial reports and SEC filings; press releases, events and presentations, and corporate governance  information, including public policy positions and PAC and corporate contributions Newsroom https://news.bd.com Latest BD news, the BD blog and ESG news BD policies, guidelines and statements Australia Modern Slavery and Human Trafficking statement https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD-FY2021-AUS-Modern-Slavery-Statement.pdf California Transparency in Supply Chains Act https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/guidelines/BD_CA-Transparency-in-Supply-Chains_EN.pdf BD Code of Conduct https://www.bd.com/content/bd-com/na/us/en-us/about-bd/our-company.html?containerId=our-company-code-of-conduct&activeTab=4  Conflict Minerals Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/policies/bd_conflict-minerals-policy_en.pdf BD Expectations for Suppliers https://www.bd.com/en-us/about-bd/policies/expectations-for-suppliers-page  Global Human Rights Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Human-Rights-Policy.pdf U.K. Modern Slavery and Human Trafficking statement https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD-FY2021-UK-Modern-Slavery-Statement.pdf Global Antibribery and Anticorruption Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-ABAC_Policy.pdf Global EHS Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Environment-Health-Safety-Policy.pdf Global Humane Handling Care and Use of Animals Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Humane-Handling-Care-and-Use-of-Animals-Policy.pdf Materials of Concern list https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD_Materials-of-Concern_List_EN.pdf Privacy statement https://www.bd.com/en-us/about-bd/policies/privacy-policy-statement2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities The following is a non-exhaustive list of acronyms and terms used throughout this report that are included to provide clarity.
","('Product_Quality_And_Safety', 0.3343680799007416)","('Employee_Health_And_Safety', 0.29666846990585327)","('Access_And_Affordability', 0.0650554746389389)","('NON-ESG', 0.3343680799007416)","('NON-ESG', 0.29666846990585327)","('NON-ESG', 0.0650554746389389)"
Line 1961,"BD Websites bd.com About BD https://www.bd.com/en-us/about-bd/our-company Includes information about BD’s business segments, leadership, and ethics and compliance Careers website https://jobs.bd.com Career opportunities at BD Cybersecurity https://cybersecurity.bd.com Links to the Trust center, bulletins and patches, and vulnerability disclosures, plus the annual Cybersecurity report ESG https://www.bd.com/en-us/about-bd/esg Links to Sustainability (including report archive), Global Public Health and Social Investing Inclusion, diversity and equity https://investors.bd.com/esg/inclusion-diversity-inclusion Links to our ID&E report Investor Relations https://investors.bd.com Links to our financial reports and SEC filings; press releases, events and presentations, and corporate governance  information, including public policy positions and PAC and corporate contributions Newsroom https://news.bd.com Latest BD news, the BD blog and ESG news BD policies, guidelines and statements Australia Modern Slavery and Human Trafficking statement https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD-FY2021-AUS-Modern-Slavery-Statement.pdf California Transparency in Supply Chains Act https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/guidelines/BD_CA-Transparency-in-Supply-Chains_EN.pdf BD Code of Conduct https://www.bd.com/content/bd-com/na/us/en-us/about-bd/our-company.html?containerId=our-company-code-of-conduct&activeTab=4  Conflict Minerals Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/policies/bd_conflict-minerals-policy_en.pdf BD Expectations for Suppliers https://www.bd.com/en-us/about-bd/policies/expectations-for-suppliers-page  Global Human Rights Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Human-Rights-Policy.pdf U.K. Modern Slavery and Human Trafficking statement https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD-FY2021-UK-Modern-Slavery-Statement.pdf Global Antibribery and Anticorruption Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-ABAC_Policy.pdf Global EHS Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Environment-Health-Safety-Policy.pdf Global Humane Handling Care and Use of Animals Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Humane-Handling-Care-and-Use-of-Animals-Policy.pdf Materials of Concern list https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD_Materials-of-Concern_List_EN.pdf Privacy statement https://www.bd.com/en-us/about-bd/policies/privacy-policy-statement2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities The following is a non-exhaustive list of acronyms and terms used throughout this report that are included to provide clarity.
","('Supply_Chain_Management', 0.5329969525337219)","('Waste_And_Hazardous_Materials_Management', 0.06017997860908508)","('Product_Design_And_Lifecycle_Management', 0.053103674203157425)","(['Supply Chain Management'], 0.5329969525337219)","('NON-ESG', 0.06017997860908508)","('NON-ESG', 0.053103674203157425)"
Line 1962,"BD Websites bd.com About BD https://www.bd.com/en-us/about-bd/our-company Includes information about BD’s business segments, leadership, and ethics and compliance Careers website https://jobs.bd.com Career opportunities at BD Cybersecurity https://cybersecurity.bd.com Links to the Trust center, bulletins and patches, and vulnerability disclosures, plus the annual Cybersecurity report ESG https://www.bd.com/en-us/about-bd/esg Links to Sustainability (including report archive), Global Public Health and Social Investing Inclusion, diversity and equity https://investors.bd.com/esg/inclusion-diversity-inclusion Links to our ID&E report Investor Relations https://investors.bd.com Links to our financial reports and SEC filings; press releases, events and presentations, and corporate governance  information, including public policy positions and PAC and corporate contributions Newsroom https://news.bd.com Latest BD news, the BD blog and ESG news BD policies, guidelines and statements Australia Modern Slavery and Human Trafficking statement https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD-FY2021-AUS-Modern-Slavery-Statement.pdf California Transparency in Supply Chains Act https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/guidelines/BD_CA-Transparency-in-Supply-Chains_EN.pdf BD Code of Conduct https://www.bd.com/content/bd-com/na/us/en-us/about-bd/our-company.html?containerId=our-company-code-of-conduct&activeTab=4  Conflict Minerals Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/policies/bd_conflict-minerals-policy_en.pdf BD Expectations for Suppliers https://www.bd.com/en-us/about-bd/policies/expectations-for-suppliers-page  Global Human Rights Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Human-Rights-Policy.pdf U.K. Modern Slavery and Human Trafficking statement https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD-FY2021-UK-Modern-Slavery-Statement.pdf Global Antibribery and Anticorruption Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-ABAC_Policy.pdf Global EHS Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Environment-Health-Safety-Policy.pdf Global Humane Handling Care and Use of Animals Policy https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/Corporate/BD-Global-Humane-Handling-Care-and-Use-of-Animals-Policy.pdf Materials of Concern list https://www.bd.com/content/dam/bdcom-assets/en/en-us/documents/policies-guidelines-and-statements/suppliers/BD_Materials-of-Concern_List_EN.pdf Privacy statement https://www.bd.com/en-us/about-bd/policies/privacy-policy-statement2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities The following is a non-exhaustive list of acronyms and terms used throughout this report that are included to provide clarity.
","('Physical_Impacts_Of_Climate_Change', 0.9464485049247742)","('Business_Model_Resilience', 0.009077967144548893)","('GHG_Emissions', 0.004654163960367441)","(['Climate Change'], 0.9464485049247742)","('NON-ESG', 0.009077967144548893)","('NON-ESG', 0.004654163960367441)"
Line 1963,"Not all acronyms are exclusive to BD.Acronyms and glossary AAALACAssociation for Assessment and Accreditation of Laboratory  Animal Care AAMI Advancement of Medical Instrumentation AdVaMed Advanced Medical Technology Association AI Artificial Intelligence AMR Antimicrobial resistance ARFC Antimicrobial Resistance Fighters Coalition ASLM Africa Society for Laboratory Medicine  BD Becton, Dickinson and Company BD SMTI BD Sustainable Medical Technology InstituteBDPS BD Production System BRAD Biomedical Research Awareness Day BSR Business for Social Responsibility CDC Center for Disease Control CEO Chief Executive Officer CFP Chemical Footprint Project cGMP current Good Manufacturing Practices CIDRAP Center for Infectious Disease Research and Policy CISA Cybersecurity and Infrastructure Security Agency COE Center of Excellence COPS Cost of products sold CPA Center for Political Activity CQRB Corporate Quality and Regulatory Board CRBSI Catheter related blood stream infection CRC Clinical Research Collaboration CSR Corporate Social Responsibility CTD Central TB Division CTP Corporate TB Pledge CVE® Common Vulnerability and ExposuresDCs Distribution centers DEFRA Department for Environment, Food and Rural Affairs DJSI Dow Jones Sustainability Indices DST Drug susceptibility testing EC/IRB Ethics Committee/Institutional Review Board EEIO Environmentally Extended Input-Output EFS Expectations for Suppliers EHS Enviroment, health and safety EM Equipment Management EMS Environmental management system EPP Environmentally preferable purchasing ERC Enterprise Risk and ESG Committee ERM the company, Environmental Resources Management ERM Enterprise Risk Management  ESG Environmental, social and governance ESOs Environmental, Health and Safety Opportunities EVP Executive Vice President EVP ISC Executive Vice President, Integrated Supply Chain  FBI Federal Bureau of Investigation FDA Food and Drug Administration FY Fiscal Year GCA Global clinical affairs GCP Good clinical practice GJS Good Jobs Strategy GHG Greenhouse gas GHGP Greenhouse Gas Protocol GLEC Global Logistics Emissions Council GMS&G Global Medical Safety and Governance GRI Global Reporting Initiative™HAP Hazardous air pollutant HIPAA Health Insurance Portability and Accountability Act HPRC Healthcare Plastics Recycling Council HQ Headquarters HR Human resources HRC Human Right Campaign HSCC Healthcare & Public Health Sector Coordinating Council HVAC Heating, ventilation, and air conditioning IACUC Institutional Animal Care and Use Committee ID&E Inclusion, Diversity and Equity ID/AST Identification, and antimicrobial susceptibility testing  IDA Industrial Development Agency IEA International Energy Agency IIR Injury and illness rate ILO International Labor Organization IMP Inventory management plan ISA International Society of Automation ISC Integrated supply chain  ISO International Organization for Standardization IVDR In vitro diagnostic medical device regulation KPI Key performance indicators LASCC Latin America Shared Service Center LC Liquid culture LLME Laboratory Leadership & Management Essentials LMIC Low-and middle-income countries LSHTM London School of Hygiene & Tropical Medicine LTIFR Lost time injury frequency rate M&A Merger and Acquisition MASC Medical Safety Specialists2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities MAUDE Manufacturer and User Facility Device Experience MDIC Medical Device Innovation Consortium MDR Medical device regulation MES Manufacturing execution system MIS Management information system MNT Maternal and neonatal tetanus MOC Materials of Concern MOH Ministry of Health MSS Medical Safety Specialists NACD National Association of Corporate Directors NGO Nongovermental organizations NIH National Institutes of Health NIST National Institute of Standards and Technology NOX Nitrogen oxides NTEP National TB Elimination Program NTP National TB Program ODA Official Development Assistance ODS Ozone-depleting substances OEM Original equipment manufacturer OHS Occupational health and safety OIFR Occupational illness frequency rate PAC Political action committee PEPFAR President’s Emergency Plan for AIDS Relief POC Point of carePPA Power purchase agreements  PPE Personal protective equipment QAN Quality Audit Network QMS Quality management system R&D Research and development RCSI Royal College of Surgeons REACHRegistration, Evaluation, Authorisation and Restriction  of Chemicals REC Renewable Energy Credits RFP Request for proposal RMW Regulated Medical Waste RoHS Restriction of Hazardous Substances Directive ROI Return on investment RRA Remote Regulatory Assessment S&EHS Sustainability and environment, health and safety SAB Scientific Advisory Board SASB Sustainability Accounting Standards Board SBTi Science Based Targets initiative SDS Safety Data Sheets SEC Securities and Exchange Commission SHC Sustainable Healthcare Coalition SHEA Society for Healthcare Epidemiology of America SKU Stock keeping unit SLIPTAStepwise Laboratory Improvement Process Towards Accreditation in the African RegionSOPs Standard operating procedures SOP Strategic Organizational Plan SOX Sulfur oxides STEM Science, Technology, Engineering, and Math STRIDES Strengthening TB Resistance Testing and Diagnostic Systems SVP Senior vice president TB Tuberculosis TCFD Task Force on Climate-related Financial Disclosures UL Underwriters’ Laboratories UN SDGs United Nations Sustainable Development GoalsUNICEF United Nations International Children’s Emergency Fund  USAID U.S. Agency for International Development VoA Voice of the Associate VOC Volatile organic compounds VP Vice president VP GCA Vice President of Global Clinical Affairs VP S&EHSVice President, Sustainability and Environment, Health  and Safety VST  Volunteer Service Trip WARM Waste Reduction Model  WBCSD World Business Council for Sustainable Development WHO World Health Organization WRI World Resources Institute   The “strong teams” operating model outlines our approach to how different parts of the organization can come together to deliver value.
","('Customer_Welfare', 0.1938955932855606)","('Selling_Practices_And_Product_Labeling', 0.12215127795934677)","('Product_Quality_And_Safety', 0.08641179651021957)","('NON-ESG', 0.1938955932855606)","('NON-ESG', 0.12215127795934677)","('NON-ESG', 0.08641179651021957)"
Line 1964,"Not all acronyms are exclusive to BD.Acronyms and glossary AAALACAssociation for Assessment and Accreditation of Laboratory  Animal Care AAMI Advancement of Medical Instrumentation AdVaMed Advanced Medical Technology Association AI Artificial Intelligence AMR Antimicrobial resistance ARFC Antimicrobial Resistance Fighters Coalition ASLM Africa Society for Laboratory Medicine  BD Becton, Dickinson and Company BD SMTI BD Sustainable Medical Technology InstituteBDPS BD Production System BRAD Biomedical Research Awareness Day BSR Business for Social Responsibility CDC Center for Disease Control CEO Chief Executive Officer CFP Chemical Footprint Project cGMP current Good Manufacturing Practices CIDRAP Center for Infectious Disease Research and Policy CISA Cybersecurity and Infrastructure Security Agency COE Center of Excellence COPS Cost of products sold CPA Center for Political Activity CQRB Corporate Quality and Regulatory Board CRBSI Catheter related blood stream infection CRC Clinical Research Collaboration CSR Corporate Social Responsibility CTD Central TB Division CTP Corporate TB Pledge CVE® Common Vulnerability and ExposuresDCs Distribution centers DEFRA Department for Environment, Food and Rural Affairs DJSI Dow Jones Sustainability Indices DST Drug susceptibility testing EC/IRB Ethics Committee/Institutional Review Board EEIO Environmentally Extended Input-Output EFS Expectations for Suppliers EHS Enviroment, health and safety EM Equipment Management EMS Environmental management system EPP Environmentally preferable purchasing ERC Enterprise Risk and ESG Committee ERM the company, Environmental Resources Management ERM Enterprise Risk Management  ESG Environmental, social and governance ESOs Environmental, Health and Safety Opportunities EVP Executive Vice President EVP ISC Executive Vice President, Integrated Supply Chain  FBI Federal Bureau of Investigation FDA Food and Drug Administration FY Fiscal Year GCA Global clinical affairs GCP Good clinical practice GJS Good Jobs Strategy GHG Greenhouse gas GHGP Greenhouse Gas Protocol GLEC Global Logistics Emissions Council GMS&G Global Medical Safety and Governance GRI Global Reporting Initiative™HAP Hazardous air pollutant HIPAA Health Insurance Portability and Accountability Act HPRC Healthcare Plastics Recycling Council HQ Headquarters HR Human resources HRC Human Right Campaign HSCC Healthcare & Public Health Sector Coordinating Council HVAC Heating, ventilation, and air conditioning IACUC Institutional Animal Care and Use Committee ID&E Inclusion, Diversity and Equity ID/AST Identification, and antimicrobial susceptibility testing  IDA Industrial Development Agency IEA International Energy Agency IIR Injury and illness rate ILO International Labor Organization IMP Inventory management plan ISA International Society of Automation ISC Integrated supply chain  ISO International Organization for Standardization IVDR In vitro diagnostic medical device regulation KPI Key performance indicators LASCC Latin America Shared Service Center LC Liquid culture LLME Laboratory Leadership & Management Essentials LMIC Low-and middle-income countries LSHTM London School of Hygiene & Tropical Medicine LTIFR Lost time injury frequency rate M&A Merger and Acquisition MASC Medical Safety Specialists2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities MAUDE Manufacturer and User Facility Device Experience MDIC Medical Device Innovation Consortium MDR Medical device regulation MES Manufacturing execution system MIS Management information system MNT Maternal and neonatal tetanus MOC Materials of Concern MOH Ministry of Health MSS Medical Safety Specialists NACD National Association of Corporate Directors NGO Nongovermental organizations NIH National Institutes of Health NIST National Institute of Standards and Technology NOX Nitrogen oxides NTEP National TB Elimination Program NTP National TB Program ODA Official Development Assistance ODS Ozone-depleting substances OEM Original equipment manufacturer OHS Occupational health and safety OIFR Occupational illness frequency rate PAC Political action committee PEPFAR President’s Emergency Plan for AIDS Relief POC Point of carePPA Power purchase agreements  PPE Personal protective equipment QAN Quality Audit Network QMS Quality management system R&D Research and development RCSI Royal College of Surgeons REACHRegistration, Evaluation, Authorisation and Restriction  of Chemicals REC Renewable Energy Credits RFP Request for proposal RMW Regulated Medical Waste RoHS Restriction of Hazardous Substances Directive ROI Return on investment RRA Remote Regulatory Assessment S&EHS Sustainability and environment, health and safety SAB Scientific Advisory Board SASB Sustainability Accounting Standards Board SBTi Science Based Targets initiative SDS Safety Data Sheets SEC Securities and Exchange Commission SHC Sustainable Healthcare Coalition SHEA Society for Healthcare Epidemiology of America SKU Stock keeping unit SLIPTAStepwise Laboratory Improvement Process Towards Accreditation in the African RegionSOPs Standard operating procedures SOP Strategic Organizational Plan SOX Sulfur oxides STEM Science, Technology, Engineering, and Math STRIDES Strengthening TB Resistance Testing and Diagnostic Systems SVP Senior vice president TB Tuberculosis TCFD Task Force on Climate-related Financial Disclosures UL Underwriters’ Laboratories UN SDGs United Nations Sustainable Development GoalsUNICEF United Nations International Children’s Emergency Fund  USAID U.S. Agency for International Development VoA Voice of the Associate VOC Volatile organic compounds VP Vice president VP GCA Vice President of Global Clinical Affairs VP S&EHSVice President, Sustainability and Environment, Health  and Safety VST  Volunteer Service Trip WARM Waste Reduction Model  WBCSD World Business Council for Sustainable Development WHO World Health Organization WRI World Resources Institute   The “strong teams” operating model outlines our approach to how different parts of the organization can come together to deliver value.
","('Access_And_Affordability', 0.29447805881500244)","('Human_Rights_And_Community_Relations', 0.2627119719982147)","('Management_Of_Legal_And_Regulatory_Framework', 0.13616487383842468)","('NON-ESG', 0.29447805881500244)","('NON-ESG', 0.2627119719982147)","('NON-ESG', 0.13616487383842468)"
Line 1965,"Not all acronyms are exclusive to BD.Acronyms and glossary AAALACAssociation for Assessment and Accreditation of Laboratory  Animal Care AAMI Advancement of Medical Instrumentation AdVaMed Advanced Medical Technology Association AI Artificial Intelligence AMR Antimicrobial resistance ARFC Antimicrobial Resistance Fighters Coalition ASLM Africa Society for Laboratory Medicine  BD Becton, Dickinson and Company BD SMTI BD Sustainable Medical Technology InstituteBDPS BD Production System BRAD Biomedical Research Awareness Day BSR Business for Social Responsibility CDC Center for Disease Control CEO Chief Executive Officer CFP Chemical Footprint Project cGMP current Good Manufacturing Practices CIDRAP Center for Infectious Disease Research and Policy CISA Cybersecurity and Infrastructure Security Agency COE Center of Excellence COPS Cost of products sold CPA Center for Political Activity CQRB Corporate Quality and Regulatory Board CRBSI Catheter related blood stream infection CRC Clinical Research Collaboration CSR Corporate Social Responsibility CTD Central TB Division CTP Corporate TB Pledge CVE® Common Vulnerability and ExposuresDCs Distribution centers DEFRA Department for Environment, Food and Rural Affairs DJSI Dow Jones Sustainability Indices DST Drug susceptibility testing EC/IRB Ethics Committee/Institutional Review Board EEIO Environmentally Extended Input-Output EFS Expectations for Suppliers EHS Enviroment, health and safety EM Equipment Management EMS Environmental management system EPP Environmentally preferable purchasing ERC Enterprise Risk and ESG Committee ERM the company, Environmental Resources Management ERM Enterprise Risk Management  ESG Environmental, social and governance ESOs Environmental, Health and Safety Opportunities EVP Executive Vice President EVP ISC Executive Vice President, Integrated Supply Chain  FBI Federal Bureau of Investigation FDA Food and Drug Administration FY Fiscal Year GCA Global clinical affairs GCP Good clinical practice GJS Good Jobs Strategy GHG Greenhouse gas GHGP Greenhouse Gas Protocol GLEC Global Logistics Emissions Council GMS&G Global Medical Safety and Governance GRI Global Reporting Initiative™HAP Hazardous air pollutant HIPAA Health Insurance Portability and Accountability Act HPRC Healthcare Plastics Recycling Council HQ Headquarters HR Human resources HRC Human Right Campaign HSCC Healthcare & Public Health Sector Coordinating Council HVAC Heating, ventilation, and air conditioning IACUC Institutional Animal Care and Use Committee ID&E Inclusion, Diversity and Equity ID/AST Identification, and antimicrobial susceptibility testing  IDA Industrial Development Agency IEA International Energy Agency IIR Injury and illness rate ILO International Labor Organization IMP Inventory management plan ISA International Society of Automation ISC Integrated supply chain  ISO International Organization for Standardization IVDR In vitro diagnostic medical device regulation KPI Key performance indicators LASCC Latin America Shared Service Center LC Liquid culture LLME Laboratory Leadership & Management Essentials LMIC Low-and middle-income countries LSHTM London School of Hygiene & Tropical Medicine LTIFR Lost time injury frequency rate M&A Merger and Acquisition MASC Medical Safety Specialists2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities MAUDE Manufacturer and User Facility Device Experience MDIC Medical Device Innovation Consortium MDR Medical device regulation MES Manufacturing execution system MIS Management information system MNT Maternal and neonatal tetanus MOC Materials of Concern MOH Ministry of Health MSS Medical Safety Specialists NACD National Association of Corporate Directors NGO Nongovermental organizations NIH National Institutes of Health NIST National Institute of Standards and Technology NOX Nitrogen oxides NTEP National TB Elimination Program NTP National TB Program ODA Official Development Assistance ODS Ozone-depleting substances OEM Original equipment manufacturer OHS Occupational health and safety OIFR Occupational illness frequency rate PAC Political action committee PEPFAR President’s Emergency Plan for AIDS Relief POC Point of carePPA Power purchase agreements  PPE Personal protective equipment QAN Quality Audit Network QMS Quality management system R&D Research and development RCSI Royal College of Surgeons REACHRegistration, Evaluation, Authorisation and Restriction  of Chemicals REC Renewable Energy Credits RFP Request for proposal RMW Regulated Medical Waste RoHS Restriction of Hazardous Substances Directive ROI Return on investment RRA Remote Regulatory Assessment S&EHS Sustainability and environment, health and safety SAB Scientific Advisory Board SASB Sustainability Accounting Standards Board SBTi Science Based Targets initiative SDS Safety Data Sheets SEC Securities and Exchange Commission SHC Sustainable Healthcare Coalition SHEA Society for Healthcare Epidemiology of America SKU Stock keeping unit SLIPTAStepwise Laboratory Improvement Process Towards Accreditation in the African RegionSOPs Standard operating procedures SOP Strategic Organizational Plan SOX Sulfur oxides STEM Science, Technology, Engineering, and Math STRIDES Strengthening TB Resistance Testing and Diagnostic Systems SVP Senior vice president TB Tuberculosis TCFD Task Force on Climate-related Financial Disclosures UL Underwriters’ Laboratories UN SDGs United Nations Sustainable Development GoalsUNICEF United Nations International Children’s Emergency Fund  USAID U.S. Agency for International Development VoA Voice of the Associate VOC Volatile organic compounds VP Vice president VP GCA Vice President of Global Clinical Affairs VP S&EHSVice President, Sustainability and Environment, Health  and Safety VST  Volunteer Service Trip WARM Waste Reduction Model  WBCSD World Business Council for Sustainable Development WHO World Health Organization WRI World Resources Institute   The “strong teams” operating model outlines our approach to how different parts of the organization can come together to deliver value.
","('Supply_Chain_Management', 0.25868454575538635)","('Human_Rights_And_Community_Relations', 0.24924148619174957)","('Business_Ethics', 0.08787865191698074)","('NON-ESG', 0.25868454575538635)","('NON-ESG', 0.24924148619174957)","('NON-ESG', 0.08787865191698074)"
Line 1966,"Not all acronyms are exclusive to BD.Acronyms and glossary AAALACAssociation for Assessment and Accreditation of Laboratory  Animal Care AAMI Advancement of Medical Instrumentation AdVaMed Advanced Medical Technology Association AI Artificial Intelligence AMR Antimicrobial resistance ARFC Antimicrobial Resistance Fighters Coalition ASLM Africa Society for Laboratory Medicine  BD Becton, Dickinson and Company BD SMTI BD Sustainable Medical Technology InstituteBDPS BD Production System BRAD Biomedical Research Awareness Day BSR Business for Social Responsibility CDC Center for Disease Control CEO Chief Executive Officer CFP Chemical Footprint Project cGMP current Good Manufacturing Practices CIDRAP Center for Infectious Disease Research and Policy CISA Cybersecurity and Infrastructure Security Agency COE Center of Excellence COPS Cost of products sold CPA Center for Political Activity CQRB Corporate Quality and Regulatory Board CRBSI Catheter related blood stream infection CRC Clinical Research Collaboration CSR Corporate Social Responsibility CTD Central TB Division CTP Corporate TB Pledge CVE® Common Vulnerability and ExposuresDCs Distribution centers DEFRA Department for Environment, Food and Rural Affairs DJSI Dow Jones Sustainability Indices DST Drug susceptibility testing EC/IRB Ethics Committee/Institutional Review Board EEIO Environmentally Extended Input-Output EFS Expectations for Suppliers EHS Enviroment, health and safety EM Equipment Management EMS Environmental management system EPP Environmentally preferable purchasing ERC Enterprise Risk and ESG Committee ERM the company, Environmental Resources Management ERM Enterprise Risk Management  ESG Environmental, social and governance ESOs Environmental, Health and Safety Opportunities EVP Executive Vice President EVP ISC Executive Vice President, Integrated Supply Chain  FBI Federal Bureau of Investigation FDA Food and Drug Administration FY Fiscal Year GCA Global clinical affairs GCP Good clinical practice GJS Good Jobs Strategy GHG Greenhouse gas GHGP Greenhouse Gas Protocol GLEC Global Logistics Emissions Council GMS&G Global Medical Safety and Governance GRI Global Reporting Initiative™HAP Hazardous air pollutant HIPAA Health Insurance Portability and Accountability Act HPRC Healthcare Plastics Recycling Council HQ Headquarters HR Human resources HRC Human Right Campaign HSCC Healthcare & Public Health Sector Coordinating Council HVAC Heating, ventilation, and air conditioning IACUC Institutional Animal Care and Use Committee ID&E Inclusion, Diversity and Equity ID/AST Identification, and antimicrobial susceptibility testing  IDA Industrial Development Agency IEA International Energy Agency IIR Injury and illness rate ILO International Labor Organization IMP Inventory management plan ISA International Society of Automation ISC Integrated supply chain  ISO International Organization for Standardization IVDR In vitro diagnostic medical device regulation KPI Key performance indicators LASCC Latin America Shared Service Center LC Liquid culture LLME Laboratory Leadership & Management Essentials LMIC Low-and middle-income countries LSHTM London School of Hygiene & Tropical Medicine LTIFR Lost time injury frequency rate M&A Merger and Acquisition MASC Medical Safety Specialists2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities MAUDE Manufacturer and User Facility Device Experience MDIC Medical Device Innovation Consortium MDR Medical device regulation MES Manufacturing execution system MIS Management information system MNT Maternal and neonatal tetanus MOC Materials of Concern MOH Ministry of Health MSS Medical Safety Specialists NACD National Association of Corporate Directors NGO Nongovermental organizations NIH National Institutes of Health NIST National Institute of Standards and Technology NOX Nitrogen oxides NTEP National TB Elimination Program NTP National TB Program ODA Official Development Assistance ODS Ozone-depleting substances OEM Original equipment manufacturer OHS Occupational health and safety OIFR Occupational illness frequency rate PAC Political action committee PEPFAR President’s Emergency Plan for AIDS Relief POC Point of carePPA Power purchase agreements  PPE Personal protective equipment QAN Quality Audit Network QMS Quality management system R&D Research and development RCSI Royal College of Surgeons REACHRegistration, Evaluation, Authorisation and Restriction  of Chemicals REC Renewable Energy Credits RFP Request for proposal RMW Regulated Medical Waste RoHS Restriction of Hazardous Substances Directive ROI Return on investment RRA Remote Regulatory Assessment S&EHS Sustainability and environment, health and safety SAB Scientific Advisory Board SASB Sustainability Accounting Standards Board SBTi Science Based Targets initiative SDS Safety Data Sheets SEC Securities and Exchange Commission SHC Sustainable Healthcare Coalition SHEA Society for Healthcare Epidemiology of America SKU Stock keeping unit SLIPTAStepwise Laboratory Improvement Process Towards Accreditation in the African RegionSOPs Standard operating procedures SOP Strategic Organizational Plan SOX Sulfur oxides STEM Science, Technology, Engineering, and Math STRIDES Strengthening TB Resistance Testing and Diagnostic Systems SVP Senior vice president TB Tuberculosis TCFD Task Force on Climate-related Financial Disclosures UL Underwriters’ Laboratories UN SDGs United Nations Sustainable Development GoalsUNICEF United Nations International Children’s Emergency Fund  USAID U.S. Agency for International Development VoA Voice of the Associate VOC Volatile organic compounds VP Vice president VP GCA Vice President of Global Clinical Affairs VP S&EHSVice President, Sustainability and Environment, Health  and Safety VST  Volunteer Service Trip WARM Waste Reduction Model  WBCSD World Business Council for Sustainable Development WHO World Health Organization WRI World Resources Institute   The “strong teams” operating model outlines our approach to how different parts of the organization can come together to deliver value.
","('GHG_Emissions', 0.9640534520149231)","('Physical_Impacts_Of_Climate_Change', 0.0046014259569346905)","('Air_Quality', 0.004211352206766605)","(['Climate Change'], 0.9640534520149231)","('NON-ESG', 0.0046014259569346905)","('NON-ESG', 0.004211352206766605)"
Line 1967,"Not all acronyms are exclusive to BD.Acronyms and glossary AAALACAssociation for Assessment and Accreditation of Laboratory  Animal Care AAMI Advancement of Medical Instrumentation AdVaMed Advanced Medical Technology Association AI Artificial Intelligence AMR Antimicrobial resistance ARFC Antimicrobial Resistance Fighters Coalition ASLM Africa Society for Laboratory Medicine  BD Becton, Dickinson and Company BD SMTI BD Sustainable Medical Technology InstituteBDPS BD Production System BRAD Biomedical Research Awareness Day BSR Business for Social Responsibility CDC Center for Disease Control CEO Chief Executive Officer CFP Chemical Footprint Project cGMP current Good Manufacturing Practices CIDRAP Center for Infectious Disease Research and Policy CISA Cybersecurity and Infrastructure Security Agency COE Center of Excellence COPS Cost of products sold CPA Center for Political Activity CQRB Corporate Quality and Regulatory Board CRBSI Catheter related blood stream infection CRC Clinical Research Collaboration CSR Corporate Social Responsibility CTD Central TB Division CTP Corporate TB Pledge CVE® Common Vulnerability and ExposuresDCs Distribution centers DEFRA Department for Environment, Food and Rural Affairs DJSI Dow Jones Sustainability Indices DST Drug susceptibility testing EC/IRB Ethics Committee/Institutional Review Board EEIO Environmentally Extended Input-Output EFS Expectations for Suppliers EHS Enviroment, health and safety EM Equipment Management EMS Environmental management system EPP Environmentally preferable purchasing ERC Enterprise Risk and ESG Committee ERM the company, Environmental Resources Management ERM Enterprise Risk Management  ESG Environmental, social and governance ESOs Environmental, Health and Safety Opportunities EVP Executive Vice President EVP ISC Executive Vice President, Integrated Supply Chain  FBI Federal Bureau of Investigation FDA Food and Drug Administration FY Fiscal Year GCA Global clinical affairs GCP Good clinical practice GJS Good Jobs Strategy GHG Greenhouse gas GHGP Greenhouse Gas Protocol GLEC Global Logistics Emissions Council GMS&G Global Medical Safety and Governance GRI Global Reporting Initiative™HAP Hazardous air pollutant HIPAA Health Insurance Portability and Accountability Act HPRC Healthcare Plastics Recycling Council HQ Headquarters HR Human resources HRC Human Right Campaign HSCC Healthcare & Public Health Sector Coordinating Council HVAC Heating, ventilation, and air conditioning IACUC Institutional Animal Care and Use Committee ID&E Inclusion, Diversity and Equity ID/AST Identification, and antimicrobial susceptibility testing  IDA Industrial Development Agency IEA International Energy Agency IIR Injury and illness rate ILO International Labor Organization IMP Inventory management plan ISA International Society of Automation ISC Integrated supply chain  ISO International Organization for Standardization IVDR In vitro diagnostic medical device regulation KPI Key performance indicators LASCC Latin America Shared Service Center LC Liquid culture LLME Laboratory Leadership & Management Essentials LMIC Low-and middle-income countries LSHTM London School of Hygiene & Tropical Medicine LTIFR Lost time injury frequency rate M&A Merger and Acquisition MASC Medical Safety Specialists2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities MAUDE Manufacturer and User Facility Device Experience MDIC Medical Device Innovation Consortium MDR Medical device regulation MES Manufacturing execution system MIS Management information system MNT Maternal and neonatal tetanus MOC Materials of Concern MOH Ministry of Health MSS Medical Safety Specialists NACD National Association of Corporate Directors NGO Nongovermental organizations NIH National Institutes of Health NIST National Institute of Standards and Technology NOX Nitrogen oxides NTEP National TB Elimination Program NTP National TB Program ODA Official Development Assistance ODS Ozone-depleting substances OEM Original equipment manufacturer OHS Occupational health and safety OIFR Occupational illness frequency rate PAC Political action committee PEPFAR President’s Emergency Plan for AIDS Relief POC Point of carePPA Power purchase agreements  PPE Personal protective equipment QAN Quality Audit Network QMS Quality management system R&D Research and development RCSI Royal College of Surgeons REACHRegistration, Evaluation, Authorisation and Restriction  of Chemicals REC Renewable Energy Credits RFP Request for proposal RMW Regulated Medical Waste RoHS Restriction of Hazardous Substances Directive ROI Return on investment RRA Remote Regulatory Assessment S&EHS Sustainability and environment, health and safety SAB Scientific Advisory Board SASB Sustainability Accounting Standards Board SBTi Science Based Targets initiative SDS Safety Data Sheets SEC Securities and Exchange Commission SHC Sustainable Healthcare Coalition SHEA Society for Healthcare Epidemiology of America SKU Stock keeping unit SLIPTAStepwise Laboratory Improvement Process Towards Accreditation in the African RegionSOPs Standard operating procedures SOP Strategic Organizational Plan SOX Sulfur oxides STEM Science, Technology, Engineering, and Math STRIDES Strengthening TB Resistance Testing and Diagnostic Systems SVP Senior vice president TB Tuberculosis TCFD Task Force on Climate-related Financial Disclosures UL Underwriters’ Laboratories UN SDGs United Nations Sustainable Development GoalsUNICEF United Nations International Children’s Emergency Fund  USAID U.S. Agency for International Development VoA Voice of the Associate VOC Volatile organic compounds VP Vice president VP GCA Vice President of Global Clinical Affairs VP S&EHSVice President, Sustainability and Environment, Health  and Safety VST  Volunteer Service Trip WARM Waste Reduction Model  WBCSD World Business Council for Sustainable Development WHO World Health Organization WRI World Resources Institute   The “strong teams” operating model outlines our approach to how different parts of the organization can come together to deliver value.
","('Air_Quality', 0.9771165251731873)","('GHG_Emissions', 0.003238821402192116)","('Energy_Management', 0.0019487770041450858)","(['Operational Eco-Efficiency'], 0.9771165251731873)","('NON-ESG', 0.003238821402192116)","('NON-ESG', 0.0019487770041450858)"
Line 1968,"Not all acronyms are exclusive to BD.Acronyms and glossary AAALACAssociation for Assessment and Accreditation of Laboratory  Animal Care AAMI Advancement of Medical Instrumentation AdVaMed Advanced Medical Technology Association AI Artificial Intelligence AMR Antimicrobial resistance ARFC Antimicrobial Resistance Fighters Coalition ASLM Africa Society for Laboratory Medicine  BD Becton, Dickinson and Company BD SMTI BD Sustainable Medical Technology InstituteBDPS BD Production System BRAD Biomedical Research Awareness Day BSR Business for Social Responsibility CDC Center for Disease Control CEO Chief Executive Officer CFP Chemical Footprint Project cGMP current Good Manufacturing Practices CIDRAP Center for Infectious Disease Research and Policy CISA Cybersecurity and Infrastructure Security Agency COE Center of Excellence COPS Cost of products sold CPA Center for Political Activity CQRB Corporate Quality and Regulatory Board CRBSI Catheter related blood stream infection CRC Clinical Research Collaboration CSR Corporate Social Responsibility CTD Central TB Division CTP Corporate TB Pledge CVE® Common Vulnerability and ExposuresDCs Distribution centers DEFRA Department for Environment, Food and Rural Affairs DJSI Dow Jones Sustainability Indices DST Drug susceptibility testing EC/IRB Ethics Committee/Institutional Review Board EEIO Environmentally Extended Input-Output EFS Expectations for Suppliers EHS Enviroment, health and safety EM Equipment Management EMS Environmental management system EPP Environmentally preferable purchasing ERC Enterprise Risk and ESG Committee ERM the company, Environmental Resources Management ERM Enterprise Risk Management  ESG Environmental, social and governance ESOs Environmental, Health and Safety Opportunities EVP Executive Vice President EVP ISC Executive Vice President, Integrated Supply Chain  FBI Federal Bureau of Investigation FDA Food and Drug Administration FY Fiscal Year GCA Global clinical affairs GCP Good clinical practice GJS Good Jobs Strategy GHG Greenhouse gas GHGP Greenhouse Gas Protocol GLEC Global Logistics Emissions Council GMS&G Global Medical Safety and Governance GRI Global Reporting Initiative™HAP Hazardous air pollutant HIPAA Health Insurance Portability and Accountability Act HPRC Healthcare Plastics Recycling Council HQ Headquarters HR Human resources HRC Human Right Campaign HSCC Healthcare & Public Health Sector Coordinating Council HVAC Heating, ventilation, and air conditioning IACUC Institutional Animal Care and Use Committee ID&E Inclusion, Diversity and Equity ID/AST Identification, and antimicrobial susceptibility testing  IDA Industrial Development Agency IEA International Energy Agency IIR Injury and illness rate ILO International Labor Organization IMP Inventory management plan ISA International Society of Automation ISC Integrated supply chain  ISO International Organization for Standardization IVDR In vitro diagnostic medical device regulation KPI Key performance indicators LASCC Latin America Shared Service Center LC Liquid culture LLME Laboratory Leadership & Management Essentials LMIC Low-and middle-income countries LSHTM London School of Hygiene & Tropical Medicine LTIFR Lost time injury frequency rate M&A Merger and Acquisition MASC Medical Safety Specialists2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities MAUDE Manufacturer and User Facility Device Experience MDIC Medical Device Innovation Consortium MDR Medical device regulation MES Manufacturing execution system MIS Management information system MNT Maternal and neonatal tetanus MOC Materials of Concern MOH Ministry of Health MSS Medical Safety Specialists NACD National Association of Corporate Directors NGO Nongovermental organizations NIH National Institutes of Health NIST National Institute of Standards and Technology NOX Nitrogen oxides NTEP National TB Elimination Program NTP National TB Program ODA Official Development Assistance ODS Ozone-depleting substances OEM Original equipment manufacturer OHS Occupational health and safety OIFR Occupational illness frequency rate PAC Political action committee PEPFAR President’s Emergency Plan for AIDS Relief POC Point of carePPA Power purchase agreements  PPE Personal protective equipment QAN Quality Audit Network QMS Quality management system R&D Research and development RCSI Royal College of Surgeons REACHRegistration, Evaluation, Authorisation and Restriction  of Chemicals REC Renewable Energy Credits RFP Request for proposal RMW Regulated Medical Waste RoHS Restriction of Hazardous Substances Directive ROI Return on investment RRA Remote Regulatory Assessment S&EHS Sustainability and environment, health and safety SAB Scientific Advisory Board SASB Sustainability Accounting Standards Board SBTi Science Based Targets initiative SDS Safety Data Sheets SEC Securities and Exchange Commission SHC Sustainable Healthcare Coalition SHEA Society for Healthcare Epidemiology of America SKU Stock keeping unit SLIPTAStepwise Laboratory Improvement Process Towards Accreditation in the African RegionSOPs Standard operating procedures SOP Strategic Organizational Plan SOX Sulfur oxides STEM Science, Technology, Engineering, and Math STRIDES Strengthening TB Resistance Testing and Diagnostic Systems SVP Senior vice president TB Tuberculosis TCFD Task Force on Climate-related Financial Disclosures UL Underwriters’ Laboratories UN SDGs United Nations Sustainable Development GoalsUNICEF United Nations International Children’s Emergency Fund  USAID U.S. Agency for International Development VoA Voice of the Associate VOC Volatile organic compounds VP Vice president VP GCA Vice President of Global Clinical Affairs VP S&EHSVice President, Sustainability and Environment, Health  and Safety VST  Volunteer Service Trip WARM Waste Reduction Model  WBCSD World Business Council for Sustainable Development WHO World Health Organization WRI World Resources Institute   The “strong teams” operating model outlines our approach to how different parts of the organization can come together to deliver value.
","('Employee_Health_And_Safety', 0.9834211468696594)","('Critical_Incident_Risk_Management', 0.0019773845560848713)","('Employee_Engagement_Inclusion_And_Diversity', 0.0013319790596142411)","(['Operational Eco-Efficiency'], 0.9834211468696594)","('NON-ESG', 0.0019773845560848713)","('NON-ESG', 0.0013319790596142411)"
Line 1969,"Not all acronyms are exclusive to BD.Acronyms and glossary AAALACAssociation for Assessment and Accreditation of Laboratory  Animal Care AAMI Advancement of Medical Instrumentation AdVaMed Advanced Medical Technology Association AI Artificial Intelligence AMR Antimicrobial resistance ARFC Antimicrobial Resistance Fighters Coalition ASLM Africa Society for Laboratory Medicine  BD Becton, Dickinson and Company BD SMTI BD Sustainable Medical Technology InstituteBDPS BD Production System BRAD Biomedical Research Awareness Day BSR Business for Social Responsibility CDC Center for Disease Control CEO Chief Executive Officer CFP Chemical Footprint Project cGMP current Good Manufacturing Practices CIDRAP Center for Infectious Disease Research and Policy CISA Cybersecurity and Infrastructure Security Agency COE Center of Excellence COPS Cost of products sold CPA Center for Political Activity CQRB Corporate Quality and Regulatory Board CRBSI Catheter related blood stream infection CRC Clinical Research Collaboration CSR Corporate Social Responsibility CTD Central TB Division CTP Corporate TB Pledge CVE® Common Vulnerability and ExposuresDCs Distribution centers DEFRA Department for Environment, Food and Rural Affairs DJSI Dow Jones Sustainability Indices DST Drug susceptibility testing EC/IRB Ethics Committee/Institutional Review Board EEIO Environmentally Extended Input-Output EFS Expectations for Suppliers EHS Enviroment, health and safety EM Equipment Management EMS Environmental management system EPP Environmentally preferable purchasing ERC Enterprise Risk and ESG Committee ERM the company, Environmental Resources Management ERM Enterprise Risk Management  ESG Environmental, social and governance ESOs Environmental, Health and Safety Opportunities EVP Executive Vice President EVP ISC Executive Vice President, Integrated Supply Chain  FBI Federal Bureau of Investigation FDA Food and Drug Administration FY Fiscal Year GCA Global clinical affairs GCP Good clinical practice GJS Good Jobs Strategy GHG Greenhouse gas GHGP Greenhouse Gas Protocol GLEC Global Logistics Emissions Council GMS&G Global Medical Safety and Governance GRI Global Reporting Initiative™HAP Hazardous air pollutant HIPAA Health Insurance Portability and Accountability Act HPRC Healthcare Plastics Recycling Council HQ Headquarters HR Human resources HRC Human Right Campaign HSCC Healthcare & Public Health Sector Coordinating Council HVAC Heating, ventilation, and air conditioning IACUC Institutional Animal Care and Use Committee ID&E Inclusion, Diversity and Equity ID/AST Identification, and antimicrobial susceptibility testing  IDA Industrial Development Agency IEA International Energy Agency IIR Injury and illness rate ILO International Labor Organization IMP Inventory management plan ISA International Society of Automation ISC Integrated supply chain  ISO International Organization for Standardization IVDR In vitro diagnostic medical device regulation KPI Key performance indicators LASCC Latin America Shared Service Center LC Liquid culture LLME Laboratory Leadership & Management Essentials LMIC Low-and middle-income countries LSHTM London School of Hygiene & Tropical Medicine LTIFR Lost time injury frequency rate M&A Merger and Acquisition MASC Medical Safety Specialists2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities MAUDE Manufacturer and User Facility Device Experience MDIC Medical Device Innovation Consortium MDR Medical device regulation MES Manufacturing execution system MIS Management information system MNT Maternal and neonatal tetanus MOC Materials of Concern MOH Ministry of Health MSS Medical Safety Specialists NACD National Association of Corporate Directors NGO Nongovermental organizations NIH National Institutes of Health NIST National Institute of Standards and Technology NOX Nitrogen oxides NTEP National TB Elimination Program NTP National TB Program ODA Official Development Assistance ODS Ozone-depleting substances OEM Original equipment manufacturer OHS Occupational health and safety OIFR Occupational illness frequency rate PAC Political action committee PEPFAR President’s Emergency Plan for AIDS Relief POC Point of carePPA Power purchase agreements  PPE Personal protective equipment QAN Quality Audit Network QMS Quality management system R&D Research and development RCSI Royal College of Surgeons REACHRegistration, Evaluation, Authorisation and Restriction  of Chemicals REC Renewable Energy Credits RFP Request for proposal RMW Regulated Medical Waste RoHS Restriction of Hazardous Substances Directive ROI Return on investment RRA Remote Regulatory Assessment S&EHS Sustainability and environment, health and safety SAB Scientific Advisory Board SASB Sustainability Accounting Standards Board SBTi Science Based Targets initiative SDS Safety Data Sheets SEC Securities and Exchange Commission SHC Sustainable Healthcare Coalition SHEA Society for Healthcare Epidemiology of America SKU Stock keeping unit SLIPTAStepwise Laboratory Improvement Process Towards Accreditation in the African RegionSOPs Standard operating procedures SOP Strategic Organizational Plan SOX Sulfur oxides STEM Science, Technology, Engineering, and Math STRIDES Strengthening TB Resistance Testing and Diagnostic Systems SVP Senior vice president TB Tuberculosis TCFD Task Force on Climate-related Financial Disclosures UL Underwriters’ Laboratories UN SDGs United Nations Sustainable Development GoalsUNICEF United Nations International Children’s Emergency Fund  USAID U.S. Agency for International Development VoA Voice of the Associate VOC Volatile organic compounds VP Vice president VP GCA Vice President of Global Clinical Affairs VP S&EHSVice President, Sustainability and Environment, Health  and Safety VST  Volunteer Service Trip WARM Waste Reduction Model  WBCSD World Business Council for Sustainable Development WHO World Health Organization WRI World Resources Institute   The “strong teams” operating model outlines our approach to how different parts of the organization can come together to deliver value.
","('Supply_Chain_Management', 0.6453374624252319)","('Product_Design_And_Lifecycle_Management', 0.08310224860906601)","('Employee_Health_And_Safety', 0.05255022644996643)","(['Supply Chain Management'], 0.6453374624252319)","('NON-ESG', 0.08310224860906601)","('NON-ESG', 0.05255022644996643)"
Line 1970,"Not all acronyms are exclusive to BD.Acronyms and glossary AAALACAssociation for Assessment and Accreditation of Laboratory  Animal Care AAMI Advancement of Medical Instrumentation AdVaMed Advanced Medical Technology Association AI Artificial Intelligence AMR Antimicrobial resistance ARFC Antimicrobial Resistance Fighters Coalition ASLM Africa Society for Laboratory Medicine  BD Becton, Dickinson and Company BD SMTI BD Sustainable Medical Technology InstituteBDPS BD Production System BRAD Biomedical Research Awareness Day BSR Business for Social Responsibility CDC Center for Disease Control CEO Chief Executive Officer CFP Chemical Footprint Project cGMP current Good Manufacturing Practices CIDRAP Center for Infectious Disease Research and Policy CISA Cybersecurity and Infrastructure Security Agency COE Center of Excellence COPS Cost of products sold CPA Center for Political Activity CQRB Corporate Quality and Regulatory Board CRBSI Catheter related blood stream infection CRC Clinical Research Collaboration CSR Corporate Social Responsibility CTD Central TB Division CTP Corporate TB Pledge CVE® Common Vulnerability and ExposuresDCs Distribution centers DEFRA Department for Environment, Food and Rural Affairs DJSI Dow Jones Sustainability Indices DST Drug susceptibility testing EC/IRB Ethics Committee/Institutional Review Board EEIO Environmentally Extended Input-Output EFS Expectations for Suppliers EHS Enviroment, health and safety EM Equipment Management EMS Environmental management system EPP Environmentally preferable purchasing ERC Enterprise Risk and ESG Committee ERM the company, Environmental Resources Management ERM Enterprise Risk Management  ESG Environmental, social and governance ESOs Environmental, Health and Safety Opportunities EVP Executive Vice President EVP ISC Executive Vice President, Integrated Supply Chain  FBI Federal Bureau of Investigation FDA Food and Drug Administration FY Fiscal Year GCA Global clinical affairs GCP Good clinical practice GJS Good Jobs Strategy GHG Greenhouse gas GHGP Greenhouse Gas Protocol GLEC Global Logistics Emissions Council GMS&G Global Medical Safety and Governance GRI Global Reporting Initiative™HAP Hazardous air pollutant HIPAA Health Insurance Portability and Accountability Act HPRC Healthcare Plastics Recycling Council HQ Headquarters HR Human resources HRC Human Right Campaign HSCC Healthcare & Public Health Sector Coordinating Council HVAC Heating, ventilation, and air conditioning IACUC Institutional Animal Care and Use Committee ID&E Inclusion, Diversity and Equity ID/AST Identification, and antimicrobial susceptibility testing  IDA Industrial Development Agency IEA International Energy Agency IIR Injury and illness rate ILO International Labor Organization IMP Inventory management plan ISA International Society of Automation ISC Integrated supply chain  ISO International Organization for Standardization IVDR In vitro diagnostic medical device regulation KPI Key performance indicators LASCC Latin America Shared Service Center LC Liquid culture LLME Laboratory Leadership & Management Essentials LMIC Low-and middle-income countries LSHTM London School of Hygiene & Tropical Medicine LTIFR Lost time injury frequency rate M&A Merger and Acquisition MASC Medical Safety Specialists2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities MAUDE Manufacturer and User Facility Device Experience MDIC Medical Device Innovation Consortium MDR Medical device regulation MES Manufacturing execution system MIS Management information system MNT Maternal and neonatal tetanus MOC Materials of Concern MOH Ministry of Health MSS Medical Safety Specialists NACD National Association of Corporate Directors NGO Nongovermental organizations NIH National Institutes of Health NIST National Institute of Standards and Technology NOX Nitrogen oxides NTEP National TB Elimination Program NTP National TB Program ODA Official Development Assistance ODS Ozone-depleting substances OEM Original equipment manufacturer OHS Occupational health and safety OIFR Occupational illness frequency rate PAC Political action committee PEPFAR President’s Emergency Plan for AIDS Relief POC Point of carePPA Power purchase agreements  PPE Personal protective equipment QAN Quality Audit Network QMS Quality management system R&D Research and development RCSI Royal College of Surgeons REACHRegistration, Evaluation, Authorisation and Restriction  of Chemicals REC Renewable Energy Credits RFP Request for proposal RMW Regulated Medical Waste RoHS Restriction of Hazardous Substances Directive ROI Return on investment RRA Remote Regulatory Assessment S&EHS Sustainability and environment, health and safety SAB Scientific Advisory Board SASB Sustainability Accounting Standards Board SBTi Science Based Targets initiative SDS Safety Data Sheets SEC Securities and Exchange Commission SHC Sustainable Healthcare Coalition SHEA Society for Healthcare Epidemiology of America SKU Stock keeping unit SLIPTAStepwise Laboratory Improvement Process Towards Accreditation in the African RegionSOPs Standard operating procedures SOP Strategic Organizational Plan SOX Sulfur oxides STEM Science, Technology, Engineering, and Math STRIDES Strengthening TB Resistance Testing and Diagnostic Systems SVP Senior vice president TB Tuberculosis TCFD Task Force on Climate-related Financial Disclosures UL Underwriters’ Laboratories UN SDGs United Nations Sustainable Development GoalsUNICEF United Nations International Children’s Emergency Fund  USAID U.S. Agency for International Development VoA Voice of the Associate VOC Volatile organic compounds VP Vice president VP GCA Vice President of Global Clinical Affairs VP S&EHSVice President, Sustainability and Environment, Health  and Safety VST  Volunteer Service Trip WARM Waste Reduction Model  WBCSD World Business Council for Sustainable Development WHO World Health Organization WRI World Resources Institute   The “strong teams” operating model outlines our approach to how different parts of the organization can come together to deliver value.
","('Product_Quality_And_Safety', 0.634128212928772)","('Employee_Health_And_Safety', 0.08282460272312164)","('Waste_And_Hazardous_Materials_Management', 0.057352952659130096)","(['Product Quality & Recall Management'], 0.634128212928772)","('NON-ESG', 0.08282460272312164)","('NON-ESG', 0.057352952659130096)"
Line 1971,"Not all acronyms are exclusive to BD.Acronyms and glossary AAALACAssociation for Assessment and Accreditation of Laboratory  Animal Care AAMI Advancement of Medical Instrumentation AdVaMed Advanced Medical Technology Association AI Artificial Intelligence AMR Antimicrobial resistance ARFC Antimicrobial Resistance Fighters Coalition ASLM Africa Society for Laboratory Medicine  BD Becton, Dickinson and Company BD SMTI BD Sustainable Medical Technology InstituteBDPS BD Production System BRAD Biomedical Research Awareness Day BSR Business for Social Responsibility CDC Center for Disease Control CEO Chief Executive Officer CFP Chemical Footprint Project cGMP current Good Manufacturing Practices CIDRAP Center for Infectious Disease Research and Policy CISA Cybersecurity and Infrastructure Security Agency COE Center of Excellence COPS Cost of products sold CPA Center for Political Activity CQRB Corporate Quality and Regulatory Board CRBSI Catheter related blood stream infection CRC Clinical Research Collaboration CSR Corporate Social Responsibility CTD Central TB Division CTP Corporate TB Pledge CVE® Common Vulnerability and ExposuresDCs Distribution centers DEFRA Department for Environment, Food and Rural Affairs DJSI Dow Jones Sustainability Indices DST Drug susceptibility testing EC/IRB Ethics Committee/Institutional Review Board EEIO Environmentally Extended Input-Output EFS Expectations for Suppliers EHS Enviroment, health and safety EM Equipment Management EMS Environmental management system EPP Environmentally preferable purchasing ERC Enterprise Risk and ESG Committee ERM the company, Environmental Resources Management ERM Enterprise Risk Management  ESG Environmental, social and governance ESOs Environmental, Health and Safety Opportunities EVP Executive Vice President EVP ISC Executive Vice President, Integrated Supply Chain  FBI Federal Bureau of Investigation FDA Food and Drug Administration FY Fiscal Year GCA Global clinical affairs GCP Good clinical practice GJS Good Jobs Strategy GHG Greenhouse gas GHGP Greenhouse Gas Protocol GLEC Global Logistics Emissions Council GMS&G Global Medical Safety and Governance GRI Global Reporting Initiative™HAP Hazardous air pollutant HIPAA Health Insurance Portability and Accountability Act HPRC Healthcare Plastics Recycling Council HQ Headquarters HR Human resources HRC Human Right Campaign HSCC Healthcare & Public Health Sector Coordinating Council HVAC Heating, ventilation, and air conditioning IACUC Institutional Animal Care and Use Committee ID&E Inclusion, Diversity and Equity ID/AST Identification, and antimicrobial susceptibility testing  IDA Industrial Development Agency IEA International Energy Agency IIR Injury and illness rate ILO International Labor Organization IMP Inventory management plan ISA International Society of Automation ISC Integrated supply chain  ISO International Organization for Standardization IVDR In vitro diagnostic medical device regulation KPI Key performance indicators LASCC Latin America Shared Service Center LC Liquid culture LLME Laboratory Leadership & Management Essentials LMIC Low-and middle-income countries LSHTM London School of Hygiene & Tropical Medicine LTIFR Lost time injury frequency rate M&A Merger and Acquisition MASC Medical Safety Specialists2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities MAUDE Manufacturer and User Facility Device Experience MDIC Medical Device Innovation Consortium MDR Medical device regulation MES Manufacturing execution system MIS Management information system MNT Maternal and neonatal tetanus MOC Materials of Concern MOH Ministry of Health MSS Medical Safety Specialists NACD National Association of Corporate Directors NGO Nongovermental organizations NIH National Institutes of Health NIST National Institute of Standards and Technology NOX Nitrogen oxides NTEP National TB Elimination Program NTP National TB Program ODA Official Development Assistance ODS Ozone-depleting substances OEM Original equipment manufacturer OHS Occupational health and safety OIFR Occupational illness frequency rate PAC Political action committee PEPFAR President’s Emergency Plan for AIDS Relief POC Point of carePPA Power purchase agreements  PPE Personal protective equipment QAN Quality Audit Network QMS Quality management system R&D Research and development RCSI Royal College of Surgeons REACHRegistration, Evaluation, Authorisation and Restriction  of Chemicals REC Renewable Energy Credits RFP Request for proposal RMW Regulated Medical Waste RoHS Restriction of Hazardous Substances Directive ROI Return on investment RRA Remote Regulatory Assessment S&EHS Sustainability and environment, health and safety SAB Scientific Advisory Board SASB Sustainability Accounting Standards Board SBTi Science Based Targets initiative SDS Safety Data Sheets SEC Securities and Exchange Commission SHC Sustainable Healthcare Coalition SHEA Society for Healthcare Epidemiology of America SKU Stock keeping unit SLIPTAStepwise Laboratory Improvement Process Towards Accreditation in the African RegionSOPs Standard operating procedures SOP Strategic Organizational Plan SOX Sulfur oxides STEM Science, Technology, Engineering, and Math STRIDES Strengthening TB Resistance Testing and Diagnostic Systems SVP Senior vice president TB Tuberculosis TCFD Task Force on Climate-related Financial Disclosures UL Underwriters’ Laboratories UN SDGs United Nations Sustainable Development GoalsUNICEF United Nations International Children’s Emergency Fund  USAID U.S. Agency for International Development VoA Voice of the Associate VOC Volatile organic compounds VP Vice president VP GCA Vice President of Global Clinical Affairs VP S&EHSVice President, Sustainability and Environment, Health  and Safety VST  Volunteer Service Trip WARM Waste Reduction Model  WBCSD World Business Council for Sustainable Development WHO World Health Organization WRI World Resources Institute   The “strong teams” operating model outlines our approach to how different parts of the organization can come together to deliver value.
","('Employee_Health_And_Safety', 0.9664348363876343)","('Critical_Incident_Risk_Management', 0.012950259260833263)","('Waste_And_Hazardous_Materials_Management', 0.0018617080058902502)","(['Operational Eco-Efficiency'], 0.9664348363876343)","('NON-ESG', 0.012950259260833263)","('NON-ESG', 0.0018617080058902502)"
Line 1972,"Not all acronyms are exclusive to BD.Acronyms and glossary AAALACAssociation for Assessment and Accreditation of Laboratory  Animal Care AAMI Advancement of Medical Instrumentation AdVaMed Advanced Medical Technology Association AI Artificial Intelligence AMR Antimicrobial resistance ARFC Antimicrobial Resistance Fighters Coalition ASLM Africa Society for Laboratory Medicine  BD Becton, Dickinson and Company BD SMTI BD Sustainable Medical Technology InstituteBDPS BD Production System BRAD Biomedical Research Awareness Day BSR Business for Social Responsibility CDC Center for Disease Control CEO Chief Executive Officer CFP Chemical Footprint Project cGMP current Good Manufacturing Practices CIDRAP Center for Infectious Disease Research and Policy CISA Cybersecurity and Infrastructure Security Agency COE Center of Excellence COPS Cost of products sold CPA Center for Political Activity CQRB Corporate Quality and Regulatory Board CRBSI Catheter related blood stream infection CRC Clinical Research Collaboration CSR Corporate Social Responsibility CTD Central TB Division CTP Corporate TB Pledge CVE® Common Vulnerability and ExposuresDCs Distribution centers DEFRA Department for Environment, Food and Rural Affairs DJSI Dow Jones Sustainability Indices DST Drug susceptibility testing EC/IRB Ethics Committee/Institutional Review Board EEIO Environmentally Extended Input-Output EFS Expectations for Suppliers EHS Enviroment, health and safety EM Equipment Management EMS Environmental management system EPP Environmentally preferable purchasing ERC Enterprise Risk and ESG Committee ERM the company, Environmental Resources Management ERM Enterprise Risk Management  ESG Environmental, social and governance ESOs Environmental, Health and Safety Opportunities EVP Executive Vice President EVP ISC Executive Vice President, Integrated Supply Chain  FBI Federal Bureau of Investigation FDA Food and Drug Administration FY Fiscal Year GCA Global clinical affairs GCP Good clinical practice GJS Good Jobs Strategy GHG Greenhouse gas GHGP Greenhouse Gas Protocol GLEC Global Logistics Emissions Council GMS&G Global Medical Safety and Governance GRI Global Reporting Initiative™HAP Hazardous air pollutant HIPAA Health Insurance Portability and Accountability Act HPRC Healthcare Plastics Recycling Council HQ Headquarters HR Human resources HRC Human Right Campaign HSCC Healthcare & Public Health Sector Coordinating Council HVAC Heating, ventilation, and air conditioning IACUC Institutional Animal Care and Use Committee ID&E Inclusion, Diversity and Equity ID/AST Identification, and antimicrobial susceptibility testing  IDA Industrial Development Agency IEA International Energy Agency IIR Injury and illness rate ILO International Labor Organization IMP Inventory management plan ISA International Society of Automation ISC Integrated supply chain  ISO International Organization for Standardization IVDR In vitro diagnostic medical device regulation KPI Key performance indicators LASCC Latin America Shared Service Center LC Liquid culture LLME Laboratory Leadership & Management Essentials LMIC Low-and middle-income countries LSHTM London School of Hygiene & Tropical Medicine LTIFR Lost time injury frequency rate M&A Merger and Acquisition MASC Medical Safety Specialists2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities MAUDE Manufacturer and User Facility Device Experience MDIC Medical Device Innovation Consortium MDR Medical device regulation MES Manufacturing execution system MIS Management information system MNT Maternal and neonatal tetanus MOC Materials of Concern MOH Ministry of Health MSS Medical Safety Specialists NACD National Association of Corporate Directors NGO Nongovermental organizations NIH National Institutes of Health NIST National Institute of Standards and Technology NOX Nitrogen oxides NTEP National TB Elimination Program NTP National TB Program ODA Official Development Assistance ODS Ozone-depleting substances OEM Original equipment manufacturer OHS Occupational health and safety OIFR Occupational illness frequency rate PAC Political action committee PEPFAR President’s Emergency Plan for AIDS Relief POC Point of carePPA Power purchase agreements  PPE Personal protective equipment QAN Quality Audit Network QMS Quality management system R&D Research and development RCSI Royal College of Surgeons REACHRegistration, Evaluation, Authorisation and Restriction  of Chemicals REC Renewable Energy Credits RFP Request for proposal RMW Regulated Medical Waste RoHS Restriction of Hazardous Substances Directive ROI Return on investment RRA Remote Regulatory Assessment S&EHS Sustainability and environment, health and safety SAB Scientific Advisory Board SASB Sustainability Accounting Standards Board SBTi Science Based Targets initiative SDS Safety Data Sheets SEC Securities and Exchange Commission SHC Sustainable Healthcare Coalition SHEA Society for Healthcare Epidemiology of America SKU Stock keeping unit SLIPTAStepwise Laboratory Improvement Process Towards Accreditation in the African RegionSOPs Standard operating procedures SOP Strategic Organizational Plan SOX Sulfur oxides STEM Science, Technology, Engineering, and Math STRIDES Strengthening TB Resistance Testing and Diagnostic Systems SVP Senior vice president TB Tuberculosis TCFD Task Force on Climate-related Financial Disclosures UL Underwriters’ Laboratories UN SDGs United Nations Sustainable Development GoalsUNICEF United Nations International Children’s Emergency Fund  USAID U.S. Agency for International Development VoA Voice of the Associate VOC Volatile organic compounds VP Vice president VP GCA Vice President of Global Clinical Affairs VP S&EHSVice President, Sustainability and Environment, Health  and Safety VST  Volunteer Service Trip WARM Waste Reduction Model  WBCSD World Business Council for Sustainable Development WHO World Health Organization WRI World Resources Institute   The “strong teams” operating model outlines our approach to how different parts of the organization can come together to deliver value.
","('Product_Quality_And_Safety', 0.4293932318687439)","('Waste_And_Hazardous_Materials_Management', 0.30004456639289856)","('Employee_Health_And_Safety', 0.060470692813396454)","('NON-ESG', 0.4293932318687439)","('NON-ESG', 0.30004456639289856)","('NON-ESG', 0.060470692813396454)"
Line 1973,"Not all acronyms are exclusive to BD.Acronyms and glossary AAALACAssociation for Assessment and Accreditation of Laboratory  Animal Care AAMI Advancement of Medical Instrumentation AdVaMed Advanced Medical Technology Association AI Artificial Intelligence AMR Antimicrobial resistance ARFC Antimicrobial Resistance Fighters Coalition ASLM Africa Society for Laboratory Medicine  BD Becton, Dickinson and Company BD SMTI BD Sustainable Medical Technology InstituteBDPS BD Production System BRAD Biomedical Research Awareness Day BSR Business for Social Responsibility CDC Center for Disease Control CEO Chief Executive Officer CFP Chemical Footprint Project cGMP current Good Manufacturing Practices CIDRAP Center for Infectious Disease Research and Policy CISA Cybersecurity and Infrastructure Security Agency COE Center of Excellence COPS Cost of products sold CPA Center for Political Activity CQRB Corporate Quality and Regulatory Board CRBSI Catheter related blood stream infection CRC Clinical Research Collaboration CSR Corporate Social Responsibility CTD Central TB Division CTP Corporate TB Pledge CVE® Common Vulnerability and ExposuresDCs Distribution centers DEFRA Department for Environment, Food and Rural Affairs DJSI Dow Jones Sustainability Indices DST Drug susceptibility testing EC/IRB Ethics Committee/Institutional Review Board EEIO Environmentally Extended Input-Output EFS Expectations for Suppliers EHS Enviroment, health and safety EM Equipment Management EMS Environmental management system EPP Environmentally preferable purchasing ERC Enterprise Risk and ESG Committee ERM the company, Environmental Resources Management ERM Enterprise Risk Management  ESG Environmental, social and governance ESOs Environmental, Health and Safety Opportunities EVP Executive Vice President EVP ISC Executive Vice President, Integrated Supply Chain  FBI Federal Bureau of Investigation FDA Food and Drug Administration FY Fiscal Year GCA Global clinical affairs GCP Good clinical practice GJS Good Jobs Strategy GHG Greenhouse gas GHGP Greenhouse Gas Protocol GLEC Global Logistics Emissions Council GMS&G Global Medical Safety and Governance GRI Global Reporting Initiative™HAP Hazardous air pollutant HIPAA Health Insurance Portability and Accountability Act HPRC Healthcare Plastics Recycling Council HQ Headquarters HR Human resources HRC Human Right Campaign HSCC Healthcare & Public Health Sector Coordinating Council HVAC Heating, ventilation, and air conditioning IACUC Institutional Animal Care and Use Committee ID&E Inclusion, Diversity and Equity ID/AST Identification, and antimicrobial susceptibility testing  IDA Industrial Development Agency IEA International Energy Agency IIR Injury and illness rate ILO International Labor Organization IMP Inventory management plan ISA International Society of Automation ISC Integrated supply chain  ISO International Organization for Standardization IVDR In vitro diagnostic medical device regulation KPI Key performance indicators LASCC Latin America Shared Service Center LC Liquid culture LLME Laboratory Leadership & Management Essentials LMIC Low-and middle-income countries LSHTM London School of Hygiene & Tropical Medicine LTIFR Lost time injury frequency rate M&A Merger and Acquisition MASC Medical Safety Specialists2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities MAUDE Manufacturer and User Facility Device Experience MDIC Medical Device Innovation Consortium MDR Medical device regulation MES Manufacturing execution system MIS Management information system MNT Maternal and neonatal tetanus MOC Materials of Concern MOH Ministry of Health MSS Medical Safety Specialists NACD National Association of Corporate Directors NGO Nongovermental organizations NIH National Institutes of Health NIST National Institute of Standards and Technology NOX Nitrogen oxides NTEP National TB Elimination Program NTP National TB Program ODA Official Development Assistance ODS Ozone-depleting substances OEM Original equipment manufacturer OHS Occupational health and safety OIFR Occupational illness frequency rate PAC Political action committee PEPFAR President’s Emergency Plan for AIDS Relief POC Point of carePPA Power purchase agreements  PPE Personal protective equipment QAN Quality Audit Network QMS Quality management system R&D Research and development RCSI Royal College of Surgeons REACHRegistration, Evaluation, Authorisation and Restriction  of Chemicals REC Renewable Energy Credits RFP Request for proposal RMW Regulated Medical Waste RoHS Restriction of Hazardous Substances Directive ROI Return on investment RRA Remote Regulatory Assessment S&EHS Sustainability and environment, health and safety SAB Scientific Advisory Board SASB Sustainability Accounting Standards Board SBTi Science Based Targets initiative SDS Safety Data Sheets SEC Securities and Exchange Commission SHC Sustainable Healthcare Coalition SHEA Society for Healthcare Epidemiology of America SKU Stock keeping unit SLIPTAStepwise Laboratory Improvement Process Towards Accreditation in the African RegionSOPs Standard operating procedures SOP Strategic Organizational Plan SOX Sulfur oxides STEM Science, Technology, Engineering, and Math STRIDES Strengthening TB Resistance Testing and Diagnostic Systems SVP Senior vice president TB Tuberculosis TCFD Task Force on Climate-related Financial Disclosures UL Underwriters’ Laboratories UN SDGs United Nations Sustainable Development GoalsUNICEF United Nations International Children’s Emergency Fund  USAID U.S. Agency for International Development VoA Voice of the Associate VOC Volatile organic compounds VP Vice president VP GCA Vice President of Global Clinical Affairs VP S&EHSVice President, Sustainability and Environment, Health  and Safety VST  Volunteer Service Trip WARM Waste Reduction Model  WBCSD World Business Council for Sustainable Development WHO World Health Organization WRI World Resources Institute   The “strong teams” operating model outlines our approach to how different parts of the organization can come together to deliver value.
","('Physical_Impacts_Of_Climate_Change', 0.9095346331596375)","('GHG_Emissions', 0.018214881420135498)","('Air_Quality', 0.010710887610912323)","(['Climate Change'], 0.9095346331596375)","('NON-ESG', 0.018214881420135498)","('NON-ESG', 0.010710887610912323)"
Line 1974,"Not all acronyms are exclusive to BD.Acronyms and glossary AAALACAssociation for Assessment and Accreditation of Laboratory  Animal Care AAMI Advancement of Medical Instrumentation AdVaMed Advanced Medical Technology Association AI Artificial Intelligence AMR Antimicrobial resistance ARFC Antimicrobial Resistance Fighters Coalition ASLM Africa Society for Laboratory Medicine  BD Becton, Dickinson and Company BD SMTI BD Sustainable Medical Technology InstituteBDPS BD Production System BRAD Biomedical Research Awareness Day BSR Business for Social Responsibility CDC Center for Disease Control CEO Chief Executive Officer CFP Chemical Footprint Project cGMP current Good Manufacturing Practices CIDRAP Center for Infectious Disease Research and Policy CISA Cybersecurity and Infrastructure Security Agency COE Center of Excellence COPS Cost of products sold CPA Center for Political Activity CQRB Corporate Quality and Regulatory Board CRBSI Catheter related blood stream infection CRC Clinical Research Collaboration CSR Corporate Social Responsibility CTD Central TB Division CTP Corporate TB Pledge CVE® Common Vulnerability and ExposuresDCs Distribution centers DEFRA Department for Environment, Food and Rural Affairs DJSI Dow Jones Sustainability Indices DST Drug susceptibility testing EC/IRB Ethics Committee/Institutional Review Board EEIO Environmentally Extended Input-Output EFS Expectations for Suppliers EHS Enviroment, health and safety EM Equipment Management EMS Environmental management system EPP Environmentally preferable purchasing ERC Enterprise Risk and ESG Committee ERM the company, Environmental Resources Management ERM Enterprise Risk Management  ESG Environmental, social and governance ESOs Environmental, Health and Safety Opportunities EVP Executive Vice President EVP ISC Executive Vice President, Integrated Supply Chain  FBI Federal Bureau of Investigation FDA Food and Drug Administration FY Fiscal Year GCA Global clinical affairs GCP Good clinical practice GJS Good Jobs Strategy GHG Greenhouse gas GHGP Greenhouse Gas Protocol GLEC Global Logistics Emissions Council GMS&G Global Medical Safety and Governance GRI Global Reporting Initiative™HAP Hazardous air pollutant HIPAA Health Insurance Portability and Accountability Act HPRC Healthcare Plastics Recycling Council HQ Headquarters HR Human resources HRC Human Right Campaign HSCC Healthcare & Public Health Sector Coordinating Council HVAC Heating, ventilation, and air conditioning IACUC Institutional Animal Care and Use Committee ID&E Inclusion, Diversity and Equity ID/AST Identification, and antimicrobial susceptibility testing  IDA Industrial Development Agency IEA International Energy Agency IIR Injury and illness rate ILO International Labor Organization IMP Inventory management plan ISA International Society of Automation ISC Integrated supply chain  ISO International Organization for Standardization IVDR In vitro diagnostic medical device regulation KPI Key performance indicators LASCC Latin America Shared Service Center LC Liquid culture LLME Laboratory Leadership & Management Essentials LMIC Low-and middle-income countries LSHTM London School of Hygiene & Tropical Medicine LTIFR Lost time injury frequency rate M&A Merger and Acquisition MASC Medical Safety Specialists2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities MAUDE Manufacturer and User Facility Device Experience MDIC Medical Device Innovation Consortium MDR Medical device regulation MES Manufacturing execution system MIS Management information system MNT Maternal and neonatal tetanus MOC Materials of Concern MOH Ministry of Health MSS Medical Safety Specialists NACD National Association of Corporate Directors NGO Nongovermental organizations NIH National Institutes of Health NIST National Institute of Standards and Technology NOX Nitrogen oxides NTEP National TB Elimination Program NTP National TB Program ODA Official Development Assistance ODS Ozone-depleting substances OEM Original equipment manufacturer OHS Occupational health and safety OIFR Occupational illness frequency rate PAC Political action committee PEPFAR President’s Emergency Plan for AIDS Relief POC Point of carePPA Power purchase agreements  PPE Personal protective equipment QAN Quality Audit Network QMS Quality management system R&D Research and development RCSI Royal College of Surgeons REACHRegistration, Evaluation, Authorisation and Restriction  of Chemicals REC Renewable Energy Credits RFP Request for proposal RMW Regulated Medical Waste RoHS Restriction of Hazardous Substances Directive ROI Return on investment RRA Remote Regulatory Assessment S&EHS Sustainability and environment, health and safety SAB Scientific Advisory Board SASB Sustainability Accounting Standards Board SBTi Science Based Targets initiative SDS Safety Data Sheets SEC Securities and Exchange Commission SHC Sustainable Healthcare Coalition SHEA Society for Healthcare Epidemiology of America SKU Stock keeping unit SLIPTAStepwise Laboratory Improvement Process Towards Accreditation in the African RegionSOPs Standard operating procedures SOP Strategic Organizational Plan SOX Sulfur oxides STEM Science, Technology, Engineering, and Math STRIDES Strengthening TB Resistance Testing and Diagnostic Systems SVP Senior vice president TB Tuberculosis TCFD Task Force on Climate-related Financial Disclosures UL Underwriters’ Laboratories UN SDGs United Nations Sustainable Development GoalsUNICEF United Nations International Children’s Emergency Fund  USAID U.S. Agency for International Development VoA Voice of the Associate VOC Volatile organic compounds VP Vice president VP GCA Vice President of Global Clinical Affairs VP S&EHSVice President, Sustainability and Environment, Health  and Safety VST  Volunteer Service Trip WARM Waste Reduction Model  WBCSD World Business Council for Sustainable Development WHO World Health Organization WRI World Resources Institute   The “strong teams” operating model outlines our approach to how different parts of the organization can come together to deliver value.
","('Waste_And_Hazardous_Materials_Management', 0.9755082130432129)","('Water_And_Wastewater_Management', 0.002987263258546591)","('Air_Quality', 0.0020248042419552803)","(['Operational Eco-Efficiency'], 0.9755082130432129)","('NON-ESG', 0.002987263258546591)","('NON-ESG', 0.0020248042419552803)"
Line 1975,"Not all acronyms are exclusive to BD.Acronyms and glossary AAALACAssociation for Assessment and Accreditation of Laboratory  Animal Care AAMI Advancement of Medical Instrumentation AdVaMed Advanced Medical Technology Association AI Artificial Intelligence AMR Antimicrobial resistance ARFC Antimicrobial Resistance Fighters Coalition ASLM Africa Society for Laboratory Medicine  BD Becton, Dickinson and Company BD SMTI BD Sustainable Medical Technology InstituteBDPS BD Production System BRAD Biomedical Research Awareness Day BSR Business for Social Responsibility CDC Center for Disease Control CEO Chief Executive Officer CFP Chemical Footprint Project cGMP current Good Manufacturing Practices CIDRAP Center for Infectious Disease Research and Policy CISA Cybersecurity and Infrastructure Security Agency COE Center of Excellence COPS Cost of products sold CPA Center for Political Activity CQRB Corporate Quality and Regulatory Board CRBSI Catheter related blood stream infection CRC Clinical Research Collaboration CSR Corporate Social Responsibility CTD Central TB Division CTP Corporate TB Pledge CVE® Common Vulnerability and ExposuresDCs Distribution centers DEFRA Department for Environment, Food and Rural Affairs DJSI Dow Jones Sustainability Indices DST Drug susceptibility testing EC/IRB Ethics Committee/Institutional Review Board EEIO Environmentally Extended Input-Output EFS Expectations for Suppliers EHS Enviroment, health and safety EM Equipment Management EMS Environmental management system EPP Environmentally preferable purchasing ERC Enterprise Risk and ESG Committee ERM the company, Environmental Resources Management ERM Enterprise Risk Management  ESG Environmental, social and governance ESOs Environmental, Health and Safety Opportunities EVP Executive Vice President EVP ISC Executive Vice President, Integrated Supply Chain  FBI Federal Bureau of Investigation FDA Food and Drug Administration FY Fiscal Year GCA Global clinical affairs GCP Good clinical practice GJS Good Jobs Strategy GHG Greenhouse gas GHGP Greenhouse Gas Protocol GLEC Global Logistics Emissions Council GMS&G Global Medical Safety and Governance GRI Global Reporting Initiative™HAP Hazardous air pollutant HIPAA Health Insurance Portability and Accountability Act HPRC Healthcare Plastics Recycling Council HQ Headquarters HR Human resources HRC Human Right Campaign HSCC Healthcare & Public Health Sector Coordinating Council HVAC Heating, ventilation, and air conditioning IACUC Institutional Animal Care and Use Committee ID&E Inclusion, Diversity and Equity ID/AST Identification, and antimicrobial susceptibility testing  IDA Industrial Development Agency IEA International Energy Agency IIR Injury and illness rate ILO International Labor Organization IMP Inventory management plan ISA International Society of Automation ISC Integrated supply chain  ISO International Organization for Standardization IVDR In vitro diagnostic medical device regulation KPI Key performance indicators LASCC Latin America Shared Service Center LC Liquid culture LLME Laboratory Leadership & Management Essentials LMIC Low-and middle-income countries LSHTM London School of Hygiene & Tropical Medicine LTIFR Lost time injury frequency rate M&A Merger and Acquisition MASC Medical Safety Specialists2021 ESG Report Transparency Appendices Responsible supply chain Product impact Climate change Introduction Healthy workforce and communities MAUDE Manufacturer and User Facility Device Experience MDIC Medical Device Innovation Consortium MDR Medical device regulation MES Manufacturing execution system MIS Management information system MNT Maternal and neonatal tetanus MOC Materials of Concern MOH Ministry of Health MSS Medical Safety Specialists NACD National Association of Corporate Directors NGO Nongovermental organizations NIH National Institutes of Health NIST National Institute of Standards and Technology NOX Nitrogen oxides NTEP National TB Elimination Program NTP National TB Program ODA Official Development Assistance ODS Ozone-depleting substances OEM Original equipment manufacturer OHS Occupational health and safety OIFR Occupational illness frequency rate PAC Political action committee PEPFAR President’s Emergency Plan for AIDS Relief POC Point of carePPA Power purchase agreements  PPE Personal protective equipment QAN Quality Audit Network QMS Quality management system R&D Research and development RCSI Royal College of Surgeons REACHRegistration, Evaluation, Authorisation and Restriction  of Chemicals REC Renewable Energy Credits RFP Request for proposal RMW Regulated Medical Waste RoHS Restriction of Hazardous Substances Directive ROI Return on investment RRA Remote Regulatory Assessment S&EHS Sustainability and environment, health and safety SAB Scientific Advisory Board SASB Sustainability Accounting Standards Board SBTi Science Based Targets initiative SDS Safety Data Sheets SEC Securities and Exchange Commission SHC Sustainable Healthcare Coalition SHEA Society for Healthcare Epidemiology of America SKU Stock keeping unit SLIPTAStepwise Laboratory Improvement Process Towards Accreditation in the African RegionSOPs Standard operating procedures SOP Strategic Organizational Plan SOX Sulfur oxides STEM Science, Technology, Engineering, and Math STRIDES Strengthening TB Resistance Testing and Diagnostic Systems SVP Senior vice president TB Tuberculosis TCFD Task Force on Climate-related Financial Disclosures UL Underwriters’ Laboratories UN SDGs United Nations Sustainable Development GoalsUNICEF United Nations International Children’s Emergency Fund  USAID U.S. Agency for International Development VoA Voice of the Associate VOC Volatile organic compounds VP Vice president VP GCA Vice President of Global Clinical Affairs VP S&EHSVice President, Sustainability and Environment, Health  and Safety VST  Volunteer Service Trip WARM Waste Reduction Model  WBCSD World Business Council for Sustainable Development WHO World Health Organization WRI World Resources Institute   The “strong teams” operating model outlines our approach to how different parts of the organization can come together to deliver value.
","('Competitive_Behavior', 0.39783623814582825)","('Systemic_Risk_Management', 0.10393146425485611)","('Management_Of_Legal_And_Regulatory_Framework', 0.08058702200651169)","('NON-ESG', 0.39783623814582825)","('NON-ESG', 0.10393146425485611)","('NON-ESG', 0.08058702200651169)"
Line 1976,"The foundation for this model is empowerment of teams and servant leadership.
","('Human_Rights_And_Community_Relations', 0.4577568769454956)","('Employee_Engagement_Inclusion_And_Diversity', 0.29083994030952454)","('Director_Removal', 0.02204914391040802)","('NON-ESG', 0.4577568769454956)","('NON-ESG', 0.29083994030952454)","('NON-ESG', 0.02204914391040802)"
Line 1977,"At the center are our customers.
","('Product_Design_And_Lifecycle_Management', 0.21422742307186127)","('Business_Model_Resilience', 0.12844644486904144)","('Competitive_Behavior', 0.11076854169368744)","('NON-ESG', 0.21422742307186127)","('NON-ESG', 0.12844644486904144)","('NON-ESG', 0.11076854169368744)"
Line 1978,"Central team These teams are typically corporate functions and drive people, process and systems excellence.
","('Business_Model_Resilience', 0.25127512216567993)","('Employee_Engagement_Inclusion_And_Diversity', 0.13044388592243195)","('Director_Removal', 0.10906734317541122)","('NON-ESG', 0.25127512216567993)","('NON-ESG', 0.13044388592243195)","('NON-ESG', 0.10906734317541122)"
Line 1979,"Business team These teams drive strategy and product portfolio.
","('Product_Design_And_Lifecycle_Management', 0.8908778429031372)","('Business_Model_Resilience', 0.025116048753261566)","('Supply_Chain_Management', 0.014802924357354641)","(['Product Stewardship'], 0.8908778429031372)","('NON-ESG', 0.025116048753261566)","('NON-ESG', 0.014802924357354641)"
Line 1980,"The teams are arranged by segment, business unit and platform.
","('Business_Model_Resilience', 0.3193315267562866)","('Systemic_Risk_Management', 0.1626511961221695)","('Supply_Chain_Management', 0.08173181116580963)","('NON-ESG', 0.3193315267562866)","('NON-ESG', 0.1626511961221695)","('NON-ESG', 0.08173181116580963)"
Line 1981,"Regional team These teams are focused on channels, customers and service.
","('Competitive_Behavior', 0.2935110032558441)","('Business_Model_Resilience', 0.2811771631240845)","('Customer_Welfare', 0.05417534336447716)","('NON-ESG', 0.2935110032558441)","('NON-ESG', 0.2811771631240845)","('NON-ESG', 0.05417534336447716)"
Line 1982,"The teams are arranged by region, country and sales team.
","('Competitive_Behavior', 0.23976249992847443)","('Employee_Engagement_Inclusion_And_Diversity', 0.13833481073379517)","('Management_Of_Legal_And_Regulatory_Framework', 0.08903692662715912)","('NON-ESG', 0.23976249992847443)","('NON-ESG', 0.13833481073379517)","('NON-ESG', 0.08903692662715912)"
Line 1983,"Advancing the world of health TMOur Purpose.
","('Access_And_Affordability', 0.47356194257736206)","('Employee_Health_And_Safety', 0.0646219551563263)","('Employee_Engagement_Inclusion_And_Diversity', 0.04348904266953468)","('NON-ESG', 0.47356194257736206)","('NON-ESG', 0.0646219551563263)","('NON-ESG', 0.04348904266953468)"
Line 1984,"BD 2025 Our current phase of value creation, anchored in three key pillars—Grow, Simplify and Empower.
","('Business_Model_Resilience', 0.810401439666748)","('Supply_Chain_Management', 0.02864537201821804)","('Systemic_Risk_Management', 0.024761062115430832)","(['Codes of Business Conduct'], 0.810401439666748)","('NON-ESG', 0.02864537201821804)","('NON-ESG', 0.024761062115430832)"
Line 1985,"THE BD WAY A set of behaviors that embodies who we are, what we stand for and why we exist.
","('Human_Rights_And_Community_Relations', 0.18470963835716248)","('Employee_Engagement_Inclusion_And_Diversity', 0.15191243588924408)","('Competitive_Behavior', 0.12615013122558594)","('NON-ESG', 0.18470963835716248)","('NON-ESG', 0.15191243588924408)","('NON-ESG', 0.12615013122558594)"
Line 1986,"Together we advance Our ESG strategy, a four-pillar framework through which we address the most relevant ESG issues for our business and stakeholders.
","('Business_Model_Resilience', 0.6784561276435852)","('Systemic_Risk_Management', 0.08197943866252899)","('Human_Rights_And_Community_Relations', 0.036775898188352585)","(['Codes of Business Conduct'], 0.6784561276435852)","('NON-ESG', 0.08197943866252899)","('NON-ESG', 0.036775898188352585)"
Line 1987,"2030+ commitments A set of commitments and goals in five impact areas—climate change, product impact, responsible supply chain, healthy workforce and communities, and transparency.
","('Physical_Impacts_Of_Climate_Change', 0.47145557403564453)","('Supply_Chain_Management', 0.37299954891204834)","('Business_Model_Resilience', 0.026234086602926254)","('NON-ESG', 0.47145557403564453)","('NON-ESG', 0.37299954891204834)","('NON-ESG', 0.026234086602926254)"
Line 1988,"These are areas where we see the most opportunity  for BD to create meaningful and measurable change over the next decade and beyond.To find out more about sustainability at BD or to provide feedback on our reporting, please contact BD_Sustainability_Office@bd.com This report contains information about BD and its operations around the world.
","('Business_Model_Resilience', 0.5508768558502197)","('Systemic_Risk_Management', 0.0635196790099144)","('Supply_Chain_Management', 0.05909482389688492)","(['Codes of Business Conduct'], 0.5508768558502197)","('NON-ESG', 0.0635196790099144)","('NON-ESG', 0.05909482389688492)"
Line 1989,"Statements regarding our future business direction and intent represent goals and objectives only and are subject to change or withdrawal without notice.
","('Business_Model_Resilience', 0.37723901867866516)","('Director_Removal', 0.13685065507888794)","('Management_Of_Legal_And_Regulatory_Framework', 0.09578374773263931)","('NON-ESG', 0.37723901867866516)","('NON-ESG', 0.13685065507888794)","('NON-ESG', 0.09578374773263931)"
Line 1990,"We undertake no  obligation to update the statements or information contained in this report.
","('Management_Of_Legal_And_Regulatory_Framework', 0.7531163096427917)","('Business_Ethics', 0.035880476236343384)","('Customer_Privacy', 0.02343648672103882)","(['Corporate Governance'], 0.7531163096427917)","('NON-ESG', 0.035880476236343384)","('NON-ESG', 0.02343648672103882)"
Line 1991,"Cautionary statement regarding forward-looking statements This report contains certain forward-looking statements within the meaning of the federal securities laws regarding BD’s business, strategy, goals, commitments and objectives.
","('Management_Of_Legal_And_Regulatory_Framework', 0.40782493352890015)","('Business_Model_Resilience', 0.29760217666625977)","('Director_Removal', 0.03527079522609711)","('NON-ESG', 0.40782493352890015)","('NON-ESG', 0.29760217666625977)","('NON-ESG', 0.03527079522609711)"
Line 1992,"Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed, projected, anticipated or implied in such statements.
","('Systemic_Risk_Management', 0.7523532509803772)","('Management_Of_Legal_And_Regulatory_Framework', 0.04446226358413696)","('Business_Model_Resilience', 0.038674306124448776)","(['Risk & Crisis Management'], 0.7523532509803772)","('NON-ESG', 0.04446226358413696)","('NON-ESG', 0.038674306124448776)"
Line 1993,"All statements, other than statements of historical facts, may be forward-looking statements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.2466098666191101)","('Business_Ethics', 0.23922321200370789)","('Customer_Privacy', 0.09356050193309784)","('NON-ESG', 0.2466098666191101)","('NON-ESG', 0.23922321200370789)","('NON-ESG', 0.09356050193309784)"
Line 1994,"Some forward-looking statements may be identified by the use of words such as “plan,” “expect,” “believe,” “intend,” “will,” “may,” “anticipate,” estimate,” “target,” and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance and strategy for growth, future product development, regulatory approvals, competitive position, sustainability initiatives and expenditures.
","('Competitive_Behavior', 0.3468286395072937)","('Management_Of_Legal_And_Regulatory_Framework', 0.28380027413368225)","('Business_Model_Resilience', 0.15493609011173248)","('NON-ESG', 0.3468286395072937)","('NON-ESG', 0.28380027413368225)","('NON-ESG', 0.15493609011173248)"
Line 1995,"Readers should not place undue reliance on forward-looking statements.
","('Management_Of_Legal_And_Regulatory_Framework', 0.30663421750068665)","('Competitive_Behavior', 0.1932341456413269)","('Business_Ethics', 0.08940917998552322)","('NON-ESG', 0.30663421750068665)","('NON-ESG', 0.1932341456413269)","('NON-ESG', 0.08940917998552322)"
Line 1996,"Forward-looking statements are, and will be, based on management’s then-current views and assumptions regarding future events, developments and operating performance, and speak only as of their dates.
","('Business_Model_Resilience', 0.792125940322876)","('Systemic_Risk_Management', 0.034694425761699677)","('Physical_Impacts_Of_Climate_Change', 0.030613752081990242)","(['Codes of Business Conduct'], 0.792125940322876)","('NON-ESG', 0.034694425761699677)","('NON-ESG', 0.030613752081990242)"
Line 1997,"Statements regarding BD’s goals, commitments and objectives may include statistics or metrics that are based on estimates and assumptions under developing standards that may change in the future.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5626062154769897)","('Business_Model_Resilience', 0.06987102329730988)","('Product_Quality_And_Safety', 0.05742297321557999)","(['Corporate Governance'], 0.5626062154769897)","('NON-ESG', 0.06987102329730988)","('NON-ESG', 0.05742297321557999)"
Line 1998,"Such goals and commitments are not intended to  be promises or guarantees, and actual results may differ, possibly materially.
","('Management_Of_Legal_And_Regulatory_Framework', 0.46860694885253906)","('Human_Rights_And_Community_Relations', 0.11205526441335678)","('Business_Model_Resilience', 0.11016357690095901)","('NON-ESG', 0.46860694885253906)","('NON-ESG', 0.11205526441335678)","('NON-ESG', 0.11016357690095901)"
Line 1999,"It is not possible to predict or identify all of these risks and uncertainties, many of which are beyond BD’s control, including, without limitation, challenges relating to economic, competitive, governmental and technological factors affecting BD’s operations, markets and products, and other factors listed in BD’s 2021 Annual Report on Form 10-K and other filings with the Securities and Exchange Commission (SEC).
","('Systemic_Risk_Management', 0.8739688992500305)","('Competitive_Behavior', 0.04726871848106384)","('Business_Model_Resilience', 0.014141812920570374)","(['Risk & Crisis Management'], 0.8739688992500305)","('NON-ESG', 0.04726871848106384)","('NON-ESG', 0.014141812920570374)"
Line 2000,"BD expressly disclaims any undertaking to update or revise any forward-looking statements set forth herein to reflect events or circumstances after the date hereof, except as required by applicable law or regulation.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9607481360435486)","('Director_Removal', 0.004097465891391039)","('Physical_Impacts_Of_Climate_Change', 0.0028608893044292927)","(['Corporate Governance'], 0.9607481360435486)","('NON-ESG', 0.004097465891391039)","('NON-ESG', 0.0028608893044292927)"
Line 2001,"The inclusion of information in this report should not be construed as a characterization regarding the materiality or financial impact of that information.
","('Management_Of_Legal_And_Regulatory_Framework', 0.45218491554260254)","('Business_Model_Resilience', 0.11643796414136887)","('Systemic_Risk_Management', 0.08968594670295715)","('NON-ESG', 0.45218491554260254)","('NON-ESG', 0.11643796414136887)","('NON-ESG', 0.08968594670295715)"
Line 2002,"For additional information regarding BD, please see our 2021 Annual Report on Form 10-K and other  filings with the SEC.
","('Management_Of_Legal_And_Regulatory_Framework', 0.9070882797241211)","('Business_Ethics', 0.017023589462041855)","('Systemic_Risk_Management', 0.006948379334062338)","(['Corporate Governance'], 0.9070882797241211)","('NON-ESG', 0.017023589462041855)","('NON-ESG', 0.006948379334062338)"
Line 2003,"This report contains links to external websites or references to third parties.
","('Management_Of_Legal_And_Regulatory_Framework', 0.6230594515800476)","('Supply_Chain_Management', 0.033907968550920486)","('Customer_Privacy', 0.030048279091715813)","(['Corporate Governance'], 0.6230594515800476)","('NON-ESG', 0.033907968550920486)","('NON-ESG', 0.030048279091715813)"
Line 2004,"Such links or websites are not endorsements of any products or services on such sites, and no information in such site has been endorsed or approved by BD or incorporated into  this report.
","('Selling_Practices_And_Product_Labeling', 0.6515645384788513)","('Product_Design_And_Lifecycle_Management', 0.08038805425167084)","('Customer_Welfare', 0.07477415353059769)","(['Marketing Practices'], 0.6515645384788513)","('NON-ESG', 0.08038805425167084)","('NON-ESG', 0.07477415353059769)"
Line 2005,"BD and the BD Logo are trademarks of Becton, Dickinson and Company.
","('Customer_Privacy', 0.23995566368103027)","('Competitive_Behavior', 0.12067288905382156)","('Business_Ethics', 0.09916854649782181)","('NON-ESG', 0.23995566368103027)","('NON-ESG', 0.12067288905382156)","('NON-ESG', 0.09916854649782181)"
Line 2006,"All other trademarks are the property of their respective owners.
","('Customer_Privacy', 0.36981719732284546)","('Competitive_Behavior', 0.16144846379756927)","('Business_Ethics', 0.05697965994477272)","('NON-ESG', 0.36981719732284546)","('NON-ESG', 0.16144846379756927)","('NON-ESG', 0.05697965994477272)"
Line 2007,"© 2022 BD.
","('Management_Of_Legal_And_Regulatory_Framework', 0.5099105834960938)","('GHG_Emissions', 0.04569802060723305)","('Waste_And_Hazardous_Materials_Management', 0.0405358262360096)","(['Corporate Governance'], 0.5099105834960938)","('NON-ESG', 0.04569802060723305)","('NON-ESG', 0.0405358262360096)"
Line 2008,"All rights reserved.BD, Franklin Lakes, NJ 07417, U.S.bd.comBD, Franklin Lakes, NJ 07417, U.S.  bd.com","('Management_Of_Legal_And_Regulatory_Framework', 0.28457972407341003)","('Customer_Privacy', 0.08003555983304977)","('Ecological_Impacts', 0.07900156080722809)","('NON-ESG', 0.28457972407341003)","('NON-ESG', 0.08003555983304977)","('NON-ESG', 0.07900156080722809)"
